Citrus Sinensis ID: 025683

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------25
Protein Sequence
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQEALALNPGFA
Secondary Structure (PSIPRED)
cccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHccccccccccccccccccccccccccHHHHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccHHHHcccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEccccccccccccccHHHccHHHcccEcccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHcccccHHHHHHHHcccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHccHHHcccccHHHccccccccccccccccccHHHHHHHHHHHHcccccccc
Coil and Loop (DISEMBL)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKyihsanvihrdlkpsnlllnancdlkicdfglarptsenefMTEYVVTRwyrapelllnssdytaAIDVWSVGCIFMElmnrrplfpgndhVHQMRLLIELlgtptdadlgfvrnEDAKRYIrqlpqhprqslaqvfphvhPLAIDLVDrmltfdpmkritvdealahpylarlhdeadepvcpepfsfdfeqQSLGEEQIKDMIYQEALALNPGFA
Flexible Loop (DISEMBL)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQEALALNPGFA
Low Complexity Region (SEG)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQEALALNPGFA
Disordered region (IsUnstruct)
*****YQIIR***SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFD*************MIYQ**********
Disordered Region (DISOPRED)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQEALALNP***
Disordered Region (DISEMBL)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQEALALNPGFA
Disordered Region (DISPRO)
*DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQEALALN****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQEALALNPGFA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	249	2.2.26 [Sep-21-2011]
Q39023	370	Mitogen-activated protein	yes	no	1.0	0.672	0.847	1e-126
Q84UI5	398	Mitogen-activated protein	yes	no	0.991	0.620	0.814	1e-120
Q06060	394	Mitogen-activated protein	N/A	no	0.991	0.626	0.806	1e-119
Q07176	387	Mitogen-activated protein	N/A	no	0.991	0.638	0.806	1e-118
Q10N20	369	Mitogen-activated protein	no	no	0.995	0.672	0.758	1e-116
A2XFC8	369	Mitogen-activated protein	N/A	no	0.995	0.672	0.758	1e-116
Q40532	393	Mitogen-activated protein	N/A	no	0.991	0.628	0.782	1e-115
Q39026	395	Mitogen-activated protein	no	no	0.991	0.625	0.778	1e-111
Q40353	371	Mitogen-activated protein	N/A	no	0.987	0.663	0.691	1e-104
Q39024	376	Mitogen-activated protein	no	no	0.987	0.654	0.695	1e-104

>sp|Q39023|MPK3_ARATH Mitogen-activated protein kinase 3 OS=Arabidopsis thaliana GN=MPK3 PE=1 SV=2

 Score =  449 bits (1156), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 211/249 (84%), Positives = 231/249 (92%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN+IHRDLKPSNLLLNANCDLKIC
Sbjct: 122 MDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANIIHRDLKPSNLLLNANCDLKIC 181

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSEN+FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR+PLFPG
Sbjct: 182 DFGLARPTSENDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPG 241

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGF  NEDAKRYIRQLP  PRQ LA++F HV+P+AIDLV
Sbjct: 242 KDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYIRQLPNFPRQPLAKLFSHVNPMAIDLV 301

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           DRMLTFDP +RITV++AL H YLA+LHD  DEP+C +PFSF+FEQQ L EEQIK+MIYQE
Sbjct: 302 DRMLTFDPNRRITVEQALNHQYLAKLHDPNDEPICQKPFSFEFEQQPLDEEQIKEMIYQE 361

Query: 241 ALALNPGFA 249
           A+ALNP + 
Sbjct: 362 AIALNPTYG 370

Involved in oxidative stress-mediated signaling cascade to oxidative (such as ozone). Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in hypersensitive response (HR)-mediated signaling cascade. May phosphorylate regulators of WRKY transcription factors. Mediates the phosphorylation of VIP1 and subsequent stress genes transcription in response to Agrobacterium.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q84UI5|MPK1_ORYSJ Mitogen-activated protein kinase 1 OS=Oryza sativa subsp. japonica GN=MPK1 PE=1 SV=1

 Score =  432 bits (1110), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 202/248 (81%), Positives = 227/248 (91%), Gaps = 1/248 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ+LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 151 MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 210

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE +FMTEYVVTRWYRAPELLLNSS+YTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct: 211 DFGLARTTSETDFMTEYVVTRWYRAPELLLNSSEYTAAIDVWSVGCIFMELMDRKPLFPG 270

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQ+RLL+EL+GTP +ADL FV NE+A+RYIRQLP+H RQS  + FPHVHPLAIDLV
Sbjct: 271 RDHVHQLRLLMELIGTPNEADLDFV-NENARRYIRQLPRHARQSFPEKFPHVHPLAIDLV 329

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++MLTFDP +RITV+ ALAHPYLA LHD +DEPVC  PFSFDFEQ +L EEQ+KD+IYQE
Sbjct: 330 EKMLTFDPRQRITVEGALAHPYLASLHDISDEPVCSSPFSFDFEQHALSEEQMKDLIYQE 389

Query: 241 ALALNPGF 248
            LA NP +
Sbjct: 390 GLAFNPDY 397

Involved in sphingolipid elicitor (SE)-dependent defense signaling pathway. Acts downstream of heterotrimeric G protein alpha subunit and small GTPase RAC1. May regulate the expression of various genes involved in biotic and abiotic stress response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q06060|MAPK_PEA Mitogen-activated protein kinase homolog D5 OS=Pisum sativum PE=2 SV=1

 Score =  427 bits (1097), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 200/248 (80%), Positives = 227/248 (91%), Gaps = 1/248 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ+LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 146 MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 205

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE +FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct: 206 DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 265

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQ+RLL+EL+GTP++ADLGF+ NE+AKRYIRQLP + RQS  + FPHVHP AIDLV
Sbjct: 266 RDHVHQLRLLMELIGTPSEADLGFL-NENAKRYIRQLPLYRRQSFQEKFPHVHPEAIDLV 324

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++MLTFDP +RITV+ ALAHPYL  LHD +DEPVC  PFSFDFEQ +L EEQ+K++IY+E
Sbjct: 325 EKMLTFDPRQRITVENALAHPYLTSLHDISDEPVCTTPFSFDFEQHALTEEQMKELIYRE 384

Query: 241 ALALNPGF 248
           ALA NP +
Sbjct: 385 ALAFNPEY 392

Pisum sativum (taxid: 3888)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q07176|MMK1_MEDSA Mitogen-activated protein kinase homolog MMK1 OS=Medicago sativa GN=MMK1 PE=1 SV=1

 Score =  424 bits (1091), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 200/248 (80%), Positives = 227/248 (91%), Gaps = 1/248 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ+LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 139 MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 198

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE +FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct: 199 DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 258

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQ+RLL+EL+GTP++ DLGF+ NE+AKRYIRQLP + RQS  + FPHVHP AIDLV
Sbjct: 259 RDHVHQLRLLMELIGTPSEDDLGFL-NENAKRYIRQLPPYRRQSFQEKFPHVHPEAIDLV 317

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++MLTFDP KRITV++ALAHPYL  LHD +DEPVC  PFSFDFEQ +L EEQ+K++IY+E
Sbjct: 318 EKMLTFDPRKRITVEDALAHPYLTSLHDISDEPVCMTPFSFDFEQHALTEEQMKELIYRE 377

Query: 241 ALALNPGF 248
           ALA NP +
Sbjct: 378 ALAFNPEY 385

May play a role in the mitogenic induction of symbiotic root nodules on Alfalfa by Rhizobium signal molecules.

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q10N20|MPK5_ORYSJ Mitogen-activated protein kinase 5 OS=Oryza sativa subsp. japonica GN=MPK5 PE=1 SV=1

 Score =  418 bits (1075), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 188/248 (75%), Positives = 226/248 (91%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+ IIRSNQ LSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 120 MDTDLHHIIRSNQELSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 179

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARP+SE++ MTEYVVTRWYRAPELLLNS+DY+AAIDVWSVGCIFMEL+NR+PLFPG
Sbjct: 180 DFGLARPSSESDMMTEYVVTRWYRAPELLLNSTDYSAAIDVWSVGCIFMELINRQPLFPG 239

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+HQMRL+ E++GTPTD +LGF+RNEDA++Y+R LPQ+PR++ A +FP V P A+DL+
Sbjct: 240 RDHMHQMRLITEVIGTPTDDELGFIRNEDARKYMRHLPQYPRRTFASMFPRVQPAALDLI 299

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           +RMLTF+P++RITV+EAL HPYL RLHD ADEP+C EPFSFDFEQ++L E+Q+K +I+ E
Sbjct: 300 ERMLTFNPLQRITVEEALDHPYLERLHDIADEPICLEPFSFDFEQKALNEDQMKQLIFNE 359

Query: 241 ALALNPGF 248
           A+ +NP  
Sbjct: 360 AIEMNPNI 367

Involved in disease resistance and abiotic stress tolerance signaling pathways. Acts as a positive regulator of drought, salt and cold tolerance. Negatively modulates pathogenesis-related (PR) gene expression and broad-spectrum disease resistance.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|A2XFC8|MPK5_ORYSI Mitogen-activated protein kinase 5 OS=Oryza sativa subsp. indica GN=MPK5 PE=1 SV=2

 Score =  418 bits (1075), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 188/248 (75%), Positives = 226/248 (91%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+ IIRSNQ LSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 120 MDTDLHHIIRSNQELSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 179

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARP+SE++ MTEYVVTRWYRAPELLLNS+DY+AAIDVWSVGCIFMEL+NR+PLFPG
Sbjct: 180 DFGLARPSSESDMMTEYVVTRWYRAPELLLNSTDYSAAIDVWSVGCIFMELINRQPLFPG 239

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+HQMRL+ E++GTPTD +LGF+RNEDA++Y+R LPQ+PR++ A +FP V P A+DL+
Sbjct: 240 RDHMHQMRLITEVIGTPTDDELGFIRNEDARKYMRHLPQYPRRTFASMFPRVQPAALDLI 299

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           +RMLTF+P++RITV+EAL HPYL RLHD ADEP+C EPFSFDFEQ++L E+Q+K +I+ E
Sbjct: 300 ERMLTFNPLQRITVEEALDHPYLERLHDIADEPICLEPFSFDFEQKALNEDQMKQLIFNE 359

Query: 241 ALALNPGF 248
           A+ +NP  
Sbjct: 360 AIEMNPNI 367

Involved in disease resistance and abiotic stress tolerance signaling pathways.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40532|NTF4_TOBAC Mitogen-activated protein kinase homolog NTF4 OS=Nicotiana tabacum GN=NTF4 PE=2 SV=1

 Score =  415 bits (1067), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 194/248 (78%), Positives = 225/248 (90%), Gaps = 1/248 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 144 MDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 203

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE +FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct: 204 DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 263

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQ+RLL+EL+GTP++A++ F+ NE+AKRYIRQLP + RQS  + FPHV+P AIDLV
Sbjct: 264 RDHVHQLRLLMELIGTPSEAEMEFL-NENAKRYIRQLPLYRRQSFVEKFPHVNPAAIDLV 322

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++MLTFDP +RITV++ALAHPYL  LHD +DEPVC  PF+FDFEQ +L EEQ+K++IY+E
Sbjct: 323 EKMLTFDPRRRITVEDALAHPYLTSLHDISDEPVCMTPFNFDFEQHALTEEQMKELIYRE 382

Query: 241 ALALNPGF 248
            LA NP +
Sbjct: 383 GLAFNPEY 390

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39026|MPK6_ARATH Mitogen-activated protein kinase 6 OS=Arabidopsis thaliana GN=MPK6 PE=1 SV=1

 Score =  400 bits (1027), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 193/248 (77%), Positives = 223/248 (89%), Gaps = 1/248 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ+LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 147 MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 206

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE++FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct: 207 DFGLARVTSESDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 266

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQ+RLL+EL+GTP++ +L    NE+AKRYIRQLP +PRQS+   FP VHPLAIDL+
Sbjct: 267 RDHVHQLRLLMELIGTPSEEEL-EFLNENAKRYIRQLPPYPRQSITDKFPTVHPLAIDLI 325

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++MLTFDP +RITV +ALAHPYL  LHD +DEP C  PF+FDFE  +L EEQ+K++IY+E
Sbjct: 326 EKMLTFDPRRRITVLDALAHPYLNSLHDISDEPECTIPFNFDFENHALSEEQMKELIYRE 385

Query: 241 ALALNPGF 248
           ALA NP +
Sbjct: 386 ALAFNPEY 393

Involved in oxidative stress-mediated signaling cascade (such as ozone). Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in hypersensitive response (HR)-mediated signaling cascade. May phosphorylate regulators of WRKY transcription factors. Phosphorylates 1-aminocyclopropane-1-carboxylic acid synthases (ACS2 and ACS6) and may be involved in the regulation of bacterial elicitor flagellin-induced ethylene production. Regulates locally gene-mediated and basal resitance response to certain pathogens. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40353|MMK2_MEDSA Mitogen-activated protein kinase homolog MMK2 OS=Medicago sativa GN=MMK2 PE=2 SV=1

 Score =  379 bits (972), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 170/246 (69%), Positives = 213/246 (86%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ ++++HC+YF+YQLLRGLKY+HSANV+HRDLKPSNLLLNANCDLKI 
Sbjct: 121 MDTDLHQIIRSNQPMTDDHCRYFVYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 180

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR TSE +FMTEYVVTRWYRAPELLLN SDYTAAID+WSVGCI  E++ R+PLFPG
Sbjct: 181 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSDYTAAIDIWSVGCILGEIVTRQPLFPG 240

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D+VHQ+RL+ EL+G+P DA LGF+R+E+A+RY+RQLPQ+P+Q+ +  FP++ P A+DL+
Sbjct: 241 RDYVHQLRLVTELIGSPDDASLGFLRSENARRYVRQLPQYPKQNFSARFPNMSPGAVDLL 300

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML FDP KRI VDEAL HPY+A LHD  +EPVC  PFSFDFE+    EE IK++I++E
Sbjct: 301 EKMLIFDPSKRIKVDEALCHPYMAPLHDINEEPVCARPFSFDFEEPMFTEEDIKELIWKE 360

Query: 241 ALALNP 246
           ++  NP
Sbjct: 361 SVRFNP 366

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2

 Score =  379 bits (972), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 171/246 (69%), Positives = 211/246 (85%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ L+++HC++FLYQLLRGLKY+HSANV+HRDLKPSNLLLNANCDLK+ 
Sbjct: 127 MDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLG 186

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR  SE +FMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI  E M R PLFPG
Sbjct: 187 DFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTREPLFPG 246

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D+VHQ+RL+ EL+G+P D+ LGF+R+++A+RY+RQLPQ+PRQ+ A  FP++   A+DL+
Sbjct: 247 KDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAGAVDLL 306

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML FDP +RITVDEAL HPYLA LHD  +EPVC  PF+FDFEQ +L EE IK++IY+E
Sbjct: 307 EKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIKELIYRE 366

Query: 241 ALALNP 246
            +  NP
Sbjct: 367 TVKFNP 372

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	249
381355659	375	mitogen-activated protein kinase 1 [Citr	1.0	0.664	1.0	1e-145
122894104	375	mitogen-activated protein kinase [Citrus	1.0	0.664	0.991	1e-144
297746188	329	unnamed protein product [Vitis vinifera]	1.0	0.756	0.887	1e-131
225435179	375	PREDICTED: mitogen-activated protein kin	1.0	0.664	0.887	1e-131
140083554	372	putative MAP kinase 3 [Catharanthus rose	1.0	0.669	0.891	1e-131
255582993	280	big map kinase/bmk, putative [Ricinus co	1.0	0.889	0.883	1e-130
297748119	376	mitogen-activated protein kinase 3 [Goss	1.0	0.662	0.875	1e-129
224106027	371	predicted protein [Populus trichocarpa]	1.0	0.671	0.875	1e-128
359904141	380	mitogen activated protein kinase [Humulu	1.0	0.655	0.859	1e-127
334702083	370	mitogen-activated protein [Cucumis melo]	0.995	0.670	0.883	1e-127

>gi|381355659|gb|AFG26277.1| mitogen-activated protein kinase 1 [Citrus sinensis]

 Score =  521 bits (1342), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 249/249 (100%), Positives = 249/249 (100%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 127 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 186

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG
Sbjct: 187 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 246

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV
Sbjct: 247 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 306

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE
Sbjct: 307 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 366

Query: 241 ALALNPGFA 249
           ALALNPGFA
Sbjct: 367 ALALNPGFA 375

Source: Citrus sinensis

Species: Citrus sinensis

Genus: Citrus

Family: Rutaceae

Order: Sapindales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|122894104|gb|ABM67698.1| mitogen-activated protein kinase [Citrus sinensis]

 Score =  516 bits (1330), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 247/249 (99%), Positives = 248/249 (99%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 127 MDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 186

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG
Sbjct: 187 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 246

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV
Sbjct: 247 KDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 306

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE
Sbjct: 307 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 366

Query: 241 ALALNPGFA 249
           ALALNPGFA
Sbjct: 367 ALALNPGFA 375

Source: Citrus sinensis

Species: Citrus sinensis

Genus: Citrus

Family: Rutaceae

Order: Sapindales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297746188|emb|CBI16244.3| unnamed protein product [Vitis vinifera]

 Score =  473 bits (1218), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 221/249 (88%), Positives = 236/249 (94%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ LSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 81  MDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 140

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPT+ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF G
Sbjct: 141 DFGLARPTAENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFAG 200

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGFVRN+DA+RYI QLPQHPRQ L  VFPH+HPLAIDL+
Sbjct: 201 KDHVHQMRLLTELLGTPTESDLGFVRNDDARRYIMQLPQHPRQPLVNVFPHIHPLAIDLI 260

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           DRMLTFDP KRITV+EALAHPYL+RLHD ADEPVCPEPFSF+FEQQ+L EEQ+KDMIYQE
Sbjct: 261 DRMLTFDPTKRITVEEALAHPYLSRLHDTADEPVCPEPFSFEFEQQALVEEQMKDMIYQE 320

Query: 241 ALALNPGFA 249
           AL  NPG+A
Sbjct: 321 ALFFNPGYA 329

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225435179|ref|XP_002284807.1| PREDICTED: mitogen-activated protein kinase 3 [Vitis vinifera]

 Score =  473 bits (1217), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 221/249 (88%), Positives = 236/249 (94%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ LSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 127 MDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 186

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPT+ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF G
Sbjct: 187 DFGLARPTAENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFAG 246

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGFVRN+DA+RYI QLPQHPRQ L  VFPH+HPLAIDL+
Sbjct: 247 KDHVHQMRLLTELLGTPTESDLGFVRNDDARRYIMQLPQHPRQPLVNVFPHIHPLAIDLI 306

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           DRMLTFDP KRITV+EALAHPYL+RLHD ADEPVCPEPFSF+FEQQ+L EEQ+KDMIYQE
Sbjct: 307 DRMLTFDPTKRITVEEALAHPYLSRLHDTADEPVCPEPFSFEFEQQALVEEQMKDMIYQE 366

Query: 241 ALALNPGFA 249
           AL  NPG+A
Sbjct: 367 ALFFNPGYA 375

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|140083554|gb|ABO84839.1| putative MAP kinase 3 [Catharanthus roseus]

 Score =  472 bits (1214), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 222/249 (89%), Positives = 236/249 (94%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ+LSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 124 MDTDLHQIIRSNQNLSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 183

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARP +ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR+ LFPG
Sbjct: 184 DFGLARPNTENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKTLFPG 243

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGFVRNEDAKRYIRQLP+ PRQ LA VF H++PLAIDL+
Sbjct: 244 RDHVHQMRLLTELLGTPTESDLGFVRNEDAKRYIRQLPRFPRQQLASVFSHINPLAIDLI 303

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           D+MLTFDP KRITVDEALAHPYLARLHD ADEPVC EPFSFDFEQQ+ GEEQIKDMIYQE
Sbjct: 304 DKMLTFDPAKRITVDEALAHPYLARLHDTADEPVCSEPFSFDFEQQAFGEEQIKDMIYQE 363

Query: 241 ALALNPGFA 249
           ALALNP +A
Sbjct: 364 ALALNPEYA 372

Source: Catharanthus roseus

Species: Catharanthus roseus

Genus: Catharanthus

Family: Apocynaceae

Order: Gentianales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255582993|ref|XP_002532266.1| big map kinase/bmk, putative [Ricinus communis] gi|223528054|gb|EEF30132.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  471 bits (1211), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 220/249 (88%), Positives = 239/249 (95%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 32  MDTDLHQIIRSNQSLSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 91

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSENEFMTEYVVTRWYRAPELLLNSS+YTAAIDVWSVGCI+MELMNR+PLFPG
Sbjct: 92  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSEYTAAIDVWSVGCIYMELMNRKPLFPG 151

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGF++NEDAKRYIRQL  +PRQ L +VFPHVHPLAIDL+
Sbjct: 152 KDHVHQMRLLTELLGTPTESDLGFIKNEDAKRYIRQLTPYPRQPLDKVFPHVHPLAIDLI 211

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           DRMLTFDP KRITV+EALAHPY+ARLHD ADEPVCPEPFSFDFEQQ LGEEQ+K+MIY+E
Sbjct: 212 DRMLTFDPTKRITVEEALAHPYVARLHDIADEPVCPEPFSFDFEQQPLGEEQMKEMIYRE 271

Query: 241 ALALNPGFA 249
           A+ALNP +A
Sbjct: 272 AIALNPEYA 280

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297748119|gb|ADI52626.1| mitogen-activated protein kinase 3 [Gossypium hirsutum]

 Score =  466 bits (1200), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 218/249 (87%), Positives = 238/249 (95%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 127 MDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 186

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARP SENEFMTEYVVTRWYRAPE+LLNSSDYTAAIDVWSVGCIFMELMNR+PLFPG
Sbjct: 187 DFGLARPASENEFMTEYVVTRWYRAPEILLNSSDYTAAIDVWSVGCIFMELMNRKPLFPG 246

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           NDHVHQMRLL ELLGTPT++DLGF++NEDA+RYIRQLP +PRQ LA VFPHV+ +A+DL+
Sbjct: 247 NDHVHQMRLLTELLGTPTESDLGFLQNEDARRYIRQLPAYPRQQLANVFPHVNRMALDLI 306

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           DRMLTFDP +RITV+EALAHPYL RLHD ADEPVCPEPF+FDFEQQ LGEEQ+KDM+Y+E
Sbjct: 307 DRMLTFDPTRRITVEEALAHPYLERLHDIADEPVCPEPFNFDFEQQPLGEEQMKDMVYRE 366

Query: 241 ALALNPGFA 249
           ALALNP +A
Sbjct: 367 ALALNPDYA 375

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224106027|ref|XP_002314017.1| predicted protein [Populus trichocarpa] gi|222850425|gb|EEE87972.1| predicted protein [Populus trichocarpa]

 Score =  463 bits (1191), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 218/249 (87%), Positives = 236/249 (94%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ LSEEHCQYFLYQ+LRGLKYIHSAN+IHRDLKPSNLLLNANCDLKIC
Sbjct: 122 MDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANIIHRDLKPSNLLLNANCDLKIC 181

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR+PLFPG
Sbjct: 182 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPG 241

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLG PT++DLGFVRNEDA+RYI+QL  HPR+SLA++FP VHPLAIDL+
Sbjct: 242 KDHVHQMRLLTELLGKPTESDLGFVRNEDARRYIQQLDSHPRRSLAELFPLVHPLAIDLI 301

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           D+MLTFDP KRITV+EALAHPYLARLHD ADEPVC EPFSF+FEQQ L EEQ+KDMIY+E
Sbjct: 302 DKMLTFDPTKRITVEEALAHPYLARLHDIADEPVCLEPFSFEFEQQPLAEEQMKDMIYEE 361

Query: 241 ALALNPGFA 249
           ALALNP +A
Sbjct: 362 ALALNPEYA 370

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359904141|gb|AEV89968.1| mitogen activated protein kinase [Humulus lupulus]

 Score =  461 bits (1187), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 214/249 (85%), Positives = 233/249 (93%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQ LSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 132 MDTDLHQIIRSNQGLSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 191

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPT+ENE+MTEYVVTRWYRAPELLLNSSDYTA+IDVWSVGCIFMELMNR+PLFPG
Sbjct: 192 DFGLARPTAENEYMTEYVVTRWYRAPELLLNSSDYTASIDVWSVGCIFMELMNRKPLFPG 251

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGF+RNEDAKRYIRQLP  PRQ L + FPHVH LAIDL+
Sbjct: 252 KDHVHQMRLLTELLGTPTESDLGFIRNEDAKRYIRQLPSFPRQQLGRAFPHVHTLAIDLI 311

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++MLTFDP +RITV+EALAHPYL RLHD ADEPVCP PFSF+FEQQ L EEQ+KDMIYQE
Sbjct: 312 EKMLTFDPNRRITVEEALAHPYLTRLHDVADEPVCPNPFSFEFEQQPLTEEQMKDMIYQE 371

Query: 241 ALALNPGFA 249
           A+ALNP +A
Sbjct: 372 AIALNPQYA 380

Source: Humulus lupulus

Species: Humulus lupulus

Genus: Humulus

Family: Cannabaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|334702083|gb|AEG89601.1| mitogen-activated protein [Cucumis melo]

 Score =  461 bits (1185), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/249 (88%), Positives = 235/249 (94%), Gaps = 1/249 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRSNQSLSEEHCQYFLYQ+LRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC
Sbjct: 123 MDTDLHQIIRSNQSLSEEHCQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 182

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLARPTSENE MTEYVVTRWYRAPELLLNS DYTAAID+WSVGCIF+ELMNRRPLFPG
Sbjct: 183 DFGLARPTSENECMTEYVVTRWYRAPELLLNS-DYTAAIDIWSVGCIFLELMNRRPLFPG 241

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHVHQMRLL ELLGTPT++DLGF+RNED+KRY+RQLP HPRQ LA VFPHVHPLAIDLV
Sbjct: 242 RDHVHQMRLLTELLGTPTESDLGFIRNEDSKRYLRQLPPHPRQPLATVFPHVHPLAIDLV 301

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           D+MLTFDP KRITV+EALAHPYL RLHD ADEPVC EPFSF+FEQQ L EEQ+K+MIY+E
Sbjct: 302 DKMLTFDPTKRITVEEALAHPYLERLHDTADEPVCSEPFSFEFEQQYLDEEQMKEMIYRE 361

Query: 241 ALALNPGFA 249
           ALALNP FA
Sbjct: 362 ALALNPEFA 370

Source: Cucumis melo

Species: Cucumis melo

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	249
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.995	0.670	0.850	4.4e-116
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.991	0.625	0.782	1.2e-106
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.987	0.654	0.695	4.7e-96
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.987	0.666	0.686	1e-93
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.971	0.666	0.665	5.5e-93
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.987	0.654	0.674	5.5e-93
TAIR|locus:2080457	393	MPK10 "MAP kinase 10" [Arabido	0.983	0.623	0.686	3e-92
TAIR|locus:2062897	372	MPK12 "mitogen-activated prote	0.987	0.661	0.630	9.9e-87
DICTYBASE|DDB_G0286353	529	erkA "mitogen-activated protei	0.987	0.465	0.580	9.7e-80
TAIR|locus:2012808	370	MPK1 "mitogen-activated protei	0.983	0.662	0.587	7.9e-78

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
 Identities = 211/248 (85%), Positives = 231/248 (93%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN+IHRDLKPSNLLLNANCDLKIC
Sbjct:   122 MDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANIIHRDLKPSNLLLNANCDLKIC 181

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLARPTSEN+FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR+PLFPG
Sbjct:   182 DFGLARPTSENDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPG 241

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              DHVHQMRLL ELLGTPT++DLGF  NEDAKRYIRQLP  PRQ LA++F HV+P+AIDLV
Sbjct:   242 KDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYIRQLPNFPRQPLAKLFSHVNPMAIDLV 301

Query:   181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
             DRMLTFDP +RITV++AL H YLA+LHD  DEP+C +PFSF+FEQQ L EEQIK+MIYQE
Sbjct:   302 DRMLTFDPNRRITVEQALNHQYLAKLHDPNDEPICQKPFSFEFEQQPLDEEQIKEMIYQE 361

Query:   241 ALALNPGF 248
             A+ALNP +
Sbjct:   362 AIALNPTY 369

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1055 (376.4 bits), Expect = 1.2e-106, P = 1.2e-106
 Identities = 194/248 (78%), Positives = 225/248 (90%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QIIRSNQ+LSEEHCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct:   147 MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 206

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR TSE++FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM+R+PLFPG
Sbjct:   207 DFGLARVTSESDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 266

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              DHVHQ+RLL+EL+GTP++ +L F+ NE+AKRYIRQLP +PRQS+   FP VHPLAIDL+
Sbjct:   267 RDHVHQLRLLMELIGTPSEEELEFL-NENAKRYIRQLPPYPRQSITDKFPTVHPLAIDLI 325

Query:   181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
             ++MLTFDP +RITV +ALAHPYL  LHD +DEP C  PF+FDFE  +L EEQ+K++IY+E
Sbjct:   326 EKMLTFDPRRRITVLDALAHPYLNSLHDISDEPECTIPFNFDFENHALSEEQMKELIYRE 385

Query:   241 ALALNPGF 248
             ALA NP +
Sbjct:   386 ALAFNPEY 393

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 955 (341.2 bits), Expect = 4.7e-96, P = 4.7e-96
 Identities = 171/246 (69%), Positives = 211/246 (85%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QIIRSNQ L+++HC++FLYQLLRGLKY+HSANV+HRDLKPSNLLLNANCDLK+ 
Sbjct:   127 MDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLG 186

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR  SE +FMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI  E M R PLFPG
Sbjct:   187 DFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTREPLFPG 246

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D+VHQ+RL+ EL+G+P D+ LGF+R+++A+RY+RQLPQ+PRQ+ A  FP++   A+DL+
Sbjct:   247 KDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAGAVDLL 306

Query:   181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
             ++ML FDP +RITVDEAL HPYLA LHD  +EPVC  PF+FDFEQ +L EE IK++IY+E
Sbjct:   307 EKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIKELIYRE 366

Query:   241 ALALNP 246
              +  NP
Sbjct:   367 TVKFNP 372

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 933 (333.5 bits), Expect = 1.0e-93, P = 1.0e-93
 Identities = 169/246 (68%), Positives = 208/246 (84%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+ IIRSNQ L+++H ++FLYQLLRGLKY+HSANV+HRDLKPSNLLLNANCDLKI 
Sbjct:   124 MDTDLHHIIRSNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 183

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR  SE +FMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI  E+M R PLFPG
Sbjct:   184 DFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPG 243

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D+V Q+RL+ EL+G+P D+ LGF+R+++A+RY+RQLPQ+PRQ+ A  FP++   A+DL+
Sbjct:   244 RDYVQQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVNAVDLL 303

Query:   181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
              +ML FDP +RITVDEAL HPYLA LH+  +EPVC  PF FDFEQ SL EE IK++IY+E
Sbjct:   304 QKMLVFDPNRRITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLTEENIKELIYRE 363

Query:   241 ALALNP 246
             ++  NP
Sbjct:   364 SVKFNP 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 926 (331.0 bits), Expect = 5.5e-93, P = 5.5e-93
 Identities = 161/242 (66%), Positives = 208/242 (85%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QIIRS Q+L+++HCQYFLYQ+LRGLKYIHSANV+HRDLKPSNL+LN NCDLKIC
Sbjct:   117 MDTDLHQIIRSTQTLTDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKIC 176

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR ++E E MTEYVVTRWYRAPELLLNSS+YT AID+WSVGCIFME++ R  LFPG
Sbjct:   177 DFGLARTSNETEIMTEYVVTRWYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRETLFPG 236

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D+V Q++L+ ELLG+P D+DL F+R+++A++Y++QLP   +QS  + FP++ P+A+DL 
Sbjct:   237 KDYVQQLKLITELLGSPDDSDLDFLRSDNARKYVKQLPHVQKQSFREKFPNISPMALDLA 296

Query:   181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
             ++ML FDP KRITVDEAL  PYLA LH+  +EP CP PFSFDFE+ +L E+ IK+++++E
Sbjct:   297 EKMLVFDPSKRITVDEALKQPYLASLHEINEEPTCPTPFSFDFEETALDEQDIKELVWRE 356

Query:   241 AL 242
             +L
Sbjct:   357 SL 358

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 926 (331.0 bits), Expect = 5.5e-93, P = 5.5e-93
 Identities = 166/246 (67%), Positives = 210/246 (85%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QIIRSNQSL+++HCQYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN+NCDLKI 
Sbjct:   127 MDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNCDLKIT 186

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR TSE E+MTEYVVTRWYRAPELLLNSS+YT+AIDVWSVGCIF E+M R PLFPG
Sbjct:   187 DFGLARTTSETEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTREPLFPG 246

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D+VHQ++L+ EL+G+P  A L F+R+ +A++Y+++LP+ PRQ+ +  FP ++  AIDL+
Sbjct:   247 KDYVHQLKLITELIGSPDGASLEFLRSANARKYVKELPKFPRQNFSARFPSMNSTAIDLL 306

Query:   181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
             ++ML FDP+KRITV+EAL +PYL+ LHD  DEPVC   FSF FE  S  EE+IK++++ E
Sbjct:   307 EKMLVFDPVKRITVEEALCYPYLSALHDLNDEPVCSNHFSFHFEDPSSTEEEIKELVWLE 366

Query:   241 ALALNP 246
             ++  NP
Sbjct:   367 SVKFNP 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 919 (328.6 bits), Expect = 3.0e-92, P = 3.0e-92
 Identities = 169/246 (68%), Positives = 205/246 (83%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             M+ DLY+ ++S+Q L+++H  YF+YQ+LRGLKYIHSANV+HRDLKPSNLLL+  CDLKIC
Sbjct:   144 MEFDLYRTLKSDQELTKDHGMYFMYQILRGLKYIHSANVLHRDLKPSNLLLSTQCDLKIC 203

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR T E+  MTEYVVTRWYRAPELLL SSDYTAAIDVWSVGCIFME+MNR PLFPG
Sbjct:   204 DFGLARATPESNLMTEYVVTRWYRAPELLLGSSDYTAAIDVWSVGCIFMEIMNREPLFPG 263

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D V+Q+RLL+EL+GTP++ +LG + +E AKRYIRQLP  PRQS  + FP+V PLAIDLV
Sbjct:   264 KDQVNQLRLLLELIGTPSEEELGSL-SEYAKRYIRQLPTLPRQSFTEKFPNVPPLAIDLV 322

Query:   181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
             ++MLTFDP +RI+V EALAHPYL+  HD  DEP C EPF+FD ++    EEQ +++IY E
Sbjct:   323 EKMLTFDPKQRISVKEALAHPYLSSFHDITDEPECSEPFNFDLDEHPFSEEQFRELIYCE 382

Query:   241 ALALNP 246
             ALA NP
Sbjct:   383 ALAFNP 388

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 867 (310.3 bits), Expect = 9.9e-87, P = 9.9e-87
 Identities = 155/246 (63%), Positives = 203/246 (82%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL +I+RSNQ+L+ + C++ +YQLLRGLKY+HSAN++HRDL+PSN+LLN+  +LKI 
Sbjct:   125 MDTDLQRILRSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNVLLNSKNELKIG 184

Query:    61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
             DFGLAR TS+ +FMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI  E+M  +PLFPG
Sbjct:   185 DFGLARTTSDTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTGQPLFPG 244

Query:   121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              D+VHQ+RL+ EL+G+P ++ LGF+R+++A+RY+RQLP++P+Q  A  FP +   AIDL+
Sbjct:   245 KDYVHQLRLITELVGSPDNSSLGFLRSDNARRYVRQLPRYPKQQFAARFPKMPTTAIDLL 304

Query:   181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
             +RML FDP +RI+VDEAL H YL+  HD A EPVC  PFSFDFE  S  EE IK++IY+E
Sbjct:   305 ERMLVFDPNRRISVDEALGHAYLSPHHDVAKEPVCSTPFSFDFEHPSCTEEHIKELIYKE 364

Query:   241 ALALNP 246
             ++  NP
Sbjct:   365 SVKFNP 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

GO:0007243 "intracellular protein kinase cascade" evidence=IC

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0080026 "response to indolebutyric acid stimulus" evidence=IMP

DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 801 (287.0 bits), Expect = 9.7e-80, P = 9.7e-80
 Identities = 144/248 (58%), Positives = 191/248 (77%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QII S Q LS++HCQYF+YQ+LRGLK+IHSANV+HRDLKPSNLL+N +C LKIC
Sbjct:   233 MDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIHSANVLHRDLKPSNLLINEDCLLKIC 292

Query:    61 DFGLAR--PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
             D GLAR    +   FMTEYV TRWYRAPE++L+ + YT AID+WSVGCIF EL+ R+PLF
Sbjct:   293 DLGLARVEDATHQGFMTEYVATRWYRAPEVILSWNKYTKAIDIWSVGCIFAELLGRKPLF 352

Query:   119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
              G D++HQ+ L+IE +G+P++ D+  + NE A+++IR +   P+ + A +FP  +P AID
Sbjct:   353 QGKDYIHQITLIIETIGSPSEEDICNIANEQARQFIRNMGNQPKVNFANMFPKANPDAID 412

Query:   179 LVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIY 238
             L++RML FDP KR+TV+EALAHPY   LHD +DEP+C   FS +FE   L  + +K++IY
Sbjct:   413 LLERMLYFDPSKRLTVEEALAHPYFQSLHDPSDEPICLHKFSLNFEAWDLNRDLLKELIY 472

Query:   239 QEALALNP 246
              E LA +P
Sbjct:   473 NEMLAYHP 480

GO:0030587 "sorocarp development" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2012808 MPK1 "mitogen-activated protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 783 (280.7 bits), Expect = 7.9e-78, P = 7.9e-78
 Identities = 145/247 (58%), Positives = 189/247 (76%)

Query:     1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
             MDTDL+QII+S+Q LS +HCQYFL+QLLRGLKYIHSAN++HRDLKP NLL+NANCDLKIC
Sbjct:   116 MDTDLHQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKIC 175

Query:    61 DFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
             DFGLAR ++ + +FMTEYVVTRWYRAPELLL   +Y  +IDVWSVGCIF EL+ R+P+F 
Sbjct:   176 DFGLARASNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFQ 235

Query:   120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
             G + ++Q++L++ +LG+  + DL F+ N  AKRYIR LP  P  SL++++P  H LAIDL
Sbjct:   236 GTECLNQLKLIVNILGSQREEDLEFIDNPKAKRYIRSLPYSPGMSLSRLYPGAHVLAIDL 295

Query:   180 VDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQ 239
             + +ML FDP KRI+V EAL HPY+A L+D    P    P   D ++  L EE I++M++ 
Sbjct:   296 LQKMLVFDPSKRISVSEALQHPYMAPLYDPNANPPAQVPIDLDVDED-LREEMIREMMWN 354

Query:   240 EALALNP 246
             E L  +P
Sbjct:   355 EMLHYHP 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006635 "fatty acid beta-oxidation" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0008219 "cell death" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009755 "hormone-mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0016558 "protein import into peroxisome matrix" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0009734 "auxin mediated signaling pathway" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.8064	0.9919	0.6269	N/A	no
Q84UI5	MPK1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8145	0.9919	0.6206	yes	no
A2XFC8	MPK5_ORYSI	2, ., 7, ., 1, 1, ., 2, 4	0.7580	0.9959	0.6720	N/A	no
P21708	MK03_RAT	2, ., 7, ., 1, 1, ., 2, 4	0.5498	0.9879	0.6473	yes	no
P27361	MK03_HUMAN	2, ., 7, ., 1, 1, ., 2, 4	0.5458	0.9879	0.6490	yes	no
Q63844	MK03_MOUSE	2, ., 7, ., 1, 1, ., 2, 4	0.5498	0.9879	0.6473	yes	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7822	0.9919	0.6284	N/A	no
P0CP66	CPK1_CRYNJ	2, ., 7, ., 1, 1, ., 2, 4	0.5393	0.9638	0.6557	yes	no
Q39023	MPK3_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8473	1.0	0.6729	yes	no
O61443	MK14B_DROME	2, ., 7, ., 1, 1, ., 2, 4	0.5180	0.9839	0.6712	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.8064	0.9919	0.6382	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.946
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	249
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-178
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-154
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-137
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-121
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-121
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-115
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-101
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-100
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-97
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-88
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-86
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-86
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-85
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-84
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-84
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-80
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-77
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-74
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-74
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-73
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-71
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-70
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-67
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-66
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-66
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-65
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-62
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-62
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-61
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-61
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-61
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-58
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-57
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-57
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-57
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-56
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-56
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-56
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-56
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-56
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-56
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-55
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-53
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-53
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-50
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-50
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-50
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-48
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-47
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-46
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-44
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-44
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-44
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-43
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-38
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-37
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-34
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-32
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-31
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-29
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-28
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-24
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-21
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-20
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-20
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-18
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-17
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-17
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-17
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-16
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-16
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-16
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	9e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-15
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-15
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-13
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-11
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-11
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-11
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-09
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	2e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	8e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.001
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.001

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  493 bits (1270), Expect = e-178
 Identities = 187/247 (75%), Positives = 219/247 (88%), Gaps = 1/247 (0%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MDTDL+QIIRS+Q+LS++HCQYFLYQLLRGLKYIHSANV+HRDLKPSNLLLNANCDLKIC
Sbjct: 91  MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 150

Query: 61  DFGLARPTSEN-EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLAR TSE  +FMTEYVVTRWYRAPELLLN S+YT AIDVWSVGCIF EL+ R+PLFP
Sbjct: 151 DFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G D+VHQ++L+ ELLG+P++ DLGF+RNE A+RYIR LP  PRQS A++FPH +PLAIDL
Sbjct: 211 GKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDL 270

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQ 239
           +++ML FDP KRITV+EALAHPYLA LHD +DEPVC  PFSFDFE+ +L EE IK++IY 
Sbjct: 271 LEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTEEDIKELIYN 330

Query: 240 EALALNP 246
           E LA +P
Sbjct: 331 EMLAYHP 337

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  431 bits (1112), Expect = e-154
 Identities = 152/245 (62%), Positives = 199/245 (81%), Gaps = 5/245 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDL+++I+S Q L+++H QYFLYQ+LRGLKY+HSANVIHRDLKPSN+L+N+NCDLKIC
Sbjct: 86  METDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKIC 145

Query: 61  DFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR       E  F+TEYVVTRWYRAPELLL+SS YT AID+WSVGCIF EL+ R+P
Sbjct: 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           LFPG D++ Q+ L++E+LGTP++ DL F+ +E A+ Y++ LP+ P++ L+++FP   P A
Sbjct: 206 LFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEA 265

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSF-DFEQQSLGEEQIKD 235
           IDL+++ML FDP KRIT DEALAHPYLA+LHD  DEPV   PF F  F+   L EE++K+
Sbjct: 266 IDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEEELKE 325

Query: 236 MIYQE 240
           +IY+E
Sbjct: 326 LIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  388 bits (999), Expect = e-137
 Identities = 146/247 (59%), Positives = 191/247 (77%), Gaps = 6/247 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY++I++ Q LS +H QYFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN NCDLKIC
Sbjct: 90  METDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKIC 148

Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR          F+TEYV TRWYRAPE++LNS  YT AID+WSVGCI  E+++ RP
Sbjct: 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           LFPG D++HQ+ L++ +LGTP+  DL  + +  A+ YI+ LP  P+    ++FP+  P A
Sbjct: 209 LFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKA 268

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFE-QQSLGEEQIKD 235
           +DL+D+MLTF+P KRITV+EALAHPYL + HD +DEPV  EPF FDFE    L +E++K+
Sbjct: 269 LDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKE 328

Query: 236 MIYQEAL 242
           +I++E +
Sbjct: 329 LIFEEIM 335

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  349 bits (896), Expect = e-121
 Identities = 140/245 (57%), Positives = 183/245 (74%), Gaps = 6/245 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+ DL+QIIRS Q L++ H Q F+YQ+L GLKYIHSANV+HRDLKP NLL+NA+C+LKIC
Sbjct: 88  MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKIC 147

Query: 61  DFGLARPTSEN-----EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           DFGLAR  SEN      FMTEYV TRWYRAPE++L+   YT AIDVWSVGCI  EL+ R+
Sbjct: 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
           P+F G D+V Q+  ++++LGTP +  L  + +  A+ YIR LP  P++    +FP+ +PL
Sbjct: 208 PVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPL 267

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKD 235
           A+DL++++L FDP KRI+V+EAL HPYLA  HD  DEPVC +PF F FE +   EE ++D
Sbjct: 268 ALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESEDSMEE-LRD 326

Query: 236 MIYQE 240
           MI +E
Sbjct: 327 MIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  348 bits (896), Expect = e-121
 Identities = 139/245 (56%), Positives = 186/245 (75%), Gaps = 5/245 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M++DL+ II S+Q L+EEH +YFLYQLLRGLKYIHSANVIHRDLKPSNLL+N +C+L+I 
Sbjct: 90  MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIG 149

Query: 61  DFGLAR-----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           DFG+AR     PT    FMTEYV TRWYRAPELLL+  +YT AID+WSVGCIF E++ RR
Sbjct: 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
            LFPG ++VHQ++L++ +LG+P++  L  + ++  ++YI+ LP+      +++FP   P 
Sbjct: 210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPE 269

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKD 235
           A+DL+ +ML FDP +RITV++AL HP+LA+ HD  DEP CP PF FDFE   L  EQ+K+
Sbjct: 270 ALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELSREQLKE 329

Query: 236 MIYQE 240
            I +E
Sbjct: 330 AIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  333 bits (856), Expect = e-115
 Identities = 126/246 (51%), Positives = 173/246 (70%), Gaps = 4/246 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q LS++H Q+ +YQ+LRGLKYIHSA +IHRDLKPSN+ +N +C+LKI 
Sbjct: 102 MGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 160

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  + LFPG
Sbjct: 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +DH+ Q++ ++ L+GTP +  L  + +E A+ YI+ LPQ P++   +VF   +PLAIDL+
Sbjct: 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLL 278

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  DP KRIT  EALAHPYLA  HD  DEPV P P+   FE + L  ++ K+++Y+E
Sbjct: 279 EKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP-PYDQSFESRDLTVDEWKELVYKE 337

Query: 241 ALALNP 246
            +   P
Sbjct: 338 IMNFKP 343

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  296 bits (761), Expect = e-101
 Identities = 113/247 (45%), Positives = 168/247 (68%), Gaps = 8/247 (3%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDL+ +IR+N  L + H +Y +YQLL+ LKYIHS NVIHRDLKPSN+LLN++C +K+ 
Sbjct: 91  METDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLA 149

Query: 61  DFGLARPTSE------NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           DFGLAR  SE      N  +T+YV TRWYRAPE+LL S+ YT  +D+WSVGCI  E++  
Sbjct: 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP 174
           +PLFPG   ++Q+  +IE++G P+  D+  +++  A   +  LP  PR+ L ++ P    
Sbjct: 210 KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASD 269

Query: 175 LAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDF-EQQSLGEEQI 233
            A+DL+ ++L F+P KR+T +EAL HPY+A+ H+ +DEPV P P +    +   L   + 
Sbjct: 270 DALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAEY 329

Query: 234 KDMIYQE 240
           ++ +Y+E
Sbjct: 330 RNKLYEE 336

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  296 bits (759), Expect = e-100
 Identities = 128/254 (50%), Positives = 175/254 (68%), Gaps = 9/254 (3%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M++DL+Q+I++N  L+ EH Q+FLYQLLR LKYIH+ANV HRDLKP N+L NA+C LKIC
Sbjct: 86  MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKIC 145

Query: 61  DFGLARP----TSENEFMTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMNRR 115
           DFGLAR     T    F T+YV TRWYRAPEL  +  S YT AID+WS+GCIF E++  +
Sbjct: 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
           PLFPG + VHQ+ L+ +LLGTP+   +  VRNE A+RY+  + +      +Q FP+  PL
Sbjct: 206 PLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPL 265

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFS---FDFEQQSLGEEQ 232
           A+ L++R+L FDP  R T +EALA PY   L     EP   +P +   F+FE++ L +E 
Sbjct: 266 ALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSA-QPITKLEFEFERRRLTKED 324

Query: 233 IKDMIYQEALALNP 246
           ++++IY+E L  +P
Sbjct: 325 VRELIYREILEYHP 338

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  287 bits (736), Expect = 2e-97
 Identities = 121/240 (50%), Positives = 166/240 (69%), Gaps = 3/240 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           + TDL++++ S + L ++  QYFLYQ+LRGLKY+HSA V+HRDLKPSN+L+N NCDLKIC
Sbjct: 92  LGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKIC 150

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR   ++  MT YV TR+YRAPE++L    Y   +D+WS GCIF E++  +PLFPG
Sbjct: 151 DFGLARI--QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DHV+Q  ++ +LLGTP D  +  + +E+  R+++ LP+      ++ F +  P AIDL+
Sbjct: 209 KDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLL 268

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML FDP KRI+  EALAHPYLA  HD  DEPV  E F + F    L  +  K M+Y E
Sbjct: 269 EKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  263 bits (674), Expect = 8e-88
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 104 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 162

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 163 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 280

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 281 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 339

Query: 241 ALALNP 246
            ++  P
Sbjct: 340 VISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  257 bits (659), Expect = 3e-86
 Identities = 100/205 (48%), Positives = 131/205 (63%), Gaps = 3/205 (1%)

Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           MDTDLY++I+  Q  L E   + +LYQLL+GL + HS  ++HRDLKP NLL+N    LK+
Sbjct: 80  MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKL 139

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR   S     T YVVTRWYRAPELLL    Y+  +D+WSVGCIF EL++RRPLF
Sbjct: 140 ADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG   + Q+  +   LGTP         +  A+ Y    P+     L ++FP+  P A+D
Sbjct: 200 PGKSEIDQLFKIFRTLGTPDPEVWPKFTS-LARNYKFSFPKKAGMPLPKLFPNASPQALD 258

Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           L+ +ML +DP KRIT ++ALAHPY 
Sbjct: 259 LLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  259 bits (663), Expect = 3e-86
 Identities = 120/246 (48%), Positives = 169/246 (68%), Gaps = 4/246 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q LS+EH Q+ +YQLLRGLKYIHSA +IHRDLKPSN+ +N +C+L+I 
Sbjct: 102 MGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 160

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR   +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  + LFPG
Sbjct: 161 DFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           ND++ Q++ ++E++GTP+   L  + +E A++YI+ LP  P+Q L ++F   +PLAIDL+
Sbjct: 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLL 278

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRI+  EALAHPY ++ HD  DEP   EP+    E +    E+ K++ Y+E
Sbjct: 279 EKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEA-EPYDESPENKERTIEEWKELTYEE 337

Query: 241 ALALNP 246
             +  P
Sbjct: 338 VSSFKP 343

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  254 bits (651), Expect = 5e-85
 Identities = 90/206 (43%), Positives = 124/206 (60%), Gaps = 6/206 (2%)

Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
            D DL + +      LS    +  +YQLLRGL Y HS  ++HRDLKP N+L+N +  LK+
Sbjct: 80  CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKL 139

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR         T  VVT WYRAPE+LL S  Y+ A+D+WSVGCIF E++  +PLF
Sbjct: 140 ADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199

Query: 119 PGNDHVHQMRLLIELLGTPTDAD-LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+  + Q+  + ++LGTPT+    G  +      Y    P+ P + L +V P + P  I
Sbjct: 200 PGDSEIDQLFKIFQILGTPTEESWPGVTKL---PDYKPTFPKFPPKDLEKVLPRLDPEGI 256

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYL 203
           DL+ +ML ++P KRI+  EAL HPY 
Sbjct: 257 DLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  255 bits (653), Expect = 3e-84
 Identities = 114/263 (43%), Positives = 160/263 (60%), Gaps = 25/263 (9%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M +DL++II S Q LS +H + FLYQ+LRGLKY+HSA ++HRD+KP NLL+N+NC LKIC
Sbjct: 86  MQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKIC 145

Query: 61  DFGLAR--PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFGLAR     E++ MT+ VVT++YRAPE+L+ S  YT+A+D+WSVGCIF EL+ RR LF
Sbjct: 146 DFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP--RQSLAQVFPHVHPLA 176
                + Q+ L+ +LLGTP+   +     E A+ +I + P  P     L  +       A
Sbjct: 206 QAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILRGPHKPPSLPVLYTLSSQATHEA 264

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYL--------------------ARLHDEADEPVCP 216
           + L+ RML FDP KRI+  +ALAHPYL                     R++    EP   
Sbjct: 265 VHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSAN 324

Query: 217 EPFSFDFEQQSLGEEQIKDMIYQ 239
            PF  ++E+      Q+K+ ++Q
Sbjct: 325 PPFDDEYEKNLTSVRQVKEELHQ 347

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  253 bits (648), Expect = 6e-84
 Identities = 110/246 (44%), Positives = 167/246 (67%), Gaps = 4/246 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL ++++ ++ LSE+  Q+ +YQ+L+GLKYIH+A +IHRDLKP NL +N +C+LKI 
Sbjct: 102 MGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKIL 160

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T     MT YVVTRWYRAPE++LN   YT  +D+WSVGCI  E++  +PLF G
Sbjct: 161 DFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +DH+ Q+  ++++ GTP+   +  +++EDAK Y+++LP+  ++    + P+ +PLA++++
Sbjct: 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVL 278

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D   RIT  EALAHPY    HD  DE   P P+   F++     E+ K + + E
Sbjct: 279 EKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP-PYDDSFDEVDQSLEEWKRLTFTE 337

Query: 241 ALALNP 246
            L+  P
Sbjct: 338 ILSFQP 343

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  245 bits (627), Expect = 1e-80
 Identities = 108/246 (43%), Positives = 156/246 (63%), Gaps = 5/246 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL +I+     LSE+  QY +YQ+L GLKYIHSA +IHRDLKP NL +N +C+LKI 
Sbjct: 102 MQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKIL 159

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTRWYRAPE++LN   Y   +D+WSVGCI  E++  + LF G
Sbjct: 160 DFGLAR--HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D++ Q+  ++++ G P    +  + ++ AK YI+ LP++PR+  + +FP   P A+DL+
Sbjct: 218 KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLL 277

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KR+T  EAL HPY     D  +E    +P+    E + L  ++ K  IY+E
Sbjct: 278 EKMLELDVDKRLTATEALEHPYFDSFRDADEETE-QQPYDDSLENEKLSVDEWKKHIYKE 336

Query: 241 ALALNP 246
             + +P
Sbjct: 337 VKSFSP 342

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  235 bits (602), Expect = 1e-77
 Identities = 83/207 (40%), Positives = 127/207 (61%), Gaps = 7/207 (3%)

Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           MD DL  ++ S +   +E   + ++ QLL GL+Y+HS  ++HRD+K SN+L+N +  LK+
Sbjct: 82  MDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKL 141

Query: 60  CDFGLARPTS--ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
            DFGLARP +   +   T  V+T WYR PELLL ++ Y   +D+WSVGCI  EL   +P+
Sbjct: 142 ADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI 201

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPHVH-PL 175
           F G+  + Q+  + EL G+PTD +   V      +    +  +  ++ L + F H+  P 
Sbjct: 202 FQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL--KPKKPYKRRLREFFKHLIDPS 259

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPY 202
           A+DL+D++LT DP KRI+ D+AL H Y
Sbjct: 260 ALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  227 bits (581), Expect = 3e-74
 Identities = 90/207 (43%), Positives = 125/207 (60%), Gaps = 11/207 (5%)

Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+TDL ++I+     L+    + ++   LRGL+Y+HS  ++HRDLKP+NLL+ ++  LK+
Sbjct: 84  METDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKL 143

Query: 60  CDFGLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR   S N  MT  VVTRWYRAPELL  +  Y   +D+WSVGCIF EL+ R P  
Sbjct: 144 ADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR---YIRQLPQHPRQSLAQVFPHVHPL 175
           PG+  + Q+  + E LGTPT+ +              Y+ +    P   L Q+FP     
Sbjct: 204 PGDSDIDQLGKIFEALGTPTEEN-----WPGVTSLPDYV-EFKPFPPTPLKQIFPAASDD 257

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPY 202
           A+DL+ R+LT +P KRIT  +AL HPY
Sbjct: 258 ALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  228 bits (582), Expect = 5e-74
 Identities = 107/246 (43%), Positives = 156/246 (63%), Gaps = 8/246 (3%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKI 59
           M+TDL  ++     LSEEH + F+YQLLRGLKYIHSANV+HRDLKP+N+ +N  +  LKI
Sbjct: 98  METDLANVLEQGP-LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156

Query: 60  CDFGLARPT----SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR      S   +++E +VT+WYR+P LLL+ ++YT AID+W+ GCIF E++  +
Sbjct: 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
           PLF G   + QM+L++E +    + D   + N     ++R     PR+ L  + P V+P 
Sbjct: 217 PLFAGAHELEQMQLILESVPVVREEDRNELLNVIPS-FVRNDGGEPRRPLRDLLPGVNPE 275

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFE-QQSLGEEQIK 234
           A+D ++++LTF+PM R+T +EAL HPY++      DEPV   PF  + E    L   +I 
Sbjct: 276 ALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIH 335

Query: 235 DMIYQE 240
            +IY  
Sbjct: 336 SIIYNW 341

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  225 bits (576), Expect = 8e-73
 Identities = 107/258 (41%), Positives = 153/258 (59%), Gaps = 26/258 (10%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I     L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 103 MDANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 160

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPG 219

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVR--NEDAKRYIRQLPQHPRQSLAQVFP-------- 170
            DH+ Q   +IE LGTP+D    F+       + Y+   P++   S  ++FP        
Sbjct: 220 TDHIDQWNKIIEQLGTPSDE---FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDS 276

Query: 171 --HVH---PLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPF--SFD 222
             H       A DL+ +ML  DP KRI+VD+AL HPY+   +D ++ E   P P+  S D
Sbjct: 277 ESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEAPPPAPYDHSID 336

Query: 223 FEQQSLGEEQIKDMIYQE 240
             + ++  E+ K++IY+E
Sbjct: 337 EREHTV--EEWKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  220 bits (563), Expect = 1e-71
 Identities = 91/215 (42%), Positives = 125/215 (58%), Gaps = 23/215 (10%)

Query: 1   MDTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           M+ +LYQ+++  +    SE   +  +YQ+L+GL +IH     HRDLKP NLL++    +K
Sbjct: 80  MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVK 139

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           I DFGLAR        T+YV TRWYRAPE+LL S+ Y++ +D+W++GCI  EL   RPLF
Sbjct: 140 IADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199

Query: 119 PGNDHVHQMRLLIELLGTPTDAD----------LGFVRNEDAKRYIRQLPQHPRQSLAQV 168
           PG+  + Q+  +  +LGTPT  D          LGF           + PQ    SL Q+
Sbjct: 200 PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF-----------RFPQFAPTSLHQL 248

Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P+  P AIDL+  ML +DP KR T  +AL HPY 
Sbjct: 249 IPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  215 bits (550), Expect = 4e-70
 Identities = 69/200 (34%), Positives = 108/200 (54%), Gaps = 28/200 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+ +++    LSE+  +++L Q+L  L+Y+HS  ++HRDLKP N+LL+ +  +K+ DFG
Sbjct: 83  DLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFG 142

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           LAR     E +T +V T  Y APE+LL    Y  A+D+WS+G I  EL+  +P FPG+D 
Sbjct: 143 LARQLDPGEKLTTFVGTPEYMAPEVLLGKG-YGKAVDIWSLGVILYELLTGKPPFPGDDQ 201

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           + ++    + +G P                                  + P A DL+ ++
Sbjct: 202 LLEL---FKKIGKPKPPFPPP------------------------EWDISPEAKDLIRKL 234

Query: 184 LTFDPMKRITVDEALAHPYL 203
           L  DP KR+T +EAL HP+ 
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  209 bits (535), Expect = 2e-67
 Identities = 87/207 (42%), Positives = 127/207 (61%), Gaps = 6/207 (2%)

Query: 1   MDTDLYQIIR-SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M +DL +++R   + L E   + ++  LL+G+ Y+H+  ++HRDLKP+NLL++A+  LKI
Sbjct: 81  MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKI 140

Query: 60  CDFGLARPTSENE--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
            DFGLAR  SE E    +  V TRWYRAPELL  +  Y   +D+W+VGCIF EL+N  PL
Sbjct: 141 ADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPL 200

Query: 118 FPGNDHVHQMRLLIELLGTPTDAD-LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           FPG + + Q+ ++   LGTP +    G     D  + I   P+     L ++FP   P A
Sbjct: 201 FPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK-ITF-PESKPIPLEEIFPDASPEA 258

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYL 203
           +DL+  +L +DP KR++  EAL HPY 
Sbjct: 259 LDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  206 bits (527), Expect = 1e-66
 Identities = 72/201 (35%), Positives = 105/201 (52%), Gaps = 25/201 (12%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +     LSE+  +    Q+LRGL+Y+HS  +IHRDLKP N+LL+ N  +KI DFG
Sbjct: 84  DLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFG 143

Query: 64  LAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA+     +  +T +V T WY APE+LL  + Y   +DVWS+G I  EL+  +P F G +
Sbjct: 144 LAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGEN 203

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
            + Q++L+  +LG P + D     +                            A DL+ +
Sbjct: 204 ILDQLQLIRRILGPPLEFDEPKWSS------------------------GSEEAKDLIKK 239

Query: 183 MLTFDPMKRITVDEALAHPYL 203
            L  DP KR T +E L HP+ 
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  205 bits (525), Expect = 7e-66
 Identities = 90/193 (46%), Positives = 122/193 (63%), Gaps = 8/193 (4%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-E 72
             SE  C   + QLL G+ ++H   ++HRDLK SNLLLN    LKICDFGLAR      +
Sbjct: 104 LQSEVKC--LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161

Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIE 132
             T+ VVT WYRAPELLL + +Y+ AID+WSVGCIF EL+ ++PLFPG   + Q+  + +
Sbjct: 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221

Query: 133 LLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP--LAIDLVDRMLTFDPM 189
           LLGTPT+    GF     AK+      ++P   L + FP +       DL++R+LT+DP 
Sbjct: 222 LLGTPTEKIWPGFSELPGAKKKTF--TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279

Query: 190 KRITVDEALAHPY 202
           KRI+ ++AL HPY
Sbjct: 280 KRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  202 bits (516), Expect = 9e-65
 Identities = 90/207 (43%), Positives = 125/207 (60%), Gaps = 8/207 (3%)

Query: 1   MDTDL--YQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL 57
           MD DL  Y      + +L     + F YQLL+G+ + H   V+HRDLKP NLL+N   +L
Sbjct: 80  MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGEL 139

Query: 58  KICDFGLARP--TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           K+ DFGLAR      N F  E VVT WYRAP++LL S  Y+ +ID+WSVGCI  E++  R
Sbjct: 140 KLADFGLARAFGIPVNTFSNE-VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
           PLFPG ++  Q+  +  ++GTPT++    +       Y    P++P Q L Q+FPH  PL
Sbjct: 199 PLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LPEYKPTFPRYPPQDLQQLFPHADPL 256

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPY 202
            IDL+ R+L  +P  RI+  +AL HP+
Sbjct: 257 GIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  197 bits (503), Expect = 2e-62
 Identities = 81/216 (37%), Positives = 120/216 (55%), Gaps = 16/216 (7%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQY--FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           MD DL  ++  N S+     Q   ++ QLL G+ Y+H  +++HRD+K +N+L++    LK
Sbjct: 97  MDHDLSGLL-ENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILK 155

Query: 59  ICDFGLARPTSENEFM------------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
           I DFGLARP                   T  VVTRWYR PELLL    YT A+D+W +GC
Sbjct: 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGC 215

Query: 107 IFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA 166
           +F E+  RRP+  G   + Q+ L+ +L GTPT+      R+      +     +PR +L 
Sbjct: 216 VFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPR-TLE 274

Query: 167 QVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPY 202
           + F  + P  +DL+ ++L+ DP KR+T  +AL HPY
Sbjct: 275 ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  197 bits (502), Expect = 8e-62
 Identities = 109/256 (42%), Positives = 154/256 (60%), Gaps = 19/256 (7%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I  +  L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 108 MDANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 165

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    N  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  EL+    +F G
Sbjct: 166 DFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQG 224

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHP----- 174
            DH+ Q   +IE LGTP+ A+         + Y+   PQ+P  S  ++FP  + P     
Sbjct: 225 TDHIDQWNKVIEQLGTPS-AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESER 283

Query: 175 ------LAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD--EADEPVCPEPFSFDFEQQ 226
                  A DL+ +ML  DP KRI+VDEAL HPY+   +D  EA+ P  P+ +    E++
Sbjct: 284 DKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPP-PQIYDAQLEER 342

Query: 227 SLGEEQIKDMIYQEAL 242
               E+ K++IY+E +
Sbjct: 343 EHAIEEWKELIYKEVM 358

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  194 bits (496), Expect = 1e-61
 Identities = 91/210 (43%), Positives = 124/210 (59%), Gaps = 13/210 (6%)

Query: 1   MDTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           +D DL + + S     L     + +LYQLL+G+ Y HS  V+HRDLKP NLL++    LK
Sbjct: 80  LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALK 139

Query: 59  ICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           + DFGLAR    P       T  VVT WYRAPE+LL S  Y+  +D+WS+GCIF E++NR
Sbjct: 140 LADFGLARAFGVPVRT---YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR 196

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
           RPLFPG+  + Q+  +   LGTP +    G     D   Y    P+  RQ L++V P++ 
Sbjct: 197 RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD---YKPTFPKWARQDLSKVVPNLD 253

Query: 174 PLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
              +DL+ +ML +DP KRI+   AL HPY 
Sbjct: 254 EDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  194 bits (495), Expect = 2e-61
 Identities = 85/205 (41%), Positives = 120/205 (58%), Gaps = 7/205 (3%)

Query: 1   MDTDLYQIIR--SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           +D DL   +       L  E  +  + QLLRG+ ++HS  ++HRDLKP N+L+ ++  +K
Sbjct: 88  VDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVK 147

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           I DFGLAR  S    +T  VVT WYRAPE+LL SS Y   +D+WSVGCIF EL  RRPLF
Sbjct: 148 IADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLF 206

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G     Q+  + +++G P++ +  + RN    R     P +  +S     P +    +D
Sbjct: 207 RGTSEADQLDKIFDVIGLPSEEE--WPRNVSLPR--SSFPSYTPRSFKSFVPEICEEGLD 262

Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           L+ +MLTF+P KRI+  EAL HPY 
Sbjct: 263 LLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  194 bits (494), Expect = 5e-61
 Identities = 89/204 (43%), Positives = 122/204 (59%), Gaps = 5/204 (2%)

Query: 2   DTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           + DL  ++ +  +  SE   +  + QLLRGL+Y+H   +IHRDLK SNLLL     LKI 
Sbjct: 91  EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIA 150

Query: 61  DFGLARPTSE-NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLAR      + MT  VVT WYRAPELLL  + YT AID+W+VGCI  EL+  +PL P
Sbjct: 151 DFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210

Query: 120 GNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           G   + Q+ L+I+LLGTP ++   GF       ++   LP+ P  +L   FP +    + 
Sbjct: 211 GKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT--LPKQPYNNLKHKFPWLSEAGLR 268

Query: 179 LVDRMLTFDPMKRITVDEALAHPY 202
           L++ +L +DP KR T +EAL   Y
Sbjct: 269 LLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  186 bits (475), Expect = 2e-58
 Identities = 74/203 (36%), Positives = 120/203 (59%), Gaps = 4/203 (1%)

Query: 1   MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           MD +LY++I+   + L E+  + ++YQLL+ L ++H   + HRD+KP N+L+  +  LK+
Sbjct: 82  MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI-LKL 140

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG  R        TEY+ TRWYRAPE LL    Y   +D+W+VGC+F E+++  PLFP
Sbjct: 141 ADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G + + Q+  + ++LGTP DA++     +          +     L ++ P+     +DL
Sbjct: 201 GTNELDQIAKIHDVLGTP-DAEVLKKFRKSRHMNYNFPSKKG-TGLRKLLPNASAEGLDL 258

Query: 180 VDRMLTFDPMKRITVDEALAHPY 202
           + ++L +DP +RIT  +AL HPY
Sbjct: 259 LKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  184 bits (470), Expect = 1e-57
 Identities = 77/205 (37%), Positives = 117/205 (57%), Gaps = 9/205 (4%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  +  S   L  +  + +++QLL+ + Y HS N+IHRD+KP N+L++ +  LK+CDFG 
Sbjct: 87  LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGF 146

Query: 65  ARPTSEN--EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           AR         +T+YV TRWYRAPELL+  ++Y   +DVW++GCI  EL++  PLFPG+ 
Sbjct: 147 ARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206

Query: 123 HVHQMRLLIELLGTPTDADLG-FVRNEDAKRY--IRQLPQHPRQSLAQVFP-HVHPLAID 178
            + Q+ L+ + LG    +    F  N    R+  +        +SL + +P  V   A+D
Sbjct: 207 DIDQLYLIQKCLGPLPPSHQELFSSN---PRFAGVAFPEPSQPESLERRYPGKVSSPALD 263

Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            +   L  DP +R+T DE L HPY 
Sbjct: 264 FLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  183 bits (467), Expect = 3e-57
 Identities = 89/210 (42%), Positives = 123/210 (58%), Gaps = 10/210 (4%)

Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +DTDL Q +      LS  + + FL+QLLRGL Y H   V+HRDLKP NLL++   +LK+
Sbjct: 85  LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKL 144

Query: 60  CDFGLARPTS--ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
            DFGLAR  S     +  E VVT WYR P++LL S++Y+ ++D+W VGCIF E+   RPL
Sbjct: 145 ADFGLARAKSVPSKTYSNE-VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203

Query: 118 FPG-NDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHV--H 173
           FPG  D   Q+  +  +LGTPT+    G   N + K Y    P +P + L    P +   
Sbjct: 204 FPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRI 261

Query: 174 PLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
           P   +L  + L ++P KRI+  EA+ HPY 
Sbjct: 262 PHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  184 bits (470), Expect = 3e-57
 Identities = 83/217 (38%), Positives = 119/217 (54%), Gaps = 18/217 (8%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M +DL +++     L+E   +  L Q+L GL  +H    +HRDL P+N+ +N+    KI 
Sbjct: 102 MASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA 161

Query: 61  DFGLAR---------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 105
           DFGLAR                    E MT  VVT WYRAPELL+ +  Y  A+D+WSVG
Sbjct: 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221

Query: 106 CIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL 165
           CIF EL+  +PLFPG + + Q+  + ELLGTP + +    +      Y    P+ P + L
Sbjct: 222 CIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKK--LPLYTEFTPRKP-KDL 278

Query: 166 AQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPY 202
             +FP+    AIDL+  +L  +P++RI+  EAL H Y
Sbjct: 279 KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315

Length = 335

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  182 bits (464), Expect = 1e-56
 Identities = 86/209 (41%), Positives = 126/209 (60%), Gaps = 10/209 (4%)

Query: 1   MDTDLYQIIRSN-----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC 55
           +D+DL + + SN     + L  +  + F+YQLL+G+ + H   V+HRDLKP NLL++   
Sbjct: 88  LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQK 147

Query: 56  D-LKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             LKI D GL R  +   +  T  +VT WYRAPE+LL S+ Y+  +D+WSVGCIF E+  
Sbjct: 148 GLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
           ++PLFPG+  + Q+  + +LLGTPT+     V      R   + PQ   Q L++  P + 
Sbjct: 208 KQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK---LRDWHEFPQWKPQDLSRAVPDLS 264

Query: 174 PLAIDLVDRMLTFDPMKRITVDEALAHPY 202
           P  +DL+ +ML +DP KRI+   AL HPY
Sbjct: 265 PEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  181 bits (460), Expect = 2e-56
 Identities = 81/184 (44%), Positives = 110/184 (59%), Gaps = 9/184 (4%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR----PTSENEFMTEYV 78
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR    P       T  V
Sbjct: 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEV 161

Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 221

Query: 139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL 198
           +     V       Y    P+  RQ  ++V P +     DL+ +ML +DP KRI+   AL
Sbjct: 222 EVVWPGV--TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279

Query: 199 AHPY 202
           AHP+
Sbjct: 280 AHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  183 bits (465), Expect = 2e-56
 Identities = 102/255 (40%), Positives = 154/255 (60%), Gaps = 17/255 (6%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 104 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 220

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279

Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VDEAL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 339

Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 340 HTIEEWKELIYKEVM 354

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  183 bits (466), Expect = 3e-56
 Identities = 106/260 (40%), Positives = 152/260 (58%), Gaps = 23/260 (8%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286

Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345

Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  179 bits (457), Expect = 7e-56
 Identities = 91/206 (44%), Positives = 123/206 (59%), Gaps = 9/206 (4%)

Query: 2   DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           D DL +   S N  +  E  + F++QLL+GL + HS NV+HRDLKP NLL+N N +LK+ 
Sbjct: 82  DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLA 141

Query: 61  DFGLARP--TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPL 117
           DFGLAR        +  E VVT WYR P++L  +  Y+ +ID+WS GCIF EL N  RPL
Sbjct: 142 DFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Query: 118 FPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           FPGND   Q++ +  LLGTPT+    G  +  D K Y          SL  V P ++   
Sbjct: 201 FPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP---MYPATTSLVNVVPKLNSTG 257

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPY 202
            DL+  +L  +P++RI+ +EAL HPY
Sbjct: 258 RDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  180 bits (458), Expect = 8e-56
 Identities = 88/206 (42%), Positives = 118/206 (57%), Gaps = 4/206 (1%)

Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           MD DL  ++ S     SE+H + F+ QLL GL Y H  N +HRD+K SN+LLN    +K+
Sbjct: 98  MDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL 157

Query: 60  CDFGLAR--PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
            DFGLAR   + E+   T  V+T WYR PELLL    Y  AIDVWS GCI  EL  ++P+
Sbjct: 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F  N  + Q+ L+  L G+P  A    V        ++   Q+ R+ L + F  +   A+
Sbjct: 218 FQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQY-RRRLREEFSFIPTPAL 276

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYL 203
           DL+D MLT DP KR T +EAL  P+L
Sbjct: 277 DLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  178 bits (453), Expect = 4e-55
 Identities = 90/215 (41%), Positives = 127/215 (59%), Gaps = 12/215 (5%)

Query: 1   MDTDLYQIIRSNQSLSEEH--CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-L 57
           +D DL + + S+   ++     + +LYQ+LRG+ Y HS  V+HRDLKP NLL++   + L
Sbjct: 83  LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL 142

Query: 58  KICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           K+ DFGLAR    P       T  VVT WYRAPE+LL S  Y+  +D+WSVGCIF E++N
Sbjct: 143 KLADFGLARAFGIPVRT---FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
           ++PLFPG+  + ++  +  +LGTP +     V +     Y    P+ P + LA V P + 
Sbjct: 200 QKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--LPDYKSAFPKWPPKDLATVVPTLE 257

Query: 174 PLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD 208
           P  +DL+ +ML  DP KRIT   AL H Y   L D
Sbjct: 258 PAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  173 bits (441), Expect = 2e-53
 Identities = 78/207 (37%), Positives = 118/207 (57%), Gaps = 14/207 (6%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +D+     +   Q +  E  + +LYQ+L+G+ + HS  V+HRDLKP NLL++    +K+ 
Sbjct: 89  LDS-----LPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLA 143

Query: 61  DFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    P       T  VVT WYRAPE+LL S  Y+  +D+WS+G IF E+  ++P
Sbjct: 144 DFGLARAFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           LF G+  + Q+  +  +LGTPT+     V       Y    P+  + SL     ++    
Sbjct: 201 LFHGDSEIDQLFRIFRILGTPTEDVWPGV--TSLPDYKNTFPKWKKGSLRSAVKNLDEDG 258

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYL 203
           +DL+++ML +DP KRI+  +AL HPY 
Sbjct: 259 LDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  174 bits (442), Expect = 4e-53
 Identities = 85/232 (36%), Positives = 120/232 (51%), Gaps = 38/232 (16%)

Query: 4   DLYQIIR-----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-- 56
           DL+QII+        S+     +  L+Q+L G+ Y+HS  V+HRDLKP+N+L+       
Sbjct: 89  DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER 148

Query: 57  --LKICDFGLAR--------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
             +KI D GLAR            +      VVT WYRAPELLL +  YT AID+W++GC
Sbjct: 149 GVVKIGDLGLARLFNAPLKPLADLDPV----VVTIWYRAPELLLGARHYTKAIDIWAIGC 204

Query: 107 IFMELMNRRPLFPGND---------HVHQMRLLIELLGTPTDADLGFVRN---EDAKRYI 154
           IF EL+   P+F G +            Q+  + E+LGTPT+ D   ++     D     
Sbjct: 205 IFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKD 264

Query: 155 RQLPQHPRQSLAQVFPHVH----PLAIDLVDRMLTFDPMKRITVDEALAHPY 202
            +   +P  SLA+     H        DL+ ++L +DP KRIT +EAL HPY
Sbjct: 265 FKTKTYPSNSLAKWM-EKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  167 bits (423), Expect = 1e-50
 Identities = 88/209 (42%), Positives = 123/209 (58%), Gaps = 5/209 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEH-CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL Q +    +    H  + FL+QLLRGL Y H   V+HRDLKP NLL+N   +LK+
Sbjct: 86  LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKL 145

Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  S   +  +  VVT WYR P++LL S+DY+  ID+W VGCIF E+   RPLF
Sbjct: 146 ADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+    Q+  +  +LGTPT+    G + NE+ K Y    P++    L    P +     
Sbjct: 206 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGA 263

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYLARL 206
           +L+ ++L F+  KRI+ +EA+ HPY   L
Sbjct: 264 ELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  166 bits (421), Expect = 3e-50
 Identities = 88/209 (42%), Positives = 125/209 (59%), Gaps = 5/209 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEH-CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL Q +    ++   H  + FLYQ+LRGL Y H   V+HRDLKP NLL+N   +LK+
Sbjct: 86  LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKL 145

Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  S   +  +  VVT WYR P++LL SS+Y+  ID+W VGCIF E+ + RPLF
Sbjct: 146 ADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+    ++ L+  LLGTPT+    G   N++ K Y    P++  Q L    P +    I
Sbjct: 206 PGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGI 263

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYLARL 206
           +L+ + L ++  KRI+ +EA+ H Y   L
Sbjct: 264 ELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  164 bits (417), Expect = 7e-50
 Identities = 84/206 (40%), Positives = 123/206 (59%), Gaps = 5/206 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEH-CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D+DL Q + +  +L   H  + F++QLLRGL Y H   ++HRDLKP NLL+N   +LK+
Sbjct: 85  LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKL 144

Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  S   +  +  VVT WYR P++LL S++Y+  ID+W VGCI  E+   RP+F
Sbjct: 145 ADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+    ++ L+  LLGTPT+    G   NE+ + Y+   PQ+  Q L    P +    I
Sbjct: 205 PGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGI 262

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYL 203
           DL+  +L ++   RI+ + AL H Y 
Sbjct: 263 DLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  160 bits (407), Expect = 4e-48
 Identities = 76/198 (38%), Positives = 108/198 (54%), Gaps = 8/198 (4%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
           N   +    +  +  LL GL YIH   ++HRD+K +N+L+  +  LK+ DFGLAR  S +
Sbjct: 113 NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS 172

Query: 72  E-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
           +       T  VVT WYR PELLL   DY   ID+W  GCI  E+  R P+  GN   HQ
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVH-PLAIDLVDRML 184
           + L+ +L G+ T      V   +  + +  LPQ   R+   ++ P+V  P A+DL+D++L
Sbjct: 233 LTLISQLCGSITPEVWPGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLL 291

Query: 185 TFDPMKRITVDEALAHPY 202
             DP KRI  D AL H +
Sbjct: 292 VLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  157 bits (400), Expect = 3e-47
 Identities = 72/204 (35%), Positives = 116/204 (56%), Gaps = 7/204 (3%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           T L ++ ++ + + E   +  ++Q L+ + + H  N IHRD+KP N+L+     +K+CDF
Sbjct: 85  TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDF 144

Query: 63  GLARPTSENEFM-TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G AR  +      T+YV TRWYRAPELL+  + Y   +DVW++GC+F EL+  +PL+PG 
Sbjct: 145 GFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204

Query: 122 DHVHQMRLLIELLG--TPTDADLGFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVHPLAID 178
             V Q+ L+ + LG   P    + F  N+  K     +P+   R+ L   FP++   A+ 
Sbjct: 205 SDVDQLYLIRKTLGDLIPRHQQI-FSTNQFFKGL--SIPEPETREPLESKFPNISSPALS 261

Query: 179 LVDRMLTFDPMKRITVDEALAHPY 202
            +   L  DP +R++ +E L HPY
Sbjct: 262 FLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  155 bits (394), Expect = 2e-46
 Identities = 73/192 (38%), Positives = 116/192 (60%), Gaps = 7/192 (3%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEF 73
           L E   + +L+Q+LRG+++ HS N+IHRD+KP N+L++ +  +K+CDFG AR   +  E 
Sbjct: 97  LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156

Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
            T+YV TRWYRAPELL+  + Y  A+D+W+VGC+  E++   PLFPG+  + Q+  +I+ 
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC 216

Query: 134 LGT--PTDADLGFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
           LG   P   ++ F +N        +LP+    + L + FP +  L +DL  + L  DP  
Sbjct: 217 LGNLIPRHQEI-FQKNPLFA--GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDD 273

Query: 191 RITVDEALAHPY 202
           R +  + L H +
Sbjct: 274 RPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  155 bits (392), Expect = 1e-44
 Identities = 80/201 (39%), Positives = 119/201 (59%), Gaps = 5/201 (2%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPT 68
           R+N +L     + + YQL R L YIHS  + HRDLKP NLL++ N   LK+CDFG A+  
Sbjct: 162 RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              +    Y+ +R+YRAPEL+L +++YT  ID+WS+GCI  E++   P+F G   V Q+ 
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281

Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP-LAIDLVDRMLTFD 187
            +I++LGTPT+  L  +    A     + P    + L +VFP   P  AI+ + + L ++
Sbjct: 282 RIIQVLGTPTEDQLKEMNPNYAD---IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE 338

Query: 188 PMKRITVDEALAHPYLARLHD 208
           P+KR+   EALA P+   L D
Sbjct: 339 PLKRLNPIEALADPFFDDLRD 359

Length = 440

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  150 bits (379), Expect = 3e-44
 Identities = 76/183 (41%), Positives = 111/183 (60%), Gaps = 13/183 (7%)

Query: 24  LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWY 83
           ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  VVT WY
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 175

Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD-- 141
           RAPE+LL SS Y   +D+WSVGCIF E+  R+PLF G+  V Q+  +++++G P + D  
Sbjct: 176 RAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234

Query: 142 --LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA 199
             +   R     +          Q + +    +  L  DL+ + LTF+P KRI+   AL+
Sbjct: 235 RDVALPRQAFHSK--------SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286

Query: 200 HPY 202
           HPY
Sbjct: 287 HPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  150 bits (379), Expect = 4e-44
 Identities = 85/216 (39%), Positives = 125/216 (57%), Gaps = 22/216 (10%)

Query: 1   MDTDLYQ-IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M TDL Q +I+    L   + + F++QLLRGL YIH  +++HRDLKP NLL++   +LK+
Sbjct: 85  MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKL 144

Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  S  ++  +  VVT WYR P++LL ++DY++A+D+W  GCIF+E++  +P F
Sbjct: 145 ADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Query: 119 PG-NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH--------PRQSLAQVF 169
           PG +D   Q+  +  +LG PT         ED    + +LP +          Q L  V+
Sbjct: 205 PGVSDVFEQLEKIWTVLGVPT---------EDTWPGVSKLPNYKPEWFLPCKPQQLRVVW 255

Query: 170 PHVH--PLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
             +   P A DL  +ML   P  RI+  +AL HPY 
Sbjct: 256 KRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  147 bits (372), Expect = 3e-43
 Identities = 78/189 (41%), Positives = 111/189 (58%), Gaps = 5/189 (2%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL 164

Query: 75  TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELL 134
           T  VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF GN    Q+  + +L+
Sbjct: 165 TPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 223

Query: 135 GTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV 194
           G P + D  + R+    R     P+ PR  +  V P +      L+  MLTF+P KRI+ 
Sbjct: 224 GLPPEDD--WPRDVTLPRGAFS-PRGPR-PVQSVVPEIEESGAQLLLEMLTFNPHKRISA 279

Query: 195 DEALAHPYL 203
             AL HP+ 
Sbjct: 280 FRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  133 bits (337), Expect = 1e-38
 Identities = 46/111 (41%), Positives = 69/111 (62%), Gaps = 3/111 (2%)

Query: 4   DLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICD 61
            L  +++ N+  LSE+     L Q+L GL+Y+HS  +IHRDLKP N+LL+++   +K+ D
Sbjct: 77  SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLAD 136

Query: 62  FGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           FGL++  TS+   +   V T  Y APE+LL    Y+   D+WS+G I  EL
Sbjct: 137 FGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  135 bits (340), Expect = 2e-38
 Identities = 70/188 (37%), Positives = 108/188 (57%), Gaps = 6/188 (3%)

Query: 18  EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE--NEFMT 75
           E  + ++YQL++ + + H  +++HRD+KP NLL++ N  LK+CDFG AR  SE  N   T
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159

Query: 76  EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLG 135
           EYV TRWYR+PELLL +  Y  A+D+WSVGCI  EL + +PLFPG   + Q+  + ++LG
Sbjct: 160 EYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG 218

Query: 136 TPTDADLGFVRNEDAKRYIRQLP--QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                 +    +      +R  P   HP+    +    +  + +DL+  +L  +P  R  
Sbjct: 219 PLPAEQMKLFYSNPRFHGLR-FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL 277

Query: 194 VDEALAHP 201
            ++ L HP
Sbjct: 278 TEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (332), Expect = 2e-37
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 32/202 (15%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  +++    L E   + +  Q+L GL Y+HS  ++HRD+K +N+L++++  +K+ DFG 
Sbjct: 88  LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147

Query: 65  AR--PTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           A+     E    T  V  T ++ APE ++   +Y  A D+WS+GC  +E+   +P +   
Sbjct: 148 AKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
            +       +  +G+  +                ++P+           H+   A D + 
Sbjct: 207 GNPMA---ALYKIGSSGEPP--------------EIPE-----------HLSEEAKDFLR 238

Query: 182 RMLTFDPMKRITVDEALAHPYL 203
           + L  DP KR T DE L HP+L
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  131 bits (330), Expect = 8e-37
 Identities = 81/217 (37%), Positives = 120/217 (55%), Gaps = 22/217 (10%)

Query: 3   TDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           TDL Q +  +   L  E+ + FL+QLLRGL YIH   ++HRDLKP NLL++   +LK+ D
Sbjct: 87  TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLAD 146

Query: 62  FGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           FGLAR  S  +   +  VVT WYR P++LL S++Y+  +D+W VGCIF+E++     FPG
Sbjct: 147 FGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206

Query: 121 -NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ--------HPRQSLAQVFPH 171
             D   Q+  +  +LGTP         NED    +  LP         +  ++L Q +  
Sbjct: 207 MKDIQDQLERIFLVLGTP---------NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNK 257

Query: 172 VHPL--AIDLVDRMLTFDPMKRITVDEALAHPYLARL 206
           +  +  A DL  ++L   P  R++   AL+H Y + L
Sbjct: 258 LSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (323), Expect = 3e-35
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 28/230 (12%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICD 61
            DL + I     LSE    + L Q+L  L+Y+HS  +IHRD+KP N+LL+ +   +K+ D
Sbjct: 86  EDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLID 145

Query: 62  FGLARPTSE-------NEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELM 112
           FGLA+   +           +  V T  Y APE+LL  S    +++ D+WS+G    EL+
Sbjct: 146 FGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL 205

Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV 172
              P F G  +       ++++                       P             +
Sbjct: 206 TGLPPFEGEKNSSATSQTLKII------------------LELPTPSLASPLSPSNPELI 247

Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFD 222
              A DL+ ++L  DP  R++    L+H  LA L  +  +          
Sbjct: 248 SKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  123 bits (311), Expect = 3e-34
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 36/205 (17%)

Query: 4   DLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           DL Q I+      +   EE    +  QL   LKY+HS  ++HRD+KP N+ L +N  +K+
Sbjct: 85  DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKL 144

Query: 60  CDFGLARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFG+++  S    + + VV T +Y +PEL  N   Y    D+WS+GC+  EL   +  F
Sbjct: 145 GDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPF 203

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G +       L+EL           +           +P      L            +
Sbjct: 204 EGEN-------LLELALK--------ILKGQ----YPPIPSQYSSEL-----------RN 233

Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           LV  +L  DP +R ++ + L  P++
Sbjct: 234 LVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  120 bits (301), Expect = 2e-32
 Identities = 83/242 (34%), Positives = 121/242 (50%), Gaps = 51/242 (21%)

Query: 4   DLYQIIRSNQS---------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           DL+ II+ +++         L     +  LYQ+L G+ Y+H+  V+HRDLKP+N+L+   
Sbjct: 85  DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 144

Query: 55  CD----LKICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
                 +KI D G AR    P      +   VVT WYRAPELLL +  YT AID+W++GC
Sbjct: 145 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204

Query: 107 IFMELMNRRPLFPGND---------HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
           IF EL+   P+F             H  Q+  +  ++G P D D      ED    IR++
Sbjct: 205 IFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDW-----ED----IRKM 255

Query: 158 PQHP-------RQSLAQV----FPHVHPLAID-----LVDRMLTFDPMKRITVDEALAHP 201
           P++P       R + A      +   H +  D     L+ ++LT DP KRIT ++AL  P
Sbjct: 256 PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315

Query: 202 YL 203
           Y 
Sbjct: 316 YF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 4e-32
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 42/206 (20%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +      SEE  +++  +++  L+Y+HS  +I+RDLKP N+LL+A+  +K+ DFG
Sbjct: 79  ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFG 138

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA+  +SE      +  T  Y APE+LL    Y  A+D WS+G +  E++  +P F   D
Sbjct: 139 LAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197

Query: 123 H--VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDL 179
              +++  L   L                                   FP  + P A DL
Sbjct: 198 RKEIYEKILKDPL----------------------------------RFPEFLSPEARDL 223

Query: 180 VDRMLTFDPMKRIT---VDEALAHPY 202
           +  +L  DP KR+     +E  AHP+
Sbjct: 224 ISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  117 bits (294), Expect = 2e-31
 Identities = 83/244 (34%), Positives = 123/244 (50%), Gaps = 55/244 (22%)

Query: 4   DLYQIIRSNQS---------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           DL+ II+ +++         L     +  LYQ+L G+ Y+H+  V+HRDLKP+N+L+   
Sbjct: 85  DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 144

Query: 55  CD----LKICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
                 +KI D G AR    P      +   VVT WYRAPELLL +  YT AID+W++GC
Sbjct: 145 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204

Query: 107 IFMELMNRRPLF--------PGNDHVH-QMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
           IF EL+   P+F          N + H Q+  +  ++G P D D      ED    I+++
Sbjct: 205 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW-----ED----IKKM 255

Query: 158 PQHPRQSLAQVFPH----------------VHP--LAIDLVDRMLTFDPMKRITVDEALA 199
           P+H   +L + F                  V P   A  L+ ++LT DP+KRIT ++A+ 
Sbjct: 256 PEH--STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313

Query: 200 HPYL 203
            PY 
Sbjct: 314 DPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  113 bits (284), Expect = 3e-30
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 34/206 (16%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L +++   + L E   + +  QLL GL Y+HS  ++HRD+KP+N+ L+ N  +K+ DFG 
Sbjct: 86  LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGC 145

Query: 65  A-----RPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPL 117
           A       T+  E +     T  Y APE++       +  A D+WS+GC+ +E+   +  
Sbjct: 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           +   D+  Q+   +     P                   +P   + S         P   
Sbjct: 206 WSELDNEFQIMFHVGAGHKP------------------PIPDSLQLS---------PEGK 238

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYL 203
           D +DR L  DP KR T  E L HP++
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  112 bits (282), Expect = 4e-30
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 30/199 (15%)

Query: 5   LYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           L  +++S NQ+L+E    Y   +LL+GL+Y+HS  +IHRD+K +N+LL ++ ++K+ DFG
Sbjct: 84  LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFG 143

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+   S+ +     V T ++ APE ++N   Y    D+WS+G   +EL   +P +     
Sbjct: 144 LSAQLSDTKARNTMVGTPYWMAPE-VINGKPYDYKADIWSLGITAIELAEGKPPYS---- 198

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                            +L  ++   A   I        ++  +          D + + 
Sbjct: 199 -----------------ELPPMK---ALFKIATNGPPGLRNPEKWSDEFK----DFLKKC 234

Query: 184 LTFDPMKRITVDEALAHPY 202
           L  +P KR T ++ L HP+
Sbjct: 235 LQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  111 bits (281), Expect = 1e-29
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 50/217 (23%)

Query: 1   MD----TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD 56
           MD    TD+  I ++   ++E    Y   ++L+GL+Y+HS NVIHRD+K  N+LL+ +  
Sbjct: 97  MDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS 154

Query: 57  LKICDFGL-ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL---- 111
           +K+ DFG  A+ T E       V T ++ APE++    DY   +D+WS+G + +E+    
Sbjct: 155 VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK-RKDYGPKVDIWSLGIMCIEMAEGE 213

Query: 112 ---MNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
              +   PL        +   LI   G P                     ++P    +  
Sbjct: 214 PPYLREPPL--------RALFLITTKGIPP-------------------LKNPE-KWSPE 245

Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
           F        D +++ L  DP KR + +E L HP+L +
Sbjct: 246 F-------KDFLNKCLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  108 bits (271), Expect = 2e-28
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 42/213 (19%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL  ++ +  SL E+  + ++ +++  L+Y+HS  +IHRDLKP N+L+++N  LK+ DFG
Sbjct: 79  DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFG 138

Query: 64  LARPTSENEFMT---------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           L++       +            V T  Y APE++L    ++  +D WS+GCI  E +  
Sbjct: 139 LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVG 197

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP 174
            P F G               TP +     + N   +                    V  
Sbjct: 198 IPPFHGE--------------TP-EEIFQNILNGKIEWP--------------EDVEVSD 228

Query: 175 LAIDLVDRMLTFDPMKRI---TVDEALAHPYLA 204
            AIDL+ ++L  DP KR+   +++E   HP+  
Sbjct: 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  105 bits (265), Expect = 1e-27
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 37/205 (18%)

Query: 4   DL-YQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL Y + +     SEE  ++++ +++  L+Y+HS  +IHRD+KP N+LL+    + I DF
Sbjct: 86  DLRYHLSQ-KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDF 144

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME-LMNRRPLFPGN 121
            +A   + +   T    T  Y APE +L    Y+ A+D WS+G    E L  +RP + G+
Sbjct: 145 NIATKVTPDTLTTSTSGTPGYMAPE-VLCRQGYSVAVDWWSLGVTAYECLRGKRP-YRGH 202

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL-AIDLV 180
                                         R IR   +  +++   ++P      AID +
Sbjct: 203 S-----------------------------RTIRDQIRAKQETADVLYPATWSTEAIDAI 233

Query: 181 DRMLTFDPMKRI--TVDEALAHPYL 203
           +++L  DP KR+   + +   HPY 
Sbjct: 234 NKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (262), Expect = 7e-27
 Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 59/225 (26%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L Q IR   SL E+  +++  ++L  L+Y+HS  +IHRDLKP N+LL+ +  +KI DFG
Sbjct: 88  ELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFG 147

Query: 64  LARPTSENEFMTE---------------------YVVTRWYRAPELLLNSSDYTAAIDVW 102
            A+    N                          +V T  Y +PELL        + D+W
Sbjct: 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLW 206

Query: 103 SVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR 162
           ++GCI  +++  +P F G++     + +++                       +      
Sbjct: 207 ALGCIIYQMLTGKPPFRGSNEYLTFQKILK----------------------LEYS---- 240

Query: 163 QSLAQVFPH-VHPLAIDLVDRMLTFDPMKRITV----DEALAHPY 202
                 FP    P A DL++++L  DP  R+ V    DE  AHP+
Sbjct: 241 ------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (256), Expect = 2e-26
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 29/199 (14%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++++   S  E   + +  Q+L GL+Y+H  N +HRD+K +N+L++ N  +K+ DFG+
Sbjct: 89  LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGM 148

Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
           A+   E  F   +  + ++ APE++     Y  A D+WS+GC  +E+   +P +      
Sbjct: 149 AKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW------ 202

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
            Q+            A     R+++       LP  P         H+   A D + + L
Sbjct: 203 SQL--------EGVAAVFKIGRSKE-------LPPIPD--------HLSDEAKDFILKCL 239

Query: 185 TFDPMKRITVDEALAHPYL 203
             DP  R T  E L HP++
Sbjct: 240 QRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  100 bits (250), Expect = 2e-25
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 34/202 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+ +I   N++L+EE     LYQ L+GL+Y+HS   IHRD+K  N+LLN     K+ DFG
Sbjct: 87  DIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG 144

Query: 64  LA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           ++ + T         + T ++ APE++     Y    D+WS+G   +E+   +P  P   
Sbjct: 145 VSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKP--P-YS 200

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLAIDLVD 181
            +H MR +                          +P  P  +L+   P    P   D V 
Sbjct: 201 DIHPMRAIFM------------------------IPNKPPPTLSD--PEKWSPEFNDFVK 234

Query: 182 RMLTFDPMKRITVDEALAHPYL 203
           + L  DP +R +  + L HP++
Sbjct: 235 KCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.5 bits (246), Expect = 1e-24
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 41/210 (19%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIH-----SANVIHRDLKPSNLLLNAN 54
           DL Q+I    +  + + EE     L QLL  L   H        V+HRDLKP+N+ L+AN
Sbjct: 87  DLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN 146

Query: 55  CDLKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            ++K+ DFGLA+    ++ F   YV T +Y +PE L + S Y    D+WS+GC+  EL  
Sbjct: 147 NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCA 205

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
             P F   + + Q+   I                ++ K   R++P      L +V     
Sbjct: 206 LSPPFTARNQL-QLASKI----------------KEGK--FRRIPYRYSSELNEV----- 241

Query: 174 PLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                 +  ML  DP KR + +E L  P +
Sbjct: 242 ------IKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 98.3 bits (245), Expect = 1e-24
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 34/204 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D   +I++   L E+  + ++ +++ G++ +H   +IHRD+KP NLL++    LK+ DFG
Sbjct: 83  DCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFG 142

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+R   EN+   ++V T  Y APE +L   D     D WS+GC+  E +   P F     
Sbjct: 143 LSRNGLENK---KFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAE-- 196

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                       TP         +      + +    P     +V     P A+DL++R+
Sbjct: 197 ------------TP---------DAVFDNILSRRINWP----EEVKEFCSPEAVDLINRL 231

Query: 184 LTFDPMKRI---TVDEALAHPYLA 204
           L  DP KR+      E  +HP+  
Sbjct: 232 LCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 96.9 bits (242), Expect = 4e-24
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 31/202 (15%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFG 63
           L  +++    + E    Y   Q+L+GL Y+H+  ++IHRD+KPSNLL+N+  ++KI DFG
Sbjct: 86  LADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFG 145

Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFPGN 121
           +++           +V T  Y +PE +   S Y+ A D+WS+G   +E  + + P F   
Sbjct: 146 ISKVLENTLDQCNTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFP-FLPP 203

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
                  L+  +   P                    P  P +  +  F        D + 
Sbjct: 204 GQPSFFELMQAICDGP-------------------PPSLPAEEFSPEF-------RDFIS 237

Query: 182 RMLTFDPMKRITVDEALAHPYL 203
             L  DP KR +  E L HP++
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 95.0 bits (237), Expect = 2e-23
 Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 30/190 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+ I+R      E   ++++  ++   +Y+H+  +I+RDLKP NLLL++N  +K+ DFG
Sbjct: 79  ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFG 138

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            A+     +    +  T  Y APE++LN   Y  ++D WS+G +  EL+  RP F G D 
Sbjct: 139 FAKKLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPF-GEDD 196

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVDR 182
              M +  ++L                 +   +L           FP ++   A DL+ +
Sbjct: 197 EDPMEIYNDIL-----------------KGNGKL----------EFPNYIDKAAKDLIKQ 229

Query: 183 MLTFDPMKRI 192
           +L  +P +R+
Sbjct: 230 LLRRNPEERL 239

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 3e-23
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 34/207 (16%)

Query: 3   TDLYQ-IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           TDL + + +  + L EE   Y L + LRGL Y+H   VIHRD+K  N+LL  N ++K+ D
Sbjct: 97  TDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156

Query: 62  FGLARP-TSENEFMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMNRRP 116
           FG++    S       ++ T ++ APE++         Y A  DVWS+G   +EL + +P
Sbjct: 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
             P  D +H MR L ++            RN             P  + ++ F       
Sbjct: 217 --PLCD-MHPMRALFKI-----------PRNPPPTLK------SPE-NWSKKF------- 248

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYL 203
            D +   L  +  +R  ++E L HP++
Sbjct: 249 NDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 94.2 bits (235), Expect = 3e-23
 Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 36/202 (17%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L QII+      E     ++YQ+L+GL Y+H   VIHRD+K +N+L   +  +K+ DFG+
Sbjct: 86  LRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGV 145

Query: 65  ARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A   ++       VV T ++ APE++   S  + A D+WS+GC                 
Sbjct: 146 ATKLNDVSKDDASVVGTPYWMAPEVI-EMSGASTASDIWSLGC----------------- 187

Query: 124 VHQMRLLIELL-GTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
                 +IELL G P   DL  +    A   I Q   HP        P  + P   D + 
Sbjct: 188 -----TVIELLTGNPPYYDLNPMA---ALFRIVQ-DDHPP------LPEGISPELKDFLM 232

Query: 182 RMLTFDPMKRITVDEALAHPYL 203
           +    DP  R T  + L HP++
Sbjct: 233 QCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.9 bits (234), Expect = 4e-23
 Identities = 58/184 (31%), Positives = 87/184 (47%), Gaps = 31/184 (16%)

Query: 25  YQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWY 83
             +L+GL Y+H    +IHRD+KPSN+L+N+   +K+CDFG++     +   T +V T  Y
Sbjct: 107 VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSY 165

Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFPGNDHVHQMRLLIELLGTPTDAD- 141
            APE  +  +DY+   D+WS+G   +EL   R P  P ND                  + 
Sbjct: 166 MAPE-RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND------------PPDGIFEL 212

Query: 142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHP 201
           L ++ NE   R    LP          F    P   D V+  L  DP +R +  E L HP
Sbjct: 213 LQYIVNEPPPR----LPSGK-------FS---PDFQDFVNLCLIKDPRERPSYKELLEHP 258

Query: 202 YLAR 205
           ++ +
Sbjct: 259 FIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 93.7 bits (233), Expect = 8e-23
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 31/200 (15%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP 67
            +R+     E+  ++F  Q+L GL Y+HS  ++HRDLK  NLL++A+   KI DFG+++ 
Sbjct: 98  CLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157

Query: 68  TSE---NEFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELM-NRRPLFPGND 122
           + +   N+       + ++ APE++ + S  Y+A +D+WS+GC+ +E+   RRP    ++
Sbjct: 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW--SDE 215

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                   +  LG                   R  P  P      V  ++ P+A+D ++ 
Sbjct: 216 EAIAA---MFKLGN-----------------KRSAPPIP----PDVSMNLSPVALDFLNA 251

Query: 183 MLTFDPMKRITVDEALAHPY 202
             T +P  R T  E L HP+
Sbjct: 252 CFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 1e-21
 Identities = 51/192 (26%), Positives = 83/192 (43%), Gaps = 31/192 (16%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF- 73
           L E +  + L ++L GL+Y+H    IHRD+K +N+LL+   D+K+ DFG++   +     
Sbjct: 95  LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154

Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
              +V T ++ APE++  S  Y    D+WS+G   +EL    P  P    +H MR+L  +
Sbjct: 155 RNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEP--P-LSDLHPMRVLFLI 210

Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                            K     L  +                 D V   L  DP +R +
Sbjct: 211 ----------------PKNNPPSLEGNK----------FSKPFKDFVSLCLNKDPKERPS 244

Query: 194 VDEALAHPYLAR 205
             E L H ++ +
Sbjct: 245 AKELLKHKFIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 88.7 bits (220), Expect = 4e-21
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 36/206 (17%)

Query: 2   DTDLYQIIRSNQS----LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL 57
             DL + I   +     + E+       QLLRGL+ +H   ++HRDLK +N+LL AN  +
Sbjct: 83  FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLV 142

Query: 58  KICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           KI D G+++   +N   T+ + T  Y APE +     Y+   D+WS+GC+  E+    P 
Sbjct: 143 KIGDLGISKVLKKNMAKTQ-IGTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F                      DL   R +  +     +P    Q L            
Sbjct: 201 FEARSM----------------QDL---RYKVQRGKYPPIPPIYSQDLQNF--------- 232

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYL 203
             +  ML   P  R   D+ LA P +
Sbjct: 233 --IRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 5e-21
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 37/201 (18%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEF 73
           L+E   +Y   Q+L  L ++HS  VIHRDLK  N+LL  + D+K+ DFG+ A+  S  + 
Sbjct: 100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159

Query: 74  MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL 129
              ++ T ++ APE++      D  Y    D+WS+G   +EL    P  P ++ ++ MR+
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRV 216

Query: 130 LIELLGT--PTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
           L+++L +  PT                   P     S             D +   L  D
Sbjct: 217 LLKILKSEPPTLDQ----------------PSKWSSSFN-----------DFLKSCLVKD 249

Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R T  E L HP+++   D
Sbjct: 250 PDDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 87.6 bits (218), Expect = 1e-20
 Identities = 42/118 (35%), Positives = 58/118 (49%), Gaps = 12/118 (10%)

Query: 4   DLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL   +R N+  LS      F  Q+ RG++Y+ S N IHRDL   N L+  N  +KI DF
Sbjct: 87  DLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDF 146

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           GL+R   +++    Y         RW  APE L     +T+  DVWS G +  E+   
Sbjct: 147 GLSRDLYDDD---YYRKRGGKLPIRWM-APESLKEGK-FTSKSDVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 87.9 bits (218), Expect = 1e-20
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 25/178 (14%)

Query: 28  LRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPE 87
           L+GL Y+HS  +IHRD+KPSN+LL     +K+CDFG++     +   T +  T +Y APE
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPE 173

Query: 88  LLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN 147
            +     Y+   DVWS+G   +E+   R  FP           IELL    +        
Sbjct: 174 RIQGKP-YSITSDVWSLGLTLLEVAQNR--FPFPPEGEPPLGPIELLSYIVNMP------ 224

Query: 148 EDAKRYIRQLPQHPRQSL--AQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                   +L   P   +  ++ F          + + L  DP +R T  + L HP++
Sbjct: 225 ------NPELKDEPGNGIKWSEEFKD-------FIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 86.7 bits (215), Expect = 2e-20
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 36/203 (17%)

Query: 5   LYQII--RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           LY  I  +  Q   EE   ++L+Q++  + YIH A ++HRD+K  N+ L     +K+ DF
Sbjct: 86  LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDF 145

Query: 63  GLARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G+++       M E VV T +Y +PE L     Y    D+W++GC+  EL+  +  F   
Sbjct: 146 GISKILGSEYSMAETVVGTPYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204

Query: 122 DHVHQMRLLIELL-GTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +    + L+++++ G  T              Y  +L                   I LV
Sbjct: 205 N---PLNLVVKIVQGNYTPVV---------SVYSSEL-------------------ISLV 233

Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
             +L  DP KR T DE L  P L
Sbjct: 234 HSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 86.8 bits (216), Expect = 2e-20
 Identities = 39/111 (35%), Positives = 54/111 (48%), Gaps = 11/111 (9%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
              + LS      F  Q+ RG++Y+ S N IHRDL   N L+  N  +KI DFGL+R   
Sbjct: 95  NRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154

Query: 70  ENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           +++    Y V       RW  APE L     +T+  DVWS G +  E+   
Sbjct: 155 DDD---YYKVKGGKLPIRWM-APESLKEGK-FTSKSDVWSFGVLLWEIFTL 200

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 86.1 bits (213), Expect = 1e-19
 Identities = 38/123 (30%), Positives = 72/123 (58%), Gaps = 13/123 (10%)

Query: 2   DTDLYQI------------IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNL 49
           D+DLY +            ++     SE+  ++++ +L+  L+++H  ++++RDLKP N+
Sbjct: 68  DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENI 127

Query: 50  LLNANCDLKICDFGLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 108
           LL+A   + +CDFGL++   ++N+    +  T  Y APE+LL+   YT  +D WS+G + 
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187

Query: 109 MEL 111
            E+
Sbjct: 188 FEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 85.3 bits (212), Expect = 1e-19
 Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 36/189 (19%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +R +    E   +++  Q++  L+Y+HS ++++RDLKP NLLL+++  +KI DFG
Sbjct: 87  ELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFG 146

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            A+      +      T  Y APE++L S  Y  A+D W++G +  E++   P F  ++ 
Sbjct: 147 FAKRVKGRTYTL--CGTPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVDR 182
           +     ++E          G VR                      FP    P A DL+  
Sbjct: 204 IQIYEKILE----------GKVR----------------------FPSFFSPDAKDLIRN 231

Query: 183 MLTFDPMKR 191
           +L  D  KR
Sbjct: 232 LLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.5 bits (209), Expect = 2e-19
 Identities = 55/188 (29%), Positives = 84/188 (44%), Gaps = 39/188 (20%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLA-----RPTSENEFMTE 76
           +  QLLRGL Y+H   +IHRD+K +NLL+++    L+I DFG A     + T   EF  +
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 77  YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL--- 133
            + T  + APE+L     Y  + DVWSVGC+ +E+   +P +    H + + L+ ++   
Sbjct: 168 LLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226

Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
              P+                  +P+H    L            D+  R L   P  R  
Sbjct: 227 TTAPS------------------IPEHLSPGLR-----------DVTLRCLELQPEDRPP 257

Query: 194 VDEALAHP 201
             E L HP
Sbjct: 258 SRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 4e-19
 Identities = 37/120 (30%), Positives = 65/120 (54%), Gaps = 1/120 (0%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
             ++E++    + ++L  LKYIH   VIHRD+K +N+L+    ++K+CDFG+A   ++N 
Sbjct: 96  GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155

Query: 73  FM-TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
              + +V T ++ APE++     Y    D+WS+G    E+    P +   D    M L+ 
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 1e-18
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 31/203 (15%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            D+YQ+ R    LSE    Y   + L+GL Y+H    IHRD+K +N+LL  + D+K+ DF
Sbjct: 88  QDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADF 145

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFP 119
           G+ A+ T+       ++ T ++ APE+        Y    D+W++G   +EL   +P  P
Sbjct: 146 GVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP--P 203

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
             D +H MR L  L+            N    +    L    + S         P+  D 
Sbjct: 204 MFD-LHPMRALF-LISK---------SNFPPPK----LKDKEKWS---------PVFHDF 239

Query: 180 VDRMLTFDPMKRITVDEALAHPY 202
           + + LT DP KR T  + L HP+
Sbjct: 240 IKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.2 bits (203), Expect = 1e-18
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 2/107 (1%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
           Q  +EE       Q++  L+Y+H    ++HRDL P+N++L  +  + I DFGLA+     
Sbjct: 108 QRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE 167

Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
             +T  V T  Y  PE++ N   Y    DVW+ GCI  ++   +P F
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.8 bits (202), Expect = 1e-18
 Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 34/198 (17%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP- 67
           +++  +L+E   + +  Q+L G++Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 95  LKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154

Query: 68  ---TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
               S    M     T ++ +PE +++   Y    DVWSVGC  +E++  +P  P  +  
Sbjct: 155 QTICSSGTGMKSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEKP--PWAEF- 210

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
             M  + ++   PT+                  PQ P         HV P A + + R  
Sbjct: 211 EAMAAIFKIATQPTN------------------PQLP--------SHVSPDARNFLRRTF 244

Query: 185 TFDPMKRITVDEALAHPY 202
             +  KR + +E L H +
Sbjct: 245 VENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.8 bits (202), Expect = 2e-18
 Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 24/182 (13%)

Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAP 86
           +++GL Y+ S  ++HRD+KPSN+L+N    +K+CDFG++     N     YV T  Y AP
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-NSIAKTYVGTNAYMAP 162

Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR 146
           E +     Y    DVWS+G  FMEL   R  +P         + ++LL    D D     
Sbjct: 163 ERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED----- 216

Query: 147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL 206
                      P  P    ++ F       +  + + +   P +R   +  + HP++ + 
Sbjct: 217 ----------PPVLPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPFIVQY 259

Query: 207 HD 208
           +D
Sbjct: 260 ND 261

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 82.0 bits (202), Expect = 2e-18
 Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 30/196 (15%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           I S   L+EE        +L+ L Y+HS  VIHRD+K  ++LL  +  +K+ DFG     
Sbjct: 108 IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167

Query: 69  SENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           S++    + +V T ++ APE +++ + Y   +D+WS+G + +E+++  P +  +  V  M
Sbjct: 168 SKDVPKRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226

Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
           + L               R+    +              +    + P+  D ++RMLT +
Sbjct: 227 KRL---------------RDSPPPK-------------LKNAHKISPVLRDFLERMLTRE 258

Query: 188 PMKRITVDEALAHPYL 203
           P +R T  E L HP+L
Sbjct: 259 PQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 1e-17
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 38/197 (19%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           +  E   + F+ Q+L+GL Y+H+  +IHRD+K +N+L++    +KI DFG+++    N  
Sbjct: 102 AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161

Query: 74  MTEYVVTR-------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+    R       ++ APE++  +S YT   D+WS+GC+ +E++  +  FP      Q
Sbjct: 162 STKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCT---Q 217

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF 186
           ++ + ++                        P+ P         ++   AID +++    
Sbjct: 218 LQAIFKIGE-------------------NASPEIPS--------NISSEAIDFLEKTFEI 250

Query: 187 DPMKRITVDEALAHPYL 203
           D  KR T  E L HP+L
Sbjct: 251 DHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (196), Expect = 2e-17
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 38/208 (18%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++          +++  +LL  L+ +H  NVI+RDLKP N+LL+    + +CDFG
Sbjct: 79  ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   +++  T  +  T  Y APELLL    YT A+D W++G +  E++   P F    
Sbjct: 139 LCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPF---- 193

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
                                   +E+     R++ Q P       FP      A DL+ 
Sbjct: 194 -----------------------YDENVNEMYRKILQEP-----LRFPDGFDRDAKDLLI 225

Query: 182 RMLTFDPMKRITV---DEALAHPYLARL 206
            +L+ DP +R+      E   HP+ ++L
Sbjct: 226 GLLSRDPTRRLGYNGAQEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.9 bits (194), Expect = 2e-17
 Identities = 53/183 (28%), Positives = 89/183 (48%), Gaps = 32/183 (17%)

Query: 24  LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE-YVVTRW 82
           L ++L+GL Y+HS   IHRD+K +N+LL+   D+K+ DFG+A   ++ +     +V T +
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADL 142
           + APE++  S+ Y +  D+WS+G   +EL    P  P +D +H MR+L            
Sbjct: 167 WMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLF----------- 211

Query: 143 GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPY 202
                         +P++   +L   F        + +D  L  DP  R T  E L H +
Sbjct: 212 -------------LIPKNNPPTLTGEFSKPFK---EFIDACLNKDPSFRPTAKELLKHKF 255

Query: 203 LAR 205
           + +
Sbjct: 256 IVK 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 78.3 bits (193), Expect = 3e-17
 Identities = 41/131 (31%), Positives = 70/131 (53%), Gaps = 4/131 (3%)

Query: 4   DLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DL+++++    + L E+    F  Q+L GL ++HS  ++HRD+K  NL L+A  ++KI D
Sbjct: 85  DLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGD 144

Query: 62  FGLARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
            G+A+  S+N      +V T +Y +PE L     Y    DVW++G +  E    +  F  
Sbjct: 145 LGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203

Query: 121 NDHVHQMRLLI 131
           N+    +  +I
Sbjct: 204 NNQGALILKII 214

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.8 bits (192), Expect = 4e-17
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 33/206 (16%)

Query: 5   LYQIIRS--NQSLSEEHC-QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           L  I++S   +   +E      L ++L+GL+Y+HS   IHRD+K  N+LL  +  +KI D
Sbjct: 86  LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIAD 145

Query: 62  FGLARPTSENEFMTE-----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           FG++   ++    T      +V T  + APE++     Y    D+WS G   +EL     
Sbjct: 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
             P + +     L++ L   P   +       D K+Y            ++ F       
Sbjct: 206 --PYSKYPPMKVLMLTLQNDPPSLE----TGADYKKY------------SKSFR------ 241

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPY 202
             ++   L  DP KR T +E L H +
Sbjct: 242 -KMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 77.9 bits (192), Expect = 5e-17
 Identities = 49/198 (24%), Positives = 94/198 (47%), Gaps = 30/198 (15%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           I ++  ++EE        +L+ L ++H+  VIHRD+K  ++LL ++  +K+ DFG     
Sbjct: 106 IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165

Query: 69  SENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           S+     + +V T ++ APE +++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 166 SKEVPRRKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM 224

Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
           + +               R+    +      ++  +        V P     +DRML  D
Sbjct: 225 KRI---------------RDNLPPKL-----KNLHK--------VSPRLRSFLDRMLVRD 256

Query: 188 PMKRITVDEALAHPYLAR 205
           P +R T  E L HP+LA+
Sbjct: 257 PAQRATAAELLNHPFLAK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 77.2 bits (191), Expect = 6e-17
 Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 13/117 (11%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL   +R + + L+ +       Q+ +G++Y+ S N +HRDL   N L+  N  +KI DF
Sbjct: 87  DLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDF 146

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GL+R   E++    Y          +W  APE L +   +T+  DVWS G +  E+ 
Sbjct: 147 GLSRDIYEDD---YYRKRGGGKLPIKWM-APESLKDGK-FTSKSDVWSFGVLLWEIF 198

Length = 258

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 77.8 bits (191), Expect = 6e-17
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 34/212 (16%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 107 IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166

Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APEL+ +   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 167 SKEVPRRKSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225

Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
           +++ +                        LP  P+         V P     +DR+L  D
Sbjct: 226 KMIRD-----------------------NLP--PKLKNLH---KVSPSLKGFLDRLLVRD 257

Query: 188 PMKRITVDEALAHPYLARLHDEADEPVCPEPF 219
           P +R T  E L HP+LA+    A  P C  P 
Sbjct: 258 PAQRATAAELLKHPFLAK----AGPPSCIVPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 77.5 bits (191), Expect = 6e-17
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 36/208 (17%)

Query: 6   YQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           Y I    +    E    ++  Q++ GL+++H   +++RDLKP N+LL+ + +++I D GL
Sbjct: 82  YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL 141

Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
           A      + +     T  Y APE+L     Y  ++D +++GC   E++  R         
Sbjct: 142 AVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGR--------- 191

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLAIDLVDRM 183
                      +P       V  E+ KR   ++           +P    P A DL + +
Sbjct: 192 -----------SPFRQRKEKVEKEELKRRTLEMAVE--------YPDKFSPEAKDLCEAL 232

Query: 184 LTFDPMKRI-----TVDEALAHPYLARL 206
           L  DP KR+     + DE   HP    L
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 77.7 bits (191), Expect = 7e-17
 Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 41/219 (18%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
           N    EE   ++  ++L GL+ +H  N ++RDLKP N+LL+    ++I D GLA    E 
Sbjct: 96  NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155

Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
           E +   V T  Y APE +LN+  YT + D W +GC+  E++  +  F G           
Sbjct: 156 ESIRGRVGTVGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG----------- 203

Query: 132 ELLGTPTDADLGFVRNEDAKR-YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
                         R E  KR  + +      +  +  F      A  +   +LT DP +
Sbjct: 204 --------------RKEKVKREEVDRRVLETEEVYSAKFSEE---AKSICKMLLTKDPKQ 246

Query: 191 RITVDEALA-----HPYLARLHDE------ADEPVCPEP 218
           R+   E  A     HP+   ++ +       D P  P+P
Sbjct: 247 RLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.6 bits (191), Expect = 7e-17
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 39/218 (17%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
           N    EE   ++  ++  GL+ +H   +++RDLKP N+LL+    ++I D GLA    E 
Sbjct: 96  NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155

Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
           E +   V T  Y APE ++ +  YT + D W +GC+  E++  +  F             
Sbjct: 156 ETIRGRVGTVGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK------- 207

Query: 132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
                        V+ E+ +R +++  +   +  +         A  +  ++LT DP  R
Sbjct: 208 -------------VKREEVERRVKEDQEEYSEKFS-------EAARSICRQLLTKDPGFR 247

Query: 192 I-----TVDEALAHPYLARLH------DEADEPVCPEP 218
           +       +E  AHP+    +         + P CP+P
Sbjct: 248 LGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.4 bits (190), Expect = 8e-17
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 32/192 (16%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E +    L ++L+GL Y+HS   IHRD+K +N+LL+   D+K+ DFG+A   ++ +  
Sbjct: 98  LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157

Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
              +V T ++ APE++  S+ Y    D+WS+G   +EL    P  P +D +H MR+L   
Sbjct: 158 RNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLF-- 211

Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                                  +P++   +L     +  P   + V+  L  DP  R T
Sbjct: 212 ----------------------LIPKNSPPTLEG--QYSKPFK-EFVEACLNKDPRFRPT 246

Query: 194 VDEALAHPYLAR 205
             E L H ++ R
Sbjct: 247 AKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.8 bits (189), Expect = 1e-16
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 28/207 (13%)

Query: 1   MDTD-LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLK 58
           MD   L +I +    +  E        ++ GL Y+++ + ++HRD+KPSN+L+N+   +K
Sbjct: 85  MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIK 144

Query: 59  ICDFGLARPTSE--NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           +CDFG+   + E  N     +V T  Y +PE  +    YT   DVWS+G   +EL   + 
Sbjct: 145 LCDFGV---SGELINSIADTFVGTSTYMSPE-RIQGGKYTVKSDVWSLGISIIELALGK- 199

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL-AQVFPHVHPL 175
            FP                     D G          ++Q+ Q P   L +  FP     
Sbjct: 200 -FPFAF--------------SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP---ED 241

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPY 202
             D VD  L  DP +R T  +  A P 
Sbjct: 242 LRDFVDACLLKDPTERPTPQQLCAMPP 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 75.8 bits (186), Expect = 2e-16
 Identities = 43/123 (34%), Positives = 62/123 (50%), Gaps = 4/123 (3%)

Query: 2   DTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
             DL Q I+  +     E+    +  Q+  G+++IH   V+HRD+K  N+ L  N  +K+
Sbjct: 82  GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKL 141

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFG AR  TS   +   YV T +Y  PE+  N   Y    D+WS+GCI  EL   +  F
Sbjct: 142 GDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPF 200

Query: 119 PGN 121
             N
Sbjct: 201 QAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 75.7 bits (186), Expect = 2e-16
 Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 32/193 (16%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R N  L E+   +F  Q+L  L ++H+  ++HRDLK  N+LL+ +   +KI DFG+++  
Sbjct: 93  RCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152

Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
           S        V T  Y +PE L     Y    D+W++GC+  EL + +  F   +    + 
Sbjct: 153 SSKSKAYTVVGTPCYISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN----LP 207

Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
            L+  + + T A +    + D ++                          L+  ML  DP
Sbjct: 208 ALVLKIMSGTFAPISDRYSPDLRQ--------------------------LILSMLNLDP 241

Query: 189 MKRITVDEALAHP 201
            KR  + + +A P
Sbjct: 242 SKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 76.4 bits (188), Expect = 3e-16
 Identities = 41/121 (33%), Positives = 69/121 (57%), Gaps = 2/121 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  SE+  +++  +++  L Y+HS +V++RDLK  NL+L+ +  +KI DFG
Sbjct: 81  ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFG 140

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 141 LCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Query: 123 H 123
           H
Sbjct: 200 H 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 75.8 bits (186), Expect = 3e-16
 Identities = 53/227 (23%), Positives = 102/227 (44%), Gaps = 40/227 (17%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +   E+  Q +  +++  L+++H   +I+RD+K  N+LL++N  + + DFG
Sbjct: 91  ELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 150

Query: 64  LARP--TSENEFMTEYVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMNRRPLFP- 119
           L++     E E    +  T  Y AP+++      +  A+D WS+G +  EL+     F  
Sbjct: 151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210

Query: 120 -GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G  +                        E ++R ++  P +P++        +  LA D
Sbjct: 211 DGEKNSQA---------------------EISRRILKSEPPYPQE--------MSALAKD 241

Query: 179 LVDRMLTFDPMKRI-----TVDEALAHPYLARLH-DEADEPVCPEPF 219
           ++ R+L  DP KR+       DE   HP+  +++ D+      P PF
Sbjct: 242 IIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPF 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 75.8 bits (186), Expect = 5e-16
 Identities = 39/118 (33%), Positives = 67/118 (56%), Gaps = 2/118 (1%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-F 73
            +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +    +   
Sbjct: 92  FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151

Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
           M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   DH     L++
Sbjct: 152 MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.2 bits (185), Expect = 5e-16
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 38/211 (18%)

Query: 1   MDTDLY----QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANC 55
           MDT L     ++     ++ E+        +++ L+Y+HS  +VIHRD+KPSN+L+N N 
Sbjct: 82  MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG 141

Query: 56  DLKICDFGLARPTSENEFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMEL- 111
            +K+CDFG++    ++   T     + Y APE +   LN   Y    DVWS+G   +EL 
Sbjct: 142 QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELA 201

Query: 112 MNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH 171
             R P         Q++ ++E                         PQ P +  +  F  
Sbjct: 202 TGRFPYDSWKTPFQQLKQVVE--EPS--------------------PQLPAEKFSPEF-- 237

Query: 172 VHPLAIDLVDRMLTFDPMKRITVDEALAHPY 202
                 D V++ L  +  +R    E L HP+
Sbjct: 238 -----QDFVNKCLKKNYKERPNYPELLQHPF 263

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 75.2 bits (185), Expect = 8e-16
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 9/156 (5%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L   L ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 84  DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 143

Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L++ + ++E     +  T  Y APE ++N   +T + D WS G +  E++     F G D
Sbjct: 144 LSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202

Query: 123 HVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQL 157
               M ++++  LG P      F+  E A+  +R L
Sbjct: 203 RKETMTMILKAKLGMPQ-----FLSPE-AQSLLRAL 232

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 75.8 bits (186), Expect = 9e-16
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 31/224 (13%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNAN----------------CDL 57
            S  H    ++Q    L Y H+  +++H DLKP N+L+  +                C +
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287

Query: 58  KICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           +ICD G      E    T  V TR YR+PE++L    +  + D+WS+GCI  EL   + L
Sbjct: 288 RICDLGGC--CDERHSRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGKLL 344

Query: 118 FPGNDHVHQMRLLIELLGT-PTD--ADLGFVRNEDAKRYIRQL-----PQH-PRQSLAQV 168
           +  +D++  + L+ + LG  P++     G            QL     P+H  R + A+ 
Sbjct: 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARP 404

Query: 169 FPHV--HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA 210
              V    L  DL+  +L +D  KR+   +   HPY+ + + E 
Sbjct: 405 VREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPEC 448

Length = 467

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.2 bits (182), Expect = 1e-15
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 30/179 (16%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF 144
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYL-NENPLRALYLIATNGTP------- 233

Query: 145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                      +L    + S          +  D ++R L  D  KR +  E L HP+L
Sbjct: 234 -----------ELQNPEKLS---------AIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.4 bits (183), Expect = 1e-15
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 41/229 (17%)

Query: 1   MDT-DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYI---HSANVIHRDLKPSNLLLNANCD 56
           MD   L Q+++    + E         +LRGL Y+   H   ++HRD+KPSN+L+N+  +
Sbjct: 81  MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGE 138

Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRR 115
           +K+CDFG++     +     +V TR Y +PE  L  + YT   D+WS+G   +E+ + R 
Sbjct: 139 IKLCDFGVSGQLI-DSMANSFVGTRSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGRY 196

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP---RQSLAQVF--- 169
           P+ P +         +E +     ++        AK   R +  HP    + +A +F   
Sbjct: 197 PIPPPD------AKELEAMFGRPVSEGE------AKESHRPVSGHPPDSPRPMA-IFELL 243

Query: 170 -----------PHVH--PLAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
                      P         D VD+ L  +P +R  + E   HP++ R
Sbjct: 244 DYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.3 bits (183), Expect = 1e-15
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 12/125 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+ +    E   +++  +++ GL+++H   +I+RDLK  N+LL++   +KI DFG
Sbjct: 82  DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFG 141

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E +   V T        Y APE+L     Y  A+D W++G +  E++  +  
Sbjct: 142 MCK-----EGILGGVTTSTFCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSP 195

Query: 118 FPGND 122
           F G+D
Sbjct: 196 FEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 32/219 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D   ++ +   LSE+H ++++ ++   +  +H    IHRDLKP N L++A+  +K+ DFG
Sbjct: 87  DFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFG 146

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L++      +    V +  Y APE +L    Y   +D WS+GC+  E +   P F G+  
Sbjct: 147 LSKGIV--TYANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                 L                     +Y ++  Q P     +        A DL+ ++
Sbjct: 204 NETWENL---------------------KYWKETLQRPVYDDPRFNLSDE--AWDLITKL 240

Query: 184 LTFDPMKRI-TVDEALAHPYLARLH----DEADEPVCPE 217
           +  DP +R  ++++   HP+   +      E   P  PE
Sbjct: 241 IN-DPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPE 278

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 73.0 bits (179), Expect = 2e-15
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 33/204 (16%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +D  L ++  + ++LSE     +  QLL G+ Y+H   ++HRDLK  N+ L  N  LKI 
Sbjct: 89  LDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIG 147

Query: 61  DFGLAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFG++R      +  T +  T +Y +PE  L    Y +  D+WS+GCI  E+      F 
Sbjct: 148 DFGVSRLLMGSCDLATTFTGTPYYMSPE-ALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G + +  +  ++E   TP+  +           Y RQL                     +
Sbjct: 207 GQNFLSVVLRIVE-GPTPSLPE----------TYSRQLNS-------------------I 236

Query: 180 VDRMLTFDPMKRITVDEALAHPYL 203
           +  ML  DP  R +  E L +P++
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 73.2 bits (180), Expect = 2e-15
 Identities = 34/102 (33%), Positives = 59/102 (57%), Gaps = 3/102 (2%)

Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVV 79
           +YF  QL   L+++HS  ++HRD+KP+N+ + A   +K+ D GL R  +S+       V 
Sbjct: 110 KYF-VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           T +Y +PE  ++ + Y    D+WS+GC+  E+   +  F G+
Sbjct: 169 TPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 74.0 bits (181), Expect = 2e-15
 Identities = 40/129 (31%), Positives = 71/129 (55%), Gaps = 2/129 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  SE+  +++  +++  L Y+HS  +++RDLK  NL+L+ +  +KI DFG
Sbjct: 81  ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFG 140

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   ++   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 141 LCKEGITDAATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 200 HEKLFELIL 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 73.0 bits (179), Expect = 2e-15
 Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 37/191 (19%)

Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-------PTSENE 72
           C+Y   Q+L G+ Y+H+  V+HRD+K +N++L  N  +K+ DFG AR         + + 
Sbjct: 105 CKY-TKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163

Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIE 132
            +     T ++ APE ++N S Y    D+WS+GC   E+   +P     D +  M  +  
Sbjct: 164 MLKSMHGTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-- 220

Query: 133 LLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI 192
                  A  G +          +LP     +           AID V   LT D  +R 
Sbjct: 221 ------GAHRGLM---------PRLPDSFSAA-----------AIDFVTSCLTRDQHERP 254

Query: 193 TVDEALAHPYL 203
           +  + L H +L
Sbjct: 255 SALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.7 bits (178), Expect = 3e-15
 Identities = 46/132 (34%), Positives = 74/132 (56%), Gaps = 6/132 (4%)

Query: 4   DLYQIIRSNQSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL-KIC 60
           DL + I   + +  SE+    +  Q+  GLK+IH   ++HRD+K  N+ L+ N  + K+ 
Sbjct: 85  DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLG 144

Query: 61  DFGLARPTSEN-EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFG+AR  +++ E     V T +Y +PE+  N   Y    D+WS+GC+  EL   +  F 
Sbjct: 145 DFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFE 203

Query: 120 GNDHVHQMRLLI 131
           GN+ +HQ+ L I
Sbjct: 204 GNN-LHQLVLKI 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 72.7 bits (178), Expect = 3e-15
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 34/203 (16%)

Query: 4   DLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DLY  ++  +   L E     +  Q+   L+Y+H  +++HRDLK  N+ L     +K+ D
Sbjct: 86  DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGD 145

Query: 62  FGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
            G+AR   ++ +  +  + T +Y +PEL  N   Y    DVW++GC   E+   +  F  
Sbjct: 146 LGIARVLENQCDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNA 204

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D    +  +IE                       +LP  P+    ++         +L+
Sbjct: 205 KDMNSLVYRIIE----------------------GKLPPMPKDYSPEL--------GELI 234

Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
             ML+  P KR +V   L  PY+
Sbjct: 235 ATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 72.6 bits (179), Expect = 3e-15
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 12/107 (11%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
            +LS +    F  Q+ +G++Y+ S   +HRDL   N L+  +  +KI DFGL+R   +++
Sbjct: 100 STLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159

Query: 73  FMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +   Y          RW  APE  L    +T+  DVWS G +  E+ 
Sbjct: 160 Y---YRKKTGGKLPIRWM-APE-SLKDGIFTSKSDVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.9 bits (179), Expect = 3e-15
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 38/224 (16%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           T LYQ     +  +E   + ++ +++  L ++H   +I+RD+K  N+LL++   + + DF
Sbjct: 94  THLYQ----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDF 149

Query: 63  GLARP--TSENEFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMNRRPLFP 119
           GL++     E E    +  T  Y APE++   S  +  A+D WS+G +  EL+     F 
Sbjct: 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            +   +                    ++E ++R ++  P  P          +   A D 
Sbjct: 210 VDGEQNS-------------------QSEISRRILKSKPPFP--------KTMSAEARDF 242

Query: 180 VDRMLTFDPMKRI---TVDEALAHPYLARLH-DEADEPVCPEPF 219
           + ++L  DP KR+     DE   HP+   +  D+      P PF
Sbjct: 243 IQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPF 286

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 72.7 bits (178), Expect = 5e-15
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 45/230 (19%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M T LYQ      + SE+  +++  +++  L+++H   +++RD+K  N+LL++   + + 
Sbjct: 92  MFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLT 147

Query: 61  DFGLARP--TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFGL++   + E E    +  T  Y APE++     +  A+D WS+G             
Sbjct: 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGI------------ 195

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRN---EDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
                     L+ ELL   +   L   RN   E ++R ++  P  P          + P 
Sbjct: 196 ----------LIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--------SFIGPE 237

Query: 176 AIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLHDEA-DEPVCPEPF 219
           A DL+ ++L  DP KR+        E   HP+   L  EA        PF
Sbjct: 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPF 287

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 72.4 bits (178), Expect = 6e-15
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 33/187 (17%)

Query: 31  LKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELL- 89
           LK  H   VIHRD+KPSN+LL+A+ ++K+CDFG++    +++  T       Y APE + 
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERID 187

Query: 90  --LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN 147
               +  Y    DVWS+G   +EL   +  +       ++              L  +  
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV--------------LTKILQ 233

Query: 148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH 207
           E+           P     + F    P     VD  LT D  KR    E L HP++ R +
Sbjct: 234 EEP----------PSLPPNEGFS---PDFCSFVDLCLTKDHRKRPKYRELLQHPFI-RRY 279

Query: 208 DEADEPV 214
           + A+  V
Sbjct: 280 ETAEVDV 286

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 72.1 bits (176), Expect = 7e-15
 Identities = 52/179 (29%), Positives = 88/179 (49%), Gaps = 30/179 (16%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF 144
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 184 APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTPE------ 235

Query: 145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                         Q+P + L+ +F        D ++R L  D  KR +  E L H +L
Sbjct: 236 -------------LQNP-EKLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.1 bits (176), Expect = 8e-15
 Identities = 51/179 (28%), Positives = 88/179 (49%), Gaps = 30/179 (16%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L+++H+  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF 144
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYL-NENPLRALYLIATNGTPE------ 234

Query: 145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                         Q+P +        + P+  D ++R L  D  KR +  E L HP+L
Sbjct: 235 -------------LQNPEK--------LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 53/236 (22%), Positives = 89/236 (37%), Gaps = 77/236 (32%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL---------- 64
            +EE  ++++ + +  +  IH    IHRD+KP NLLL+A   +K+ DFGL          
Sbjct: 98  FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157

Query: 65  ------------------ARPTSENEFMTEY-----------VVTRWYRAPELLLNSSDY 95
                             ++P S       +           V T  Y APE+ L +  Y
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-Y 216

Query: 96  TAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR 155
               D WS+G I  E++   P F  ++     R +I                        
Sbjct: 217 NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII------------------------ 252

Query: 156 QLPQHPRQSLAQVFP---HVHPLAIDLVDRMLTFDPMKRI---TVDEALAHPYLAR 205
               + +++L   FP    + P A DL+ R+   +  +R+    V+E  +HP+   
Sbjct: 253 ----NWKETL--QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.6 bits (175), Expect = 1e-14
 Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 18/172 (10%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSE 70
           ++ L+E   Q    Q+L  L+Y+HS  +IHRDLK  N+LL  + D+K+ DFG+ A+    
Sbjct: 104 DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163

Query: 71  NEFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            +    ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P +  ++ 
Sbjct: 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 220

Query: 127 MRLLIEL-------LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH 171
           MR+L+++       L  P+   + F   +  K  + + P+  R S AQ+  H
Sbjct: 221 MRVLLKIAKSEPPTLSQPSKWSMEF--RDFLKTALDKHPE-TRPSAAQLLEH 269

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 81  ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 140

Query: 63  GLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 141 GLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199

Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 200 DHEKLFELIL 209

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 71.4 bits (175), Expect = 1e-14
 Identities = 41/100 (41%), Positives = 56/100 (56%), Gaps = 8/100 (8%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVTRWYR 84
             L+GL Y+HS   IHRD+K  N+LL     +K+ DFG A   S  N F    V T ++ 
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF----VGTPYWM 178

Query: 85  APELLL--NSSDYTAAIDVWSVGCIFMELMNRR-PLFPGN 121
           APE++L  +   Y   +DVWS+G   +EL  R+ PLF  N
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 71.2 bits (174), Expect = 1e-14
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 23/169 (13%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSEN 71
           + L+E   +    Q L  L Y+H   +IHRDLK  N+L   + D+K+ DFG+ A+ T   
Sbjct: 98  RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157

Query: 72  EFMTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           +    ++ T ++ APE+++   S D  Y    DVWS+G   +E+     + P +  ++ M
Sbjct: 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ---IEPPHHELNPM 214

Query: 128 RLLIEL-------LGTPTDADLGF--------VRNEDAKRYIRQLPQHP 161
           R+L+++       L  P+     F         +N DA+    QL QHP
Sbjct: 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 71.3 bits (174), Expect = 1e-14
 Identities = 39/117 (33%), Positives = 69/117 (58%), Gaps = 5/117 (4%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DFG+A   ++ +  
Sbjct: 98  LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157

Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y +  D+WS+G   +EL       P +  +H M++L
Sbjct: 158 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGE---PPHSELHPMKVL 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 71.3 bits (174), Expect = 1e-14
 Identities = 53/179 (29%), Positives = 88/179 (49%), Gaps = 30/179 (16%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L ++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF 144
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYL-NENPLRALYLIATNGTPE------ 234

Query: 145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                         Q+P + L+ VF        D ++R L  D  +R +  E L HP+L
Sbjct: 235 -------------LQNP-ERLSAVFR-------DFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 71.0 bits (174), Expect = 2e-14
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 37/226 (16%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H   +I+RDLKP N+LL+ + +++I D GL
Sbjct: 84  IYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGL 143

Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGND 122
           A    + +  T+ Y  T  + APELL    +Y  ++D +++G    E++  R P     +
Sbjct: 144 AVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 202

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
            V    L   +L              D+  Y  +     +                  + 
Sbjct: 203 KVENKELKQRIL-------------NDSVTYPDKFSPASK---------------SFCEA 234

Query: 183 MLTFDPMKRI-----TVDEALAHPYLARLH-DEADEPVCPEPFSFD 222
           +L  DP KR+       D    HP    L+  + +  + P PF  D
Sbjct: 235 LLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 71.2 bits (174), Expect = 2e-14
 Identities = 40/117 (34%), Positives = 70/117 (59%), Gaps = 4/117 (3%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++  + + EE        +LRGL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 90  LDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG 149

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +EL + R P+ P
Sbjct: 150 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.6 bits (173), Expect = 2e-14
 Identities = 37/105 (35%), Positives = 59/105 (56%), Gaps = 3/105 (2%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPTSENEFMT 75
           E+   ++  Q+L GLKY+H   ++HRD+K  N+L+N     +KI DFG ++  +     T
Sbjct: 107 EQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166

Query: 76  E-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           E +  T  Y APE++      Y A  D+WS+GC  +E+   +P F
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.9 bits (174), Expect = 2e-14
 Identities = 43/130 (33%), Positives = 66/130 (50%), Gaps = 23/130 (17%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I ++   SE    ++   ++ GL+Y+H   +++RDLK  NLLL+    +KI DFG
Sbjct: 88  DLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFG 146

Query: 64  LARP-------TS----ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           L +        TS      EF+          APE+L  +S YT A+D W +G +  E++
Sbjct: 147 LCKEGMGFGDRTSTFCGTPEFL----------APEVLTETS-YTRAVDWWGLGVLIYEML 195

Query: 113 NRRPLFPGND 122
                FPG+D
Sbjct: 196 VGESPFPGDD 205

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 70.8 bits (173), Expect = 2e-14
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 34/212 (16%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +LR L Y+H+  VIHRD+K  ++LL ++  +K+ DFG  A+ 
Sbjct: 109 IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168

Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE +++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 169 SKEVPKRKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 227

Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
           R + + L  P   D                  H   S+ + F          +D ML  +
Sbjct: 228 RRIRDNL-PPRVKDS-----------------HKVSSVLRGF----------LDLMLVRE 259

Query: 188 PMKRITVDEALAHPYLARLHDEADEPVCPEPF 219
           P +R T  E L HP+L      A  P C  P 
Sbjct: 260 PSQRATAQELLQHPFLKL----AGPPSCIVPL 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 70.0 bits (171), Expect = 4e-14
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 35/202 (17%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-AR 66
           ++   Q L E    Y LY  L GL+++H+  +IHRD+K +N+LL     +K+ DFG+ A+
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177

Query: 67  PTSENEFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGN 121
            TS        V T ++ APE++         Y A  DVWS+G   +EL +   PLF   
Sbjct: 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF--- 234

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
             +H ++ L ++   P    L                 HP +   + F H        + 
Sbjct: 235 -DMHPVKTLFKIPRNPPPTLL-----------------HPEK-WCRSFNH-------FIS 268

Query: 182 RMLTFDPMKRITVDEALAHPYL 203
           + L  D   R +V   L HP++
Sbjct: 269 QCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 69.7 bits (170), Expect = 5e-14
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 38/209 (18%)

Query: 3   TDLYQ-IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           TDL +  ++  + + E    Y L++ L GL+++H    IHRD+K +N+LL     +K+ D
Sbjct: 108 TDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167

Query: 62  FGL-ARPTSENEFMTEYVVTRWYRAPELL-----LNSSDYTAAIDVWSVGCIFMELMNRR 115
           FG+ A+ TS        V T ++ APE++     L+S+ Y A  DVWS+G   +EL +  
Sbjct: 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGD 226

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
           P  P  D +H MR L                         ++P++P  +L Q  P +   
Sbjct: 227 P--PLAD-LHPMRALF------------------------KIPRNPPPTLHQ--PELWSN 257

Query: 176 AI-DLVDRMLTFDPMKRITVDEALAHPYL 203
              D + + LT D  KR TV + L H ++
Sbjct: 258 EFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.3 bits (169), Expect = 5e-14
 Identities = 45/130 (34%), Positives = 71/130 (54%), Gaps = 9/130 (6%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+Y +      LSE    Y   + L+GL Y+HS   +HRD+K +N+LL  N D+K+ DFG
Sbjct: 95  DIYHV---TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFG 151

Query: 64  L-ARPTSENEFMTEYVVTRWYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           + A+ T+       ++ T ++ APE+  +  +  Y    D+W+VG   +EL   +P  P 
Sbjct: 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP--PM 209

Query: 121 NDHVHQMRLL 130
            D +H MR L
Sbjct: 210 FD-LHPMRAL 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 69.7 bits (170), Expect = 5e-14
 Identities = 37/91 (40%), Positives = 55/91 (60%), Gaps = 5/91 (5%)

Query: 28  LRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPE 87
           L+GL Y+HS N+IHRD+K  N+LL     +K+ DFG A  +S       +V T ++ APE
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPE 187

Query: 88  LLL--NSSDYTAAIDVWSVGCIFMELMNRRP 116
           ++L  +   Y   +DVWS+G   +EL  R+P
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.3 bits (169), Expect = 5e-14
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 32/202 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+Y +      LSE    Y   + L+GL Y+HS   +HRD+K +N+LL  N  +K+ DFG
Sbjct: 95  DIYHV---TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFG 151

Query: 64  L-ARPTSENEFMTEYVVTRWYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           + A+ T+       ++ T ++ APE+  +     Y    D+W+VG   +EL   +P  P 
Sbjct: 152 VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP--PM 209

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D +H MR L  +    T ++    + +D  ++            +  F H        V
Sbjct: 210 FD-LHPMRALFLM----TKSNFQPPKLKDKMKW------------SNSFHH-------FV 245

Query: 181 DRMLTFDPMKRITVDEALAHPY 202
              LT +P KR T ++ L HP+
Sbjct: 246 KMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 70.3 bits (172), Expect = 6e-14
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 20/212 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +  L  E       +LL  L Y+H   +IHRD+K  N+ L+   +  + DFG
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG 230

Query: 64  LARPTSENEFMTE---YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFME-LMNRRPLF 118
            A     +    +   +  T    +PELL L+   Y A  D+WS G +  E  +    LF
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTLF 288

Query: 119 --PGNDHVHQMRLLIELLGTPTDADLGFVRNEDA------KRYIRQLPQHPRQSLAQVFP 170
                    Q+R +I  +       L F +N         K+Y   L + P      +  
Sbjct: 289 GKQVKSSSSQLRSIIRCMQV---HPLEFPQNGSTNLCKHFKQYAIVL-RPPYTIPPVIRK 344

Query: 171 HVHPLAID-LVDRMLTFDPMKRITVDEALAHP 201
           +   + ++ L+ +MLTFD   R +  + L+ P
Sbjct: 345 YGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376

Length = 392

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 68.7 bits (169), Expect = 8e-14
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 37/206 (17%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKIC 60
           D DL+ +++    LSE   +  + QL+  L  +H  N+IH D+K  N+L +   D + +C
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 61  DFGLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           D+GL +   +     + Y  T  Y +PE  +   +Y  + D W+VG +  EL+       
Sbjct: 153 DYGLCKIIGTP----SCYDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTG----- 202

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAID 178
                            P      F  +ED +  +  L    RQ     F  +V   A D
Sbjct: 203 ---------------KHP------FKEDEDEELDLESL--LKRQQKKLPFIKNVSKNAND 239

Query: 179 LVDRMLTFDPMKR-ITVDEALAHPYL 203
            V  ML ++   R    +E + HP+L
Sbjct: 240 FVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 69.0 bits (169), Expect = 8e-14
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 6/104 (5%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           ++L+++    F YQ+ RG++++ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 73  FMTEYVVTR----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +  +    R    W  APE L +   YT   DVWS G +  E+ 
Sbjct: 187 YYRKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.3 bits (169), Expect = 8e-14
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 5/91 (5%)

Query: 28  LRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPE 87
           L+GL Y+HS N+IHRD+K  N+LL     +K+ DFG A   S       +V T ++ APE
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFVGTPYWMAPE 191

Query: 88  LLL--NSSDYTAAIDVWSVGCIFMELMNRRP 116
           ++L  +   Y   +DVWS+G   +EL  R+P
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 37/120 (30%), Positives = 64/120 (53%), Gaps = 2/120 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S+    E   +++  +++ GL+++H   +I+RDLK  N+LL+ +  +KI DFG
Sbjct: 82  DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +     E     +  T  Y APE+L     Y  ++D WS G +  E++  +  F G D
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGED 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.2 bits (166), Expect = 1e-13
 Identities = 41/172 (23%), Positives = 87/172 (50%), Gaps = 8/172 (4%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           +++  +L+E   + +  Q+L G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 97  LKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156

Query: 69  S----ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
                    +     T ++ +PE +++   Y    DVWS+GC  +E++  +P  P  ++ 
Sbjct: 157 QTICMSGTGIRSVTGTPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKP--PWAEY- 212

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
             M  + ++   PT+  L    +E A+ ++  +    R   +      HP A
Sbjct: 213 EAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELLRHPFA 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.2 bits (167), Expect = 2e-13
 Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 34/222 (15%)

Query: 1   MDTDL---YQII--RSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNAN 54
           MD  L   Y+ +       + EE         ++ L Y+     +IHRD+KPSN+LL+ N
Sbjct: 85  MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN 144

Query: 55  CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELM 112
            ++K+CDFG++    ++   T     R Y APE +  S+   Y    DVWS+G    E+ 
Sbjct: 145 GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVA 204

Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV 172
             +  +P  + V       + L      D   + N + + +                   
Sbjct: 205 TGKFPYPKWNSV------FDQLTQVVKGDPPILSNSEEREFSPSF--------------- 243

Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
               ++ ++  L  D  KR    E L HP++ + ++E +  V
Sbjct: 244 ----VNFINLCLIKDESKRPKYKELLEHPFI-KDYEERNVDV 280

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.1 bits (166), Expect = 2e-13
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 1/107 (0%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
           N    E+   ++  +L  GL+ +    +++RDLKP N+LL+    ++I D GLA    E 
Sbjct: 96  NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155

Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           E +   V T  Y APE++ N   YT + D W +GC+  E++  +  F
Sbjct: 156 ETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.7 bits (165), Expect = 2e-13
 Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 39/213 (18%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE 76
           E    ++  ++  GL+ +H   +++RDLKP N+LL+ +  ++I D GLA    E + +  
Sbjct: 101 EGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160

Query: 77  YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGT 136
            V T  Y APE++ N   YT + D W++GC+  E++       G     Q +  I     
Sbjct: 161 RVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIA------GQSPFQQRKKKI----- 208

Query: 137 PTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI---- 192
                    + E+ +R ++++ +   +  +       P A  L   +L  DP +R+    
Sbjct: 209 ---------KREEVERLVKEVQEEYSEKFS-------PDARSLCKMLLCKDPKERLGCQG 252

Query: 193 -TVDEALAHPYLARLHDEA------DEPVCPEP 218
               E   HP   +++ +       + P  P+P
Sbjct: 253 GGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 2e-13
 Identities = 34/107 (31%), Positives = 61/107 (57%), Gaps = 2/107 (1%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT-SENEFMT 75
           E+   ++L ++   L+++H   +I+RDLKP N+LL+A   +K+ DFGL + +  E     
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 76  EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F   +
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 67.9 bits (166), Expect = 2e-13
 Identities = 44/117 (37%), Positives = 60/117 (51%), Gaps = 14/117 (11%)

Query: 4   DLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DL   +R  +   L+ E    F YQ+ +G+ ++ S N IHRDL   N+LL     +KICD
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184

Query: 62  FGLARPTSENEFMTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           FGLAR    +   + YVV        +W  APE + N   YT   DVWS G +  E+
Sbjct: 185 FGLARDIMND---SNYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.4 bits (164), Expect = 2e-13
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 23/178 (12%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TDL +  + N +L EE   Y   ++LRGL ++H   VIHRD+K  N+LL  N ++K+ DF
Sbjct: 97  TDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 155

Query: 63  GLARPTSEN-EFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMNRRPL 117
           G++            ++ T ++ APE++    +    Y    D+WS+G   +E+    P 
Sbjct: 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 214

Query: 118 FPGNDHVHQMRLLIELLGTPTD--------------ADLGFVRNEDAKRYIRQLPQHP 161
            P  D +H MR L  +   P                 +   V+N   +    QL +HP
Sbjct: 215 -PLCD-MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP 270

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.7 bits (165), Expect = 3e-13
 Identities = 29/97 (29%), Positives = 57/97 (58%), Gaps = 1/97 (1%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           ++  Q+  G+ ++HS ++++RD+KP N+LL+   + ++ D GLA    + + +T+   T 
Sbjct: 99  HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            Y APE+L     Y+  +D +++GC   E++  R  F
Sbjct: 159 GYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 67.2 bits (164), Expect = 3e-13
 Identities = 35/118 (29%), Positives = 62/118 (52%), Gaps = 4/118 (3%)

Query: 4   DLYQIIRSNQSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DLY+ I + + +   E+    +  Q+   LK++H   ++HRD+K  N+ L  +  +K+ D
Sbjct: 85  DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGD 144

Query: 62  FGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG+AR   S  E     + T +Y +PE+  N   Y    D+W++GC+  E+   +  F
Sbjct: 145 FGIARVLNSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.3 bits (164), Expect = 3e-13
 Identities = 35/109 (32%), Positives = 68/109 (62%), Gaps = 1/109 (0%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE+  +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 83  DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   S+ +     V T  Y APE+L   + Y ++ D +S+GC+  +L+
Sbjct: 143 LACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 67.0 bits (163), Expect = 4e-13
 Identities = 47/199 (23%), Positives = 90/199 (45%), Gaps = 35/199 (17%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           ++S  +L+E   + +  Q+L G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 97  LKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156

Query: 69  S----ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
                    M     T ++ +PE +++   Y    D+WSVGC  +E++  +P +      
Sbjct: 157 QTICLSGTGMKSVTGTPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEKPPWA---EF 212

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
             M  + ++   PT+                  P  P        PHV     D + R+ 
Sbjct: 213 EAMAAIFKIATQPTN------------------PVLP--------PHVSDHCRDFLKRIF 246

Query: 185 TFDPMKRITVDEALAHPYL 203
             +   R + DE L H ++
Sbjct: 247 V-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 4e-13
 Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 30/202 (14%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-PTSENEFMTEYVVTRWYR 84
           Q+L GL+Y+H+  +IHRD+K  N+ +N    + I D G A+ P     F+     T    
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVETN 223

Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELM------NRRPLFPGNDHV----HQMRLLIELL 134
           APE+L     Y +  D+WS G +  E++         P     ++V      +  +I  L
Sbjct: 224 APEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282

Query: 135 GT-----PTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP--LAID---LVDRML 184
                  P D     VR      +I       RQ   + +P      L ID   LV +ML
Sbjct: 283 KVHPEEFPRDPGSRLVRG-----FIEYASLE-RQPYTR-YPCFQRVNLPIDGEFLVHKML 335

Query: 185 TFDPMKRITVDEALAHPYLARL 206
           TFD   R + +E L +P  A+L
Sbjct: 336 TFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 67.3 bits (164), Expect = 4e-13
 Identities = 36/125 (28%), Positives = 69/125 (55%), Gaps = 3/125 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +S  E   +++  ++   L Y+HS N+++RDLKP N+LL++   + + DFG
Sbjct: 82  ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFG 141

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   ++++  T +  T  Y APE ++    Y   +D W +G +  E++   P F   D
Sbjct: 142 LCKEGIAQSDTTTTFCGTPEYLAPE-VIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200

Query: 123 HVHQM 127
            V +M
Sbjct: 201 -VAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 4e-13
 Identities = 33/115 (28%), Positives = 64/115 (55%), Gaps = 3/115 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +R++   S     ++  +++  L+Y+HS  +++RDLKP N+LL+    +K+ DFG
Sbjct: 87  ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFG 146

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+   +  +      T  Y APE ++ S  +  A+D W++G +  E++   P F
Sbjct: 147 FAKKLRDRTWTL--CGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 67.0 bits (163), Expect = 5e-13
 Identities = 40/116 (34%), Positives = 64/116 (55%), Gaps = 7/116 (6%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +DL ++    + L E       +  L+GL Y+HS N+IHRD+K  N+LL+    +K+ DF
Sbjct: 102 SDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRP 116
           G A   +       +V T ++ APE++L  +   Y   +DVWS+G   +EL  R+P
Sbjct: 160 GSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 5e-13
 Identities = 62/248 (25%), Positives = 97/248 (39%), Gaps = 73/248 (29%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA--- 65
           IR +    EE  ++++ +L+  L  +H    IHRD+KP N+L++A+  +K+ DFGL    
Sbjct: 93  IRKDV-FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151

Query: 66  ---------RPTSENEFMTEYVVTRW------------------YRAPELLLNSSDYTAA 98
                       S N    + V+ R                   Y APE+L   + Y   
Sbjct: 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLE 210

Query: 99  IDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP 158
            D WS+G I  E++   P F  +                          E   + I    
Sbjct: 211 CDWWSLGVILYEMLYGFPPFYSDT-----------------------LQETYNKII---- 243

Query: 159 QHPRQSLAQVFPHVHPL---AIDLVDRMLTFDPMKRIT-VDEALAHPY-----LARLHDE 209
            + ++SL   FP   P+   AIDL+ R+L  DP  R+   +E  +HP+        L + 
Sbjct: 244 -NWKESL--RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLRET 299

Query: 210 ADEPVCPE 217
              P  PE
Sbjct: 300 -KPPFVPE 306

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.8 bits (163), Expect = 5e-13
 Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 40/191 (20%)

Query: 25  YQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWY 83
           Y +++GLK++    N+IHRD+KP+N+L+N N  +K+CDFG++     +   T  +  + Y
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-IGCQSY 167

Query: 84  RAPELL--LNSSD---YTAAIDVWSVGCIFMEL-MNRRPLFP--GNDHVHQMRLLIELLG 135
            APE +     +    YT   DVWS+G   +E+ + R P  P    +   Q+  +++  G
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--G 225

Query: 136 TPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVD 195
            P                    P  P              A D V + L   P +R T  
Sbjct: 226 DP--------------------PTLP--------SGYSDDAQDFVAKCLNKIPNRRPTYA 257

Query: 196 EALAHPYLARL 206
           + L HP+L + 
Sbjct: 258 QLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.1 bits (164), Expect = 5e-13
 Identities = 38/125 (30%), Positives = 63/125 (50%), Gaps = 12/125 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++HS  +I+RDLK  N++L+A   +KI DFG
Sbjct: 87  DLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFG 146

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E +     TR       Y APE++     Y  ++D W+ G +  E++  +P 
Sbjct: 147 MCK-----ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPP 200

Query: 118 FPGND 122
           F G D
Sbjct: 201 FDGED 205

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 67.2 bits (164), Expect = 5e-13
 Identities = 41/105 (39%), Positives = 54/105 (51%), Gaps = 12/105 (11%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           +L  E    F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +  
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND-- 267

Query: 74  MTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + YVV        +W  APE + N   YT   DVWS G +  E+
Sbjct: 268 -SNYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 66.9 bits (163), Expect = 6e-13
 Identities = 39/125 (31%), Positives = 66/125 (52%), Gaps = 3/125 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +   E   +++  ++   + Y+HS N+I+RDLKP N+LL++   + + DFG
Sbjct: 82  ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFG 141

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   E E  T  +  T  Y APE +L    Y   +D W +G +  E++   P F   D
Sbjct: 142 LCKEGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Query: 123 HVHQM 127
            V QM
Sbjct: 201 -VSQM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 66.2 bits (161), Expect = 6e-13
 Identities = 41/112 (36%), Positives = 61/112 (54%), Gaps = 6/112 (5%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           F  Q+  G+ +I   N IHRDL+ +N+L++A+   KI DFGLAR   +NE+         
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 166

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLL 130
            +W  APE  +N   +T   DVWS G + ME++   R  +PG  +   +R L
Sbjct: 167 IKW-TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.4 bits (162), Expect = 8e-13
 Identities = 37/121 (30%), Positives = 64/121 (52%), Gaps = 2/121 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +S  E   +++  ++   L Y+HS N+I+RDLKP N+LL++   + + DFG
Sbjct: 82  ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFG 141

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   E+   T  +  T  Y APE+L     Y   +D W +G +  E++   P F   D
Sbjct: 142 LCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Query: 123 H 123
            
Sbjct: 201 T 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 66.9 bits (163), Expect = 8e-13
 Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 28/232 (12%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TDLY  + + ++++          +LR ++Y+H   +IHRD+K  N+ +N   D+ + DF
Sbjct: 167 TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226

Query: 63  GLARPTSENEFMTEYVVTRWY--------RAPELLLNSSDYTAAIDVWSVGCIFME---- 110
           G A       F  +    ++Y         APELL     Y  A+D+WS G +  E    
Sbjct: 227 GAAC------FPVDINANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATC 279

Query: 111 ---LMNRRPLFPGNDHVHQMRLLIELLGT-PTDADLGFVRNEDAKRYIRQLPQHPRQSLA 166
              L  +  L    D   Q++L+I   GT P +  +    N D + YI    +  R+  +
Sbjct: 280 HDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD-EIYIGLAKKSSRKPGS 338

Query: 167 Q-VFPHVHPLAID---LVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
           + ++ +++ L ID   L+ +ML FD   R + +  L       + D    P+
Sbjct: 339 RPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPNPM 390

Length = 391

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 66.2 bits (161), Expect = 9e-13
 Identities = 44/140 (31%), Positives = 73/140 (52%), Gaps = 9/140 (6%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TDL +  + N +L E+   Y   ++LRGL ++H+  VIHRD+K  N+LL  N ++K+ DF
Sbjct: 107 TDLVKNTKGN-ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165

Query: 63  GLARPTSEN-EFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPL 117
           G++            ++ T ++ APE++       + Y    D+WS+G   +E+    P 
Sbjct: 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP- 224

Query: 118 FPGNDHVHQMRLLIELLGTP 137
            P  D +H MR L  +   P
Sbjct: 225 -PLCD-MHPMRALFLIPRNP 242

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.4 bits (162), Expect = 9e-13
 Identities = 35/115 (30%), Positives = 62/115 (53%), Gaps = 3/115 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +R       +  +++  +L+   +Y+HS ++I+RDLKP NLLL+    +K+ DFG
Sbjct: 104 ELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFG 163

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+   +  F      T  Y APE ++ S  +  A+D W++G +  E +   P F
Sbjct: 164 FAKKVPDRTFT--LCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.7 bits (160), Expect = 1e-12
 Identities = 38/120 (31%), Positives = 69/120 (57%), Gaps = 3/120 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 83  DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+  R   P   H
Sbjct: 143 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL--RGHSPFRQH 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 65.4 bits (160), Expect = 1e-12
 Identities = 38/100 (38%), Positives = 52/100 (52%), Gaps = 8/100 (8%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VVTRW 82
           Q+  G+ Y+ S N IHRDL   N+L+  N   KI DFGLAR   ++E+          +W
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW 170

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
             APE   N   +T   DVWS G +  E++   R P +PG
Sbjct: 171 -TAPE-AANYGRFTIKSDVWSFGILLTEIVTYGRVP-YPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.8 bits (160), Expect = 1e-12
 Identities = 58/236 (24%), Positives = 110/236 (46%), Gaps = 44/236 (18%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 90  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 149

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFPGND 122
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P + 
Sbjct: 150 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD- 206

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH-PLAI---- 177
                + L  + G P + D        A+      P+ P + L+   P    P+AI    
Sbjct: 207 ----AKELELMFGCPVEGD-------PAESETSPRPRPPGRPLSSYGPDSRPPMAIFELL 255

Query: 178 ---------------------DLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE 212
                                D V++ L  +P +R  + + + H ++ R   EA+E
Sbjct: 256 DYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR--SEAEE 309

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 35/95 (36%), Positives = 58/95 (61%), Gaps = 6/95 (6%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTE---YV 78
           F YQ+ RG++++ S N +HRDL   N+LL     +KICDFGLAR    ++ ++++   ++
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             +W  APE + ++  YT   DVWS G +  E+ +
Sbjct: 302 PVKWM-APESIFDNL-YTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 64.4 bits (157), Expect = 3e-12
 Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 6/115 (5%)

Query: 4   DLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
            L   +RS   Q L          Q+  G+ Y+   N IHRDL   N+L+  +   K+ D
Sbjct: 88  SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVAD 147

Query: 62  FGLARPTSENEFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           FGLAR   E+ +++    +  +W  APE   +   ++   DVWS G +  E+   
Sbjct: 148 FGLARLIKEDVYLSSDKKIPYKW-TAPE-AASHGTFSTKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.3 bits (156), Expect = 3e-12
 Identities = 36/153 (23%), Positives = 82/153 (53%), Gaps = 8/153 (5%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           +++  +L+E   + +  Q+L+G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 97  LKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156

Query: 69  S----ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
                    +     T ++ +PE +++   Y    DVWSV C  +E++  +P  P  ++ 
Sbjct: 157 QTICMSGTGIKSVTGTPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKP--PWAEY- 212

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
             M  + ++   PT   L    ++  + +++Q+
Sbjct: 213 EAMAAIFKIATQPTKPMLPDGVSDACRDFLKQI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 64.8 bits (158), Expect = 3e-12
 Identities = 38/100 (38%), Positives = 58/100 (58%), Gaps = 10/100 (10%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEYVVTRW 82
           Q+L G+ Y+H  +++HRD+KPSNLL+N+  ++KI DFG++R     + M      V T  
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIA 233

Query: 83  YRAPELL---LNSSDYTA-AIDVWSVGCIFMEL-MNRRPL 117
           Y +PE +   LN   Y   A D+WS+G   +E  + R P 
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 64.7 bits (157), Expect = 3e-12
 Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 2/116 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 141

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F
Sbjct: 142 MCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.5 bits (157), Expect = 3e-12
 Identities = 36/115 (31%), Positives = 62/115 (53%), Gaps = 3/115 (2%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           ++QI RS +   E   +++  ++   L ++H   VI+RDLK  N+LL+A    K+ DFG+
Sbjct: 84  MFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGM 142

Query: 65  ARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            +         T +  T  Y APE +L   +Y  ++D W++G +  E+M  +P F
Sbjct: 143 CKEGILNGVTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 64.3 bits (156), Expect = 4e-12
 Identities = 34/116 (29%), Positives = 65/116 (56%), Gaps = 2/116 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L ++H   +I+RDLK  N+LL+A+  +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYG 141

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + +      +  + +  T  Y APE +L   +Y  ++D W++G +  E+M  R  F
Sbjct: 142 MCKEGLGPGDTTSTFCGTPNYIAPE-ILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.3 bits (156), Expect = 5e-12
 Identities = 34/116 (29%), Positives = 63/116 (54%), Gaps = 2/116 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +   E   +++  ++   L Y+HS N+++RDLKP N+LL++   + + DFG
Sbjct: 82  ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 141

Query: 64  LARPTSE-NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           L +   E N   + +  T  Y APE +L+   Y   +D W +G +  E++   P F
Sbjct: 142 LCKENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.1 bits (156), Expect = 5e-12
 Identities = 40/117 (34%), Positives = 62/117 (52%), Gaps = 17/117 (14%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
             +LY+     + L+ E    + +Q+ RG++++ S   IHRDL   N+LL+ N  +KICD
Sbjct: 162 GDELYK-----EPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICD 216

Query: 62  FGLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           FGLAR   ++    +YV         +W  APE + +   YT   DVWS G +  E+
Sbjct: 217 FGLARDIYKD---PDYVRKGDARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.9 bits (155), Expect = 6e-12
 Identities = 40/117 (34%), Positives = 63/117 (53%), Gaps = 17/117 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DLY+     + L+ E    + +Q+ +G++++ S   IHRDL   N+LL+ N  +KICDFG
Sbjct: 170 DLYK-----KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 224

Query: 64  LARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           LAR   ++    +YV         +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 225 LARDIYKD---PDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.5 bits (154), Expect = 6e-12
 Identities = 38/99 (38%), Positives = 52/99 (52%), Gaps = 6/99 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VVTRW 82
           Q+  G+ YI   N IHRDL+ +N+L+      KI DFGLAR   +NE+          +W
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL+ + R  +PG
Sbjct: 170 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.8 bits (155), Expect = 7e-12
 Identities = 37/119 (31%), Positives = 63/119 (52%), Gaps = 3/119 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           + +  +R N+    +   ++  Q++   +Y+ S N+++RDLKP NLLL+ +  +K+ DFG
Sbjct: 117 EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            A+      +      T  Y APE+LLN     AA D W++G    E++   P F  N+
Sbjct: 177 FAKVVDTRTYT--LCGTPEYIAPEILLNVGHGKAA-DWWTLGIFIYEILVGCPPFYANE 232

Length = 340

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 63.1 bits (153), Expect = 8e-12
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 6/123 (4%)

Query: 4   DLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           DL ++I+      + + E+    +  QL   L+++HS  V+HRD+KP+N+ + A   +K+
Sbjct: 88  DLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKL 147

Query: 60  CDFGLARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            D GL R  S        +V T +Y +PE  ++ + Y    D+WS+GC+  E+   +  F
Sbjct: 148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Query: 119 PGN 121
            G+
Sbjct: 207 YGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.8 bits (152), Expect = 9e-12
 Identities = 39/99 (39%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VVTRW 82
           Q+  G+ YI   N IHRDL+ +N+L+  N   KI DFGLAR   +NE+          +W
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL+ + R  +PG
Sbjct: 170 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 62.8 bits (152), Expect = 1e-11
 Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 6/102 (5%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VV 79
              Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+         
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
            +W  APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 167 IKW-TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 62.7 bits (152), Expect = 1e-11
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 6/123 (4%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           DL Q+I    +  + + E     +  QL   ++++HS  V+HRD+KP+N+ + A   +K+
Sbjct: 88  DLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKL 147

Query: 60  CDFGLAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            D GL R  +S+       V T +Y +PE  ++ + Y    D+WS+GC+  E+   +  F
Sbjct: 148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Query: 119 PGN 121
            G+
Sbjct: 207 YGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 62.7 bits (152), Expect = 1e-11
 Identities = 43/127 (33%), Positives = 69/127 (54%), Gaps = 18/127 (14%)

Query: 12  NQSLSEEHCQYFLYQL---LRG----LKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           ++ L +   ++  YQL   LRG    +KY+   N +HRDL   N+L+N+N + K+ DFGL
Sbjct: 94  DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGL 153

Query: 65  ARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
           +R   E++    Y  +      RW  APE  +    +T+A DVWS G +  E+M+   RP
Sbjct: 154 SR-VLEDDPEGTYTTSGGKIPIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Query: 117 LFPGNDH 123
            +  ++H
Sbjct: 211 YWDMSNH 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 37/120 (30%), Positives = 65/120 (54%), Gaps = 2/120 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 82  DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFG 141

Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +     +  T  +  T  Y APE+LL    Y  ++D WS G +  E++  +  F G+D
Sbjct: 142 MCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 6/102 (5%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           F  Q+  G+ YI   N IHRDL+ +N+L++ +   KI DFGLAR   +NE+         
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPG 120
            +W  APE  +N   +T   DVWS G +  E++    + +PG
Sbjct: 168 IKW-TAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.6 bits (152), Expect = 1e-11
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 28/176 (15%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR---- 81
           Q+ +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +    ++   EY   +    
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK---EYYTVKDDLD 173

Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
               WY APE L+ S  Y A+ DVWS G    EL+        +     M L ++++G P
Sbjct: 174 SPVFWY-APECLIQSKFYIAS-DVWSFGVTLYELLTY-----CDSESSPMTLFLKMIG-P 225

Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           T   +   R        ++LP+ P     +V+         L+ +   F P KR T
Sbjct: 226 THGQMTVTRLVRVLEEGKRLPR-PPNCPEEVY--------QLMRKCWEFQPSKRTT 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.4 bits (152), Expect = 1e-11
 Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 13/100 (13%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+ +G+ Y+ S   IHRDL   N+L+ +   +KI DFGLA+   E++   +Y   + 
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK---DYYYVKE 170

Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
                  WY APE  L +S +++A DVWS G    EL   
Sbjct: 171 PGESPIFWY-APE-CLRTSKFSSASDVWSFGVTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 40/107 (37%), Positives = 57/107 (53%), Gaps = 15/107 (14%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F  Q+ +G+ ++ S N IHRD+   N+LL      KICDFGLAR    N+  + YVV   
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-MND--SNYVVKGN 273

Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MNRRPLFPG 120
                +W  APE + +   YT   DVWS G +  E+  + + P +PG
Sbjct: 274 ARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 2/116 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L ++H   +I+RDLK  N+LL+A   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 141

Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F
Sbjct: 142 MCKEGIRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 52/226 (23%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTEY 77
           ++  +++ GL+++HS  +I+RDLK  N++L+ +  +KI DFG+ +   EN F     + +
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTF 156

Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
             T  Y APE+L     YT ++D WS G +  E++  +  F G+D               
Sbjct: 157 CGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------------- 201

Query: 138 TDADLGFVRNEDAKRYIRQ-LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDE 196
                     ++    IR   P +PR    +        + D+++++   DP +R+ V  
Sbjct: 202 ----------DELFESIRVDTPHYPRWITKE--------SKDILEKLFERDPTRRLGVVG 243

Query: 197 AL-AHPYLARLH------DEADEPVCPEPFS----FDFEQQSLGEE 231
            +  HP+   ++       E D P  P+  S     +F+++ L E+
Sbjct: 244 NIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEK 289

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.8 bits (150), Expect = 2e-11
 Identities = 38/100 (38%), Positives = 50/100 (50%), Gaps = 13/100 (13%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+HS + IHRDL   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 168

Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
                  WY A E L  +    A+ DVWS G    EL+  
Sbjct: 169 DGDSPVFWY-AVECLKENKFSYAS-DVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 61.8 bits (150), Expect = 2e-11
 Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 8/100 (8%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVVTRW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 170 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.5 bits (149), Expect = 2e-11
 Identities = 34/111 (30%), Positives = 59/111 (53%), Gaps = 7/111 (6%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ ++E++    ++Q+  G+KY+   N +HRDL   N+LL      KI DFGL
Sbjct: 82  LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL 141

Query: 65  ARPTSENEFMTEYVVT-----RWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++    +E   +         +WY APE  +N   +++  DVWS G +  E
Sbjct: 142 SKALGADENYYKAKTHGKWPVKWY-APE-CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 61.7 bits (150), Expect = 3e-11
 Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 10/109 (9%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW--- 82
           Q+  G+ Y+ + N IHRDL   N+L+  N   K+ DFGLAR   E+ +       ++   
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIK 169

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG--NDHVHQM 127
           + APE     + ++   DVWS G +  E++   R P +PG  N  V Q 
Sbjct: 170 WTAPE-AALYNRFSIKSDVWSFGILLTEIVTYGRMP-YPGMTNAEVLQQ 216

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 38/113 (33%), Positives = 63/113 (55%), Gaps = 6/113 (5%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           T    +I  + +LS      F YQ+  G++++ S N +HRDL   N+L+     +KICDF
Sbjct: 224 TRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDF 283

Query: 63  GLARP-TSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           GLAR    ++ ++++   ++  +W  APE + N+  YT   DVWS G +  E+
Sbjct: 284 GLARDIMRDSNYISKGSTFLPLKWM-APESIFNNL-YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 12/98 (12%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           + +Q+ RG++++ S   IHRDL   N+LL+ N  +KICDFGLAR   ++    +YV    
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGS 235

Query: 81  -----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 236 ARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 3e-11
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQ+ RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203

Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 204 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 61.2 bits (149), Expect = 4e-11
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 12/99 (12%)

Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV 79
           C Y + Q+  G++Y+ S   IHRDL   N+LL ++  +KI DFGL R   +NE   ++ V
Sbjct: 100 CDYAV-QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE---DHYV 155

Query: 80  TRWYR-------APELLLNSSDYTAAIDVWSVGCIFMEL 111
              +        APE  L +  ++ A DVW  G    E+
Sbjct: 156 MEEHLKVPFAWCAPE-SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 61.0 bits (148), Expect = 5e-11
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 11/96 (11%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY-------VVTRW 82
           G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R   ++     Y       +  RW
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
             APE  +    +T+A DVWS G +  E+M+   RP
Sbjct: 178 -TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 60.5 bits (147), Expect = 5e-11
 Identities = 28/90 (31%), Positives = 50/90 (55%), Gaps = 7/90 (7%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTR 81
            +   ++Y+ S   IHRDL   N L+  +  +K+ DFGLAR   ++++     T++ V +
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV-K 166

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           W  AP  + + S +++  DVWS G +  E+
Sbjct: 167 W--APPEVFDYSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.2 bits (148), Expect = 5e-11
 Identities = 35/120 (29%), Positives = 63/120 (52%), Gaps = 2/120 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++HS  +I+RDLK  N++L++   +KI DFG
Sbjct: 87  DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG 146

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +    +   T+ +  T  Y APE ++    Y  ++D W+ G +  E++  +  F G D
Sbjct: 147 MCKENMWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 60.5 bits (147), Expect = 6e-11
 Identities = 45/189 (23%), Positives = 72/189 (38%), Gaps = 38/189 (20%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
            SL       + YQL   L Y+ S   +HRD+   N+L+++   +K+ DFGL+R   +  
Sbjct: 102 YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161

Query: 73  FMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR--RPLFPGNDHVHQM 127
           +          +W  APE  +N   +T+A DVW  G    E++    +P           
Sbjct: 162 YYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ--------- 210

Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
                            V+N D    I ++    R  +    P   P    L+ +   +D
Sbjct: 211 ----------------GVKNNDV---IGRIENGERLPMPPNCP---PTLYSLMTKCWAYD 248

Query: 188 PMKRITVDE 196
           P KR    E
Sbjct: 249 PSKRPRFTE 257

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 6e-11
 Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 24  LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTE--YVV 79
           L  +  G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R    SE  + T+   + 
Sbjct: 112 LRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 172 IRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.5 bits (147), Expect = 7e-11
 Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 27/139 (19%)

Query: 18  EHCQYFLY--QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT 75
           +H +  LY  Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGL +   +++   
Sbjct: 106 DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK--- 162

Query: 76  EYVVTR--------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP--LF-- 118
           EY   R        WY APE  L  S ++ A DVWS G +  EL      +  P   F  
Sbjct: 163 EYYKVREPGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR 220

Query: 119 -PGNDHVHQMRL--LIELL 134
             GND   QM +  LIELL
Sbjct: 221 MMGNDKQGQMIVYHLIELL 239

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.8 bits (147), Expect = 7e-11
 Identities = 37/125 (29%), Positives = 63/125 (50%), Gaps = 12/125 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E    ++  ++  GL ++H   +I+RDLK  N++L++   +KI DFG
Sbjct: 87  DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFG 146

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E M + V TR       Y APE++     Y  ++D W+ G +  E++  +P 
Sbjct: 147 MCK-----EHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPP 200

Query: 118 FPGND 122
           F G D
Sbjct: 201 FDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 60.2 bits (146), Expect = 8e-11
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 6/85 (7%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTRWYRA 85
           G++Y+ S N IHRDL   N L+  N  LKI DFG++R      +      + +  +W  A
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TA 163

Query: 86  PELLLNSSDYTAAIDVWSVGCIFME 110
           PE  LN   YT+  DVWS G +  E
Sbjct: 164 PE-ALNYGRYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.9 bits (148), Expect = 8e-11
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 5/107 (4%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           SN  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG       
Sbjct: 135 SNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194

Query: 71  NEFM--TEYVVTRWYRAPELLLN---SSDYTAAIDVWSVGCIFMELM 112
           N  +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 38/126 (30%), Positives = 68/126 (53%), Gaps = 8/126 (6%)

Query: 4   DLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           DL Q I+S    N++  E        Q+L  + ++HS ++IHRD+K +N+LL +N  +K+
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 60  CDFGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
            DFG ++    T  ++    +  T +Y APE +     Y+   D++S+G +  EL+  + 
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKR 243

Query: 117 LFPGND 122
            F G +
Sbjct: 244 PFDGEN 249

Length = 496

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 49/204 (24%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--------------- 66
           YF   +L  L+Y+H+  ++HRDLKP NLL+ +   +K+ DFGL++               
Sbjct: 106 YFAETVL-ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 67  PTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
                EF+ + V  T  Y APE++L    Y   +D W++G I  E +     F G+    
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPE- 222

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                 EL G     D+ +   ++A      LP                 A DL+ R+L 
Sbjct: 223 ------ELFGQVISDDIEWPEGDEA------LP---------------ADAQDLISRLLR 255

Query: 186 FDPMKRITVDEAL---AHPYLARL 206
            +P++R+    A     H +   L
Sbjct: 256 QNPLERLGTGGAFEVKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 1e-10
 Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 5/100 (5%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     ++  +    R   
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200

Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPG 120
            + APE L +   YT   DVWS G +  E+       +PG
Sbjct: 201 KWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 1e-10
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 6/108 (5%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
             + Q+LS +   +   Q+  G+ Y+H   VIH+D+   N +++    +KI D  L+R  
Sbjct: 108 ANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Query: 69  SENEFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
              ++      E    +W  A E L+N  +Y++A DVWS G +  ELM
Sbjct: 168 FPMDYHCLGDNENRPVKWM-ALESLVN-KEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR   + ++  +    R   
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV 200

Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 201 KWMAPEALFDRV-YTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.9 bits (142), Expect = 3e-10
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     ++  +    R   
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206

Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 207 KWMAPEALFDRI-YTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 3e-10
 Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 51/170 (30%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS----- 69
           LSEE  +++  ++L  L+Y+H   +++RDLKP N+LL+ +  + + DF L++ +      
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159

Query: 70  -----------------ENEFMTE--------YVVTRWYRAPELLLNSSDYTAAIDVWSV 104
                             +E  +E        +V T  Y APE +++   + +A+D W++
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTL 218

Query: 105 GCIFMELM---------NRR----------PLFPGNDHV-HQMRLLIELL 134
           G +  E++         NR             FPG+  V    R LI  L
Sbjct: 219 GILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKL 268

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.0 bits (140), Expect = 4e-10
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 11/95 (11%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT------RWY 83
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+R   E++    Y         RW 
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRW- 175

Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
            APE  +    +T+A DVWS G +  E+M+   RP
Sbjct: 176 TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 58.8 bits (142), Expect = 4e-10
 Identities = 59/202 (29%), Positives = 85/202 (42%), Gaps = 39/202 (19%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG---LARPTSENEFMTEYVVTRW 82
           QLL  + YIH   +IHRD+K  N+L+N   D+ + DFG    AR +    F      T  
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 83  YRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLF--PGNDHVHQMRLLIELLGTPTD 139
             APE+L     YT ++D+WS G  IF   ++   LF     D              P D
Sbjct: 328 TNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR-----------PYD 375

Query: 140 ADLGFVRNEDAKRYIRQLPQHPRQSLAQVF----------PHVHP-------LAID---L 179
           A +  +  + A+ ++ + PQH    L   +           +  P       L +D   L
Sbjct: 376 AQILRIIRQ-AQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYL 434

Query: 180 VDRMLTFDPMKRITVDEALAHP 201
           V R LTFD  +R +  E L  P
Sbjct: 435 VCRALTFDGARRPSAAELLRLP 456

Length = 461

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 35/123 (28%), Positives = 62/123 (50%), Gaps = 4/123 (3%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           ++  + Q ++ +    E       YQ++  L  +HS  ++HRDLK +N+ L     +K+ 
Sbjct: 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211

Query: 61  DFGLARPTSEN---EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           DFG ++  S++   +  + +  T +Y APE L     Y+   D+WS+G I  EL+     
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRP 270

Query: 118 FPG 120
           F G
Sbjct: 271 FKG 273

Length = 478

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.9 bits (140), Expect = 5e-10
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 13/120 (10%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL   IRS   + + +    F  Q+ +G++Y+ S   +HRDL   N +L+ +  +K+ DF
Sbjct: 83  DLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADF 142

Query: 63  GLARPTSENEFMTEYVVTRWYRAPEL--------LLNSSDYTAAIDVWSVGCIFMELMNR 114
           GLAR   + E+   Y V   +   +L         L +  +T   DVWS G +  ELM R
Sbjct: 143 GLARDIYDKEY---YSVHN-HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 42/151 (27%), Positives = 63/151 (41%), Gaps = 37/151 (24%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+  ++    +LSEE  Q+++ + +  +  IH    IHRD+KP NLLL+A   +K+ DFG
Sbjct: 87  DMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFG 146

Query: 64  LA-----------------RPTSENEFMT-------------------EYVVTRWYRAPE 87
           L                   P S+  F                       V T  Y APE
Sbjct: 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206

Query: 88  LLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + + +  Y    D WS+G I  E++   P F
Sbjct: 207 VFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.3 bits (141), Expect = 6e-10
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 37/205 (18%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
           R      E+  Q++L +L+  +  +H    +HRD+KP N+L++    +K+ DFG A   +
Sbjct: 94  RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153

Query: 70  ENE--FMTEYVVTRWYRAPELL--LNSSD---YTAAIDVWSVGCIFMELM-NRRPLFPGN 121
            N+       V T  Y APE+L  +N      Y    D WS+G I  E++  R P   G 
Sbjct: 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
                  ++                  + +R+++  P+ P+ S            +DL+ 
Sbjct: 214 SAKTYNNIM------------------NFQRFLK-FPEDPKVSSD---------FLDLIQ 245

Query: 182 RMLTFDPMKRITVDEALAHPYLARL 206
            +L     +R+  +    HP+ +++
Sbjct: 246 SLLC-GQKERLGYEGLCCHPFFSKI 269

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.0 bits (140), Expect = 6e-10
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 14/96 (14%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY-------- 77
           Q+  G+KY+ S N +HRDL   N L+  N  +KI DFG++R    N +  +Y        
Sbjct: 138 QIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSGDYYRIQGRAV 193

Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           +  RW     +LL    +T A DVW+ G    E++ 
Sbjct: 194 LPIRWMSWESILLGK--FTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 6e-10
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 11/108 (10%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++  + +     +   +Q+  G+ Y+ S + +HRDL   N+LL      KI DFG+
Sbjct: 82  LLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGM 141

Query: 65  ARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVG 105
           +R          Y  T       +WY APE  +N   +++  DVWS G
Sbjct: 142 SRALGAGS--DYYRATTAGRWPLKWY-APE-CINYGKFSSKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 58.6 bits (141), Expect = 8e-10
 Identities = 40/127 (31%), Positives = 57/127 (44%), Gaps = 25/127 (19%)

Query: 26  QLLRGLKYIHS-------ANVIHRDLKPSNLLL-----------------NANCDLKICD 61
           QLL  L Y H+         V+HRDLKP N+ L                 N     KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPG 120
           FGL++           V T +Y +PELLL+ +  Y    D+W++GCI  EL + +  F  
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 121 NDHVHQM 127
            ++  Q+
Sbjct: 246 ANNFSQL 252

Length = 1021

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 8e-10
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 8/97 (8%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTE--YVVTR 81
           Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  E   V  +
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
           W  A E +L+   YT   DVWS G    ELM    +P
Sbjct: 177 WM-ALESILH-RIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 57.7 bits (139), Expect = 8e-10
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YV 78
           F +Q+ RG++Y+    ++HRDL   N+L+     +KI DFGL+R   E +   +     +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
             +W  A E L +   YT   DVWS G +  E++
Sbjct: 192 PVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 56.5 bits (136), Expect = 1e-09
 Identities = 32/84 (38%), Positives = 46/84 (54%), Gaps = 5/84 (5%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT---EYVVTRWYRAP 86
           G+ Y+ S N IHRDL   N L+  N  LKI DFG++R   +  + +   + +  +W  AP
Sbjct: 105 GMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAP 163

Query: 87  ELLLNSSDYTAAIDVWSVGCIFME 110
           E  LN   Y++  DVWS G +  E
Sbjct: 164 E-ALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 56.5 bits (136), Expect = 1e-09
 Identities = 31/86 (36%), Positives = 52/86 (60%), Gaps = 7/86 (8%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTRWYRA 85
           G+ Y+ S+NVIHRDL   N L+  N  +K+ DFG+ R   ++++     T++ V +W  +
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV-KW-SS 169

Query: 86  PELLLNSSDYTAAIDVWSVGCIFMEL 111
           PE + + S Y++  DVWS G +  E+
Sbjct: 170 PE-VFSFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.0 bits (137), Expect = 1e-09
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 5/109 (4%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           + SN  + E+  +++  +++  L  IHS  +IHRD+KP N+LL+ +  LK+ DFG     
Sbjct: 133 LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192

Query: 69  SENEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
            E   +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 53/189 (28%), Positives = 82/189 (43%), Gaps = 21/189 (11%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY--VVTRWY 83
           QLL  ++YIH   +IHRD+K  N+ LN +  + + DFG A P  +     +Y  V T   
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334

Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMNRR--PLFPGNDHVH-QMRLLIELLGT---- 136
            +PE+L     Y    D+WS G I +++++    P+  G      Q+  +I+ L      
Sbjct: 335 NSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEE 393

Query: 137 ---PTDADLGFVRNEDAKRYIRQLPQHPRQ-SLAQVFPHVHPLAIDLVDRMLTFDPMKRI 192
              P      ++ + +       +P   R   L   F   +PL      +MLTFD   R 
Sbjct: 394 FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFE--YPLV-----KMLTFDWHLRP 446

Query: 193 TVDEALAHP 201
              E LA P
Sbjct: 447 GAAELLALP 455

Length = 501

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.1 bits (135), Expect = 2e-09
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F+  +  G++Y+ S N IHRDL   N +LN N  + + DFGL++     ++  +   +  
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 81  --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
             +W     L  N   YT   DVW+ G    E+M R
Sbjct: 178 PVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 5/85 (5%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VVTRWYRAP 86
           G++Y+   + IHRDL   N L+++   +K+ DFG+ R   ++E+ +        +W   P
Sbjct: 112 GMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPP 170

Query: 87  ELLLNSSDYTAAIDVWSVGCIFMEL 111
           E + N S Y++  DVWS G +  E+
Sbjct: 171 E-VFNFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 3/89 (3%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F   +  G++Y+   N +HRDL   N+L++ +   K+ DFGLA+  S+ +   +  V +W
Sbjct: 107 FALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-KW 165

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
             APE L     ++   DVWS G +  E+
Sbjct: 166 -TAPEALREKK-FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.8 bits (134), Expect = 4e-09
 Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 5/106 (4%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--P 67
            +  +LS +   +F   + RG+ Y+     IHRDL   N+L+  N   KI DFGL+R   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 175

Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
               + M    V RW       LN S YT   DVWS G +  E+++
Sbjct: 176 VYVKKTMGRLPV-RWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 55.7 bits (134), Expect = 4e-09
 Identities = 31/110 (28%), Positives = 57/110 (51%), Gaps = 2/110 (1%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+ ++   E   +++  ++   L ++H   +I+RDLK  N+LL+     K+ DFG
Sbjct: 82  DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 141

Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           + +    N   T  +  T  Y APE +L    Y  ++D W++G +  E++
Sbjct: 142 MCKEGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (133), Expect = 5e-09
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 14/106 (13%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           S+S  +  Y   Q+  G+KY+ S N +HRDL   N L+  +  +KI DFG++R    N +
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR----NLY 180

Query: 74  MTEY--------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
             +Y        +  RW     +LL    +T A DVW+ G    E+
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 54.7 bits (131), Expect = 6e-09
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 5/102 (4%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F+  +  G++Y+ S + IHRDL   N +LN N ++ + DFGL++     ++  +  + + 
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 83  ---YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
              + A E L +   YT   DVWS G    E+  R +  +PG
Sbjct: 177 PVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 54.5 bits (131), Expect = 7e-09
 Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 7/91 (7%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVT 80
             +  G+ Y+ S   IHRDL   N L++    +K+ DFGL+R   ++E+     +++ V 
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV- 165

Query: 81  RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           RW   PE+LL S  +++  DVW+ G +  E+
Sbjct: 166 RW-SPPEVLLYSK-FSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 7e-09
 Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 14/94 (14%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY-------- 77
           ++  G+ Y+ +   +HRDL   N ++  +  +KI DFG+ R   E    T+Y        
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE----TDYYRKGGKGL 182

Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  RW  APE  L    +T   DVWS G +  E+
Sbjct: 183 LPVRWM-APE-SLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 55.6 bits (134), Expect = 8e-09
 Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 20/131 (15%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICD 61
           L +++ ++ +L        + Q+L  L   H+  ++HRDLKP N++++        K+ D
Sbjct: 66  LREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLD 125

Query: 62  FGL------------ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
           FG+            A  T      TE + T  Y APE L      T   D+++ G IF+
Sbjct: 126 FGIGTLLPGVRDADVATLTRT----TEVLGTPTYCAPEQLRGEP-VTPNSDLYAWGLIFL 180

Query: 110 ELMNRRPLFPG 120
           E +  + +  G
Sbjct: 181 ECLTGQRVVQG 191

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 54.7 bits (131), Expect = 9e-09
 Identities = 39/151 (25%), Positives = 62/151 (41%), Gaps = 37/151 (24%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+  ++    +L+EE  Q+++ + +  +  IH    IHRD+KP NLLL++   +K+ DFG
Sbjct: 87  DMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFG 146

Query: 64  LA---RPTSENEFMTEY---------------------------------VVTRWYRAPE 87
           L    +     EF                                     V T  Y APE
Sbjct: 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206

Query: 88  LLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + + +  Y    D WS+G I  E++   P F
Sbjct: 207 VFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 5/109 (4%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           + SN  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG     
Sbjct: 133 LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192

Query: 69  SENEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
           ++   +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 54.2 bits (130), Expect = 1e-08
 Identities = 36/113 (31%), Positives = 58/113 (51%), Gaps = 7/113 (6%)

Query: 5   LYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           L   +R ++ ++  ++   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG
Sbjct: 95  LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFG 154

Query: 64  LAR--PTSENEFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA+     E E+  E   V  +W  A E +L+   YT   DVWS G    ELM
Sbjct: 155 LAKLLGADEKEYHAEGGKVPIKWM-ALESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 53.6 bits (129), Expect = 1e-08
 Identities = 31/122 (25%), Positives = 56/122 (45%), Gaps = 14/122 (11%)

Query: 4   DLYQIIRSNQS---------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           DL Q +R+ +S         LS +       Q+  G+ ++ +A  +HRDL   N L+++ 
Sbjct: 94  DLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ 153

Query: 55  CDLKICDFGLARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            ++K+    L++    +E        +  RW  APE +    D++   DVWS G +  E+
Sbjct: 154 REVKVSLLSLSKDVYNSEYYKLRNALIPLRWL-APEAVQE-DDFSTKSDVWSFGVLMWEV 211

Query: 112 MN 113
             
Sbjct: 212 FT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 57/266 (21%), Positives = 98/266 (36%), Gaps = 78/266 (29%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D+  ++   +   E   ++++ +L   ++ +H    IHRD+KP N+L++ +  +K+ DFG
Sbjct: 87  DMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFG 146

Query: 64  L------------------------------------------------ARPTSENEFMT 75
           L                                                A    +     
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206

Query: 76  EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLG 135
             V T  Y APE+LL    YT   D WSVG I  E++  +P F              L  
Sbjct: 207 SLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLVGQPPF--------------LAP 251

Query: 136 TPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF--DPMKRIT 193
           TPT+  L  +  E+       +P   + S         P A+DL+ ++     + + R  
Sbjct: 252 TPTETQLKVINWENT----LHIPPQVKLS---------PEAVDLITKLCCSAEERLGRNG 298

Query: 194 VDEALAHPYLARLHDEADEPVCPEPF 219
            D+  AHP+ + +   +D    P P+
Sbjct: 299 ADDIKAHPFFSEVDFSSDIRTQPAPY 324

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 31/111 (27%), Positives = 57/111 (51%), Gaps = 7/111 (6%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E+  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG      E+  +
Sbjct: 99  LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158

Query: 75  TEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMNRRPLF 118
              V   T  Y +PE+L    D    Y    D WS+G C++  L    P +
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 33/93 (35%), Positives = 47/93 (50%), Gaps = 10/93 (10%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY------VV 79
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR    +E  TEY      V 
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE--TEYHADGGKVP 174

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            +W     +L     +T   DVWS G    ELM
Sbjct: 175 IKWMALESIL--HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 6/85 (7%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----EYVVTRWYRA 85
           G++Y+ S + IHRDL   N L+     LKI DFG++R   +  + +    + +  +W  A
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TA 164

Query: 86  PELLLNSSDYTAAIDVWSVGCIFME 110
           PE  LN   Y++  DVWS G +  E
Sbjct: 165 PE-ALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 31/111 (27%), Positives = 58/111 (52%), Gaps = 7/111 (6%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E+  ++++ +++  +  IH  + +HRD+KP N+LL+ N  +++ DFG     +++  +
Sbjct: 99  LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158

Query: 75  TEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMNRRPLF 118
              V   T  Y +PE+L    D    Y    D WS+G C++  L    P +
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 7/103 (6%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           +L+ +    F   +  G++Y+     IHRDL   N+L+  N   KI DFGL+R   E  +
Sbjct: 115 TLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVY 172

Query: 74  MTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           + +    +  RW       LN S YT   DVWS G +  E+++
Sbjct: 173 VKKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 52.3 bits (125), Expect = 3e-08
 Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 12/100 (12%)

Query: 26  QLLR-------GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV 78
           QLL+       G++Y+ S  ++HRDL   N+L++ +   K+ DFGLAR  S     ++  
Sbjct: 101 QLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160

Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
           V +W  APE L +   +++  DVWS G +  E+ +  R P
Sbjct: 161 V-KW-TAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.2 bits (125), Expect = 4e-08
 Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 11/101 (10%)

Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-PTSENEFMTE--- 76
           Q    ++  GL ++H  N IH DL   N LL A+  +KI D+GL+     E+ ++T    
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162

Query: 77  YVVTRWYRAPELL------LNSSDYTAAIDVWSVGCIFMEL 111
           +V  RW  APEL+      L   D T   +VWS+G    EL
Sbjct: 163 WVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 52.4 bits (125), Expect = 4e-08
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 7/103 (6%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           +LS +   +F   + RG+ Y+     IHRDL   N+L+  N   KI DFGL+R   +  +
Sbjct: 108 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVY 165

Query: 74  MTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           + +    +  RW       LN S YT   DVWS G +  E+++
Sbjct: 166 VKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 51.8 bits (124), Expect = 7e-08
 Identities = 31/99 (31%), Positives = 46/99 (46%), Gaps = 17/99 (17%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R       MT    T 
Sbjct: 108 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR------LMTGDTYTA 161

Query: 81  --------RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
                   +W  APE L  +  ++   DVW+ G +  E+
Sbjct: 162 HAGAKFPIKW-TAPESLAYNK-FSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 5/92 (5%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVVTR 81
            ++Q+  G+KY+   N +HRDL   N+LL      KI DFGL++   +++ +       +
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159

Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFME 110
           W   + APE  +N   +++  DVWS G    E
Sbjct: 160 WPLKWYAPE-CINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 8/118 (6%)

Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR 66
           Q  ++   L      +   Q+  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 67  PTSENEFMT----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
                ++        +  RW   PE ++    +T   DVWS G I  E+    ++P F
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 50.7 bits (121), Expect = 2e-07
 Identities = 41/123 (33%), Positives = 61/123 (49%), Gaps = 16/123 (13%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQ-----LLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           DL   +RSN+ +  +  Q  + Q     +  GL ++H A+ IH DL   N  L A+  +K
Sbjct: 81  DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVK 140

Query: 59  ICDFGLARPT-SENEFMTE---YVVTRWYRAPELL------LNSSDYTAAIDVWSVGCIF 108
           I D+GLA     E+ ++T+    V  RW  APEL+      L   D T   ++WS+G   
Sbjct: 141 IGDYGLALEQYPEDYYITKDCHAVPLRWL-APELVEIRGQDLLPKDQTKKSNIWSLGVTM 199

Query: 109 MEL 111
            EL
Sbjct: 200 WEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 50.6 bits (121), Expect = 2e-07
 Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 14/94 (14%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--------PTSENEFMTEY 77
           Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R          SEN+ +   
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIP-- 195

Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
              RW     +  N   YT   DVW+ G +  E+
Sbjct: 196 --IRWMPPESIFYNR--YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.6 bits (121), Expect = 2e-07
 Identities = 39/146 (26%), Positives = 63/146 (43%), Gaps = 45/146 (30%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA---RPTSEN-- 71
           E+  ++++ +L   ++ +H    IHRD+KP N+L++ +  +K+ DFGL    R T ++  
Sbjct: 100 EDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 72  ------------EFMTEY---------------------------VVTRWYRAPELLLNS 92
                       E   E+                           V T  Y APE+LL +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219

Query: 93  SDYTAAIDVWSVGCIFMELMNRRPLF 118
             YT   D WSVG I  E++  +P F
Sbjct: 220 G-YTQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 50.3 bits (120), Expect = 2e-07
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 14/95 (14%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY-------- 77
           Q+  G+KY+ S N +HRDL   N L+  N  +KI DFG++R    N +  +Y        
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR----NLYAGDYYRIQGRAV 201

Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +  RW     +L+    +T A DVW+ G    E++
Sbjct: 202 LPIRWMAWECILMGK--FTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 2e-07
 Identities = 47/215 (21%), Positives = 81/215 (37%), Gaps = 56/215 (26%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL  ++    + SE+  ++++ + +  ++ +H    IHRD+KP N+L++    +K+ DFG
Sbjct: 87  DLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFG 146

Query: 64  LA-----------------------RPTSENEFMTEYV---------VTRW--------- 82
           L+                       R  + N    + +         +  W         
Sbjct: 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAY 206

Query: 83  -------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI---E 132
                  Y APE+ L    Y    D WS+G I  E +   P F   +     R +I   E
Sbjct: 207 STVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE 265

Query: 133 LLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
            L  P D  L      +A+  IR+L  +    L +
Sbjct: 266 TLYFPDDIHLSV----EAEDLIRRLITNAENRLGR 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 15/125 (12%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV----- 79
            Q+  G++Y+ S + +HRDL   N L+     +KI DFGL+R     ++   Y V     
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY---YRVQSKSL 187

Query: 80  --TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR--RPLFP-GNDHVHQMRLLIELL 134
              RW   PE +L    +T   D+WS G +  E+ +   +P +   N  V +M    +LL
Sbjct: 188 LPVRWM-PPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL 245

Query: 135 GTPTD 139
             P D
Sbjct: 246 PCPED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 60/261 (22%), Positives = 99/261 (37%), Gaps = 89/261 (34%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA---RPTSEN-- 71
           E+  ++++ +L   ++ +H    IHRD+KP N+L++ +  +K+ DFGL    R T ++  
Sbjct: 100 EDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 72  ------------EFMTEY-------------------------------VVTRWYRAPEL 88
                       +F  E+                               V T  Y APE+
Sbjct: 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219

Query: 89  LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNE 148
           LL +  YT   D WSVG I  E++  +P F              L  TP +  +  +  +
Sbjct: 220 LLRTG-YTQLCDWWSVGVILYEMLVGQPPF--------------LAQTPLETQMKVINWQ 264

Query: 149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF--DPMKRITVDEALAHPYLARL 206
            +      +P   + S         P A DL+ ++     D + +   DE  AHP+   +
Sbjct: 265 TS----LHIPPQAKLS---------PEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTI 311

Query: 207 HDEADEPVCPEPFSFDFEQQS 227
                       FS D  QQS
Sbjct: 312 D-----------FSSDLRQQS 321

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 49.3 bits (118), Expect = 5e-07
 Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 12/106 (11%)

Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           SLS     Y   Q+  G++Y+ S N +HRDL   N L+  N  +KI DFG++R    +++
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185

Query: 74  MTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
              Y V        RW     +LL    +T   DVW+ G    E++
Sbjct: 186 ---YRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 49.0 bits (117), Expect = 7e-07
 Identities = 38/159 (23%), Positives = 66/159 (41%), Gaps = 27/159 (16%)

Query: 4   DLYQIIRSN--------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNL 49
           DL + +RS+                L+         Q+  G+ Y+ S + +HRDL   N 
Sbjct: 94  DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153

Query: 50  LLNANCDLKICDFGLARPTSENEFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 105
           L+  +  +KI DFG++R     ++        +  RW   PE ++    +T   DVWS G
Sbjct: 154 LVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFG 211

Query: 106 CIFMELMN--RRPLFPGND-----HVHQMRLLIELLGTP 137
            +  E+    ++P +  ++      + Q RLL      P
Sbjct: 212 VVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCP 250

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 48.4 bits (115), Expect = 7e-07
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 3/89 (3%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F   +   ++Y+ + N +HRDL   N+L++ +   K+ DFGL +  S  +   +  V +W
Sbjct: 107 FSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KW 165

Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
             APE  L    ++   DVWS G +  E+
Sbjct: 166 -TAPE-ALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 48.5 bits (115), Expect = 8e-07
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 6/102 (5%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L++    +   Q+  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R     ++ 
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 75  T----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                  +  RW   PE ++    +T   DVWS+G +  E+ 
Sbjct: 177 RVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 8/97 (8%)

Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F+  +  G++Y+ + N IHRDL   N +L  +  + + DFGL++     ++   Y   R 
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY---YRQGRI 174

Query: 83  YRAPE--LLLNS-SD--YTAAIDVWSVGCIFMELMNR 114
            + P   + + S +D  YT+  DVW+ G    E+  R
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.9 bits (114), Expect = 1e-06
 Identities = 31/116 (26%), Positives = 55/116 (47%), Gaps = 9/116 (7%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L+  I    ++ EE  + +  +++  L  +H   ++ RDL P+N+LL+    +++  F  
Sbjct: 72  LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR 131

Query: 65  AR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
                 + + E      V   Y APE +   S+ T A D WS+G I  EL+  + L
Sbjct: 132 WSEVEDSCDGE-----AVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 19/42 (45%), Positives = 29/42 (69%)

Query: 24  LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA 65
           + Q+L GL+ +H   ++HRD+KP NLL+  +  +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 21/56 (37%), Positives = 34/56 (60%)

Query: 17  EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           EE    ++ ++   L Y+H   +IHRDLKP N+L++    +K+ DFGL++ T   E
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 47.0 bits (111), Expect = 3e-06
 Identities = 33/122 (27%), Positives = 62/122 (50%), Gaps = 11/122 (9%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTR 81
           ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++  +     +  R
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MNRRPLFPGNDHVHQMRLLIE--LLGTP 137
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   +R ++E  LL  P
Sbjct: 187 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGMSNEQVLRFVMEGGLLDKP 243

Query: 138 TD 139
            +
Sbjct: 244 DN 245

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 33/113 (29%), Positives = 58/113 (51%), Gaps = 5/113 (4%)

Query: 5   LYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           L   +R ++ SL  +    +  Q+ +G+ Y+    ++HR+L   N+LL ++  ++I DFG
Sbjct: 95  LLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFG 154

Query: 64  LAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           +A    P  +  F +E+     + A E +L    YT   DVWS G    E+M+
Sbjct: 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 34/205 (16%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV--- 78
           + L  +L  L YIHS   IHR +K S++LL+ +  + +     +    ++      V   
Sbjct: 105 FILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164

Query: 79  ------VTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
                    W  +PE+L  N   Y    D++SVG    EL N     P  D +   ++L+
Sbjct: 165 PKSSVKNLPWL-SPEVLQQNLQGYNEKSDIYSVGITACELAN--GHVPFKD-MPATQMLL 220

Query: 132 ELL-GTP-----------TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAID 178
           E + GT             +  +   R+ +     R    HP     + F  H H     
Sbjct: 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYT---RTFSEHFH----Q 273

Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            V+  L  DP  R +  + L H + 
Sbjct: 274 FVELCLQRDPESRPSASQLLNHSFF 298

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 26/86 (30%), Positives = 46/86 (53%), Gaps = 6/86 (6%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTRWYRA 85
           G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++  +     +  RW  A
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-A 189

Query: 86  PELLLNSSDYTAAIDVWSVGCIFMEL 111
           PE L +   +T + D+WS G +  E+
Sbjct: 190 PESLKDGV-FTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 22/167 (13%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG-LARPTSENEF 73
           L E+  +++L +++  +  +H    +HRD+KP N+LL+ N  +++ DFG   R  ++   
Sbjct: 99  LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158

Query: 74  MTEYVV-TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMNRRPLFP-------G 120
            +   V T  Y +PE+L    D    Y    D WS+G C++  L    P +        G
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
               H+          P   D+    +E+AK  IR+L   P   L +
Sbjct: 219 KIMNHKEHFQF----PPDVTDV----SEEAKDLIRRLICSPETRLGR 257

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 46.6 bits (110), Expect = 4e-06
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTE--YVVTR 81
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR     E E+  +   +  +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           W       ++   +T   DVWS G    ELM
Sbjct: 177 WMALE--CIHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 45.6 bits (108), Expect = 7e-06
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 11/93 (11%)

Query: 29  RGLKYIHSANVIHRDLKPSNLLLNA---NCD--LKICDFGLARPTSENEFMTE----YVV 79
           +G  Y+   + IHRDL   N L++    + D  +KI DFGLAR   ++++  +     + 
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            RW  APE LL+   +T   DVWS G +  E++
Sbjct: 177 VRWM-APESLLDGK-FTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 45.3 bits (107), Expect = 1e-05
 Identities = 58/235 (24%), Positives = 89/235 (37%), Gaps = 41/235 (17%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL---------- 64
           +SE    Y L  +L+ L YIH    +HR +K S++L++   D K+   GL          
Sbjct: 98  MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMINHG 155

Query: 65  ARPTSENEFMTEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            R    ++F    V    + +PE+L  N   Y A  D++SVG    EL N     P  D 
Sbjct: 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDM 213

Query: 124 VHQMRLLIELLGT----------PTD----------ADLGFVRNEDAKRYIRQLPQHPRQ 163
                LL +L GT          P +          A+ G   +           +    
Sbjct: 214 PATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSH 273

Query: 164 SLAQVF-PHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPE 217
              + F PH H      V++ L  +P  R +    L H +  ++   A E + PE
Sbjct: 274 PYNRTFSPHFH----HFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEAL-PE 323

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 31/121 (25%), Positives = 57/121 (47%), Gaps = 9/121 (7%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTR 81
           Q+  G++Y+ S   +H+DL   N+L+     +KI D GL+R     ++        +  R
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFP-GNDHVHQMRLLIELLGTPT 138
           W   PE ++    +++  D+WS G +  E+ +   +P +   N  V +M    +LL    
Sbjct: 192 WM-PPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSE 249

Query: 139 D 139
           D
Sbjct: 250 D 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 3e-05
 Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 59/221 (26%)

Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARP--TSENEFMTEY 77
           Q  + Q+L  L  +HS  ++HRD+KP N++ +      KI D G A       N    E+
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEF 317

Query: 78  VVTRWYRAPELLLNSSDYTAA---------------------IDVWSVGCIFMELMNRRP 116
           ++   Y APE  + S+   +A                      D++S G IF+++     
Sbjct: 318 LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA---- 373

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADL-GFVR-----NEDAKRYIRQLPQHPRQSLAQVFP 170
            FP       +R         +D++L  F R     + D   + + +       L + F 
Sbjct: 374 -FPN------LR---------SDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGF- 416

Query: 171 HVHPLAID------LVDRMLTFDPMKRITVDEALAHPYLAR 205
               L +D      L+  M+ F   +RI+   ALAHPY  R
Sbjct: 417 --EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455

Length = 566

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.8 bits (103), Expect = 3e-05
 Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 6/90 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTR 81
           Q+  G+ Y+ S + +HRDL   N L+     +KI DFG++R     ++        +  R
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           W   PE +L    +T   D+WS G +  E+
Sbjct: 190 WM-PPESILYRK-FTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.6 bits (100), Expect = 8e-05
 Identities = 25/92 (27%), Positives = 47/92 (51%), Gaps = 11/92 (11%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----EYVVTRWYRA 85
           G+ ++H  N +H DL   N  L ++  +K+ D+G+     + +++     + V  RW  A
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-A 169

Query: 86  PELL------LNSSDYTAAIDVWSVGCIFMEL 111
           PEL+      L +++ T   +VW++G    EL
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 42.2 bits (99), Expect = 1e-04
 Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 7/92 (7%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG-LARPTSENEF--MTEYVVTRWYRAP 86
           G+KY+     +H+ L    +L+N++   KI  F  L    SE  +  M+      W  AP
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW-AAP 177

Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
           E  +    +++A DVWS G +  E+M+   RP
Sbjct: 178 E-AIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 17/36 (47%), Positives = 25/36 (69%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA 65
            ++Y+HS  V+HRDLKP N+LL    ++ I D+G A
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160

Length = 932

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 41.0 bits (97), Expect = 2e-04
 Identities = 14/39 (35%), Positives = 24/39 (61%), Gaps = 1/39 (2%)

Query: 34  IHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           +H A ++H DL  SN+++  +  L + DFGL + + E E
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDEIE 143

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 40.7 bits (96), Expect = 2e-04
 Identities = 16/40 (40%), Positives = 24/40 (60%), Gaps = 1/40 (2%)

Query: 35  HSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           HSA +IH DL  SN++L+    + + DFGLA  + + E  
Sbjct: 112 HSAGIIHGDLTTSNMILSGG-KIYLIDFGLAEFSKDLEDR 150

Length = 211

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 41.2 bits (96), Expect = 3e-04
 Identities = 24/92 (26%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEYVVTR 81
           Q+  G++++ S +V+H+DL   N+L+    ++KI D GL R     ++        +  R
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191

Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           W  +PE ++    ++   D+WS G +  E+ +
Sbjct: 192 WM-SPEAIMYGK-FSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.6 bits (92), Expect = 8e-04
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 13/135 (9%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD----FGLARPT 68
           + +SE      L+  LRGL Y+H    IHR++K S++L++ +  + +      + L R  
Sbjct: 96  EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155

Query: 69  SENEFMTEY-----VVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            + + + ++      V  W  +PELL      Y    D++SVG    EL   R   P  D
Sbjct: 156 QKAKVVYDFPQFSTSVLPWL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQD 212

Query: 123 HVHQMRLLIELLGTP 137
            +    LL +L G P
Sbjct: 213 MLRTQMLLQKLKGPP 227

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 39.0 bits (91), Expect = 0.001
 Identities = 30/98 (30%), Positives = 40/98 (40%), Gaps = 25/98 (25%)

Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENEFMTEYVVTRWYR-- 84
           G KY+   + IHRD+   N LL         KI DFG+AR      +   Y     YR  
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI----YRASY-----YRKG 178

Query: 85  ----------APELLLNSSDYTAAIDVWSVGCIFMELM 112
                      PE  L+   +T+  DVWS G +  E+ 
Sbjct: 179 GRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIF 215

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.1 bits (92), Expect = 0.001
 Identities = 13/39 (33%), Positives = 22/39 (56%), Gaps = 1/39 (2%)

Query: 34  IHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           +H A ++H DL  SN ++  +  L + DFGL + +   E
Sbjct: 444 LHKAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDLIE 481

Length = 535

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	249
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.98
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
KOG0589	426	consensus Serine/threonine protein kinase [General	99.98
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.98
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.98
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.98
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.98
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.98
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.98
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.98
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.98
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.98
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.98
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.98
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.98
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.98
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.98
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.98
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
PHA02988	283	hypothetical protein; Provisional	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.96
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.96
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.96
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.96
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.96
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.96
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.96
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.96
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.96
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.96
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.96
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.96
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.96
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.96
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.96
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.96
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.96
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.96
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.96
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.96
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.96
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.96
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.96
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.96
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.95
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.95
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.94
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.94
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.93
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.93
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.92
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.92
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.92
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.92
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.92
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.92
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.91
KOG3653	534	consensus Transforming growth factor beta/activin	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.89
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.89
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.89
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.88
KOG1152	772	consensus Signal transduction serine/threonine kin	99.87
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.86
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.85
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.77
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.75
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.71
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.66
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.64
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.59
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.58
PRK12274	218	serine/threonine protein kinase; Provisional	99.49
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.49
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.43
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.39
PRK09188	365	serine/threonine protein kinase; Provisional	99.35
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.33
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.29
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.29
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.25
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.21
smart00090	237	RIO RIO-like kinase.	99.17
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.14
PRK10345	210	hypothetical protein; Provisional	99.12
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.05
PRK14879	211	serine/threonine protein kinase; Provisional	98.98
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.96
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.93
COG4248	637	Uncharacterized protein with protein kinase and he	98.92
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.89
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.81
KOG1243	690	consensus Protein kinase [General function predict	98.8
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.65
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.59
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.55
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.54
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.51
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.39
PRK09902	216	hypothetical protein; Provisional	98.31
KOG3087	229	consensus Serine/threonine protein kinase [General	98.31
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.3
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.23
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.2
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.01
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.87
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.82
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.37
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	97.26
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.02
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.87
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.6
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.2
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.0
COG0661	517	AarF Predicted unusual protein kinase [General fun	95.96
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.94
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	95.85
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	95.82
PRK05231	319	homoserine kinase; Provisional	95.64
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.63
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.45
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	95.4
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	95.24
PRK10271	188	thiK thiamine kinase; Provisional	95.08
PF01636	239	APH: Phosphotransferase enzyme family This family	94.89
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.84
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	94.64
KOG0576	829	consensus Mitogen-activated protein kinase kinase	94.45
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.44
KOG1235	538	consensus Predicted unusual protein kinase [Genera	94.42
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	94.32
PLN02236	344	choline kinase	94.26
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.25
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.21
PRK11768	325	serine/threonine protein kinase; Provisional	94.04
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	94.03
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	93.98
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.57
COG2334	331	Putative homoserine kinase type II (protein kinase	93.39
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	93.25
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	93.06
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	92.83
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	91.78
PRK06148	1013	hypothetical protein; Provisional	91.43
PRK06149	972	hypothetical protein; Provisional	90.74
PHA03111	444	Ser/Thr kinase; Provisional	89.68
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	89.24
PRK09550	401	mtnK methylthioribose kinase; Reviewed	88.21
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	87.62
PRK12396	409	5-methylribose kinase; Reviewed	86.77
PTZ00296	442	choline kinase; Provisional	85.97
PTZ00384	383	choline kinase; Provisional	85.33
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	83.05

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=321.19  Aligned_cols=246  Identities=65%  Similarity=1.152  Sum_probs=229.9

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC---CCccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE---NEFMTEY   77 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~---~~~~~~~   77 (249)
                      |+.||.+.|+++..|+++.+..++.||+.||.|+|+.|++|||+||.|++++.+..+|+||||+++....   .......
T Consensus       108 MetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeY  187 (359)
T KOG0660|consen  108 METDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEY  187 (359)
T ss_pred             HhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcc
Confidence            6889999999988899999999999999999999999999999999999999999999999999987653   3445567


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +.|..|+|||++.....++.+.||||+||++.||++|++.|++.+...++..|...+|.+............+..++...
T Consensus       188 VaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~sl  267 (359)
T KOG0660|consen  188 VATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSL  267 (359)
T ss_pred             eeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhC
Confidence            88999999999988888999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHH
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMI  237 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (249)
                      +..+.+.+..+.++.++.+++|+.+||.+||.+|+|++|+|+|||++.+.+...+|.+...+.. ++.. .+.+++++++
T Consensus       268 p~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~-~~~~-~~~~~~r~~i  345 (359)
T KOG0660|consen  268 PQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS-FEHE-LTEEELRELI  345 (359)
T ss_pred             CCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc-cccc-ccHHHHHHHH
Confidence            9999999999999999999999999999999999999999999999999999999987766655 4444 8899999999


Q ss_pred             HHHHHHhCCCC
Q 025683          238 YQEALALNPGF  248 (249)
Q Consensus       238 ~~~~~~~~~~~  248 (249)
                      ++|..+|+|..
T Consensus       346 ~~e~~~~~~~~  356 (359)
T KOG0660|consen  346 YKEILDFHPDV  356 (359)
T ss_pred             HHHHHhhCccc
Confidence            99999999964

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-43  Score=286.51  Aligned_cols=208  Identities=41%  Similarity=0.719  Sum_probs=187.4

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      |..+|+++++.. +.|+++.++.|+.||++||+|+|.+|+.|||+||+|||+.....+||+|||+++...........+.
T Consensus        92 Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVS  171 (538)
T KOG0661|consen   92 MDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVS  171 (538)
T ss_pred             hhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcchhhh
Confidence            678899999875 6799999999999999999999999999999999999999999999999999999888888888899


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      |+.|+|||++..++.|+.+.|+|++||+++|+.+-++.|++.++.+++.+|...+|.|....+... ...+..+-...++
T Consensus       172 TRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg-~~La~~mnf~~P~  250 (538)
T KOG0661|consen  172 TRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG-YNLASAMNFRFPQ  250 (538)
T ss_pred             cccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH-HHHHHHhccCCCc
Confidence            999999999999999999999999999999999999999999999999999999999998877654 2223333345566


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      ...-.+..+.+..+.++.++|.+||++||.+||||.++|+||||+.....
T Consensus       251 ~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  251 VKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             CCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            66677788888899999999999999999999999999999999976643

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.7e-43  Score=277.15  Aligned_cols=222  Identities=39%  Similarity=0.755  Sum_probs=187.6

Q ss_pred             CCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC-CCeEEeecCCccCCCCCCccc
Q 025683            1 MDTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMT   75 (249)
Q Consensus         1 ~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~-~~~kL~dfg~~~~~~~~~~~~   75 (249)
                      |..+|..+++.    +.+++...++-+..||++||+|||+.|||||||||.|+|+|.+ |.+||||||.++....++...
T Consensus       104 mP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epni  183 (364)
T KOG0658|consen  104 MPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNI  183 (364)
T ss_pred             chHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCce
Confidence            34577788874    5789999999999999999999999999999999999999987 899999999999988888777


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ....|.+|+|||.+.+...++.+.||||.||++.||+.|++.|++.+..+++..|.+.+|.|+.++...+..........
T Consensus       184 SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p  263 (364)
T KOG0658|consen  184 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFP  263 (364)
T ss_pred             eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCc
Confidence            88899999999999999999999999999999999999999999999999999999999999998877665554322222


Q ss_pred             hCCCCCCcchhh-cCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCC--CCCCCCchhc
Q 025683          156 QLPQHPRQSLAQ-VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVC--PEPFSFDFEQ  225 (249)
Q Consensus       156 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~--~~~~~~~~~~  225 (249)
                      +..   ...+.+ .....+++..+|+.++|.++|.+|.++.+++.||||..+++..-.-+.  +.|..++|..
T Consensus       264 ~ik---~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~  333 (364)
T KOG0658|consen  264 QIK---AHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKR  333 (364)
T ss_pred             ccc---cccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCchH
Confidence            211   222222 455788999999999999999999999999999999999977444443  4444454443

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-41  Score=281.73  Aligned_cols=246  Identities=76%  Similarity=1.308  Sum_probs=215.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Cccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~   79 (249)
                      ++++|.+++.+.+.+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus        91 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  170 (337)
T cd07858          91 MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV  170 (337)
T ss_pred             CCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCccccccccc
Confidence            46789999998889999999999999999999999999999999999999999999999999998765443 22234466


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.....++.++|+|||||++|+|++|..||.+.+.......+....+.+...............+....+.
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (337)
T cd07858         171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPY  250 (337)
T ss_pred             ccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCc
Confidence            88899999887655588999999999999999999999998888888888888888877776666666666666666555


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHH
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQ  239 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (249)
                      ..........+.+++++.++|++||+.||.+|||++++++||||+.+......+..+.++.+++++..-..+++++.|+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (337)
T cd07858         251 TPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTEEDIKELIYN  330 (337)
T ss_pred             ccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccchhhhhhhcCHHHHHHHHHH
Confidence            55555566667889999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhCC
Q 025683          240 EALALNP  246 (249)
Q Consensus       240 ~~~~~~~  246 (249)
                      |+.+++|
T Consensus       331 ~~~~~~~  337 (337)
T cd07858         331 EMLAYHP  337 (337)
T ss_pred             HHhhcCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=275.85  Aligned_cols=178  Identities=29%  Similarity=0.524  Sum_probs=151.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ||||.+++...+++++....+++.+|++||.|||+ ++|+||||||+|||++..|.+||||||.+.....+ .....+||
T Consensus       162 gGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT  240 (364)
T KOG0581|consen  162 GGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGT  240 (364)
T ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hccccccc
Confidence            78999999999999999999999999999999995 89999999999999999999999999999876655 56789999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN-----DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..|||||.+.+. .|+.++||||||++++|+.+|+.||...     +....+..|.   ..+++                
T Consensus       241 ~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv---~~ppP----------------  300 (364)
T KOG0581|consen  241 SAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV---DEPPP----------------  300 (364)
T ss_pred             ccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh---cCCCC----------------
Confidence            999999999765 4899999999999999999999999774     2222222222   11111                


Q ss_pred             hCCCCCCcchhhcCC-CCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          156 QLPQHPRQSLAQVFP-HVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                                 .++. .+|+++++||..||++||.+|||+.++++|||+++......
T Consensus       301 -----------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v  346 (364)
T KOG0581|consen  301 -----------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNV  346 (364)
T ss_pred             -----------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence                       1222 38899999999999999999999999999999998755443

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-40  Score=275.53  Aligned_cols=246  Identities=51%  Similarity=0.956  Sum_probs=199.3

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC----cccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTE   76 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~   76 (249)
                      |+++|.+++.+...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+.......    ....
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  165 (338)
T cd07859          86 MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD  165 (338)
T ss_pred             CCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccC
Confidence            578999999988899999999999999999999999999999999999999999999999999987543221    1123


Q ss_pred             ccccccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+.......+....+.++..............+..
T Consensus       166 ~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  245 (338)
T cd07859         166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLS  245 (338)
T ss_pred             CCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHH
Confidence            5688999999987542 457889999999999999999999999988888888888888877766555555444444444


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCC--CCCchhccccCHHHH
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEP--FSFDFEQQSLGEEQI  233 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  233 (249)
                      ..............+.+++.+.+++.+||+.||.+|||++++++||||+........+...+.  ....++....+.+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (338)
T cd07859         246 SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTKEDV  325 (338)
T ss_pred             hhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhcCHHHH
Confidence            444433444455556788999999999999999999999999999999998876655543333  233445678888999


Q ss_pred             HHHHHHHHHHhCC
Q 025683          234 KDMIYQEALALNP  246 (249)
Q Consensus       234 ~~~~~~~~~~~~~  246 (249)
                      +..++++.+.+||
T Consensus       326 ~~~~~~~~~~~~~  338 (338)
T cd07859         326 RELIYREILEYHP  338 (338)
T ss_pred             HHHHHHHHHhcCC
Confidence            9999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1e-41  Score=265.12  Aligned_cols=208  Identities=33%  Similarity=0.703  Sum_probs=170.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC-CCCccccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~-~~~~~~~~~~   79 (249)
                      +.++.+-|+.. ..++.+.+++++.|++.|+.|+|+++++||||||+|||++.+|.+||||||+++... .+......+.
T Consensus        84 dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVA  163 (396)
T KOG0593|consen   84 DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVA  163 (396)
T ss_pred             chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhh
Confidence            34555566664 579999999999999999999999999999999999999999999999999999776 4555666788


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      |.+|+|||.+.+...|+.++|||++||++.||++|++.|++.++.+++-.|...+|...+.-.........=.-+.-...
T Consensus       164 TRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~  243 (396)
T KOG0593|consen  164 TRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEP  243 (396)
T ss_pred             hhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCC
Confidence            99999999999988899999999999999999999999999999999999999999876543322211110000000001


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      .-..+++.-.++++.-+.+|+++||..||.+|++.++++.|+||.++.+.
T Consensus       244 ~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  244 EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence            12234556667788889999999999999999999999999999887644

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.1e-40  Score=251.84  Aligned_cols=207  Identities=43%  Similarity=0.751  Sum_probs=179.9

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc-cccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-TEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~-~~~~   78 (249)
                      |..||...++.+ ..|+..+++.++.+++.|++|||++.|.||||||.|+|++.+|.+|+.|||+++........ ...+
T Consensus        83 m~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V  162 (318)
T KOG0659|consen   83 MPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQV  162 (318)
T ss_pred             ccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccce
Confidence            567899999875 67999999999999999999999999999999999999999999999999999987765433 3347


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      -|..|+|||.+++...|+..+|+||.||++.||+.+.+.|++.++.+++..|...+|.|....|..+.....-..+... 
T Consensus       163 ~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~-  241 (318)
T KOG0659|consen  163 VTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF-  241 (318)
T ss_pred             eeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC-
Confidence            7999999999999999999999999999999999999999999999999999999999999988876554443333333 


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                        +......+.+..+.++.+|+.+||.+||.+|+|+.|+|+|+||++.....
T Consensus       242 --P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt  291 (318)
T KOG0659|consen  242 --PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT  291 (318)
T ss_pred             --CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence              33344447778899999999999999999999999999999999854333

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=276.31  Aligned_cols=177  Identities=31%  Similarity=0.548  Sum_probs=158.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---------   72 (249)
                      +|+|.++|++.+.|++.-++.++.||+.||+|||++||+||||||+|||++.+++++|.|||.++......         
T Consensus       158 nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~  237 (604)
T KOG0592|consen  158 NGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDP  237 (604)
T ss_pred             CCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCc
Confidence            69999999999999999999999999999999999999999999999999999999999999997654321         


Q ss_pred             -----ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           73 -----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        73 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                           ....++||..|.+||++.. ...+..+|+|+|||++|+|+.|.+||.+.++.-..++|+..-             
T Consensus       238 ~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~-------------  303 (604)
T KOG0592|consen  238 NQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD-------------  303 (604)
T ss_pred             ccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc-------------
Confidence                 1145799999999999854 458999999999999999999999999999999999998743             


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                                        .++++++++.+++||+++|..||.+|+|+.+|.+||||.++..+.
T Consensus       304 ------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  304 ------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             ------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence                              334557889999999999999999999999999999999988544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-42  Score=277.03  Aligned_cols=179  Identities=34%  Similarity=0.586  Sum_probs=152.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC---CCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~---~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|++++..++.+.+...+.+++|++.|+.|||++||+||||||+|||+..+   ..+|++|||+++..+....+.+.+
T Consensus       260 GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlC  339 (475)
T KOG0615|consen  260 GGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLC  339 (475)
T ss_pred             CccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhc
Confidence            89999999999999999999999999999999999999999999999999877   678999999999999888889999


Q ss_pred             ccccccCchhccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           79 VTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH-QMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ||+.|.|||++...+  .+..++|+||+||++|-+++|.+||....... ...+|....-..                  
T Consensus       340 GTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f------------------  401 (475)
T KOG0615|consen  340 GTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF------------------  401 (475)
T ss_pred             CCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc------------------
Confidence            999999999997544  34568999999999999999999998764333 333333211111                  


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                               ....|..++++.++||..||..||++|||++|+|+||||+...
T Consensus       402 ---------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  402 ---------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ---------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence                     1123456889999999999999999999999999999999654

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.3e-41  Score=256.75  Aligned_cols=187  Identities=33%  Similarity=0.601  Sum_probs=161.5

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW   82 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~   82 (249)
                      |.|+|||.+.-.+|++..+++++|+++|++|||..+|||||+||+|||++++.+++|+|||++.....+......+||++
T Consensus       108 GELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPg  187 (411)
T KOG0599|consen  108 GELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPG  187 (411)
T ss_pred             chHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCc
Confidence            78999999999999999999999999999999999999999999999999999999999999999999988889999999


Q ss_pred             ccCchhcc-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           83 YRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        83 y~aPE~~~-----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      |+|||.+.     +.+.++..+|+|++||++|-++.|++||-.....-.++.|++.--....                  
T Consensus       188 YLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s------------------  249 (411)
T KOG0599|consen  188 YLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS------------------  249 (411)
T ss_pred             ccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC------------------
Confidence            99999985     3456899999999999999999999999777666666666542222211                  


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCP  216 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~  216 (249)
                               .-|.+++...++||.+||+.||++|.|++|+|.||||..+..+.....+|
T Consensus       250 ---------peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP  299 (411)
T KOG0599|consen  250 ---------PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP  299 (411)
T ss_pred             ---------cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence                     22346788899999999999999999999999999998776555444443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-40  Score=275.47  Aligned_cols=181  Identities=34%  Similarity=0.559  Sum_probs=160.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      .++|..+++..+.|+|.+++.+++||+.||.|||+++|+|||||..|++++.+..+|++|||++...... +...+.+||
T Consensus       102 ~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGT  181 (592)
T KOG0575|consen  102 RGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGT  181 (592)
T ss_pred             CccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCC
Confidence            3688999998899999999999999999999999999999999999999999999999999999887644 667789999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++...+ .+..+||||+||++|-|+.|++||...+-...+.+|...-                          
T Consensus       182 PNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~--------------------------  234 (592)
T KOG0575|consen  182 PNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE--------------------------  234 (592)
T ss_pred             CcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC--------------------------
Confidence            9999999997554 8999999999999999999999999998888888876421                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV  214 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~  214 (249)
                           ..++..++.++++||.++|+.||.+|||++++|.|+||++-......+.
T Consensus       235 -----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~  283 (592)
T KOG0575|consen  235 -----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPS  283 (592)
T ss_pred             -----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCc
Confidence                 2334468899999999999999999999999999999966655555554

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-39  Score=257.40  Aligned_cols=207  Identities=43%  Similarity=0.801  Sum_probs=177.1

Q ss_pred             CccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccc
Q 025683            2 DTDLYQIIRSNQ----SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~   76 (249)
                      ..||.+|+....    .++...++++++||+.||+|||+++|+||||||.||+++.+|.+||+|||+++....+ .....
T Consensus       100 d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~  179 (323)
T KOG0594|consen  100 DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTP  179 (323)
T ss_pred             cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccc
Confidence            468899998865    5888999999999999999999999999999999999999999999999999876643 44666


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .+.|..|+|||++.+...++...|+||+||+++||++++..|++..+..++..|...+|.|....|+.+.....-..  .
T Consensus       180 evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~--~  257 (323)
T KOG0594|consen  180 EVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA--P  257 (323)
T ss_pred             cEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc--c
Confidence            78899999999999998899999999999999999999999999999999999999999999888776543222111  2


Q ss_pred             CCCCC-CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          157 LPQHP-RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       157 ~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                      .+... .+.+....+..+++..+++.+||+++|.+|.|+..+++||||.......
T Consensus       258 f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  258 FPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             CcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence            22222 4455666677778999999999999999999999999999999875443

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-38  Score=263.90  Aligned_cols=242  Identities=50%  Similarity=0.932  Sum_probs=193.2

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      +|++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......  .....++
T Consensus       102 ~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t  178 (343)
T cd07878         102 MGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVAT  178 (343)
T ss_pred             CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC--cCCcccc
Confidence            47888888764 67999999999999999999999999999999999999999999999999998765432  2345788


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+...++.++|||||||++|+|++|..||...+.......+....+.+...............+....+..
T Consensus       179 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (343)
T cd07878         179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHM  258 (343)
T ss_pred             ccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccc
Confidence            99999999876556889999999999999999999999988888888888877777665554444444444455444444


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHHH
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE  240 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (249)
                      +...+.......++.+.+||.+||+.||.+|||+.++++||||..+......+. ..+............++++..-+.+
T Consensus       259 ~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  337 (343)
T cd07878         259 PQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPE-AEPYDESPENKERTIEEWKELTYEE  337 (343)
T ss_pred             cchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccc-cCccccchhhhhccHHHHHHHHHHH
Confidence            455555556677888999999999999999999999999999998876544433 3344444445666778888888877


Q ss_pred             HHHhCC
Q 025683          241 ALALNP  246 (249)
Q Consensus       241 ~~~~~~  246 (249)
                      -..|.|
T Consensus       338 ~~~~~~  343 (343)
T cd07878         338 VSSFKP  343 (343)
T ss_pred             HHhcCC
Confidence            777665

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=256.96  Aligned_cols=176  Identities=28%  Similarity=0.528  Sum_probs=155.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCC-CCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT-SENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~-~~~~~~~~~~~~   80 (249)
                      ||+|+-.|++++.|+++.++.++.+|+.||.|||++||+|||+||+|||++.+|.++|+|||+++.. ..+......+||
T Consensus       109 GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT  188 (357)
T KOG0598|consen  109 GGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGT  188 (357)
T ss_pred             CccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCC
Confidence            8899999999999999999999999999999999999999999999999999999999999999854 344556678999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++...+ ++..+|.||||+++|+|++|.+||.+.+.......|...-.                         
T Consensus       189 ~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-------------------------  242 (357)
T KOG0598|consen  189 PEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-------------------------  242 (357)
T ss_pred             ccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-------------------------
Confidence            9999999998775 89999999999999999999999999987777777764221                         


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC----CHHHHhcCccccCCcC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI----TVDEALAHPYLARLHD  208 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp----t~~~ll~h~~~~~~~~  208 (249)
                           ...+.-++.+.+++++++|..||++|.    ++.++.+||||..+..
T Consensus       243 -----~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW  289 (357)
T KOG0598|consen  243 -----PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW  289 (357)
T ss_pred             -----CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence                 111223778999999999999999996    6999999999999873

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=269.25  Aligned_cols=174  Identities=33%  Similarity=0.550  Sum_probs=155.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC-CCeEEeecCCccCC-CCCCccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPT-SENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~-~~~kL~dfg~~~~~-~~~~~~~~~~~   79 (249)
                      ||+|++++.+.+++++..++++++||+.|++|||++||+||||||+||+++.+ +.+||+|||++... .........+|
T Consensus       104 gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cG  183 (370)
T KOG0583|consen  104 GGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCG  183 (370)
T ss_pred             CccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCC
Confidence            68999999999999999999999999999999999999999999999999999 99999999999887 56677788999


Q ss_pred             cccccCchhccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++.|+|||++.+.. +-+.++||||+||++|.|++|..||...+.......+...-                        
T Consensus       184 sp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~------------------------  239 (370)
T KOG0583|consen  184 SPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE------------------------  239 (370)
T ss_pred             CcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC------------------------
Confidence            99999999998776 66899999999999999999999999877666666644211                        


Q ss_pred             CCCCcchhhcCCCC-ChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          159 QHPRQSLAQVFPHV-HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       159 ~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                             ..++..+ ++++..++++||..||.+|+|+.+++.||||+..
T Consensus       240 -------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  240 -------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             -------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence                   1233345 8999999999999999999999999999999973

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-39  Score=273.82  Aligned_cols=182  Identities=30%  Similarity=0.509  Sum_probs=164.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||.|++||-..++|++.++.++++||+.|+.|+|..+|+|||+||+|+|++..+++|++|||++..-..+....+.+|++
T Consensus        96 gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSP  175 (786)
T KOG0588|consen   96 GGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSP  175 (786)
T ss_pred             CchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCc
Confidence            89999999999999999999999999999999999999999999999999999999999999998887888888999999


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      +|.+||++.+.++.+.++||||.|||+|.|++|..||.+++-...+.++..                             
T Consensus       176 HYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~-----------------------------  226 (786)
T KOG0588|consen  176 HYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR-----------------------------  226 (786)
T ss_pred             ccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-----------------------------
Confidence            999999999999899999999999999999999999997775555544432                             


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV  214 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~  214 (249)
                        -..++++.++.++++||++||..||.+|.|.+|+++|||++++........
T Consensus       227 --G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~  277 (786)
T KOG0588|consen  227 --GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKS  277 (786)
T ss_pred             --CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhh
Confidence              224456689999999999999999999999999999999999986665533

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.1e-39  Score=252.20  Aligned_cols=206  Identities=41%  Similarity=0.715  Sum_probs=176.4

Q ss_pred             CCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            1 MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      |..||.++|.+-+ +|+..+++.++.|++.|++|||.+.|+|||+|++|+|++..|.+|++|||+++..+.. ......+
T Consensus       159 ~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lV  238 (419)
T KOG0663|consen  159 VEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLV  238 (419)
T ss_pred             HHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceE
Confidence            3568999999864 9999999999999999999999999999999999999999999999999999987765 3344567


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      -|..|+|||.+.+...++.+.|+||+|||+.|++.+.+.|++....+++.+|+..+|.|....|...........+.. .
T Consensus       239 VTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f-~  317 (419)
T KOG0663|consen  239 VTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTF-S  317 (419)
T ss_pred             EEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcccc-C
Confidence            799999999999999999999999999999999999999999999999999999999999888876665554433222 2


Q ss_pred             CCCCcchhhcCCC--CChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          159 QHPRQSLAQVFPH--VHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       159 ~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      ..+...+...++.  +++...+|+..+|.+||.+|.|+++.|+|.||....
T Consensus       318 ~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  318 EHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             CCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            2222222332323  568899999999999999999999999999999844

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-39  Score=264.72  Aligned_cols=201  Identities=39%  Similarity=0.659  Sum_probs=174.9

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEY   77 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~   77 (249)
                      |..||..++.+. -.|++.+++.++.||+.||+|||.+|+.|||||.+|||++.+|.+||+|||+++......  .....
T Consensus       200 MdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~r  279 (560)
T KOG0600|consen  200 MDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSR  279 (560)
T ss_pred             ccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccc
Confidence            677899999884 589999999999999999999999999999999999999999999999999999655443  34556


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH-Hh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI-RQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  156 (249)
                      +-|..|+|||++.+...|+.++|+||.|||+.||+.|.+.|.+.++..++..|.+.+|.|....|. ..+..  .+. ..
T Consensus       280 VvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP--~~~~~k  356 (560)
T KOG0600|consen  280 VVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLP--HATIFK  356 (560)
T ss_pred             eEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCC--cccccC
Confidence            779999999999999999999999999999999999999999999999999999999999998876 22211  111 12


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                      ........+.+....++....+|+..+|..||.+|.|+.++|.++||.
T Consensus       357 p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  357 PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             CCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            223335567777888999999999999999999999999999999994

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-38  Score=261.82  Aligned_cols=242  Identities=52%  Similarity=0.983  Sum_probs=205.8

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      +|++|.+++.. ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+......  .....++
T Consensus       102 ~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~  178 (343)
T cd07851         102 MGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVAT  178 (343)
T ss_pred             CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc--ccCCccc
Confidence            46789999886 57999999999999999999999999999999999999999999999999998765432  2344667


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+....+.++|+||||++++++++|..||...........+....+.++..............+.......
T Consensus       179 ~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (343)
T cd07851         179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQM  258 (343)
T ss_pred             ccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhcccc
Confidence            88999999865545788999999999999999999999988888888888887777666555555555555665555555


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHHH
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE  240 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (249)
                      .+..+.......++++.++|++||+.||.+|||+.+|++||||+++.....++. ..++..+++..+....+++.+++.|
T Consensus       259 ~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  337 (343)
T cd07851         259 PKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV-APPYDQSFESRDLTVDEWKELVYKE  337 (343)
T ss_pred             CCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc-ccccCcchhhhhcCHHHHHHHhHHH
Confidence            555666666677999999999999999999999999999999999988876665 6677888899999999999999999


Q ss_pred             HHHhCC
Q 025683          241 ALALNP  246 (249)
Q Consensus       241 ~~~~~~  246 (249)
                      .++|.|
T Consensus       338 ~~~~~~  343 (343)
T cd07851         338 IMNFKP  343 (343)
T ss_pred             HHhccC
Confidence            999987

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6e-38  Score=261.15  Aligned_cols=239  Identities=58%  Similarity=1.062  Sum_probs=197.2

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-----ccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-----FMT   75 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-----~~~   75 (249)
                      ++++|.+++.....+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......     ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  167 (332)
T cd07857          88 MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT  167 (332)
T ss_pred             ccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccccccccc
Confidence            467899999888899999999999999999999999999999999999999999999999999987543221     122


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...++..|+|||.+.+...++.++|+||+|+++++|++|..||...+.......+...++.+...............+..
T Consensus       168 ~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (332)
T cd07857         168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR  247 (332)
T ss_pred             CcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHH
Confidence            34678899999987655557899999999999999999999999988888888888888877665444444433333444


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHH
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKD  235 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (249)
                      .........+....+..+..+.+++.+||+.||.+|||+.+++.|||++++.+....+.|..+..+++++ ..+.+++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  326 (332)
T cd07857         248 SLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES-EDSMEELRD  326 (332)
T ss_pred             hccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc-cccHHHHHH
Confidence            4444444455556667789999999999999999999999999999999999988888898888887765 456788999


Q ss_pred             HHHHH
Q 025683          236 MIYQE  240 (249)
Q Consensus       236 ~~~~~  240 (249)
                      +|.+|
T Consensus       327 ~~~~~  331 (332)
T cd07857         327 MIIEE  331 (332)
T ss_pred             HHhhc
Confidence            98765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.3e-38  Score=262.94  Aligned_cols=239  Identities=57%  Similarity=1.063  Sum_probs=203.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-----ccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-----FMT   75 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-----~~~   75 (249)
                      ++++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.......     ...
T Consensus        90 ~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  169 (334)
T cd07855          90 MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT  169 (334)
T ss_pred             hhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccc
Confidence            357899999888889999999999999999999999999999999999999999999999999886543221     112


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...++..|+|||.+.....++.++|+|||||++|+|++|..||.+.+.......+....+.++.................
T Consensus       170 ~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~  249 (334)
T cd07855         170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQ  249 (334)
T ss_pred             cccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHh
Confidence            34678889999998655557899999999999999999999999988888888888888888776665555555555554


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHH
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKD  235 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (249)
                      .........+....+..++++.++|++||+.||.+|||+++++.||||+++.....++.+..++..+++....+.+++.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (334)
T cd07855         250 NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELSREQLKE  329 (334)
T ss_pred             hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCCCCCCChhhhhcChhhHHH
Confidence            44444445555666778999999999999999999999999999999999999999999999999999999899999988


Q ss_pred             HHHH
Q 025683          236 MIYQ  239 (249)
Q Consensus       236 ~~~~  239 (249)
                      .|..
T Consensus       330 ~~~~  333 (334)
T cd07855         330 AIVK  333 (334)
T ss_pred             Hhhc
Confidence            8864

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=266.07  Aligned_cols=173  Identities=27%  Similarity=0.518  Sum_probs=151.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      ||+|.|.+.. ..++|.++..|+++++.||+|||.+||+|+|||.+||++..+|.+||+|||+|..+.... .....+||
T Consensus       354 ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGT  432 (550)
T KOG0578|consen  354 GGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGT  432 (550)
T ss_pred             CCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCC
Confidence            7889999887 559999999999999999999999999999999999999999999999999998877654 56678999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ++|||||+..... |+.++||||||++++||+-|++||...++...+..|.......                       
T Consensus       433 PYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~-----------------------  488 (550)
T KOG0578|consen  433 PYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPK-----------------------  488 (550)
T ss_pred             CCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCC-----------------------
Confidence            9999999996554 8999999999999999999999999887776666665422111                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                           ...++.+|+.+++|+.+||..|+.+|+++.+||+||||+
T Consensus       489 -----lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  489 -----LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             -----cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence                 112346899999999999999999999999999999996

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-38  Score=261.96  Aligned_cols=239  Identities=63%  Similarity=1.163  Sum_probs=206.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC----ccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~~   77 (249)
                      +++|.+++.+...+++..+..++.||+.||+|||++|++|+||+|.||+++.++.++|+|||.+.......    .....
T Consensus        87 ~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~  166 (330)
T cd07834          87 ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY  166 (330)
T ss_pred             hhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccccccccc
Confidence            56799999888899999999999999999999999999999999999999999999999999987654432    23345


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|+|||.+.+....+.++|+||||+++++|++|..||.+.........+....+.+....+..........+....
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (330)
T cd07834         167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSL  246 (330)
T ss_pred             ccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhc
Confidence            67888999999876646889999999999999999999999999988888888888888877666555555566666656


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCC-chhccccCHHHHHHH
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSF-DFEQQSLGEEQIKDM  236 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  236 (249)
                      .......+....+.+++++.++|.+||+.||.+|||+++++.||||+++..+..+++...++.. .++..+.+++|.+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (330)
T cd07834         247 PKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEEELKEL  326 (330)
T ss_pred             ccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccccccchhhcCHHHHhHH
Confidence            6666666677777889999999999999999999999999999999999999999998888877 466799999999999


Q ss_pred             HHHH
Q 025683          237 IYQE  240 (249)
Q Consensus       237 ~~~~  240 (249)
                      |.+|
T Consensus       327 ~~~~  330 (330)
T cd07834         327 IYEE  330 (330)
T ss_pred             hhcC
Confidence            9764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=260.07  Aligned_cols=178  Identities=30%  Similarity=0.524  Sum_probs=146.3

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-CCCeEEeecCCccCCCC----CCccc
Q 025683            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSE----NEFMT   75 (249)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~~----~~~~~   75 (249)
                      ||+|.+++.+.+ .|++..++.+.+||++||+|||++|++|+||||+|||++. ++.+||+|||.+.....    .....
T Consensus       100 ~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~  179 (313)
T KOG0198|consen  100 GGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSEL  179 (313)
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccc
Confidence            789999999987 8999999999999999999999999999999999999999 79999999998876553    22234


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN-DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ...||+.|+|||++........++|||||||++.||++|..||... ......-.+..                      
T Consensus       180 ~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~----------------------  237 (313)
T KOG0198|consen  180 SVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR----------------------  237 (313)
T ss_pred             cccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc----------------------
Confidence            5789999999999975323345999999999999999999999763 21111111110                      


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                             ......++..++++.++|+.+|+.+||.+|||++++|+|||.++-..
T Consensus       238 -------~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  238 -------EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -------cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                   00112456678999999999999999999999999999999987554

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.5e-37  Score=261.17  Aligned_cols=243  Identities=46%  Similarity=0.763  Sum_probs=187.3

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC--Ccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN--EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~--~~~~~~~   78 (249)
                      ++++|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++......  .......
T Consensus        86 ~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  165 (372)
T cd07853          86 MQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV  165 (372)
T ss_pred             cccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCC
Confidence            35789999988889999999999999999999999999999999999999999999999999998754322  2223346


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.+.......+...++.++.......... .........
T Consensus       166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~~~~~~~~~  244 (372)
T cd07853         166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG-ARAHILRGP  244 (372)
T ss_pred             cCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH-HHHHHHhCC
Confidence            7889999999877666789999999999999999999999999999999999888887765443322221 111221111


Q ss_pred             CCCC--cchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC--------------------CCCCCCCC
Q 025683          159 QHPR--QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD--------------------EADEPVCP  216 (249)
Q Consensus       159 ~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~--------------------~~~~~~~~  216 (249)
                      ..+.  .....+....++++.+||.+||+.||.+|||+.++++||||++...                    ...++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (372)
T cd07853         245 HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSAN  324 (372)
T ss_pred             CCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCCcccCCCCC
Confidence            1111  1112234456889999999999999999999999999999998532                    12233344


Q ss_pred             CCCCCchhccccCHHHHHHHHHHHHHHh
Q 025683          217 EPFSFDFEQQSLGEEQIKDMIYQEALAL  244 (249)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (249)
                      .++..+++....+..++++.+.++..++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (372)
T cd07853         325 PPFDDEYEKNLTSVRQVKEELHQFILEQ  352 (372)
T ss_pred             CCCCcccccccCCHHHHHHHHHHHHHHh
Confidence            5566666666778888999888877655

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=258.51  Aligned_cols=241  Identities=61%  Similarity=1.123  Sum_probs=196.1

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC----cccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTE   76 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~   76 (249)
                      ++++|.+++.. ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.......    ....
T Consensus        90 ~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  168 (336)
T cd07849          90 METDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE  168 (336)
T ss_pred             cccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCC
Confidence            35678887754 679999999999999999999999999999999999999999999999999886543321    1123


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|+|||.+.+...++.++|+||+||++++|++|..||.+.+.......+...++.+...............+...
T Consensus       169 ~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (336)
T cd07849         169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKS  248 (336)
T ss_pred             cCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhh
Confidence            46788899999876555588999999999999999999999998887778888888777766555444333333334433


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhc-cccCHHHHHH
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQ-QSLGEEQIKD  235 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  235 (249)
                      .+......+....+.+++++.+++.+||+.||.+|||+.++++||||+.+......+....++++|++. .....+.+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (336)
T cd07849         249 LPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKE  328 (336)
T ss_pred             cCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccccccCHHHHHH
Confidence            333344444555567789999999999999999999999999999999999988889888888999985 6777899999


Q ss_pred             HHHHHHH
Q 025683          236 MIYQEAL  242 (249)
Q Consensus       236 ~~~~~~~  242 (249)
                      .|+.|.+
T Consensus       329 ~~~~~~~  335 (336)
T cd07849         329 LIFEEIM  335 (336)
T ss_pred             HHHHHhc
Confidence            9988865

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.9e-38  Score=269.06  Aligned_cols=202  Identities=37%  Similarity=0.678  Sum_probs=163.8

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC--CeEEeecCCccCCCCCCcccc
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC--DLKICDFGLARPTSENEFMTE   76 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~   76 (249)
                      ++.+|+++|+.+  ..|+...++.++.||+.||.+||+.||+|+||||+|||+...+  .+||+|||.+......-  ..
T Consensus       270 L~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v--yt  347 (586)
T KOG0667|consen  270 LSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV--YT  347 (586)
T ss_pred             hhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc--ee
Confidence            467899999987  5799999999999999999999999999999999999997654  68999999998765443  37


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .+.++.|+|||++.+.+ ++.+.|+|||||+++||++|.++|++.+..++++.|++.+|.|+..........  ..+++.
T Consensus       348 YiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~--~kff~~  424 (586)
T KOG0667|consen  348 YIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA--HKFFTS  424 (586)
T ss_pred             eeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc--ceehhc
Confidence            78899999999998776 999999999999999999999999999999999999999999987765533332  111111


Q ss_pred             --------------------------------CCCC-CCcchhhcCC-CCChHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 025683          157 --------------------------------LPQH-PRQSLAQVFP-HVHPLAIDLVDRMLTFDPMKRITVDEALAHPY  202 (249)
Q Consensus       157 --------------------------------~~~~-~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~  202 (249)
                                                      .... ....+....+ .....+.+||++||.+||.+|+|+.++|+|||
T Consensus       425 ~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpf  504 (586)
T KOG0667|consen  425 LKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPF  504 (586)
T ss_pred             cCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcc
Confidence                                            0000 1111112222 23356899999999999999999999999999


Q ss_pred             ccCCc
Q 025683          203 LARLH  207 (249)
Q Consensus       203 ~~~~~  207 (249)
                      |+...
T Consensus       505 l~~~~  509 (586)
T KOG0667|consen  505 LTGTS  509 (586)
T ss_pred             ccccc
Confidence            99544

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=245.50  Aligned_cols=172  Identities=30%  Similarity=0.541  Sum_probs=155.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||.|+++|.+.++|++.+++.++.||+.||+|||+++|++||+||+||+++++|.+|+.|||+++.....  ..+.+||+
T Consensus       128 GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTP  205 (355)
T KOG0616|consen  128 GGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTP  205 (355)
T ss_pred             CccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEecCCc
Confidence            8999999999999999999999999999999999999999999999999999999999999999876544  55789999


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||++...+ ++.++|.|+|||++|||+.|.+||...++...+.+|...--                          
T Consensus       206 eYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--------------------------  258 (355)
T KOG0616|consen  206 EYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--------------------------  258 (355)
T ss_pred             cccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--------------------------
Confidence            999999997554 89999999999999999999999999998888888875222                          


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                           ..++.+++++++||+++|+.|-++|.     ...++..||||+...
T Consensus       259 -----~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  259 -----KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             -----cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence                 22335789999999999999999993     678999999999877

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.4e-37  Score=265.25  Aligned_cols=206  Identities=36%  Similarity=0.675  Sum_probs=160.8

Q ss_pred             CCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCCCCccc
Q 025683            1 MDTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMT   75 (249)
Q Consensus         1 ~~~~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~~~~~   75 (249)
                      ++++|.+++.    ....+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++.........
T Consensus       149 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  228 (440)
T PTZ00036        149 IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV  228 (440)
T ss_pred             CCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcc
Confidence            3567777765    346899999999999999999999999999999999999999665 69999999998665444444


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+......+..+...++.+...............   
T Consensus       229 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~---  305 (440)
T PTZ00036        229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI---  305 (440)
T ss_pred             cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcc---
Confidence            56779999999998766668999999999999999999999999998888888888888876544322111100000   


Q ss_pred             hCCCCCCcch-hhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          156 QLPQHPRQSL-AQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       156 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      ..+......+ ..++...++++++||.+||.+||.+|||+.++++||||+.++..
T Consensus       306 ~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence            0000001111 12334578899999999999999999999999999999988754

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.1e-37  Score=249.87  Aligned_cols=201  Identities=40%  Similarity=0.776  Sum_probs=161.0

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      ++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+...... .......
T Consensus        85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~  164 (288)
T cd07871          85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV  164 (288)
T ss_pred             CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCce
Confidence            467899999765 45899999999999999999999999999999999999999999999999998754322 2223456


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhh-HHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNED-AKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  157 (249)
                      ++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.+.......+....+.++...+....... ...+.  .
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  242 (288)
T cd07871         165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL--F  242 (288)
T ss_pred             ecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc--c
Confidence            78899999998766668899999999999999999999999988888888888888877766554332211 11111  1


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      +...........+.+++++++||++||++||.+|||++|+++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            1111222334455788999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-36  Score=254.13  Aligned_cols=237  Identities=41%  Similarity=0.725  Sum_probs=174.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ++++|.+++..  .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.............++
T Consensus       111 ~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t  188 (364)
T cd07875         111 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT  188 (364)
T ss_pred             CCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCccc
Confidence            35678887764  6889999999999999999999999999999999999999999999999999766554444456789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+...++.+........... ...+....+..
T Consensus       189 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  266 (364)
T cd07875         189 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT-VRTYVENRPKY  266 (364)
T ss_pred             CCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH-HHHHHhhCCCc
Confidence            999999998654 4789999999999999999999999999888888888887776654432222111 11222221111


Q ss_pred             CCcch------------hhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCC-CCchhccc
Q 025683          161 PRQSL------------AQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPF-SFDFEQQS  227 (249)
Q Consensus       161 ~~~~~------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~-~~~~~~~~  227 (249)
                      .....            .......+.++++||.+||+.||.+|||+.++|+||||..+......+..++.. ....++..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (364)
T cd07875         267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDERE  346 (364)
T ss_pred             CCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCCCCCCCCCccchhhh
Confidence            11111            111223456789999999999999999999999999999877655444322211 22223345


Q ss_pred             cCHHHHHHHHHHHH
Q 025683          228 LGEEQIKDMIYQEA  241 (249)
Q Consensus       228 ~~~~~~~~~~~~~~  241 (249)
                      ...+++++.++.+-
T Consensus       347 ~~~~~~~~~~~~~~  360 (364)
T cd07875         347 HTIEEWKELIYKEV  360 (364)
T ss_pred             ccHHHHHHHHHHHH
Confidence            55567777666654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=240.07  Aligned_cols=242  Identities=42%  Similarity=0.725  Sum_probs=188.6

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |..+|.+.+.  -.++-+.+..++.|++.|++|||+.||+||||||+||++..+..+|++|||++......-.....+.+
T Consensus       103 m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvt  180 (369)
T KOG0665|consen  103 MDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVT  180 (369)
T ss_pred             hhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhhe
Confidence            4567777777  37888999999999999999999999999999999999999999999999999876655345567889


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||+..+.+ +...+||||+||++.||++|...|++.+.-+++.++...+|.+............ ..+....++-
T Consensus       181 Ryyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~-r~yv~~~~~y  258 (369)
T KOG0665|consen  181 RYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV-RNYVENRPQY  258 (369)
T ss_pred             eeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH-HHHhhcChHh
Confidence            9999999998877 8999999999999999999999999999999999999999998876544332221 1122222211


Q ss_pred             CCcchhhc------------CCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC-CCCCCCCCchhccc
Q 025683          161 PRQSLAQV------------FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP-VCPEPFSFDFEQQS  227 (249)
Q Consensus       161 ~~~~~~~~------------~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~-~~~~~~~~~~~~~~  227 (249)
                      ....+.+.            .+.-+..+++++.+||..||++|.+++++|+|||++-|..+.... +.+.++..-++...
T Consensus       259 ~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe~~d~~~d~~~  338 (369)
T KOG0665|consen  259 QAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPEIYDKQLDERE  338 (369)
T ss_pred             hccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCchhhhhccccc
Confidence            11222222            222345578999999999999999999999999999554222211 22223333445566


Q ss_pred             cCHHHHHHHHHHHHHHhCC
Q 025683          228 LGEEQIKDMIYQEALALNP  246 (249)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~  246 (249)
                      .+.+|+++.|++|.++|++
T Consensus       339 ~t~~e~ke~If~ev~~f~~  357 (369)
T KOG0665|consen  339 HTIEEWKELIFKEVQRFEE  357 (369)
T ss_pred             CCHHHHHHHHHHHHHhhcc
Confidence            6699999999999999998

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-36  Score=250.85  Aligned_cols=242  Identities=45%  Similarity=0.883  Sum_probs=197.8

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      +|++|.+++.+ ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+......  .....++
T Consensus       102 ~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~  178 (343)
T cd07880         102 MGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVT  178 (343)
T ss_pred             CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC--ccccccC
Confidence            36788888875 67999999999999999999999999999999999999999999999999998765432  2234568


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|++||.+.+...++.++|+||||++++++++|..||...+.......+....+..+..............+....+..
T Consensus       179 ~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (343)
T cd07880         179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF  258 (343)
T ss_pred             CcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhcccc
Confidence            88999999865455788999999999999999999999988877777777666555544433333333344444444444


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHHH
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE  240 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (249)
                      ....+..+.+.+++++.++|.+||+.||.+|||+.+++.||||+.+.....++ ...++..+.+....+-+|++...+.|
T Consensus       259 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (343)
T cd07880         259 RKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET-EAPPYDDSFDEVDQSLEEWKRLTFTE  337 (343)
T ss_pred             CcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccccc-CCCCccccHHhhccchHHHHHHHHHH
Confidence            44445556678899999999999999999999999999999999998776655 45578888999999999999999999


Q ss_pred             HHHhCC
Q 025683          241 ALALNP  246 (249)
Q Consensus       241 ~~~~~~  246 (249)
                      ...|.|
T Consensus       338 ~~~~~~  343 (343)
T cd07880         338 ILSFQP  343 (343)
T ss_pred             HHhcCC
Confidence            999976

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1e-36  Score=248.92  Aligned_cols=198  Identities=39%  Similarity=0.727  Sum_probs=160.6

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccc
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ++++|.+++...  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.............
T Consensus        91 ~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  170 (290)
T cd07862          91 VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV  170 (290)
T ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCccccccc
Confidence            357899999764  458999999999999999999999999999999999999999999999999987655444344567


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+... .++.++|+|||||++|+|++|..||.+..+...+..+....+.+....+.......    .....
T Consensus       171 ~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~----~~~~~  245 (290)
T cd07862         171 VTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP----RQAFH  245 (290)
T ss_pred             ccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhccc----chhcc
Confidence            89999999998654 47889999999999999999999999998888898888877766544332111100    01111


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      .........+.+.+++.+.+++.+||+.||.+|||+.++++||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         246 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             CCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            223344555666788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=264.00  Aligned_cols=209  Identities=28%  Similarity=0.480  Sum_probs=160.1

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCC----------------CeEEeecC
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANC----------------DLKICDFG   63 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~----------------~~kL~dfg   63 (249)
                      +|++|.+++.+.+.+++..++.++.||+.||+|||+ .||+||||||+||+++.++                .+||+|||
T Consensus       214 ~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG  293 (467)
T PTZ00284        214 YGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG  293 (467)
T ss_pred             cCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCC
Confidence            478999999998899999999999999999999998 5999999999999998765                49999999


Q ss_pred             CccCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 025683           64 LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (249)
                      .+.....  ......+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+....+..+...++.++.....
T Consensus       294 ~~~~~~~--~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~  370 (467)
T PTZ00284        294 GCCDERH--SRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAG  370 (467)
T ss_pred             ccccCcc--ccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Confidence            8754322  223467899999999997554 8899999999999999999999999988888888888888877655443


Q ss_pred             ccchhhHHHHHHhCCCC----CCcchhhcC-------CCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC
Q 025683          144 FVRNEDAKRYIRQLPQH----PRQSLAQVF-------PHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE  212 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~----~~~~~~~~~-------~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~  212 (249)
                      .+.......++......    ....+..+.       ...++.+.+||.+||++||.+|||++|+|+||||+++......
T Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~  450 (467)
T PTZ00284        371 RCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQ  450 (467)
T ss_pred             hccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCcccc
Confidence            33222222222211110    000000000       0124568899999999999999999999999999987654433

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.6e-36  Score=252.35  Aligned_cols=207  Identities=46%  Similarity=0.796  Sum_probs=158.8

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ++++|.+++..  .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.............++
T Consensus       108 ~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t  185 (359)
T cd07876         108 MDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVT  185 (359)
T ss_pred             CCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCccc
Confidence            35677777754  6899999999999999999999999999999999999999999999999998765444334456778


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+...++.+.......... ....+....+..
T Consensus       186 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  263 (359)
T cd07876         186 RYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP-TVRNYVENRPQY  263 (359)
T ss_pred             CCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH-HHHHHHhhCCCC
Confidence            999999998654 478899999999999999999999999888888888887777665433222111 112222222221


Q ss_pred             CCcchhh------------cCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          161 PRQSLAQ------------VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       161 ~~~~~~~------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                      ....+.+            .....++++++||.+||..||.+|||+.|+++||||+.+.....
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~  326 (359)
T cd07876         264 PGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE  326 (359)
T ss_pred             CCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccc
Confidence            1111111            12234678999999999999999999999999999998765543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=239.61  Aligned_cols=186  Identities=30%  Similarity=0.521  Sum_probs=155.0

Q ss_pred             CccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc---CCCeEEeecCCccCCCCCCcccc
Q 025683            2 DTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~---~~~~kL~dfg~~~~~~~~~~~~~   76 (249)
                      ||+|++.++..+.  |++.++..|++||..|+.|||+.+|.||||||+|+|...   +..+||+|||+++.........+
T Consensus       143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~T  222 (400)
T KOG0604|consen  143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMT  222 (400)
T ss_pred             chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccC
Confidence            8999999999765  999999999999999999999999999999999999965   45789999999998877777778


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH----VHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                      .+.|++|.|||++ +..++..+.|+||+||++|-|++|.+||.+...    ....++|....-..+..            
T Consensus       223 Pc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p------------  289 (400)
T KOG0604|consen  223 PCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP------------  289 (400)
T ss_pred             CcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh------------
Confidence            8899999999988 455699999999999999999999999976542    22333332211111111            


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCC
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVC  215 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~  215 (249)
                                     -|..+|++.+++|+++|..+|++|.|++++++|||+.+...-...+++
T Consensus       290 ---------------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~  337 (400)
T KOG0604|consen  290 ---------------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS  337 (400)
T ss_pred             ---------------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence                           233688999999999999999999999999999999998776666654

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7e-36  Score=249.68  Aligned_cols=239  Identities=45%  Similarity=0.850  Sum_probs=189.5

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW   82 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~   82 (249)
                      .+|.+++.  ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+......  .....++..
T Consensus       104 ~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~  179 (342)
T cd07879         104 TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRW  179 (342)
T ss_pred             cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--CCCceeeec
Confidence            34555543  47999999999999999999999999999999999999999999999999998754322  223466888


Q ss_pred             ccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCC
Q 025683           83 YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR  162 (249)
Q Consensus        83 y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (249)
                      |+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+....+.+...............+....+..+.
T Consensus       180 y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (342)
T cd07879         180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPR  259 (342)
T ss_pred             ccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCccc
Confidence            99999986655578899999999999999999999998887777877777777666554444444333444444444455


Q ss_pred             cchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHHHHH
Q 025683          163 QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQEAL  242 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (249)
                      ..+....+..++.+.+||.+||+.||.+||++.+++.||||..+++...++ ++.++....+......+++...+++|.+
T Consensus       260 ~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (342)
T cd07879         260 KDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET-EQQPYDDSLENEKLSVDEWKKHIYKEVK  338 (342)
T ss_pred             chHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC-CCCcccchhhhhhCCHHHHHHHhhhhhh
Confidence            555556667889999999999999999999999999999999998644333 3555555555566677999999999999


Q ss_pred             HhCC
Q 025683          243 ALNP  246 (249)
Q Consensus       243 ~~~~  246 (249)
                      .|-|
T Consensus       339 ~~~~  342 (342)
T cd07879         339 SFSP  342 (342)
T ss_pred             ccCC
Confidence            8876

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=252.68  Aligned_cols=190  Identities=28%  Similarity=0.492  Sum_probs=159.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-----------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-----------   70 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-----------   70 (249)
                      |||+..+|.+.+.|+++.++.++.+++.|++-+|+.|++||||||+|+||+..|.+||+|||++.....           
T Consensus       225 GGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~  304 (550)
T KOG0605|consen  225 GGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDE  304 (550)
T ss_pred             CccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchh
Confidence            899999999999999999999999999999999999999999999999999999999999999842110           


Q ss_pred             -----------C--C------------------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 025683           71 -----------N--E------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN  113 (249)
Q Consensus        71 -----------~--~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~  113 (249)
                                 .  .                        .....+|||.|+|||++.+.+ ++..+|.||||||+|||+.
T Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLv  383 (550)
T KOG0605|consen  305 QMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLV  383 (550)
T ss_pred             hhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHh
Confidence                       0  0                        001347899999999998776 8999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-
Q 025683          114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-  192 (249)
Q Consensus       114 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-  192 (249)
                      |.+||.+.++..+.++|+..-.......                           ....++++.+||.+||. ||.+|. 
T Consensus       384 GyPPF~s~tp~~T~rkI~nwr~~l~fP~---------------------------~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  384 GYPPFCSETPQETYRKIVNWRETLKFPE---------------------------EVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhhhccCCC---------------------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999999999986443222111                           01356889999999999 999998 


Q ss_pred             --CHHHHhcCccccCCcCCCCCCCCCCCCCC
Q 025683          193 --TVDEALAHPYLARLHDEADEPVCPEPFSF  221 (249)
Q Consensus       193 --t~~~ll~h~~~~~~~~~~~~~~~~~~~~~  221 (249)
                        +++||.+||||+.+..+...... +||.+
T Consensus       436 ~~G~~EIK~HPfF~~v~W~~l~~~~-apfvP  465 (550)
T KOG0605|consen  436 SKGAEEIKKHPFFKGVDWDHLREMP-APFVP  465 (550)
T ss_pred             cccHHHHhcCCccccCCcchhhcCC-CCCCC
Confidence              49999999999999876655543 44444

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-35  Score=249.46  Aligned_cols=235  Identities=41%  Similarity=0.725  Sum_probs=169.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      +++|.+++..  .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.............++.
T Consensus       105 ~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~  182 (355)
T cd07874         105 DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR  182 (355)
T ss_pred             cccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccC
Confidence            5667777764  68999999999999999999999999999999999999999999999999998765544445567899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+...++.+........... ...+....+...
T Consensus       183 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  260 (355)
T cd07874         183 YYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT-VRNYVENRPKYA  260 (355)
T ss_pred             CccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH-HHHHHhcCCccc
Confidence            99999998654 4789999999999999999999999998888888888777776554433222211 112222111110


Q ss_pred             C------------cchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC-CCCCCCCCchhcccc
Q 025683          162 R------------QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP-VCPEPFSFDFEQQSL  228 (249)
Q Consensus       162 ~------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  228 (249)
                      .            ..........+.++.+||.+||..||.+|||+.++++||||+.+.+..... +.+..+..+.++...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (355)
T cd07874         261 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH  340 (355)
T ss_pred             cccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhhccCCCccccccchhhhhc
Confidence            0            001112223467789999999999999999999999999999776443222 222222333334444


Q ss_pred             CHHHHHHHHHHH
Q 025683          229 GEEQIKDMIYQE  240 (249)
Q Consensus       229 ~~~~~~~~~~~~  240 (249)
                      +.++.++.+..+
T Consensus       341 ~~~~~~~~~~~~  352 (355)
T cd07874         341 TIEEWKELIYKE  352 (355)
T ss_pred             cHHHHHHHHHHH
Confidence            455555554443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=231.16  Aligned_cols=177  Identities=34%  Similarity=0.543  Sum_probs=150.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc---CCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~---~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.--+-+.--+++..+-.+++||++||+|+|.+||+|||+||.|+++..   ..-+||+|||++...+.+.-.....
T Consensus        94 G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~  173 (355)
T KOG0033|consen   94 GGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFA  173 (355)
T ss_pred             chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccccccc
Confidence            5666655555466889999999999999999999999999999999999954   3468999999999887666666789


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||++...+ ++.++|||+.||++|-++.|.+||.+.+....+..|...--..+.                   
T Consensus       174 GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~-------------------  233 (355)
T KOG0033|consen  174 GTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS-------------------  233 (355)
T ss_pred             CCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC-------------------
Confidence            999999999997665 899999999999999999999999998888888777653222221                   


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                              ..|++++++.++||++||..||.+|.|+.|+|+|||+.+-
T Consensus       234 --------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  234 --------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             --------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence                    2355789999999999999999999999999999999863

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.5e-36  Score=242.95  Aligned_cols=197  Identities=39%  Similarity=0.694  Sum_probs=157.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      +++|.+++.+.  ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.............+
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  169 (288)
T cd07863          90 DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV  169 (288)
T ss_pred             ccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccc
Confidence            56888888764  4599999999999999999999999999999999999999999999999999876554443445567


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+. .++.++|+||+||++++|++|..||...........+....+.+....+.......    ......
T Consensus       170 ~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  244 (288)
T cd07863         170 TLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP----RGAFSP  244 (288)
T ss_pred             cccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc----ccccCC
Confidence            8899999998654 48899999999999999999999999888888888888777665443322111000    001112


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ..........+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         245 RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            22334455666788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-36  Score=243.64  Aligned_cols=189  Identities=24%  Similarity=0.396  Sum_probs=149.6

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----c-
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----M-   74 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~-   74 (249)
                      +||+.++++..  ..|++..+..|+++++.||.|||++|.+|||||+.|||++.+|.++|+|||.+......+.    . 
T Consensus       108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf  187 (516)
T KOG0582|consen  108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRF  187 (516)
T ss_pred             CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEee
Confidence            68999999885  5699999999999999999999999999999999999999999999999998765433321    1 


Q ss_pred             ccccccccccCchhc-cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHH
Q 025683           75 TEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~-~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (249)
                      ....|++.|+|||++ .....|..|+||||||++..|+.+|..||...-+...+-  ...-+.++...........    
T Consensus       188 ~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~tLqn~pp~~~t~~~~~d~----  261 (516)
T KOG0582|consen  188 NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LTLQNDPPTLLTSGLDKDE----  261 (516)
T ss_pred             ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HHhcCCCCCcccccCChHH----
Confidence            556899999999994 444569999999999999999999999998765443332  2222333322221111111    


Q ss_pred             HHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                                     ...++..++.+|..||.+||.+|||++++|+|+||++.+...-
T Consensus       262 ---------------~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~  304 (516)
T KOG0582|consen  262 ---------------DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY  304 (516)
T ss_pred             ---------------hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence                           1246678999999999999999999999999999998874443

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.8e-35  Score=243.66  Aligned_cols=242  Identities=50%  Similarity=0.938  Sum_probs=192.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      +|++|.+++.. ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+......  .....++
T Consensus       104 ~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--~~~~~~~  180 (345)
T cd07877         104 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVAT  180 (345)
T ss_pred             cccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc--ccccccC
Confidence            46788888765 57999999999999999999999999999999999999999999999999998754322  2345668


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+...++.++|+||+||++++|++|..||...........+....+.++..............+.......
T Consensus       181 ~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (345)
T cd07877         181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM  260 (345)
T ss_pred             CCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhccc
Confidence            88999998866555788999999999999999999999888877777777777776666555545444444444444444


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHHH
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE  240 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (249)
                      +...+.......++++.++|.+||+.||.+||++.+++.||||+++......+..+ ++...+.......+++.+..++|
T Consensus       261 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  339 (345)
T cd07877         261 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDE  339 (345)
T ss_pred             CCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC-CccCcchhcccCHHHHHHHHHHH
Confidence            44444444456788999999999999999999999999999999988877776544 45555555566668888989888


Q ss_pred             HHHhCC
Q 025683          241 ALALNP  246 (249)
Q Consensus       241 ~~~~~~  246 (249)
                      --.|-|
T Consensus       340 ~~~~~~  345 (345)
T cd07877         340 VISFVP  345 (345)
T ss_pred             HHhcCC
Confidence            776654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-35  Score=243.03  Aligned_cols=208  Identities=41%  Similarity=0.756  Sum_probs=164.1

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~   78 (249)
                      ++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+....... ......
T Consensus        86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  165 (309)
T cd07872          86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV  165 (309)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccccc
Confidence            356888888765 458999999999999999999999999999999999999999999999999986543322 223346


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+...++.+....+........... ...+
T Consensus       166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  244 (309)
T cd07872         166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN-YNFP  244 (309)
T ss_pred             ccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh-hhcC
Confidence            688999999987666688999999999999999999999999988888888888888777655443322211111 1111


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      ...........+.+++++.++|.+||+.||.+|||+.++++||||+.+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence            112222233445688999999999999999999999999999999987533

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-35  Score=249.62  Aligned_cols=208  Identities=24%  Similarity=0.350  Sum_probs=153.1

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC--Ccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN--EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~--~~~~~~~   78 (249)
                      ++++|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......  .......
T Consensus       165 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  244 (391)
T PHA03212        165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA  244 (391)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccccc
Confidence            46789999998889999999999999999999999999999999999999999999999999998653221  2223457


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND-------HVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      ||+.|+|||.+... .++.++|+|||||++|+|++|..||....       ...++..+....+..+.............
T Consensus       245 gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~  323 (391)
T PHA03212        245 GTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDE  323 (391)
T ss_pred             CccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHH
Confidence            89999999998654 48899999999999999999998765432       34566666666665543322111111111


Q ss_pred             HH---HHhCCCCC-CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          152 RY---IRQLPQHP-RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       152 ~~---~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      .+   .......+ ..........++.++.+||.+||++||.+|||++++|+||||+.+...
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        324 IYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             HHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            11   11111110 011111112356789999999999999999999999999999986544

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-35  Score=243.89  Aligned_cols=206  Identities=37%  Similarity=0.674  Sum_probs=152.0

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      ++++|.+++.+. +.++++.++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||.+...... .......
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  164 (303)
T cd07869          85 VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEV  164 (303)
T ss_pred             CCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCc
Confidence            467888888765 67999999999999999999999999999999999999999999999999988654322 2223456


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCcccccccchhhHHHHH-Hh
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYI-RQ  156 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  156 (249)
                      +++.|+|||.+.+...++.++|+||+||++|+|++|..||.+..+ ......+....+.+....+.......  .+. ..
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  242 (303)
T cd07869         165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP--HFKPER  242 (303)
T ss_pred             ccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc--cccccc
Confidence            788999999987666688899999999999999999999987544 44555666655555433322111000  000 00


Q ss_pred             CCCCCCcchhhcC--CCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          157 LPQHPRQSLAQVF--PHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       157 ~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      ............+  ...++++.+|+.+||+.||.+|||+.++++||||++...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            0000011111111  124578899999999999999999999999999998643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.4e-35  Score=242.55  Aligned_cols=236  Identities=51%  Similarity=0.959  Sum_probs=194.1

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      +|++|.+++.. ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+......  .....++
T Consensus        92 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~  168 (328)
T cd07856          92 LGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVST  168 (328)
T ss_pred             hccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--cCCCccc
Confidence            46788888875 56899999999999999999999999999999999999999999999999988754322  2234567


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|++||.+.+...++.++|+||||+++++|++|..||...........+...++.++..............+.......
T Consensus       169 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (328)
T cd07856         169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKR  248 (328)
T ss_pred             ccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcccc
Confidence            88999998765455889999999999999999999999988888888888888887776554444333333333333333


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHH
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQ  239 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (249)
                      ......+..+.+++.+.++|++||+.+|.+|||+++++.|+||+.+..+..++.....+.|.+++++...+.++-+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (328)
T cd07856         249 EPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYS  327 (328)
T ss_pred             CCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchhhcCCchhcccCCHHHHHHHhcC
Confidence            3334445556788999999999999999999999999999999999999999988889999999999999999887764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=243.18  Aligned_cols=201  Identities=32%  Similarity=0.599  Sum_probs=157.8

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc--------------------CCCeE
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--------------------NCDLK   58 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~--------------------~~~~k   58 (249)
                      ||-|++++|.++  .+++...++.|++|+++++++||+.+++|.|+||+||++-.                    +..++
T Consensus       173 lG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~  252 (415)
T KOG0671|consen  173 LGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIK  252 (415)
T ss_pred             cChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceE
Confidence            577999999986  57999999999999999999999999999999999999832                    23489


Q ss_pred             EeecCCccCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 025683           59 ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT  138 (249)
Q Consensus        59 L~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  138 (249)
                      ++|||.+....+..  ...+.|.+|+|||++.+-+ |+..+||||+|||+.|+.+|..+|..-++...+..+...+|+.|
T Consensus       253 vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P  329 (415)
T KOG0671|consen  253 VIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIP  329 (415)
T ss_pred             EEecCCcceeccCc--ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCc
Confidence            99999987654433  4668899999999998776 99999999999999999999999999889999999999999777


Q ss_pred             cccccccchhhHHHHH-------------------HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          139 DADLGFVRNEDAKRYI-------------------RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       139 ~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ........   ..+++                   .+.+....... ........++.+|+++||.+||.+|+|+.|+|.
T Consensus       330 ~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~-~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  330 SRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYM-LQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHh-ccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence            65433221   11111                   11111111000 001112244889999999999999999999999


Q ss_pred             CccccCCcC
Q 025683          200 HPYLARLHD  208 (249)
Q Consensus       200 h~~~~~~~~  208 (249)
                      ||||+....
T Consensus       406 HpFF~~~~~  414 (415)
T KOG0671|consen  406 HPFFARLTP  414 (415)
T ss_pred             CHHhhcCCC
Confidence            999997653

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.2e-36  Score=247.74  Aligned_cols=174  Identities=29%  Similarity=0.534  Sum_probs=145.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........|+
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence            689999999989999999999999999999999999999999999999999999999999999875322 2233446789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....                          
T Consensus       159 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--------------------------  211 (323)
T cd05571         159 PEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------------------------  211 (323)
T ss_pred             ccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            999999998654 47899999999999999999999998766444333332100                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                           ..++..+++++.++|++||+.||.+||     ++.++++||||++..
T Consensus       212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         212 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                 112335788999999999999999999     899999999998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.3e-35  Score=242.73  Aligned_cols=238  Identities=47%  Similarity=0.910  Sum_probs=187.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC------ccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE------FMT   75 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~------~~~   75 (249)
                      +++|.+++.+. .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......      ...
T Consensus        92 ~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~  170 (337)
T cd07852          92 ETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT  170 (337)
T ss_pred             ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchh
Confidence            56888988875 88999999999999999999999999999999999999999999999999887543321      122


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+........++....+.+..................
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (337)
T cd07852         171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLD  250 (337)
T ss_pred             cccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhh
Confidence            34678889999988765567889999999999999999999999888888888888777766654444333333333333


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCch-hccccCHHHHH
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDF-EQQSLGEEQIK  234 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (249)
                      ..............+..+.++.++|.+||+.||.+|||+.++++|||++++.....++....+....+ .....+..+-+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (337)
T cd07852         251 SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAEYR  330 (337)
T ss_pred             hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCccccceeeHHHHH
Confidence            33334444455556668899999999999999999999999999999999988777776655544333 35666777777


Q ss_pred             HHHHHH
Q 025683          235 DMIYQE  240 (249)
Q Consensus       235 ~~~~~~  240 (249)
                      ..|++|
T Consensus       331 ~~~~~~  336 (337)
T cd07852         331 NKLYEE  336 (337)
T ss_pred             hhhhhc
Confidence            777765

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=245.40  Aligned_cols=180  Identities=28%  Similarity=0.488  Sum_probs=162.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee-ccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-NANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~-~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ||||+|||.++ ..++++.++++++||+.|+.|+|+..+||||+||+||.+ .+-|-+||.|||++..+..+......+|
T Consensus       101 ~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCG  180 (864)
T KOG4717|consen  101 GGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCG  180 (864)
T ss_pred             CchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccc
Confidence            68999999886 679999999999999999999999999999999999766 4668899999999999888888899999


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|-|||++.+..+..+++||||||||+|-|++|+.||...++...+.+|+..-.                        
T Consensus       181 SLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY------------------------  236 (864)
T KOG4717|consen  181 SLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY------------------------  236 (864)
T ss_pred             hhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc------------------------
Confidence            99999999999998888999999999999999999999999999998888875432                        


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE  212 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~  212 (249)
                             .++..++.++++||.+||..||.+|-+.+++..++|++........
T Consensus       237 -------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT  282 (864)
T KOG4717|consen  237 -------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST  282 (864)
T ss_pred             -------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence                   2334688999999999999999999999999999999987755444

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-34  Score=243.08  Aligned_cols=235  Identities=42%  Similarity=0.776  Sum_probs=172.6

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ++++|.+++...  +++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.............++
T Consensus       103 ~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  180 (353)
T cd07850         103 MDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT  180 (353)
T ss_pred             cCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCccc
Confidence            357888888763  999999999999999999999999999999999999999999999999999766544433445678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++|+|||||++++|++|..||...+.......+...++.++......... ....+....+..
T Consensus       181 ~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  258 (353)
T cd07850         181 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP-TVRNYVENRPKY  258 (353)
T ss_pred             ccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh-hhhHHhhcCCCC
Confidence            889999998654 478999999999999999999999999888888888888887766543322211 111122211111


Q ss_pred             CCcchhhc-------------CCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCC-CCCCCCCchhcc
Q 025683          161 PRQSLAQV-------------FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV-CPEPFSFDFEQQ  226 (249)
Q Consensus       161 ~~~~~~~~-------------~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~-~~~~~~~~~~~~  226 (249)
                      ....+...             ....++.+.++|.+||+.||.+|||+.++|.||||+.|......+. .+..+....++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (353)
T cd07850         259 AGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEAPPPAPYDHSIDER  338 (353)
T ss_pred             CCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCCCCCCccccccccc
Confidence            11111111             2234667899999999999999999999999999998776544333 333333333344


Q ss_pred             ccCHHHHHHHHHH
Q 025683          227 SLGEEQIKDMIYQ  239 (249)
Q Consensus       227 ~~~~~~~~~~~~~  239 (249)
                      ....++++..++.
T Consensus       339 ~~~~~~~~~~~~~  351 (353)
T cd07850         339 EHTVEEWKELIYK  351 (353)
T ss_pred             cccHHHHHHHHHh
Confidence            4445666665544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.5e-35  Score=238.94  Aligned_cols=200  Identities=34%  Similarity=0.666  Sum_probs=148.0

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--cccccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVVT   80 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~   80 (249)
                      +++..+......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+.......  ......++
T Consensus        85 ~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  164 (287)
T cd07848          85 NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVAT  164 (287)
T ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccc
Confidence            3344444445679999999999999999999999999999999999999999999999999987654322  22335678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhH-HHHHHhCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA-KRYIRQLPQ  159 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  159 (249)
                      ..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+.+.......+....+..+............ .........
T Consensus       165 ~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (287)
T cd07848         165 RWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVN  243 (287)
T ss_pred             cccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCccc
Confidence            8999999986554 78899999999999999999999998887777777776666554332211100000 000000000


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ............++.++.+||++||++||.+|||++++++||||
T Consensus       244 ~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         244 HPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            01111122233578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-35  Score=239.97  Aligned_cols=173  Identities=24%  Similarity=0.461  Sum_probs=146.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+......  .....|++
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~  162 (291)
T cd05612          85 GGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTLCGTP  162 (291)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccccCCh
Confidence            6899999999899999999999999999999999999999999999999999999999999998765432  22456899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+.......+....                           
T Consensus       163 ~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---------------------------  214 (291)
T cd05612         163 EYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK---------------------------  214 (291)
T ss_pred             hhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------------------
Confidence            999999986544 7899999999999999999999998876555544443210                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLHD  208 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~~  208 (249)
                          ..+...+++.+.++|++||+.||.+|++     ++++++||||+....
T Consensus       215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence                0122246788999999999999999995     999999999987653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.3e-34  Score=237.91  Aligned_cols=207  Identities=40%  Similarity=0.743  Sum_probs=160.5

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~   78 (249)
                      ++++|.+++.+. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  165 (301)
T cd07873          86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV  165 (301)
T ss_pred             cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccc
Confidence            357888988764 579999999999999999999999999999999999999999999999999987543322 223345


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.+...++.++|+|||||++|+|++|..||...+.......+...++.+....+........ ......+
T Consensus       166 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  244 (301)
T cd07873         166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE-FKSYNYP  244 (301)
T ss_pred             eeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc-ccccccC
Confidence            688899999987666678899999999999999999999998888888888877777666544332211100 0000111


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      .............+++++.+||.+||+.||.+|||+.++++||||+.+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            11111223344568889999999999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.4e-35  Score=240.36  Aligned_cols=203  Identities=36%  Similarity=0.663  Sum_probs=147.1

Q ss_pred             CCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee----ccCCCeEEeecCCccC
Q 025683            1 MDTDLYQIIRSN---------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGLARP   67 (249)
Q Consensus         1 ~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~----~~~~~~kL~dfg~~~~   67 (249)
                      ++++|.+++...         ..+++..++.++.||+.||+|||++|++||||||+||++    +..+.+||+|||.+..
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            356788887532         258999999999999999999999999999999999999    4567899999999876


Q ss_pred             CCCCC----ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 025683           68 TSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---------VHQMRLLIELL  134 (249)
Q Consensus        68 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~---------~~~~~~~~~~~  134 (249)
                      .....    ......+|+.|+|||.+.+...++.++|+||+||++++|++|..||.....         ...+..+...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            54321    223457789999999997766688999999999999999999999965432         35566677777


Q ss_pred             CCCCcccccccchhh-----HHHHHHhCCC--CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          135 GTPTDADLGFVRNED-----AKRYIRQLPQ--HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       135 ~~~~~~~~~~~~~~~-----~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      +.+....+.......     .+.+......  .............+..+.+||++||+.||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            766554433221100     0000000000  00001111122345678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.9e-35  Score=234.48  Aligned_cols=183  Identities=25%  Similarity=0.427  Sum_probs=153.8

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC--------
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE--------   70 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~--------   70 (249)
                      .||||+.+++++  +.|+++.++.++.+|+.||+|||..|||+|||||+||||..+|.+.|+||.++.....        
T Consensus       160 pGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~  239 (459)
T KOG0610|consen  160 PGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSS  239 (459)
T ss_pred             CCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccC
Confidence            489999999986  6799999999999999999999999999999999999999999999999998632110        


Q ss_pred             -------------------------C-C-----------------------ccccccccccccCchhccCCCCCCchhHH
Q 025683           71 -------------------------N-E-----------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDV  101 (249)
Q Consensus        71 -------------------------~-~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  101 (249)
                                               . .                       ....++||..|+|||++.+.+ .+.++|.
T Consensus       240 ~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDW  318 (459)
T KOG0610|consen  240 SPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDW  318 (459)
T ss_pred             CCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-CCchhhH
Confidence                                     0 0                       112357899999999998776 8999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHH
Q 025683          102 WSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD  181 (249)
Q Consensus       102 wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  181 (249)
                      |+|||++|||+.|..||.+.+...++..++..--..+                       .      .+.++..+++||+
T Consensus       319 WtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp-----------------------~------~~~vs~~akDLIr  369 (459)
T KOG0610|consen  319 WTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFP-----------------------E------EPEVSSAAKDLIR  369 (459)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCC-----------------------C------CCcchhHHHHHHH
Confidence            9999999999999999999998888888764211111                       1      1156788999999


Q ss_pred             HhcCCCCCCCCC----HHHHhcCccccCCcCCCCCC
Q 025683          182 RMLTFDPMKRIT----VDEALAHPYLARLHDEADEP  213 (249)
Q Consensus       182 ~~L~~dp~~Rpt----~~~ll~h~~~~~~~~~~~~~  213 (249)
                      ++|.+||.+|..    +.||.+||||+.++..-...
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~  405 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRC  405 (459)
T ss_pred             HHhccChhhhhccccchHHhhcCccccCCChhheec
Confidence            999999999998    99999999999999764443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.7e-35  Score=239.37  Aligned_cols=179  Identities=25%  Similarity=0.383  Sum_probs=144.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ||+|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.............|
T Consensus        84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g  163 (285)
T cd05631          84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVG  163 (285)
T ss_pred             CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCC
Confidence            68898888653  4699999999999999999999999999999999999999999999999999876544444445678


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+. .++.++|||||||++|+|++|..||...........+.......                      
T Consensus       164 ~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------  220 (285)
T cd05631         164 TVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------------------  220 (285)
T ss_pred             CCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------------------
Confidence            9999999998654 48899999999999999999999998765332222222111100                      


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLHD  208 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~~  208 (249)
                           .......+++++.+|+++||+.||.+||+     ++++++||||+....
T Consensus       221 -----~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         221 -----QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             -----cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence                 01223357889999999999999999997     899999999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.2e-35  Score=242.28  Aligned_cols=174  Identities=22%  Similarity=0.434  Sum_probs=146.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..... ........|+
T Consensus        80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            689999999989999999999999999999999999999999999999999999999999999865322 2233345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....                          
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--------------------------  212 (320)
T cd05590         160 PDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--------------------------  212 (320)
T ss_pred             ccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--------------------------
Confidence            999999998644 47889999999999999999999998877655544443200                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH------HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV------DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~~ll~h~~~~~~~  207 (249)
                           ...+..++.++.++|++||+.||.+|+++      ++++.||||+.+.
T Consensus       213 -----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         213 -----VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence                 01122467889999999999999999998      9999999998865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-35  Score=240.63  Aligned_cols=174  Identities=29%  Similarity=0.553  Sum_probs=145.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... .......|+
T Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          77 GGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence            7899999999889999999999999999999999999999999999999999999999999998753322 223345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+||+||++|+|++|..||...........+..   .+                       
T Consensus       157 ~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~---~~-----------------------  209 (312)
T cd05585         157 PEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ---EP-----------------------  209 (312)
T ss_pred             cccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc---CC-----------------------
Confidence            999999998654 478999999999999999999999987665444333321   00                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC---CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI---TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~~ll~h~~~~~~~  207 (249)
                           ..++..+++++.++|.+||+.||.+||   ++.+++.||||++..
T Consensus       210 -----~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         210 -----LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             -----CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                 112335778899999999999999997   589999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.7e-35  Score=244.47  Aligned_cols=180  Identities=33%  Similarity=0.588  Sum_probs=153.8

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc-cccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT-EYVVTR   81 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~-~~~~~~   81 (249)
                      |+|+.+|..++.++++.++.++.+++.||.|||+++|.|+|+||.||++.+.|.+|+||||+++....+.... ..-||+
T Consensus        85 g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtP  164 (808)
T KOG0597|consen   85 GDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTP  164 (808)
T ss_pred             hhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcc
Confidence            5999999999999999999999999999999999999999999999999999999999999999877665433 356899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|||||...+ ..++..+|+|||||++||++.|++||....-......|...--.+                        
T Consensus       165 lYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~------------------------  219 (808)
T KOG0597|consen  165 LYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP------------------------  219 (808)
T ss_pred             cccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC------------------------
Confidence            9999999874 459999999999999999999999998776555555554311111                        


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV  214 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~  214 (249)
                             +.+.+..+..|+..+|.+||.+|.|..+++.|||.++-......+.
T Consensus       220 -------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~  265 (808)
T KOG0597|consen  220 -------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPA  265 (808)
T ss_pred             -------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccc
Confidence                   1157788999999999999999999999999999998775444443

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-35  Score=242.55  Aligned_cols=172  Identities=26%  Similarity=0.470  Sum_probs=144.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.......  ....|++
T Consensus       102 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~  179 (329)
T PTZ00263        102 GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FTLCGTP  179 (329)
T ss_pred             CChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ceecCCh
Confidence            78999999998999999999999999999999999999999999999999999999999999987654322  2457899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.........+....                           
T Consensus       180 ~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~---------------------------  231 (329)
T PTZ00263        180 EYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR---------------------------  231 (329)
T ss_pred             hhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---------------------------
Confidence            999999986544 7889999999999999999999998776554444432100                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                          ..++..++..+.+||.+||+.||.+|++     +++++.||||++..
T Consensus       232 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        232 ----LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             ----cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence                0112246788999999999999999996     79999999998753

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.2e-35  Score=242.27  Aligned_cols=174  Identities=26%  Similarity=0.485  Sum_probs=145.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC-CCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~-~~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.... .........|+
T Consensus        85 ~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  164 (324)
T cd05587          85 GGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT  164 (324)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCC
Confidence            68999999998899999999999999999999999999999999999999999999999999886432 22223345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+.+.......+....                          
T Consensus       165 ~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--------------------------  217 (324)
T cd05587         165 PDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--------------------------  217 (324)
T ss_pred             ccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            9999999986544 7889999999999999999999998877555554443210                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV-----DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~~ll~h~~~~~~~  207 (249)
                           ...+..+++++.+++++||..||.+|++.     .++++||||+...
T Consensus       218 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         218 -----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                 11223567889999999999999999976     8999999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.1e-34  Score=232.85  Aligned_cols=201  Identities=42%  Similarity=0.716  Sum_probs=151.2

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccc
Q 025683            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~   78 (249)
                      ++++|.+++.+ .+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (284)
T cd07839          81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV  160 (284)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence            35788888876 4679999999999999999999999999999999999999999999999999987554322 222345


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF-PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+.+...++.++|+|||||++|+|++|..|+ .+.+.......+...++.+....+.......  .+....
T Consensus       161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  238 (284)
T cd07839         161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP--DYKPYP  238 (284)
T ss_pred             cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc--cccccC
Confidence            6788999999876666789999999999999999988774 5555566666666666554433221111000  000000


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      .......+.+..+.+++++.++|.+||+.||.+|||+++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0011112234455788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.7e-35  Score=242.71  Aligned_cols=172  Identities=26%  Similarity=0.456  Sum_probs=146.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+......  .....|++
T Consensus       115 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--~~~~~gt~  192 (340)
T PTZ00426        115 GGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTP  192 (340)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--cceecCCh
Confidence            7899999999899999999999999999999999999999999999999999999999999998765332  23457899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+....                           
T Consensus       193 ~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------------------------  244 (340)
T PTZ00426        193 EYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------------------------  244 (340)
T ss_pred             hhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------------------------
Confidence            999999986543 7889999999999999999999998877655554443211                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                          ...++.+++.+.++|++||+.||.+|+     +++++++||||+++.
T Consensus       245 ----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        245 ----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                112234678899999999999999995     899999999999765

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9.2e-35  Score=241.98  Aligned_cols=179  Identities=23%  Similarity=0.427  Sum_probs=143.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~   79 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......  ......|
T Consensus        89 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~g  168 (332)
T cd05614          89 GGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG  168 (332)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccC
Confidence            68999999988899999999999999999999999999999999999999999999999999987543322  2234578


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+...++.++|||||||++|+|++|..||...........+....                   ...   
T Consensus       169 t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-------------------~~~---  226 (332)
T cd05614         169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI-------------------LKC---  226 (332)
T ss_pred             CccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH-------------------hcC---
Confidence            9999999998765557889999999999999999999996432211111111100                   000   


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                           ...+...+++.+.+++.+||+.||.+||     +++++++||||+...
T Consensus       227 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         227 -----DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence                 0112335778899999999999999999     889999999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.5e-34  Score=231.34  Aligned_cols=201  Identities=39%  Similarity=0.727  Sum_probs=156.7

Q ss_pred             CCccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccc
Q 025683            1 MDTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (249)
Q Consensus         1 ~~~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~   76 (249)
                      ++++|.+++...   ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (285)
T cd07861          81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH  160 (285)
T ss_pred             CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence            356788888653   569999999999999999999999999999999999999999999999999987543322 1223


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|+|||.+.+...++.++|+||||+++++|++|..||.+.........+....+.+....+.....  ...+...
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  238 (285)
T cd07861         161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS--LPDYKNT  238 (285)
T ss_pred             CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh--hHHHHhh
Confidence            45678899999987665678899999999999999999999998887777777777766655444332221  1112222


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ...............+++++.++|++||..||.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            22222233334455688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.9e-34  Score=238.56  Aligned_cols=174  Identities=24%  Similarity=0.468  Sum_probs=143.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+..... ........|+
T Consensus        80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            689999999888999999999999999999999999999999999999999999999999998864322 2223346789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+....                          
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--------------------------  212 (316)
T cd05620         160 PDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--------------------------  212 (316)
T ss_pred             cCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            999999998654 47899999999999999999999998776544433332100                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH-HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV-DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-~~ll~h~~~~~~~  207 (249)
                           ......++.++.++|.+||+.||.+|+++ +++++||||+...
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         213 -----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence                 01122467889999999999999999997 5899999998865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-34  Score=239.70  Aligned_cols=174  Identities=28%  Similarity=0.529  Sum_probs=145.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|..++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........|+
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence            689999999988999999999999999999999999999999999999999999999999998865322 2223345689


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....                          
T Consensus       159 ~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--------------------------  211 (323)
T cd05595         159 PEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--------------------------  211 (323)
T ss_pred             cCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------------------
Confidence            999999998644 47899999999999999999999998776544433332100                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                           ..++..+++++.++|.+||+.||.+|+     ++.++++|+||.+..
T Consensus       212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         212 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence                 012235788999999999999999998     899999999999765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-34  Score=238.61  Aligned_cols=205  Identities=24%  Similarity=0.348  Sum_probs=144.7

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+.............|
T Consensus       139 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~g  218 (357)
T PHA03209        139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAG  218 (357)
T ss_pred             cCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccc
Confidence            357899998764 6799999999999999999999999999999999999999999999999999875444333345678


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCC---------hHHHHHHHHHHhCCCCcccccccchhh
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF-PGND---------HVHQMRLLIELLGTPTDADLGFVRNED  149 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~-~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (249)
                      +..|+|||.+.+. .++.++|+|||||++|+|+++..++ ....         ....+..+...++..+...........
T Consensus       219 t~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  297 (357)
T PHA03209        219 TVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRL  297 (357)
T ss_pred             cccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHH
Confidence            9999999998654 4889999999999999999865444 3221         122333334444433322111111111


Q ss_pred             HHHHHHhCC--CCCCcchh-hcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          150 AKRYIRQLP--QHPRQSLA-QVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       150 ~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                      ...+.....  ..+..... ....+++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        298 VRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             HHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            111211110  00000000 0112567788899999999999999999999999999864

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-34  Score=240.71  Aligned_cols=174  Identities=28%  Similarity=0.508  Sum_probs=144.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++..... ........|+
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence            689999999888999999999999999999999999999999999999999999999999999875332 2223345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+...                           
T Consensus       159 ~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~---------------------------  210 (328)
T cd05593         159 PEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------------------------  210 (328)
T ss_pred             cCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC---------------------------
Confidence            999999998654 4789999999999999999999999876544333322110                           


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                          ...++..+++++.++|++||..||.+|+     ++.++++|+||....
T Consensus       211 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         211 ----DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             ----CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                0112335788899999999999999997     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.7e-34  Score=239.39  Aligned_cols=174  Identities=25%  Similarity=0.446  Sum_probs=146.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+..... ........|+
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            689999999989999999999999999999999999999999999999999999999999998875332 2223345689


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+... .++.++|+|||||++|+|++|..||...+.......+....                          
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--------------------------  212 (321)
T cd05591         160 PDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--------------------------  212 (321)
T ss_pred             ccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            999999998644 47889999999999999999999998877665555443210                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-------CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-------TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-------t~~~ll~h~~~~~~~  207 (249)
                           ...+..+++++.+++.+||+.||.+|+       ++.++++||||+...
T Consensus       213 -----~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         213 -----VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence                 011224678899999999999999999       999999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=242.84  Aligned_cols=178  Identities=30%  Similarity=0.514  Sum_probs=146.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---------   72 (249)
                      |++|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.......         
T Consensus        85 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~  164 (350)
T cd05573          85 GGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS  164 (350)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccc
Confidence            68999999998899999999999999999999999999999999999999999999999999987654332         


Q ss_pred             ---------------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 025683           73 ---------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI  131 (249)
Q Consensus        73 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~  131 (249)
                                           ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~  243 (350)
T cd05573         165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKII  243 (350)
T ss_pred             ccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHh
Confidence                                 22345689999999998655 48899999999999999999999998877555554444


Q ss_pred             HHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-HHHHhcCccccCCcC
Q 025683          132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-VDEALAHPYLARLHD  208 (249)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~~ll~h~~~~~~~~  208 (249)
                      ........                           .....+++++.++|.+||. ||.+|++ ++++++||||+....
T Consensus       244 ~~~~~~~~---------------------------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         244 NWKESLRF---------------------------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             ccCCcccC---------------------------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence            31111000                           0011267889999999998 9999999 999999999998653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-35  Score=243.20  Aligned_cols=176  Identities=26%  Similarity=0.475  Sum_probs=145.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... .......|+
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            6899999999899999999999999999999999999999999999999999999999999998754322 223346789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+...++.++|||||||++|+|++|..||...+.......+.......                       
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------------  216 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF-----------------------  216 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC-----------------------
Confidence            999999998765557899999999999999999999998776544433332100000                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC----CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI----TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp----t~~~ll~h~~~~~~~  207 (249)
                             ....+++++.++|++||+.||.+||    ++.++++||||....
T Consensus       217 -------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         217 -------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             -------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence                   0013678899999999999999998    799999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.1e-33  Score=233.16  Aligned_cols=207  Identities=42%  Similarity=0.714  Sum_probs=159.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~   79 (249)
                      +++|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        91 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  170 (309)
T cd07845          91 EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV  170 (309)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccc
Confidence            56788888764 679999999999999999999999999999999999999999999999999987654332 2222345


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+...++.++|+||||+++|+|++|..||...++......+....+.+....+............. ...
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  249 (309)
T cd07845         171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT-LPK  249 (309)
T ss_pred             cccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccccc-ccC
Confidence            7789999998765667899999999999999999999999998888888888877766544332211111000000 011


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      .....+......+++.+.++|.+||+.||.+|||+++++.||||++....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         250 QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             CCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            11112222234468889999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-34  Score=238.88  Aligned_cols=174  Identities=26%  Similarity=0.526  Sum_probs=145.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... .......|+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  163 (323)
T cd05584          84 GGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGT  163 (323)
T ss_pred             CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCC
Confidence            6799999999899999999999999999999999999999999999999999999999999998643322 223345689


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+....                          
T Consensus       164 ~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--------------------------  216 (323)
T cd05584         164 IEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--------------------------  216 (323)
T ss_pred             ccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            9999999986544 7889999999999999999999998776554444332200                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                           ..++..+++++.++|.+||+.||.+||     +++++++||||+...
T Consensus       217 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         217 -----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence                 112335678899999999999999999     899999999998754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9.9e-34  Score=230.67  Aligned_cols=203  Identities=41%  Similarity=0.814  Sum_probs=159.7

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEY   77 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~   77 (249)
                      +|++|.+++.+. ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+.......  .....
T Consensus        81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (286)
T cd07832          81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ  160 (286)
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence            378999998763 679999999999999999999999999999999999999999999999999887654432  13345


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|+|||.+.+...++.++|+||+|+++++|++|.++|.+..+......+....+.+....+........... ...
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  239 (286)
T cd07832         161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK-ITF  239 (286)
T ss_pred             cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc-ccC
Confidence            6788999999987666678999999999999999999999988888888888887777665433322211110000 011


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                      .......+.+..++.+.++.++|.+||+.||.+|||++++++||||.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            11222234455567789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.2e-34  Score=237.41  Aligned_cols=174  Identities=25%  Similarity=0.481  Sum_probs=145.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..... ........++
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            689999999988999999999999999999999999999999999999999999999999998864322 2223345688


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....                          
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--------------------------  212 (318)
T cd05570         160 PDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--------------------------  212 (318)
T ss_pred             ccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            999999998654 47899999999999999999999998776544443332100                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV-----DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~~ll~h~~~~~~~  207 (249)
                           ...+..+++++.+||++||+.||.+|||+     .++++||||++..
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         213 -----VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             -----CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence                 01123467889999999999999999999     9999999998864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=238.98  Aligned_cols=180  Identities=24%  Similarity=0.464  Sum_probs=147.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....  ......|++
T Consensus        85 g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~  162 (333)
T cd05600          85 GGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSP  162 (333)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcccCc
Confidence            789999999988999999999999999999999999999999999999999999999999999875543  233567899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+.........                      
T Consensus       163 ~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----------------------  219 (333)
T cd05600         163 DYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR----------------------  219 (333)
T ss_pred             cccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC----------------------
Confidence            99999998655 5889999999999999999999999887765555444321110000                      


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                       .........+++++.++|.+||..+|.+||++.++++||||+...
T Consensus       220 -~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         220 -PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             -CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence             000000124678899999999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-33  Score=231.53  Aligned_cols=207  Identities=43%  Similarity=0.776  Sum_probs=160.2

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccccc
Q 025683            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~   79 (249)
                      +++|.+++.+.. .+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  164 (298)
T cd07841          85 ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV  164 (298)
T ss_pred             CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccccccc
Confidence            689999998876 89999999999999999999999999999999999999999999999999987654432 2223455


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+...++.++|+|||||++++|++|..+|.+..+......+....+.+....+......  ..+. ....
T Consensus       165 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~  241 (298)
T cd07841         165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL--PDYV-EFKP  241 (298)
T ss_pred             ceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc--cccc-cccc
Confidence            778999998866556789999999999999999998888888777777777666555443322111110  0110 1111


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                      .............+..+.++|.+||+.||.+|||+.+++.|+||++...++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         242 FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             cCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence            1222334445567889999999999999999999999999999998766554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-35  Score=247.26  Aligned_cols=174  Identities=28%  Similarity=0.497  Sum_probs=150.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC-CCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~-~~~~~~~~~~~   80 (249)
                      |||+. .+...+.|++..++.++.+|+.||.|||++||+|||||.+|||+|.+|.+||+|||+++..- .+....+.+||
T Consensus       453 Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGT  531 (694)
T KOG0694|consen  453 GGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGT  531 (694)
T ss_pred             CCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCC
Confidence            66733 33334889999999999999999999999999999999999999999999999999998654 55667789999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++.+.. |+.++|.|+|||+||||+.|+.||++.+.......|...--.+                       
T Consensus       532 pey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y-----------------------  587 (694)
T KOG0694|consen  532 PEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY-----------------------  587 (694)
T ss_pred             hhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-----------------------
Confidence            9999999997655 9999999999999999999999999999888887776422221                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLHD  208 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~~  208 (249)
                              +..+|.++.++++++|.++|++|..     +++|..||||++...
T Consensus       588 --------P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w  632 (694)
T KOG0694|consen  588 --------PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW  632 (694)
T ss_pred             --------CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence                    2257899999999999999999984     689999999999883

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.7e-34  Score=236.84  Aligned_cols=174  Identities=26%  Similarity=0.499  Sum_probs=144.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||+|.+++...+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... .......|+
T Consensus        80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            7899999998889999999999999999999999999999999999999999999999999998754322 223345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+.......+....                          
T Consensus       160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------------------------  212 (316)
T cd05592         160 PDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--------------------------  212 (316)
T ss_pred             ccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            9999999986544 7899999999999999999999998876554444332100                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH-HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV-DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-~~ll~h~~~~~~~  207 (249)
                           ..++..++.++.+++.+||+.||.+||++ .+++.||||+...
T Consensus       213 -----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         213 -----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence                 01122467889999999999999999986 5888999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-34  Score=235.61  Aligned_cols=169  Identities=29%  Similarity=0.413  Sum_probs=143.0

Q ss_pred             CccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCCCCeeeccCC-CeEEeecCCccCCCCC-Ccccc
Q 025683            2 DTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANC-DLKICDFGLARPTSEN-EFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~-i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~-~~~~~   76 (249)
                      +|+|+.+|.+  .+.++...+.+++.||+.||+|||+++ |+|||||++|||++.++ .+||+|||+++..... .....
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~  203 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTS  203 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccC
Confidence            7999999988  689999999999999999999999999 99999999999999997 9999999999876554 33444


Q ss_pred             ccccccccCchhccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..||..|||||++.+ ...++.++||||||+++|||++|..||...........+......+                  
T Consensus       204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp------------------  265 (362)
T KOG0192|consen  204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP------------------  265 (362)
T ss_pred             CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC------------------
Confidence            788999999999975 3569999999999999999999999999988754444443322111                  


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                 .++...++.+..++..||+.||.+||++.+++.
T Consensus       266 -----------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  266 -----------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             -----------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                       122246788999999999999999999999876

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-33  Score=239.71  Aligned_cols=204  Identities=25%  Similarity=0.332  Sum_probs=152.6

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~   77 (249)
                      ++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........   ....
T Consensus       168 ~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~  247 (392)
T PHA03207        168 YKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW  247 (392)
T ss_pred             cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccccc
Confidence            4678999998888999999999999999999999999999999999999999999999999999875543321   2235


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND---HVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      .|+..|+|||.+... .++.++|+|||||++|+|++|..||.+..   ....+..+...++..+............+. .
T Consensus       248 ~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~-~  325 (392)
T PHA03207        248 SGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH-F  325 (392)
T ss_pred             ccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHH-H
Confidence            689999999998654 47899999999999999999999997643   355666666666654433221111111111 1


Q ss_pred             HhCCCCCCc--chhhc--CCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          155 RQLPQHPRQ--SLAQV--FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       155 ~~~~~~~~~--~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                      .......+.  .....  ...++.++.++|++||..||.+|||+.++|.||||++.
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            111111111  11111  12456788999999999999999999999999999864

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.1e-34  Score=238.93  Aligned_cols=174  Identities=26%  Similarity=0.511  Sum_probs=145.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........|+
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            689999999989999999999999999999999999999999999999999999999999998865322 2223345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+...   .                       
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-----------------------  212 (323)
T cd05575         160 PEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P-----------------------  212 (323)
T ss_pred             hhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-----------------------
Confidence            999999998654 4788999999999999999999999877654444433210   0                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV----DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~~ll~h~~~~~~~  207 (249)
                           ..+.+.+++.+.++|.+||+.||.+||++    .++++||||....
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         213 -----LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence                 11233567889999999999999999987    6999999998765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.8e-33  Score=233.19  Aligned_cols=216  Identities=46%  Similarity=0.862  Sum_probs=159.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-CCCeEEeecCCccCCCCC----Ccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSEN----EFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~~~----~~~~~   76 (249)
                      +++|.+++.. +.+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.++|+|||.+......    .....
T Consensus        99 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  177 (342)
T cd07854          99 ETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE  177 (342)
T ss_pred             cccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccc
Confidence            5678888865 57999999999999999999999999999999999999975 557899999998654321    11122


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|+|||.+.....++.++|+|||||++|+|++|..||....+......+.................... .....
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  256 (342)
T cd07854         178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIP-SFVRN  256 (342)
T ss_pred             ccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhh-hhhhh
Confidence            35678899999876555678899999999999999999999988877666666554433222211111111111 11111


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPF  219 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~  219 (249)
                      .............+.++.++.+||++||+.||.+|||+++++.||||+.+......++...|+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~  319 (342)
T cd07854         257 DGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPF  319 (342)
T ss_pred             cccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCCCCCc
Confidence            122233444455667889999999999999999999999999999999887666666554433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=240.25  Aligned_cols=174  Identities=28%  Similarity=0.480  Sum_probs=147.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~   80 (249)
                      ||++.+.|+....+++..+.-++++++.|+.|||.++.+|+|||+.||++..+|.+||+|||.+........ ...++||
T Consensus        95 gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGT  174 (467)
T KOG0201|consen   95 GGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGT  174 (467)
T ss_pred             CcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccccccc
Confidence            789999999988889999999999999999999999999999999999999999999999999987665433 3678999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ++|||||++.+. .|+.++||||||++.+||.+|.+|+....+...+..|-                           +.
T Consensus       175 PfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp---------------------------k~  226 (467)
T KOG0201|consen  175 PFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP---------------------------KS  226 (467)
T ss_pred             ccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc---------------------------CC
Confidence            999999999744 49999999999999999999999998776522221111                           11


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                      ..   ..+...+++.+++||..||.+||..||+|.+||+|+|+++.
T Consensus       227 ~P---P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  227 AP---PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             CC---CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            11   11222578899999999999999999999999999999974

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.7e-34  Score=237.52  Aligned_cols=174  Identities=24%  Similarity=0.430  Sum_probs=146.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........|+
T Consensus        85 ~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  164 (323)
T cd05616          85 GGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGT  164 (323)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCC
Confidence            689999999888999999999999999999999999999999999999999999999999999875432 2233346789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+... .++.++|+|||||++|+|++|..||.+.+.......+....                          
T Consensus       165 ~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--------------------------  217 (323)
T cd05616         165 PDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------------------------  217 (323)
T ss_pred             hhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            999999998654 47899999999999999999999998877655554443211                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                           ...+..+++++.+++.+||+.||.+|++     ..++++|+||+...
T Consensus       218 -----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         218 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             -----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence                 0112346788999999999999999997     48999999998765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-33  Score=229.58  Aligned_cols=202  Identities=33%  Similarity=0.685  Sum_probs=150.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      +++|..++.+...+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  163 (286)
T cd07847          84 HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT  163 (286)
T ss_pred             ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccc
Confidence            35566666666789999999999999999999999999999999999999999999999999987654432 22234567


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+...++.++|+||+|+++++|++|..||.+.........+....+.................-.......
T Consensus       164 ~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (286)
T cd07847         164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPE  243 (286)
T ss_pred             cccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcc
Confidence            88999999876556788999999999999999999999988777777666665554332111100000000000000001


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      .........+.++..+.+|+.+||+.||.+|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         244 TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            1112233345678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.3e-34  Score=239.00  Aligned_cols=178  Identities=25%  Similarity=0.418  Sum_probs=141.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---------   72 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......         
T Consensus        85 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  164 (363)
T cd05628          85 GGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLN  164 (363)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccc
Confidence            68999999998999999999999999999999999999999999999999999999999999986432110         


Q ss_pred             ---------------------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 025683           73 ---------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH  125 (249)
Q Consensus        73 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~  125 (249)
                                                 .....+||+.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~  243 (363)
T cd05628         165 HSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE  243 (363)
T ss_pred             ccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence                                       01234789999999998654 47899999999999999999999998877665


Q ss_pred             HHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCC---CCCCHHHHhcCcc
Q 025683          126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPM---KRITVDEALAHPY  202 (249)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~---~Rpt~~~ll~h~~  202 (249)
                      ....+........                          +.. ...+++++.++|.+|+. +|.   .||+++++++|||
T Consensus       244 ~~~~i~~~~~~~~--------------------------~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~  295 (363)
T cd05628         244 TYKKVMNWKETLI--------------------------FPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPF  295 (363)
T ss_pred             HHHHHHcCcCccc--------------------------CCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCC
Confidence            5555543111000                          000 11367889999998765 444   5689999999999


Q ss_pred             ccCCcC
Q 025683          203 LARLHD  208 (249)
Q Consensus       203 ~~~~~~  208 (249)
                      |+....
T Consensus       296 f~~~~~  301 (363)
T cd05628         296 FEGVDW  301 (363)
T ss_pred             CCCCCH
Confidence            998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-33  Score=232.98  Aligned_cols=203  Identities=36%  Similarity=0.650  Sum_probs=145.1

Q ss_pred             CCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee----ccCCCeEEeecCCccC
Q 025683            1 MDTDLYQIIRSN---------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGLARP   67 (249)
Q Consensus         1 ~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~----~~~~~~kL~dfg~~~~   67 (249)
                      ++++|.+++...         ..+++..+..++.||+.||.|||++|++|+||||+||++    +.++.++|+|||+++.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            356788887532         358999999999999999999999999999999999999    4567899999999976


Q ss_pred             CCCCC----ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 025683           68 TSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---------VHQMRLLIELL  134 (249)
Q Consensus        68 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~---------~~~~~~~~~~~  134 (249)
                      .....    ......++..|+|||.+.+...++.++|+|||||++|+|++|..||.....         ......+...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            54322    123356788999999987666688999999999999999999999975432         34555666666


Q ss_pred             CCCCcccccccchhh----HHHHHHhCCCC---CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          135 GTPTDADLGFVRNED----AKRYIRQLPQH---PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       135 ~~~~~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      +.+....+.......    ...........   ............+..+.+++.+||+.||.+|||+.|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            655444332211100    00000000000   0001111122345678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-33  Score=231.11  Aligned_cols=202  Identities=43%  Similarity=0.786  Sum_probs=154.4

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      ++++|.+++... ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+...... .......
T Consensus        88 ~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  167 (293)
T cd07843          88 VEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV  167 (293)
T ss_pred             cCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccccccc
Confidence            356888988775 45999999999999999999999999999999999999999999999999988765543 2223345


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.+....+.++|+||+|+++++|++|..||..........++....+.+....+........... ....
T Consensus       168 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  246 (293)
T cd07843         168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK-KTFT  246 (293)
T ss_pred             ccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc-cccc
Confidence            678899999987655578899999999999999999999999888888888887777665544332111100000 0000


Q ss_pred             CCCCcchhhcCCC--CChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPH--VHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ......+....+.  +++.+.++|++||+.||++|||+.|++.|+||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            0001111111222  47889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.4e-33  Score=229.30  Aligned_cols=200  Identities=38%  Similarity=0.768  Sum_probs=154.2

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ++++|.+++.+. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++. +.++|+|||.+.............+
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~  160 (282)
T cd07831          82 MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYIS  160 (282)
T ss_pred             CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCC
Confidence            357888888764 57999999999999999999999999999999999999999 9999999999876654443344567


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+......+.++|+||+||++|+|++|..||.+.+.......+....+.+...............  ...+.
T Consensus       161 ~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  238 (282)
T cd07831         161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN--YNFPS  238 (282)
T ss_pred             CcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc--ccCcc
Confidence            8889999987655557889999999999999999999999988887777777766655543211100000000  00011


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ........+...++.++.++|.+||+.+|.+|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            11112223344678999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-34  Score=222.07  Aligned_cols=162  Identities=30%  Similarity=0.498  Sum_probs=135.5

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh--CC--cccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHS--AN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~--~~--i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~   73 (249)
                      +|||.+.++.    .+.+++..+.+++.|++.||..+|.  ..  +.||||||.||+++.+|.+||+|||+++.......
T Consensus       104 ~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t  183 (375)
T KOG0591|consen  104 AGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT  183 (375)
T ss_pred             ccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH
Confidence            5889888865    3679999999999999999999998  44  99999999999999999999999999998766543


Q ss_pred             -cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           74 -MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        74 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                       ....+|||+||+||.+.+.+ ++.++||||+||++|||..-+.||.+++-...-.+|... ..++              
T Consensus       184 fA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~--------------  247 (375)
T KOG0591|consen  184 FAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPP--------------  247 (375)
T ss_pred             HHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCC--------------
Confidence             34579999999999997665 999999999999999999999999998644444444431 1111              


Q ss_pred             HHHhCCCCCCcchhhcC-CCCChHHHHHHHHhcCCCCCCCCCH
Q 025683          153 YIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFDPMKRITV  194 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~Rpt~  194 (249)
                                     ++ +-+|.++..+|..|+..||..||+.
T Consensus       248 ---------------~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  248 ---------------LPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             ---------------CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence                           11 2467889999999999999999985

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-34  Score=239.75  Aligned_cols=174  Identities=30%  Similarity=0.534  Sum_probs=144.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~   79 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||+|||+ .|++||||||+||+++.++.++|+|||.+..... ........|
T Consensus        79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence            68999999988899999999999999999999997 7999999999999999999999999998865322 222334568


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      ++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....                         
T Consensus       159 t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-------------------------  212 (325)
T cd05594         159 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------------------  212 (325)
T ss_pred             CcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-------------------------
Confidence            9999999998654 47899999999999999999999998776544333332100                         


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                            ..++..+++++.++|.+||+.||.+|+     ++.++++|+||++..
T Consensus       213 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         213 ------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence                  112235778899999999999999997     999999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-33  Score=229.79  Aligned_cols=180  Identities=26%  Similarity=0.429  Sum_probs=142.0

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~   76 (249)
                      ||+|.+++..    +..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            6889888743    3579999999999999999999999999999999999999999999999999987554332 2233


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...........+.......                   
T Consensus       157 ~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------  216 (280)
T cd05608         157 YAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-------------------  216 (280)
T ss_pred             cCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-------------------
Confidence            5678899999998654 47889999999999999999999997654322211111111000                   


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcCC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLHDE  209 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~~~  209 (249)
                              .......+++++.+++.+||+.||.+||     +++++++||||+.....
T Consensus       217 --------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         217 --------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             --------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence                    0112335788999999999999999999     88999999999986544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.1e-34  Score=234.46  Aligned_cols=174  Identities=25%  Similarity=0.470  Sum_probs=144.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+..... ........|+
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            689999999888999999999999999999999999999999999999999999999999998865322 2223345689


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+....                          
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--------------------------  212 (316)
T cd05619         160 PDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--------------------------  212 (316)
T ss_pred             ccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            999999998654 47899999999999999999999998776544443332100                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHH-HHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVD-EALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~-~ll~h~~~~~~~  207 (249)
                           ...+..++.++.++|.+||+.||.+||++. ++++||||+...
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         213 -----PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             -----CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence                 001124677899999999999999999996 899999999865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-33  Score=213.29  Aligned_cols=204  Identities=35%  Similarity=0.625  Sum_probs=170.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-----cc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MT   75 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-----~~   75 (249)
                      ..||..+|.+. .+|+..++++++.++..||.|+|+..|.|||+|+.|+||+.+|.++|.|||+++.......     ..
T Consensus       107 ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kpryt  186 (376)
T KOG0669|consen  107 EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYT  186 (376)
T ss_pred             hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcc
Confidence            46788888775 7899999999999999999999999999999999999999999999999999976544321     22


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..+-|..|++||.+.+...++++.|+|..||++.+|+++.+.+.+.+...++..|...+|....+.|+.+.....-..+.
T Consensus       187 nrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie  266 (376)
T KOG0669|consen  187 NRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIE  266 (376)
T ss_pred             cceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhcc
Confidence            23458899999999999999999999999999999999999999999999999999999999999888777665544442


Q ss_pred             --hCCCCCCcchhhcCC--CCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          156 --QLPQHPRQSLAQVFP--HVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       156 --~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                        ..++...........  .-.++..+++.++|..||.+|++++++++|.||.+
T Consensus       267 ~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  267 LEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence              223222222222222  12457889999999999999999999999999975

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.9e-33  Score=226.51  Aligned_cols=200  Identities=41%  Similarity=0.750  Sum_probs=157.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~   78 (249)
                      +++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        82 ~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~  161 (284)
T cd07860          82 HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV  161 (284)
T ss_pred             ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccccc
Confidence            46788888653  578999999999999999999999999999999999999999999999999887544322 122345


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.+....+.++|+||||+++|+|++|..||...+......++....+.+....+....  ....+.....
T Consensus       162 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  239 (284)
T cd07860         162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT--SLPDYKPSFP  239 (284)
T ss_pred             ccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh--HHHHHHhhcc
Confidence            57789999988765556889999999999999999999999888777777777777766543322111  1122222333


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ....+....+.+.+++++.++|.+||+.||.+|||+++++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            333444555566788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=235.67  Aligned_cols=180  Identities=33%  Similarity=0.542  Sum_probs=153.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC----CCeEEeecCCccCCCCCCccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN----CDLKICDFGLARPTSENEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~----~~~kL~dfg~~~~~~~~~~~~~~   77 (249)
                      ||+|++.+.+. .+++..+..+++|++.++.|||+.|++|+|+||+|+++...    +.++++|||++............
T Consensus       120 GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~  198 (382)
T KOG0032|consen  120 GGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTI  198 (382)
T ss_pred             CchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeee
Confidence            79999999986 49999999999999999999999999999999999999643    47999999999988776677889


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +||+.|+|||++... .++..+|+||+|+++|.|++|..||.+.+.......+...--                      
T Consensus       199 ~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~----------------------  255 (382)
T KOG0032|consen  199 VGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF----------------------  255 (382)
T ss_pred             cCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC----------------------
Confidence            999999999999644 489999999999999999999999998876665554432111                      


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                           .-....|+.++..+.++|+.||..||.+|+|+.++|+|||++......
T Consensus       256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~  303 (382)
T KOG0032|consen  256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT  303 (382)
T ss_pred             -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence                 001234557889999999999999999999999999999999765444

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.6e-33  Score=232.31  Aligned_cols=198  Identities=25%  Similarity=0.444  Sum_probs=145.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |++|.+++.+...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+...... ......++
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~  165 (331)
T cd06649          87 GGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGT  165 (331)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccccCCCC
Confidence            689999999988999999999999999999999985 6999999999999999999999999998755332 23345689


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc-----------------
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG-----------------  143 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------  143 (249)
                      ..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......    ++.+......                 
T Consensus       166 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd06649         166 RSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEPHSISPRPRPPGRPV  240 (331)
T ss_pred             cCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCccccCcccccccccc
Confidence            999999998654 488999999999999999999999987664433222    1111100000                 


Q ss_pred             ------ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          144 ------FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       144 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                            .....................  .....+++++++||.+||.+||++|||++++++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         241 SGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                  000000000011000000000  01124678999999999999999999999999999999754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.8e-34  Score=238.83  Aligned_cols=183  Identities=24%  Similarity=0.455  Sum_probs=141.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC-CCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~-~~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.... .........|+
T Consensus        80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            68999999988999999999999999999999999999999999999999999999999999986432 22333446789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++|+|||||++|+|++|..||........          + .   ..............    
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----------~-~---~~~~~~~~~~~~~~----  220 (329)
T cd05588         160 PNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN----------P-D---QNTEDYLFQVILEK----  220 (329)
T ss_pred             ccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCccccccccc----------c-c---ccchHHHHHHHHcC----
Confidence            999999998654 478899999999999999999999963211000          0 0   00000000000000    


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC------HHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT------VDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt------~~~ll~h~~~~~~~  207 (249)
                          ...++..++..+.++|++||+.||.+|++      ++++++||||....
T Consensus       221 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~  269 (329)
T cd05588         221 ----QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID  269 (329)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence                01233457888999999999999999987      78999999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-33  Score=239.70  Aligned_cols=179  Identities=26%  Similarity=0.457  Sum_probs=140.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---------   72 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......         
T Consensus        85 gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~  164 (381)
T cd05626          85 GGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGS  164 (381)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccc
Confidence            78999999998899999999999999999999999999999999999999999999999999875321000         


Q ss_pred             ---------------------------------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 025683           73 ---------------------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN  113 (249)
Q Consensus        73 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~  113 (249)
                                                             ......||+.|+|||.+.+. .++.++|||||||++|+|++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il~ellt  243 (381)
T cd05626         165 HIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVILFEMLV  243 (381)
T ss_pred             cccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhHHHHHHh
Confidence                                                   01134689999999998654 47899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhc--CCCCCCC
Q 025683          114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML--TFDPMKR  191 (249)
Q Consensus       114 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L--~~dp~~R  191 (249)
                      |..||...+.......+........                           ......+++++.+||.+|+  ..++..|
T Consensus       244 G~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~dli~~ll~~~~~~~~R  296 (381)
T cd05626         244 GQPPFLAPTPTETQLKVINWENTLH---------------------------IPPQVKLSPEAVDLITKLCCSAEERLGR  296 (381)
T ss_pred             CCCCCcCCCHHHHHHHHHccccccC---------------------------CCCCCCCCHHHHHHHHHHccCcccccCC
Confidence            9999987765544443332110000                           0001246788999999955  4555669


Q ss_pred             CCHHHHhcCccccCCcC
Q 025683          192 ITVDEALAHPYLARLHD  208 (249)
Q Consensus       192 pt~~~ll~h~~~~~~~~  208 (249)
                      ++++++++||||++...
T Consensus       297 ~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         297 NGADDIKAHPFFSEVDF  313 (381)
T ss_pred             CCHHHHhcCcccCCCCh
Confidence            99999999999998653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-33  Score=220.81  Aligned_cols=206  Identities=41%  Similarity=0.728  Sum_probs=163.3

Q ss_pred             ccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC----CCeEEeecCCccCCCCCC-
Q 025683            3 TDLYQIIRSN-----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN----CDLKICDFGLARPTSENE-   72 (249)
Q Consensus         3 ~~L~~~l~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~----~~~kL~dfg~~~~~~~~~-   72 (249)
                      .||..+|+-.     +.++..++++++.||+.|+.|||++.+.|||+||.||+|..+    |++|++|+|+++.....- 
T Consensus       112 hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plk  191 (438)
T KOG0666|consen  112 HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLK  191 (438)
T ss_pred             hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccc
Confidence            3566666432     469999999999999999999999999999999999999988    899999999998765432 


Q ss_pred             ---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHHhCCCCcc
Q 025683           73 ---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND---------HVHQMRLLIELLGTPTDA  140 (249)
Q Consensus        73 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~  140 (249)
                         .....+-|..|+|||.+.+...++.+.|+|++||++.||++.++.|.+..         ..+++.+|.+.+|.|...
T Consensus       192 pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~  271 (438)
T KOG0666|consen  192 PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDK  271 (438)
T ss_pred             ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccc
Confidence               23345679999999999999999999999999999999999999997643         478999999999999998


Q ss_pred             cccccchhhHH-HHHHhCCCC-----CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          141 DLGFVRNEDAK-RYIRQLPQH-----PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       141 ~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      .|....+...- ..+......     .-..+......-++...+|+.+||.+||.+|.|++++++|+||.+-.-
T Consensus       272 ~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~l  345 (438)
T KOG0666|consen  272 DWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPL  345 (438)
T ss_pred             cchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCC
Confidence            88755443221 111111100     012233344445666889999999999999999999999999997643

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-33  Score=225.22  Aligned_cols=201  Identities=44%  Similarity=0.810  Sum_probs=156.8

Q ss_pred             CCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccc
Q 025683            1 MDTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEY   77 (249)
Q Consensus         1 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~   77 (249)
                      ++++|.+++.+..  .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence            3578999998765  79999999999999999999999999999999999999999999999999987543321 12233


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|+|||.+.+...++.++|+||||+++|+|++|..||...++......+....+.+....+...  .....+....
T Consensus       160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  237 (283)
T cd07835         160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV--TSLPDYKPTF  237 (283)
T ss_pred             ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh--hhchhhhhhc
Confidence            55788999998866555788999999999999999999999988877777777776665554432211  1111112222


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ............+.++..+.++|.+||+.||.+|||+++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            2222233344456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-34  Score=239.08  Aligned_cols=177  Identities=29%  Similarity=0.525  Sum_probs=142.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---------   72 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        85 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  164 (364)
T cd05599          85 GGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS  164 (364)
T ss_pred             CcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccc
Confidence            78999999998899999999999999999999999999999999999999999999999999886432110         


Q ss_pred             ------------------------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 025683           73 ------------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND  122 (249)
Q Consensus        73 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~  122 (249)
                                                    .....+||+.|+|||.+... .++.++|+|||||++|+|++|..||...+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~Pf~~~~  243 (364)
T cd05599         165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPFCSDN  243 (364)
T ss_pred             ccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCCCCCCCC
Confidence                                          01123589999999998654 47899999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC---HHHHhc
Q 025683          123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT---VDEALA  199 (249)
Q Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~~ll~  199 (249)
                      .......+........                     .+      ....+++++.++|.+||. +|.+|++   +.++++
T Consensus       244 ~~~~~~~i~~~~~~~~---------------------~~------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         244 PQETYRKIINWKETLQ---------------------FP------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHHHHHHHHcCCCccC---------------------CC------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            6554444432100000                     00      011467889999999997 9999998   999999


Q ss_pred             CccccCCc
Q 025683          200 HPYLARLH  207 (249)
Q Consensus       200 h~~~~~~~  207 (249)
                      ||||+...
T Consensus       296 h~~~~~~~  303 (364)
T cd05599         296 HPFFKGVD  303 (364)
T ss_pred             CCCcCCCC
Confidence            99998865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-33  Score=233.26  Aligned_cols=173  Identities=27%  Similarity=0.511  Sum_probs=143.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      |++|..++.+ +.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||.+..... ........|+
T Consensus        86 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~  164 (324)
T cd05589          86 GGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGT  164 (324)
T ss_pred             CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccC
Confidence            6788888865 6799999999999999999999999999999999999999999999999998865332 2223346789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+....                          
T Consensus       165 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--------------------------  217 (324)
T cd05589         165 PEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--------------------------  217 (324)
T ss_pred             ccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            999999998654 47889999999999999999999998876554444433210                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                           ...+..+++.+.++|.+||+.||.+||     ++.++++||||++..
T Consensus       218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence                 011234678899999999999999999     799999999998865

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-34  Score=237.74  Aligned_cols=174  Identities=27%  Similarity=0.515  Sum_probs=145.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||+|.+++.+...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+...... .......|+
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~  161 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT  161 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCC
Confidence            6899999998889999999999999999999999999999999999999999999999999998765433 223345788


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+... .++.++|+|||||++|+|++|..||...+.......+....                          
T Consensus       162 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------------------------  214 (318)
T cd05582         162 VEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------------------------  214 (318)
T ss_pred             hhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            999999998654 47889999999999999999999998776555444432210                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                           ..++..+++++.++|++||+.||.+||+     +.+++.|+||+...
T Consensus       215 -----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         215 -----LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence                 1122346788999999999999999999     78899999998764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-33  Score=227.22  Aligned_cols=178  Identities=27%  Similarity=0.433  Sum_probs=144.0

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ||+|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  163 (285)
T cd05605          84 GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVG  163 (285)
T ss_pred             CCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccC
Confidence            68899888654  4699999999999999999999999999999999999999999999999999876544433344578


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+. .++.++|+||+||++|+|++|..||.+.........+........                     
T Consensus       164 ~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------  221 (285)
T cd05605         164 TVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------------------  221 (285)
T ss_pred             CCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------------------
Confidence            8999999998654 478899999999999999999999987654333333322111100                     


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                            ......++..+.+|+.+||+.||.+||     +++++++|+||+...
T Consensus       222 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         222 ------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             ------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence                  112234778899999999999999999     999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.6e-34  Score=237.58  Aligned_cols=180  Identities=24%  Similarity=0.443  Sum_probs=145.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--ccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~   78 (249)
                      ||+|.+++.+. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+........  .....
T Consensus        85 ~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  164 (330)
T cd05601          85 GGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV  164 (330)
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeeccc
Confidence            78999999886 7899999999999999999999999999999999999999999999999999876543322  22346


Q ss_pred             ccccccCchhccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHH
Q 025683           79 VTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (249)
Q Consensus        79 ~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (249)
                      +++.|+|||.+..     ...++.++|||||||++|+|++|..||...........+.......                
T Consensus       165 gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------  228 (330)
T cd05601         165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL----------------  228 (330)
T ss_pred             CCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc----------------
Confidence            7899999999863     3346789999999999999999999998877655554443210000                


Q ss_pred             HHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                           .      ......+++++.+||.+||+ +|.+|||++++++||||+.....
T Consensus       229 -----~------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         229 -----K------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             -----C------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence                 0      00112467889999999998 99999999999999999986533

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.9e-33  Score=232.15  Aligned_cols=174  Identities=24%  Similarity=0.451  Sum_probs=145.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... .......|+
T Consensus        85 ~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt  164 (323)
T cd05615          85 GGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGT  164 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCC
Confidence            6899999999889999999999999999999999999999999999999999999999999998754322 223345689


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++|+||+||++|+|++|..||.+.........+...-                          
T Consensus       165 ~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--------------------------  217 (323)
T cd05615         165 PDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--------------------------  217 (323)
T ss_pred             ccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            999999998654 47899999999999999999999998876555544443211                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                           ...+..++.++.+++.+||+.||.+|++     ..++++||||+...
T Consensus       218 -----~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         218 -----VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             -----CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence                 0112246788999999999999999997     57999999999875

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-33  Score=224.60  Aligned_cols=201  Identities=45%  Similarity=0.824  Sum_probs=158.5

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~   78 (249)
                      ++++|.+++.+. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+....... ......
T Consensus        80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (282)
T cd07829          80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV  159 (282)
T ss_pred             cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence            357899999886 689999999999999999999999999999999999999999999999999887654332 222344


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      .+..|+|||.+......+.++|+||||++++++++|..||...........+...++.+....+.......  .+....+
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  237 (282)
T cd07829         160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP--DYKPTFP  237 (282)
T ss_pred             cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc--ccccccc
Confidence            56779999998766568899999999999999999999999988888888888877766554433222211  0111111


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ...........+.++..+.++|++||..||.+||++++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            112222334445668899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=229.66  Aligned_cols=206  Identities=39%  Similarity=0.714  Sum_probs=161.9

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC---------
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---------   71 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---------   71 (249)
                      ++++|.+++.+...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+......         
T Consensus       102 ~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  181 (335)
T PTZ00024        102 MASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD  181 (335)
T ss_pred             cccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccc
Confidence            46789999998889999999999999999999999999999999999999999999999999988654411         


Q ss_pred             ------CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           72 ------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        72 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                            .......++..|+|||.+.+...++.++|+|||||++++|++|..||.+.++...+..+....+.+....+...
T Consensus       182 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (335)
T PTZ00024        182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQA  261 (335)
T ss_pred             ccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcch
Confidence                  11122345778999999876555789999999999999999999999999888888888888777665433211


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      ...  ..+ ..................+.++.++|.+||+.+|.+|||+++++.|+||+.....
T Consensus       262 ~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        262 KKL--PLY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             hhc--ccc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence            100  000 0111112223334455678889999999999999999999999999999976443

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-33  Score=238.73  Aligned_cols=177  Identities=27%  Similarity=0.473  Sum_probs=141.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC----------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----------   71 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~----------   71 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......          
T Consensus        85 gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~  164 (382)
T cd05625          85 GGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGD  164 (382)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccc
Confidence            6899999998889999999999999999999999999999999999999999999999999986421100          


Q ss_pred             --------------------------------------CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 025683           72 --------------------------------------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN  113 (249)
Q Consensus        72 --------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~  113 (249)
                                                            .......||+.|+|||.+.+.. ++.++|+|||||++|+|++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil~ellt  243 (382)
T cd05625         165 HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLV  243 (382)
T ss_pred             ccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHHHHHHh
Confidence                                                  0011246889999999986554 7899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC
Q 025683          114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT  193 (249)
Q Consensus       114 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt  193 (249)
                      |..||.+.++......+........                           ......+++++.++|.+|+ .+|.+|++
T Consensus       244 G~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------~p~~~~~s~~~~~li~~l~-~~p~~R~~  295 (382)
T cd05625         244 GQPPFLAQTPLETQMKVINWQTSLH---------------------------IPPQAKLSPEASDLIIKLC-RGPEDRLG  295 (382)
T ss_pred             CCCCCCCCCHHHHHHHHHccCCCcC---------------------------CCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence            9999988776544444432111000                           0011246788999999976 59999997


Q ss_pred             ---HHHHhcCccccCCc
Q 025683          194 ---VDEALAHPYLARLH  207 (249)
Q Consensus       194 ---~~~ll~h~~~~~~~  207 (249)
                         ++++++||||+...
T Consensus       296 ~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         296 KNGADEIKAHPFFKTID  312 (382)
T ss_pred             CCCHHHHhcCCCcCCcC
Confidence               99999999998864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2e-33  Score=233.63  Aligned_cols=178  Identities=24%  Similarity=0.477  Sum_probs=140.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..... ........|+
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            689999999888999999999999999999999999999999999999999999999999999865322 2223345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-----HQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..|+|||.+.+. .++.++|+|||||++|+|++|..||......     .....+..                   ....
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~-------------------~i~~  219 (329)
T cd05618         160 PNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------------------VILE  219 (329)
T ss_pred             ccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH-------------------HHhc
Confidence            999999998654 4788999999999999999999999532100     00000000                   0000


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC------HHHHhcCccccCCc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT------VDEALAHPYLARLH  207 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt------~~~ll~h~~~~~~~  207 (249)
                      .        ...++..++..+.++|.+||+.||.+||+      +.++++||||++..
T Consensus       220 ~--------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         220 K--------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             C--------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            0        01233457788999999999999999998      58999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=226.66  Aligned_cols=177  Identities=29%  Similarity=0.499  Sum_probs=149.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC------CCeEEeecCCccCCCCCCccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN------CDLKICDFGLARPTSENEFMT   75 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~------~~~kL~dfg~~~~~~~~~~~~   75 (249)
                      ||||.+||.+.+.+++..++.++.||+.||++||+++|+||||||+|||++..      -.+||.|||+++.........
T Consensus        93 gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~  172 (429)
T KOG0595|consen   93 GGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAE  172 (429)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHH
Confidence            79999999999999999999999999999999999999999999999999875      458999999999988877778


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      +.+|++.|||||++.. ..|..|+|+||+|+++|+|++|..||...+..+....+...-...                  
T Consensus       173 tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~------------------  233 (429)
T KOG0595|consen  173 TLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV------------------  233 (429)
T ss_pred             HhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc------------------
Confidence            8999999999999964 459999999999999999999999999888776666443211111                  


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                ..+...++....+++...|..++..|.+..+-+.|++...-.
T Consensus       234 ----------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  234 ----------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             ----------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence                      111223556677899999999999999999988888887654

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.4e-33  Score=236.59  Aligned_cols=178  Identities=28%  Similarity=0.414  Sum_probs=143.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~   79 (249)
                      ||+|.+++.+ ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.......  ......|
T Consensus       127 gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~g  205 (370)
T cd05596         127 GGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG  205 (370)
T ss_pred             CCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCC
Confidence            7899999876 569999999999999999999999999999999999999999999999999987654322  2234578


Q ss_pred             cccccCchhccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           80 TRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        80 ~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ++.|+|||.+...   ..++.++|+|||||++|+|++|..||.+.+.......+........                  
T Consensus       206 t~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------  267 (370)
T cd05596         206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT------------------  267 (370)
T ss_pred             CcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC------------------
Confidence            9999999998643   2367899999999999999999999988776555555432111000                  


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITVDEALAHPYLARLH  207 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~h~~~~~~~  207 (249)
                              + .....++.++.++|++||+.+|.+  |+|++++++||||++..
T Consensus       268 --------~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         268 --------F-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             --------C-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence                    0 001146889999999999999988  99999999999998743

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=223.71  Aligned_cols=201  Identities=48%  Similarity=0.879  Sum_probs=158.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~   79 (249)
                      +++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV  160 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence            56888888774 689999999999999999999999999999999999999999999999999887654433 2223456


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+....+.++|+||||+++++|++|+.||...+.......+...++.+....+......... .....+.
T Consensus       161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  239 (283)
T cd05118         161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN-YKFSFPK  239 (283)
T ss_pred             cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh-hhhhhcc
Confidence            778999999876546889999999999999999999999998888888888777766554433332221111 1111122


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ..........+.++.++.++|.+||+.||.+||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            22223344556788999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.4e-32  Score=226.33  Aligned_cols=202  Identities=37%  Similarity=0.645  Sum_probs=150.5

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-----c
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----M   74 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-----~   74 (249)
                      ++++|.+++.+. ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+........     .
T Consensus       101 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  180 (310)
T cd07865         101 CEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY  180 (310)
T ss_pred             CCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCc
Confidence            356888888765 3799999999999999999999999999999999999999999999999999875533221     1


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....++..|+|||.+.+...++.++|+||||+++++|++|..||.+.+.......+....+..+................
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (310)
T cd07865         181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKM  260 (310)
T ss_pred             cCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhc
Confidence            23456778999998866555788999999999999999999999988877777777777766554433222111110000


Q ss_pred             HhCCCCCCcch-hhcC-CCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          155 RQLPQHPRQSL-AQVF-PHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       155 ~~~~~~~~~~~-~~~~-~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      . .+....... ..+. ...++.+.+||.+||..||.+|||++++++||||
T Consensus       261 ~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         261 E-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             c-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            0 011111111 1111 1235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=231.29  Aligned_cols=167  Identities=31%  Similarity=0.494  Sum_probs=139.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC------CccccccccccccCchh
Q 025683           15 LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN------EFMTEYVVTRWYRAPEL   88 (249)
Q Consensus        15 l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~   88 (249)
                      |++.+++++++.++.||+|||.+||+||||||+|+|++.+|++||+|||.+.....+      ......+||+.|+|||.
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~  286 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL  286 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence            899999999999999999999999999999999999999999999999998755221      22344789999999999


Q ss_pred             ccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcch
Q 025683           89 LLNS---SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL  165 (249)
Q Consensus        89 ~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (249)
                      +...   ...+.+.||||+||++|.|+.|+.||.+........+|+..--..+.                          
T Consensus       287 c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~--------------------------  340 (576)
T KOG0585|consen  287 CSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPE--------------------------  340 (576)
T ss_pred             hcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCC--------------------------
Confidence            8762   34578999999999999999999999998877777777642111111                          


Q ss_pred             hhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          166 AQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       166 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                         .+.+.+++++||.+||.+||.+|.++.++..|||...-.+..
T Consensus       341 ---~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  341 ---NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             ---cccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence               113567899999999999999999999999999999765443

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-33  Score=234.73  Aligned_cols=174  Identities=25%  Similarity=0.499  Sum_probs=144.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|..++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... ........|+
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            689999999989999999999999999999999999999999999999999999999999999865322 2223345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+...   .                       
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~---~-----------------------  212 (325)
T cd05604         160 PEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK---P-----------------------  212 (325)
T ss_pred             hhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC---C-----------------------
Confidence            999999998654 4788999999999999999999999877655444433210   0                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV----DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~~ll~h~~~~~~~  207 (249)
                           ....+..+..+.++|++||..||.+||++    .++++||||+...
T Consensus       213 -----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         213 -----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             -----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence                 11223467889999999999999999976    5999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.8e-32  Score=224.34  Aligned_cols=201  Identities=43%  Similarity=0.804  Sum_probs=154.0

Q ss_pred             CCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-CCCeEEeecCCccCCCCC-Cc
Q 025683            1 MDTDLYQIIRSN-----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSEN-EF   73 (249)
Q Consensus         1 ~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~~~-~~   73 (249)
                      ++++|.+++...     ..+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||.+...... ..
T Consensus        88 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~  167 (295)
T cd07837          88 LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS  167 (295)
T ss_pred             cCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccc
Confidence            356888888653     35899999999999999999999999999999999999998 889999999988754322 11


Q ss_pred             cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHH
Q 025683           74 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (249)
                      .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.++......+...++.+....+......  ...
T Consensus       168 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  245 (295)
T cd07837         168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL--RDW  245 (295)
T ss_pred             cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhc--cch
Confidence            223356778999998866555789999999999999999999999988888888777776665544332211110  000


Q ss_pred             HHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                       ...+...........+.+++.+.+||.+||..||.+||++++++.||||+
T Consensus       246 -~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         246 -HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             -hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence             01111112222334456889999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.5e-33  Score=232.06  Aligned_cols=178  Identities=23%  Similarity=0.465  Sum_probs=141.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC-CCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~-~~~~~~~~~~~   80 (249)
                      ||+|..++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.... .........|+
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            78999999988899999999999999999999999999999999999999999999999999887532 22333456789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH---QMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +.|+|||.+.+. .++.++|+|||||++|+|++|..||.......   ....+....                   ... 
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~~~-  218 (327)
T cd05617         160 PNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-------------------LEK-  218 (327)
T ss_pred             cccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-------------------HhC-
Confidence            999999998654 47899999999999999999999996432100   000000000                   000 


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC------HHHHhcCccccCCc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT------VDEALAHPYLARLH  207 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt------~~~ll~h~~~~~~~  207 (249)
                             ...++..++..+.+++.+||+.||.+|++      ++++++||||+...
T Consensus       219 -------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         219 -------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence                   01123357788999999999999999997      57999999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.1e-33  Score=233.25  Aligned_cols=174  Identities=26%  Similarity=0.514  Sum_probs=144.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++..... ........|+
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            679999999988999999999999999999999999999999999999999999999999999865332 2223345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+...   +                       
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-----------------------  212 (325)
T cd05602         160 PEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P-----------------------  212 (325)
T ss_pred             ccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-----------------------
Confidence            999999998654 4788999999999999999999999877655544443321   0                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHH----HHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVD----EALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~----~ll~h~~~~~~~  207 (249)
                           ....+.+++.+.++|.+||+.||.+|+++.    ++++|+||....
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         213 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             -----cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence                 112235788899999999999999999865    899999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.3e-33  Score=240.93  Aligned_cols=177  Identities=26%  Similarity=0.442  Sum_probs=145.0

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC---Ccc
Q 025683            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFM   74 (249)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---~~~   74 (249)
                      ||+|.+++...    ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.....   ...
T Consensus       123 ~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~  202 (496)
T PTZ00283        123 AGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG  202 (496)
T ss_pred             CCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeecccccccccc
Confidence            68999998753    57999999999999999999999999999999999999999999999999998754322   223


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....|++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+....                    
T Consensus       203 ~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~--------------------  261 (496)
T PTZ00283        203 RTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR--------------------  261 (496)
T ss_pred             ccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--------------------
Confidence            345789999999998654 48899999999999999999999998766444333322100                    


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                                ...+++.+++++.+++.+||+.||.+||++.++++|||++.+...
T Consensus       262 ----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~~  306 (496)
T PTZ00283        262 ----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISG  306 (496)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhhh
Confidence                      011234578899999999999999999999999999999876543

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-33  Score=202.76  Aligned_cols=203  Identities=43%  Similarity=0.743  Sum_probs=174.6

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~   79 (249)
                      +.+|..|..+ ++.++.+.+++++.|++.||.++|++++.|||+||.|.+++.+|.+||.|||+++..+..- .....+-
T Consensus        84 dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevv  163 (292)
T KOG0662|consen   84 DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV  163 (292)
T ss_pred             hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceee
Confidence            4567777776 5889999999999999999999999999999999999999999999999999998877653 3444567


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      |..|++|.++.+...++.+.|+||.||++.|+.. |.+.|++.+..+++.+|...+|.+..+.|+.+.....  |..-..
T Consensus       164 tlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd--yk~yp~  241 (292)
T KOG0662|consen  164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD--YKPYPI  241 (292)
T ss_pred             eeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC--CcccCC
Confidence            9999999999999889999999999999999985 8899999999999999999999999888775543221  111122


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                      ..+...+.++.++++...++++.++|..+|.+|.+++++++||||+..
T Consensus       242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            334556788888898999999999999999999999999999999865

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-32  Score=235.85  Aligned_cols=203  Identities=26%  Similarity=0.351  Sum_probs=142.8

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---cccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTE   76 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---~~~~   76 (249)
                      ++++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++......   ....
T Consensus       242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  321 (461)
T PHA03211        242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG  321 (461)
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence            357899998764 579999999999999999999999999999999999999999999999999987543221   1123


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CC------hHHHHHHHHHHhCCCCcccccccchhh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG-ND------HVHQMRLLIELLGTPTDADLGFVRNED  149 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~-~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (249)
                      ..||..|+|||.+.+. .++.++|||||||++|+|++|..++.. ..      ......++....+..............
T Consensus       322 ~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        322 IAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             cCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence            5689999999998655 478999999999999999987754422 11      123344444433322221111111111


Q ss_pred             HHHHHHh-----CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          150 AKRYIRQ-----LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       150 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                      ...+...     ........+.. ...++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            1111111     00111111111 1246678999999999999999999999999999974

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-33  Score=248.63  Aligned_cols=196  Identities=22%  Similarity=0.400  Sum_probs=164.0

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc--cccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~   78 (249)
                      .||||-++|.+.++++++.++.++.+|+.||+-||+.|+|||||||+|||++..|.+||.|||.+......+..  ...+
T Consensus       158 pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aV  237 (1317)
T KOG0612|consen  158 PGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAV  237 (1317)
T ss_pred             cCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEecccc
Confidence            49999999999999999999999999999999999999999999999999999999999999999887755433  3468


Q ss_pred             ccccccCchhccC---C-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           79 VTRWYRAPELLLN---S-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        79 ~~~~y~aPE~~~~---~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      |||.|++||++..   . +.|+..+|.||+||++|||+.|..||...+-..++.+|+..-....                
T Consensus       238 GTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~----------------  301 (1317)
T KOG0612|consen  238 GTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS----------------  301 (1317)
T ss_pred             CCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC----------------
Confidence            9999999999852   2 4589999999999999999999999999999999999986411100                


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCcCCCCCCCCCCCCCCchhc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT---VDEALAHPYLARLHDEADEPVCPEPFSFDFEQ  225 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~  225 (249)
                                ++. ...+|+++++||++.+. +|..|..   ++++..||||.+........ +++|+.++.+.
T Consensus       302 ----------FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~-~~pP~vPevss  362 (1317)
T KOG0612|consen  302 ----------FPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRE-SVPPVVPEVSS  362 (1317)
T ss_pred             ----------CCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhh-cCCCCCCcCCC
Confidence                      000 01488999999999887 7888888   99999999999988743333 35566666553

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-32  Score=224.39  Aligned_cols=200  Identities=43%  Similarity=0.825  Sum_probs=155.1

Q ss_pred             CccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccc
Q 025683            2 DTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~   77 (249)
                      +++|.+++...   ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (284)
T cd07836          81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE  160 (284)
T ss_pred             CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccc
Confidence            56888888764   368999999999999999999999999999999999999999999999999886543321 12234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|++||.+.+...++.++|+|+||+++|+|++|..||.+.+.......+......+....+.....  ...+....
T Consensus       161 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  238 (284)
T cd07836         161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LPEYKPTF  238 (284)
T ss_pred             cccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--Cchhcccc
Confidence            5678899999987665678899999999999999999999998888888887777766655443322221  11111111


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      +.........+.+..++.+.+++.+||+.||.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            1212222333444578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-33  Score=226.34  Aligned_cols=171  Identities=29%  Similarity=0.525  Sum_probs=154.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|+||+...+.|++.+++.+++||+.|+.|+|.++++|||+|.+|||++.++++|+.|||++..........+++|++
T Consensus       137 ~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSP  216 (668)
T KOG0611|consen  137 GGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSP  216 (668)
T ss_pred             CccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCc
Confidence            79999999999999999999999999999999999999999999999999999999999999998888888888899999


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      -|.+||+..+.++-++.+|.|||||++|-|+.|..||.+.+.....++|....                           
T Consensus       217 LYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga---------------------------  269 (668)
T KOG0611|consen  217 LYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA---------------------------  269 (668)
T ss_pred             ccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc---------------------------
Confidence            99999999888888999999999999999999999999998777777665311                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                           ...+..+.+...||+-||..+|++|-|++++-+|=|.+
T Consensus       270 -----YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  270 -----YREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             -----ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                 11223556688999999999999999999999986665

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-32  Score=222.21  Aligned_cols=202  Identities=44%  Similarity=0.785  Sum_probs=157.8

Q ss_pred             CCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccc
Q 025683            1 MDTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ++|+|.+++.+..  .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+.............
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (283)
T cd07830          80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV  159 (283)
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCC
Confidence            3688999998865  79999999999999999999999999999999999999999999999999987665443334456


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.....++.++|+||||+++++|++|..||...........+...++.+....+...... ........+
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  238 (283)
T cd07830         160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL-ASKLGFRFP  238 (283)
T ss_pred             CcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh-hcccccccc
Confidence            7888999998866666788999999999999999999999998888888888887776654432111000 000000111


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ...........+..+.++.++|++||+.||.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            111112233334457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.9e-32  Score=222.40  Aligned_cols=206  Identities=43%  Similarity=0.795  Sum_probs=157.3

Q ss_pred             CCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-CCCeEEeecCCccCCCCCC-cccc
Q 025683            1 MDTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENE-FMTE   76 (249)
Q Consensus         1 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~~~~-~~~~   76 (249)
                      ++++|.+++....  .+++..+..++.||+.||+|||++|++|+||+|+||+++. ++.++|+|||.+....... ....
T Consensus        83 ~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (294)
T PLN00009         83 LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH  162 (294)
T ss_pred             ccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccccc
Confidence            3567888887654  3588899999999999999999999999999999999985 4578999999987543321 2233


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|+|||.+.+...++.++|+||+|+++|+|++|..||...........+....+.+....+......  ..+...
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  240 (294)
T PLN00009        163 EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL--PDYKSA  240 (294)
T ss_pred             CceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc--hhhhhh
Confidence            456788999998876556788999999999999999999999988877777777777766654443322111  111111


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      .+...........+.+++++.+++.+||+.+|.+||++.++++||||..+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            1111222333445678899999999999999999999999999999998754

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.6e-33  Score=231.38  Aligned_cols=174  Identities=26%  Similarity=0.471  Sum_probs=143.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      |++|..++.+...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..... ........++
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            689999999888999999999999999999999999999999999999999999999999998875322 2223345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+..   .+                       
T Consensus       160 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~-----------------------  212 (321)
T cd05603         160 PEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH---KP-----------------------  212 (321)
T ss_pred             cccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc---CC-----------------------
Confidence            999999998654 478899999999999999999999987764443333321   00                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV----DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~~ll~h~~~~~~~  207 (249)
                           ..+++..+.++.++|.+||+.||.+|+++    .++++|+||....
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         213 -----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence                 11233567789999999999999999875    5999999998755

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=220.63  Aligned_cols=172  Identities=24%  Similarity=0.455  Sum_probs=140.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc----ccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~----~~~   77 (249)
                      |++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........    ...
T Consensus        88 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  167 (263)
T cd06625          88 GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV  167 (263)
T ss_pred             CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCC
Confidence            6799999998889999999999999999999999999999999999999999999999999998654332111    234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|+|||.+.+.. .+.++|+||||+++|++++|..||...........+....                       
T Consensus       168 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------------------  223 (263)
T cd06625         168 TGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-----------------------  223 (263)
T ss_pred             CcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-----------------------
Confidence            5678899999987554 7899999999999999999999997665443332222100                       


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                            ....+...++..+.++|.+||..+|.+|||+.++++|+||
T Consensus       224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 ------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                  0012233577889999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.2e-33  Score=226.32  Aligned_cols=178  Identities=26%  Similarity=0.457  Sum_probs=141.5

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      |++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.............+
T Consensus        84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g  163 (285)
T cd05630          84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG  163 (285)
T ss_pred             CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCC
Confidence            68999998654  4699999999999999999999999999999999999999999999999999876544333344578


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+... .++.++|+||+|+++|+|++|..||................                    .... 
T Consensus       164 ~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~--------------------~~~~-  221 (285)
T cd05630         164 TVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--------------------KEVQ-  221 (285)
T ss_pred             CccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh--------------------hhhh-
Confidence            8999999998654 48899999999999999999999997653211111111100                    0000 


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                            ......+++++.+|+++||+.||.+|||     ++++++||||++..
T Consensus       222 ------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05630         222 ------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN  268 (285)
T ss_pred             ------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence                  1122356788999999999999999999     99999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=222.74  Aligned_cols=201  Identities=41%  Similarity=0.759  Sum_probs=154.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--cccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~   78 (249)
                      +++|.+++.+. ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......  ......
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  162 (287)
T cd07840          83 DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV  162 (287)
T ss_pred             cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccc
Confidence            56888888775 689999999999999999999999999999999999999999999999999987654432  122345


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.+...++.++|+||||+++++|++|..||...+.......+....+.+....+.............. .
T Consensus       163 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  241 (287)
T cd07840         163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP-K  241 (287)
T ss_pred             cccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc-c
Confidence            577899999876655678999999999999999999999998888777777777766655443332222100000000 0


Q ss_pred             CCCCcchhhcCCC-CChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPH-VHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ........+.... +++.+.+++++||+.+|.+||++.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         242 KPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            1111122233333 38899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.1e-32  Score=221.97  Aligned_cols=202  Identities=35%  Similarity=0.683  Sum_probs=150.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~   80 (249)
                      +++|..+......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  163 (286)
T cd07846          84 HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVAT  163 (286)
T ss_pred             ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccce
Confidence            356666666666799999999999999999999999999999999999999999999999998875433222 2234568


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+...++.++|+||||+++++|++|..||...........+....+.........................
T Consensus       164 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (286)
T cd07846         164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVK  243 (286)
T ss_pred             eeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccccccc
Confidence            88999999876555788999999999999999999999887777766666665554332111100000000000000000


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      .........+.++..+.+++.+||+.+|.+||++.+++.|+||
T Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         244 EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             CcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            1112233455788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-33  Score=235.60  Aligned_cols=177  Identities=27%  Similarity=0.457  Sum_probs=140.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---------   72 (249)
                      ||+|.+++.+.+.+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......         
T Consensus        85 gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  164 (377)
T cd05629          85 GGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL  164 (377)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccc
Confidence            78999999998999999999999999999999999999999999999999999999999999885321100         


Q ss_pred             ---c------------------------------------cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh
Q 025683           73 ---F------------------------------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN  113 (249)
Q Consensus        73 ---~------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~  113 (249)
                         .                                    .....||+.|+|||.+... .++.++|+|||||++|+|++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt  243 (377)
T cd05629         165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIMFECLI  243 (377)
T ss_pred             cccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchhhhhhhc
Confidence               0                                    0023688999999998654 47899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCC--
Q 025683          114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR--  191 (249)
Q Consensus       114 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R--  191 (249)
                      |..||...........+........                     .+      -...++.++.+||.+||. +|.+|  
T Consensus       244 G~~Pf~~~~~~~~~~~i~~~~~~~~---------------------~p------~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         244 GWPPFCSENSHETYRKIINWRETLY---------------------FP------DDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             CCCCCCCCCHHHHHHHHHccCCccC---------------------CC------CCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            9999987776555544432110000                     00      011367889999999998 77765  


Q ss_pred             -CCHHHHhcCccccCCc
Q 025683          192 -ITVDEALAHPYLARLH  207 (249)
Q Consensus       192 -pt~~~ll~h~~~~~~~  207 (249)
                       +++.+++.||||+...
T Consensus       296 r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         296 RGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             CCCHHHHhcCCCcCCCC
Confidence             5999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-32  Score=222.07  Aligned_cols=197  Identities=42%  Similarity=0.752  Sum_probs=153.0

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      +++|.+++.+..  .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        89 ~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  168 (287)
T cd07838          89 DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV  168 (287)
T ss_pred             ccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccc
Confidence            567888887753  599999999999999999999999999999999999999999999999999876654443344556


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+.. ++.++|+||+||++++|++|..||..........++...........+..........    ...
T Consensus       169 ~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~  243 (287)
T cd07838         169 TLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS----FPS  243 (287)
T ss_pred             cccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhh----ccc
Confidence            88899999986544 7889999999999999999999999888887777777665544332221111100000    011


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ..........+.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         244 YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            11222234444667889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-33  Score=223.84  Aligned_cols=178  Identities=33%  Similarity=0.569  Sum_probs=142.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCC-CCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT-SENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~-~~~~~~~~~~~~   80 (249)
                      +++|.+++.+.+.+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+... ..........++
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  161 (260)
T PF00069_consen   82 GGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGT  161 (260)
T ss_dssp             TEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4599999998789999999999999999999999999999999999999999999999999998753 233344456778


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+......+.++|+||||+++++|++|..||...........+.............                 
T Consensus       162 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------  224 (260)
T PF00069_consen  162 PEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----------------  224 (260)
T ss_dssp             GGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----------------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----------------
Confidence            899999998635568999999999999999999999998774344444333322111100000                 


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                             .....++.+.++|.+||+.||.+|||+.++++||||
T Consensus       225 -------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                   000122679999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.5e-32  Score=223.36  Aligned_cols=177  Identities=25%  Similarity=0.419  Sum_probs=142.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+.+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++....... .....++.
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  159 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence            68999999988899999999999999999999999999999999999999999999999999886543322 22346788


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.....++.++|+||+||++++|++|..||......... .+......                         
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~-------------------------  213 (279)
T cd05633         160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT-------------------------  213 (279)
T ss_pred             CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhc-------------------------
Confidence            9999998864445788999999999999999999999654321111 01100000                         


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                        ....++..+++++.++|.+||+.||.+|+     |+.++++||||+...
T Consensus       214 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         214 --VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             --CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence              00122345778899999999999999999     699999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.8e-32  Score=228.24  Aligned_cols=202  Identities=23%  Similarity=0.421  Sum_probs=142.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ......++
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~  165 (333)
T cd06650          87 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGT  165 (333)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCC
Confidence            689999999988999999999999999999999975 7999999999999999999999999988654322 12335678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCcccccccc-------------
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLG-TPTDADLGFVR-------------  146 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-------------  146 (249)
                      ..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+..... .+.........             
T Consensus       166 ~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (333)
T cd06650         166 RSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPD  244 (333)
T ss_pred             ccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhccc
Confidence            899999998654 478899999999999999999999976654332221111000 00000000000             


Q ss_pred             ---hhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          147 ---NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       147 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                         ...................  ....++.++.+|+.+||+.||.+|||+.+++.|+||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         245 SRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             ccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence               0000000000000000000  0113578899999999999999999999999999998654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.2e-33  Score=236.52  Aligned_cols=177  Identities=27%  Similarity=0.449  Sum_probs=140.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC----------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----------   71 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~----------   71 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......          
T Consensus        85 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~  164 (376)
T cd05598          85 GGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD  164 (376)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccc
Confidence            7899999999889999999999999999999999999999999999999999999999999986422100          


Q ss_pred             ----------------------------------CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 025683           72 ----------------------------------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL  117 (249)
Q Consensus        72 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p  117 (249)
                                                        .......|++.|+|||.+.+. .++.++|||||||++|+|++|..|
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyell~G~~P  243 (376)
T cd05598         165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPP  243 (376)
T ss_pred             ccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeeehhhCCCC
Confidence                                              001124689999999998654 478999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC---CH
Q 025683          118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI---TV  194 (249)
Q Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~  194 (249)
                      |.+.........+........                           ......+++++.++|.+|+ .+|.+|+   ++
T Consensus       244 f~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         244 FLADTPAETQLKVINWETTLH---------------------------IPSQAKLSREASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             CCCCCHHHHHHHHhccCcccc---------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence            988765544433321100000                           0011246788999999976 5999999   99


Q ss_pred             HHHhcCccccCCc
Q 025683          195 DEALAHPYLARLH  207 (249)
Q Consensus       195 ~~ll~h~~~~~~~  207 (249)
                      .++++||||+.+.
T Consensus       296 ~ell~h~~~~~~~  308 (376)
T cd05598         296 DEIKAHPFFKGID  308 (376)
T ss_pred             HHHhCCCCcCCCC
Confidence            9999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-32  Score=222.51  Aligned_cols=202  Identities=42%  Similarity=0.764  Sum_probs=148.8

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~   78 (249)
                      ++++|.+++.+. ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  164 (291)
T cd07844          85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEV  164 (291)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccc
Confidence            356899998764 578999999999999999999999999999999999999999999999999886543221 112234


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+.+...++.++|+||+|+++|+|++|..||.... .......+...++.+....+........... ...
T Consensus       165 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  243 (291)
T cd07844         165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP-YSF  243 (291)
T ss_pred             cccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc-ccc
Confidence            57789999998765567889999999999999999999997665 4555666666666554433222111000000 000


Q ss_pred             CCCCCcchhhcCCCCC--hHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          158 PQHPRQSLAQVFPHVH--PLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ............+.++  .++.+++.+||+.+|.+|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         244 PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0011111222233444  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.4e-32  Score=223.27  Aligned_cols=180  Identities=23%  Similarity=0.354  Sum_probs=141.0

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      |++|.+++...  ..+++..+..++.||+.||+|||+.|++||||+|+||+++.++.++|+|||.+.............+
T Consensus        77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCC
Confidence            68998888654  3589999999999999999999999999999999999999999999999999876654443344567


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.... ++.++|+||+||++|+|++|..||...........+......                   .   
T Consensus       157 ~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~---  213 (277)
T cd05607         157 TNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------------------D---  213 (277)
T ss_pred             CCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-------------------c---
Confidence            88999999986555 889999999999999999999999754322111111110000                   0   


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH----HHHhcCccccCCcC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV----DEALAHPYLARLHD  208 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~~ll~h~~~~~~~~  208 (249)
                          ........+++++.+++.+||+.||.+||++    ++++.|+||+.+..
T Consensus       214 ----~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~  262 (277)
T cd05607         214 ----EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF  262 (277)
T ss_pred             ----ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence                0000112467889999999999999999999    67889999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-33  Score=228.15  Aligned_cols=181  Identities=27%  Similarity=0.413  Sum_probs=151.8

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ||||.=.|-+.+  .|++..++.++.+|+.||++||+.+||+||+||+|||+|+.|.++|+|+|++..+.........+|
T Consensus       269 GGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvG  348 (591)
T KOG0986|consen  269 GGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVG  348 (591)
T ss_pred             CCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccC
Confidence            678877777755  899999999999999999999999999999999999999999999999999998888877777799


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      |.+|||||++.+.. |+.+.|.|+|||++|+|+.|+.||...........+....                    .    
T Consensus       349 T~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--------------------~----  403 (591)
T KOG0986|consen  349 TVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--------------------L----  403 (591)
T ss_pred             cccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--------------------h----
Confidence            99999999997665 9999999999999999999999997654322222221111                    0    


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcCCC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLHDEA  210 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~~~~  210 (249)
                         ..-.+.++++|+++++|.+.+|++||.+|.     ++.++.+||||+.++...
T Consensus       404 ---~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  404 ---EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             ---cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence               111334557999999999999999999998     577999999999987443

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.3e-33  Score=234.42  Aligned_cols=177  Identities=30%  Similarity=0.489  Sum_probs=141.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---------   72 (249)
                      ||+|.+++.+.+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        85 gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~  164 (360)
T cd05627          85 GGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT  164 (360)
T ss_pred             CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccc
Confidence            68999999998999999999999999999999999999999999999999999999999999876432110         


Q ss_pred             ---------------------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 025683           73 ---------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH  125 (249)
Q Consensus        73 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~  125 (249)
                                                 .....+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||...+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~  243 (360)
T cd05627         165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQE  243 (360)
T ss_pred             cCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCCCCCHHH
Confidence                                       011346899999999986544 7899999999999999999999998877655


Q ss_pred             HHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC---CHHHHhcCcc
Q 025683          126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI---TVDEALAHPY  202 (249)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~~ll~h~~  202 (249)
                      ....+........                          +. -...+++++.++|.+|+. ||.+|+   +++++++|||
T Consensus       244 ~~~~i~~~~~~~~--------------------------~p-~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~  295 (360)
T cd05627         244 TYRKVMNWKETLV--------------------------FP-PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF  295 (360)
T ss_pred             HHHHHHcCCCcee--------------------------cC-CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence            5544432100000                          00 001367889999999774 999998   5899999999


Q ss_pred             ccCCc
Q 025683          203 LARLH  207 (249)
Q Consensus       203 ~~~~~  207 (249)
                      |+...
T Consensus       296 f~~~~  300 (360)
T cd05627         296 FEGVD  300 (360)
T ss_pred             CCCCC
Confidence            99865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.9e-32  Score=219.49  Aligned_cols=176  Identities=27%  Similarity=0.524  Sum_probs=143.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+.............++.
T Consensus        77 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          77 GGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCc
Confidence            68999999998889999999999999999999999999999999999999999999999999987665443233456788


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND--HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      .|++||.+... .++.++|+|++|+++|+|++|..||....  .......+.....                        
T Consensus       157 ~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------  211 (262)
T cd05572         157 EYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG------------------------  211 (262)
T ss_pred             CccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC------------------------
Confidence            89999987544 47889999999999999999999997665  3323322221000                        


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                           ....+...++++.++|.+||+.+|.+||+     +.++++||||+++.
T Consensus       212 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         212 -----KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             -----CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence                 01112234678999999999999999999     99999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.4e-33  Score=233.21  Aligned_cols=177  Identities=26%  Similarity=0.396  Sum_probs=142.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~   79 (249)
                      ||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......  ......|
T Consensus       127 gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~g  205 (370)
T cd05621         127 GGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG  205 (370)
T ss_pred             CCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCC
Confidence            7899999976 469999999999999999999999999999999999999999999999999987654322  1234578


Q ss_pred             cccccCchhccCCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           80 TRWYRAPELLLNSS---DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        80 ~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      |+.|+|||.+...+   .++.++|+||+||++|+|++|..||...+.......+.........                 
T Consensus       206 t~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-----------------  268 (370)
T cd05621         206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF-----------------  268 (370)
T ss_pred             CcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC-----------------
Confidence            99999999986432   3678999999999999999999999887766555555432111100                 


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCC--CCCHHHHhcCccccCC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITVDEALAHPYLARL  206 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~h~~~~~~  206 (249)
                               . ....++..+.+++.+||..++.+  |+++.++++||||+..
T Consensus       269 ---------p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         269 ---------P-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             ---------C-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence                     0 01136788999999999865543  8999999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=212.03  Aligned_cols=168  Identities=27%  Similarity=0.443  Sum_probs=141.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCchhcc
Q 025683           12 NQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLL   90 (249)
Q Consensus        12 ~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~   90 (249)
                      .+++++..+-++...++.||.||.+ +|++|||+||+|||++..|.+||||||.+.+..++.......|.+.|||||.+.
T Consensus       185 k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERid  264 (391)
T KOG0983|consen  185 KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERID  264 (391)
T ss_pred             cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccC
Confidence            3689999999999999999999995 599999999999999999999999999999887777666788999999999985


Q ss_pred             CC--CCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhh
Q 025683           91 NS--SDYTAAIDVWSVGCIFMELMNRRPLFPGN-DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ  167 (249)
Q Consensus        91 ~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (249)
                      ..  ..|...+||||||++++||.+|+.||.+. .+...+.++..  ..|+.-                          .
T Consensus       265 p~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--~ePP~L--------------------------~  316 (391)
T KOG0983|consen  265 PPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--EEPPLL--------------------------P  316 (391)
T ss_pred             CCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--cCCCCC--------------------------C
Confidence            43  35788999999999999999999999875 44555555543  111110                          0


Q ss_pred             cCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       168 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      -..++|+++++|+..||.+|+.+||...+||+|||+....
T Consensus       317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            1124889999999999999999999999999999998653

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.5e-32  Score=228.80  Aligned_cols=180  Identities=22%  Similarity=0.429  Sum_probs=143.2

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--ccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~   78 (249)
                      ||+|.+++.+ ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+........  .....
T Consensus        85 ~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~  164 (332)
T cd05623          85 GGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV  164 (332)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccc
Confidence            7899999987 46899999999999999999999999999999999999999999999999998865433221  22356


Q ss_pred             ccccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           79 VTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        79 ~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      |++.|+|||.+..    ...++.++|+|||||++|+|++|..||...+.......+.....                   
T Consensus       165 gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------------  225 (332)
T cd05623         165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-------------------  225 (332)
T ss_pred             cCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-------------------
Confidence            8999999999852    33478899999999999999999999988776555555432110                   


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITVDEALAHPYLARLH  207 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~h~~~~~~~  207 (249)
                             +..+......+++++.+++++||..++.+  |++++++++||||++..
T Consensus       226 -------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         226 -------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             -------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence                   00111122357889999999999765544  78999999999999765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-33  Score=229.75  Aligned_cols=167  Identities=28%  Similarity=0.425  Sum_probs=143.3

Q ss_pred             CccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      .|+|.+||.+  ...+...+...++.||++||+||+++++|||||.+.||||+.+..+|++|||+++...+........+
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~  364 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG  364 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence            4899999998  47899999999999999999999999999999999999999999999999999996555443222211


Q ss_pred             --cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           80 --TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        80 --~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                        +..|.|||++... .++.++|||||||++|||++ |+.||++.+..+.+..+.+..+.+.+.                
T Consensus       365 kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~----------------  427 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE----------------  427 (468)
T ss_pred             CCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC----------------
Confidence              4559999999644 59999999999999999997 999999999999988888765554432                


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                    ..|+++-+++..||+.+|++|||++.+..
T Consensus       428 --------------~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  428 --------------GCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             --------------CCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence                          56788999999999999999999997653

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.1e-32  Score=222.65  Aligned_cols=201  Identities=38%  Similarity=0.756  Sum_probs=151.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-------
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-------   73 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-------   73 (249)
                      +++|.+++... ..+++..++.++.||++||+|||++|++|+||+|+||+++.++.++|+|||.+........       
T Consensus        98 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  177 (311)
T cd07866          98 DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG  177 (311)
T ss_pred             CcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCc
Confidence            45677777653 5799999999999999999999999999999999999999999999999998865432211       


Q ss_pred             -----cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchh
Q 025683           74 -----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNE  148 (249)
Q Consensus        74 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (249)
                           .....+++.|+|||.+.+...++.++|+||||+++++|++|..||.+.+.......+....+.+....+......
T Consensus       178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (311)
T cd07866         178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSL  257 (311)
T ss_pred             ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhc
Confidence                 112345777999998866555788999999999999999999999988888888888877776554432211110


Q ss_pred             hHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ...... .................++.+.++|.+||+.||.+|||+.+++.||||
T Consensus       258 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         258 PGCEGV-HSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             cccccc-ccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            000000 000011122233344566889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-33  Score=237.49  Aligned_cols=178  Identities=28%  Similarity=0.504  Sum_probs=148.2

Q ss_pred             CccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-CCCeEEeecCCccCCC-CCCcccc
Q 025683            2 DTDLYQIIRSN-QSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTS-ENEFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l--~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~-~~~~~~~   76 (249)
                      ||||.++|.+. +++  .+..+..+.+||++||.|||++.|||||||-+||||+. .|.+|++|||.+++.. .+....+
T Consensus       656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence            89999999987 778  89999999999999999999999999999999999986 6899999999998754 3445567


Q ss_pred             ccccccccCchhccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      +.||..|||||++.. ...|+.++|||||||++.||.+|++||......+...--+.+                      
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm----------------------  793 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM----------------------  793 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc----------------------
Confidence            899999999999853 356999999999999999999999999765433222222211                      


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                            .+....++..++.+++.||.+|+..||.+||++.++|.+||++--.
T Consensus       794 ------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  794 ------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             ------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence                  1122334556788899999999999999999999999999998663

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-32  Score=220.43  Aligned_cols=199  Identities=38%  Similarity=0.721  Sum_probs=148.7

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--cccccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVVT   80 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~   80 (249)
                      +.+..++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.......  ......++
T Consensus        85 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~  164 (288)
T cd07833          85 TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVAT  164 (288)
T ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccc
Confidence            4455555556779999999999999999999999999999999999999999999999999987655433  23345668


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccch-hhHHHHHHhCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQ  159 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  159 (249)
                      ..|+|||.+.....++.++|+||||+++|+|++|..||...........+....+............ .....  .....
T Consensus       165 ~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  242 (288)
T cd07833         165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG--VAFPE  242 (288)
T ss_pred             cCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc--cccCC
Confidence            8899999987664688999999999999999999999988877777776666665544322211110 00000  00000


Q ss_pred             CC-Ccchhh-cCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          160 HP-RQSLAQ-VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       160 ~~-~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      .. ...... ....++.++.+||++||..+|.+|||+++++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            00 011111 222358889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-32  Score=207.24  Aligned_cols=172  Identities=27%  Similarity=0.471  Sum_probs=153.5

Q ss_pred             CccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIR--SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~--~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      +|+|+..|.  ...++++.....++.|++.|+.|+|..+++||||||+|+|++..+.+|++|||.+.... .......+|
T Consensus       106 ~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcg  184 (281)
T KOG0580|consen  106 RGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLCG  184 (281)
T ss_pred             CchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeeec
Confidence            588999999  66889999999999999999999999999999999999999999999999999987665 445678899


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      |..|.+||...+.. ....+|+|++|++.||++.|.+||.......++++|.+.--..                      
T Consensus       185 t~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~----------------------  241 (281)
T KOG0580|consen  185 TLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKF----------------------  241 (281)
T ss_pred             ccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccC----------------------
Confidence            99999999886554 7899999999999999999999999988888888887643222                      


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                               +..++.++.++|.+||..+|.+|.+..|++.|||+...
T Consensus       242 ---------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  242 ---------PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ---------CcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                     23688999999999999999999999999999999764

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-32  Score=217.71  Aligned_cols=175  Identities=30%  Similarity=0.528  Sum_probs=142.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....   .....++.
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~  157 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP  157 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence            689999999888999999999999999999999999999999999999999999999999998865433   22345678


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|++||.+.+.. ++.++|+||+|+++++|++|..||...+.......+.......                        
T Consensus       158 ~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------  212 (260)
T cd05611         158 DYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW------------------------  212 (260)
T ss_pred             CccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC------------------------
Confidence            899999986554 7889999999999999999999998776544433332110000                        


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCC---CHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI---TVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~~ll~h~~~~~~~  207 (249)
                         .......+++++.+++.+||+.||.+||   +++++++||||++..
T Consensus       213 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         213 ---PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             ---CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence               0111224678899999999999999999   557999999998754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.1e-32  Score=219.68  Aligned_cols=177  Identities=26%  Similarity=0.433  Sum_probs=142.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+.+.+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+....... .....++.
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~  159 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence            78999999988899999999999999999999999999999999999999999999999999886543322 23456788


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.....++.++|+||+|+++++|++|..||.................                          
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------------  213 (278)
T cd05606         160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------------------------  213 (278)
T ss_pred             CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--------------------------
Confidence            999999986554578899999999999999999999976532111110000000                          


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                        ....++..+++++.+++.+||..+|.+||     ++.++++||||+...
T Consensus       214 --~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         214 --MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             --cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence              00122334678899999999999999999     999999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.9e-32  Score=235.62  Aligned_cols=175  Identities=27%  Similarity=0.427  Sum_probs=143.0

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---cc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FM   74 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---~~   74 (249)
                      ||+|.++|.+    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......   ..
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~  228 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA  228 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccc
Confidence            7899888754    3579999999999999999999999999999999999999999999999999987654332   12


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....||+.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+....  .                 
T Consensus       229 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~--~-----------------  288 (478)
T PTZ00267        229 SSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK--Y-----------------  288 (478)
T ss_pred             cccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C-----------------
Confidence            345689999999988654 48899999999999999999999998776544444433210  0                 


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                 ...+..++.++.++|.+||..||.+||++++++.|+|++...
T Consensus       289 -----------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~~  330 (478)
T PTZ00267        289 -----------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVA  330 (478)
T ss_pred             -----------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHHH
Confidence                       011224678899999999999999999999999999997653

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.5e-32  Score=221.66  Aligned_cols=205  Identities=25%  Similarity=0.416  Sum_probs=145.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||+ ++++|+||+|+||+++.++.++|+|||.+....... .....++
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  161 (308)
T cd06615          83 GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGT  161 (308)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-cccCCCC
Confidence            67999999998899999999999999999999997 699999999999999999999999999886543322 2345678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc---------ccccchhhHH
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD---------LGFVRNEDAK  151 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~  151 (249)
                      ..|+|||.+.+. .++.++|+||||+++++|++|..||...+.......+...........         ..........
T Consensus       162 ~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (308)
T cd06615         162 RSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF  240 (308)
T ss_pred             cCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHH
Confidence            899999988544 478899999999999999999999976653322222211110000000         0000000000


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                      ...+.........  .-...++.++.+|+.+||..||++|||+.++++||||.++..+.
T Consensus       241 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  297 (308)
T cd06615         241 ELLDYIVNEPPPK--LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEE  297 (308)
T ss_pred             HHHHHHhcCCCcc--CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccccc
Confidence            1111100000000  00113678899999999999999999999999999999865443

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.7e-32  Score=217.87  Aligned_cols=172  Identities=27%  Similarity=0.484  Sum_probs=138.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |++|.+++.++..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||.+.......   ...++
T Consensus        93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~  169 (267)
T PHA03390         93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CYDGT  169 (267)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc---cCCCC
Confidence            689999999888999999999999999999999999999999999999999998 99999999886554322   34568


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ-MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      ..|+|||.+.+.. ++.++|+||+|+++++|++|..||........ ...+.....                        
T Consensus       170 ~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------  224 (267)
T PHA03390        170 LDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ------------------------  224 (267)
T ss_pred             CcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc------------------------
Confidence            8899999986544 78899999999999999999999975432211 111111000                        


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-HHHHhcCccccC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-VDEALAHPYLAR  205 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~~ll~h~~~~~  205 (249)
                          ......+..++.+.+||.+||+.||.+|++ ++++++||||++
T Consensus       225 ----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        225 ----KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ----ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                001122357889999999999999999996 699999999974

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.9e-32  Score=220.10  Aligned_cols=178  Identities=29%  Similarity=0.453  Sum_probs=143.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      |++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g  163 (285)
T cd05632          84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVG  163 (285)
T ss_pred             CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCC
Confidence            57898888653  4699999999999999999999999999999999999999999999999998866543333344578


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+........                     
T Consensus       164 ~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------------------  221 (285)
T cd05632         164 TVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---------------------  221 (285)
T ss_pred             CcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---------------------
Confidence            8999999998654 478899999999999999999999987654433333322111110                     


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                            ......+++++.+|+.+||+.||.+||+     +.+++.|+||+...
T Consensus       222 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         222 ------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             ------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence                  0122356788999999999999999999     89999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-32  Score=229.73  Aligned_cols=178  Identities=25%  Similarity=0.369  Sum_probs=141.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~   79 (249)
                      ||+|.+++.+ ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+.......  ......|
T Consensus       127 gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~g  205 (371)
T cd05622         127 GGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG  205 (371)
T ss_pred             CCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCccc
Confidence            6899999976 568999999999999999999999999999999999999999999999999987654322  2234578


Q ss_pred             cccccCchhccCCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           80 TRWYRAPELLLNSS---DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        80 ~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      |+.|+|||.+....   .++.++|+|||||++|+|++|..||.+.+.......+........                  
T Consensus       206 t~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------------------  267 (371)
T cd05622         206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT------------------  267 (371)
T ss_pred             CccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc------------------
Confidence            99999999986432   367899999999999999999999988776555555432111100                  


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITVDEALAHPYLARLH  207 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~h~~~~~~~  207 (249)
                               ......++..+.++|.+||..++.+  |++++++++|+||++..
T Consensus       268 ---------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         268 ---------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             ---------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence                     0011247888999999999844433  78999999999998743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.98  E-value=8.5e-32  Score=217.82  Aligned_cols=173  Identities=24%  Similarity=0.458  Sum_probs=136.8

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      +++|.+++...  ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++...... .......
T Consensus        93 ~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  172 (272)
T cd06637          93 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI  172 (272)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCccc
Confidence            57999999874  46899999999999999999999999999999999999999999999999998754332 2223456


Q ss_pred             ccccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           79 VTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        79 ~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ++..|+|||.+..    ...++.++|+||+||++|+|++|..||...........+..   ..                 
T Consensus       173 g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~-----------------  232 (272)
T cd06637         173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP-----------------  232 (272)
T ss_pred             ccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CC-----------------
Confidence            7888999998853    22467899999999999999999999965543322221110   00                 


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                             ..  .......+.++.+|+.+||..||.+|||+.+++.||||
T Consensus       233 -------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 -------AP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -------CC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                   00  00112466789999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=7.3e-32  Score=224.49  Aligned_cols=180  Identities=22%  Similarity=0.413  Sum_probs=141.6

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc--cccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~   78 (249)
                      ||+|.+++.+ ...+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.........  ....
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  164 (331)
T cd05597          85 GGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV  164 (331)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccccee
Confidence            7899999987 468999999999999999999999999999999999999999999999999998654433221  2246


Q ss_pred             ccccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           79 VTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        79 ~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      |++.|+|||.+..    ...++.++|+||+||++|+|++|..||...........+......                  
T Consensus       165 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------------  226 (331)
T cd05597         165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH------------------  226 (331)
T ss_pred             ccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc------------------
Confidence            8999999999863    234678999999999999999999999877655544444321100                  


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITVDEALAHPYLARLH  207 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~h~~~~~~~  207 (249)
                              ..+......+++++.++|++||..++.+  |++++++++||||+...
T Consensus       227 --------~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         227 --------FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             --------ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence                    0011112247888999999998764444  78999999999998764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=1.3e-31  Score=233.90  Aligned_cols=203  Identities=26%  Similarity=0.355  Sum_probs=141.6

Q ss_pred             CccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--cc
Q 025683            2 DTDLYQIIRSN-----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FM   74 (249)
Q Consensus         2 ~~~L~~~l~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~   74 (249)
                      +++|.+++...     .......++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......  ..
T Consensus       246 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  325 (501)
T PHA03210        246 DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD  325 (501)
T ss_pred             ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCccccccc
Confidence            56777777543     234567888999999999999999999999999999999999999999999997654332  12


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC-CCC--CChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPG--NDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      ....|+..|+|||.+.+. .++.++|||||||++|+|++|..+ +..  ......+..+...++........  ......
T Consensus       326 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~  402 (501)
T PHA03210        326 YGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPD--PPCKLF  402 (501)
T ss_pred             ccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCC--cHHHHH
Confidence            235789999999998655 488999999999999999998754 432  23344555555444332221111  001111


Q ss_pred             HHHHhCC-CCCCcchhhc--CCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          152 RYIRQLP-QHPRQSLAQV--FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       152 ~~~~~~~-~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      .++.... ......+...  ...++.++.++|.+||++||.+|||+.|+|+||||+...
T Consensus       403 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        403 DYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence            1111100 0000111111  113567889999999999999999999999999998754

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=1.5e-32  Score=227.52  Aligned_cols=177  Identities=30%  Similarity=0.487  Sum_probs=156.8

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~   78 (249)
                      ||+|.+.|.+.  .-|+++.+..++.|++.|++|||+++|+|||||+.||+..+++.++|+|||+++...... .....+
T Consensus        88 Gg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvv  167 (426)
T KOG0589|consen   88 GGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVV  167 (426)
T ss_pred             CCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheec
Confidence            79999999886  469999999999999999999999999999999999999999999999999999887765 667789


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|++||.+.+.+ ++.++|||||||.+|||++-+++|.+.+-.....++......+                     
T Consensus       168 GTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P---------------------  225 (426)
T KOG0589|consen  168 GTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP---------------------  225 (426)
T ss_pred             CCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC---------------------
Confidence            999999999996554 9999999999999999999999999998777777777644222                     


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                               ++..++.+++.+|+.||..+|..||++.+||.+|.......+
T Consensus       226 ---------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~~~  267 (426)
T KOG0589|consen  226 ---------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYLVE  267 (426)
T ss_pred             ---------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHHHh
Confidence                     233577889999999999999999999999999998866533

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.98  E-value=1.1e-31  Score=216.67  Aligned_cols=171  Identities=27%  Similarity=0.562  Sum_probs=139.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-------cc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-------FM   74 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-------~~   74 (249)
                      |++|.+++.+.+.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.......       ..
T Consensus        90 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (267)
T cd06628          90 GGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR  169 (267)
T ss_pred             CCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccc
Confidence            67999999988899999999999999999999999999999999999999999999999999887654211       11


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+....                    
T Consensus       170 ~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------  228 (267)
T cd06628         170 PSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--------------------  228 (267)
T ss_pred             cccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC--------------------
Confidence            123467889999988654 47889999999999999999999998765433332222100                    


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                                ...+...++..+.++|++||+.||.+||++.++++||||
T Consensus       229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 ----------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ----------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                      011223567889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.98  E-value=1.9e-31  Score=214.00  Aligned_cols=171  Identities=29%  Similarity=0.514  Sum_probs=138.3

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      |++|.+++.+.  ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+...... .......
T Consensus        84 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  163 (257)
T cd08223          84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI  163 (257)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcccccc
Confidence            57899999763  56999999999999999999999999999999999999999999999999988755332 2223346


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +++.|+|||..... .++.++|+||+|++++++++|..||...+.......+....  .                     
T Consensus       164 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~---------------------  219 (257)
T cd08223         164 GTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--L---------------------  219 (257)
T ss_pred             CCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C---------------------
Confidence            78889999988654 47889999999999999999999997665433332222100  0                     


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                             ......+++++.+++.+||+.||.+|||+.+++.||||
T Consensus       220 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 -------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                   01122467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.98  E-value=1.3e-31  Score=218.50  Aligned_cols=178  Identities=28%  Similarity=0.516  Sum_probs=143.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      |++|.+++.+ +++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+....... ......++
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  178 (285)
T cd06648         100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGT  178 (285)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCC
Confidence            6899999988 789999999999999999999999999999999999999999999999999876543322 12234578


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||...+.. ++.++|+||+|+++++|++|..||...+.......+...   .+..                    
T Consensus       179 ~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~~~~--------------------  234 (285)
T cd06648         179 PYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---LPPK--------------------  234 (285)
T ss_pred             ccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---CCCC--------------------
Confidence            8899999986543 788999999999999999999999776654444433221   0000                    


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                           ......++..+.+++.+||+.+|.+|||+.++++|+||++..+.
T Consensus       235 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         235 -----LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             -----CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence                 00111366789999999999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.98  E-value=1.7e-31  Score=218.99  Aligned_cols=182  Identities=26%  Similarity=0.491  Sum_probs=144.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~   80 (249)
                      |++|..++.+ ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus       100 ~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  178 (296)
T cd06655         100 GGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  178 (296)
T ss_pred             CCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCC
Confidence            6789998876 5699999999999999999999999999999999999999999999999998875443322 2234678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+... .++.++|+|||||++|++++|..||...+.......+... ..+.                      
T Consensus       179 ~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~----------------------  234 (296)
T cd06655         179 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE----------------------  234 (296)
T ss_pred             ccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc----------------------
Confidence            889999988644 4788999999999999999999999877654433322210 0000                      


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP  213 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~  213 (249)
                           ...+..+++.+.++|++||..||.+|||+.+++.||||+..++....+
T Consensus       235 -----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~~  282 (296)
T cd06655         235 -----LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLT  282 (296)
T ss_pred             -----cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccccCC
Confidence                 111234678899999999999999999999999999999877544433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.98  E-value=1.7e-31  Score=217.29  Aligned_cols=177  Identities=22%  Similarity=0.387  Sum_probs=140.4

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Cccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~   79 (249)
                      |++|..++.+ ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... .......+
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  165 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG  165 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccc
Confidence            5788888765 467999999999999999999999999999999999999999999999999998654332 22234567


Q ss_pred             cccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           80 TRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        80 ~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      +..|+|||.+..    ...++.++|+||+||++|+|++|..||...+.......+......                   
T Consensus       166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  226 (282)
T cd06643         166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-------------------  226 (282)
T ss_pred             cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC-------------------
Confidence            889999998742    233677999999999999999999999876654443333221100                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                               .......++.++.++|.+||+.||.+||+++++++||||+..
T Consensus       227 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         227 ---------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ---------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                     001122467789999999999999999999999999999964

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.98  E-value=1.1e-31  Score=216.73  Aligned_cols=172  Identities=24%  Similarity=0.485  Sum_probs=136.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC----Cccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----EFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~----~~~~~~   77 (249)
                      |++|.+++.+.+.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......    ......
T Consensus        90 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (266)
T cd06651          90 GGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV  169 (266)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccC
Confidence            5789999998888999999999999999999999999999999999999999999999999988754321    111234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|+|||.+.+. .++.++|+||+||++|+|++|..||...........+..   ...                   
T Consensus       170 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~-------------------  226 (266)
T cd06651         170 TGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT-------------------  226 (266)
T ss_pred             CccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCC-------------------
Confidence            567889999988654 478899999999999999999999976644333322211   000                   


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                             ...+...+++.+.+++ +||..+|.+||+++++++||||+
T Consensus       227 -------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 -------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             -------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                   0111223567788888 67778999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=1.2e-31  Score=217.66  Aligned_cols=179  Identities=27%  Similarity=0.421  Sum_probs=142.9

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      |++|.+++.+..  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccC
Confidence            579999998765  799999999999999999999999999999999999999999999999998876544333334566


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|++||.+.+.. ++.++|+||+|+++++|++|..||...........+.....                        
T Consensus       157 ~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------------  211 (277)
T cd05577         157 TPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL------------------------  211 (277)
T ss_pred             CCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc------------------------
Confidence            78899999986554 78899999999999999999999976543211111111000                        


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLHD  208 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~~  208 (249)
                         .......+..++.+.++|.+||+.||.+||     ++.+++.||||+++..
T Consensus       212 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         212 ---EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             ---cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence               001122335688899999999999999999     8999999999987663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=2.3e-31  Score=218.51  Aligned_cols=201  Identities=43%  Similarity=0.707  Sum_probs=152.5

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--cccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~   78 (249)
                      +++|.+++.+. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  ......
T Consensus        99 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  178 (302)
T cd07864          99 DHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV  178 (302)
T ss_pred             CccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccce
Confidence            56777888764 579999999999999999999999999999999999999999999999999887654332  112234


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|++||.+.+....+.++|+|||||++++|++|..||........+..+....+.+....+............+ ..
T Consensus       179 ~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  257 (302)
T cd07864         179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK-PK  257 (302)
T ss_pred             eccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccc-cc
Confidence            57789999988655557889999999999999999999999888888888888777665543322111100000000 00


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      .............++..+.+++.+||+.||.+|||+++++.||||
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         258 KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            011112223344578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-31  Score=227.15  Aligned_cols=166  Identities=31%  Similarity=0.508  Sum_probs=134.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee-ccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-NANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~-~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |+.|.+.+.+.+.+. ..+..|+++|+.|+.|||++|++|||+||+|||+ +..+.++|+|||..+.....  ....+-|
T Consensus       400 g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t  476 (612)
T KOG0603|consen  400 GGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALT  476 (612)
T ss_pred             ccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchh
Confidence            445555666555555 7888899999999999999999999999999999 68899999999998765544  4455668


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|.|||+... ..++.++|+||||+++|+|++|+.||.....-   ..+...++.+.-                     
T Consensus       477 ~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~---------------------  531 (612)
T KOG0603|consen  477 LQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF---------------------  531 (612)
T ss_pred             hcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc---------------------
Confidence            89999999974 45899999999999999999999999654322   222222222111                     


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                              ...+|..+++||++||+.||.+||++.+++.||||
T Consensus       532 --------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  532 --------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             --------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                    13689999999999999999999999999999999

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.8e-32  Score=224.56  Aligned_cols=179  Identities=27%  Similarity=0.532  Sum_probs=163.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |||+|-..|.+.++|++..++.++..+++|++|||++||++||+||+|.+++.+|-+||.|||+++....+....+++||
T Consensus       503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGT  582 (732)
T KOG0614|consen  503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGT  582 (732)
T ss_pred             cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCC
Confidence            79999999999999999999999999999999999999999999999999999999999999999999999888899999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|.|||++...+ ...++|.|+||++++||++|.+||.+.++...+..|.+.+..                        
T Consensus       583 pEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~------------------------  637 (732)
T KOG0614|consen  583 PEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK------------------------  637 (732)
T ss_pred             cccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh------------------------
Confidence            9999999998766 789999999999999999999999999999999998864422                        


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLHDE  209 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~~~  209 (249)
                           -+++..++....++|+++-..+|.+|..     +.++..|.||.++..+
T Consensus       638 -----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  638 -----IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             -----hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence                 1223357778899999999999999985     8999999999998743

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=215.85  Aligned_cols=174  Identities=30%  Similarity=0.526  Sum_probs=153.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccC-CCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~-~~~~~~~~~~~~~   80 (249)
                      ||+|+-.|...+.|++...+.+..+|+.||.|||+++||+||+|.+|.+++++|.+|+.|||+++. +..+...+..+||
T Consensus       252 GGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGT  331 (516)
T KOG0690|consen  252 GGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGT  331 (516)
T ss_pred             CceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCC
Confidence            788999999999999999999999999999999999999999999999999999999999999986 3445667889999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++. ...++.++|.|.+||++|||++|+.||...+.......|...-                          
T Consensus       332 PEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed--------------------------  384 (516)
T KOG0690|consen  332 PEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED--------------------------  384 (516)
T ss_pred             hhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh--------------------------
Confidence            9999999995 4459999999999999999999999999887666655554311                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                           ..++.+++++++.|+..+|.+||.+|.     .+.++.+|+||..+.
T Consensus       385 -----~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  385 -----LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             -----ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence                 123447899999999999999999997     588999999999887

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.98  E-value=1.7e-31  Score=215.32  Aligned_cols=173  Identities=28%  Similarity=0.456  Sum_probs=140.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-------Ccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-------EFM   74 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-------~~~   74 (249)
                      |++|.+++.+...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......       ...
T Consensus        86 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  165 (265)
T cd06631          86 GGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML  165 (265)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccc
Confidence            6799999998888999999999999999999999999999999999999999999999999988654211       112


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....++..|+|||.+.+. .++.++|+||||+++++|++|..||...+.......+....+                   
T Consensus       166 ~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------  225 (265)
T cd06631         166 KSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG-------------------  225 (265)
T ss_pred             cccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC-------------------
Confidence            234578889999988644 478899999999999999999999976654333222221100                   


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                               ....+...++.++.++|++||+.+|.+||++.++++||||
T Consensus       226 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         226 ---------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                     0112233577889999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.4e-31  Score=219.92  Aligned_cols=176  Identities=26%  Similarity=0.518  Sum_probs=141.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-------
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-------   72 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-------   72 (249)
                      |++|.+++.+.  ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+.......       
T Consensus        85 ~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (316)
T cd05574          85 GGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL  164 (316)
T ss_pred             CCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccccc
Confidence            67999999864  579999999999999999999999999999999999999999999999999876442211       


Q ss_pred             -----------------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 025683           73 -----------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL  129 (249)
Q Consensus        73 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~  129 (249)
                                             ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+.......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  243 (316)
T cd05574         165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSN  243 (316)
T ss_pred             ccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHH
Confidence                                   111235688899999986544 78899999999999999999999987765444433


Q ss_pred             HHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC----HHHHhcCccccC
Q 025683          130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT----VDEALAHPYLAR  205 (249)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~~ll~h~~~~~  205 (249)
                      +...   ...                    .      ......++++.++|.+||..||.+|||    +++++.||||++
T Consensus       244 ~~~~---~~~--------------------~------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         244 ILKK---EVT--------------------F------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             HhcC---Ccc--------------------C------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            3210   000                    0      001126788999999999999999999    999999999998


Q ss_pred             Cc
Q 025683          206 LH  207 (249)
Q Consensus       206 ~~  207 (249)
                      ..
T Consensus       295 ~~  296 (316)
T cd05574         295 VN  296 (316)
T ss_pred             CC
Confidence            65

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.6e-32  Score=209.73  Aligned_cols=206  Identities=47%  Similarity=0.830  Sum_probs=167.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC--Cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN--EFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~--~~~~~~~~   79 (249)
                      -.||..++-+-..|+.+.++-++.||+.||.|||+.||.||||||.|.+++.+..+|+||||+++.....  ......+-
T Consensus       140 QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVV  219 (449)
T KOG0664|consen  140 QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVV  219 (449)
T ss_pred             HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHH
Confidence            4577778887789999999999999999999999999999999999999999999999999999865433  33444566


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      |.+|+|||++++...++.+.||||.||++.|++..+..|...++.+++..|...+|.+..+...........-..+....
T Consensus       220 TQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k  299 (449)
T KOG0664|consen  220 TQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLR  299 (449)
T ss_pred             HHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCC
Confidence            89999999999999999999999999999999999999999999999999999999998776544333322222332222


Q ss_pred             C-CCcchhhcCC--CCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          160 H-PRQSLAQVFP--HVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       160 ~-~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      . .-..+..+..  .-..+...++.++|.+||.+|.+.++++.|++..+.+
T Consensus       300 ~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  300 APDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             CCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            2 2222333322  2334567899999999999999999999999988776

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.6e-31  Score=216.50  Aligned_cols=174  Identities=26%  Similarity=0.478  Sum_probs=141.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      |++|.+++... .+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus        83 ~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  161 (274)
T cd06609          83 GGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGT  161 (274)
T ss_pred             CCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCC
Confidence            57899999875 8999999999999999999999999999999999999999999999999998765543 223345678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+....  .                       
T Consensus       162 ~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~-----------------------  215 (274)
T cd06609         162 PFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--P-----------------------  215 (274)
T ss_pred             ccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--C-----------------------
Confidence            8899999986554 8899999999999999999999997665433322222110  0                       


Q ss_pred             CCcchhhcCCC-CChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPH-VHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                           ..+... ++.++.+++.+||..||.+|||++++++||||++..
T Consensus       216 -----~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         216 -----PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             -----CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                 011112 677899999999999999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.2e-32  Score=227.95  Aligned_cols=177  Identities=25%  Similarity=0.455  Sum_probs=145.0

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~   79 (249)
                      ||-+-.++-. ...|++.++.-+++|++.||+|||+++|+|||+|+.|||+..+|.++|.|||.+..... ......++|
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIG  192 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIG  192 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccC
Confidence            3444444433 46899999999999999999999999999999999999999999999999998765432 345567899


Q ss_pred             cccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           80 TRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        80 ~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      |++|||||+..+    ..+|..++||||||+++.+|..+.+|....++..++-+|.+.   .|+..              
T Consensus       193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePPTL--------------  255 (1187)
T KOG0579|consen  193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTL--------------  255 (1187)
T ss_pred             CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCCcc--------------
Confidence            999999999864    346889999999999999999999999988877777666541   11100              


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                                 -.+...+..|.+|+.+||.+||..||++.+|+.|||+++.
T Consensus       256 -----------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  256 -----------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             -----------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence                       0122456779999999999999999999999999999964

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.98  E-value=1.8e-31  Score=218.11  Aligned_cols=172  Identities=30%  Similarity=0.570  Sum_probs=144.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||.+......  .....+++
T Consensus        85 ~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~  162 (290)
T cd05580          85 GGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTP  162 (290)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCCCCCc
Confidence            7899999999899999999999999999999999999999999999999999999999999998765443  33456788


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|++||.+.+. ..+.++|+||||+++++|++|..||...........+..  +.                         
T Consensus       163 ~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~-------------------------  214 (290)
T cd05580         163 EYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GK-------------------------  214 (290)
T ss_pred             cccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CC-------------------------
Confidence            99999988654 478899999999999999999999987664433333321  00                         


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                          ..+...++..+.++|.+||..||.+|+     +++++++||||+.+.
T Consensus       215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence                011224578899999999999999999     999999999998876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.98  E-value=1.4e-31  Score=222.46  Aligned_cols=204  Identities=21%  Similarity=0.275  Sum_probs=139.3

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-------
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-------   72 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-------   72 (249)
                      +|+|.+++...  ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++++||+.........       
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  162 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH  162 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccc
Confidence            57899999763  569999999999999999999999999999999999999999999999997643321110       


Q ss_pred             -ccccccccccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc-ccccchhh
Q 025683           73 -FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD-LGFVRNED  149 (249)
Q Consensus        73 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  149 (249)
                       ......++..|+|||.+... ..++.++|+|||||++|+|++|..||..............  +..+... ......+.
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  240 (327)
T cd08227         163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchhhhh
Confidence             11123456779999998653 3478999999999999999999999976543332222211  1111000 00000000


Q ss_pred             HH----------HHHH------hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          150 AK----------RYIR------QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       150 ~~----------~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      ..          ....      ................+++++.+|+++||+.||.+|||++++++||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            00          0000      0000000011112334678899999999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.98  E-value=1.7e-31  Score=220.54  Aligned_cols=202  Identities=40%  Similarity=0.739  Sum_probs=144.7

Q ss_pred             CccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc----CCCeEEeecCCccCCCCCC
Q 025683            2 DTDLYQIIRSN-----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA----NCDLKICDFGLARPTSENE   72 (249)
Q Consensus         2 ~~~L~~~l~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~----~~~~kL~dfg~~~~~~~~~   72 (249)
                      +++|.+++...     ..+++..+..++.||+.||+|||+.+++|+||+|+||+++.    ++.++|+|||.+.......
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~  166 (316)
T cd07842          87 EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL  166 (316)
T ss_pred             CcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCc
Confidence            56777777532     36899999999999999999999999999999999999999    8999999999887654322


Q ss_pred             c----cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHHhCCCCc
Q 025683           73 F----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV---------HQMRLLIELLGTPTD  139 (249)
Q Consensus        73 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~  139 (249)
                      .    .....++..|+|||.+.+...++.++|+||||+++++|++|..||......         ..+..+...++.+..
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  246 (316)
T cd07842         167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTE  246 (316)
T ss_pred             ccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCch
Confidence            1    223456888999999876666789999999999999999999999755432         345555555554433


Q ss_pred             ccccccchh-hHHHHHHhCCCC--CCcc---hhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          140 ADLGFVRNE-DAKRYIRQLPQH--PRQS---LAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       140 ~~~~~~~~~-~~~~~~~~~~~~--~~~~---~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ..+...... ............  ....   ..+.....+..+.+++.+||+.||.+|||+.+++.||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         247 KDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             hHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            222111100 000000000000  0001   111112567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.98  E-value=3.6e-31  Score=212.18  Aligned_cols=171  Identities=30%  Similarity=0.463  Sum_probs=140.0

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~   78 (249)
                      |++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  162 (256)
T cd08529          83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV  162 (256)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccc
Confidence            68999999874  6799999999999999999999999999999999999999999999999998876544322 22346


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.... ++.++|+||||+++++|++|..||...+.......+....                        
T Consensus       163 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------------  217 (256)
T cd08529         163 GTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV------------------------  217 (256)
T ss_pred             cCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence            788899999886544 7889999999999999999999998776544443332100                        


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                            ...+...++.++.+++.+||+.+|++||++.++++|||+
T Consensus       218 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 ------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                  011122467889999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.98  E-value=3.2e-31  Score=212.56  Aligned_cols=173  Identities=29%  Similarity=0.542  Sum_probs=141.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+.+.+++..+..++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+.............++.
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  165 (258)
T cd06632          86 GGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSP  165 (258)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCc
Confidence            57999999988889999999999999999999999999999999999999999999999999887654433334456788


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|++||.+.....++.++|+||||+++|+|++|..||...........+...                            
T Consensus       166 ~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------------------------  217 (258)
T cd06632         166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS----------------------------  217 (258)
T ss_pred             ceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc----------------------------
Confidence            8999998854434788999999999999999999999766533322222110                            


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                       .....++..+++++.+++++||+.+|.+||++.+++.|||+
T Consensus       218 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         218 -KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence             00112233577889999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=2.1e-31  Score=223.66  Aligned_cols=170  Identities=26%  Similarity=0.371  Sum_probs=130.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccccccccccCchhccC
Q 025683           13 QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVTRWYRAPELLLN   91 (249)
Q Consensus        13 ~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~   91 (249)
                      ...++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++....... ......|+..|+|||.+..
T Consensus       163 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  242 (353)
T PLN00034        163 HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT  242 (353)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCcccccc
Confidence            346788889999999999999999999999999999999999999999999987654322 2234578999999998743


Q ss_pred             C----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhh
Q 025683           92 S----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ  167 (249)
Q Consensus        92 ~----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (249)
                      .    ...+.++|||||||++|+|++|..||...........+......                           ....
T Consensus       243 ~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------------------~~~~  295 (353)
T PLN00034        243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS---------------------------QPPE  295 (353)
T ss_pred             ccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc---------------------------CCCC
Confidence            2    23456899999999999999999999743221111111110000                           0011


Q ss_pred             cCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       168 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      ....++.++.+||.+||+.||.+|||+.++++||||.+-...
T Consensus       296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        296 APATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            223577889999999999999999999999999999986543

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=6.8e-31  Score=214.73  Aligned_cols=201  Identities=40%  Similarity=0.719  Sum_probs=144.1

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      ++++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+...... .......
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  164 (291)
T cd07870          85 MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEV  164 (291)
T ss_pred             ccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCcc
Confidence            356777777653 56889999999999999999999999999999999999999999999999988654332 1223345


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCcccccccchhhHHHHHH-h
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIR-Q  156 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  156 (249)
                      ++..|+|||.+.+...++.++|+||||+++|+|++|..||....+ ...+..+....+.+...........  ..+.. .
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  242 (291)
T cd07870         165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL--PNYKPEW  242 (291)
T ss_pred             ccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc--ccccchh
Confidence            688899999886655578899999999999999999999976543 3444444454554433222111100  00000 0


Q ss_pred             CCCCCCcchhhcCCC--CChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          157 LPQHPRQSLAQVFPH--VHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                      ...........++..  .+.++.+++.+||..||.+|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            001111112222221  35678999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=2.4e-31  Score=217.63  Aligned_cols=178  Identities=28%  Similarity=0.495  Sum_probs=141.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      |++|.+++.. +.+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++....... ......++
T Consensus       103 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  181 (292)
T cd06658         103 GGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGT  181 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecC
Confidence            5788888865 579999999999999999999999999999999999999999999999999886543221 22334678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+... .++.++|+||+|+++++|++|..||...........+........                      
T Consensus       182 ~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------  238 (292)
T cd06658         182 PYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV----------------------  238 (292)
T ss_pred             ccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc----------------------
Confidence            889999988544 478899999999999999999999987665444333222111000                      


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                            .....++..+.+++.+||..||.+|||++++++||||+.....
T Consensus       239 ------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         239 ------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             ------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence                  0111356788999999999999999999999999999975443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=2.2e-31  Score=216.68  Aligned_cols=173  Identities=24%  Similarity=0.478  Sum_probs=136.1

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      +|+|.+++...  ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... .......
T Consensus       103 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  182 (282)
T cd06636         103 AGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI  182 (282)
T ss_pred             CCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCccc
Confidence            46899999764  46899999999999999999999999999999999999999999999999988654322 2223456


Q ss_pred             ccccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           79 VTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        79 ~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ++..|+|||.+..    ...++.++|+|||||++|+|++|..||....+......+..   ...                
T Consensus       183 ~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~----------------  243 (282)
T cd06636         183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPP----------------  243 (282)
T ss_pred             ccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---CCC----------------
Confidence            7889999998753    23467789999999999999999999976543322221110   000                


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                              .  ......++.++.+||.+||+.||.+|||+.+++.||||
T Consensus       244 --------~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 --------P--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --------C--CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                    0  00112467889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=2.6e-31  Score=214.47  Aligned_cols=175  Identities=27%  Similarity=0.427  Sum_probs=136.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      |++|.+++...+.+++..+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus        90 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (267)
T cd06645          90 GGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGT  169 (267)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCc
Confidence            5799999998899999999999999999999999999999999999999999999999999988654332 122345678


Q ss_pred             ccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        81 ~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ..|+|||.+..  ...++.++|+|||||++|+|++|..||...............  ....                   
T Consensus       170 ~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~~~-------------------  228 (267)
T cd06645         170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQP-------------------  228 (267)
T ss_pred             ccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CCCC-------------------
Confidence            89999998742  234778999999999999999999998655432222111110  0000                   


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPY  202 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~  202 (249)
                          ... .-...++..+.++|.+||+.+|.+|||++++++|||
T Consensus       229 ----~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         229 ----PKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ----Ccc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                000 001135678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=1.7e-31  Score=215.17  Aligned_cols=177  Identities=27%  Similarity=0.437  Sum_probs=140.5

Q ss_pred             CccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-----
Q 025683            2 DTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----   73 (249)
Q Consensus         2 ~~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-----   73 (249)
                      |++|.+++.+.   ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........     
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~  162 (267)
T cd06610          83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV  162 (267)
T ss_pred             CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccc
Confidence            67999999874   4699999999999999999999999999999999999999999999999998865543321     


Q ss_pred             cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHH
Q 025683           74 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (249)
                      .....++..|++||.+.....++.++|+||||+++++|++|..||...............   .+..             
T Consensus       163 ~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~-------------  226 (267)
T cd06610         163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPS-------------  226 (267)
T ss_pred             cccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCC-------------
Confidence            123457888999999866545788999999999999999999999776544333332211   1000             


Q ss_pred             HHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                               .........+++++.+++.+||..||.+|||+.+++.||||
T Consensus       227 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         227 ---------LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ---------cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                     00000123577889999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=1.7e-31  Score=220.54  Aligned_cols=204  Identities=20%  Similarity=0.251  Sum_probs=140.6

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-------
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-------   72 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-------   72 (249)
                      +++|.+++.+.  ..+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++++||+.+.......       
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            57899999864  568999999999999999999999999999999999999999999999999876432211       


Q ss_pred             -ccccccccccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc-ccchh-
Q 025683           73 -FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG-FVRNE-  148 (249)
Q Consensus        73 -~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-  148 (249)
                       ......++..|+|||.+... ..++.++|+||+||++|+|++|..||...........  ...+..+..... ..... 
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccCccccccCchhhhc
Confidence             11233456789999998653 3478899999999999999999999987654332211  111111100000 00000 


Q ss_pred             -hHHHH--HHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          149 -DAKRY--IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       149 -~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                       .....  ..................++.++.+|+.+||..||.+|||++++++||||+.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence             00000  000000000000111223557789999999999999999999999999999876

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=3.1e-31  Score=216.72  Aligned_cols=175  Identities=26%  Similarity=0.418  Sum_probs=137.6

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~   76 (249)
                      |++|.+++..    ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus       108 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  187 (291)
T cd06639         108 GGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT  187 (291)
T ss_pred             CCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccC
Confidence            6799988863    4679999999999999999999999999999999999999999999999999887644322 1223


Q ss_pred             ccccccccCchhccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           77 YVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                      ..++..|+|||.+....    .++.++|+|||||++|+|++|..||...........+..   .....            
T Consensus       188 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~------------  252 (291)
T cd06639         188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPT------------  252 (291)
T ss_pred             ccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCC------------
Confidence            46788899999875332    257899999999999999999999987654433333211   00000            


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                                   .......+..+.++|.+||+.||.+||++.++++||||+
T Consensus       253 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 -------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             -------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                         001123557799999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=3.3e-31  Score=212.36  Aligned_cols=173  Identities=28%  Similarity=0.517  Sum_probs=137.7

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~   79 (249)
                      |++|.+++.. ...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  161 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIG  161 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccC
Confidence            5799999976 4678999999999999999999999999999999999999999999999999987654432 2233456


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+. .++.++|+||||+++++|++|..||...........+..   ...                     
T Consensus       162 ~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~---------------------  216 (256)
T cd06612         162 TPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPP---------------------  216 (256)
T ss_pred             CccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCC---------------------
Confidence            7889999988654 478899999999999999999999976543322211110   000                     


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                          ........++..+.+++.+||+.||.+|||+.+++.||||
T Consensus       217 ----~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         217 ----PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ----CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                0001122466789999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=2.9e-31  Score=217.55  Aligned_cols=176  Identities=26%  Similarity=0.492  Sum_probs=139.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~   80 (249)
                      |++|.+++.+ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus       101 ~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  179 (296)
T cd06654         101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  179 (296)
T ss_pred             CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCC
Confidence            6899999875 5689999999999999999999999999999999999999999999999998875433221 2234678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+.. .+.+.                      
T Consensus       180 ~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~----------------------  235 (296)
T cd06654         180 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE----------------------  235 (296)
T ss_pred             ccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCC----------------------
Confidence            889999988644 478899999999999999999999976654322221110 00000                      


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                           ......++..+.+++.+||..||.+|||+.++++|+||...+
T Consensus       236 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         236 -----LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             -----CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence                 011224677899999999999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=2.8e-31  Score=216.64  Aligned_cols=171  Identities=26%  Similarity=0.426  Sum_probs=132.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCchhcc
Q 025683           12 NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLL   90 (249)
Q Consensus        12 ~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~   90 (249)
                      ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+.............++..|+|||.+.
T Consensus       101 ~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  180 (288)
T cd06616         101 KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID  180 (288)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhc
Confidence            46799999999999999999999974 99999999999999999999999999986544333333446788899999986


Q ss_pred             CC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhc
Q 025683           91 NS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV  168 (249)
Q Consensus        91 ~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (249)
                      ..  ..++.++|+||+|+++|+|++|..||.....  ....+...........                       ....
T Consensus       181 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~-----------------------~~~~  235 (288)
T cd06616         181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL-----------------------SNSE  235 (288)
T ss_pred             cccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC-----------------------CCcC
Confidence            55  3578899999999999999999999975541  1111211111110000                       0011


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       169 ~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      ...++.++.+|+.+||+.||.+|||+++++.||||+...
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            124778899999999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=6.8e-31  Score=216.25  Aligned_cols=178  Identities=25%  Similarity=0.387  Sum_probs=141.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---------   72 (249)
                      |++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|.||+++.++.++|+|||.++......         
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (305)
T cd05609          85 GGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI  164 (305)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccccccc
Confidence            67999999988899999999999999999999999999999999999999999999999999876321100         


Q ss_pred             -------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           73 -------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        73 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                             ......++..|+|||.+... .++.++|+||||+++|++++|..||.+.........+.......+       
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------  236 (305)
T cd05609         165 EKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-------  236 (305)
T ss_pred             ccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-------
Confidence                   00123457789999988654 478999999999999999999999987665444443322110000       


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCcC
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT---VDEALAHPYLARLHD  208 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~~ll~h~~~~~~~~  208 (249)
                                           .....++.++.++|.+||+.||.+||+   +.++++||||.....
T Consensus       237 ---------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         237 ---------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             ---------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence                                 011146788999999999999999998   799999999987653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=7.1e-31  Score=214.76  Aligned_cols=180  Identities=23%  Similarity=0.433  Sum_probs=139.7

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Cccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~   79 (249)
                      |++|..++.+ ...+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus        93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  172 (292)
T cd06644          93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIG  172 (292)
T ss_pred             CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecC
Confidence            5788887765 467999999999999999999999999999999999999999999999999987653322 22233456


Q ss_pred             cccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           80 TRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        80 ~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      +..|+|||.+..    ...++.++|+|||||++|+|++|..||...+.......+..   ....                
T Consensus       173 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~----------------  233 (292)
T cd06644         173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPP----------------  233 (292)
T ss_pred             CccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCc----------------
Confidence            788999998752    23367789999999999999999999976654333222211   1000                


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                               .......++.++.++|.+||+.||.+||+++++++||||+.+...
T Consensus       234 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         234 ---------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             ---------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                     001122466789999999999999999999999999999876543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=2.5e-31  Score=214.25  Aligned_cols=176  Identities=30%  Similarity=0.542  Sum_probs=138.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      |++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+........ ....+
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~  161 (265)
T cd06605          83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-KTFVG  161 (265)
T ss_pred             CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-hcccC
Confidence            47999999876 789999999999999999999999 9999999999999999999999999998865433221 12567


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH--VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +..|+|||.+.+. .++.++|+||||+++++|++|..||.....  ......+........                   
T Consensus       162 ~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------  221 (265)
T cd06605         162 TSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------------------  221 (265)
T ss_pred             ChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-------------------
Confidence            7889999998655 588999999999999999999999865421  111111111111100                   


Q ss_pred             CCCCCcchhhcCCC-CChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          158 PQHPRQSLAQVFPH-VHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       158 ~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                              ...... ++.++.++|.+||..||.+|||+.+++.||||+++
T Consensus       222 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         222 --------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             --------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                    001111 67889999999999999999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=8.8e-31  Score=213.51  Aligned_cols=180  Identities=27%  Similarity=0.475  Sum_probs=141.6

Q ss_pred             CccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccc
Q 025683            2 DTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~   77 (249)
                      |++|..++.+.   ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~  161 (286)
T cd06622          83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-AKTN  161 (286)
T ss_pred             CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-cccC
Confidence            67898888773   479999999999999999999996 599999999999999999999999999886543322 2334


Q ss_pred             cccccccCchhccCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           78 VVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                      .++..|+|||.+....     .++.++|+|||||++|+|++|..||...........+.......+              
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  227 (286)
T cd06622         162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP--------------  227 (286)
T ss_pred             CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC--------------
Confidence            6778899999875432     247799999999999999999999976543333322222111110              


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                                   ..+++.+++++.+||.+||..+|.+||++++++.||||......
T Consensus       228 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         228 -------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             -------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                         12233577889999999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=4.5e-31  Score=212.34  Aligned_cols=175  Identities=32%  Similarity=0.570  Sum_probs=141.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---------   72 (249)
                      |++|.+++.+.+.+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.......         
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          77 GGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            67999999988899999999999999999999999999999999999999999999999999886543321         


Q ss_pred             ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        73 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                      ......++..|++||...... .+.++|+||||++++++++|..||...........+..  +...              
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~--------------  219 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIE--------------  219 (265)
T ss_pred             cccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcC--------------
Confidence            122345677899999886554 78899999999999999999999987765444433322  0000              


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH---HHHhcCccccCC
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV---DEALAHPYLARL  206 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~---~~ll~h~~~~~~  206 (249)
                             .     .. ...++..+.+++++||+.+|.+|||+   .++++||||++.
T Consensus       220 -------~-----~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         220 -------W-----PE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             -------C-----Cc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence                   0     00 00247889999999999999999999   999999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA02988 hypothetical protein; Provisional

Probab=99.97  E-value=5.2e-31  Score=214.76  Aligned_cols=167  Identities=20%  Similarity=0.225  Sum_probs=136.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+||+++.++.+||+|||.+.......  ....++
T Consensus       106 ~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~  183 (283)
T PHA02988        106 RGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNVNF  183 (283)
T ss_pred             CCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccccCc
Confidence            68999999998899999999999999999999998 499999999999999999999999999987543322  234678


Q ss_pred             ccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           81 RWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        81 ~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      ..|+|||.+.+. ..++.++|||||||++|+|++|..||...+.......+......+                      
T Consensus       184 ~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------  241 (283)
T PHA02988        184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL----------------------  241 (283)
T ss_pred             ccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC----------------------
Confidence            889999998642 458899999999999999999999998776554444433211110                      


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                             ......++.+.+|+.+||+.||.+|||+.++++
T Consensus       242 -------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 -------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                   011245778999999999999999999999986

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=6.3e-31  Score=219.44  Aligned_cols=156  Identities=28%  Similarity=0.449  Sum_probs=120.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccccccccccCchhcc
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYVVTRWYRAPELLL   90 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~   90 (249)
                      ++++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++........   .....++..|+|||.+.
T Consensus       170 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  249 (338)
T cd05102         170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF  249 (338)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhh
Confidence            488899999999999999999999999999999999999999999999999875432211   11234467899999886


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcC
Q 025683           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (249)
Q Consensus        91 ~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (249)
                      .. .++.++|||||||++|+|++ |..||.+............. +.                            .....
T Consensus       250 ~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~----------------------------~~~~~  299 (338)
T cd05102         250 DK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GT----------------------------RMRAP  299 (338)
T ss_pred             cC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CC----------------------------CCCCC
Confidence            54 47899999999999999997 99999765432222111110 00                            00112


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          170 PHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       170 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ...++++.+++.+||+.||.+|||+.++++
T Consensus       300 ~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         300 ENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            346788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=1.9e-31  Score=221.95  Aligned_cols=180  Identities=22%  Similarity=0.424  Sum_probs=142.3

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc--cccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~   78 (249)
                      ||+|.+++.+ ...+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.........  ....
T Consensus        85 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  164 (331)
T cd05624          85 GGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV  164 (331)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeecccc
Confidence            7899999987 478999999999999999999999999999999999999999999999999998765433221  2346


Q ss_pred             ccccccCchhccCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           79 VTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        79 ~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      |++.|+|||.+...    ..++.++|+||+||++|+|++|..||...+.......+.....                   
T Consensus       165 gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------------  225 (331)
T cd05624         165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-------------------  225 (331)
T ss_pred             CCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC-------------------
Confidence            89999999988542    3467899999999999999999999987765544444332110                   


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITVDEALAHPYLARLH  207 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~h~~~~~~~  207 (249)
                             +..+......+++++.+++.+||..++.+  |++++++++|+||+...
T Consensus       226 -------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         226 -------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             -------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence                   00111112346788999999999876654  56899999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=6.7e-31  Score=210.59  Aligned_cols=171  Identities=28%  Similarity=0.446  Sum_probs=138.8

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.+++.+.  ..+++..+..++.|++.+|+|||++|++|+||+|+||+++.++ .++|+|||.+.............
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  162 (256)
T cd08220          83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV  162 (256)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccc
Confidence            67999999874  4589999999999999999999999999999999999998654 57999999987665544334456


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+... ..+.++|+||+|+++++|++|..||...+.......+....                        
T Consensus       163 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~------------------------  217 (256)
T cd08220         163 GTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT------------------------  217 (256)
T ss_pred             cCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC------------------------
Confidence            78889999988644 47889999999999999999999997765443333332100                        


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                            ...+...+++++.+++.+||+.+|.+|||+.++++||||
T Consensus       218 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         218 ------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                  011223467889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=9.8e-31  Score=211.68  Aligned_cols=177  Identities=29%  Similarity=0.541  Sum_probs=139.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---cccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---~~~~~~   78 (249)
                      |++|.+++.+.+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.......   ......
T Consensus        92 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  171 (272)
T cd06629          92 GGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ  171 (272)
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccccccccccccc
Confidence            78999999998899999999999999999999999999999999999999999999999999987543221   122345


Q ss_pred             ccccccCchhccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+.... .++.++|+||||++++++++|..||...........+......                     
T Consensus       172 ~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  230 (272)
T cd06629         172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA---------------------  230 (272)
T ss_pred             CCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC---------------------
Confidence            678899999986543 4688999999999999999999999655433222221110000                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                          ..........++.++.+++.+||..||.+|||++++++||||
T Consensus       231 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         231 ----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                000011223467889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=6.9e-31  Score=211.34  Aligned_cols=175  Identities=29%  Similarity=0.518  Sum_probs=142.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc-ccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-TEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~-~~~~~   79 (249)
                      |++|.+++.+...+++..+..++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||.+......... ....+
T Consensus        83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  162 (264)
T cd06623          83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVG  162 (264)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceee
Confidence            58999999988899999999999999999999999 99999999999999999999999999988765443322 23456


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      +..|+|||.+... .++.++|+||||+++|+|++|..||.....   ......+.   ....                  
T Consensus       163 ~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~------------------  220 (264)
T cd06623         163 TVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DGPP------------------  220 (264)
T ss_pred             cccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cCCC------------------
Confidence            7889999988654 578899999999999999999999976642   11111111   0000                  


Q ss_pred             CCCCCCcchhhcCCC-CChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          157 LPQHPRQSLAQVFPH-VHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                               ...... ++..+.++|.+||+.+|.+|||+.++++||||+...
T Consensus       221 ---------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 ---------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                     111223 678899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=8e-31  Score=211.49  Aligned_cols=172  Identities=26%  Similarity=0.509  Sum_probs=137.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC----Cccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----EFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~----~~~~~~   77 (249)
                      |++|.+++.+.+.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+......    ......
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  169 (265)
T cd06652          90 GGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV  169 (265)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccC
Confidence            6799999998888999999999999999999999999999999999999999999999999988754321    112234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.   ..+..                  
T Consensus       170 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~------------------  227 (265)
T cd06652         170 TGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTN------------------  227 (265)
T ss_pred             CCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCC------------------
Confidence            578889999998654 47889999999999999999999997654333322221   11100                  


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                              ...+..++..+.+++.+|+. +|.+||+++++++|||+.
T Consensus       228 --------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         228 --------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             --------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                    11223466778899999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.8e-31  Score=213.17  Aligned_cols=177  Identities=27%  Similarity=0.453  Sum_probs=140.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Cccccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~   79 (249)
                      |++|.+++.+. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus        86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  165 (280)
T cd06611          86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIG  165 (280)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeec
Confidence            57899998774 57999999999999999999999999999999999999999999999999987654332 22233567


Q ss_pred             cccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           80 TRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        80 ~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      +..|++||.+..    ...++.++|+||||+++|+|++|..||...+.......+..   ....                
T Consensus       166 ~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~----------------  226 (280)
T cd06611         166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK---SEPP----------------  226 (280)
T ss_pred             chhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc---CCCC----------------
Confidence            888999998742    23367799999999999999999999977654433322211   1000                


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                               .......++.++.++|.+||+.||.+||+++++++|+||.+.
T Consensus       227 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         227 ---------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             ---------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence                     001122467789999999999999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=7.4e-31  Score=211.79  Aligned_cols=176  Identities=30%  Similarity=0.549  Sum_probs=138.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCCCC-----ccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE-----FMT   75 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~~-----~~~   75 (249)
                      |++|.+++.+.+++++..+..++.||+.||+|||++|++|+||+|+||+++.++ .++|+|||.+.......     ...
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  166 (268)
T cd06630          87 GGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG  166 (268)
T ss_pred             CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccc
Confidence            679999999888999999999999999999999999999999999999998776 58999999987654321     112


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...++..|+|||.+.+. .++.++|+||+|++++++++|..||...........+.......                  
T Consensus       167 ~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------  227 (268)
T cd06630         167 QLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT------------------  227 (268)
T ss_pred             ccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC------------------
Confidence            34567889999998644 47889999999999999999999996544322222221111000                  


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                              ........+++++.+++.+||..+|.+||++.++++||||+
T Consensus       228 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         228 --------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             --------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                    00122335678899999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=7.8e-31  Score=213.37  Aligned_cols=178  Identities=30%  Similarity=0.475  Sum_probs=137.8

Q ss_pred             CCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc
Q 025683            1 MDTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT   75 (249)
Q Consensus         1 ~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~   75 (249)
                      |+++|.+++..    +..+++..+..++.||+.||+|||++ +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (283)
T cd06617          82 MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT  161 (283)
T ss_pred             hcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            35678777764    35799999999999999999999997 99999999999999999999999999987654333233


Q ss_pred             cccccccccCchhccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           76 EYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      ...++..|+|||.+.+.   ..++.++|+|||||++|+|++|..||.... ..........   ....            
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~------------  226 (283)
T cd06617         162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE---EPSP------------  226 (283)
T ss_pred             cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh---cCCC------------
Confidence            35678889999988542   235789999999999999999999986432 2222222111   0000            


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                             .       -....++.++.++|.+||..+|.+||++.++++||||++..
T Consensus       227 -------~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         227 -------Q-------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             -------C-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                   0       00113678899999999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=1.6e-30  Score=209.12  Aligned_cols=171  Identities=33%  Similarity=0.534  Sum_probs=139.5

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHh-----hCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIH-----SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH-----~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~   72 (249)
                      |++|.+++.+    ...+++..+..++.||+.||+|||     +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        85 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  164 (265)
T cd08217          85 GGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS  164 (265)
T ss_pred             CCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCc
Confidence            5789999876    368999999999999999999999     8999999999999999999999999999987665443


Q ss_pred             c-cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           73 F-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        73 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      . .....++..|++||.+.... .+.++|+||||+++++|++|..||...+.......+...                  
T Consensus       165 ~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------  225 (265)
T cd08217         165 SFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG------------------  225 (265)
T ss_pred             ccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC------------------
Confidence            2 33456788999999986544 788999999999999999999999876533322222110                  


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                                  ....+....+.++.+++.+||+.+|.+||++.++++|||+
T Consensus       226 ------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 ------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                        0111223567889999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.1e-31  Score=212.38  Aligned_cols=174  Identities=27%  Similarity=0.491  Sum_probs=136.1

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~   76 (249)
                      |++|.+++..    +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~  172 (275)
T cd06608          93 GGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT  172 (275)
T ss_pred             CCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcC
Confidence            4688888865    358999999999999999999999999999999999999999999999999988654332 22234


Q ss_pred             ccccccccCchhccCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           77 YVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                      ..++..|+|||.+...    ..++.++|+||||+++++|++|..||...........+..   .....            
T Consensus       173 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~------------  237 (275)
T cd06608         173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPT------------  237 (275)
T ss_pred             ccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCC------------
Confidence            5678889999987532    3367789999999999999999999976544333332221   00000            


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                                   .......+.++.++|.+||..||.+|||+.++++|||+
T Consensus       238 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 -------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                         00011356789999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=5.8e-31  Score=215.89  Aligned_cols=180  Identities=26%  Similarity=0.480  Sum_probs=141.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~   80 (249)
                      |++|.+++.+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  178 (297)
T cd06656         100 GGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  178 (297)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCC
Confidence            6789999876 5689999999999999999999999999999999999999999999999998865443322 2234678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|++||.+.+. .++.++|+|||||++|++++|..||...+.......+.. .+.+                       
T Consensus       179 ~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~-----------------------  233 (297)
T cd06656         179 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-----------------------  233 (297)
T ss_pred             ccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC-----------------------
Confidence            889999988654 478999999999999999999999976543221111100 0000                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                          .......++..+.+++.+||..||.+||+++++++||||+..+....
T Consensus       234 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         234 ----ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence                00112246778899999999999999999999999999998765444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9e-31  Score=218.27  Aligned_cols=178  Identities=30%  Similarity=0.483  Sum_probs=134.2

Q ss_pred             CccHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccc
Q 025683            2 DTDLYQIIRSNQSL-SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l-~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~   77 (249)
                      +.||..+|.+.... +.-.++.+..|++.|+.+.|++||||.||||.|+++- .|.+||+|||.+..+.....   ....
T Consensus       443 d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQ  521 (677)
T KOG0596|consen  443 DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQ  521 (677)
T ss_pred             cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccc
Confidence            35899999987543 3358999999999999999999999999999999875 47999999999987765432   3457


Q ss_pred             cccccccCchhccCCC----------CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           78 VVTRWYRAPELLLNSS----------DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~----------~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                      +||..||+||++....          +.+.++|||||||++|+|+.|..||.....  .++++........         
T Consensus       522 vGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI~~P~~---------  590 (677)
T KOG0596|consen  522 VGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAITDPNH---------  590 (677)
T ss_pred             cCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhhcCCCc---------
Confidence            9999999999985321          257799999999999999999999954321  1222221111100         


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                    ...+.++.+  ..++.++++.||.+||.+|||+.+||+|||.+-+.
T Consensus       591 --------------~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  591 --------------EIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             --------------cccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence                          001111111  12388999999999999999999999999999643

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-32  Score=227.19  Aligned_cols=168  Identities=22%  Similarity=0.397  Sum_probs=142.1

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW   82 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~   82 (249)
                      |.|..+|+....++.+....|..+|+.|++|||.+.|+|||||.-||||..+..+|++|||.++......+...++||..
T Consensus       197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVa  276 (904)
T KOG4721|consen  197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVA  276 (904)
T ss_pred             ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHh
Confidence            68999999999999999999999999999999999999999999999999999999999999988777777778999999


Q ss_pred             ccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCC
Q 025683           83 YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR  162 (249)
Q Consensus        83 y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (249)
                      |||||++...+ .+.++|||||||++|||++|..||...+...   .|..+ |..                         
T Consensus       277 WMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssA---IIwGV-GsN-------------------------  326 (904)
T KOG4721|consen  277 WMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---IIWGV-GSN-------------------------  326 (904)
T ss_pred             hhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchhe---eEEec-cCC-------------------------
Confidence            99999997654 8999999999999999999999997664221   11110 000                         


Q ss_pred             cchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          163 QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      -.-.-.+...++.|.-||+.||+-+|..||++.+++.|
T Consensus       327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            00011233567789999999999999999999999997

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-30  Score=209.47  Aligned_cols=175  Identities=28%  Similarity=0.476  Sum_probs=138.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~   79 (249)
                      |++|.+++.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  163 (262)
T cd06613          84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIG  163 (262)
T ss_pred             CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccC
Confidence            57899999886 789999999999999999999999999999999999999999999999999887654322 2233567


Q ss_pred             cccccCchhccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           80 TRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        80 ~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +..|++||.+...  +.++.++|+||||+++++|++|..||...+.......+... ...+..                 
T Consensus       164 ~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~-~~~~~~-----------------  225 (262)
T cd06613         164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS-NFPPPK-----------------  225 (262)
T ss_pred             CccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCcc-----------------
Confidence            8889999988544  24778999999999999999999999876644433322210 000000                 


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPY  202 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~  202 (249)
                              .......+.++.+++++||..+|.+|||+.+++.|+|
T Consensus       226 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         226 --------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             --------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                    0011134577899999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=9.1e-31  Score=210.28  Aligned_cols=173  Identities=28%  Similarity=0.487  Sum_probs=141.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.............++.
T Consensus        84 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  163 (258)
T cd05578          84 GGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTP  163 (258)
T ss_pred             CCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCCh
Confidence            78999999988899999999999999999999999999999999999999999999999999987665443334456788


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.... ++.++|+||||+++|+|++|..||...... ....+......                         
T Consensus       164 ~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-------------------------  216 (258)
T cd05578         164 GYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET-------------------------  216 (258)
T ss_pred             hhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc-------------------------
Confidence            899999986544 789999999999999999999999866532 11111111110                         


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH--HHHhcCccc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV--DEALAHPYL  203 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~--~~ll~h~~~  203 (249)
                        .....+..++.++.++|.+||..||.+||++  .++++||||
T Consensus       217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 --ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             --ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence              0011233467889999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=1.5e-30  Score=213.45  Aligned_cols=177  Identities=30%  Similarity=0.545  Sum_probs=141.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      |++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus       102 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  180 (297)
T cd06659         102 GGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT  180 (297)
T ss_pred             CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecC
Confidence            5788887765 679999999999999999999999999999999999999999999999999886543322 12335678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+.. ++.++|+||||+++++|++|..||...........+..   ....                     
T Consensus       181 ~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------------------  235 (297)
T cd06659         181 PYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPPP---------------------  235 (297)
T ss_pred             ccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCCC---------------------
Confidence            8999999986544 78899999999999999999999987665444333221   0000                     


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                          .......++..+.++|.+||+.+|.+||+++++++|+||.+...
T Consensus       236 ----~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         236 ----KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             ----CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence                00112246778999999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.7e-31  Score=224.32  Aligned_cols=172  Identities=23%  Similarity=0.401  Sum_probs=143.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeeccC-CCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      +|+|+.|+++.++++.+.+++|++||+.||.|||++.  |+|||||=+||+|+.+ |.+|++|+|++.....+. ....+
T Consensus       127 SGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-aksvI  205 (632)
T KOG0584|consen  127 SGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-AKSVI  205 (632)
T ss_pred             CCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-cceec
Confidence            6899999999999999999999999999999999985  9999999999999875 899999999997665443 34589


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      |||.|||||.+.  ..|...+||||||+.++||+|+..||..-. +.+.++++...  ..|. ..               
T Consensus       206 GTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG--iKP~-sl---------------  265 (632)
T KOG0584|consen  206 GTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG--IKPA-AL---------------  265 (632)
T ss_pred             cCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC--CCHH-Hh---------------
Confidence            999999999996  458999999999999999999999997644 44555554431  1111 11               


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                                 ..--.+++++||.+||.. ...|+|+.|||.|+||..=
T Consensus       266 -----------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  266 -----------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -----------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                       111247899999999999 9999999999999999973

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-30  Score=211.53  Aligned_cols=174  Identities=25%  Similarity=0.497  Sum_probs=139.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      |++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus        86 ~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (277)
T cd06917          86 GGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGT  164 (277)
T ss_pred             CCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCC
Confidence            6799999876 589999999999999999999999999999999999999999999999999887654432 22334678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.....++.++|+||||+++|+|++|..||...........+..   ..+                      
T Consensus       165 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~----------------------  219 (277)
T cd06917         165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---SKP----------------------  219 (277)
T ss_pred             cceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---CCC----------------------
Confidence            8899999886555578899999999999999999999976543222111100   000                      


Q ss_pred             CCcchhhcCC-CCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          161 PRQSLAQVFP-HVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       161 ~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                           ..+.. ..+.++.+++.+||+.||.+||++.+++.|+||++.
T Consensus       220 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         220 -----PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             -----CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence                 00111 266789999999999999999999999999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=8.4e-31  Score=211.50  Aligned_cols=175  Identities=27%  Similarity=0.402  Sum_probs=135.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      +++|.+++.+.+.+++..+..++.|++.||+|||+.|++|+|++|.||+++.++.++|+|||.+....... ......++
T Consensus        90 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (267)
T cd06646          90 GGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGT  169 (267)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccC
Confidence            57999999888899999999999999999999999999999999999999999999999999987653322 12335678


Q ss_pred             ccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        81 ~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ..|+|||.+..  ...++.++|+||+||++++|++|..||....+......+.....                       
T Consensus       170 ~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----------------------  226 (267)
T cd06646         170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF-----------------------  226 (267)
T ss_pred             ccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC-----------------------
Confidence            88999998742  23467899999999999999999999865442221111100000                       


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPY  202 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~  202 (249)
                         ..........++..+.+++++||+.||.+|||++++++|+|
T Consensus       227 ---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         227 ---QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ---CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence               00000011246788999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1.3e-30  Score=236.34  Aligned_cols=178  Identities=27%  Similarity=0.411  Sum_probs=140.7

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhC-------CcccCCCCCCCeeecc-----------------
Q 025683            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSA-------NVIHRDLKPSNLLLNA-----------------   53 (249)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~-------~i~H~dik~~nil~~~-----------------   53 (249)
                      +++|.++|.+.    +.+++..++.|+.||+.||.|||+.       +|+|+||||+|||++.                 
T Consensus        98 gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng  177 (1021)
T PTZ00266         98 AGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG  177 (1021)
T ss_pred             CCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCC
Confidence            57999999763    5799999999999999999999984       4999999999999964                 


Q ss_pred             CCCeEEeecCCccCCCCCCccccccccccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 025683           54 NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIE  132 (249)
Q Consensus        54 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~  132 (249)
                      .+.++|+|||++.............+++.|+|||++... ..++.++|||||||++|+|++|..||........+.....
T Consensus       178 ~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk  257 (1021)
T PTZ00266        178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK  257 (1021)
T ss_pred             CCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHh
Confidence            234899999998766544434456789999999998643 3478899999999999999999999976654433322221


Q ss_pred             HhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          133 LLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      .   .+.                           ......+.++.+||..||..+|.+||++.++|.|+|++.....
T Consensus       258 ~---~p~---------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        258 R---GPD---------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             c---CCC---------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            1   000                           0011356889999999999999999999999999999877543

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=3.3e-30  Score=207.44  Aligned_cols=175  Identities=31%  Similarity=0.532  Sum_probs=137.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-----ccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-----~~~   76 (249)
                      |++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........     ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~  162 (264)
T cd06626          83 GGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS  162 (264)
T ss_pred             CCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccC
Confidence            589999999888899999999999999999999999999999999999999999999999998876543322     112


Q ss_pred             ccccccccCchhccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           77 YVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ..++..|+|||.+....  ....++|+||||++++++++|..||............... +..+.               
T Consensus       163 ~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~---------------  226 (264)
T cd06626         163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP---------------  226 (264)
T ss_pred             CcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC---------------
Confidence            45677899999986443  3678999999999999999999999765432222111110 10000               


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                                 ......+++.+.++|.+||+.+|.+|||+.+++.|||+
T Consensus       227 -----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         227 -----------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -----------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                       00011347788999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=1.4e-30  Score=213.52  Aligned_cols=182  Identities=26%  Similarity=0.424  Sum_probs=138.6

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      +++|.+++.. ...+++..+..++.||+.||+|||+ .|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus        97 ~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  176 (296)
T cd06618          97 STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAG  176 (296)
T ss_pred             CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCC
Confidence            4566677665 4679999999999999999999997 5999999999999999999999999999876544333333456


Q ss_pred             cccccCchhccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           80 TRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        80 ~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      +..|+|||.+...   +.++.++|+||||+++|+|++|..||..... ...+..+..   .....               
T Consensus       177 ~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~---------------  238 (296)
T cd06618         177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEPPS---------------  238 (296)
T ss_pred             CccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---CCCCC---------------
Confidence            7789999998543   2367899999999999999999999965432 122222111   10000               


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                                ......++.++.+|+.+||+.||.+||++++++.|+||..+.....
T Consensus       239 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  284 (296)
T cd06618         239 ----------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV  284 (296)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence                      0001135678999999999999999999999999999997654433

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=2.2e-30  Score=210.73  Aligned_cols=168  Identities=21%  Similarity=0.354  Sum_probs=134.8

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      |++|.+++...                ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~  171 (283)
T cd05048          92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS  171 (283)
T ss_pred             CCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcce
Confidence            57999999765                45889999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      .......   ......++..|+|||.+... .++.++|+|||||++|+|++ |..||.+.........+....       
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~-------  243 (283)
T cd05048         172 RDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ-------  243 (283)
T ss_pred             eeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            7543322   12234557789999988654 47899999999999999997 999998766544433332100       


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                             .......+++++.+|+.+||+.||.+||++.+++++
T Consensus       244 -----------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         244 -----------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             -----------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                   011223578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=9.4e-31  Score=207.90  Aligned_cols=164  Identities=24%  Similarity=0.423  Sum_probs=132.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.+++.+...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++|||.+......  .....++.
T Consensus        69 ~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~  146 (237)
T cd05576          69 GGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVEN  146 (237)
T ss_pred             CCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCc
Confidence            6899999988888999999999999999999999999999999999999999999999999977554332  22334566


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||..... ..+.++|+||+|+++++|++|..|+......     +            .                  
T Consensus       147 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~------------------  190 (237)
T cd05576         147 MYCAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------N------------------  190 (237)
T ss_pred             cccCCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------c------------------
Confidence            79999987543 4688999999999999999999776432100     0            0                  


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH-----HHHhcCccc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV-----DEALAHPYL  203 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~~ll~h~~~  203 (249)
                      ......++..+++.+.++|.+||+.||.+|+++     +++++||||
T Consensus       191 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         191 THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            000011233577889999999999999999985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=2.4e-30  Score=209.94  Aligned_cols=170  Identities=35%  Similarity=0.666  Sum_probs=141.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---------   72 (249)
                      |++|.+++.+.+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......         
T Consensus        86 ~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  165 (280)
T cd05581          86 NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA  165 (280)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCC
Confidence            78999999998899999999999999999999999999999999999999999999999999887544322         


Q ss_pred             ------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 025683           73 ------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDA  140 (249)
Q Consensus        73 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  140 (249)
                                  ......++..|++||..... ..+.++|+||||++++++++|..||...........+....      
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------  238 (280)
T cd05581         166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE------  238 (280)
T ss_pred             ccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC------
Confidence                        11223567889999988654 47889999999999999999999998776544444333110      


Q ss_pred             cccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH----HHHhcCccc
Q 025683          141 DLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV----DEALAHPYL  203 (249)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~~ll~h~~~  203 (249)
                                               ......+++.+.+++.+||+.||.+||++    +++++||||
T Consensus       239 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         239 -------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence                                     11222457889999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=4e-30  Score=205.35  Aligned_cols=170  Identities=32%  Similarity=0.605  Sum_probs=141.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      |++|.+++.+...+++..+..++.|++.|+.|||+.+++|+||+|.||+++.++.++|+|||.+...... .......++
T Consensus        77 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          77 GGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCC
Confidence            7899999999888999999999999999999999999999999999999999999999999988765443 223345668


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|++||...+.. .+.++|+|+||+++|++++|..||...+.......+..  ..                        
T Consensus       157 ~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~------------------------  209 (250)
T cd05123         157 PEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DP------------------------  209 (250)
T ss_pred             ccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CC------------------------
Confidence            8899999886543 78899999999999999999999977765333333321  00                        


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH---HHHhcCccc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV---DEALAHPYL  203 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~---~~ll~h~~~  203 (249)
                           ..+...++..+.+++++||..||.+||++   +++++||||
T Consensus       210 -----~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         210 -----LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                 11222457889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=4.3e-30  Score=206.08  Aligned_cols=171  Identities=31%  Similarity=0.563  Sum_probs=140.2

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~   78 (249)
                      |++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (256)
T cd08221          83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV  162 (256)
T ss_pred             CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccC
Confidence            67999999875  569999999999999999999999999999999999999999999999999887554332 233456


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.+.. ++.++|+||||+++++|++|..||...........+..  +...                    
T Consensus       163 ~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~--------------------  219 (256)
T cd08221         163 GTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYT--------------------  219 (256)
T ss_pred             CCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCC--------------------
Confidence            788999999886543 77899999999999999999999987665544444331  1100                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                              .....++.++.+++.+||..+|.+||++.++++|+|+
T Consensus       220 --------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 --------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             --------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                    1112467889999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=2.5e-30  Score=211.28  Aligned_cols=180  Identities=24%  Similarity=0.438  Sum_probs=141.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~   79 (249)
                      |++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  ......+
T Consensus        89 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  168 (290)
T cd05613          89 GGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG  168 (290)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccC
Confidence            67999999988899999999999999999999999999999999999999999999999999887654322  1223457


Q ss_pred             cccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +..|++||.+... ...+.++|+||||+++|+|++|..||...........+........                    
T Consensus       169 ~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------  228 (290)
T cd05613         169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--------------------  228 (290)
T ss_pred             CcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--------------------
Confidence            8889999988643 2367889999999999999999999864432222222221110000                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCcC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLHD  208 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~~  208 (249)
                             ......+++.+.+++.+||+.||.+||     ++++++.||||++...
T Consensus       229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence                   011224677899999999999999997     8999999999998863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=1.6e-30  Score=211.11  Aligned_cols=174  Identities=28%  Similarity=0.468  Sum_probs=138.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~   80 (249)
                      |++|.+++.+ +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus        86 ~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (277)
T cd06642          86 GGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT  164 (277)
T ss_pred             CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCc
Confidence            5789998875 6799999999999999999999999999999999999999999999999999876543321 2234567


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++|+||||+++++|++|..||...........+...                           
T Consensus       165 ~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------------------  216 (277)
T cd06642         165 PFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---------------------------  216 (277)
T ss_pred             ccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------------------
Confidence            889999998654 4788999999999999999999998655432222111000                           


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                         ....+....+.++.+++.+||+.+|.+||++.++++||||.++.
T Consensus       217 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         217 ---SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence               00111224667899999999999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=3.1e-30  Score=206.50  Aligned_cols=171  Identities=30%  Similarity=0.531  Sum_probs=139.6

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccc
Q 025683            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~   76 (249)
                      |++|.+++.+.    ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  162 (258)
T cd08215          83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT  162 (258)
T ss_pred             CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecc
Confidence            57899999874    789999999999999999999999999999999999999999999999999887654433 2233


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+++.|+|||..... .++.++|+||+|+++++|++|..||...+............                      
T Consensus       163 ~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------  219 (258)
T cd08215         163 VVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ----------------------  219 (258)
T ss_pred             eeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC----------------------
Confidence            5678889999987644 37889999999999999999999997765433333322100                      


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                              ...+...++.++.+++.+||..+|.+|||+.++++||||
T Consensus       220 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 --------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                    111222467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=4.9e-30  Score=206.05  Aligned_cols=167  Identities=23%  Similarity=0.318  Sum_probs=134.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----cccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~~   77 (249)
                      +++|.+++.+...+++..+..++.|++.||+|||++|++|+||||.||+++.++.++|+|||.+........    ....
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence            578999999888899999999999999999999999999999999999999999999999999876543321    1122


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+.. ..++.++|+|||||++|+|++ |..||...........+....  .                   
T Consensus       159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~--~-------------------  216 (257)
T cd05116         159 KWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE--R-------------------  216 (257)
T ss_pred             CCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--C-------------------
Confidence            33567999998854 347889999999999999997 999998765544433332100  0                   


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ...+...++++.++|.+||+.||.+||++.+|..
T Consensus       217 ---------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         217 ---------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                     1122357788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=3.9e-30  Score=207.80  Aligned_cols=174  Identities=28%  Similarity=0.516  Sum_probs=134.4

Q ss_pred             CccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-CCCeEEeecCCccCCCCCC-cccc
Q 025683            2 DTDLYQIIRSN-QSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENE-FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l--~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~~~~-~~~~   76 (249)
                      |++|.+++.+. ..+  ++..+..++.||+.||+|||+.|++|+||+|+||+++. ++.++|+|||.+....... ....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~  168 (268)
T cd06624          89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET  168 (268)
T ss_pred             CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence            67999999875 456  88999999999999999999999999999999999976 6789999999886543322 1223


Q ss_pred             ccccccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+... ..++.++|+||+|+++|+|++|..||................                     
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  227 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF---------------------  227 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh---------------------
Confidence            4568889999988543 236789999999999999999999986543211111000000                     


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                             .....++..+++++.+++.+||+.+|.+|||+.+++.||||
T Consensus       228 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         228 -------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                   00112233567889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.3e-31  Score=224.35  Aligned_cols=183  Identities=22%  Similarity=0.374  Sum_probs=158.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      +||++++|+.+++++.+..++.++.|++.|++|||+++|||||||++||+++.+..+||+|||++............+|+
T Consensus       138 ~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgs  217 (596)
T KOG0586|consen  138 SGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGS  217 (596)
T ss_pred             cCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccCCC
Confidence            58999999999999999999999999999999999999999999999999999999999999999988877777889999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|.|||++.+..+.++.+|+||+|+++|-|+.|..||.+.+-.....+.                              
T Consensus       218 ppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv------------------------------  267 (596)
T KOG0586|consen  218 PPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV------------------------------  267 (596)
T ss_pred             CCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh------------------------------
Confidence            99999999998888899999999999999999999999877521111111                              


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV  214 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~  214 (249)
                       -.....++--++.++.++|+++|..+|.+|++.+++..|.|...........+
T Consensus       268 -l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p  320 (596)
T KOG0586|consen  268 -LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEARLLAP  320 (596)
T ss_pred             -eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhhhhhhc
Confidence             01112233357888999999999999999999999999999999887733333

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=2.8e-30  Score=207.10  Aligned_cols=171  Identities=25%  Similarity=0.480  Sum_probs=138.5

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~   78 (249)
                      |++|.+++...  ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  162 (256)
T cd08218          83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI  162 (256)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhcc
Confidence            67899999764  3689999999999999999999999999999999999999999999999998876543321 22345


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.+. ..+.++|+||||+++++|++|..||...+.......+..  +..                     
T Consensus       163 ~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~---------------------  218 (256)
T cd08218         163 GTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSY---------------------  218 (256)
T ss_pred             CCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCC---------------------
Confidence            67889999988654 477899999999999999999999977655444333321  000                     


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                             ......++.++.++|.+||+.+|.+||++.+++.||||
T Consensus       219 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 -------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                   11122467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=1.2e-30  Score=212.06  Aligned_cols=167  Identities=26%  Similarity=0.503  Sum_probs=129.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCchhccCC
Q 025683           13 QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNS   92 (249)
Q Consensus        13 ~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~   92 (249)
                      ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+.
T Consensus        90 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~  168 (279)
T cd06619          90 RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGE  168 (279)
T ss_pred             hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCC
Confidence            35789999999999999999999999999999999999999999999999998755432 23345778899999988654


Q ss_pred             CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcC
Q 025683           93 SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ---MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (249)
Q Consensus        93 ~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (249)
                       .++.++|+||||+++|+|++|..||........   ........                   ......      ....
T Consensus       169 -~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~~~~~~------~~~~  222 (279)
T cd06619         169 -QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-------------------VDEDPP------VLPV  222 (279)
T ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-------------------hccCCC------CCCC
Confidence             478899999999999999999999965321100   00000000                   000000      0011


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          170 PHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       170 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                      ...++++.+++.+||+.||.+||+++++++||||+..
T Consensus       223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            2467889999999999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=5.9e-30  Score=205.38  Aligned_cols=168  Identities=26%  Similarity=0.389  Sum_probs=137.9

Q ss_pred             CccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC
Q 025683            2 DTDLYQIIRSN---------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (249)
Q Consensus         2 ~~~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~   72 (249)
                      |++|.+++.+.         ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            78999999885         789999999999999999999999999999999999999999999999999987665432


Q ss_pred             ---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchh
Q 025683           73 ---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNE  148 (249)
Q Consensus        73 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (249)
                         ......++..|+|||.+... .++.++|+||||+++++|++ |..||...........+...               
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------  223 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---------------  223 (262)
T ss_pred             ccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------------
Confidence               12234567789999988654 48899999999999999998 69999877654444433320               


Q ss_pred             hHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                     ........++.++.+++.+||..+|.+|||+.+++++
T Consensus       224 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 ---------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ---------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                           0011223467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=3.6e-30  Score=209.81  Aligned_cols=174  Identities=26%  Similarity=0.407  Sum_probs=135.3

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~   76 (249)
                      |++|.+++.+    ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus       104 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  183 (286)
T cd06638         104 GGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT  183 (286)
T ss_pred             CCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCcccc
Confidence            6789888753    3578999999999999999999999999999999999999999999999999987554322 2233


Q ss_pred             ccccccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           77 YVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                      ..++..|+|||.+..    ...++.++|+||+||++|+|++|..||...........+..   ....             
T Consensus       184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~-------------  247 (286)
T cd06638         184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---NPPP-------------  247 (286)
T ss_pred             ccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---cCCC-------------
Confidence            567889999998742    23367899999999999999999999976543322211110   0000             


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                                  ........+..+.+++.+||+.||.+|||+.++++|+||
T Consensus       248 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 ------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                        000112356779999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=4e-30  Score=205.87  Aligned_cols=173  Identities=29%  Similarity=0.521  Sum_probs=141.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---ccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~~   78 (249)
                      |++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........   .....
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  164 (260)
T cd06606          85 GGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR  164 (260)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCC
Confidence            689999999988999999999999999999999999999999999999999999999999999876655442   33456


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|++||.+.... .+.++|+||||+++++|++|..||........  .+.....                       
T Consensus       165 ~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~-----------------------  218 (260)
T cd06606         165 GTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS-----------------------  218 (260)
T ss_pred             CCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc-----------------------
Confidence            788899999885444 78999999999999999999999977651111  1111000                       


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                         ......++...+..+.+++.+||..||.+||++.+++.||||
T Consensus       219 ---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 ---SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ---cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence               001112333457889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=6e-30  Score=209.43  Aligned_cols=177  Identities=28%  Similarity=0.522  Sum_probs=140.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      |++|.+++.. +.+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+....... ......++
T Consensus       101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence            5688887754 578999999999999999999999999999999999999999999999999876543322 12234568


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|++||.+.. ..++.++|+||+|+++++|++|..||...........+......                        
T Consensus       180 ~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~------------------------  234 (292)
T cd06657         180 PYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP------------------------  234 (292)
T ss_pred             ccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc------------------------
Confidence            88999998754 34788999999999999999999999876544333332211100                        


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                         . ......+++.+.+++.+||..||.+||++.+++.||||..+..
T Consensus       235 ---~-~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         235 ---K-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             ---c-cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence               0 0011246788999999999999999999999999999998864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=6e-30  Score=204.05  Aligned_cols=172  Identities=29%  Similarity=0.530  Sum_probs=138.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |++|.+++... ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.+.............++
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  160 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGT  160 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecC
Confidence            58999999886 68999999999999999999999999999999999999999999999999988766554323445678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|++||.+.... .+.++|+||||+++++|++|..||...+..........  ...+..                    
T Consensus       161 ~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~--------------------  217 (253)
T cd05122         161 PYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPGL--------------------  217 (253)
T ss_pred             CcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCCc--------------------
Confidence            8899999886544 78899999999999999999999977653333222221  000000                    


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPY  202 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~  202 (249)
                            .....++..+.++|.+||+.||.+|||+.+++.|||
T Consensus       218 ------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         218 ------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                  000113678999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=4.5e-30  Score=208.47  Aligned_cols=174  Identities=27%  Similarity=0.479  Sum_probs=139.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~   80 (249)
                      |++|.+++.+ +.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus        86 ~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (277)
T cd06640          86 GGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT  164 (277)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCc
Confidence            6799999876 6799999999999999999999999999999999999999999999999999865543221 2234567


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. ..+.++|+||||+++|+|++|..||...........+..  +.                        
T Consensus       165 ~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~------------------------  217 (277)
T cd06640         165 PFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NN------------------------  217 (277)
T ss_pred             ccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CC------------------------
Confidence            789999988644 478899999999999999999999976654322221100  00                        


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                          ...+...++..+.+++.+||+.+|.+||++.+++.|+||.+..
T Consensus       218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         218 ----PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             ----CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                0112224567789999999999999999999999999998653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=7.8e-30  Score=209.17  Aligned_cols=168  Identities=23%  Similarity=0.309  Sum_probs=130.8

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      +++|.+++.+..                .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  166 (297)
T cd05089          87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS  166 (297)
T ss_pred             CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCC
Confidence            578999997642                5889999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 025683           66 RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (249)
Q Consensus        66 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (249)
                      ..............+..|+|||..... .++.++|||||||++|+|++ |..||...........+.....         
T Consensus       167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~---------  236 (297)
T cd05089         167 RGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---------  236 (297)
T ss_pred             ccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence            643222111112234569999988544 47899999999999999997 9999977664443333221100         


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                           ...+..++..+.+|+.+||+.+|.+|||++++++.
T Consensus       237 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 ---------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 01123467889999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=3.2e-30  Score=195.63  Aligned_cols=166  Identities=22%  Similarity=0.307  Sum_probs=126.5

Q ss_pred             ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            3 TDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         3 ~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |||.+++.+. +.+++..+..++.||+.||.|||+++      ||+||+++.++.+++  ||.+.......    ..+++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            7999999874 56999999999999999999999998      999999999999999  99887554322    25789


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      .|+|||.+.+. .++.++|||||||++|+|++|..||...... .....+...........                   
T Consensus        69 ~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  128 (176)
T smart00750       69 YFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD-------------------  128 (176)
T ss_pred             cccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-------------------
Confidence            99999999654 4789999999999999999999999655432 22222221111100000                   


Q ss_pred             CCcchhhcCCCCCh--HHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          161 PRQSLAQVFPHVHP--LAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       161 ~~~~~~~~~~~~~~--~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                       ...    ...++.  .+.+++.+||..||.+||++.+++.|+|+..
T Consensus       129 -~~~----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      129 -RSN----LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             -ccc----HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence             000    001222  5889999999999999999999999998763

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.5e-30  Score=203.75  Aligned_cols=171  Identities=29%  Similarity=0.515  Sum_probs=140.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus        83 ~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  162 (254)
T cd06627          83 NGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGT  162 (254)
T ss_pred             CCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccc
Confidence            568999999888999999999999999999999999999999999999999999999999999876554332 2234668


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|++||...... .+.++|+|++|+++++|++|..||...........+..                            
T Consensus       163 ~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------------------------  213 (254)
T cd06627         163 PYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ----------------------------  213 (254)
T ss_pred             hhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc----------------------------
Confidence            8899999886544 78899999999999999999999976553332222211                            


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                        .....+.+.++..+.+++.+||..+|++|||+.+++.||||
T Consensus       214 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         214 --DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             --cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence              00112233567889999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-30  Score=200.65  Aligned_cols=192  Identities=27%  Similarity=0.454  Sum_probs=143.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC---eEEeecCCccCCCCC-------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSEN-------   71 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~---~kL~dfg~~~~~~~~-------   71 (249)
                      ||+|.+.|.+...|++.++.+++.+|+.||.+||.+||.|||+||+|||......   +|||||.+.......       
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            8999999999999999999999999999999999999999999999999977654   799999876533221       


Q ss_pred             -CccccccccccccCchhcc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc-cc
Q 025683           72 -EFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG-FV  145 (249)
Q Consensus        72 -~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  145 (249)
                       ....+.+|+..|||||+..    ....|....|+|||||++|-|++|.+||.+.=            |.-=-++-+ .+
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C------------g~dCGWdrGe~C  307 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC------------GADCGWDRGEVC  307 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc------------CCcCCccCCCcc
Confidence             1123467888899999863    23457889999999999999999999996531            100000000 11


Q ss_pred             chhhHHH---HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          146 RNEDAKR---YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       146 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      +..+.+.   +-+..-..+.+    -|..+|.+.+++|..+|..|+.+|.++.++++|||++....+
T Consensus       308 r~CQ~~LFesIQEGkYeFPdk----dWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  308 RVCQNKLFESIQEGKYEFPDK----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHHHHHHHHhccCCcCChh----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            1111111   11111111222    244688999999999999999999999999999999998766

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=239.45  Aligned_cols=179  Identities=27%  Similarity=0.438  Sum_probs=149.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-----Ccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-----EFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-----~~~~~   76 (249)
                      ||+|.+.++..+..++.+.+-+..|++.|++|||++|||||||||.||+++.+|.+|++|||.+.....+     +....
T Consensus      1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~ 1397 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQS 1397 (1509)
T ss_pred             cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHh
Confidence            7999999999888999999999999999999999999999999999999999999999999998765543     22345


Q ss_pred             ccccccccCchhccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           77 YVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ..||+.|||||++.+..  +..-+.|||||||++.||++|+.||...+....+.-.+...-.                  
T Consensus      1398 ~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~------------------ 1459 (1509)
T KOG4645|consen 1398 MMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK------------------ 1459 (1509)
T ss_pred             hcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC------------------
Confidence            78999999999997653  3567999999999999999999999877655444333332211                  


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                                 .+++.+++++..+||..||..||.+|.++.||++|.|=+...++
T Consensus      1460 -----------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1460 -----------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             -----------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence                       12334588999999999999999999999999999987765544

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=1.1e-29  Score=207.36  Aligned_cols=167  Identities=22%  Similarity=0.358  Sum_probs=131.8

Q ss_pred             CccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683            2 DTDLYQIIRSNQ-------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus         2 ~~~L~~~l~~~~-------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      +++|.+++.+.+             .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+...
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  170 (288)
T cd05093          91 HGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV  170 (288)
T ss_pred             CCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccc
Confidence            579999997643             4999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 025683           69 SENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (249)
Q Consensus        69 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (249)
                      .....   .....++..|+|||.+... .++.++|+|||||++++|++ |..||...........+...  ..       
T Consensus       171 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~--~~-------  240 (288)
T cd05093         171 YSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG--RV-------  240 (288)
T ss_pred             cCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--Cc-------
Confidence            33221   1223346679999988644 47889999999999999998 89998776644433333210  00       


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                           .......+.++.+|+.+||+.||.+|||+.++++
T Consensus       241 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         241 ---------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                 0112246788999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=3.6e-30  Score=210.79  Aligned_cols=182  Identities=25%  Similarity=0.461  Sum_probs=142.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      |++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus       100 ~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  178 (293)
T cd06647         100 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  178 (293)
T ss_pred             CCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCC
Confidence            6799999876 468999999999999999999999999999999999999999999999999876543322 22234677


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|++||.+... .++.++|+||||+++|++++|..||...+.......+.. .+.                        
T Consensus       179 ~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~------------------------  232 (293)
T cd06647         179 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT------------------------  232 (293)
T ss_pred             hhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCC------------------------
Confidence            889999988654 478899999999999999999999976653322111110 000                        


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP  213 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~  213 (249)
                         ........++..+.++|++||..+|.+||++++++.|+||+..+....-+
T Consensus       233 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~  282 (293)
T cd06647         233 ---PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLT  282 (293)
T ss_pred             ---CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccccc
Confidence               00011224567899999999999999999999999999999876544433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=5.3e-30  Score=208.97  Aligned_cols=175  Identities=30%  Similarity=0.543  Sum_probs=140.9

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccccc
Q 025683            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~   79 (249)
                      |++|.+++.+.. .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus        99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  178 (286)
T cd06614          99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG  178 (286)
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccC
Confidence            589999999876 89999999999999999999999999999999999999999999999999876543321 1223456


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|++||.+.+. .++.++|+||||+++|+|++|..||....+......+...  ..+.                    
T Consensus       179 ~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~--------------------  235 (286)
T cd06614         179 TPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK--GIPP--------------------  235 (286)
T ss_pred             CcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCC--------------------
Confidence            7789999988654 4788999999999999999999999776554433332210  0000                    


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                            ......++..+.++|.+||+.+|.+|||+.+++.|+||++
T Consensus       236 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         236 ------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             ------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence                  0001135678999999999999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=1.1e-29  Score=209.28  Aligned_cols=173  Identities=28%  Similarity=0.431  Sum_probs=137.3

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      .|+|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+......   ....++
T Consensus        98 ~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~~~~  174 (307)
T cd06607          98 LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSFVGT  174 (307)
T ss_pred             CCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CCccCC
Confidence            4677777764 467999999999999999999999999999999999999999999999999988654332   234567


Q ss_pred             ccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        81 ~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.......+...  ..+.                   
T Consensus       175 ~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~-------------------  233 (307)
T cd06607         175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT-------------------  233 (307)
T ss_pred             ccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCC-------------------
Confidence            88999998742  345788999999999999999999999776544433322110  0000                   


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                              ......+..+.++|.+||+.||.+||++.+++.||||..-
T Consensus       234 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         234 --------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             --------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                    0011246779999999999999999999999999999963

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.1e-30  Score=195.11  Aligned_cols=201  Identities=31%  Similarity=0.624  Sum_probs=158.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCCCCccccccccccccCchhccC
Q 025683           13 QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLN   91 (249)
Q Consensus        13 ~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~   91 (249)
                      ..|+.-+++.++.+++.||.|+|+.||.|||+||.|++++... .++|+|+|++.........+-.+.+.+|.-||.+..
T Consensus       127 ~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVd  206 (338)
T KOG0668|consen  127 PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD  206 (338)
T ss_pred             hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheee
Confidence            4688899999999999999999999999999999999999765 699999999988777665555677889999999988


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCccc-ccccchhhHHHHHHhCCCCCCcchhhcC
Q 025683           92 SSDYTAAIDVWSVGCIFMELMNRRPLF-PGNDHVHQMRLLIELLGTPTDAD-LGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (249)
Q Consensus        92 ~~~~~~~~DiwslG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (249)
                      ...+..+.|+|||||++..|+....|| .+.++.+++-+|.+.+|.-.... .....-.-...+.+-++...++.+..+.
T Consensus       207 y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi  286 (338)
T KOG0668|consen  207 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFI  286 (338)
T ss_pred             chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhC
Confidence            888999999999999999999877665 67888999999999888632111 0000001111222333444555555543


Q ss_pred             C-----CCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC
Q 025683          170 P-----HVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP  213 (249)
Q Consensus       170 ~-----~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~  213 (249)
                      +     -+++++.+|+.++|..|..+|+|+.|++.||||....+....+
T Consensus       287 ~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~~  335 (338)
T KOG0668|consen  287 NSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESSR  335 (338)
T ss_pred             CccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhcc
Confidence            2     3579999999999999999999999999999999877655444

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=3.4e-30  Score=214.17  Aligned_cols=210  Identities=20%  Similarity=0.268  Sum_probs=141.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc------
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF------   73 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~------   73 (249)
                      +++|.+++.+.  ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++++||+..........      
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            57899998874  4589999999999999999999999999999999999999999999999975432211110      


Q ss_pred             --cccccccccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhH
Q 025683           74 --MTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (249)
Q Consensus        74 --~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (249)
                        .....++..|++||.+.+. ..++.++|+||+||++++|++|..||...................+ ...........
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  241 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP-LDITTFPCEES  241 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC-ccccccchhhh
Confidence              0111235569999998653 3478899999999999999999999987654433322222111000 00000000000


Q ss_pred             HH------HHHhCCC---------CC--CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC
Q 025683          151 KR------YIRQLPQ---------HP--RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE  212 (249)
Q Consensus       151 ~~------~~~~~~~---------~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~  212 (249)
                      ..      .......         ..  ..........+++.+.+|+++||+.||.+|||++++++|+||.+.......
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~~~  320 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQG  320 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhccc
Confidence            00      0000000         00  000001122456789999999999999999999999999999988765433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=1.3e-29  Score=207.24  Aligned_cols=167  Identities=22%  Similarity=0.382  Sum_probs=131.9

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      |++|.+++...                +.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a  170 (291)
T cd05094          91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS  170 (291)
T ss_pred             CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcc
Confidence            68999999764                34899999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      ........   .....++..|+|||.+... .++.++|+||||+++|+|++ |..||...........+..  +.     
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~-----  242 (291)
T cd05094         171 RDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ--GR-----  242 (291)
T ss_pred             cccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC--CC-----
Confidence            75443221   1234457789999988654 47889999999999999998 9999877654433332211  00     


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                             ........+..+.+++.+||+.||.+|||+.++++
T Consensus       243 -----------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         243 -----------------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence                                   00112235678999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=2.4e-29  Score=207.82  Aligned_cols=174  Identities=28%  Similarity=0.420  Sum_probs=139.0

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      .|+|.+++.. ...+++..+..++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||.+.....   .....++
T Consensus       104 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~~~  180 (313)
T cd06633         104 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGT  180 (313)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCcccc
Confidence            4678888865 46799999999999999999999999999999999999999999999999998754322   2345678


Q ss_pred             ccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        81 ~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.......+....  .+.                   
T Consensus       181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~-------------------  239 (313)
T cd06633         181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPT-------------------  239 (313)
T ss_pred             ccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCC-------------------
Confidence            88999998742  3447889999999999999999999997776544444332110  000                   


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                              ......+..+.+|+.+||+.+|.+||++.+++.||||+...
T Consensus       240 --------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         240 --------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             --------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                    01123556789999999999999999999999999999743

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=2.5e-29  Score=201.40  Aligned_cols=170  Identities=29%  Similarity=0.453  Sum_probs=138.2

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~   77 (249)
                      |++|.+++.+    ...+++..+..++.|++.||+|||+.|++|+||+|.||+++.++.++|+|||.+...... .....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~  161 (256)
T cd08530          83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQ  161 (256)
T ss_pred             CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccccc
Confidence            5789998876    467999999999999999999999999999999999999999999999999998765444 23335


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|++||.+.+. .++.++|+||+|+++++|++|..||...+.......+..                         
T Consensus       162 ~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------------------------  215 (256)
T cd08530         162 IGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-------------------------  215 (256)
T ss_pred             cCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------------------
Confidence            678889999998654 478899999999999999999999987764433222211                         


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                           .....+....+.++.+++.+||+.+|.+||++.++++||++
T Consensus       216 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         216 -----GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             -----CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                 00111222467889999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.2e-29  Score=203.63  Aligned_cols=167  Identities=19%  Similarity=0.251  Sum_probs=133.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc----cc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----EY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~----~~   77 (249)
                      +++|.+++.+.+.+++..+..++.|++.||+|||..+++|+||+|+||+++.++.++|+|||.+..........    ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~  158 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG  158 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence            57999999998889999999999999999999999999999999999999999999999999987654332211    11


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++|+||||+++|++++ |..||...+.......+.... .                    
T Consensus       159 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~--------------------  216 (257)
T cd05060         159 RWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-R--------------------  216 (257)
T ss_pred             cccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-c--------------------
Confidence            224579999988544 48889999999999999997 999997766544333322100 0                    


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               .......+..+.+++.+||..+|.+||++.++++
T Consensus       217 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 ---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                     0122346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=1.5e-29  Score=202.84  Aligned_cols=171  Identities=29%  Similarity=0.513  Sum_probs=136.4

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC-eEEeecCCccCCCCCCc-cccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPTSENEF-MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~-~kL~dfg~~~~~~~~~~-~~~~   77 (249)
                      |++|.+++.+..  .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+........ ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  162 (257)
T cd08225          83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC  162 (257)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccccc
Confidence            678999997653  5899999999999999999999999999999999999998864 69999998876543321 2234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|+|||.+... .++.++|+||||++++++++|..||...+.......+..   .                     
T Consensus       163 ~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~---------------------  217 (257)
T cd08225         163 VGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ---G---------------------  217 (257)
T ss_pred             CCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---c---------------------
Confidence            578889999987544 478899999999999999999999976654333322211   0                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                            ......+..+.++.++|.+||..+|++|||+.+++.||||
T Consensus       218 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         218 ------YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                  0011223567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=3.3e-29  Score=220.59  Aligned_cols=182  Identities=24%  Similarity=0.349  Sum_probs=121.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-CCCeEEeecCCccCCCCC--CccccccccccccCchhccCCC
Q 025683           17 EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSEN--EFMTEYVVTRWYRAPELLLNSS   93 (249)
Q Consensus        17 ~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~   93 (249)
                      ...+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++......  .......+++.|+|||.+....
T Consensus       254 ~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~  333 (566)
T PLN03225        254 NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST  333 (566)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccC
Confidence            3457789999999999999999999999999999986 579999999999754322  2233467789999999764221


Q ss_pred             ---------------------CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           94 ---------------------DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        94 ---------------------~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                                           ++..++||||+||++|+|+++..++  .........+....+.....         ...
T Consensus       334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~---------~~~  402 (566)
T PLN03225        334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVA---------WRK  402 (566)
T ss_pred             CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHH---------HHH
Confidence                                 1234569999999999999866543  33333333333322211000         000


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      ..............++.........+||.+||++||.+|||+.++|+||||++....
T Consensus       403 ~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        403 LVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             hhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence            000000000001112222334557799999999999999999999999999986544

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=1.2e-29  Score=207.09  Aligned_cols=181  Identities=23%  Similarity=0.416  Sum_probs=140.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~   79 (249)
                      |++|.+++.+...+++..++.++.|++.+|.|||+.|++|+||+|.||+++.++.++|+|||.+........  .....+
T Consensus        89 ~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  168 (288)
T cd05583          89 GGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG  168 (288)
T ss_pred             CCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccC
Confidence            579999998888899999999999999999999999999999999999999999999999998865433221  122457


Q ss_pred             cccccCchhccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +..|++||.+.+.. ..+.++|+||||+++++|++|..||...........+....                   .... 
T Consensus       169 ~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-------------------~~~~-  228 (288)
T cd05583         169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI-------------------LKSK-  228 (288)
T ss_pred             CccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH-------------------HccC-
Confidence            88899999875432 36789999999999999999999996433221111111110                   0000 


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC---HHHHhcCccccCCcCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT---VDEALAHPYLARLHDE  209 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~~ll~h~~~~~~~~~  209 (249)
                             ......++..+.+++.+||+.||++|||   +.++++||||+++...
T Consensus       229 -------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         229 -------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             -------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                   1112346788999999999999999998   5678999999987643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=1.6e-29  Score=205.37  Aligned_cols=167  Identities=25%  Similarity=0.301  Sum_probs=131.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc---ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~---~~~   77 (249)
                      +|+|.+++... +.+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.........   ...
T Consensus        92 ~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~  171 (279)
T cd05109          92 YGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG  171 (279)
T ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCC
Confidence            57999999774 57999999999999999999999999999999999999999999999999998765432221   112


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|++||..... .++.++|+|||||++|+|++ |..||...........+.. ...+                   
T Consensus       172 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~-------------------  230 (279)
T cd05109         172 KVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERL-------------------  230 (279)
T ss_pred             ccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC-------------------
Confidence            335679999998654 47889999999999999988 8899876543333222211 0000                   


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ......+.++.+++.+||..||.+||++.+++.
T Consensus       231 ----------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         231 ----------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      112246678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.4e-29  Score=208.77  Aligned_cols=177  Identities=28%  Similarity=0.412  Sum_probs=138.1

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      .|+|.+++.. ...+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||.+......   ....++
T Consensus        98 ~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~  174 (308)
T cd06634          98 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGT  174 (308)
T ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---ccccCC
Confidence            4677777754 456999999999999999999999999999999999999999999999999988654332   234567


Q ss_pred             ccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        81 ~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ..|+|||.+..  ....+.++|+|||||++|+|++|..||...........+....  .+                    
T Consensus       175 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~--------------------  232 (308)
T cd06634         175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SP--------------------  232 (308)
T ss_pred             ccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC--CC--------------------
Confidence            88999998752  2346789999999999999999999986654333222222100  00                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                             .......+..+.++|.+||+.+|.+||++++++.|+|+.......
T Consensus       233 -------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~  277 (308)
T cd06634         233 -------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  277 (308)
T ss_pred             -------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCChh
Confidence                   000124667789999999999999999999999999999854333

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=3.1e-29  Score=204.65  Aligned_cols=185  Identities=26%  Similarity=0.463  Sum_probs=136.3

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~   77 (249)
                      |++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~  163 (287)
T cd06621          85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-AGTF  163 (287)
T ss_pred             CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-cccc
Confidence            5788887754    3568999999999999999999999999999999999999999999999999976543322 1234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH--VHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      .++..|++||.+.+. .++.++|+||||+++|+|++|..||.....  ..... ...........               
T Consensus       164 ~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~---------------  226 (287)
T cd06621         164 TGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE-LLSYIVNMPNP---------------  226 (287)
T ss_pred             cCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHH-HHHHHhcCCch---------------
Confidence            567789999988543 478899999999999999999999976521  00000 11110000000               


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                          ..... .......++.+.+++.+||..+|.+|||+.+++.|+||++....
T Consensus       227 ----~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         227 ----ELKDE-PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             ----hhccC-CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence                00000 00001245678999999999999999999999999999765443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=2.6e-29  Score=202.48  Aligned_cols=167  Identities=24%  Similarity=0.387  Sum_probs=132.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc--cc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~--~~   77 (249)
                      |++|.+++...  ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+..........  ..
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~  165 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  165 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence            68999999764  468999999999999999999999999999999999999999999999999987654332111  12


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+..|+|||.+... .++.++|+|||||++|+|++ |..||.+.+.......+.....                     
T Consensus       166 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------------  223 (263)
T cd05052         166 KFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---------------------  223 (263)
T ss_pred             CCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---------------------
Confidence            235579999988544 47889999999999999998 8999987654433333321000                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ......+++++.+++.+||+.||++|||+.++++
T Consensus       224 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         224 ---------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                     0122357788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=3e-29  Score=203.70  Aligned_cols=167  Identities=23%  Similarity=0.392  Sum_probs=132.2

Q ss_pred             CccHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683            2 DTDLYQIIRSN--------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus         2 ~~~L~~~l~~~--------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      |++|.+++...              ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        92 ~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~  171 (280)
T cd05049          92 HGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD  171 (280)
T ss_pred             CCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCccccee
Confidence            68999999764              3488999999999999999999999999999999999999999999999998865


Q ss_pred             CCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 025683           68 TSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        68 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (249)
                      .....   ......++..|+|||.+... .++.++|+||||+++|+|++ |..||...........+..  +.       
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~--~~-------  241 (280)
T cd05049         172 VYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ--GR-------  241 (280)
T ss_pred             cccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CC-------
Confidence            43221   11223446789999988654 48889999999999999998 9999977665443333221  00       


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                           ........+..+.+++++||..||.+||++.++++
T Consensus       242 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         242 ---------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             ---------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                 01112246788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=2.7e-29  Score=201.66  Aligned_cols=168  Identities=20%  Similarity=0.318  Sum_probs=132.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc--cccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~   78 (249)
                      +++|.+++.+. ..+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||.+.........  ....
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK  162 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence            57899999874 47999999999999999999999999999999999999999999999999988754333211  1123


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|++||.+... .++.++|+||||+++|+|++ |..||...........+......                     
T Consensus       163 ~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  220 (256)
T cd05113         163 FPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---------------------  220 (256)
T ss_pred             cChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC---------------------
Confidence            45679999988644 37889999999999999998 99999766654433333221100                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                               ......+..+.+++.+||+.||.+||++.+++.+
T Consensus       221 ---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 ---------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                     0112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=2.1e-29  Score=210.11  Aligned_cols=157  Identities=27%  Similarity=0.427  Sum_probs=121.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---ccccccccccccCchhcc
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEYVVTRWYRAPELLL   90 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~   90 (249)
                      .+++..+..++.||+.||+|||++|++||||||.||+++.++.++|+|||++.......   ......++..|+|||.+.
T Consensus       169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  248 (337)
T cd05054         169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF  248 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence            68999999999999999999999999999999999999999999999999987643221   111234466799999886


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcC
Q 025683           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (249)
Q Consensus        91 ~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (249)
                      .. .++.++|+|||||++++|++ |..||.+...............                          .   ....
T Consensus       249 ~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------------------~---~~~~  298 (337)
T cd05054         249 DK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--------------------------R---MRAP  298 (337)
T ss_pred             CC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC--------------------------C---CCCC
Confidence            54 48899999999999999997 9999976432222211111000                          0   0112


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          170 PHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       170 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ...++++.+++.+||+.+|.+||+++++++|
T Consensus       299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.6e-29  Score=202.58  Aligned_cols=171  Identities=23%  Similarity=0.475  Sum_probs=137.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC----Cccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----EFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~----~~~~~~   77 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+......    ......
T Consensus        90 ~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (264)
T cd06653          90 GGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV  169 (264)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCcccccc
Confidence            6799999998888999999999999999999999999999999999999999999999999998754321    111234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|+|||.+.+. .++.++|+|||||+++++++|..||...........+   ...+..                  
T Consensus       170 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~------------------  227 (264)
T cd06653         170 TGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPTK------------------  227 (264)
T ss_pred             CCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCCC------------------
Confidence            578889999988654 3788999999999999999999999765433322222   111110                  


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                              ..++..+++.+.+++.+||. +|.+||++.+++.|||.
T Consensus       228 --------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         228 --------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             --------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                    12344677889999999999 57999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=3e-29  Score=203.58  Aligned_cols=168  Identities=22%  Similarity=0.388  Sum_probs=130.6

Q ss_pred             CccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC
Q 025683            2 DTDLYQIIRSNQ----------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (249)
Q Consensus         2 ~~~L~~~l~~~~----------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~   71 (249)
                      |++|.+++.+..          .++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  172 (277)
T cd05062          93 RGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET  172 (277)
T ss_pred             CCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCc
Confidence            689999997632          3678889999999999999999999999999999999999999999999988654332


Q ss_pred             Ccc---ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           72 EFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        72 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                      ...   ....++..|+|||.+... .++.++|+|||||++|+|++ |..||...........+....             
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-------------  238 (277)
T cd05062         173 DYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-------------  238 (277)
T ss_pred             ceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            211   122346779999998644 47899999999999999998 788887765443333222100             


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                       ........+..+.+++.+||+.||.+|||+.+++++
T Consensus       239 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 -----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             -----------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             001122456789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=2.5e-29  Score=204.08  Aligned_cols=168  Identities=23%  Similarity=0.370  Sum_probs=131.4

Q ss_pred             CccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC---CeEEeecCCccCCCCC
Q 025683            2 DTDLYQIIRSNQ-------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPTSEN   71 (249)
Q Consensus         2 ~~~L~~~l~~~~-------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~---~~kL~dfg~~~~~~~~   71 (249)
                      |++|.+++...+       .+++..+..++.||+.||+|||+++++|+||+|+||+++.++   .++|+|||.+......
T Consensus        93 g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~  172 (277)
T cd05036          93 GGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA  172 (277)
T ss_pred             CCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCc
Confidence            789999998753       589999999999999999999999999999999999998765   5899999998765322


Q ss_pred             Cc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           72 EF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        72 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                      ..   ......+..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+.... .           
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~-----------  239 (277)
T cd05036         173 SYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-R-----------  239 (277)
T ss_pred             cceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c-----------
Confidence            11   1122335679999998654 48899999999999999996 999998766544333221100 0           


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                        ......++..+.+++.+||+.+|.+|||+.++++|
T Consensus       240 ------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 ------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                              01123467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=1.2e-29  Score=208.69  Aligned_cols=168  Identities=26%  Similarity=0.339  Sum_probs=129.8

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      |++|.+++.+.+                .+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~  171 (303)
T cd05088          92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  171 (303)
T ss_pred             CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccC
Confidence            679999997643                5789999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 025683           66 RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (249)
Q Consensus        66 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (249)
                      ..............+..|+|||.+... .++.++|+|||||++++|++ |..||...........+..   ...      
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---~~~------  241 (303)
T cd05088         172 RGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYR------  241 (303)
T ss_pred             cccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc---CCc------
Confidence            643221111112235679999988544 47889999999999999998 9999976654333222210   000      


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                           ...+..+++++.+++.+||+.+|.+||++++++.+
T Consensus       242 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         242 ---------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 00112467789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=2.2e-29  Score=203.71  Aligned_cols=167  Identities=26%  Similarity=0.337  Sum_probs=128.9

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      +++|.+++.+.+                .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            579999997643                4889999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 025683           66 RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (249)
Q Consensus        66 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (249)
                      ..............+..|+|||.+.. ..++.++|+||||+++++|++ |..||...........+....          
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----------  228 (270)
T cd05047         160 RGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----------  228 (270)
T ss_pred             cccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC----------
Confidence            53322111111223556999998854 347889999999999999996 999997655433333221100          


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                          ........+.++.+++.+||+.||.+|||+.+++.
T Consensus       229 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 --------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             --------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                00112246678999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.96  E-value=2.3e-29  Score=208.21  Aligned_cols=168  Identities=23%  Similarity=0.294  Sum_probs=131.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc---ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~---~~~   77 (249)
                      +|+|.+++.+. ..++...+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.........   ...
T Consensus        92 ~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  171 (316)
T cd05108          92 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG  171 (316)
T ss_pred             CCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCC
Confidence            68999999875 56899999999999999999999999999999999999999999999999999865433221   112


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+..|++||.+... .++.++|+||||+++|+|++ |..||.+........ +.......                   
T Consensus       172 ~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~-------------------  230 (316)
T cd05108         172 KVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERL-------------------  230 (316)
T ss_pred             ccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCC-------------------
Confidence            335679999988654 47899999999999999987 999997665433222 21110000                   


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                ......+.++.+++.+||..||.+||++.+++.+
T Consensus       231 ----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         231 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      0112355778999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.96  E-value=6.3e-29  Score=202.90  Aligned_cols=174  Identities=22%  Similarity=0.392  Sum_probs=134.9

Q ss_pred             CccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC
Q 025683            2 DTDLYQIIRSN----------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (249)
Q Consensus         2 ~~~L~~~l~~~----------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~   71 (249)
                      ||+|.+++.+.          ..++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.++.....
T Consensus        93 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~  172 (288)
T cd05061          93 HGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET  172 (288)
T ss_pred             CCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcccccccc
Confidence            68999999753          23567789999999999999999999999999999999999999999999998754332


Q ss_pred             Cc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           72 EF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        72 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                      ..   .....++..|+|||.+... .++.++|+|||||++++|++ |..||.+.........+...  .           
T Consensus       173 ~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--~-----------  238 (288)
T cd05061         173 DYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG--G-----------  238 (288)
T ss_pred             ccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C-----------
Confidence            21   1122345679999988644 47889999999999999998 78888766544433322210  0           


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc------CccccCC
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA------HPYLARL  206 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~------h~~~~~~  206 (249)
                                       ........++.+.+++.+||+.||.+|||+.++++      ||||+..
T Consensus       239 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         239 -----------------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence                             00112245678999999999999999999999987      8988864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.96  E-value=3.6e-29  Score=203.73  Aligned_cols=168  Identities=18%  Similarity=0.337  Sum_probs=131.0

Q ss_pred             CccHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRS----------------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~----------------~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      +++|.+++..                ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++
T Consensus        92 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~  171 (283)
T cd05091          92 HSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLF  171 (283)
T ss_pred             CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccc
Confidence            4678888753                235889999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      +.......   .....++..|+|||.+... .++.++|+|||||++|+|++ |..||.+.........+.....      
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------  244 (283)
T cd05091         172 REVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV------  244 (283)
T ss_pred             cccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc------
Confidence            76543221   1223446789999988644 37889999999999999997 8888877655443333322100      


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                              .......+..+.+++.+||+.+|.+||++.++++.
T Consensus       245 ------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         245 ------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence                                    01123567889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=2.6e-29  Score=205.83  Aligned_cols=173  Identities=16%  Similarity=0.238  Sum_probs=129.8

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--------cc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--------FM   74 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--------~~   74 (249)
                      .++.+.+......++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.......        ..
T Consensus       111 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~  190 (294)
T PHA02882        111 ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK  190 (294)
T ss_pred             cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccc
Confidence            4566777665667899999999999999999999999999999999999999999999999987543211        11


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....||+.|+|||.+.+. .++.++|||||||++++|++|..||.+.............                  .+.
T Consensus       191 ~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~------------------~~~  251 (294)
T PHA02882        191 DLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC------------------DFI  251 (294)
T ss_pred             cccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH------------------HHH
Confidence            224689999999988654 4799999999999999999999999876432222111110                  000


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ...... .    ...+..++.+.+++..|+..+|.+||++.++++
T Consensus       252 ~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        252 KRLHEG-K----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhhhh-h----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            000000 0    011235678999999999999999999999875

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=2.4e-29  Score=212.57  Aligned_cols=156  Identities=25%  Similarity=0.392  Sum_probs=120.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc---ccccccccccCchhcc
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEYVVTRWYRAPELLL   90 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~   90 (249)
                      ++++..+.+++.||+.||.|||++|++||||||+||+++.++.++|+|||++.........   ....++..|+|||.+.
T Consensus       208 ~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~  287 (374)
T cd05106         208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF  287 (374)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhc
Confidence            5788999999999999999999999999999999999999999999999998754332211   1123356799999986


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcC
Q 025683           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (249)
Q Consensus        91 ~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (249)
                      .. .++.++|+|||||++|+|++ |..||...........+......                             ....
T Consensus       288 ~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~-----------------------------~~~~  337 (374)
T cd05106         288 DC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ-----------------------------MSRP  337 (374)
T ss_pred             CC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC-----------------------------ccCC
Confidence            54 48899999999999999997 99999765433222222211000                             0011


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          170 PHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       170 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ...++++.+++.+||+.||.+|||+.++++
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            235788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.96  E-value=3.6e-29  Score=203.19  Aligned_cols=173  Identities=27%  Similarity=0.479  Sum_probs=138.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      |++|.+++.+ ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus        86 ~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (277)
T cd06641          86 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT  164 (277)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCC
Confidence            5789988875 579999999999999999999999999999999999999999999999999876543322 12234567


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|++||.+.+. ..+.++|+||+||++++|++|..||...........+..  +.                        
T Consensus       165 ~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~------------------------  217 (277)
T cd06641         165 PFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK--NN------------------------  217 (277)
T ss_pred             ccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc--CC------------------------
Confidence            889999988643 478899999999999999999999976554333322211  00                        


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                          ...+...++.++.+++.+||+.+|.+||++.++++||||.+.
T Consensus       218 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         218 ----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ----CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                011223467889999999999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.96  E-value=3.9e-29  Score=200.62  Aligned_cols=165  Identities=21%  Similarity=0.352  Sum_probs=131.1

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      |++|.+++.+.+  .+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+.......  .....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~  161 (256)
T cd05082          84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKL  161 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--CCCcc
Confidence            579999998753  48999999999999999999999999999999999999999999999999887543322  12334


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +..|+|||.+... .++.++|+|||||++|+|++ |..||...........+....   .                    
T Consensus       162 ~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---~--------------------  217 (256)
T cd05082         162 PVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---K--------------------  217 (256)
T ss_pred             ceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---C--------------------
Confidence            5679999988544 47889999999999999997 999987665433333322100   0                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                             ....+..++.+.+++.+||+.+|.+|||+.++++
T Consensus       218 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         218 -------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                   0122356788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=3.7e-29  Score=201.98  Aligned_cols=167  Identities=18%  Similarity=0.242  Sum_probs=131.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc--ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~--~~~   78 (249)
                      ||+|.+++.+. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++++|||.+..........  ...
T Consensus        90 ~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  169 (266)
T cd05064          90 NGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGK  169 (266)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCC
Confidence            57999999874 579999999999999999999999999999999999999999999999999775433221111  223


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+... .++.++|+|||||++|++++ |..||...........+.....                      
T Consensus       170 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----------------------  226 (266)
T cd05064         170 SPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR----------------------  226 (266)
T ss_pred             CceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC----------------------
Confidence            45679999988654 48899999999999999775 9999987765544333321100                      


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                              ...+...+..+.+++.+||+.+|.+||+++++++
T Consensus       227 --------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         227 --------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                    0112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.96  E-value=4.6e-29  Score=201.84  Aligned_cols=168  Identities=23%  Similarity=0.356  Sum_probs=130.7

Q ss_pred             CccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--
Q 025683            2 DTDLYQIIRS------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--   73 (249)
Q Consensus         2 ~~~L~~~l~~------~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--   73 (249)
                      +|+|.+++..      ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+........  
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  169 (272)
T cd05075          90 HGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR  169 (272)
T ss_pred             CCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCccccee
Confidence            5788888743      23589999999999999999999999999999999999999999999999999876543321  


Q ss_pred             -cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           74 -MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        74 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                       .....++..|++||..... .++.++|+||||+++|+|++ |..||...........+...  ..              
T Consensus       170 ~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~--------------  232 (272)
T cd05075         170 QGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--NR--------------  232 (272)
T ss_pred             cCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CC--------------
Confidence             1122346679999988644 47899999999999999998 78999776544333322210  00              


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                    ....+..+..+.++|.+||+.||.+|||+.++++.
T Consensus       233 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 --------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                          01122466789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=5.8e-29  Score=204.63  Aligned_cols=174  Identities=25%  Similarity=0.339  Sum_probs=130.2

Q ss_pred             CccHHHHHHhC-------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeec
Q 025683            2 DTDLYQIIRSN-------------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF   62 (249)
Q Consensus         2 ~~~L~~~l~~~-------------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~df   62 (249)
                      |++|.+++...                   ..+++..+.+++.||+.||.|||++|++|+||||+||+++.++.+||+||
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Df  182 (304)
T cd05096         103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADF  182 (304)
T ss_pred             CCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCC
Confidence            67899998653                   24678889999999999999999999999999999999999999999999


Q ss_pred             CCccCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCC
Q 025683           63 GLARPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPGNDHVHQMRLLIELLGTP  137 (249)
Q Consensus        63 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~  137 (249)
                      |.+........   .....++..|+|||.+... .++.++|+||||+++|+|++  +..||...........+.......
T Consensus       183 G~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~  261 (304)
T cd05096         183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQ  261 (304)
T ss_pred             ccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhc
Confidence            99875433221   1123446789999988644 48899999999999999986  557777665444443332211110


Q ss_pred             CcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      .                       ........+..+..+.+++.+||+.||.+|||+.++.+
T Consensus       262 ~-----------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         262 G-----------------------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             c-----------------------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            0                       00001112346788999999999999999999999943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=9.2e-30  Score=233.55  Aligned_cols=174  Identities=20%  Similarity=0.262  Sum_probs=125.7

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC-------------------eEEe
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-------------------LKIC   60 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~-------------------~kL~   60 (249)
                      ++++|+++|.+. ..+++..++.++.||+.||+|||++||+||||||+|||++..+.                   +|++
T Consensus        62 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~  141 (793)
T PLN00181         62 EDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSR  141 (793)
T ss_pred             CCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCccccc
Confidence            478999999763 56999999999999999999999999999999999999965444                   5555


Q ss_pred             ecCCccCCCCCC-----------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 025683           61 DFGLARPTSENE-----------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH  123 (249)
Q Consensus        61 dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~  123 (249)
                      |||+++......                 ......+|+.|+|||.+.+.. ++.++|||||||++|||++|..|+.....
T Consensus       142 DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~  220 (793)
T PLN00181        142 EIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSR  220 (793)
T ss_pred             ccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHH
Confidence            555554211000                 001134688899999986554 78999999999999999998877643211


Q ss_pred             HHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                        ....+.... .++.                             .....+...+++.+||+.||.+||++.++++||||
T Consensus       221 --~~~~~~~~~-~~~~-----------------------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~  268 (793)
T PLN00181        221 --TMSSLRHRV-LPPQ-----------------------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI  268 (793)
T ss_pred             --HHHHHHHhh-cChh-----------------------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence              111111100 0000                             00112345688999999999999999999999999


Q ss_pred             cCCc
Q 025683          204 ARLH  207 (249)
Q Consensus       204 ~~~~  207 (249)
                      .+..
T Consensus       269 ~~~~  272 (793)
T PLN00181        269 NEPR  272 (793)
T ss_pred             hhhh
Confidence            8754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1.8e-30  Score=215.25  Aligned_cols=200  Identities=37%  Similarity=0.649  Sum_probs=154.9

Q ss_pred             CccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCCCCccccc
Q 025683            2 DTDLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~   77 (249)
                      .-+|+.+|++.+   .|....++.++.|++.||..|-.+|++|.||||+||||+... .+||||||.+...+.+... ..
T Consensus       517 slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit-PY  595 (752)
T KOG0670|consen  517 SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEIT-PY  595 (752)
T ss_pred             hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccccc-HH
Confidence            457899999864   599999999999999999999999999999999999999765 5799999999887776643 44


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .-+..|+|||++.+-+ |....|+||.||.+|||.+|...|++.++.+.+...+.+-|..+...+.....  ....++..
T Consensus       596 LVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF--~dqHFD~d  672 (752)
T KOG0670|consen  596 LVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF--KDQHFDQD  672 (752)
T ss_pred             HHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch--hhhhcccc
Confidence            5578899999998766 89999999999999999999999999999999999999888877543321100  00011111


Q ss_pred             CCC---------------------CCcchh-hc---------CCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          158 PQH---------------------PRQSLA-QV---------FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       158 ~~~---------------------~~~~~~-~~---------~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                      ...                     +.+.+. ++         .+..-..+.+|+.+||..||.+|.|+.++|.||||+.
T Consensus       673 ~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  673 LNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             cceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence            100                     000010 01         1112245789999999999999999999999999974

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=1.1e-28  Score=204.30  Aligned_cols=174  Identities=28%  Similarity=0.434  Sum_probs=138.5

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      .|+|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.....   .....++
T Consensus       108 ~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~  184 (317)
T cd06635         108 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFVGT  184 (317)
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cccccCC
Confidence            5678787765 46799999999999999999999999999999999999999999999999998765432   2244678


Q ss_pred             ccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           81 RWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        81 ~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ..|+|||.+..  ...++.++|+|||||++|+|++|..||...........+.......                     
T Consensus       185 ~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------  243 (317)
T cd06635         185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------------------  243 (317)
T ss_pred             ccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------------------
Confidence            88999998742  3447889999999999999999999987765444444333211100                     


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                              ......++.+.+++.+||+.+|.+||++.++++|+|+....
T Consensus       244 --------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         244 --------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             --------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                    00113567789999999999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=5e-29  Score=203.09  Aligned_cols=182  Identities=26%  Similarity=0.403  Sum_probs=138.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++....... .....++
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~~~~~~~  165 (284)
T cd06620          87 CGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-ADTFVGT  165 (284)
T ss_pred             CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-cCccccC
Confidence            57899999888889999999999999999999997 699999999999999999999999999876542222 2245678


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ----MRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..|+|||.+... .++.++|+|||||+++++++|..||........    ...+...                .......
T Consensus       166 ~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~  228 (284)
T cd06620         166 STYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL----------------LQQIVQE  228 (284)
T ss_pred             cccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH----------------HHHHhhc
Confidence            899999988654 578899999999999999999999976543210    0000000                0000000


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      ..    ...  ....++.++.+|+.+||+.||.+|||+.++++|+||.+-.
T Consensus       229 ~~----~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         229 PP----PRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             cC----CCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            00    000  0012567899999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=4.8e-29  Score=200.59  Aligned_cols=167  Identities=26%  Similarity=0.373  Sum_probs=133.0

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      |++|.+++.+.  ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+........  ....
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA  164 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence            68999999763  5689999999999999999999999999999999999999999999999999876543221  1123


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++|+||||+++|+|++ |..||...........+.....                     
T Consensus       165 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---------------------  222 (261)
T cd05072         165 KFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---------------------  222 (261)
T ss_pred             ccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            345679999988544 47889999999999999998 9999987665544444322110                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ......++.++.+++.+||+.+|++||+++++++
T Consensus       223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 ---------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                     0111246788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.96  E-value=5.7e-29  Score=199.96  Aligned_cols=167  Identities=19%  Similarity=0.277  Sum_probs=131.7

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc----cc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~----~~   76 (249)
                      |++|.+++.. ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.........    ..
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            6899999975 467999999999999999999999999999999999999999999999999998754332211    11


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+... .++.++|+||||+++|++++ |..||...........+....  .                  
T Consensus       158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~------------------  216 (257)
T cd05115         158 GKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--R------------------  216 (257)
T ss_pred             CCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--C------------------
Confidence            1224679999988644 47889999999999999996 999998766544333332110  0                  


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                .......++++.+++.+||..||.+||++.++.+
T Consensus       217 ----------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ----------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      0122346788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=3.1e-29  Score=201.04  Aligned_cols=168  Identities=28%  Similarity=0.466  Sum_probs=134.3

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~   78 (249)
                      |++|.+++...  ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  161 (255)
T cd08219          82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV  161 (255)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccccc
Confidence            57899988753  468999999999999999999999999999999999999999999999999986554322 223356


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.+. ..+.++|+||||+++++|++|..||...+.......+...  .                      
T Consensus       162 ~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~----------------------  216 (255)
T cd08219         162 GTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG--S----------------------  216 (255)
T ss_pred             CCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC--C----------------------
Confidence            78889999998654 4788999999999999999999999876543333322210  0                      


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                            .......++..+.++|.+||+.||.+|||+.++++-
T Consensus       217 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 ------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                  001122466789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.96  E-value=7.4e-29  Score=201.63  Aligned_cols=167  Identities=23%  Similarity=0.295  Sum_probs=130.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---ccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---~~~~~   77 (249)
                      +|+|.+++.+. +.+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+.......   .....
T Consensus        92 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  171 (279)
T cd05111          92 LGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH  171 (279)
T ss_pred             CCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCC
Confidence            68999999764 679999999999999999999999999999999999999999999999999987543321   11223


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|++||.+... .++.++|+||||+++|++++ |..||.+....... .+......++                  
T Consensus       172 ~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~------------------  231 (279)
T cd05111         172 KTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERLA------------------  231 (279)
T ss_pred             CCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCC------------------
Confidence            456679999988644 47899999999999999998 99999776533222 2211100000                  


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                 .....+.++.+++.+||..||.+|||+.++++
T Consensus       232 -----------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         232 -----------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             -----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                       01124567889999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=204.85  Aligned_cols=181  Identities=25%  Similarity=0.441  Sum_probs=158.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCC-CCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT-SENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~-~~~~~~~~~~~~   80 (249)
                      ||||.=.+++-+++-+..+..++.+|+-||-+||++||++||+|.+||+++.+|.+||.|||+++.. ....+..+.+||
T Consensus       434 GGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGT  513 (683)
T KOG0696|consen  434 GGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGT  513 (683)
T ss_pred             CchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCC
Confidence            7899989999999999999999999999999999999999999999999999999999999999853 345566789999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++. ..+|+.++|.|++||++|||+.|++||.+.+.....+.|...-..++                      
T Consensus       514 PdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----------------------  570 (683)
T KOG0696|consen  514 PDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----------------------  570 (683)
T ss_pred             CcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----------------------
Confidence            9999999885 44599999999999999999999999999998888888876433333                      


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcCCCCCCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLHDEADEPV  214 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~~~~~~~~  214 (249)
                               ..+|.++.++++..|.+.|.+|..     -.++-.||||+....+..+.-
T Consensus       571 ---------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~  620 (683)
T KOG0696|consen  571 ---------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERR  620 (683)
T ss_pred             ---------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhc
Confidence                     357888999999999999999974     357888999999886555543

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.96  E-value=5.7e-29  Score=202.36  Aligned_cols=167  Identities=20%  Similarity=0.359  Sum_probs=131.0

Q ss_pred             CccHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683            2 DTDLYQIIRSNQ---------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus         2 ~~~L~~~l~~~~---------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      +++|.+++.+.+               .+++..+..++.||+.|++|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~  170 (280)
T cd05092          91 HGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR  170 (280)
T ss_pred             CCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCcee
Confidence            578999987643               48999999999999999999999999999999999999999999999999886


Q ss_pred             CCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 025683           67 PTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADL  142 (249)
Q Consensus        67 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  142 (249)
                      .......   .....++..|+|||.+.... ++.++|+|||||++|+|++ |..||...........+.....       
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------  242 (280)
T cd05092         171 DIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE-------  242 (280)
T ss_pred             EcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc-------
Confidence            5432211   11223467799999886544 7889999999999999998 8999876654443333221000       


Q ss_pred             cccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          143 GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                             ......+++.+.+++.+||+.||.+||++.+++.
T Consensus       243 -----------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         243 -----------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                   0112246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=6.3e-29  Score=200.29  Aligned_cols=164  Identities=20%  Similarity=0.269  Sum_probs=126.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC-------eEEeecCCccCCCCCCc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-------LKICDFGLARPTSENEF   73 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~-------~kL~dfg~~~~~~~~~~   73 (249)
                      +++|..++.+. ..+++..+.+++.||+.||+|||++|++|+||||+||+++.++.       ++++|||.+......  
T Consensus        88 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--  165 (262)
T cd05077          88 FGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--  165 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc--
Confidence            46888888764 57999999999999999999999999999999999999987664       899999987654322  


Q ss_pred             cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           74 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                       ....++..|+|||.+.....++.++|||||||++|+|+ .|..||.......... ...   ..               
T Consensus       166 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~---~~---------------  225 (262)
T cd05077         166 -QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYE---GQ---------------  225 (262)
T ss_pred             -ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHh---cC---------------
Confidence             23456778999998865556889999999999999998 5788876543221111 100   00               


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                   .......++++.+|+.+||+.||.+||++.+|+.+
T Consensus       226 -------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 -------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                         00111234678899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.96  E-value=6.5e-29  Score=199.40  Aligned_cols=168  Identities=19%  Similarity=0.286  Sum_probs=132.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc--ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~--~~~   78 (249)
                      |++|.+++.+. ..+++..+..++.||+.|+.|||+.|++|+||+|+||+++.++.++|+|||.+..........  ...
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  162 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK  162 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCC
Confidence            67899999764 578999999999999999999999999999999999999999999999999887544322111  112


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+.+. .++.++|+||||+++|++++ |..||....+......+.....                      
T Consensus       163 ~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------  219 (256)
T cd05059         163 FPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR----------------------  219 (256)
T ss_pred             CCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc----------------------
Confidence            34569999988654 47889999999999999998 7899976654443333221100                      


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                              .......+.++.+++.+||+.+|.+|||+.++++.
T Consensus       220 --------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 --------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             --------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                    01122467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=8.6e-29  Score=198.63  Aligned_cols=167  Identities=21%  Similarity=0.333  Sum_probs=132.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc--cccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~   78 (249)
                      ||+|.+++... +.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.........  ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK  162 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence            68999999764 56899999999999999999999999999999999999999999999999988754332221  1223


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+... .++.++|+||||+++|+|++ |..||...+.......+......                     
T Consensus       163 ~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------------------  220 (256)
T cd05114         163 FPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL---------------------  220 (256)
T ss_pred             CchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC---------------------
Confidence            45679999988644 47889999999999999999 89999877655444444321000                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       221 ---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 ---------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                     011134577899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.96  E-value=1.1e-28  Score=198.03  Aligned_cols=168  Identities=23%  Similarity=0.306  Sum_probs=134.3

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----cc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MT   75 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~   75 (249)
                      +++|.+++.+..  .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+........    ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            689999998864  689999999999999999999999999999999999999999999999999876543211    11


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ...++..|+|||.+... .++.++|+||||+++++|++ |..||...+.......+......                  
T Consensus       159 ~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------  219 (257)
T cd05040         159 HLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER------------------  219 (257)
T ss_pred             CCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc------------------
Confidence            23456779999987544 47889999999999999998 99999777655544444321000                  


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                 .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       220 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 -----------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -----------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                       0011245678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.96  E-value=7.7e-29  Score=202.97  Aligned_cols=174  Identities=25%  Similarity=0.334  Sum_probs=133.7

Q ss_pred             CccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC
Q 025683            2 DTDLYQIIRSNQ-----------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE   70 (249)
Q Consensus         2 ~~~L~~~l~~~~-----------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~   70 (249)
                      +++|.+++.+..           .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05051         103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             CCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeeccc
Confidence            578999998765           799999999999999999999999999999999999999999999999999875433


Q ss_pred             CC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           71 NE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        71 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                      ..   ......++..|+|||.+... .++.++|+|||||++|+|++  +..||....................       
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-------  254 (296)
T cd05051         183 SDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG-------  254 (296)
T ss_pred             CcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc-------
Confidence            22   11223456789999988654 47899999999999999987  6678876655444444332111100       


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                      ...........+.++.+++.+||+.||.+|||+.++++
T Consensus       255 ----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         255 ----------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ----------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence                            00001112346688999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.96  E-value=6.7e-29  Score=209.97  Aligned_cols=157  Identities=29%  Similarity=0.430  Sum_probs=120.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc---ccccccccccCchhcc
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEYVVTRWYRAPELLL   90 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~   90 (249)
                      .+++..+.+++.||+.||+|||++|++||||||+||+++.++.++|+|||++.........   ....++..|+|||.+.
T Consensus       210 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  289 (375)
T cd05104         210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF  289 (375)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhc
Confidence            5788999999999999999999999999999999999999999999999998755432211   1123356799999986


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcC
Q 025683           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (249)
Q Consensus        91 ~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (249)
                      +. .++.++|+|||||++|+|++ |..||..................                             ...+
T Consensus       290 ~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~  339 (375)
T cd05104         290 NC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR-----------------------------MLSP  339 (375)
T ss_pred             CC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc-----------------------------CCCC
Confidence            54 47899999999999999997 88888765433222222110000                             0011


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          170 PHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       170 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ...+.++.+|+.+||+.||.+|||+.++++.
T Consensus       340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            2356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=3.1e-29  Score=205.03  Aligned_cols=168  Identities=27%  Similarity=0.445  Sum_probs=131.7

Q ss_pred             CccHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRS----------------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~----------------~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      +|+|.+++..                .+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~  179 (293)
T cd05053         100 HGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA  179 (293)
T ss_pred             CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccc
Confidence            5789999864                356899999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      ........   .....++..|+|||.+... .++.++|+|||||++|++++ |..||...........+.....      
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------  252 (293)
T cd05053         180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR------  252 (293)
T ss_pred             cccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc------
Confidence            76543221   1112235679999987544 47889999999999999997 8999977654443333221000      


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                              ...+...+..+.+|+.+||..||.+|||+.+++++
T Consensus       253 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         253 ------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                                    01122456789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.96  E-value=9.9e-29  Score=198.79  Aligned_cols=167  Identities=27%  Similarity=0.370  Sum_probs=131.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      |++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........  ....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence            57999999764  3589999999999999999999999999999999999999999999999999875533221  1123


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||..... ..+.++|+||||+++|+|++ |..||.+..+......+.....                     
T Consensus       164 ~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------------  221 (260)
T cd05069         164 KFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---------------------  221 (260)
T ss_pred             ccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            346679999987544 47889999999999999998 8999987665444433321100                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               .......+..+.+++++||+.||.+||+++++++
T Consensus       222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         222 ---------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ---------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                     0112246788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.96  E-value=9.8e-29  Score=197.81  Aligned_cols=167  Identities=22%  Similarity=0.356  Sum_probs=128.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc---cc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT---EY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~---~~   77 (249)
                      |++|.+++.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..........   ..
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            67999999764 468999999999999999999999999999999999999999999999999987543221111   11


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+..|+|||.+... .++.++|+||||+++|+|++ |..||...........+.....                     
T Consensus       157 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---------------------  214 (252)
T cd05084         157 QIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---------------------  214 (252)
T ss_pred             CCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------------------
Confidence            224569999988544 47889999999999999997 8888866544332222221000                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               .......+..+.+++.+||+.||.+|||+.++++
T Consensus       215 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         215 ---------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                     0112245778999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.96  E-value=8.7e-29  Score=199.05  Aligned_cols=167  Identities=26%  Similarity=0.379  Sum_probs=131.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc--ccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~   77 (249)
                      |++|.+++.+.  ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.........  ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence            57999999764  46899999999999999999999999999999999999999999999999998765432211  122


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||..... .++.++|+||||+++++|++ |..||...+.......+.....                     
T Consensus       164 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------------  221 (260)
T cd05070         164 KFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR---------------------  221 (260)
T ss_pred             CCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            345679999987544 47889999999999999998 8899977654444433321100                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               .......+..+.+++.+||..+|.+|||+.++++
T Consensus       222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         222 ---------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                     0112246778999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=1.2e-28  Score=198.67  Aligned_cols=167  Identities=26%  Similarity=0.385  Sum_probs=131.8

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc--ccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~   77 (249)
                      |++|.+++.+.  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........  ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~  163 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  163 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence            57999999864  45899999999999999999999999999999999999999999999999998755433221  123


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||..... .++.++|+||||+++|+|++ |..||...........+......                    
T Consensus       164 ~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------------------  222 (262)
T cd05071         164 KFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------------  222 (262)
T ss_pred             cccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC--------------------
Confidence            446679999987544 47899999999999999999 88888776544443332210000                    


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ......+..+.+++.+||+.||.+||++.++++
T Consensus       223 ----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 ----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                      011246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=1.2e-28  Score=198.19  Aligned_cols=170  Identities=31%  Similarity=0.533  Sum_probs=133.9

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~   76 (249)
                      |++|.+++.+    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+....... ....
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~  164 (260)
T cd08222          86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATT  164 (260)
T ss_pred             CCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcccccC
Confidence            5688888754    367999999999999999999999999999999999999975 679999999886653322 2223


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|++||.+... .++.++|+||+|+++|+|++|..||...........+..   ...                  
T Consensus       165 ~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---~~~------------------  222 (260)
T cd08222         165 FTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---GPT------------------  222 (260)
T ss_pred             CCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---CCC------------------
Confidence            4567889999987543 477899999999999999999999976554333332211   100                  


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                               .......+.++.++|.+||..||.+||++.++++||||
T Consensus       223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         223 ---------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ---------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                     01122466789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-29  Score=198.19  Aligned_cols=182  Identities=23%  Similarity=0.440  Sum_probs=145.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCC-CCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT-SENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~-~~~~~~~~~~~~   80 (249)
                      ||+|.-.++++++|+++.++.+..+|+.||+|||++||++||+|.+|+|++..|.+||.|||.++.. ..+....+.+||
T Consensus       335 ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgt  414 (593)
T KOG0695|consen  335 GGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGT  414 (593)
T ss_pred             CcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCC
Confidence            7888888899999999999999999999999999999999999999999999999999999999864 445667789999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++.+.. ++.++|.|+|||+++||+.|+.||.-...                    ..++...+.|..+..- 
T Consensus       415 pnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm--------------------~n~d~ntedylfqvil-  472 (593)
T KOG0695|consen  415 PNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGM--------------------DNPDMNTEDYLFQVIL-  472 (593)
T ss_pred             Ccccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecC--------------------CCcccchhHHHHHHHh-
Confidence            9999999997665 89999999999999999999999952210                    0001111111110000 


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC------CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI------TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp------t~~~ll~h~~~~~~~  207 (249)
                       + .-..++..+|.....+++..|++||.+|.      .+.++..|+||+...
T Consensus       473 -e-kqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  473 -E-KQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             -h-hcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence             0 00123445677788999999999999997      478999999999776

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=1e-28  Score=198.75  Aligned_cols=167  Identities=25%  Similarity=0.346  Sum_probs=132.3

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc--ccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~   77 (249)
                      |++|.+++.+..  .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.........  ...
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA  164 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence            789999998754  7999999999999999999999999999999999999999999999999988765432211  111


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+..|+|||..... .++.++|+||||+++++|++ |..||.+.........+......                    
T Consensus       165 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------------  223 (261)
T cd05068         165 KFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM--------------------  223 (261)
T ss_pred             cCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            224579999987544 47889999999999999998 99999876654444433221000                    


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ......+..+.+++.+||+.+|.+||++.++++
T Consensus       224 ----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 ----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                      011245678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=9.1e-29  Score=199.59  Aligned_cols=168  Identities=23%  Similarity=0.335  Sum_probs=132.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cc--ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FM--TEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~--~~~   77 (249)
                      |++|.+++.+. +.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+....... ..  ...
T Consensus        89 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  168 (266)
T cd05033          89 NGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGG  168 (266)
T ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCC
Confidence            67999999774 579999999999999999999999999999999999999999999999999988764211 11  112


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++|+||||+++|+|++ |..||...........+......                    
T Consensus       169 ~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  227 (266)
T cd05033         169 KIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL--------------------  227 (266)
T ss_pred             CCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            335679999988644 47889999999999999997 99998766544433333211000                    


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                ......++.+.+++.+||+.+|.+||++.+++++
T Consensus       228 ----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         228 ----------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                      0112467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=1.2e-28  Score=198.30  Aligned_cols=167  Identities=22%  Similarity=0.358  Sum_probs=133.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~   78 (249)
                      |++|.+++.+.  ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~  165 (261)
T cd05148          86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK  165 (261)
T ss_pred             cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCC
Confidence            57999999864  4689999999999999999999999999999999999999999999999999876543221 11233


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|++||..... .++.++|+||||+++++|++ |..||...........+......                     
T Consensus       166 ~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  223 (261)
T cd05148         166 IPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---------------------  223 (261)
T ss_pred             CceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---------------------
Confidence            45679999988644 47889999999999999998 89999876654444443321100                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ......++.+.+++.+||+.||.+|||+.++++
T Consensus       224 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 ---------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                     112246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.96  E-value=1.4e-28  Score=203.38  Aligned_cols=167  Identities=28%  Similarity=0.414  Sum_probs=131.1

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      +|+|.+++.+.                ..++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+
T Consensus       102 ~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~  181 (314)
T cd05099         102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA  181 (314)
T ss_pred             CCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEcccccc
Confidence            57999999763                34889999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      +.......   .....++..|+|||.+... .++.++|+||||+++|+|++ |..||...........+....       
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------  253 (314)
T cd05099         182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH-------  253 (314)
T ss_pred             ccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            76543221   1112234579999988654 47889999999999999998 888987765444333332100       


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                             ........+.++.+++.+||+.||.+|||+.++++
T Consensus       254 -----------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         254 -----------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                   00112346678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.96  E-value=8.5e-29  Score=200.21  Aligned_cols=168  Identities=22%  Similarity=0.315  Sum_probs=131.2

Q ss_pred             CccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc-
Q 025683            2 DTDLYQIIRSN------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-   74 (249)
Q Consensus         2 ~~~L~~~l~~~------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~-   74 (249)
                      +++|.+++...      ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++........ 
T Consensus        91 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  170 (273)
T cd05035          91 HGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR  170 (273)
T ss_pred             CCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeecccccccc
Confidence            57888888543      36899999999999999999999999999999999999999999999999998754432211 


Q ss_pred             --ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           75 --TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        75 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                        .....+..|++||.+.. ..++.++|+|||||++|+|++ |..||.+.........+....                 
T Consensus       171 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----------------  232 (273)
T cd05035         171 QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-----------------  232 (273)
T ss_pred             ccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence              11233567999998754 347889999999999999998 889987765444333222100                 


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                   ....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       233 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 -------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             -------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         011223567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.96  E-value=1.4e-28  Score=202.20  Aligned_cols=168  Identities=30%  Similarity=0.443  Sum_probs=130.9

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---ccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~   76 (249)
                      ||+|.+++....  .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+........   ...
T Consensus       123 ~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  202 (302)
T cd05055         123 YGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN  202 (302)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCC
Confidence            689999997643  389999999999999999999999999999999999999999999999999875543221   112


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+.... ++.++|+||+||++|+|++ |..||..................                   
T Consensus       203 ~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------------  262 (302)
T cd05055         203 ARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR-------------------  262 (302)
T ss_pred             CCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc-------------------
Confidence            33467799999886544 7889999999999999998 89998765433322222110000                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                .......++++.+++.+||+.+|.+|||+.+++.
T Consensus       263 ----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         263 ----------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                      0011245688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=1.5e-28  Score=197.78  Aligned_cols=168  Identities=28%  Similarity=0.416  Sum_probs=128.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-----cc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MT   75 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-----~~   75 (249)
                      +++|.+++.+. ..++...+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||.+........     ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  160 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT  160 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence            58999999874 4578888999999999999999999999999999999999999999999999875432211     11


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ...++..|+|||.+... .++.++|+||||+++|+|++| .+||...+.......+..  +..                 
T Consensus       161 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~--~~~-----------------  220 (262)
T cd05058         161 GAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRR-----------------  220 (262)
T ss_pred             cCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc--CCC-----------------
Confidence            23346679999988654 488999999999999999995 566665543332222111  000                 


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                 .......++.+.+++.+||..+|.+||++.+++..
T Consensus       221 -----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         221 -----------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             -----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                       00111356789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.96  E-value=1.8e-29  Score=203.19  Aligned_cols=167  Identities=31%  Similarity=0.467  Sum_probs=131.0

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---ccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~   76 (249)
                      +|+|.++|...  ..++...+..++.||+.||.|||+++++|++|+++||+++.++.+||+|||+.........   ...
T Consensus        85 ~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~  164 (259)
T PF07714_consen   85 GGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSS  164 (259)
T ss_dssp             TEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            57999999997  7899999999999999999999999999999999999999999999999999876632221   122


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ......|+|||.+.... ++.++||||||+++||+++ |..||...+.......+.....                    
T Consensus       165 ~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------------------  223 (259)
T PF07714_consen  165 QQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------------------  223 (259)
T ss_dssp             SESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------------------
T ss_pred             ccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------------------
Confidence            34567799999986554 7899999999999999999 7899877765554444422111                    


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                .......+..+.++|..||+.||.+|||+.++++
T Consensus       224 ----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  224 ----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                      1122346788999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.6e-28  Score=196.96  Aligned_cols=165  Identities=24%  Similarity=0.375  Sum_probs=131.8

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      +++|.+++.+..  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........  ....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~~~~  161 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SGKL  161 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--cCCC
Confidence            479999998765  799999999999999999999999999999999999999999999999999876633221  2334


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +..|+|||.+... .++.++|+||||++++++++ |..||...........+....                        
T Consensus       162 ~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------------------  216 (256)
T cd05039         162 PVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY------------------------  216 (256)
T ss_pred             cccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC------------------------
Confidence            5679999988544 47889999999999999997 999987665443322221100                        


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                         .   .......++.+.++|.+||..+|.+|||+++++.
T Consensus       217 ---~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 ---R---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             ---C---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence               0   0112246788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=203.51  Aligned_cols=175  Identities=25%  Similarity=0.432  Sum_probs=144.1

Q ss_pred             ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            3 TDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         3 ~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||+.|++.- ++.|++.++..+++..+.||+|||...-+|||||..|||++.+|..||.|||.+...... ...+..+||
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGT  192 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGT  192 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccC
Confidence            688888865 478999999999999999999999999999999999999999999999999998765443 445678999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++..-+ |...+||||||++..||..|++||....+...+..|   -..|++.                    
T Consensus       193 PFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPT--------------------  248 (502)
T KOG0574|consen  193 PFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPT--------------------  248 (502)
T ss_pred             cccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCC--------------------
Confidence            9999999997665 889999999999999999999999876543222111   1111110                    


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                           ..-++..|.++-+||++||.++|++|-|+.+|++|+|+++.
T Consensus       249 -----F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  249 -----FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             -----CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence                 11122356789999999999999999999999999999975

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.96  E-value=1.4e-28  Score=200.96  Aligned_cols=155  Identities=26%  Similarity=0.386  Sum_probs=121.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccccccccccCchhcc
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYVVTRWYRAPELLL   90 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~   90 (249)
                      .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........   .....++..|+|||.+.
T Consensus       123 ~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  202 (290)
T cd05045         123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF  202 (290)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence            588999999999999999999999999999999999999999999999999875432211   11223456799999875


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcC
Q 025683           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (249)
Q Consensus        91 ~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (249)
                      .. .++.++|+||||+++++|++ |..||.+.........+.....                              ....
T Consensus       203 ~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~  251 (290)
T cd05045         203 DH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR------------------------------MERP  251 (290)
T ss_pred             cC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC------------------------------CCCC
Confidence            44 47899999999999999998 9999977654443332221000                              0012


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          170 PHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       170 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ...+.++.+++.+||+.+|.+||++.++++
T Consensus       252 ~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         252 ENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            246788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=216.64  Aligned_cols=177  Identities=33%  Similarity=0.567  Sum_probs=146.4

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC---CCeEEeecCCccCCCCCCccc
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSENEFMT   75 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~---~~~kL~dfg~~~~~~~~~~~~   75 (249)
                      |.||....|.++  ++|++...+.++.||+.||.|||-+||+|+|+||+|||+...   ..+||||||+++.+++.....
T Consensus       645 l~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr  724 (888)
T KOG4236|consen  645 LHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR  724 (888)
T ss_pred             hcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence            356666666543  899999999999999999999999999999999999999754   468999999999999988888


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..+||+.|+|||++...+ +..+.|+||.||++|--+.|..||..+.+  ...+|....=.++.                
T Consensus       725 sVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp----------------  785 (888)
T KOG4236|consen  725 SVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPP----------------  785 (888)
T ss_pred             hhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCC----------------
Confidence            999999999999997665 89999999999999999999999976542  12222211111111                


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                 +-|..+++.+++||..+|+.+-.+|.|++..|+|||++...
T Consensus       786 -----------~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  786 -----------NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             -----------CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence                       12335788999999999999999999999999999999864

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=1.6e-28  Score=198.20  Aligned_cols=170  Identities=27%  Similarity=0.424  Sum_probs=130.4

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~   76 (249)
                      +++|.+++..    ...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  165 (267)
T cd08228          86 AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS  165 (267)
T ss_pred             CCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhc
Confidence            4688888853    35589999999999999999999999999999999999999999999999998876543221 223


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+.+. .++.++|+||+|+++|+|++|..||..... ...........+.++                 
T Consensus       166 ~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------  227 (267)
T cd08228         166 LVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP-----------------  227 (267)
T ss_pred             CCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC-----------------
Confidence            4677889999988654 478899999999999999999999865432 111111111111100                 


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                 ......+..+.+++.+||..+|.+||++.++++.
T Consensus       228 -----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         228 -----------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             -----------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                       0011356779999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.7e-28  Score=199.03  Aligned_cols=167  Identities=22%  Similarity=0.405  Sum_probs=131.3

Q ss_pred             CccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC
Q 025683            2 DTDLYQIIRSN----------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (249)
Q Consensus         2 ~~~L~~~l~~~----------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~   71 (249)
                      +++|.+++...          ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||.++.....
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~  172 (277)
T cd05032          93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET  172 (277)
T ss_pred             CCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccC
Confidence            57999999753          24788899999999999999999999999999999999999999999999998754433


Q ss_pred             Cc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           72 EF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        72 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                      ..   .....++..|+|||.+... .++.++|+|||||++|++++ |..||...+.......+..  +..          
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~~----------  239 (277)
T cd05032         173 DYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GGH----------  239 (277)
T ss_pred             cccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc--CCC----------
Confidence            21   1223456789999988644 47889999999999999998 8999977654443333221  000          


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                        ...+...+.++.+++.+||+.+|.+|||+.++++
T Consensus       240 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         240 ------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                              1112245788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=2.1e-28  Score=196.73  Aligned_cols=164  Identities=16%  Similarity=0.242  Sum_probs=127.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC--------eEEeecCCccCCCCCC
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--------LKICDFGLARPTSENE   72 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~--------~kL~dfg~~~~~~~~~   72 (249)
                      +|+|.+++.+. ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.        ++++|||.+...... 
T Consensus        83 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-  161 (258)
T cd05078          83 FGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-  161 (258)
T ss_pred             CCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc-
Confidence            67999999875 46899999999999999999999999999999999999987764        699999987654322 


Q ss_pred             ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        73 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                        ....++..|+|||.+.....++.++|+||||+++|+|++|. .||..............                   
T Consensus       162 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-------------------  220 (258)
T cd05078         162 --EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED-------------------  220 (258)
T ss_pred             --hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc-------------------
Confidence              23456778999999876555788999999999999999984 56554433222111100                   


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                           .        ..++...+.++.+++.+||+.||.+|||++++++.
T Consensus       221 -----~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 -----R--------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             -----c--------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                 0        01122345678999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=1.8e-28  Score=196.82  Aligned_cols=163  Identities=20%  Similarity=0.251  Sum_probs=127.2

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-------CeEEeecCCccCCCCCCc
Q 025683            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-------DLKICDFGLARPTSENEF   73 (249)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-------~~kL~dfg~~~~~~~~~~   73 (249)
                      ||+|.+++.+.+ .++...+..++.||+.||+|||++|++|+||||+||+++.++       .++|+|||.+.....   
T Consensus        84 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---  160 (259)
T cd05037          84 FGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---  160 (259)
T ss_pred             CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc---
Confidence            689999998866 799999999999999999999999999999999999999887       799999998876443   


Q ss_pred             cccccccccccCchhccCC-CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           74 MTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      .....++..|+|||.+... ..++.++|+||||+++|+|++ |..||...+..........                   
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-------------------  221 (259)
T cd05037         161 REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-------------------  221 (259)
T ss_pred             ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-------------------
Confidence            2233456679999998655 357899999999999999998 5777755532211111110                   


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                           ..        .........+.+++.+||..+|.+|||+.++++
T Consensus       222 -----~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         222 -----QH--------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -----CC--------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                 00        000012267889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.96  E-value=1.8e-28  Score=197.22  Aligned_cols=167  Identities=25%  Similarity=0.354  Sum_probs=132.6

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      |++|.+++.+.  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........  ....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA  163 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCC
Confidence            67999998764  4689999999999999999999999999999999999999999999999999876542221  1122


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... ..+.++|+||||++++++++ |..||.+.+.......+......                    
T Consensus       164 ~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  222 (260)
T cd05067         164 KFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM--------------------  222 (260)
T ss_pred             cccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------------------
Confidence            345679999988544 47889999999999999998 99999877655444433221100                    


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ......+.++.+++.+||+.+|.+|||++++++
T Consensus       223 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 ----------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                      112246678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=2.4e-28  Score=198.94  Aligned_cols=168  Identities=19%  Similarity=0.362  Sum_probs=130.5

Q ss_pred             CccHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCC
Q 025683            2 DTDLYQIIRSN-----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL   64 (249)
Q Consensus         2 ~~~L~~~l~~~-----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~   64 (249)
                      +++|.+++...                 ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~  170 (283)
T cd05090          91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL  170 (283)
T ss_pred             CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccc
Confidence            57899998532                 2478999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 025683           65 ARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDA  140 (249)
Q Consensus        65 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  140 (249)
                      +.......   ......++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.........+.. ..     
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~-----  243 (283)
T cd05090         171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK-RQ-----  243 (283)
T ss_pred             cccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CC-----
Confidence            87643322   11223345679999988644 47899999999999999998 8889876654333332221 00     


Q ss_pred             cccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          141 DLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                              ....+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       244 ------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         244 ------------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             ------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                                    011223467889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.96  E-value=2.5e-28  Score=197.02  Aligned_cols=169  Identities=28%  Similarity=0.435  Sum_probs=129.9

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~   76 (249)
                      |++|.+++..    ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd08229          86 AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS  165 (267)
T ss_pred             CCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCccccc
Confidence            5789998874    35689999999999999999999999999999999999999999999999998865543222 223


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-HQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+... ..+.++|+||||+++|+|++|..||.+.... ............+                  
T Consensus       166 ~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------  226 (267)
T cd08229         166 LVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP------------------  226 (267)
T ss_pred             ccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC------------------
Confidence            4678889999988544 4788999999999999999999999654321 1110100000000                  


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ......+++.+.+++.+||+.||.+|||+.++++
T Consensus       227 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         227 ----------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ----------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                      0011246778999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=1.7e-28  Score=202.17  Aligned_cols=168  Identities=27%  Similarity=0.407  Sum_probs=130.1

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      +++|.+++.+.                ..++...+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus       108 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a  187 (307)
T cd05098         108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA  187 (307)
T ss_pred             CCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCccc
Confidence            57999999764                24889999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcc---ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENEFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      .........   ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+...   .    
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~----  259 (307)
T cd05098         188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG---H----  259 (307)
T ss_pred             ccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC---C----
Confidence            755432211   112234679999988654 47889999999999999998 88888665433222222110   0    


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                             ....+...+.++.+++.+||+.+|.+|||+.+++++
T Consensus       260 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         260 -----------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             -----------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                                   001223467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=2.3e-28  Score=195.93  Aligned_cols=167  Identities=29%  Similarity=0.454  Sum_probs=133.6

Q ss_pred             CccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc--cc
Q 025683            2 DTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~--~~   77 (249)
                      |++|.+++.....  +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+..........  ..
T Consensus        85 ~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (258)
T smart00219       85 GGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGG  164 (258)
T ss_pred             CCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccC
Confidence            6799999987654  9999999999999999999999999999999999999999999999999987655432221  12


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|++||.+. ...++.++|+||+|+++++|++ |..||...........+.....                     
T Consensus       165 ~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------------  222 (258)
T smart00219      165 KLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---------------------  222 (258)
T ss_pred             CCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------------------
Confidence            3567899999884 4458899999999999999998 7888877654444443322100                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               .......+.++.+++.+||+.||.+|||+.++++
T Consensus       223 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 ---------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                     0112236788999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.5e-28  Score=196.39  Aligned_cols=167  Identities=27%  Similarity=0.381  Sum_probs=132.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      |++|.+++.+.  ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+........  ....
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  164 (261)
T cd05034          85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA  164 (261)
T ss_pred             CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence            57999999875  4799999999999999999999999999999999999999999999999998876543211  1122


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+..|+|||.+.+. ..+.++|+||+|++++++++ |..||.+.........+......                    
T Consensus       165 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------------------  223 (261)
T cd05034         165 KFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM--------------------  223 (261)
T ss_pred             CCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            335679999988644 47889999999999999998 99999877655555444321110                    


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ......+.++.+++.+||+.+|.+||+++++++
T Consensus       224 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 ----------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                      011234678999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.96  E-value=2.5e-28  Score=200.90  Aligned_cols=168  Identities=27%  Similarity=0.407  Sum_probs=131.1

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      +++|.+++.+.                ..++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~  184 (304)
T cd05101         105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA  184 (304)
T ss_pred             CCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccc
Confidence            57999999764                24788899999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      ........   .....++..|+|||.+.+. .++.++|+||||+++|++++ |..||.+.........+.....      
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------  257 (304)
T cd05101         185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR------  257 (304)
T ss_pred             eecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc------
Confidence            76543221   1123345679999988654 47889999999999999998 7788876654443333221000      


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                              .......+..+.+|+.+||+.+|.+|||+.++++.
T Consensus       258 ------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         258 ------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence                                    01122467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=2.5e-28  Score=197.32  Aligned_cols=172  Identities=24%  Similarity=0.337  Sum_probs=129.1

Q ss_pred             CccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---
Q 025683            2 DTDLYQIIRSNQ-----SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---   73 (249)
Q Consensus         2 ~~~L~~~l~~~~-----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---   73 (249)
                      +|+|.+++.+..     .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+........   
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            579999998743     346788899999999999999999999999999999999999999999998865332211   


Q ss_pred             cccccccccccCchhccC------CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 025683           74 MTEYVVTRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR  146 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (249)
                      .....++..|+|||.+..      ...++.++|+|||||++|+|++ |..||....+...............        
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------  230 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--------  230 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC--------
Confidence            122344667999998743      2246789999999999999998 7888877765544444332111100        


Q ss_pred             hhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                       ....+....++.+.+++..|+ .||.+|||+++|++
T Consensus       231 -----------------~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         231 -----------------PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -----------------CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                             001122346778889999998 59999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-29  Score=219.61  Aligned_cols=163  Identities=26%  Similarity=0.451  Sum_probs=130.0

Q ss_pred             CccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cc--
Q 025683            2 DTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FM--   74 (249)
Q Consensus         2 ~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~--   74 (249)
                      ||.|-|+|.+  +.+|++.++++|+.++++|+.+||..+  |+|||||.+|||++.+|..||||||.+.-..... ..  
T Consensus       126 gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e  205 (738)
T KOG1989|consen  126 GGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQE  205 (738)
T ss_pred             CCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHH
Confidence            4799999986  367999999999999999999999997  9999999999999999999999999876433221 11  


Q ss_pred             -------ccccccccccCchhcc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           75 -------TEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        75 -------~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                             -....|+.|++||.+.  .....+.|+|||+|||++|.|+..+.||........+   -.             
T Consensus       206 ~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl---ng-------------  269 (738)
T KOG1989|consen  206 VNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL---NG-------------  269 (738)
T ss_pred             HHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE---ec-------------
Confidence                   1134588999999974  2334789999999999999999999999765211000   00             


Q ss_pred             chhhHHHHHHhCCCCCCcchhhc--CCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQV--FPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                      .   ..+  .++++..+.+||+.||+.||.+||++.+++.
T Consensus       270 ----------------~---Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  270 ----------------N---YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             ----------------c---ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence                            0   011  1357888999999999999999999999986

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=3e-28  Score=194.83  Aligned_cols=167  Identities=25%  Similarity=0.360  Sum_probs=130.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc---ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~---~~~   77 (249)
                      |++|.+++.+. ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+.........   ...
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            68899999764 57899999999999999999999999999999999999999999999999998754422111   112


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+..|+|||.+.+. .++.++|+||||+++++|++ |..||...........+.....                     
T Consensus       156 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~---------------------  213 (251)
T cd05041         156 QIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR---------------------  213 (251)
T ss_pred             cceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---------------------
Confidence            235569999988544 47899999999999999998 7888876654333332221000                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               .......+.++.+++.+||+.+|.+|||+.++++
T Consensus       214 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         214 ---------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             ---------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                     0011245678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.96  E-value=2.6e-28  Score=198.35  Aligned_cols=167  Identities=22%  Similarity=0.309  Sum_probs=130.8

Q ss_pred             CccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc
Q 025683            2 DTDLYQIIRSN--------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (249)
Q Consensus         2 ~~~L~~~l~~~--------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~   73 (249)
                      +++|.+++...        ..+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||+++.......
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~  172 (280)
T cd05043          93 WGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY  172 (280)
T ss_pred             CCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCce
Confidence            57999999764        4589999999999999999999999999999999999999999999999999875433221


Q ss_pred             ---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhh
Q 025683           74 ---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNED  149 (249)
Q Consensus        74 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (249)
                         .....++..|+|||.+... .++.++||||||+++|++++ |..||...+.......+....  .            
T Consensus       173 ~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~------------  237 (280)
T cd05043         173 HCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY--R------------  237 (280)
T ss_pred             EEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC--C------------
Confidence               1123346679999988654 47899999999999999998 999997765433222221100  0            


Q ss_pred             HHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          150 AKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                      .......++++.+++.+||+.||++|||+.++++
T Consensus       238 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 ----------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                            0011235678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=3.9e-28  Score=192.27  Aligned_cols=173  Identities=40%  Similarity=0.728  Sum_probs=138.8

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW   82 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~   82 (249)
                      ++|.+++.....++...+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.............++..
T Consensus        72 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  151 (244)
T smart00220       72 GDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE  151 (244)
T ss_pred             CCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence            49999998877799999999999999999999999999999999999999999999999999887655444445667888


Q ss_pred             ccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCC
Q 025683           83 YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR  162 (249)
Q Consensus        83 y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (249)
                      |++||.+... ..+.++|+|++|++++++++|..||....................                        
T Consensus       152 ~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------------  206 (244)
T smart00220      152 YMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF------------------------  206 (244)
T ss_pred             CCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC------------------------
Confidence            9999988644 477899999999999999999999977433222222211100000                        


Q ss_pred             cchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          163 QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                         ......++.++.+++.+||..+|.+||++.++++||||
T Consensus       207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence               00011166789999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=3.3e-28  Score=195.02  Aligned_cols=165  Identities=22%  Similarity=0.342  Sum_probs=130.4

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      |++|.+++....  .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+......  ......
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~  159 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKL  159 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCCCCC
Confidence            679999998753  5899999999999999999999999999999999999999999999999988654322  122333


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +..|+|||.+... .++.++|+||||+++++|++ |..||...........+.....                       
T Consensus       160 ~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------  215 (254)
T cd05083         160 PVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-----------------------  215 (254)
T ss_pred             CceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-----------------------
Confidence            5679999988544 47889999999999999997 9999977654333222211000                       


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                             ......++..+.+++.+||+.+|.+||++.+++.
T Consensus       216 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 -------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   0112246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=4.8e-28  Score=196.38  Aligned_cols=164  Identities=20%  Similarity=0.256  Sum_probs=126.8

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-------CeEEeecCCccCCCCCCc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-------DLKICDFGLARPTSENEF   73 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-------~~kL~dfg~~~~~~~~~~   73 (249)
                      ||+|.+++.+ .+.+++..+..++.||+.||+|||++|++||||||+||+++..+       .++++|||.+......  
T Consensus       100 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--  177 (274)
T cd05076         100 HGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--  177 (274)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--
Confidence            5789999876 46799999999999999999999999999999999999997643       3899999987543221  


Q ss_pred             cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           74 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                       ....++..|+|||.+.+...++.++|+||||+++|+++ +|..||................                  
T Consensus       178 -~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------------  238 (274)
T cd05076         178 -EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKH------------------  238 (274)
T ss_pred             -cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhcc------------------
Confidence             12345777999998866556889999999999999985 6888887654332221111000                  


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                    ......++.+.++|.+||+.+|.+|||+.+++++
T Consensus       239 --------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         239 --------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             --------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence                          0111234678899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=212.70  Aligned_cols=172  Identities=22%  Similarity=0.370  Sum_probs=133.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC---CCccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE---NEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~---~~~~~~~   77 (249)
                      |.+|+.+|+-. .+|.....+.|++||++|+.|||.++|+|+|||..||++..+++|||+|||++.....   .......
T Consensus       471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp  550 (678)
T KOG0193|consen  471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQP  550 (678)
T ss_pred             CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCC
Confidence            67899998764 6799999999999999999999999999999999999999999999999999754322   1223345


Q ss_pred             cccccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           78 VVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        78 ~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      .+..-|+|||++..  ..+++..+|||+||+++|||++|..||. ....+++--++.....                   
T Consensus       551 ~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l-------------------  610 (678)
T KOG0193|consen  551 HGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYL-------------------  610 (678)
T ss_pred             ccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEeccccc-------------------
Confidence            56777999999863  3458999999999999999999999998 4333332222111000                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                            ......+..+.++++++|+..||.+++++||++.+||.
T Consensus       611 ------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  611 ------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                  11112223356678999999999999999999999987

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.96  E-value=4.9e-28  Score=195.75  Aligned_cols=168  Identities=25%  Similarity=0.369  Sum_probs=132.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc--ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~--~~~   78 (249)
                      +++|.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..........  ...
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  169 (270)
T cd05056          90 LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK  169 (270)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCC
Confidence            57999999875 468999999999999999999999999999999999999999999999999887554332111  122


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+... .++.++|+||||++++++++ |..||...........+.....                      
T Consensus       170 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~----------------------  226 (270)
T cd05056         170 LPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER----------------------  226 (270)
T ss_pred             ccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc----------------------
Confidence            34579999987544 47899999999999999986 9999987765444433321000                      


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                              ...++..+..+.+++.+|+..+|.+|||+.+++..
T Consensus       227 --------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         227 --------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                    01223567889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=3.6e-28  Score=197.88  Aligned_cols=181  Identities=23%  Similarity=0.281  Sum_probs=130.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----cccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~~   77 (249)
                      +++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+........    ....
T Consensus        92 ~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  170 (283)
T cd05080          92 LGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG  170 (283)
T ss_pred             CCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCC
Confidence            5789999987 4699999999999999999999999999999999999999999999999999876543221    1122


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|+|||.+... ..+.++|+||||+++++|++|..||.......  ..+.   ....    ...............
T Consensus       171 ~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~---~~~~----~~~~~~~~~~~~~~~  240 (283)
T cd05080         171 DSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMI---GPKQ----GQMTVVRLIELLERG  240 (283)
T ss_pred             CCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhh---cccc----cccchhhhhhhhhcC
Confidence            345669999988644 47889999999999999999999986543211  0110   0000    000000011111100


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ..      .......+..+.+++.+||+.||++|||+.++++
T Consensus       241 ~~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         241 MR------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CC------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            00      1123356789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=190.97  Aligned_cols=172  Identities=29%  Similarity=0.389  Sum_probs=128.0

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--
Q 025683            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--   73 (249)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--   73 (249)
                      .|||.+.+...    ..+++.++..++.+|++||++||+..  ++|+||||.||++.+++.+++.|||.+......-.  
T Consensus       107 ~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~  186 (302)
T KOG2345|consen  107 RGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGS  186 (302)
T ss_pred             cccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeech
Confidence            36788887653    47999999999999999999999998  99999999999999999999999998875432211  


Q ss_pred             --------cccccccccccCchhccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 025683           74 --------MTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        74 --------~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (249)
                              ......|..|+|||.+....  ..+.++|||||||++|.|+.|..||...-         +..++..-.   
T Consensus       187 ~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~GgSlaLA---  254 (302)
T KOG2345|consen  187 RQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQGGSLALA---  254 (302)
T ss_pred             HHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcCCeEEEe---
Confidence                    11234588899999985332  35789999999999999999999995321         100100000   


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                       +.+             ..-++.+ ...+|+.+.++|+.||+.||.+||++.+++.+
T Consensus       255 -v~n-------------~q~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  255 -VQN-------------AQISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             -eec-------------cccccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence             000             0000011 11378899999999999999999999999864

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.96  E-value=5.1e-28  Score=195.35  Aligned_cols=167  Identities=24%  Similarity=0.356  Sum_probs=131.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc----c
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----E   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~----~   76 (249)
                      +++|.+++.+. +.+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+..........    .
T Consensus        90 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  169 (268)
T cd05063          90 NGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG  169 (268)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccC
Confidence            57899999764 679999999999999999999999999999999999999999999999999887554322111    1


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...+..|++||.+... .++.++|+|||||++|++++ |..||...........+......+                  
T Consensus       170 ~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~------------------  230 (268)
T cd05063         170 GKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP------------------  230 (268)
T ss_pred             CCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC------------------
Confidence            1224569999988654 47899999999999999987 999997766554444443211100                  


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                  .....+.++.+++.+||+.+|.+||++.++++
T Consensus       231 ------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 ------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                        01135678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.96  E-value=4.4e-28  Score=202.03  Aligned_cols=168  Identities=27%  Similarity=0.408  Sum_probs=131.1

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      +|+|.+++.+.                ..++...+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus       102 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~  181 (334)
T cd05100         102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA  181 (334)
T ss_pred             CCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccc
Confidence            67999999763                24788999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcc---ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENEFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      .........   ....++..|+|||.+... .++.++|+||||+++|+|++ |..||.+.........+....       
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------  253 (334)
T cd05100         182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH-------  253 (334)
T ss_pred             eecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------
Confidence            755432211   112334579999988654 47889999999999999998 888887765444333322100       


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                             ........+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       254 -----------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         254 -----------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                                   001122456789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.96  E-value=6.8e-28  Score=192.62  Aligned_cols=167  Identities=24%  Similarity=0.378  Sum_probs=131.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc--ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT--EYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~--~~~   78 (249)
                      |++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..........  ...
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            68999998764 568999999999999999999999999999999999999999999999999886543322111  123


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+.. ..++.++|+||||+++|++++ |..||...........+.....                      
T Consensus       156 ~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------  212 (250)
T cd05085         156 IPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----------------------  212 (250)
T ss_pred             CcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence            3566999998854 447889999999999999998 9999977654433333221000                      


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                              ......++..+.+++.+||+.+|.+||++.++++
T Consensus       213 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         213 --------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                    0112246788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=5.5e-28  Score=195.26  Aligned_cols=169  Identities=27%  Similarity=0.450  Sum_probs=134.3

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~   76 (249)
                      |++|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|.||+++.++.++|+|||.+...........
T Consensus        93 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  172 (269)
T cd08528          93 GAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS  172 (269)
T ss_pred             CCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccccccc
Confidence            5788888743    3579999999999999999999996 6899999999999999999999999999876554443345


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|++||.+.+. .++.++|+||||+++|+|++|..||...........+......+.                  
T Consensus       173 ~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------  233 (269)
T cd08528         173 VVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL------------------  233 (269)
T ss_pred             ccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC------------------
Confidence            5678889999998654 478999999999999999999999976654433333322110000                  


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                 .....++.+.+++.+||+.||.+||++.++..+
T Consensus       234 -----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 -----------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             -----------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                       011356889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=6.5e-28  Score=195.44  Aligned_cols=169  Identities=22%  Similarity=0.320  Sum_probs=132.4

Q ss_pred             CccHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC
Q 025683            2 DTDLYQIIRSNQ---------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (249)
Q Consensus         2 ~~~L~~~l~~~~---------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~   72 (249)
                      +++|.+++....         .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++++|||.+.......
T Consensus        92 ~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~  171 (275)
T cd05046          92 LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE  171 (275)
T ss_pred             CCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCccc
Confidence            579999998765         79999999999999999999999999999999999999999999999999876432221


Q ss_pred             --ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhh
Q 025683           73 --FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNED  149 (249)
Q Consensus        73 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (249)
                        ......++..|++||.+... ..+.++|+||||++++++++ |..||...........+......             
T Consensus       172 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~-------------  237 (275)
T cd05046         172 YYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-------------  237 (275)
T ss_pred             ccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC-------------
Confidence              12234556779999988644 37889999999999999998 78888665443333322110000             


Q ss_pred             HHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          150 AKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                      ......++..+.+++.+||+.+|.+|||+.++++.
T Consensus       238 ----------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 ----------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                            00122467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=7.4e-28  Score=194.44  Aligned_cols=167  Identities=25%  Similarity=0.378  Sum_probs=130.4

Q ss_pred             CccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-----CeEEeecCCccCCC
Q 025683            2 DTDLYQIIRSN-------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-----DLKICDFGLARPTS   69 (249)
Q Consensus         2 ~~~L~~~l~~~-------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-----~~kL~dfg~~~~~~   69 (249)
                      |++|.+++.+.       ..+++..+..++.||+.||+|||+.+++|+||+|+||+++.++     .++|+|||++....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~  162 (269)
T cd05044          83 GGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY  162 (269)
T ss_pred             CCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccc
Confidence            67999999753       3488999999999999999999999999999999999999877     89999999987543


Q ss_pred             CCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           70 ENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        70 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                      ....   .....++..|+|||.+... ..+.++|+||||+++|+|++ |..||...+.......+....           
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-----------  230 (269)
T cd05044         163 KSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-----------  230 (269)
T ss_pred             cccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-----------
Confidence            3221   1122446779999988644 47899999999999999998 999997665444333221100           


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                         ........+..+.+++.+||..+|.+||++.++++
T Consensus       231 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                               00112246788999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.96  E-value=6.6e-28  Score=193.36  Aligned_cols=168  Identities=22%  Similarity=0.345  Sum_probs=131.5

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--ccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~   78 (249)
                      |++|.+++... +.++++.+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||.+........  .....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK  162 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence            67899999764 5689999999999999999999999999999999999999999999999998875433221  11223


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+......                     
T Consensus       163 ~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  220 (256)
T cd05112         163 FPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL---------------------  220 (256)
T ss_pred             cchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC---------------------
Confidence            45679999988644 47889999999999999998 89999766544333332110000                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                               ......+..+.+|+.+||+.+|.+|||+.++++.
T Consensus       221 ---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         221 ---------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                     0111346789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.96  E-value=7.3e-28  Score=193.74  Aligned_cols=167  Identities=27%  Similarity=0.390  Sum_probs=131.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      +++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........  ....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  163 (260)
T cd05073          84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  163 (260)
T ss_pred             CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence            57999999863  4688999999999999999999999999999999999999999999999998865433221  1122


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++|+||||++++++++ |..||...+.......+.....                     
T Consensus       164 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---------------------  221 (260)
T cd05073         164 KFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---------------------  221 (260)
T ss_pred             cccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---------------------
Confidence            345669999988644 47889999999999999998 8999987765444433321100                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               .......+.++.+++.+||+.+|.+||++.++++
T Consensus       222 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         222 ---------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ---------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                     0112246788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.1e-27  Score=196.19  Aligned_cols=174  Identities=25%  Similarity=0.371  Sum_probs=130.6

Q ss_pred             CccHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC
Q 025683            2 DTDLYQIIRSNQ------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (249)
Q Consensus         2 ~~~L~~~l~~~~------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~   69 (249)
                      |++|.+++....            .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus       101 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  180 (295)
T cd05097         101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY  180 (295)
T ss_pred             CCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccc
Confidence            678999986532            47889999999999999999999999999999999999999999999999987543


Q ss_pred             CCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 025683           70 ENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (249)
Q Consensus        70 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (249)
                      ....   .....++..|+|||.+... .++.++|+||||+++++|++  +..||...........+........      
T Consensus       181 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------  253 (295)
T cd05097         181 SGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQG------  253 (295)
T ss_pred             cCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcc------
Confidence            3221   1122346679999988654 47899999999999999987  5677776654444433322111000      


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                       ........+..++.+.+|+++||+.||.+|||++++++
T Consensus       254 -----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         254 -----------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             -----------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                             00011122346788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.96  E-value=9.4e-28  Score=195.88  Aligned_cols=167  Identities=22%  Similarity=0.327  Sum_probs=128.8

Q ss_pred             CccHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEE
Q 025683            2 DTDLYQIIRSN----------------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI   59 (249)
Q Consensus         2 ~~~L~~~l~~~----------------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL   59 (249)
                      +++|.+++...                      ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l  171 (288)
T cd05050          92 YGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI  171 (288)
T ss_pred             CCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEE
Confidence            46899998753                      24788899999999999999999999999999999999999999999


Q ss_pred             eecCCccCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 025683           60 CDFGLARPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLG  135 (249)
Q Consensus        60 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~  135 (249)
                      +|||.+........   ......+..|+|||.+... .++.++|+|||||++|+|++ |..||.+.........+...  
T Consensus       172 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~--  248 (288)
T cd05050         172 ADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG--  248 (288)
T ss_pred             CccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--
Confidence            99998865432211   1122335679999988644 48899999999999999997 77888766544433322210  


Q ss_pred             CCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          136 TPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      .                            ........+.++.+|+.+||+.||.+|||+.|+++
T Consensus       249 ~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         249 N----------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             C----------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            0                            00112246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.96  E-value=8.9e-28  Score=197.55  Aligned_cols=168  Identities=23%  Similarity=0.276  Sum_probs=129.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~   77 (249)
                      +|+|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+........   ....
T Consensus        92 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  171 (303)
T cd05110          92 HGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG  171 (303)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCC
Confidence            57899999875 4689999999999999999999999999999999999999999999999999876543221   1123


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|++||.+.+. .++.++|+||||+++|++++ |..||.+...... ..+......+                   
T Consensus       172 ~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~-------------------  230 (303)
T cd05110         172 KMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERL-------------------  230 (303)
T ss_pred             ccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCC-------------------
Confidence            346679999988544 47899999999999999987 8899876543222 2222110000                   


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                ......+.++.+++.+||..+|.+||+++++++.
T Consensus       231 ----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         231 ----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      0112345678999999999999999999998873

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=9.4e-28  Score=195.03  Aligned_cols=167  Identities=25%  Similarity=0.304  Sum_probs=131.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc---cc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT---EY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~---~~   77 (249)
                      +|+|.+++.+. ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+..........   ..
T Consensus        92 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  171 (279)
T cd05057          92 LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG  171 (279)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCC
Confidence            68999999875 579999999999999999999999999999999999999999999999999987654322111   12


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|++||.+... .++.++|+||||++++++++ |..||...........+... ..                    
T Consensus       172 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~--------------------  229 (279)
T cd05057         172 KVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ER--------------------  229 (279)
T ss_pred             cccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CC--------------------
Confidence            224579999988543 47889999999999999998 99999776544433333210 00                    


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               .......+..+.+++.+||..||.+||++.++++
T Consensus       230 ---------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         230 ---------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                     0111234567889999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.96  E-value=8.9e-28  Score=194.12  Aligned_cols=167  Identities=23%  Similarity=0.310  Sum_probs=129.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc---ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~---~~~   77 (249)
                      |++|.+++... +.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.........   ...
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  168 (269)
T cd05065          89 NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS  168 (269)
T ss_pred             CCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccc
Confidence            57999999864 56899999999999999999999999999999999999999999999999988654332111   111


Q ss_pred             c---ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHH
Q 025683           78 V---VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (249)
Q Consensus        78 ~---~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (249)
                      .   .+..|++||.+... .++.++|+||+||++|++++ |..||...+.......+......                 
T Consensus       169 ~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~-----------------  230 (269)
T cd05065         169 LGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL-----------------  230 (269)
T ss_pred             cCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC-----------------
Confidence            1   13469999988644 47889999999999999886 99999776544433333211000                 


Q ss_pred             HHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                   ......+..+.+++.+||..+|.+||++++++.
T Consensus       231 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         231 -------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             -------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         011245678899999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.95  E-value=1.4e-27  Score=192.52  Aligned_cols=169  Identities=28%  Similarity=0.459  Sum_probs=129.3

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~   76 (249)
                      |++|.+++.+    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        86 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  165 (267)
T cd08224          86 AGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS  165 (267)
T ss_pred             CCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccce
Confidence            5799999864    3568999999999999999999999999999999999999999999999999886543322 1223


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|+|||.+.+. .++.++|+||||+++|+|++|..||......  ...........                   
T Consensus       166 ~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~-------------------  223 (267)
T cd08224         166 LVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKC-------------------  223 (267)
T ss_pred             ecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhcC-------------------
Confidence            4677889999988644 4788999999999999999999998654311  00111000000                   


Q ss_pred             CCCCCCcchhhc-CCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQV-FPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                             ..... .+.++..+.++|.+||..+|.+|||+.++++
T Consensus       224 -------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         224 -------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             -------CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                   00001 1145678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.95  E-value=1.6e-27  Score=195.35  Aligned_cols=174  Identities=23%  Similarity=0.342  Sum_probs=129.5

Q ss_pred             CccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC
Q 025683            2 DTDLYQIIRSNQ-----------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE   70 (249)
Q Consensus         2 ~~~L~~~l~~~~-----------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~   70 (249)
                      |++|.+++.+..           .+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05095         103 NGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             CCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccC
Confidence            679999997642           377789999999999999999999999999999999999999999999999875433


Q ss_pred             CCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           71 NEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        71 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                      ...   ......+..|++||..... .++.++|+|||||++|+|++  |..||.................          
T Consensus       183 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~----------  251 (296)
T cd05095         183 GDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR----------  251 (296)
T ss_pred             CcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHh----------
Confidence            221   1122335679999987544 48899999999999999998  6788876654433322211110          


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ...   ...........++.+.+|+..||+.||.+||++.++++
T Consensus       252 ----------~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         252 ----------DQG---RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ----------hcc---ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                      000   00001112245688999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.95  E-value=9.6e-28  Score=193.76  Aligned_cols=167  Identities=22%  Similarity=0.306  Sum_probs=131.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc----cc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~----~~   76 (249)
                      |++|.+++.+. +.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.........    ..
T Consensus        89 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  168 (267)
T cd05066          89 NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG  168 (267)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCC
Confidence            67999999875 56899999999999999999999999999999999999999999999999998765432211    11


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|++||.+... .++.++|+||||++++++++ |..||...........+......                   
T Consensus       169 ~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  228 (267)
T cd05066         169 GKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL-------------------  228 (267)
T ss_pred             CccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC-------------------
Confidence            2224579999988644 47899999999999999886 99999776654443333221100                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                 ......++.+.+++.+||+.+|.+||++.++++
T Consensus       229 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         229 -----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                       011245778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=206.58  Aligned_cols=172  Identities=29%  Similarity=0.459  Sum_probs=141.6

Q ss_pred             ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            3 TDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         3 ~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||-.|++.=. +++-+..+..|..+.+.||+|||+++.+|||||..|||++..|.+||+|||.+...   .+.+.++||+
T Consensus       110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---~PAnsFvGTP  186 (948)
T KOG0577|consen  110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---APANSFVGTP  186 (948)
T ss_pred             ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---CchhcccCCc
Confidence            4555555432 58999999999999999999999999999999999999999999999999987654   3355789999


Q ss_pred             cccCchhcc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           82 WYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        82 ~y~aPE~~~--~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +|||||++.  ..+.|.-++||||||++-.||.-..+|+...+....+..|...-. |.      ..             
T Consensus       187 ywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-Pt------Lq-------------  246 (948)
T KOG0577|consen  187 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PT------LQ-------------  246 (948)
T ss_pred             cccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-CC------CC-------------
Confidence            999999985  456789999999999999999999999888776666655553111 00      00             


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                               ....+..|++|+.+||++-|.+|||.+++|.|+|...-
T Consensus       247 ---------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  247 ---------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             ---------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence                     11345779999999999999999999999999999863

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=2.3e-27  Score=191.80  Aligned_cols=172  Identities=22%  Similarity=0.285  Sum_probs=127.4

Q ss_pred             CccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---
Q 025683            2 DTDLYQIIRSN-----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---   73 (249)
Q Consensus         2 ~~~L~~~l~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---   73 (249)
                      ||+|.+++.+.     ..++...+..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||.+........   
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            68999999753     2467788899999999999999999999999999999999999999999998865433221   


Q ss_pred             cccccccccccCchhccCCC------CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 025683           74 MTEYVVTRWYRAPELLLNSS------DYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR  146 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (249)
                      .....++..|+|||.+....      .++.++|+||||+++|+|++ |..||...................         
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------  229 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK---------  229 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCC---------
Confidence            11234567899999885321      24779999999999999996 999997765444332222110000         


Q ss_pred             hhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                      .....+....++.+.+++..|+ .+|.+|||+++|+.
T Consensus       230 ----------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         230 ----------------LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ----------------CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                            0001111235677889999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.7e-28  Score=198.55  Aligned_cols=130  Identities=28%  Similarity=0.445  Sum_probs=95.3

Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC------CChHHHHHHHHHHhCCCCcccccccchhhH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG------NDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (249)
                      .+.|..|+|||++.+.+ |+..+||||++|+++||+||..+|..      ..+.+.++.|++.+|..|....-  .....
T Consensus       411 DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~--~Gk~S  487 (590)
T KOG1290|consen  411 DIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIAL--GGKYS  487 (590)
T ss_pred             hhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHh--cCcch
Confidence            35688899999999887 99999999999999999999998853      23688999999999987754321  11222


Q ss_pred             HHHHHhCCCCCCcc-------------hhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          151 KRYIRQLPQHPRQS-------------LAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       151 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      ..++...+.--...             ..+.......++.+|+.-||.++|.+||||.++|+|||+......
T Consensus       488 RdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  488 RDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            33333222111100             111222334668899999999999999999999999999987655

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=2.1e-27  Score=198.65  Aligned_cols=157  Identities=27%  Similarity=0.427  Sum_probs=119.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccccccccccCchhcc
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYVVTRWYRAPELLL   90 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~   90 (249)
                      .++...+..++.||+.||+|||++|++|+||||.||+++.++.++|+|||++........   .....++..|+|||.+.
T Consensus       175 ~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  254 (343)
T cd05103         175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF  254 (343)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhc
Confidence            478888999999999999999999999999999999999999999999999875432211   11223456799999886


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcC
Q 025683           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (249)
Q Consensus        91 ~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (249)
                      .. .++.++|+||||+++|+|++ |..||.................                          .   ...+
T Consensus       255 ~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------------------~---~~~~  304 (343)
T cd05103         255 DR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------------------------R---MRAP  304 (343)
T ss_pred             CC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC--------------------------C---CCCC
Confidence            54 47889999999999999996 8899876542222111111000                          0   0111


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          170 PHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       170 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ...++++.+++..||+.||.+|||+.++++|
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=1.5e-27  Score=194.28  Aligned_cols=183  Identities=22%  Similarity=0.382  Sum_probs=131.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~   76 (249)
                      |++|.+++.+. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+........    ...
T Consensus        92 g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  171 (284)
T cd05079          92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD  171 (284)
T ss_pred             CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCC
Confidence            78999999765 4689999999999999999999999999999999999999999999999999876543221    122


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|+|||.+.+. .++.++|+||||+++++|+++..|+.....     ......+.....    ............
T Consensus       172 ~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~----~~~~~~~~~~~~  241 (284)
T cd05079         172 LDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQ----MTVTRLVRVLEE  241 (284)
T ss_pred             CCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhccccccc----ccHHHHHHHHHc
Confidence            3456679999988654 478899999999999999998765433211     001111111000    000000001111


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ..      ....+..++..+.+|+.+||+.||.+|||+.++++.
T Consensus       242 ~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GK------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             Cc------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            00      112234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.95  E-value=1.9e-27  Score=192.49  Aligned_cols=168  Identities=23%  Similarity=0.354  Sum_probs=129.1

Q ss_pred             CccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--
Q 025683            2 DTDLYQIIRSN------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--   73 (249)
Q Consensus         2 ~~~L~~~l~~~------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--   73 (249)
                      +|+|.+++...      ..++...+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+........  
T Consensus        91 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~  170 (273)
T cd05074          91 HGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR  170 (273)
T ss_pred             CCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCccee
Confidence            57888887532      2589999999999999999999999999999999999999999999999999876543221  


Q ss_pred             -cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           74 -MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        74 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                       .....++..|++||.+... .++.++|+||||+++|+|++ |..||...........+....  .              
T Consensus       171 ~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~--------------  233 (273)
T cd05074         171 QGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN--R--------------  233 (273)
T ss_pred             cCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC--c--------------
Confidence             1123345679999988544 47889999999999999998 888887665433333222100  0              


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                    .......++.+.+++.+||+.+|.+|||+.+++..
T Consensus       234 --------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         234 --------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                          00112456789999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=4e-27  Score=190.31  Aligned_cols=172  Identities=19%  Similarity=0.256  Sum_probs=127.5

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---cc
Q 025683            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FM   74 (249)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---~~   74 (249)
                      ||+|.+++.+.    ..+++..+..++.||+.||+|||+.+++|+||||+||+++.++.++|+|||.+.......   ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            57999999864    346778889999999999999999999999999999999999999999999875432211   12


Q ss_pred             ccccccccccCchhccCC------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           75 TEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                      ....++..|+|||.+...      ...+.++|+||||+++|+|++ +..||....+......+........         
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~---------  229 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL---------  229 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc---------
Confidence            234567889999987431      124678999999999999986 5678876665444444322111000         


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                   .+   ..+...+++.+.+++..|| .+|.+||+++++++
T Consensus       230 -------------~~---~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         230 -------------FK---PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -------------CC---CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                         00   1112246678899999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=3.4e-27  Score=192.14  Aligned_cols=183  Identities=20%  Similarity=0.331  Sum_probs=129.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc----cc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~----~~   76 (249)
                      |++|.+++.+. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.........    ..
T Consensus        91 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  170 (284)
T cd05081          91 YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREP  170 (284)
T ss_pred             CCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCC
Confidence            68999999765 56999999999999999999999999999999999999999999999999998765432211    11


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|+|||.+.+. .++.++|+||||+++++|++|..++......     .....+.....   .............
T Consensus       171 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~  241 (284)
T cd05081         171 GESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-----FMRMMGNDKQG---QMIVYHLIELLKN  241 (284)
T ss_pred             CCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-----hhhhccccccc---ccchHHHHHHHhc
Confidence            2234469999988644 4788999999999999999987765433211     01111110000   0000001111111


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ...      ......++.++.+|+.+||+.+|.+|||+.+++.
T Consensus       242 ~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         242 NGR------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             CCc------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            100      1123356788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.4e-28  Score=206.94  Aligned_cols=177  Identities=25%  Similarity=0.478  Sum_probs=140.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC---------CCC
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS---------ENE   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~---------~~~   72 (249)
                      |||+.++|.+.+.|.++.++.++.++..|+++.|..|++||||||+|||||.+|.+||.|||+|.-..         .+.
T Consensus       713 GGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gd  792 (1034)
T KOG0608|consen  713 GGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGD  792 (1034)
T ss_pred             CccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCC
Confidence            89999999999999999999999999999999999999999999999999999999999999984210         000


Q ss_pred             ----------------------------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 025683           73 ----------------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF  118 (249)
Q Consensus        73 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~  118 (249)
                                                        .....+||+.|+|||++...+ +...+|.||.||+++||+.|++||
T Consensus       793 H~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~g~~pf  871 (1034)
T KOG0608|consen  793 HHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLVGQPPF  871 (1034)
T ss_pred             ccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHhhCCCCc
Confidence                                              001347899999999997665 889999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC---CHH
Q 025683          119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI---TVD  195 (249)
Q Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~  195 (249)
                      ....+.....++...-.                 +    ...      ....++++++.++|.++- .+++.|.   .++
T Consensus       872 ~~~tp~~tq~kv~nw~~-----------------~----l~~------~~~~~ls~e~~~li~kLc-~sad~RLGkng~d  923 (1034)
T KOG0608|consen  872 LADTPGETQYKVINWRN-----------------F----LHI------PYQGNLSKEALDLIQKLC-CSADSRLGKNGAD  923 (1034)
T ss_pred             cCCCCCcceeeeeehhh-----------------c----ccc------ccccccCHHHHHHHHHHh-cChhhhhcccchh
Confidence            88775544433332100                 0    000      012268899999998743 4778887   477


Q ss_pred             HHhcCccccCCc
Q 025683          196 EALAHPYLARLH  207 (249)
Q Consensus       196 ~ll~h~~~~~~~  207 (249)
                      ++..||||+.+.
T Consensus       924 ~vKaHpfFkgID  935 (1034)
T KOG0608|consen  924 QVKAHPFFKGID  935 (1034)
T ss_pred             hhhcCccccccc
Confidence            899999999875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=6.5e-29  Score=190.72  Aligned_cols=175  Identities=25%  Similarity=0.386  Sum_probs=138.2

Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCchhc
Q 025683           11 SNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELL   89 (249)
Q Consensus        11 ~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~   89 (249)
                      ++..++++.+-.|....+.||+||-+. .|+|||+||+|||++..|.+||||||.+.....+-......|...|+|||.+
T Consensus       160 q~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi  239 (361)
T KOG1006|consen  160 QKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERI  239 (361)
T ss_pred             HhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhcc
Confidence            346899999999999999999999954 8999999999999999999999999999776655444456788889999999


Q ss_pred             cCCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhh
Q 025683           90 LNSSD-YTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ  167 (249)
Q Consensus        90 ~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (249)
                      ..... +...+|+||||++++|+.+|..||.+-+. .+++..++  .|.++.-..+                       .
T Consensus       240 ~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l~~~-----------------------~  294 (361)
T KOG1006|consen  240 DPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPILLFD-----------------------K  294 (361)
T ss_pred             CCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCeecCc-----------------------c
Confidence            75544 88999999999999999999999976443 22333222  2222221111                       0


Q ss_pred             cCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       168 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                      -.-.++..+..||..||.+|-+.||...+|+++||++-.....
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~  337 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEG  337 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcC
Confidence            0114678899999999999999999999999999999765443

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=5.5e-27  Score=211.00  Aligned_cols=65  Identities=31%  Similarity=0.624  Sum_probs=62.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      |++|.+++...+.+++..++.++.||+.||+|||.+||+|+||||+||+++.++.++|+|||+++
T Consensus        88 g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          88 GGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            78999999988889999999999999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.95  E-value=4.4e-27  Score=199.96  Aligned_cols=167  Identities=26%  Similarity=0.389  Sum_probs=127.6

Q ss_pred             ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccc
Q 025683            3 TDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (249)
Q Consensus         3 ~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~   77 (249)
                      +++.+++...  ..+++..+..++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++........   ....
T Consensus       220 ~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~  299 (400)
T cd05105         220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGST  299 (400)
T ss_pred             hhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCc
Confidence            4566777654  5699999999999999999999999999999999999999999999999999875432211   1223


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+.+. .++.++|||||||++|+|++ |..||..................                    
T Consensus       300 ~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~--------------------  358 (400)
T cd05105         300 FLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR--------------------  358 (400)
T ss_pred             CCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCC--------------------
Confidence            456779999988654 47889999999999999996 88998765322222111110000                    


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               .......+.++.+++.+||+.||.+|||+.++.+
T Consensus       359 ---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         359 ---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             ---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence                     0112246788999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=1.2e-26  Score=197.27  Aligned_cols=157  Identities=26%  Similarity=0.365  Sum_probs=121.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccccccccccCchhcc
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEYVVTRWYRAPELLL   90 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~   90 (249)
                      .+++..+..++.||+.||+|||+.+++|+||||+||+++.++.++|+|||++........   .....++..|++||.+.
T Consensus       235 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~  314 (401)
T cd05107         235 ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF  314 (401)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc
Confidence            477888999999999999999999999999999999999999999999999875432211   12234577899999886


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcC
Q 025683           91 NSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF  169 (249)
Q Consensus        91 ~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (249)
                      .. .++.++|+||||+++|+|++ |..||............... +..                            ...+
T Consensus       315 ~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~-~~~----------------------------~~~p  364 (401)
T cd05107         315 NN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR-GYR----------------------------MAKP  364 (401)
T ss_pred             CC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc-CCC----------------------------CCCC
Confidence            54 47889999999999999998 88898765433322222110 000                            0112


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          170 PHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       170 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ..++.++.+++.+||..+|.+||++.+|+..
T Consensus       365 ~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         365 AHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2467889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.95  E-value=5.3e-27  Score=212.00  Aligned_cols=169  Identities=22%  Similarity=0.355  Sum_probs=126.7

Q ss_pred             CccHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC
Q 025683            2 DTDLYQIIRSN-----------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE   70 (249)
Q Consensus         2 ~~~L~~~l~~~-----------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~   70 (249)
                      |++|.+++.+.           ..++...+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.....
T Consensus        86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~  165 (932)
T PRK13184         86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKL  165 (932)
T ss_pred             CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceeccc
Confidence            78999998742           3456778899999999999999999999999999999999999999999999875411


Q ss_pred             C-------------------CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 025683           71 N-------------------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI  131 (249)
Q Consensus        71 ~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~  131 (249)
                      .                   .......||+.|+|||.+.+. .++.++|+|||||++++|++|..||...........  
T Consensus       166 ~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--  242 (932)
T PRK13184        166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--  242 (932)
T ss_pred             ccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--
Confidence            0                   011124689999999998654 478999999999999999999999976442211111  


Q ss_pred             HHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      .....+..                          ......+++.+.+++.+||+.||.+|++..+.+.
T Consensus       243 ~~i~~P~~--------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        243 DVILSPIE--------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhccChhh--------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            00000000                          0001256788999999999999999987655443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=6e-27  Score=210.29  Aligned_cols=172  Identities=35%  Similarity=0.555  Sum_probs=125.6

Q ss_pred             cHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC-------------
Q 025683            4 DLYQIIRSNQSL-SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-------------   69 (249)
Q Consensus         4 ~L~~~l~~~~~l-~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~-------------   69 (249)
                      .|++++..+... ....+.+++++|++||.|+|++|++||||||.||+++.++.+||+|||++....             
T Consensus       682 ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~  761 (1351)
T KOG1035|consen  682 LLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFS  761 (1351)
T ss_pred             HHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCcc
Confidence            455666655443 478899999999999999999999999999999999999999999999986511             


Q ss_pred             ------CCCccccccccccccCchhccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           70 ------ENEFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        70 ------~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                            ........+||.-|+|||++.+..  ++..|+|+||||++++||+.   ||...  ..-. .+...++...-  
T Consensus       762 ~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa-~iL~~LR~g~i--  833 (1351)
T KOG1035|consen  762 TNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERA-SILTNLRKGSI--  833 (1351)
T ss_pred             ccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch--HHHH-HHHHhcccCCC--
Confidence                  011334568899999999998766  68999999999999999973   34322  1111 12221211110  


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                                         +..  ..++.+.-+.-..+|+.||+.||.+||||.|||++.||-
T Consensus       834 -------------------P~~--~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  834 -------------------PEP--ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             -------------------CCC--cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence                               000  111112223345899999999999999999999999887

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.95  E-value=2.8e-27  Score=206.45  Aligned_cols=165  Identities=24%  Similarity=0.415  Sum_probs=139.9

Q ss_pred             CccHHHHHHhC----------C----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683            2 DTDLYQIIRSN----------Q----SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus         2 ~~~L~~~l~~~----------~----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      .|||..||...          .    +|+..+...|+.||+.||+||-++.+|||||...|+||..+..+|++|||+++.
T Consensus       573 ~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRd  652 (774)
T KOG1026|consen  573 HGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRD  652 (774)
T ss_pred             cccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchh
Confidence            37999999653          1    288999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCccc---cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 025683           68 TSENEFMT---EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        68 ~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (249)
                      ....+..+   ....+.+|||||.++- ++++.++||||+||++||+++ |.-||.+..+.+.+..+..           
T Consensus       653 iYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~-----------  720 (774)
T KOG1026|consen  653 IYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA-----------  720 (774)
T ss_pred             hhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc-----------
Confidence            66554332   2334778999999974 459999999999999999997 8899999888777777653           


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHH
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA  197 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~l  197 (249)
                                         ..+-+.+++.|.++.+|+..||+..|.+||++.||
T Consensus       721 -------------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  721 -------------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             -------------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence                               12234455788999999999999999999999998

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-27  Score=212.93  Aligned_cols=167  Identities=24%  Similarity=0.397  Sum_probs=139.1

Q ss_pred             CccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc
Q 025683            2 DTDLYQIIRSN-------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM   74 (249)
Q Consensus         2 ~~~L~~~l~~~-------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~   74 (249)
                      ||||.+||++.       ..|+..+...++.+|+.|++||+++++|||||..+|+|++....+|++|||+++.+......
T Consensus       779 gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yy  858 (1025)
T KOG1095|consen  779 GGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYY  858 (1025)
T ss_pred             cCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchhe
Confidence            89999999986       35999999999999999999999999999999999999999999999999999854433221


Q ss_pred             -cc--ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhH
Q 025683           75 -TE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (249)
Q Consensus        75 -~~--~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (249)
                       ..  ...+..|||||.+.. +.++.++|||||||++||+++ |..||++.++.+.+.......+..+            
T Consensus       859 r~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~------------  925 (1025)
T KOG1095|consen  859 RKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP------------  925 (1025)
T ss_pred             eccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC------------
Confidence             11  133567999999975 569999999999999999997 8999999987777665544322222            


Q ss_pred             HHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                        +...+..+.+++..||+.+|++||++..|++
T Consensus       926 ------------------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  926 ------------------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ------------------CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                              2246677889999999999999999999987

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=1.1e-26  Score=188.77  Aligned_cols=182  Identities=22%  Similarity=0.335  Sum_probs=130.3

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc----cc
Q 025683            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~----~~   76 (249)
                      |++|.+++.+.. .+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+.........    ..
T Consensus        92 ~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  171 (284)
T cd05038          92 SGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP  171 (284)
T ss_pred             CCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCC
Confidence            679999998754 6999999999999999999999999999999999999999999999999998766532111    11


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|++||.+... .++.++|+||||+++++|++|..|+.......     ....+....    .............
T Consensus       172 ~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~  241 (284)
T cd05038         172 GESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQG----QMIVTRLLELLKE  241 (284)
T ss_pred             CCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccc----cccHHHHHHHHHc
Confidence            2335569999988654 47889999999999999999998875432111     000000000    0000111111111


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ....      ......+.++.+++.+||+.+|.+|||+.++++
T Consensus       242 ~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         242 GERL------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             CCcC------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1000      112245678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-27  Score=199.96  Aligned_cols=167  Identities=26%  Similarity=0.393  Sum_probs=138.7

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc-cccc
Q 025683            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT-EYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~-~~~~   79 (249)
                      ||+|.+||++++ .++..+...++.+.+.||+|||+++++||||.++|+|++.++.+|++|||++.......... ..--
T Consensus       245 gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~kl  324 (474)
T KOG0194|consen  245 GGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKL  324 (474)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccC
Confidence            789999999987 59999999999999999999999999999999999999999999999999987654222222 1123


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH-hCCCCcccccccchhhHHHHHHhC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +..|+|||.+... .++.++||||+||++||+++ |..||.+....+..+.+... ...+.                   
T Consensus       325 PirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~-------------------  384 (474)
T KOG0194|consen  325 PIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI-------------------  384 (474)
T ss_pred             cceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC-------------------
Confidence            5679999999644 69999999999999999997 88899999888777777432 11111                   


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                 +...+.++..++.+|+..||..|||+.++.+
T Consensus       385 -----------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  385 -----------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             -----------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                       1135677889999999999999999999865

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=6.4e-26  Score=195.79  Aligned_cols=173  Identities=21%  Similarity=0.318  Sum_probs=120.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccc--ccccccccCchhccCC
Q 025683           15 LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE--YVVTRWYRAPELLLNS   92 (249)
Q Consensus        15 l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~   92 (249)
                      +++..++.++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||++...........  ..+++.|++||.+...
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~  385 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP  385 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence            46778999999999999999999999999999999999999999999999865433222222  2347889999987532


Q ss_pred             CC---------------------CCchhHHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCcccccccchhhH
Q 025683           93 SD---------------------YTAAIDVWSVGCIFMELMNRRP-LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (249)
Q Consensus        93 ~~---------------------~~~~~DiwslG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (249)
                      ..                     .....|+||+||++++|+++.. ||............               .....
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~---------------~~~~~  450 (507)
T PLN03224        386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ---------------YDNDL  450 (507)
T ss_pred             CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh---------------ccchH
Confidence            10                     1234799999999999999875 55432211100000               00000


Q ss_pred             HHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCC---CCCCCHHHHhcCccccC
Q 025683          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP---MKRITVDEALAHPYLAR  205 (249)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~Rpt~~~ll~h~~~~~  205 (249)
                      ..+......  ... ...+...++..++|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       451 ~~~r~~~~~--~~~-~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        451 NRWRMYKGQ--KYD-FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             HHHHhhccc--CCC-cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            000000000  111 12355678999999999999876   68999999999999964

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.8e-27  Score=196.57  Aligned_cols=182  Identities=25%  Similarity=0.358  Sum_probs=129.5

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMT   75 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~---i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~   75 (249)
                      +|+|.+.|....  .++|..+.+|+.+++.||+|||+..   |+|||||++|||+|.+...||+|||+++.... .....
T Consensus       156 nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~  235 (361)
T KOG1187|consen  156 NGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVS  235 (361)
T ss_pred             CCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccccee
Confidence            479999998875  8999999999999999999999854   99999999999999999999999999976554 33333


Q ss_pred             cc-cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           76 EY-VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND---HVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        76 ~~-~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      .. .||..|++||.... +..+.++|||||||+++|+++|+.+.....   ...........+.           .....
T Consensus       236 ~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~-----------~~~~~  303 (361)
T KOG1187|consen  236 TTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE-----------EGKLR  303 (361)
T ss_pred             eecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH-----------Ccchh
Confidence            33 78999999998864 558999999999999999999998776432   1111111111111           11111


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      .+++.....  ......  ..-..+..+...|++.+|.+||++.++++
T Consensus       304 eiiD~~l~~--~~~~~~--~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  304 EIVDPRLKE--GEYPDE--KEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             heeCCCccC--CCCChH--HHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            111111100  000000  01122667888999999999999999754

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.94  E-value=4.9e-27  Score=198.69  Aligned_cols=166  Identities=24%  Similarity=0.399  Sum_probs=138.6

Q ss_pred             ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc--
Q 025683            3 TDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--   79 (249)
Q Consensus         3 ~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~--   79 (249)
                      |.|+.||+.+ ..|+......++.||+.||.|||+.++|||||...||||..+..+||+|||+++............+  
T Consensus       475 GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kL  554 (974)
T KOG4257|consen  475 GELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKL  554 (974)
T ss_pred             hhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcccccc
Confidence            6899999886 6899999999999999999999999999999999999999999999999999998777655444333  


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +.-|+|||.+- -..++.++|||+|||.+||++. |..||.+..+.+.+..+...-+.                      
T Consensus       555 PIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl----------------------  611 (974)
T KOG4257|consen  555 PIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL----------------------  611 (974)
T ss_pred             ceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC----------------------
Confidence            55699999873 3458999999999999999975 99999888766665555432222                      


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                              ..+++.++.+-.++.+||.+||.+||.+.++..
T Consensus       612 --------P~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  612 --------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             --------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence                    234467888999999999999999999887754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=8.8e-27  Score=202.43  Aligned_cols=175  Identities=29%  Similarity=0.431  Sum_probs=129.8

Q ss_pred             CCccHHHHHHhC-CC---CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc---C--CCeEEeecCCccCCCCC
Q 025683            1 MDTDLYQIIRSN-QS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---N--CDLKICDFGLARPTSEN   71 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~---l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~---~--~~~kL~dfg~~~~~~~~   71 (249)
                      |-.+|.++++.. ..   ......+.++.|++.||++||+.+||||||||.||||..   +  .+++|+|||+++....+
T Consensus       585 C~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  585 CACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            346899999884 11   112456889999999999999999999999999999976   3  46899999999876543


Q ss_pred             ----CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 025683           72 ----EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDADLGFVR  146 (249)
Q Consensus        72 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (249)
                          .......||-+|+|||.+.... -..++||+|+||++|..++| ..||......+  ..|..              
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~--------------  727 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT--------------  727 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc--------------
Confidence                2344578899999999997665 46799999999999998875 89996542110  01100              


Q ss_pred             hhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                                    ....+..+.+....++.+||.+|++.||..||++.++|.||+|=..
T Consensus       728 --------------~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  728 --------------GNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             --------------CccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence                          0111111111222268899999999999999999999999999543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.93  E-value=9.7e-26  Score=167.50  Aligned_cols=125  Identities=29%  Similarity=0.524  Sum_probs=105.7

Q ss_pred             HHHhCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCc
Q 025683            8 IIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAP   86 (249)
Q Consensus         8 ~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aP   86 (249)
                      .+++.+.+++..+-+|+..++.||.|||++ .++|||+||+|||++.+|++|+||||.+....++-...-..|...|+||
T Consensus       138 v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaP  217 (282)
T KOG0984|consen  138 VLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAP  217 (282)
T ss_pred             HHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCCh
Confidence            455678899999999999999999999977 8999999999999999999999999998766554333335677789999


Q ss_pred             hhccCC---CCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 025683           87 ELLLNS---SDYTAAIDVWSVGCIFMELMNRRPLFPG-NDHVHQMRLLIE  132 (249)
Q Consensus        87 E~~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~-~~~~~~~~~~~~  132 (249)
                      |.+...   ..|+.++||||||+++.||.+++.||.. .++.+++.++++
T Consensus       218 Eri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  218 ERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            998532   2578899999999999999999999975 567777777764

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-25  Score=190.64  Aligned_cols=175  Identities=25%  Similarity=0.334  Sum_probs=144.1

Q ss_pred             CccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      .|||.+.|.+  ...|-......++.||+.||.||..+++||||+...|+++.....+|+||||+.+..+.++.......
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p  273 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAP  273 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecC
Confidence            4799999987  36788999999999999999999999999999999999999999999999999998776654332222


Q ss_pred             ----cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           80 ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        80 ----~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                          ...|.|||.+. ...++.++|+|++||++|||++ |+.||.+....+.+..+...-..+                 
T Consensus       274 ~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp-----------------  335 (1039)
T KOG0199|consen  274 QRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP-----------------  335 (1039)
T ss_pred             CCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC-----------------
Confidence                44599999985 5569999999999999999997 889999998887777765321111                 


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                   .++..++++-++++.||..+|.+|||+..|.+.-+.....
T Consensus       336 -------------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaq  375 (1039)
T KOG0199|consen  336 -------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQ  375 (1039)
T ss_pred             -------------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcC
Confidence                         1234678889999999999999999999997655555443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-26  Score=198.06  Aligned_cols=167  Identities=23%  Similarity=0.341  Sum_probs=145.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~   79 (249)
                      +|+|-.||.++ +.|+..+..-|++.|+.|++||-+.|+|||||.+.||||+.+..+|++|||+++...+.. ......|
T Consensus       714 NGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~G  793 (996)
T KOG0196|consen  714 NGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLG  793 (996)
T ss_pred             CCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccC
Confidence            58999999886 789999999999999999999999999999999999999999999999999998664432 1111122


Q ss_pred             ---cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           80 ---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        80 ---~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                         +.+|+|||++. ..+++.++||||+|++|||.++ |..||-..++-+.+..|++.++.|++-               
T Consensus       794 GKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm---------------  857 (996)
T KOG0196|consen  794 GKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM---------------  857 (996)
T ss_pred             CccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC---------------
Confidence               56799999984 5669999999999999999875 999999999999999999888877754               


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                     +.+..+-+|+..||++|-..||++.+|++
T Consensus       858 ---------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  858 ---------------DCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ---------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                           35677889999999999999999999987

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=2.4e-25  Score=194.42  Aligned_cols=176  Identities=26%  Similarity=0.458  Sum_probs=144.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      |||..|++++-  .++.+..+..|++.++.|+.+||.+.++|||||-.|||+..++.+||+|||.+...... ....+.+
T Consensus       105 gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~i  184 (953)
T KOG0587|consen  105 GGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFI  184 (953)
T ss_pred             CccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcC
Confidence            78999998874  78999999999999999999999999999999999999999999999999998765543 4456789


Q ss_pred             ccccccCchhccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           79 VTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ||+.|||||++.+..    .+...+|+||||++..||.-|.+|+....+...+-.|   -+.|++..             
T Consensus       185 GtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPkL-------------  248 (953)
T KOG0587|consen  185 GTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPKL-------------  248 (953)
T ss_pred             CCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCccc-------------
Confidence            999999999986543    3567899999999999999999998776544333222   22222211             


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                                  ..+.+.++.+.+||..||.+|-.+||+..++|+|||++.
T Consensus       249 ------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  249 ------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             ------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence                        112345678999999999999999999999999999994

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.8e-25  Score=181.84  Aligned_cols=181  Identities=29%  Similarity=0.504  Sum_probs=140.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCCCCeeec---cCCCeEEeecCCccCCCCCC----
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLLN---ANCDLKICDFGLARPTSENE----   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~--~i~H~dik~~nil~~---~~~~~kL~dfg~~~~~~~~~----   72 (249)
                      |.||--||+.++.+++.++++|+.||+.||.||.+.  .|+|-|+||.|||+-   ..|.+|+.|||+++......    
T Consensus       552 GNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~v  631 (775)
T KOG1151|consen  552 GNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSV  631 (775)
T ss_pred             CCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcc
Confidence            668888999999999999999999999999999987  499999999999984   34789999999998765432    


Q ss_pred             ----ccccccccccccCchhccC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           73 ----FMTEYVVTRWYRAPELLLN---SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        73 ----~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                          ......||-+|++||++.-   .++.+.++||||+||++|.++.|+.||.....-.   .|...-.-         
T Consensus       632 dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dILqeNTI---------  699 (775)
T KOG1151|consen  632 DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DILQENTI---------  699 (775)
T ss_pred             cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---HHHhhhch---------
Confidence                2345678999999999863   3567889999999999999999999996543211   11110000         


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                          .+  ..+.. .+      .-+-++.+..+||++||++.-++|..+-+|..||||.--.
T Consensus       700 ----lk--AtEVq-FP------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~  748 (775)
T KOG1151|consen  700 ----LK--ATEVQ-FP------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI  748 (775)
T ss_pred             ----hc--ceecc-CC------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence                00  00000 00      0124789999999999999999999999999999997643

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-24  Score=184.34  Aligned_cols=165  Identities=24%  Similarity=0.375  Sum_probs=137.2

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccc
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      +-|+|.+||...  ..++.-....|+.||..|++||..++++||||...|.||..+..+|+.|||+++........ ...
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AHA  424 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AHA  424 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-ccc
Confidence            358999999875  45888899999999999999999999999999999999999999999999999877654432 222


Q ss_pred             c---cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           79 V---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        79 ~---~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      |   ..-|+|||.+- ...++.++|||+|||++||+.+ |..||++.+-...+..+.+.++...                
T Consensus       425 GAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~----------------  487 (1157)
T KOG4278|consen  425 GAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG----------------  487 (1157)
T ss_pred             CccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC----------------
Confidence            2   45599999874 4458999999999999999987 8899999987777776665333211                


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHH
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA  197 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~l  197 (249)
                                    +...++.+-+|++.||++.|.+||++.|+
T Consensus       488 --------------PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  488 --------------PEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             --------------CCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                          23567888999999999999999999987

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=2.3e-24  Score=191.69  Aligned_cols=167  Identities=29%  Similarity=0.482  Sum_probs=131.9

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      .|+|.+||.+.+                .++..+...++.||+.|++||++.+++|||+...|||+..+..+|++|||++
T Consensus       386 ~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGla  465 (609)
T KOG0200|consen  386 HGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLA  465 (609)
T ss_pred             CCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccce
Confidence            478999998865                4999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCccc--ccc--ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHHHHHhCCCCc
Q 025683           66 RPTSENEFMT--EYV--VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGND-HVHQMRLLIELLGTPTD  139 (249)
Q Consensus        66 ~~~~~~~~~~--~~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~-~~~~~~~~~~~~~~~~~  139 (249)
                      +.........  ...  .+..|+|||.+.. ..++.++||||+|+++||+++ |..||++.. .......+....+    
T Consensus       466 r~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r----  540 (609)
T KOG0200|consen  466 RDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNR----  540 (609)
T ss_pred             eccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCC----
Confidence            8654433221  122  3455999999976 569999999999999999987 889998744 2333322221110    


Q ss_pred             ccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          140 ADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                                -+.+...++++.++++.||+.+|.+||++.++..
T Consensus       541 --------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  541 --------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence                                      0112245678889999999999999999999865

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-25  Score=191.19  Aligned_cols=120  Identities=32%  Similarity=0.513  Sum_probs=108.7

Q ss_pred             CccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc--CCC--eEEeecCCccCCCCCCcc
Q 025683            2 DTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCD--LKICDFGLARPTSENEFM   74 (249)
Q Consensus         2 ~~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~--~~~--~kL~dfg~~~~~~~~~~~   74 (249)
                      ||||+.+|.+-   ..|++.+++.++..+..||.|||++||+||||||.||++..  +|+  .||+|||.++...++...
T Consensus       101 gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~  180 (732)
T KOG4250|consen  101 GGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLF  180 (732)
T ss_pred             CCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCee
Confidence            79999999873   67999999999999999999999999999999999998743  343  599999999999888888


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN  121 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~  121 (249)
                      ...+||..|++||.+....+++..+|.|||||++|+++||..||-..
T Consensus       181 ~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  181 TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            88999999999999976667999999999999999999999999543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.92  E-value=2.4e-24  Score=181.24  Aligned_cols=173  Identities=23%  Similarity=0.338  Sum_probs=139.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc---c
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT---E   76 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~---~   76 (249)
                      .|+|.+||.++  ..+..+...+|+.||+.|++||.+.++|||||.+.|+|++.++++|++|||.++.........   .
T Consensus       619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr  698 (807)
T KOG1094|consen  619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR  698 (807)
T ss_pred             cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence            38999999987  334566777899999999999999999999999999999999999999999998655443321   2


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM--NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      .+.+.+|+|+|.+... +++.++|+|+||+++||++  +.+.||....+.+........+...+                
T Consensus       699 ~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~----------------  761 (807)
T KOG1094|consen  699 AVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG----------------  761 (807)
T ss_pred             eeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC----------------
Confidence            4557889999998754 5999999999999999985  57899988877766666655444333                


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHh
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL  198 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll  198 (249)
                             .+.....++-.+..+.+++..||..|..+||+++++-
T Consensus       762 -------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  762 -------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             -------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence                   2223334445778889999999999999999999983

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=1.3e-24  Score=176.36  Aligned_cols=194  Identities=30%  Similarity=0.513  Sum_probs=136.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-CCCeEEeecCCccCCC-----------------C--C--
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTS-----------------E--N--   71 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~-----------------~--~--   71 (249)
                      .++...++.+++.++.||.++|.+||+||||||.|++++. .++-.|+|||++....                 .  .  
T Consensus       128 ~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~  207 (418)
T KOG1167|consen  128 SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKD  207 (418)
T ss_pred             cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCc
Confidence            5789999999999999999999999999999999999985 4678999999885100                 0  0  


Q ss_pred             -------------Cc-----------cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHH
Q 025683           72 -------------EF-----------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP-GNDHVHQ  126 (249)
Q Consensus        72 -------------~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~-~~~~~~~  126 (249)
                                   ..           .-...||++|+|||++...+.-++++|+||.||+++.++++..||. ..++.+.
T Consensus       208 ~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~a  287 (418)
T KOG1167|consen  208 VHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADA  287 (418)
T ss_pred             ccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccch
Confidence                         00           0123679999999999988888999999999999999999998875 4555556


Q ss_pred             HHHHHHHhCCCCccccc-------ccc-h-----hhHHHHHHhC----CCCCCc---chhhcCCCCChHHHHHHHHhcCC
Q 025683          127 MRLLIELLGTPTDADLG-------FVR-N-----EDAKRYIRQL----PQHPRQ---SLAQVFPHVHPLAIDLVDRMLTF  186 (249)
Q Consensus       127 ~~~~~~~~~~~~~~~~~-------~~~-~-----~~~~~~~~~~----~~~~~~---~~~~~~~~~~~~~~~li~~~L~~  186 (249)
                      +..++...|...-....       .+. .     ......++..    ....++   ......+..+..+.+|+.+||..
T Consensus       288 l~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~  367 (418)
T KOG1167|consen  288 LAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLEL  367 (418)
T ss_pred             HHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccC
Confidence            66655444431110000       000 0     0001111111    111111   22223334556889999999999


Q ss_pred             CCCCCCCHHHHhcCccccCCc
Q 025683          187 DPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       187 dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      ||.+|.|++++|.||||....
T Consensus       368 np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  368 NPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ChhhcccHHHHhcCcCCcchh
Confidence            999999999999999999554

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-23  Score=168.77  Aligned_cols=166  Identities=19%  Similarity=0.260  Sum_probs=133.3

Q ss_pred             ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-
Q 025683            3 TDLYQIIRSN--------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-   73 (249)
Q Consensus         3 ~~L~~~l~~~--------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-   73 (249)
                      |+|..||.-.        +.++..+...++.|++.|++|||.+|++|.||...|.+|++.-++||+|=.+++..-+... 
T Consensus       373 gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYh  452 (563)
T KOG1024|consen  373 GNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYH  452 (563)
T ss_pred             chHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCccccc
Confidence            6889999721        4588889999999999999999999999999999999999999999999988875433321 


Q ss_pred             --cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhH
Q 025683           74 --MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (249)
Q Consensus        74 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (249)
                        ......+..||+||.+... .++.++|+|||||++|||++ |+.||...++......+....+..             
T Consensus       453 cLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla-------------  518 (563)
T KOG1024|consen  453 CLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA-------------  518 (563)
T ss_pred             ccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec-------------
Confidence              1122346679999999755 49999999999999999987 889998887766555544322111             


Q ss_pred             HHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                       .+-+.++++..++--||..+|++||+++++..
T Consensus       519 -----------------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  519 -----------------QPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -----------------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                             11257888999999999999999999999864

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=4.4e-23  Score=169.75  Aligned_cols=185  Identities=22%  Similarity=0.314  Sum_probs=126.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhC---------CcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA---------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-   71 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~---------~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-   71 (249)
                      .|+|.+||+. ..+++....+++..+++||+|||+.         .|+|||||+.||||..|+++.|+|||++...... 
T Consensus       292 kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~  370 (534)
T KOG3653|consen  292 KGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGK  370 (534)
T ss_pred             CCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCC
Confidence            4899999998 5689999999999999999999963         4999999999999999999999999999875543 


Q ss_pred             --CccccccccccccCchhccCCCCCC-----chhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCccccc
Q 025683           72 --EFMTEYVVTRWYRAPELLLNSSDYT-----AAIDVWSVGCIFMELMNRRPLFP-GNDHVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        72 --~~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DiwslG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~  143 (249)
                        ......+||.+|||||++.+.-++.     ...||||+|.++|||++....+. +..+..++.--. .+|.-|.    
T Consensus       371 ~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~-evG~hPt----  445 (534)
T KOG3653|consen  371 PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA-EVGNHPT----  445 (534)
T ss_pred             CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH-HhcCCCC----
Confidence              2234478999999999997765554     36999999999999998764432 111111111000 1111110    


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCC--CCChHHHHHHHHhcCCCCCCCCCHHHH
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFP--HVHPLAIDLVDRMLTFDPMKRITVDEA  197 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt~~~l  197 (249)
                         -+.+..++-.  +..+..+...|.  .--.-+.+.+..||..||+.|.|+.=+
T Consensus       446 ---~e~mq~~VV~--kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  446 ---LEEMQELVVR--KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             ---HHHHHHHHHh--hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence               0111111111  111111222221  122447899999999999999997633

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=5.6e-24  Score=187.43  Aligned_cols=184  Identities=30%  Similarity=0.403  Sum_probs=145.6

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-----Cccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-----EFMTEY   77 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-----~~~~~~   77 (249)
                      +||++++...+.++...+..++.|++.|++|+|+.|+.|+|+|++|+++...|.+|++|||.+......     ......
T Consensus       405 ~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~  484 (601)
T KOG0590|consen  405 YDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGI  484 (601)
T ss_pred             HHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCc
Confidence            389999999889999999999999999999999999999999999999999999999999988654322     223456


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +|+..|+|||.+.+...-....||||.|+++..|.+|+.||......+....-.    ..                  ..
T Consensus       485 ~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----~~------------------~~  542 (601)
T KOG0590|consen  485 VGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----NY------------------SD  542 (601)
T ss_pred             ccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----cc------------------cc
Confidence            889999999999887777889999999999999999999997654322211000    00                  00


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      ..........++..++...+.+|.+||+.||.+|.|+++|++.+||+....
T Consensus       543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            000011122344457788899999999999999999999999999998754

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-22  Score=166.22  Aligned_cols=172  Identities=22%  Similarity=0.314  Sum_probs=125.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhC--------CcccCCCCCCCeeeccCCCeEEeecCCccCCCCC--
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN--   71 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~--------~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~--   71 (249)
                      .|||+|||.. ..++.+...+++..++.||++||..        .|+|||||+.||+|.+++.+.+.|+|++......  
T Consensus       293 ~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~  371 (513)
T KOG2052|consen  293 HGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTD  371 (513)
T ss_pred             CCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCC
Confidence            4899999998 7899999999999999999999952        3999999999999999999999999999765443  


Q ss_pred             ---CccccccccccccCchhccCCCCC-----CchhHHHHHHHHHHHHHhC----------CCCCCCCC----hHHHHHH
Q 025683           72 ---EFMTEYVVTRWYRAPELLLNSSDY-----TAAIDVWSVGCIFMELMNR----------RPLFPGND----HVHQMRL  129 (249)
Q Consensus        72 ---~~~~~~~~~~~y~aPE~~~~~~~~-----~~~~DiwslG~~l~~l~~g----------~~p~~~~~----~~~~~~~  129 (249)
                         ...+..+||.+|||||++...-+.     =..+||||||.++||+...          +.||....    ....+++
T Consensus       372 ~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrk  451 (513)
T KOG2052|consen  372 TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRK  451 (513)
T ss_pred             cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhc
Confidence               234567999999999999654332     1269999999999998753          35664322    1222222


Q ss_pred             HHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCC--hHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH--PLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ++-.-.                         .+......|...+  ..+.++++.||.-+|.-|.|+-.+.+
T Consensus       452 VVCv~~-------------------------~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  452 VVCVQK-------------------------LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             ceeecc-------------------------cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            221111                         1111122222111  23568999999999999999877643

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.89  E-value=4.9e-23  Score=193.42  Aligned_cols=177  Identities=18%  Similarity=0.248  Sum_probs=119.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH---SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH---~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|.+++.   .+++..+.+++.||+.||+|||   +.+++||||||+||+++.++..++. ++.......   .....
T Consensus       767 ~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~  839 (968)
T PLN00113        767 GKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCF  839 (968)
T ss_pred             CCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCcc
Confidence            689999996   4899999999999999999999   6699999999999999998887775 544332211   11236


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+... .++.++|||||||++|||++|+.||..... .............          ........+..
T Consensus       840 ~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~  908 (968)
T PLN00113        840 ISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS----------DCHLDMWIDPS  908 (968)
T ss_pred             ccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC----------ccchhheeCcc
Confidence            68899999988644 488999999999999999999999853211 0001111110000          00000000000


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ... .   .........++.+++.+||+.||.+|||+.++++.
T Consensus       909 ~~~-~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        909 IRG-D---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccC-C---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            000 0   00000112356789999999999999999999875

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.7e-22  Score=175.84  Aligned_cols=167  Identities=25%  Similarity=0.313  Sum_probs=132.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccc---
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~---   77 (249)
                      +|.|.||++.+ +.+-.+....|..||++||.|||++++|||||-+.||||.....+|+.|||+++...........   
T Consensus       781 ~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~g  860 (1177)
T KOG1025|consen  781 LGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGG  860 (1177)
T ss_pred             cchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccccccc
Confidence            57899999886 67999999999999999999999999999999999999999999999999999876554332221   


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      -....|+|-|.+. .+.++.++||||+||++||++| |..||.+.........+....+                     
T Consensus       861 K~pikwmale~i~-~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---------------------  918 (1177)
T KOG1025|consen  861 KVPIKWMALESIR-IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---------------------  918 (1177)
T ss_pred             ccCcHHHHHHHhh-ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc---------------------
Confidence            1244588888875 4458999999999999999987 9999987754333333221111                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               -..++..+-++..++.+||..|+..||+++++..
T Consensus       919 ---------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  919 ---------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ---------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                     1223356677889999999999999999999865

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.88  E-value=6.6e-22  Score=152.88  Aligned_cols=138  Identities=41%  Similarity=0.708  Sum_probs=118.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-CCCeEEeecCCccCCCCCC-cccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENE-FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~~~~-~~~~~~   78 (249)
                      |++|.+++... ..++...+..++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+....... ......
T Consensus        75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence            47999999876 57999999999999999999999999999999999999999 8999999999887554332 122345


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +...|++||........+.+.|+|++|++++++                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            677899999886543578899999999999998                                               


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHP  201 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~  201 (249)
                                     ..+.+++.+|++.+|.+||++.++++++
T Consensus       188 ---------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                           1266899999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.87  E-value=8.4e-23  Score=171.77  Aligned_cols=118  Identities=25%  Similarity=0.479  Sum_probs=108.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |-||++||.-+.++++..++.|++||+.|+++||++||+|||||-+|++++.+|.+||+|||.+... .+++...+.||.
T Consensus       654 gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~-ksgpfd~f~gtv  732 (772)
T KOG1152|consen  654 GIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT-KSGPFDVFVGTV  732 (772)
T ss_pred             CcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh-cCCCcceeeeec
Confidence            4689999999999999999999999999999999999999999999999999999999999987544 345567789999


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG  120 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  120 (249)
                      .|.|||++.+..+.+...|||+||+++|-++....||..
T Consensus       733 ~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  733 DYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999999998888889999999999999999998888753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.86  E-value=4.3e-22  Score=169.86  Aligned_cols=179  Identities=27%  Similarity=0.442  Sum_probs=143.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||+|.+.-.-.+++++.++..+.++.+.|++|||+.|-.|||||-.||++++.|.+||.|||.+..+... ...+.+.||
T Consensus        96 ggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGt  175 (829)
T KOG0576|consen   96 GGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGT  175 (829)
T ss_pred             CCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCC
Confidence            6788888877889999999999999999999999999999999999999999999999999998766543 345678999


Q ss_pred             ccccCchhcc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           81 RWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        81 ~~y~aPE~~~--~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++|+|||+..  ..+.+...+|+|++|+...|+-.-++|-....+...+..+.+..-.++...                 
T Consensus       176 pywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk-----------------  238 (829)
T KOG0576|consen  176 PYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK-----------------  238 (829)
T ss_pred             ccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc-----------------
Confidence            9999999863  344588899999999999999888877666655544444433222222110                 


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                               -..+.++.|-+|++.+|.++|.+|||++.+|.|||.+.-
T Consensus       239 ---------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  239 ---------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             ---------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence                     011345668899999999999999999999999998754

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.7e-21  Score=150.61  Aligned_cols=165  Identities=25%  Similarity=0.385  Sum_probs=115.3

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc--CCCeEEeecCCccCCCCCCcccccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~--~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |||.+-+.. ..+-+.-.++++.|+++|+.|+|++++||||||.+||||-.  ..++||||||.+...+..-  ...-.+
T Consensus       107 gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV--~~~~~~  183 (378)
T KOG1345|consen  107 GDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV--KYLEYV  183 (378)
T ss_pred             chhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee--hhhhhh
Confidence            456655555 45788999999999999999999999999999999999954  3589999999987654321  122224


Q ss_pred             ccccCchhccCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           81 RWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-HQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        81 ~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..|-+||.....    -...+..|+|.||++++.+++|.+||...... ..+...+...+...                 
T Consensus       184 ~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~-----------------  246 (378)
T KOG1345|consen  184 NNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN-----------------  246 (378)
T ss_pred             cccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC-----------------
Confidence            557888876432    22467899999999999999999999643211 11111111111111                 


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV  194 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  194 (249)
                             .........+++.+..+.++-|..++.+|...
T Consensus       247 -------~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki  278 (378)
T KOG1345|consen  247 -------PALPKKFNPFSEKALRLFKKSLTPRFKDRCKI  278 (378)
T ss_pred             -------ccCchhhcccCHHHHHHHHHhcCCcccccchh
Confidence                   11222334577888899999999999999433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.83  E-value=1.1e-19  Score=142.52  Aligned_cols=119  Identities=40%  Similarity=0.737  Sum_probs=103.3

Q ss_pred             CccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--cccccc
Q 025683            2 DTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~-l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~   78 (249)
                      +++|.+++..... +++..+..++.+++.++.+||+++++|+|+++.||+++.++.++|+|||.+.......  ......
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK  160 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence            4599999998766 9999999999999999999999999999999999999999999999999887655432  233456


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG  120 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  120 (249)
                      ++..|++||.+.....++.++|+|+||+++++|++|..||..
T Consensus       161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            677899999874334567799999999999999999999977

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.82  E-value=1.8e-20  Score=167.28  Aligned_cols=168  Identities=26%  Similarity=0.416  Sum_probs=137.1

Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC------------
Q 025683            5 LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE------------   72 (249)
Q Consensus         5 L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~------------   72 (249)
                      =.+.++.-+.++...        +.+++|||+.||+|+|+||+|.+|..-|.+|+.|||+.+......            
T Consensus       138 c~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~  209 (1205)
T KOG0606|consen  138 CATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKD  209 (1205)
T ss_pred             hhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHH
Confidence            344455556666665        678999999999999999999999999999999999987543211            


Q ss_pred             ----ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchh
Q 025683           73 ----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNE  148 (249)
Q Consensus        73 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (249)
                          .-+..+||+.|+|||++...+ |+..+|.|++|+++|+.+.|+.||.+..+.......+.....++..+       
T Consensus       210 t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d-------  281 (1205)
T KOG0606|consen  210 THEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED-------  281 (1205)
T ss_pred             HHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC-------
Confidence                113458899999999997665 89999999999999999999999999999888888876555444332       


Q ss_pred             hHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC---CHHHHhcCccccCCcCC
Q 025683          149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI---TVDEALAHPYLARLHDE  209 (249)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~~ll~h~~~~~~~~~  209 (249)
                                           ..++++++++|.++|..+|..|.   .+-++.+|+||+.+...
T Consensus       282 ---------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  282 ---------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ---------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence                                 24778999999999999999996   46788899999987654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=6.3e-20  Score=164.40  Aligned_cols=167  Identities=28%  Similarity=0.423  Sum_probs=120.1

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC----Ccccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----EFMTEYV   78 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~----~~~~~~~   78 (249)
                      .+|+|.|....-|..-+.+-|+.||+.||..+|..||+|||||.+||||..=+.+.|+||..-+.....    .....+.
T Consensus       105 hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFF  184 (1431)
T KOG1240|consen  105 HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFF  184 (1431)
T ss_pred             hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEE
Confidence            478888887777888899999999999999999999999999999999999999999999865542211    1111111


Q ss_pred             c----cccccCchhccCCC----------CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 025683           79 V----TRWYRAPELLLNSS----------DYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        79 ~----~~~y~aPE~~~~~~----------~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (249)
                      .    ..-|+|||.+....          ...++.||+|+||+++|+++ |++||...       ++..-....      
T Consensus       185 DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------QL~aYr~~~------  251 (1431)
T KOG1240|consen  185 DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------QLLAYRSGN------  251 (1431)
T ss_pred             ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------HHHhHhccC------
Confidence            1    22399999996522          14678999999999999987 78888421       111100000      


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                    ...+++-++.+.   +..++.+|..|++.||++|.++++.|+
T Consensus       252 --------------~~~~e~~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~  290 (1431)
T KOG1240|consen  252 --------------ADDPEQLLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQ  290 (1431)
T ss_pred             --------------ccCHHHHHHhCc---CccHHHHHHHHHccCchhccCHHHHHH
Confidence                          000111111221   245889999999999999999999998

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=4.8e-20  Score=147.43  Aligned_cols=139  Identities=21%  Similarity=0.258  Sum_probs=95.9

Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCchhccCC---
Q 025683           16 SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNS---   92 (249)
Q Consensus        16 ~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---   92 (249)
                      .......+..|++..+++||..|++|+||+|+|++++.+|.+.|+||+.....+.....  ...+..|.+||.....   
T Consensus       143 ~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~  220 (288)
T PF14531_consen  143 AFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQF  220 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSC
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhccc
Confidence            34445666699999999999999999999999999999999999999887765543322  3335678999977432   


Q ss_pred             ----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhc
Q 025683           93 ----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV  168 (249)
Q Consensus        93 ----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (249)
                          -.++.+.|.|+||+++|.||++..||.........                                  ...+...
T Consensus       221 ~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~----------------------------------~~~f~~C  266 (288)
T PF14531_consen  221 GQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADP----------------------------------EWDFSRC  266 (288)
T ss_dssp             HHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS----------------------------------GGGGTTS
T ss_pred             CcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccc----------------------------------cccchhc
Confidence                13678999999999999999999999765311000                                  0022333


Q ss_pred             CCCCChHHHHHHHHhcCCCCCCC
Q 025683          169 FPHVHPLAIDLVDRMLTFDPMKR  191 (249)
Q Consensus       169 ~~~~~~~~~~li~~~L~~dp~~R  191 (249)
                      . ++++.+++||+.+|+.+|.+|
T Consensus       267 ~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  267 R-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S----HHHHHHHHHHT-SSGGGS
T ss_pred             C-CcCHHHHHHHHHHccCCcccC
Confidence            4 688899999999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=6.2e-20  Score=156.34  Aligned_cols=167  Identities=25%  Similarity=0.412  Sum_probs=140.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|+..+.+...+++...+.+...++.+++++|+.+++|+|+|++||+++.+|.+++.|||.++........   +|+.
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~  157 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTY  157 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccch
Confidence            6788888888888999999999999999999999999999999999999999999999999999876554432   8899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|||||+..   .....+|.||+|+++++|++|..||..    +.+..|....-                          
T Consensus       158 eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~--------------------------  204 (612)
T KOG0603|consen  158 EYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL--------------------------  204 (612)
T ss_pred             hhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc--------------------------
Confidence            999999985   367899999999999999999999977    44444443111                          


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCcCC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLHDE  209 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~~~  209 (249)
                           ..+..++..+.+++..++..+|.+|.-     +.++++|+||+.....
T Consensus       205 -----~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  205 -----EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             -----CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence                 112245677889999999999999974     5799999999988755

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=2.8e-18  Score=139.42  Aligned_cols=177  Identities=24%  Similarity=0.328  Sum_probs=124.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec--cCC--CeEEeecCCccCCCCC------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANC--DLKICDFGLARPTSEN------   71 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~--~~~--~~kL~dfg~~~~~~~~------   71 (249)
                      ..+|+.|+.. ...+....+-++.|+++|+.|||.+|+.|||+|++|||+.  +|+  .+.++|||-+-.....      
T Consensus       326 ~~tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy  404 (598)
T KOG4158|consen  326 RQTLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPY  404 (598)
T ss_pred             hhhHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeecccccccccc
Confidence            4688899987 4567888889999999999999999999999999999994  333  4688999976422211      


Q ss_pred             -CccccccccccccCchhccCCCC-----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           72 -EFMTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        72 -~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                       ......-|.-..+|||+...-+.     .=.++|.|+.|.+.||++....||.+.........-               
T Consensus       405 ~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---------------  469 (598)
T KOG4158|consen  405 ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---------------  469 (598)
T ss_pred             ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh---------------
Confidence             11112344556899999853321     124899999999999999999999764311100000               


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHH---HHhc------CccccCCcC
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVD---EALA------HPYLARLHD  208 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~---~ll~------h~~~~~~~~  208 (249)
                             |-       +..+..++..+++.+++++..+|+.||++|+++.   .+++      |.|++.+.+
T Consensus       470 -------Yq-------e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~  527 (598)
T KOG4158|consen  470 -------YQ-------ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMME  527 (598)
T ss_pred             -------hh-------hhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhcc
Confidence                   00       1122344557889999999999999999999854   4554      555555443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.75  E-value=6.7e-17  Score=132.87  Aligned_cols=191  Identities=32%  Similarity=0.512  Sum_probs=141.7

Q ss_pred             CccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCCCC-----
Q 025683            2 DTDLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE-----   72 (249)
Q Consensus         2 ~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~~-----   72 (249)
                      |+++.+++....   .++...+..++.|++.++.|+|+.+++|+|+||+||+++..+ .++++|||.+.......     
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (384)
T COG0515          82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI  161 (384)
T ss_pred             CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccc
Confidence            577887777765   799999999999999999999999999999999999999998 69999999987443332     


Q ss_pred             --ccccccccccccCchhccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCC-Ccccccc
Q 025683           73 --FMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIELLGTP-TDADLGF  144 (249)
Q Consensus        73 --~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~~~~~~  144 (249)
                        ......++..|++||.....  .......|+|++|+++++++.|..||.....   .............. .....  
T Consensus       162 ~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  239 (384)
T COG0515         162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL--  239 (384)
T ss_pred             cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccccc--
Confidence              23567889999999999763  4688999999999999999999999876653   22222222222111 00000  


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCC
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV  214 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~  214 (249)
                                       .....   ......+.+++..++..+|..|.+..+...+++............
T Consensus       240 -----------------~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~  289 (384)
T COG0515         240 -----------------SPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS  289 (384)
T ss_pred             -----------------Ccccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccccccccc
Confidence                             00000   112256789999999999999999999988877766554444433

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=9e-17  Score=133.25  Aligned_cols=173  Identities=17%  Similarity=0.161  Sum_probs=127.8

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC-----CCeEEeecCCcc--CCCCC
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-----CDLKICDFGLAR--PTSEN   71 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~-----~~~kL~dfg~~~--~~~~~   71 (249)
                      +|.+|.++....  +.|+..++..++.|++.+|++||+.|++||||||.|+.+...     ..+.|.|||+++  .....
T Consensus       103 ~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~  182 (322)
T KOG1164|consen  103 LGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGD  182 (322)
T ss_pred             cCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCC
Confidence            588999988654  689999999999999999999999999999999999999865     358999999998  32111


Q ss_pred             C--------c-cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 025683           72 E--------F-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADL  142 (249)
Q Consensus        72 ~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  142 (249)
                      .        . .....||..|.++.+..+.. .+...|+||++.++.++..|..||....................... 
T Consensus       183 ~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~-  260 (322)
T KOG1164|consen  183 SGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR-  260 (322)
T ss_pred             CCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc-
Confidence            1        1 12345899999999886554 78999999999999999999999976654333333222111100000 


Q ss_pred             cccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          143 GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                               .....+..+.++...+-..+...+|....+...
T Consensus       261 -------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  261 -------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             -------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence                                     111244567777777777889999988777554

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.71  E-value=1.3e-17  Score=139.72  Aligned_cols=164  Identities=27%  Similarity=0.410  Sum_probs=118.6

Q ss_pred             ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-------
Q 025683            3 TDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-------   72 (249)
Q Consensus         3 ~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-------   72 (249)
                      .+|.+||...   ..-+....+.++.|+..|++|   +|.+|+|+||.||++..+..+++.|||+........       
T Consensus       341 ~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a  417 (516)
T KOG1033|consen  341 ETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAA  417 (516)
T ss_pred             hhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhh
Confidence            4788999754   457788999999999999999   999999999999999999999999999986544333       


Q ss_pred             ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        73 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      ......||..|++||.+.+.. ++.++|||+||++++|++. -...+...   .....+.  -+..++.           
T Consensus       418 ~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r--~g~ip~~-----------  480 (516)
T KOG1033|consen  418 SHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIR--DGIIPPE-----------  480 (516)
T ss_pred             hhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhhh--cCCCChH-----------
Confidence            344568899999999997554 8999999999999999986 22111100   0000000  0000000           


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                                      ..-++ +.-..|+..+|...|.+||++.+.--|.|.
T Consensus       481 ----------------~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  481 ----------------FLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ----------------HhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                            01112 223479999999999999987777666664

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.66  E-value=7.1e-16  Score=131.15  Aligned_cols=177  Identities=26%  Similarity=0.327  Sum_probs=125.9

Q ss_pred             ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCc-ccCCCCCCCeeeccCCCeEEeecCCccCCCCC---Cccccc
Q 025683            3 TDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANV-IHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEY   77 (249)
Q Consensus         3 ~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i-~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---~~~~~~   77 (249)
                      |+|.|.+.+ ...++..-...++++|+.||+|||...+ +||.+++.|.+++....+||+|||+.......   ......
T Consensus        32 Gsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~  111 (484)
T KOG1023|consen   32 GSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPI  111 (484)
T ss_pred             ccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchh
Confidence            789999988 4678888999999999999999998765 99999999999999999999999988665321   111112


Q ss_pred             cccccccCchhccCCC--C----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           78 VVTRWYRAPELLLNSS--D----YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~--~----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      .....|.|||.+....  .    .+.+.|+||+|++++|+++...||...........++..+..               
T Consensus       112 ~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~---------------  176 (484)
T KOG1023|consen  112 RKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK---------------  176 (484)
T ss_pred             HHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh---------------
Confidence            2345599999986531  1    366799999999999999999999764321111222211110               


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                          ......+....... ...+++..++..||..+|.+||+++++-.
T Consensus       177 ----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  177 ----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHh
Confidence                00001111111111 34567899999999999999999998854

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.64  E-value=1.6e-15  Score=117.93  Aligned_cols=161  Identities=18%  Similarity=0.293  Sum_probs=120.5

Q ss_pred             ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeeccCCCeEEe--ecCCccCCCCCCcccc
Q 025683            3 TDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKIC--DFGLARPTSENEFMTE   76 (249)
Q Consensus         3 ~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~~~~~~kL~--dfg~~~~~~~~~~~~~   76 (249)
                      |||++.|....  .++..++.+++..++.|++|||+..  |.--.+.+..++++.+.+.+++  |--++.  ..    ..
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--qe----~g  345 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE----VG  345 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--ec----cc
Confidence            68999998864  3678899999999999999999874  4444678889999998877654  322111  11    12


Q ss_pred             ccccccccCchhccCCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....+.|++||.+...+.  .-.++|+|||++++||+.+...||....+...-.++.-                      
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----------------------  403 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----------------------  403 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----------------------
Confidence            344788999999975442  34589999999999999999999987776554444431                      


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHh
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL  198 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll  198 (249)
                             +.....++++++..+..++.-|++.||.+||.++.++
T Consensus       404 -------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 -------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                   1111345667888899999999999999999988764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.59  E-value=3.2e-14  Score=113.45  Aligned_cols=121  Identities=21%  Similarity=0.351  Sum_probs=101.5

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-----CeEEeecCCccCCCCCCcc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-----DLKICDFGLARPTSENEFM   74 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-----~~kL~dfg~~~~~~~~~~~   74 (249)
                      +|.||.|+..=. ++|+.+.+..++.|++.-++|+|++.+++|||||+|+||...+     .+.++|||+++...+..+.
T Consensus       106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk  185 (449)
T KOG1165|consen  106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK  185 (449)
T ss_pred             hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence            578888888664 6899999999999999999999999999999999999997654     5889999999876654332


Q ss_pred             --------ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 025683           75 --------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND  122 (249)
Q Consensus        75 --------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~  122 (249)
                              +...||.+||+--...+.. -+...|+=+||-++...+.|..||.+..
T Consensus       186 qHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  186 QHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             ccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCcccccc
Confidence                    3457899999976665444 5778999999999999999999997654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.58  E-value=1.1e-14  Score=111.31  Aligned_cols=131  Identities=22%  Similarity=0.308  Sum_probs=104.6

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc---CCCeEEeecCCccCCCCCCcc--
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFM--   74 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~---~~~~kL~dfg~~~~~~~~~~~--   74 (249)
                      +|.||.++..-. ++|+..++.-++-|++.-++|+|.++++||||||+|+|..-   ..++.|+|||+++...+....  
T Consensus        93 LGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H  172 (341)
T KOG1163|consen   93 LGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH  172 (341)
T ss_pred             cCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence            577888887653 68999999999999999999999999999999999999864   356899999999876554322  


Q ss_pred             ------ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 025683           75 ------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIE  132 (249)
Q Consensus        75 ------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~  132 (249)
                            ....||..|.+--+..+.. -+...|+=|+|.++...-.|..||.+.......++.+.
T Consensus       173 Ipyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk  235 (341)
T KOG1163|consen  173 IPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK  235 (341)
T ss_pred             CccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence                  2346788898876664333 46788999999999999999999988766555555443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.49  E-value=1.2e-13  Score=105.65  Aligned_cols=101  Identities=19%  Similarity=0.150  Sum_probs=75.9

Q ss_pred             HHHHHHHHHHHHHHhhCCcccCCC-CCCCeeeccCCCeEEeecCCccCCCCCCcc----c----------cccccccccC
Q 025683           21 QYFLYQLLRGLKYIHSANVIHRDL-KPSNLLLNANCDLKICDFGLARPTSENEFM----T----------EYVVTRWYRA   85 (249)
Q Consensus        21 ~~i~~qil~~l~~LH~~~i~H~di-k~~nil~~~~~~~kL~dfg~~~~~~~~~~~----~----------~~~~~~~y~a   85 (249)
                      ..++.|++.+|.++|++|++|+|| ||.||+++.++.++|+|||.+.........    .          ....++.|++
T Consensus        94 ~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~  173 (218)
T PRK12274         94 LAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALT  173 (218)
T ss_pred             HHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence            457889999999999999999999 799999999999999999999855443311    0          0123666777


Q ss_pred             chhccCCCCCC-chhHHHHHHHHHHHHHhCCCCCCCC
Q 025683           86 PELLLNSSDYT-AAIDVWSVGCIFMELMNRRPLFPGN  121 (249)
Q Consensus        86 PE~~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~  121 (249)
                      |+...-....+ ...+.++.|+-+|.++|+..++-++
T Consensus       174 ~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        174 PVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            77543222223 4566777899999999999887554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=3.4e-15  Score=132.14  Aligned_cols=178  Identities=27%  Similarity=0.426  Sum_probs=139.7

Q ss_pred             CccHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCC-C---Cc
Q 025683            2 DTDLYQII-RSNQ-SLSEEHCQYFLYQLLRGLKYIH-SANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSE-N---EF   73 (249)
Q Consensus         2 ~~~L~~~l-~~~~-~l~~~~~~~i~~qil~~l~~LH-~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~-~---~~   73 (249)
                      |+++++-+ .... ..+...+..++.|+..++.|+| ..+++|+|++|+|.+++..+ .++..|||++..... .   ..
T Consensus       105 g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~  184 (601)
T KOG0590|consen  105 GGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERS  184 (601)
T ss_pred             ccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCccee
Confidence            56777777 5554 7888899999999999999999 99999999999999999999 999999999876544 2   22


Q ss_pred             cccccc-cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           74 MTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        74 ~~~~~~-~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                      ....+| ++.|.+||...+........|+||.|+++.-+++|..|+.........                         
T Consensus       185 ~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------------------------  239 (601)
T KOG0590|consen  185 LKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------------------------  239 (601)
T ss_pred             eecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-------------------------
Confidence            334577 899999999977666789999999999999999999998655422100                         


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                      +....... .......+..++....+++.+++..+|..|.+.+++..++|+..
T Consensus       240 ~~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  240 YSSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ceeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            00000000 01112334567788899999999999999999999999999998

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=3.8e-13  Score=122.45  Aligned_cols=113  Identities=23%  Similarity=0.372  Sum_probs=98.2

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-------CCCeEEeecCCccCC---CCCC
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------NCDLKICDFGLARPT---SENE   72 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-------~~~~kL~dfg~~~~~---~~~~   72 (249)
                      |+|.+++..++.+++..++.+..|++..++.||.++|+||||||+|+++..       ...++|+|||.+.-.   ....
T Consensus       779 Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~  858 (974)
T KOG1166|consen  779 GTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGT  858 (974)
T ss_pred             ccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCc
Confidence            699999999999999999999999999999999999999999999999943       346899999988643   2334


Q ss_pred             ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 025683           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP  116 (249)
Q Consensus        73 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~  116 (249)
                      ......+|-.+-++|...+.+ |+..+|.|.|+.+++-|+.|+.
T Consensus       859 ~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  859 KFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence            556677888899999886554 9999999999999999999873

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.39  E-value=7.4e-13  Score=101.43  Aligned_cols=65  Identities=20%  Similarity=0.287  Sum_probs=55.7

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-hhCCcccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYI-HSANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~L-H~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      +++...+.+.+.++...+..++.|++.+|.++ |+.|++||||||+||+++ ++.++|+|||.+...
T Consensus       102 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         102 DGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            34444444457899999999999999999999 799999999999999998 578999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.35  E-value=1.2e-12  Score=109.32  Aligned_cols=70  Identities=26%  Similarity=0.411  Sum_probs=57.9

Q ss_pred             HHHHHHHHHHHHHHhhCCcccCCC-CCCCeeeccCCCeEEeecCCccCCCCCCcc---------ccccccccccCchhcc
Q 025683           21 QYFLYQLLRGLKYIHSANVIHRDL-KPSNLLLNANCDLKICDFGLARPTSENEFM---------TEYVVTRWYRAPELLL   90 (249)
Q Consensus        21 ~~i~~qil~~l~~LH~~~i~H~di-k~~nil~~~~~~~kL~dfg~~~~~~~~~~~---------~~~~~~~~y~aPE~~~   90 (249)
                      ..++.|++.+|.|||++|++|||| ||+||+++.++.++|+|||++.........         ....+++.|.+||.+.
T Consensus       114 ~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        114 PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            578899999999999999999999 999999999999999999999865433211         2345677789999875

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.33  E-value=3.6e-12  Score=97.76  Aligned_cols=58  Identities=22%  Similarity=0.316  Sum_probs=53.0

Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCC
Q 025683           11 SNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (249)
Q Consensus        11 ~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~   69 (249)
                      ....++...+..++.|++.++.++|. .|++|+||||+||+++ ++.++|+|||.+....
T Consensus       110 ~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         110 KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            34678899999999999999999999 9999999999999999 8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.29  E-value=4.4e-12  Score=114.48  Aligned_cols=183  Identities=26%  Similarity=0.335  Sum_probs=144.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-----------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-----------   70 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-----------   70 (249)
                      |++|...|.+.+..+.+.++.....+..++++||...+.|+|++|.|.+...++..++.+|+.....+.           
T Consensus       888 ~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~  967 (1205)
T KOG0606|consen  888 GGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPS  967 (1205)
T ss_pred             cCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCccccc
Confidence            478888899888899999999999999999999999999999999999999999999999973321110           


Q ss_pred             ----------C-----------CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 025683           71 ----------N-----------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL  129 (249)
Q Consensus        71 ----------~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~  129 (249)
                                .           .......+++.|.+||...+.. .+..+|.|++|+.+++.++|..||....+....+.
T Consensus       968 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~n 1046 (1205)
T KOG0606|consen  968 SSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFEN 1046 (1205)
T ss_pred             ccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhc
Confidence                      0           0112346788999999987655 77889999999999999999999988876655544


Q ss_pred             HHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHH---HHhcCccccCC
Q 025683          130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVD---EALAHPYLARL  206 (249)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~---~ll~h~~~~~~  206 (249)
                      +...-                            ..+.......+....+++...|..+|.+|..+.   ++-.|+||+..
T Consensus      1047 i~~~~----------------------------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1047 ILNRD----------------------------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             cccCC----------------------------CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            43211                            112223335677889999999999999999877   88899999988


Q ss_pred             cCCCCCC
Q 025683          207 HDEADEP  213 (249)
Q Consensus       207 ~~~~~~~  213 (249)
                      ..+....
T Consensus      1099 ~~~~l~~ 1105 (1205)
T KOG0606|consen 1099 DWENLAL 1105 (1205)
T ss_pred             Ccccccc
Confidence            7555443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.29  E-value=1.7e-12  Score=101.16  Aligned_cols=76  Identities=14%  Similarity=0.234  Sum_probs=57.4

Q ss_pred             HHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCchhccCCCCCCchhHHH
Q 025683           23 FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  102 (249)
Q Consensus        23 i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  102 (249)
                      ...+++.++..+|+.|++|||++|+||+++.+| ++|+|||............            .+.-...+..++|+|
T Consensus       140 ~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d------------~~vler~y~~~~di~  206 (232)
T PRK10359        140 VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD------------RIDLERHYGIKNEIK  206 (232)
T ss_pred             HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH------------HHHHHhHhccccccc
Confidence            466999999999999999999999999999988 9999999775443222111            111122245789999


Q ss_pred             HHHHHHHHH
Q 025683          103 SVGCIFMEL  111 (249)
Q Consensus       103 slG~~l~~l  111 (249)
                      +||+++.-.
T Consensus       207 ~lg~~~~~~  215 (232)
T PRK10359        207 DLGYYLLIY  215 (232)
T ss_pred             ceeEeehHH
Confidence            999987654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=2.7e-12  Score=111.51  Aligned_cols=164  Identities=22%  Similarity=0.312  Sum_probs=115.3

Q ss_pred             HHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--------ccc--ccccccccCch
Q 025683           19 HCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--------MTE--YVVTRWYRAPE   87 (249)
Q Consensus        19 ~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--------~~~--~~~~~~y~aPE   87 (249)
                      ..-.=+.+++.|+.|+|.. ++||++|.|++|.++..+..|+++|+++........        ...  ......|.+||
T Consensus       100 ~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE  179 (700)
T KOG2137|consen  100 DGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE  179 (700)
T ss_pred             HhhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence            3344455666899999966 899999999999999999999999998865443211        011  12355699999


Q ss_pred             hccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchh
Q 025683           88 LLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA  166 (249)
Q Consensus        88 ~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (249)
                      .+.. ...+.++|++|+||+++.+.. |...+...........-....+.                           ...
T Consensus       180 ~~~~-~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~---------------------------~~~  231 (700)
T KOG2137|consen  180 YLLG-TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA---------------------------GAF  231 (700)
T ss_pred             hhcc-ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc---------------------------ccc
Confidence            9865 447889999999999999984 55444433221111111110000                           001


Q ss_pred             hcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          167 QVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       167 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                      ....+++.++++=+.++|..++..||++..++..+||+...-..
T Consensus       232 ~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~a  275 (700)
T KOG2137|consen  232 GYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKA  275 (700)
T ss_pred             cccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchhhh
Confidence            11246889999999999999999999999999999999765433

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=4.8e-11  Score=95.53  Aligned_cols=170  Identities=20%  Similarity=0.279  Sum_probs=113.4

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeeccCCCeEEeecCCc--cCCCCC--
Q 025683            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLA--RPTSEN--   71 (249)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~~~~~~kL~dfg~~--~~~~~~--   71 (249)
                      .|+|.++|++.    ..+....-++++.||+.||.|||+..  ++|+++.-+.|++..+|-+|+..-.-.  +.....  
T Consensus       156 sgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~  235 (458)
T KOG1266|consen  156 SGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTR  235 (458)
T ss_pred             chhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhh
Confidence            36788888763    56889999999999999999999884  999999999999999998887532211  111100  


Q ss_pred             -CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCcccccccchhh
Q 025683           72 -EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNED  149 (249)
Q Consensus        72 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (249)
                       .......+-++|.+||.-. ..+...++|||++|.-.++|..+..--..... ...-..+.....              
T Consensus       236 ~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~--------------  300 (458)
T KOG1266|consen  236 EAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII--------------  300 (458)
T ss_pred             HhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee--------------
Confidence             0111123456788887442 23466789999999999999877643221110 000000000000              


Q ss_pred             HHHHHHhCCCCCCcchhhcCCCCC-hHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          150 AKRYIRQLPQHPRQSLAQVFPHVH-PLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                           ..+ ..-++++.+||.-.|..||++.+++.||..=++.
T Consensus       301 ---------------------~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  301 ---------------------GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             ---------------------eccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence                                 011 1134789999999999999999999999876553

>smart00090 RIO RIO-like kinase

Probab=99.17  E-value=3.3e-11  Score=95.45  Aligned_cols=65  Identities=17%  Similarity=0.193  Sum_probs=55.1

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~-i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      ++|..++.+...+....+..++.||+.++.+||++| ++|+||||+||+++ ++.++|+|||.+...
T Consensus       133 ~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      133 DGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            345555544566777788999999999999999999 99999999999999 889999999987543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.14  E-value=6.2e-11  Score=101.53  Aligned_cols=177  Identities=24%  Similarity=0.219  Sum_probs=132.5

Q ss_pred             CCccHHHHHHhCC-CCCHHHHHHHHHHHHH----HHHHHhhCCcccCCCCCCCeeeccC-CCeEEeecCCccCCCCCCcc
Q 025683            1 MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLR----GLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFM   74 (249)
Q Consensus         1 ~~~~L~~~l~~~~-~l~~~~~~~i~~qil~----~l~~LH~~~i~H~dik~~nil~~~~-~~~kL~dfg~~~~~~~~~~~   74 (249)
                      +|.+|.++...-. .++...+...+.+...    ||..+|..+++|.|++|.||+...+ ..++++|||+...++.....
T Consensus       200 ~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~  279 (524)
T KOG0601|consen  200 CGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFS  279 (524)
T ss_pred             ccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccc
Confidence            3567777777653 4888999999999999    9999999999999999999999999 88999999998877655321


Q ss_pred             ------ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCCcccccccc
Q 025683           75 ------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN--DHVHQMRLLIELLGTPTDADLGFVR  146 (249)
Q Consensus        75 ------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  146 (249)
                            ....+...|++||...+  -++...|++++|.++.+..++..++..+  ....+.+.+.               
T Consensus       280 ~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---------------  342 (524)
T KOG0601|consen  280 SVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---------------  342 (524)
T ss_pred             cceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---------------
Confidence                  12255677999998843  3789999999999999998887666443  1111111100               


Q ss_pred             hhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                                       .-.+.....+.++...+..|+..++..|++...++.++++.+......
T Consensus       343 -----------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~  390 (524)
T KOG0601|consen  343 -----------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHL  390 (524)
T ss_pred             -----------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcc
Confidence                             001122234556667899999999999999999999999986654443

>PRK10345 hypothetical protein; Provisional

Probab=99.12  E-value=1.2e-10  Score=90.39  Aligned_cols=59  Identities=25%  Similarity=0.367  Sum_probs=49.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHhhCCcccCCCCCCCeeeccC----CCeEEeecC
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGL-KYIHSANVIHRDLKPSNLLLNAN----CDLKICDFG   63 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l-~~LH~~~i~H~dik~~nil~~~~----~~~kL~dfg   63 (249)
                      +++|.+++.+ +.+++.  ..++.|++.++ +|||+++|+|+||||+||+++..    +.++|+|++
T Consensus        91 ~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         91 SITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             chhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            4799999977 457666  46688888777 99999999999999999999743    379999954

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.05  E-value=5.8e-10  Score=88.51  Aligned_cols=60  Identities=28%  Similarity=0.429  Sum_probs=51.5

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      .+|.+++.+ ..+++..    +.+|+.+|.+||++||+|+||||.||+++.++.++|+|||.+..
T Consensus       132 ~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        132 RDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             CCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            588888865 4566553    67899999999999999999999999999999999999997754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.98  E-value=1.7e-09  Score=84.15  Aligned_cols=61  Identities=33%  Similarity=0.421  Sum_probs=54.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      |++|.+++.....    ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus        83 G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         83 GEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            6788888876432    8889999999999999999999999999999999 78999999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.96  E-value=1.3e-09  Score=84.14  Aligned_cols=52  Identities=23%  Similarity=0.296  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC
Q 025683           18 EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (249)
Q Consensus        18 ~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~   69 (249)
                      .....++.+++.++.++|+.|++|+||+|.||+++.++.++|+|||.+....
T Consensus       125 ~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         125 EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            4567899999999999999999999999999999999999999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.93  E-value=2.3e-09  Score=82.70  Aligned_cols=58  Identities=28%  Similarity=0.478  Sum_probs=50.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      |++|.+++.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            5677777665321       8899999999999999999999999999999 89999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.92  E-value=2.2e-08  Score=83.25  Aligned_cols=109  Identities=14%  Similarity=0.168  Sum_probs=87.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCchhccCC
Q 025683           13 QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNS   92 (249)
Q Consensus        13 ~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~   92 (249)
                      ....+.-..++++.++.+.+-||.+|-+-||+.++|++|++++.+.|.|-..-.....+......+|...|++||.-.-.
T Consensus       112 P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~  191 (637)
T COG4248         112 PHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLP  191 (637)
T ss_pred             CccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhccc
Confidence            45778889999999999999999999999999999999999999999875433322333334557889999999975311


Q ss_pred             ----CCCCchhHHHHHHHHHHHHHhC-CCCCCCC
Q 025683           93 ----SDYTAAIDVWSVGCIFMELMNR-RPLFPGN  121 (249)
Q Consensus        93 ----~~~~~~~DiwslG~~l~~l~~g-~~p~~~~  121 (249)
                          -......|.+.||+++++++.| +.||.+.
T Consensus       192 sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         192 SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             cccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence                1245689999999999999875 9999764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.89  E-value=3.3e-09  Score=94.00  Aligned_cols=58  Identities=24%  Similarity=0.426  Sum_probs=50.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      |++|.+++.        ....++.+++.+|.+||+.|++|||+||+||++ .++.++|+|||.++..
T Consensus       420 g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        420 GKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            567777765        357899999999999999999999999999999 6789999999998653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.81  E-value=7.7e-09  Score=78.92  Aligned_cols=51  Identities=24%  Similarity=0.307  Sum_probs=47.0

Q ss_pred             HHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCC
Q 025683           18 EHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (249)
Q Consensus        18 ~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~   69 (249)
                      ..+..++.+++.++.++|. .|++|+||+|+||+++ ++.++|+|||.+....
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         114 EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            6788999999999999999 9999999999999999 8999999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.80  E-value=7.2e-08  Score=84.22  Aligned_cols=104  Identities=23%  Similarity=0.450  Sum_probs=77.6

Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccccccccc
Q 025683            5 LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH-SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTEYVVTRW   82 (249)
Q Consensus         5 L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH-~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~   82 (249)
                      |..++++   ++...+.--++||+.||.||| +.+++|++|.-..|+|+..|.-||++|.++........ ......-..
T Consensus        94 l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s  170 (690)
T KOG1243|consen   94 LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIES  170 (690)
T ss_pred             HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhc
Confidence            4444553   336677888999999999998 66899999999999999999999999998765443321 112222334


Q ss_pred             ccCchhccCCCCCCchhHHHHHHHHHHHHHhC
Q 025683           83 YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR  114 (249)
Q Consensus        83 y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g  114 (249)
                      |..|+.....   .-..|.|.|||++++++.|
T Consensus       171 ~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  171 FDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence            6777755322   2467999999999999998

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.65  E-value=6.1e-08  Score=74.09  Aligned_cols=56  Identities=23%  Similarity=0.380  Sum_probs=48.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHH-hhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC
Q 025683           13 QSLSEEHCQYFLYQLLRGLKYI-HSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (249)
Q Consensus        13 ~~l~~~~~~~i~~qil~~l~~L-H~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~   69 (249)
                      ..++.+....+..+++.+|..| |..|++|||+++.||++. ++.+.++|||.+....
T Consensus       119 ~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         119 AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            3566677888899999999998 899999999999999997 5789999999775543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.59  E-value=1.3e-07  Score=73.34  Aligned_cols=64  Identities=27%  Similarity=0.426  Sum_probs=57.4

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC---CeEEeecCCccC
Q 025683            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARP   67 (249)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~---~~kL~dfg~~~~   67 (249)
                      +|.+++.....++......++.+++..+.-||.+|++|+|+++.|||++.++   .+.|+||+.+..
T Consensus       104 ~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  104 DLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             cHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            6888888755588888999999999999999999999999999999999887   899999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.55  E-value=2.5e-07  Score=74.45  Aligned_cols=63  Identities=17%  Similarity=0.252  Sum_probs=54.3

Q ss_pred             cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-------CCCeEEeecCCcc
Q 025683            4 DLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------NCDLKICDFGLAR   66 (249)
Q Consensus         4 ~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-------~~~~kL~dfg~~~   66 (249)
                      +|.+++..  ....+......++.+++..+..||..|++|+|+++.||+++.       ++.+.|+||+.+.
T Consensus       122 sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        122 SLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             cHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            68888764  345677888899999999999999999999999999999985       4678999999774

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.54  E-value=3.9e-08  Score=84.65  Aligned_cols=157  Identities=25%  Similarity=0.272  Sum_probs=108.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC-CCeEEeecCCccCCCCCCccccccccccccCchhccC
Q 025683           13 QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLN   91 (249)
Q Consensus        13 ~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~   91 (249)
                      .-+.+...+++..|++.++.++|+..++|+|++|+||++..+ +..+++||+......-.. .........|-..|++..
T Consensus       361 ~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-~~~~~~~r~~p~~~~~~e  439 (524)
T KOG0601|consen  361 QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-GVFHHIDRLYPIAEILLE  439 (524)
T ss_pred             HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec-ccccccccccccchhhcc
Confidence            457788899999999999999999999999999999999886 777899998765421111 111112233323555656


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCC
Q 025683           92 SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH  171 (249)
Q Consensus        92 ~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (249)
                      ...+..+.|+++||..+.+..++.+.-.........+.                                  ......+.
T Consensus       440 ~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~----------------------------------~~~p~~~~  485 (524)
T KOG0601|consen  440 DYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRS----------------------------------GDTPNLPG  485 (524)
T ss_pred             ccccccccccccccccccccccCcccCcccccceeeec----------------------------------ccccCCCc
Confidence            66688999999999999999888755333221100000                                  00001112


Q ss_pred             CChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          172 VHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       172 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                      ...++..+.+.+...|+..||.+.++..|.=|.
T Consensus       486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  486 LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            335577888899999999999999988876544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.51  E-value=3.2e-07  Score=68.50  Aligned_cols=59  Identities=25%  Similarity=0.378  Sum_probs=47.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      |..|.+++...       ...+++.+-.-+.-||..||+|||+.++||++...+ +.++|||++...
T Consensus        83 G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          83 GELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             ChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            34566677664       255677777778889999999999999999998766 999999998643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.39  E-value=7.4e-07  Score=64.89  Aligned_cols=51  Identities=33%  Similarity=0.376  Sum_probs=46.0

Q ss_pred             CHHHHHHHHHHHHHHHHHHhhC---CcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           16 SEEHCQYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        16 ~~~~~~~i~~qil~~l~~LH~~---~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      +......++.+++.++.++|..   +++|+|++|.||+++..+.++++||+.+.
T Consensus        84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            4567788999999999999985   69999999999999998999999999775

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK09902 hypothetical protein; Provisional

Probab=98.31  E-value=2.3e-06  Score=65.83  Aligned_cols=65  Identities=17%  Similarity=0.155  Sum_probs=56.7

Q ss_pred             ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC--eEEeecCCccC
Q 025683            3 TDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICDFGLARP   67 (249)
Q Consensus         3 ~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~--~kL~dfg~~~~   67 (249)
                      .||.+++.+.  .+.+......++.+|+.++.-||+.|+.|+|+-+.||+++.++.  +.++||..++.
T Consensus       111 ~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        111 ISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             ccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            5788888763  45688888999999999999999999999999999999987777  89999987653

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.31  E-value=2.6e-06  Score=63.61  Aligned_cols=65  Identities=25%  Similarity=0.366  Sum_probs=52.0

Q ss_pred             cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC---CeEEeecCCccCC
Q 025683            4 DLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPT   68 (249)
Q Consensus         4 ~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~---~~kL~dfg~~~~~   68 (249)
                      ++.+++...  ..........+++.|-+.+.-||.++++|||+..+||++..++   .+.++|||++...
T Consensus        97 ~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   97 TVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            677888764  2333444478899999999999999999999999999997665   3589999988644

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.30  E-value=1.6e-06  Score=64.92  Aligned_cols=45  Identities=33%  Similarity=0.457  Sum_probs=40.0

Q ss_pred             HHHHHHHHHHHHHHhhCCc-----ccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           21 QYFLYQLLRGLKYIHSANV-----IHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        21 ~~i~~qil~~l~~LH~~~i-----~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      ...+.+++.+|..||..++     +|||++|.||+++ ++.++++||+.+.
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            4567899999999999885     9999999999999 6789999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.23  E-value=1.8e-06  Score=74.50  Aligned_cols=65  Identities=23%  Similarity=0.317  Sum_probs=48.5

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLR-GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~-~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~   69 (249)
                      |++|.++.... ..+   ....++..++. .+..+|..|++|+|++|.||+++.+++++++|||.+....
T Consensus       242 G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       242 GIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            45566555421 112   23456666665 4788999999999999999999999999999999986654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.20  E-value=1.3e-05  Score=74.67  Aligned_cols=167  Identities=22%  Similarity=0.349  Sum_probs=114.0

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCC---CeeeccCCCeEEe--ecCCccCCCCCCcccccc
Q 025683            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPS---NLLLNANCDLKIC--DFGLARPTSENEFMTEYV   78 (249)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~---nil~~~~~~~kL~--dfg~~~~~~~~~~~~~~~   78 (249)
                      ++.+.+..-+.++.+.++.+..+++.|+.|+|+..+.|.-+...   +-.++..+....+  ||+..+............
T Consensus       272 ~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~  351 (1351)
T KOG1035|consen  272 ELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDL  351 (1351)
T ss_pred             chHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhc
Confidence            56677777788999999999999999999999997666555544   3344455555555  888777665554444444


Q ss_pred             ccccccCchhccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .+..+.++|...... ......|+|++|.....+..|..+-.....      ..                          
T Consensus       352 ~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~------~~--------------------------  399 (1351)
T KOG1035|consen  352 LAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV------PV--------------------------  399 (1351)
T ss_pred             CccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc------hh--------------------------
Confidence            556677777664322 233457999999999999887744221110      00                          


Q ss_pred             CCCCCcchhhcCCCCC-hHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          158 PQHPRQSLAQVFPHVH-PLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~-~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                               .+.+..+ ....+...+|+.-|+++|+++.+++.|+|.+.......
T Consensus       400 ---------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  400 ---------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES  445 (1351)
T ss_pred             ---------hhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence                     0000111 14668899999999999999999999999986554444

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.04  E-value=5.2e-05  Score=65.15  Aligned_cols=135  Identities=17%  Similarity=0.234  Sum_probs=95.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCchhccC
Q 025683           12 NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLN   91 (249)
Q Consensus        12 ~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~   91 (249)
                      +...+++.++.++.|+..||.++|+.|+.-+-+.+.+|++..+.+++++..|.........           .+|  +. 
T Consensus       387 ~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-----------~~~--le-  452 (655)
T KOG3741|consen  387 NLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-----------TEP--LE-  452 (655)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-----------Ccc--hh-
Confidence            3568899999999999999999999999999999999999999999998877654332221           011  11 


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCC
Q 025683           92 SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH  171 (249)
Q Consensus        92 ~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (249)
                         -..+.|.-.||.+++.|.+|..---.. +..+..                                   ....+...
T Consensus       453 ---~~Qq~D~~~lG~ll~aLAt~~~ns~~~-d~~~~s-----------------------------------~~~~I~~~  493 (655)
T KOG3741|consen  453 ---SQQQNDLRDLGLLLLALATGTENSNRT-DSTQSS-----------------------------------HLTRITTT  493 (655)
T ss_pred             ---HHhhhhHHHHHHHHHHHhhcccccccc-cchHHH-----------------------------------HHHHhhhh
Confidence               224578999999999999986321011 000000                                   01223346


Q ss_pred             CChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          172 VHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       172 ~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ++.+++++|.-.....+.+ -++.+++.+
T Consensus       494 yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  494 YSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            7788888888888888876 677777764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.01  E-value=1.2e-05  Score=61.18  Aligned_cols=51  Identities=29%  Similarity=0.486  Sum_probs=39.3

Q ss_pred             HHHHHHHHHHHHHHHHH-HhhCCcccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683           17 EEHCQYFLYQLLRGLKY-IHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus        17 ~~~~~~i~~qil~~l~~-LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      .+....++.+++..+.. +|..|++|||+++.||+++.+ .+.++|||.+...
T Consensus       105 ~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  105 PEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             GSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             chhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence            44567788888885555 679999999999999999987 9999999977544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.87  E-value=1.2e-05  Score=70.66  Aligned_cols=62  Identities=19%  Similarity=0.416  Sum_probs=44.0

Q ss_pred             CccHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC----CeEEeecCCccCCCC
Q 025683            2 DTDLYQI--IRSNQ----SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSE   70 (249)
Q Consensus         2 ~~~L~~~--l~~~~----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~----~~kL~dfg~~~~~~~   70 (249)
                      |++|.++  +.+.+    .+.+..+..++.|++       ..|++|+|++|.||+++.++    +++++|||.......
T Consensus       245 G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        245 GIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             CccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            5566553  33322    244444555555554       58999999999999999988    999999999876543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.82  E-value=3.5e-05  Score=59.65  Aligned_cols=43  Identities=26%  Similarity=0.460  Sum_probs=36.5

Q ss_pred             HHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           23 FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        23 i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      +...|.+++..||+.|++|||++|.|+++..+ .++++|++-.+
T Consensus       140 ~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence            45667788999999999999999999999855 49999997543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.37  E-value=0.00046  Score=54.96  Aligned_cols=52  Identities=23%  Similarity=0.375  Sum_probs=44.2

Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683           16 SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus        16 ~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      +.+....++..|++-+.-.-..|++|||++.-||+++.+|.+.++||--+..
T Consensus       200 ~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         200 DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccccc
Confidence            4667777788888877777789999999999999999999999999965543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=97.26  E-value=0.00042  Score=53.95  Aligned_cols=30  Identities=23%  Similarity=0.444  Sum_probs=25.8

Q ss_pred             CCcccCCCCCCCeeecc--CCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNA--NCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~--~~~~kL~dfg~~~   66 (249)
                      ..++|||+++.||+++.  ++.+.++||+.+.
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence            35799999999999998  5668999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.02  E-value=0.002  Score=50.76  Aligned_cols=54  Identities=20%  Similarity=0.287  Sum_probs=45.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCC
Q 025683           15 LSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (249)
Q Consensus        15 l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~   69 (249)
                      +..+++..+..++++.+.-|-. .++||+|++.-|||+. ++.+.++|+|-+....
T Consensus       163 ~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         163 LELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            3444688888999999888876 8999999999999999 8899999999775443

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.87  E-value=0.01  Score=45.35  Aligned_cols=54  Identities=22%  Similarity=0.171  Sum_probs=48.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~---~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      .-++..+.+++.++++.+.+|+.   ..+.-.|++++|+-++.++++|++|......
T Consensus        55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            35899999999999999999997   3577899999999999999999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.60  E-value=0.0022  Score=62.37  Aligned_cols=117  Identities=15%  Similarity=0.123  Sum_probs=85.5

Q ss_pred             CCccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhC-C----cccCCCCCCCeeeccCCCeEEeecCCcc-CCCC
Q 025683            1 MDTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSA-N----VIHRDLKPSNLLLNANCDLKICDFGLAR-PTSE   70 (249)
Q Consensus         1 ~~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~-~----i~H~dik~~nil~~~~~~~kL~dfg~~~-~~~~   70 (249)
                      ++|.+++.|.++    ..+....+.....+.+....-+|+. +    -+|.++++.|.++..+..+++.++|+.+ ....
T Consensus      1314 ~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~ 1393 (2724)
T KOG1826|consen 1314 EFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV 1393 (2724)
T ss_pred             HHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch
Confidence            367889998875    3455555555555546777776644 2    6889999999999999999999999998 3333


Q ss_pred             CCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 025683           71 NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF  118 (249)
Q Consensus        71 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~  118 (249)
                      ........+++.|+.++....- .++.++|+|..|+.++....|..+|
T Consensus      1394 ~sf~Gl~l~sp~~v~qli~N~i-k~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1394 LSFFGLELCSPIYVLQLIKNEI-KFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HhhhhhhhCCHHHHHHHHHHHH-hhhhHHHHHHHHHHHHHHhcccHHH
Confidence            3334456778889998877433 3666799999999999887776554

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.20  E-value=0.0039  Score=54.19  Aligned_cols=93  Identities=16%  Similarity=0.184  Sum_probs=64.2

Q ss_pred             CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCCh
Q 025683           95 YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP  174 (249)
Q Consensus        95 ~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (249)
                      .++++|||++|.++.++..|...+...........+.+....+..-..-.+.+    .               +.-..++
T Consensus       108 ~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~----~---------------~~~~~d~  168 (725)
T KOG1093|consen  108 IGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH----L---------------IQLLADK  168 (725)
T ss_pred             CCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH----H---------------HHHhhhH
Confidence            34699999999999999999988877665555555554332221111110101    0               0012345


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          175 LAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       175 ~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                      -+.++..+|+...|..||...++.+++-|++.
T Consensus       169 ~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  169 KRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             hHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            57889999999999999999999999999876

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.00  E-value=0.013  Score=46.15  Aligned_cols=30  Identities=27%  Similarity=0.420  Sum_probs=26.5

Q ss_pred             CCcccCCCCCCCeeecc-CCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNA-NCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~-~~~~kL~dfg~~~   66 (249)
                      .+++|+|+.+.||+++. ++.+.|+||..+.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            36999999999999998 5789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=95.96  E-value=0.02  Score=50.53  Aligned_cols=40  Identities=20%  Similarity=0.453  Sum_probs=34.1

Q ss_pred             HHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC
Q 025683           32 KYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (249)
Q Consensus        32 ~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~   71 (249)
                      ..+-..|++|+|.+|.||+++.+|++.+.|||........
T Consensus       279 ~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         279 RQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            3444589999999999999999999999999998766543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.94  E-value=0.018  Score=47.32  Aligned_cols=29  Identities=34%  Similarity=0.442  Sum_probs=26.0

Q ss_pred             CcccCCCCCCCeeeccC----CCeEEeecCCcc
Q 025683           38 NVIHRDLKPSNLLLNAN----CDLKICDFGLAR   66 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~----~~~kL~dfg~~~   66 (249)
                      .++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            58999999999999985    889999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=95.85  E-value=0.012  Score=46.48  Aligned_cols=30  Identities=33%  Similarity=0.447  Sum_probs=25.1

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .+++|||+.+.||+++.++..-++||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            459999999999999876556799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=95.82  E-value=0.02  Score=47.27  Aligned_cols=30  Identities=37%  Similarity=0.540  Sum_probs=26.8

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .+++|||+++.||+++.++.+.++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            589999999999999988877899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=95.64  E-value=0.031  Score=46.34  Aligned_cols=30  Identities=33%  Similarity=0.370  Sum_probs=25.9

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .+++|||+.+.||+++.+....++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            489999999999999976656899998764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.63  E-value=0.032  Score=45.97  Aligned_cols=29  Identities=24%  Similarity=0.428  Sum_probs=25.3

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .+++|||+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.45  E-value=0.037  Score=44.76  Aligned_cols=53  Identities=28%  Similarity=0.332  Sum_probs=41.4

Q ss_pred             CHHHHHHHHHHHHHHHHHHhhC--CcccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683           16 SEEHCQYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus        16 ~~~~~~~i~~qil~~l~~LH~~--~i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      +...+.+.+..+-.++.-.+..  -+||+|+.+.|++.++.+.++|+||..+...
T Consensus       130 ~~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~  184 (269)
T COG0510         130 DNHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN  184 (269)
T ss_pred             hhHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence            3445555666666666666655  5899999999999999999999999987643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=95.40  E-value=0.028  Score=45.97  Aligned_cols=30  Identities=33%  Similarity=0.399  Sum_probs=26.5

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .+++|||+.|.||+++.++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            479999999999999988777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=95.24  E-value=0.056  Score=42.54  Aligned_cols=28  Identities=21%  Similarity=0.281  Sum_probs=25.1

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .++|||+.|.||+++.++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            479999999999999888 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.08  E-value=0.023  Score=43.21  Aligned_cols=30  Identities=27%  Similarity=0.426  Sum_probs=25.5

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      -.+|+|+.|.|+++..++ ++|+||+.+...
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            369999999999998776 999999987543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.89  E-value=0.019  Score=44.81  Aligned_cols=29  Identities=38%  Similarity=0.641  Sum_probs=20.4

Q ss_pred             CCcccCCCCCCCeeec-cCCCeEEeecCCc
Q 025683           37 ANVIHRDLKPSNLLLN-ANCDLKICDFGLA   65 (249)
Q Consensus        37 ~~i~H~dik~~nil~~-~~~~~kL~dfg~~   65 (249)
                      ..++|||+.+.||+++ .++.+.++||+.+
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             cEEEEeccccccceeeeccceeEEEecccc
Confidence            4699999999999999 6666689999765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.84  E-value=0.016  Score=44.98  Aligned_cols=29  Identities=38%  Similarity=0.682  Sum_probs=21.0

Q ss_pred             CcccCCCCCCCeee-ccCCCeEEeecCCcc
Q 025683           38 NVIHRDLKPSNLLL-NANCDLKICDFGLAR   66 (249)
Q Consensus        38 ~i~H~dik~~nil~-~~~~~~kL~dfg~~~   66 (249)
                      .++|+|+.+.||++ ..++.++|+||.++.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            58999999999999 888999999998774

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02721 ycfN_thiK thiamine kinase

Probab=94.64  E-value=0.029  Score=44.95  Aligned_cols=29  Identities=28%  Similarity=0.453  Sum_probs=25.6

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      .++|+|+.+.||+++.++ +.|+||+.+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            589999999999999877 78999988754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=94.45  E-value=0.019  Score=51.27  Aligned_cols=162  Identities=17%  Similarity=0.127  Sum_probs=103.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCchhccCCCCCCch
Q 025683           19 HCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAA   98 (249)
Q Consensus        19 ~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~   98 (249)
                      +...+.+.-.+++++||+..-+|+|    ||+-. ++..++.+|+...............+++.+++||+..... +...
T Consensus       337 ~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~-~~~~  410 (829)
T KOG0576|consen  337 QFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENT-IDGC  410 (829)
T ss_pred             hhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcccccccCCCCCCCCCchhhcccc-cccC
Confidence            4455666667889999988778887    55544 3678899998877665554566778899999999876554 6778


Q ss_pred             hHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHH
Q 025683           99 IDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID  178 (249)
Q Consensus        99 ~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (249)
                      .|+|++|+-..++.-|.+|-...-  ...    ...+..+..     .....+               +.|..  ..-.+
T Consensus       411 p~~~~~~~~~~~~ap~~pPr~~P~--~~~----~~~g~~p~s-----~~L~~~---------------~aw~~--~~~~~  462 (829)
T KOG0576|consen  411 PDSGSLAVSAIQMAPGLPPRSSPP--AVL----PMIGNGPNS-----PMLTDK---------------SAWSP--VFHRD  462 (829)
T ss_pred             CCccCCCcchhhcCCCCCCCCCCc--ccc----CCCCCCCCc-----cccchh---------------hhcCc--ccccC
Confidence            899999987777777766653311  000    000000000     000000               00100  11115


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCC
Q 025683          179 LVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV  214 (249)
Q Consensus       179 li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~  214 (249)
                      +...|+...|..|+....++.|.+|....-......
T Consensus       463 ~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~~aa  498 (829)
T KOG0576|consen  463 FPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIHCAA  498 (829)
T ss_pred             CcccccCCCCCCCcchhhHHHHHHhccCcccceecc
Confidence            778899999999999999999999998765444443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.44  E-value=0.11  Score=43.68  Aligned_cols=53  Identities=23%  Similarity=0.389  Sum_probs=46.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683           15 LSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus        15 l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      -..+++.+++++.+..+.-+... .+-|+++...||+++ +|.+.|+||..++..
T Consensus       318 ~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            34678899999999888888765 789999999999999 999999999998743

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.42  E-value=0.16  Score=44.97  Aligned_cols=61  Identities=21%  Similarity=0.312  Sum_probs=41.9

Q ss_pred             HHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc----CCCeEEeecCCccCCCC
Q 025683            7 QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA----NCDLKICDFGLARPTSE   70 (249)
Q Consensus         7 ~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~----~~~~kL~dfg~~~~~~~   70 (249)
                      ++|.+ ..++...+...+.+...  +.+-..|++|+|-+|.||++.+    ++.+.+-|||+......
T Consensus       293 ~~i~~-~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  293 DAIDK-RGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHH-cCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            44444 34555544444444332  3445678999999999999994    66899999999876544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=94.32  E-value=0.04  Score=43.72  Aligned_cols=30  Identities=20%  Similarity=0.175  Sum_probs=25.9

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      -.++|||+.|.||+++.++...|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            359999999999999997777899998653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02236 choline kinase

Probab=94.26  E-value=0.078  Score=44.59  Aligned_cols=31  Identities=23%  Similarity=0.417  Sum_probs=26.4

Q ss_pred             CCcccCCCCCCCeeecc-CCCeEEeecCCccC
Q 025683           37 ANVIHRDLKPSNLLLNA-NCDLKICDFGLARP   67 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~   67 (249)
                      ..++|+|+++.||+++. ++.+.++||..+..
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            36899999999999986 46899999987753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.25  E-value=0.09  Score=43.57  Aligned_cols=52  Identities=19%  Similarity=0.273  Sum_probs=42.8

Q ss_pred             HHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC
Q 025683           18 EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS   69 (249)
Q Consensus        18 ~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~   69 (249)
                      +.+..+...+..-+.-|..+|++|||+.--||++..++.++++||--.....
T Consensus       202 ~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  202 EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhhccC
Confidence            3455666677777888999999999999999999999999999997654433

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.21  E-value=0.084  Score=43.61  Aligned_cols=29  Identities=21%  Similarity=0.253  Sum_probs=26.7

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      ++||||+.+.|++++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.04  E-value=0.17  Score=42.20  Aligned_cols=28  Identities=29%  Similarity=0.419  Sum_probs=23.6

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .+++|||+.+.||+++ + .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4689999999999995 4 57899998763

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=94.03  E-value=0.16  Score=39.01  Aligned_cols=30  Identities=27%  Similarity=0.458  Sum_probs=24.8

Q ss_pred             CCcccCCCCCCCeeeccCC-----CeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANC-----DLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~-----~~kL~dfg~~~   66 (249)
                      ..++|||+.+.|+++..++     .+.++||..+.
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            4589999999999998654     58999998764

subfamily of choline kinases

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=93.98  E-value=0.24  Score=38.15  Aligned_cols=55  Identities=22%  Similarity=0.369  Sum_probs=39.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC----CeEEee
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICD   61 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~----~~kL~d   61 (249)
                      +.+|.+++.+ +.++. .....+.   +-..||-+++|+.+|++|.||++....    .+.|+|
T Consensus       107 s~TL~~~l~~-~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  107 SPTLEDYLKE-GGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CccHHHHHHc-CCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence            4688999965 45666 4444444   445678889999999999999996532    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.57  E-value=0.066  Score=41.87  Aligned_cols=37  Identities=27%  Similarity=0.392  Sum_probs=31.8

Q ss_pred             HHHHHHHhh--CCcccCCCCCCCeeeccCCCeEEeecCC
Q 025683           28 LRGLKYIHS--ANVIHRDLKPSNLLLNANCDLKICDFGL   64 (249)
Q Consensus        28 l~~l~~LH~--~~i~H~dik~~nil~~~~~~~kL~dfg~   64 (249)
                      +.+|.-.|+  .+..|||..|+||+-++.|.+||.|-+.
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            466778884  3699999999999999999999999764

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.39  E-value=0.14  Score=42.68  Aligned_cols=28  Identities=39%  Similarity=0.659  Sum_probs=25.2

Q ss_pred             cccCCCCCCCeeeccCCC-eEEeecCCcc
Q 025683           39 VIHRDLKPSNLLLNANCD-LKICDFGLAR   66 (249)
Q Consensus        39 i~H~dik~~nil~~~~~~-~kL~dfg~~~   66 (249)
                      ++|+|+.+.||+++.+.. +.++||+.+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999999885 8899998763

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=93.25  E-value=0.077  Score=43.14  Aligned_cols=30  Identities=23%  Similarity=0.562  Sum_probs=24.9

Q ss_pred             CcccCCCCCCCeeeccCCCe-EEeecCCccC
Q 025683           38 NVIHRDLKPSNLLLNANCDL-KICDFGLARP   67 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~-kL~dfg~~~~   67 (249)
                      .++|||+++.||+++.++++ -++||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            48999999999999975664 6999987643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=93.06  E-value=0.23  Score=41.56  Aligned_cols=29  Identities=34%  Similarity=0.469  Sum_probs=25.6

Q ss_pred             cccCCCCCCCeeecc-CCCeEEeecCCccC
Q 025683           39 VIHRDLKPSNLLLNA-NCDLKICDFGLARP   67 (249)
Q Consensus        39 i~H~dik~~nil~~~-~~~~kL~dfg~~~~   67 (249)
                      ++|+|+.+.||+++. ++.++++||.++..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            899999999999975 57899999998754

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=92.83  E-value=0.11  Score=43.29  Aligned_cols=50  Identities=22%  Similarity=0.367  Sum_probs=32.0

Q ss_pred             HHHHHHHHHHHHHH---HHh-hCCcccCCCCCCCeeeccC------------------CCeEEeecCCccCC
Q 025683           19 HCQYFLYQLLRGLK---YIH-SANVIHRDLKPSNLLLNAN------------------CDLKICDFGLARPT   68 (249)
Q Consensus        19 ~~~~i~~qil~~l~---~LH-~~~i~H~dik~~nil~~~~------------------~~~kL~dfg~~~~~   68 (249)
                      =++.++.||+.-.-   -|- ..+++|.||||+|||+-+.                  -+++|.||.+++..
T Consensus       276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence            34556666654321   122 3469999999999999543                  23677777776543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=91.78  E-value=0.17  Score=41.87  Aligned_cols=33  Identities=24%  Similarity=0.466  Sum_probs=29.0

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecCCccCCCC
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICDFGLARPTSE   70 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~   70 (249)
                      .++|||+++.|++++..+.+-+.||+.+.....
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            589999999999999999999999998865443

>PRK06148 hypothetical protein; Provisional

Probab=91.43  E-value=0.37  Score=46.54  Aligned_cols=31  Identities=39%  Similarity=0.564  Sum_probs=26.3

Q ss_pred             CCcccCCCCCCCeeeccCC--CeE-EeecCCccC
Q 025683           37 ANVIHRDLKPSNLLLNANC--DLK-ICDFGLARP   67 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~--~~k-L~dfg~~~~   67 (249)
                      .+++|+|+.+.||+++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999875  554 999998754

>PRK06149 hypothetical protein; Provisional

Probab=90.74  E-value=0.39  Score=46.21  Aligned_cols=32  Identities=19%  Similarity=0.284  Sum_probs=25.8

Q ss_pred             hCCcccCCCCCCCeeeccCC--C---eEEeecCCccC
Q 025683           36 SANVIHRDLKPSNLLLNANC--D---LKICDFGLARP   67 (249)
Q Consensus        36 ~~~i~H~dik~~nil~~~~~--~---~kL~dfg~~~~   67 (249)
                      ..+++|+|+.+.||+++.+.  .   .-++|||.+..
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~  243 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR  243 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence            46899999999999998653  3   37999997753

>PHA03111 Ser/Thr kinase; Provisional

Probab=89.68  E-value=0.69  Score=38.55  Aligned_cols=37  Identities=30%  Similarity=0.431  Sum_probs=26.1

Q ss_pred             HHHHHHHHHHHHHHHHH---h-hCCcccCCCCCCCeeeccC
Q 025683           18 EHCQYFLYQLLRGLKYI---H-SANVIHRDLKPSNLLLNAN   54 (249)
Q Consensus        18 ~~~~~i~~qil~~l~~L---H-~~~i~H~dik~~nil~~~~   54 (249)
                      +=++.++.||+.-.-..   - ..+++|.||||+|||+-+.
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            34566778886654333   2 3469999999999999654

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=89.24  E-value=0.76  Score=37.53  Aligned_cols=47  Identities=23%  Similarity=0.390  Sum_probs=31.2

Q ss_pred             HHHHHHHHHHHHHHHh-h-----CCcccCCCCCCCeeeccCC-----CeEEeecCCcc
Q 025683           20 CQYFLYQLLRGLKYIH-S-----ANVIHRDLKPSNLLLNANC-----DLKICDFGLAR   66 (249)
Q Consensus        20 ~~~i~~qil~~l~~LH-~-----~~i~H~dik~~nil~~~~~-----~~kL~dfg~~~   66 (249)
                      ...+...+.+.+..+. .     .-++|||+++.||++..++     .+++.||-.++
T Consensus       192 l~~~~~~~~~~~~~~~~~~~~~~~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  192 LEALLDKFFERMQELVDPSKEPFNVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             HHHHHHHHHHHHHHHhccccCCceEEEcCccCHHhEeEccccccccccceeecccccc
Confidence            3344444554444444 1     1289999999999997653     58999997653

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=88.21  E-value=0.44  Score=40.88  Aligned_cols=31  Identities=19%  Similarity=0.366  Sum_probs=25.6

Q ss_pred             hCCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683           36 SANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus        36 ~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      ...++|||+++.||++..+ .++++||..+..
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            3469999999999999766 589999986643

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=87.62  E-value=0.45  Score=40.15  Aligned_cols=31  Identities=19%  Similarity=0.324  Sum_probs=25.2

Q ss_pred             hCCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683           36 SANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus        36 ~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      ...++|||+.+.||++..++ ++++|+..+..
T Consensus       191 ~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~  221 (370)
T TIGR01767       191 AETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY  221 (370)
T ss_pred             cceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence            34699999999999997654 77999986643

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=86.77  E-value=1.2  Score=38.19  Aligned_cols=29  Identities=24%  Similarity=0.403  Sum_probs=24.4

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      ..++|||++|.||+++.+ ..|++|..++.
T Consensus       227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAf  255 (409)
T PRK12396        227 QALIHGDLHTGSVFVKND-STKVIDPEFAF  255 (409)
T ss_pred             hhhccCcCCCCCEEecCC-ceEEEcccccc
Confidence            459999999999999976 48899877664

>PTZ00296 choline kinase; Provisional

Probab=85.97  E-value=1.7  Score=37.89  Aligned_cols=28  Identities=25%  Similarity=0.445  Sum_probs=23.7

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .++|+|+.+.||+...+ .++|+||..+.
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeecccc
Confidence            58999999999987654 49999998774

>PTZ00384 choline kinase; Provisional

Probab=85.33  E-value=2.3  Score=36.35  Aligned_cols=29  Identities=31%  Similarity=0.304  Sum_probs=24.4

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      ..++|+|+.+.||+.. ++.+.++||..+.
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEecccc
Confidence            4689999999999875 4569999998774

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=83.05  E-value=2  Score=33.26  Aligned_cols=41  Identities=34%  Similarity=0.483  Sum_probs=34.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683           20 CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus        20 ~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      ..+-+.+|++-+..+|..||+-+|+++.|..     .=+|+|||.+
T Consensus       166 ~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  166 QIRDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             chhHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            4556788999999999999999999999986     3388999854

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	249
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-79
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-78
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-77
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-77
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-77
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-77
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-77
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-77
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-77
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-77
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-77
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-77
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-77
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-77
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-76
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-76
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-76
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-76
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-76
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-76
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-75
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-75
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-75
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-75
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-74
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-74
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-73
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-72
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-72
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-68
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-68
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-68
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-68
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-68
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-68
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-68
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-68
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-68
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-68
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-68
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-68
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-68
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-68
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-68
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-68
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-68
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-68
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-68
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-68
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-68
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-68
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-68
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-68
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-68
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-68
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-68
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-68
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-68
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-68
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-68
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-68
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-68
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-67
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-67
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-67
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-67
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-67
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-67
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-67
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-67
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-67
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-67
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-67
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-67
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-67
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-67
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-67
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-67
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-67
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-67
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-67
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-67
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-67
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-67
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-67
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-67
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-67
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-66
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-66
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-66
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-65
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-59
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-59
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-58
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-50
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-50
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-50
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-49
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-48
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-48
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-48
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-48
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-48
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-47
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-47
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-47
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-47
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-47
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-47
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-47
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-47
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-47
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-47
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-47
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-47
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-47
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-47
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-47
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-47
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-47
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-47
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-46
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-46
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-46
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-46
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-46
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-46
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-46
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-46
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-46
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-45
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-44
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-43
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-41
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-40
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-40
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-39
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-39
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-39
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-39
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-39
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-39
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-39
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-39
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-39
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-39
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-38
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-38
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-38
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-38
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-38
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-38
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-38
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-38
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-38
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-38
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-38
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-38
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-38
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-38
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-38
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-38
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-38
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-38
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-38
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-38
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-38
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-38
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-38
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-38
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-38
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-38
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-38
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-37
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-37
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-37
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-37
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-37
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-37
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-37
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-37
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-37
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-37
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-37
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-37
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-37
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-37
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-37
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-37
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-37
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-37
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-37
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-37
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-37
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-37
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-37
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-37
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-37
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-37
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-36
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-36
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-36
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-36
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-35
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-34
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-34
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-34
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-34
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-32
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-32
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-31
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-31
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-30
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-30
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-30
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-30
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-27
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-26
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-26
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-26
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-25
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-25
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-25
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-25
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-25
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-25
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-25
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-25
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-25
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-25
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-25
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-25
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-25
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-25
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-25
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-25
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-25
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-25
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-25
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-25
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-25
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-25
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-25
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-25
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-25
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-25
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-25
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-25
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-25
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-24
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-24
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-24
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-24
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-24
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-23
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-23
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-23
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		5e-21
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-20
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		6e-20
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		6e-20
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-20
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		7e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-19
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-19
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-19
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-19
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-19
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-19
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-19
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-19
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-18
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-18
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-18
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-18
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-18
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-18
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-18
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-18
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-18
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-18
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-18
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-18
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-18
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		9e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-17
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-17
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-17
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-17
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-17
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-17
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-17
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-17
3soa_A	444	Full-Length Human Camkii Length = 444		1e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-16
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-16
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-16
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-16
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-16
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-16
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-16
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-16
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-16
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-16
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-16
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-16
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-16
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-16
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-16
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-16
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-16
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-16
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-16
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-15
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-15
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-15
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-15
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-15
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-15
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-15
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-15
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-15
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-15
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-15
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-15
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-15
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-15
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-15
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-14
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-14
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-14
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-14
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-14
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-13
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-13
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-13
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-13
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-13
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-13
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-13
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-13
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-13
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-12
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-12
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-12
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-12
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-12
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-12
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-11
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-10
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-10
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-08
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-07
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-07
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-06
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-06
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-06
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-06
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-06
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-06
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-06
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-06
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-06
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-06
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-06
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-06
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-06
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-06

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  291 bits (744), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 136/251 (54%), Positives = 183/251 (72%), Gaps = 5/251 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY++++S Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLL+N  CDLKIC
Sbjct: 128 METDLYKLLKSQQ-LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKIC 186
Query: 61  DFGLARPTS----ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR          F+TE V TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 187 DFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y++ LP   + + A++FP     A
Sbjct: 247 IFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKA 306
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+DRMLTF+P KRITV+EALAHPYL + +D  DEPV  EPF+F  E   L +E++K++
Sbjct: 307 LDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKEL 366
Query: 237 IYQEALALNPG 247
           I+QE     PG
Sbjct: 367 IFQETARFQPG 377

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  286 bits (732), Expect = 8e-78,   Method: Compositional matrix adjust.
 Identities = 132/252 (52%), Positives = 184/252 (73%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 110 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 168
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 229 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 288
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYLA+ +D +DEP+   PF FD E   L +E++K++
Sbjct: 289 LDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 348
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 349 IFEETARFQPGY 360

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  284 bits (726), Expect = 4e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 110 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 168
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 229 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 288
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 289 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 348
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 349 IFEETARFQPGY 360

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  284 bits (726), Expect = 4e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 108 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 166
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 227 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 286
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 287 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 346
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 347 IFEETARFQPGY 358

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  283 bits (725), Expect = 4e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 106 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 164
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 165 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 225 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 284
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 285 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 344
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 345 IFEETARFQPGY 356

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  283 bits (725), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 113 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 171
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 172 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 232 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 291
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 292 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 351
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 352 IFEETARFQPGY 363

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  283 bits (725), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 114 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 172
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 173 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 232
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 233 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 292
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 293 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 352
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 353 IFEETARFQPGY 364

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  283 bits (725), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 105 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 163
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 164 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 223
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 224 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 283
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 284 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 343
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 344 IFEETARFQPGY 355

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  283 bits (725), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 291 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 350
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 351 IFEETARFQPGY 362

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  283 bits (725), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 291 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 350
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 351 IFEETARFQPGY 362

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  283 bits (725), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 128 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 186
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 187 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 247 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 306
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 307 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 366
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 367 IFEETARFQPGY 378

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  283 bits (725), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 116 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 174
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 175 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 234
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 235 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 294
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 295 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 354
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 355 IFEETARFQPGY 366

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  283 bits (725), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 108 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 166
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 227 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 286
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 287 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 346
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 347 IFEETARFQPGY 358

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  283 bits (723), Expect = 9e-77,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 182/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 106 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 164
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 165 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P   DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 225 IFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 284
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 285 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 344
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 345 IFEETARFQPGY 356

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  282 bits (722), Expect = 1e-76,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 182/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY++++  Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 112 METDLYKLLKC-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 291 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 350
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 351 IFEETARFQPGY 362

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  280 bits (717), Expect = 4e-76,   Method: Compositional matrix adjust.
 Identities = 131/252 (51%), Positives = 182/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 110 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKIC 168
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL    N  A+ Y+  LP   +    ++FP+    A
Sbjct: 229 IFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKA 288
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYLA+ +D +DEP+   PF FD E   L +E++K++
Sbjct: 289 LDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 348
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 349 IFEETARFQPGY 360

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  280 bits (716), Expect = 6e-76,   Method: Compositional matrix adjust.
 Identities = 130/252 (51%), Positives = 182/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 108 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 166
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 227 IFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 286
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 287 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 346
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 347 IFEETARFQPGY 358

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  280 bits (715), Expect = 7e-76,   Method: Compositional matrix adjust.
 Identities = 130/252 (51%), Positives = 182/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 291 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 350
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 351 IFEETARFQPGY 362

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  280 bits (715), Expect = 8e-76,   Method: Compositional matrix adjust.
 Identities = 130/252 (51%), Positives = 182/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 108 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 166
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 227 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 286
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 287 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 346
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 347 IFEETARFQPGY 358

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  280 bits (715), Expect = 8e-76,   Method: Compositional matrix adjust.
 Identities = 130/252 (51%), Positives = 182/252 (72%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 291 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 350
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 351 IFEETARFQPGY 362

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  278 bits (711), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 129/252 (51%), Positives = 181/252 (71%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+ E V TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 291 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 350
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 351 IFEETARFQPGY 362

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  278 bits (711), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 129/252 (51%), Positives = 181/252 (71%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 113 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 171
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+ E V TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 172 DFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 232 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 291
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 292 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 351
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 352 IFEETARFQPGY 363

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  277 bits (708), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 129/252 (51%), Positives = 180/252 (71%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKIC
Sbjct: 128 MGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 186
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 187 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 247 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 306
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 307 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 366
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 367 IFEETARFQPGY 378

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  276 bits (706), Expect = 7e-75,   Method: Compositional matrix adjust.
 Identities = 129/252 (51%), Positives = 181/252 (71%), Gaps = 5/252 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN   DLKI 
Sbjct: 108 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIX 166
Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 227 IFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 286
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 287 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 346
Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 347 IFEETARFQPGY 358

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  274 bits (701), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 136/247 (55%), Positives = 177/247 (71%), Gaps = 9/247 (3%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M++DL+QII S+Q L+ EH +YFLYQLLRGLKY+HSA VIHRDLKPSNLL+N NC+LKI 
Sbjct: 141 MESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIG 200
Query: 61  DFGLAR-----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           DFG+AR     P     FMTEYV TRWYRAPEL+L+  +YT AID+WSVGCIF E++ RR
Sbjct: 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL--AQVFPHVH 173
            LFPG ++VHQ++L++ +LGTP+ A +  V  E  + YI+ LP  PRQ +    V+P   
Sbjct: 261 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLP--PRQPVPWETVYPGAD 318
Query: 174 PLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQI 233
             A+ L+ RML F+P  RI+   AL HP+LA+ HD  DEP C  PF F F++++L  E+I
Sbjct: 319 RQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERI 378
Query: 234 KDMIYQE 240
           K+ I  E
Sbjct: 379 KEAIVAE 385

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  273 bits (699), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 136/247 (55%), Positives = 177/247 (71%), Gaps = 9/247 (3%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M++DL+QII S+Q L+ EH +YFLYQLLRGLKY+HSA VIHRDLKPSNLL+N NC+LKI 
Sbjct: 142 MESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIG 201
Query: 61  DFGLAR-----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           DFG+AR     P     FMTEYV TRWYRAPEL+L+  +YT AID+WSVGCIF E++ RR
Sbjct: 202 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA--QVFPHVH 173
            LFPG ++VHQ++L++ +LGTP+ A +  V  E  + YI+ LP  PRQ +    V+P   
Sbjct: 262 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLP--PRQPVPWETVYPGAD 319
Query: 174 PLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQI 233
             A+ L+ RML F+P  RI+   AL HP+LA+ HD  DEP C  PF F F++++L  E+I
Sbjct: 320 RQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERI 379
Query: 234 KDMIYQE 240
           K+ I  E
Sbjct: 380 KEAIVAE 386

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  272 bits (696), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 133/259 (51%), Positives = 176/259 (67%), Gaps = 17/259 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL+++I S Q LS++H QYF+YQ LR +K +H +NVIHRDLKPSNLL+N+NCDLK+C
Sbjct: 96  MQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVC 154
Query: 61  DFGLAR-----------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
           DFGLAR           PT +   MTEYV TRWYRAPE++L S+ Y+ A+DVWS GCI  
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214
Query: 110 ELMNRRPLFPGNDHVHQMRLLIELLGTP-TDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
           EL  RRP+FPG D+ HQ+ L+  ++GTP +D DL  + +  A+ YI+ LP +P   L ++
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD----EPVCPEPFSFDFE 224
           FP V+P  IDL+ RML FDP KRIT  EAL HPYL   HD  D    EP+ P  F FD  
Sbjct: 275 FPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHY 334
Query: 225 QQSLGEEQIKDMIYQEALA 243
           +++L  + +K +I+ E  +
Sbjct: 335 KEALTTKDLKKLIWNEIFS 353

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  269 bits (688), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 132/259 (50%), Positives = 175/259 (67%), Gaps = 17/259 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL+++I S Q LS++H QYF+YQ LR +K +H +NVIHRDLKPSNLL+N+NCDLK+C
Sbjct: 96  MQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVC 154
Query: 61  DFGLAR-----------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
           DFGLAR           PT +   MTE V TRWYRAPE++L S+ Y+ A+DVWS GCI  
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214
Query: 110 ELMNRRPLFPGNDHVHQMRLLIELLGTP-TDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
           EL  RRP+FPG D+ HQ+ L+  ++GTP +D DL  + +  A+ YI+ LP +P   L ++
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD----EPVCPEPFSFDFE 224
           FP V+P  IDL+ RML FDP KRIT  EAL HPYL   HD  D    EP+ P  F FD  
Sbjct: 275 FPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHY 334
Query: 225 QQSLGEEQIKDMIYQEALA 243
           +++L  + +K +I+ E  +
Sbjct: 335 KEALTTKDLKKLIWNEIFS 353

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  269 bits (687), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 131/259 (50%), Positives = 175/259 (67%), Gaps = 17/259 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL+++I S Q LS++H QYF+YQ LR +K +H +NVIHRDLKPSNLL+N+NCDLK+C
Sbjct: 96  MQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVC 154
Query: 61  DFGLAR-----------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
           DFGLAR           PT +   M E+V TRWYRAPE++L S+ Y+ A+DVWS GCI  
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214
Query: 110 ELMNRRPLFPGNDHVHQMRLLIELLGTP-TDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
           EL  RRP+FPG D+ HQ+ L+  ++GTP +D DL  + +  A+ YI+ LP +P   L ++
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD----EPVCPEPFSFDFE 224
           FP V+P  IDL+ RML FDP KRIT  EAL HPYL   HD  D    EP+ P  F FD  
Sbjct: 275 FPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHY 334
Query: 225 QQSLGEEQIKDMIYQEALA 243
           +++L  + +K +I+ E  +
Sbjct: 335 KEALTTKDLKKLIWNEIFS 353

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  255 bits (651), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 169/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN+  Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  254 bits (650), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 123/246 (50%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +PF   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPFDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  254 bits (649), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 169/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T++   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 175 DFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 351
Query: 241 ALALNP 246
            ++  P
Sbjct: 352 VISFVP 357

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  254 bits (648), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  254 bits (648), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 121 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 179
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 180 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 238 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 297
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 298 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 356
Query: 241 ALALNP 246
            ++  P
Sbjct: 357 VISFVP 362

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  254 bits (648), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 121 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 179
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 180 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 238 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 297
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 298 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 356
Query: 241 ALALNP 246
            ++  P
Sbjct: 357 VISFVP 362

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  254 bits (648), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 121 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 179
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 180 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 237
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 238 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 297
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 298 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 356
Query: 241 ALALNP 246
            ++  P
Sbjct: 357 VISFVP 362

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  254 bits (648), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 119 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 177
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 178 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 235
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 236 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 295
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 296 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 354
Query: 241 ALALNP 246
            ++  P
Sbjct: 355 VISFVP 360

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 170 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 228 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 287
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 288 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 346
Query: 241 ALALNP 246
            ++  P
Sbjct: 347 VISFVP 352

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 172
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 173 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 231 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 290
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 291 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 349
Query: 241 ALALNP 246
            ++  P
Sbjct: 350 VISFVP 355

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 132 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 190
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 191 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 249 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 308
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 309 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 367
Query: 241 ALALNP 246
            ++  P
Sbjct: 368 VISFVP 373

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 170 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 228 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 287
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 288 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 346
Query: 241 ALALNP 246
            ++  P
Sbjct: 347 VISFVP 352

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 120 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 178
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 179 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 237 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 296
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 297 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 355
Query: 241 ALALNP 246
            ++  P
Sbjct: 356 VISFVP 361

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 175 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 351
Query: 241 ALALNP 246
            ++  P
Sbjct: 352 VISFVP 357

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 172
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 173 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 231 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 290
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 291 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 349
Query: 241 ALALNP 246
            ++  P
Sbjct: 350 VISFVP 355

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 108 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 167 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 225 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 284
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 285 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 343
Query: 241 ALALNP 246
            ++  P
Sbjct: 344 VISFVP 349

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 128 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 186
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 187 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 245 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 304
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 305 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 363
Query: 241 ALALNP 246
            ++  P
Sbjct: 364 VISFVP 369

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  253 bits (647), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 174 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 232 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 291
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 292 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 350
Query: 241 ALALNP 246
            ++  P
Sbjct: 351 VISFVP 356

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  253 bits (647), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 164 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 282 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 340
Query: 241 ALALNP 246
            ++  P
Sbjct: 341 VISFVP 346

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  253 bits (647), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 164 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 281
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 282 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 340
Query: 241 ALALNP 246
            ++  P
Sbjct: 341 VISFVP 346

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  253 bits (647), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 129 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 187
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 188 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 246 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 305
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 306 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 364
Query: 241 ALALNP 246
            ++  P
Sbjct: 365 VISFVP 370

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  253 bits (647), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  253 bits (647), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 128 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 186
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 187 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 244
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 245 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 304
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 305 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 363
Query: 241 ALALNP 246
            ++  P
Sbjct: 364 VISFVP 369

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  253 bits (647), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  253 bits (646), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 106 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 164
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 165 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 223 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 282
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 283 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 341
Query: 241 ALALNP 246
            ++  P
Sbjct: 342 VISFVP 347

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  253 bits (646), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 107 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 165
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 166 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 223
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 224 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 283
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 284 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 342
Query: 241 ALALNP 246
            ++  P
Sbjct: 343 VISFVP 348

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  253 bits (646), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 170 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 228 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 287
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 288 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 346
Query: 241 ALALNP 246
            ++  P
Sbjct: 347 VISFVP 352

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  253 bits (646), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 106 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 164
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 165 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 222
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 223 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 282
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 283 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 341
Query: 241 ALALNP 246
            ++  P
Sbjct: 342 VISFVP 347

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  253 bits (646), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 129 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 187
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 188 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 246 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 305
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 306 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 364
Query: 241 ALALNP 246
            ++  P
Sbjct: 365 VISFVP 370

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  253 bits (646), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 174 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 232 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 291
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 292 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 350
Query: 241 ALALNP 246
            ++  P
Sbjct: 351 VISFVP 356

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  253 bits (646), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 174 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 232 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 291
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 292 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 350
Query: 241 ALALNP 246
            ++  P
Sbjct: 351 VISFVP 356

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  252 bits (644), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           D+GLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DYGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  252 bits (644), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T++   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 175 DFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+    E + L  ++ K + Y E
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSLESRDLLIDEWKSLTYDE 351
Query: 241 ALALNP 246
            ++  P
Sbjct: 352 VISFVP 357

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  252 bits (643), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 121/244 (49%), Positives = 168/244 (68%), Gaps = 4/244 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 138 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 196
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 197 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPG 254
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH++Q++ ++ L GTP  + +  + + +A+ YI  LPQ P+++ A VF   +PLA+DL+
Sbjct: 255 TDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLL 314
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  EALAHPY ++ HD  DEP   EP+   FE + L  E+ K + Y+E
Sbjct: 315 EKMLVLDTDKRITASEALAHPYFSQYHDPDDEPES-EPYDQSFESRQLEIEEWKRLTYEE 373
Query: 241 ALAL 244
             + 
Sbjct: 374 VCSF 377

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  252 bits (643), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P    FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPTDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  251 bits (642), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 132 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 190
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   M  YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 191 DFGLARHTDDE--MXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 248
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 249 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 308
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 309 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 367
Query: 241 ALALNP 246
            ++  P
Sbjct: 368 VISFVP 373

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  251 bits (642), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  + L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 105 MGADLNNIVKCAK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 164 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 281
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 282 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 340
Query: 241 ALALNP 246
            ++  P
Sbjct: 341 VISFVP 346

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  251 bits (641), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P    FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPRDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  251 bits (641), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T++   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 175 DFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+    E + L  ++ K + Y E
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSSESRDLLIDEWKSLTYDE 351
Query: 241 ALALNP 246
            ++  P
Sbjct: 352 VISFVP 357

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  251 bits (641), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
            FGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 GFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  251 bits (641), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 122/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P    FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPQDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  250 bits (639), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           D GLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DAGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  250 bits (639), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 119/246 (48%), Positives = 168/246 (68%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q+LS+EH Q+ +YQLLRGLKYIHSA +IHRDLKPSN+ +N +C+L+I 
Sbjct: 107 MGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 165
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR   E   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  + LFPG
Sbjct: 166 DFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 223
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +D++ Q++ ++E++GTP+   L  + +E A+ YI+ LP  P++ L+ +F   +PLAIDL+
Sbjct: 224 SDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLL 283
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
            RML  D  +R++  EALAH Y ++ HD  DEP   EP+    E +    E+ K++ YQE
Sbjct: 284 GRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EPYDESVEAKERTLEEWKELTYQE 342
Query: 241 ALALNP 246
            L+  P
Sbjct: 343 VLSFKP 348

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  250 bits (639), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           D GLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DGGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  250 bits (639), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 170 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 228 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 287
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 288 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 346
Query: 241 ALALNP 246
            ++  P
Sbjct: 347 VISFVP 352

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  250 bits (639), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT  V TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  250 bits (638), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 120/246 (48%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   M  +V TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  250 bits (638), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 120/246 (48%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   M  +V TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 164 DFGLARHTDDE--MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 281
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 282 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 340
Query: 241 ALALNP 246
            ++  P
Sbjct: 341 VISFVP 346

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  250 bits (638), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 109 MGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  250 bits (638), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 174 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 232 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 291
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 292 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 350
Query: 241 ALALNP 246
            ++  P
Sbjct: 351 VISFVP 356

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  250 bits (638), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           D GLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DRGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  250 bits (638), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 120/246 (48%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   M  +V TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLARHTDDE--MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  249 bits (637), Expect = 7e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 120 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKIL 178
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 179 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 236
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 237 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 296
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 297 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 355
Query: 241 ALALNP 246
            ++  P
Sbjct: 356 VISFVP 361

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  249 bits (637), Expect = 8e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKIL 172
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 173 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 231 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 290
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 291 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 349
Query: 241 ALALNP 246
            ++  P
Sbjct: 350 VISFVP 355

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  249 bits (636), Expect = 9e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKIL 172
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 173 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 230
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 231 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 290
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 291 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 349
Query: 241 ALALNP 246
            ++  P
Sbjct: 350 VISFVP 355

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  249 bits (636), Expect = 9e-67,   Method: Compositional matrix adjust.
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DF LAR T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFYLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  248 bits (633), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 120/246 (48%), Positives = 166/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++S Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N + +LKI 
Sbjct: 109 MGADLNNIVKS-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL R T +   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 168 DFGLCRHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 226 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 285
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+    E + L  ++ K + Y E
Sbjct: 286 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSLESRDLLIDEWKSLTYDE 344
Query: 241 ALALNP 246
            ++  P
Sbjct: 345 VISFVP 350

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  248 bits (633), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 120/246 (48%), Positives = 166/246 (67%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 129 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 187
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T +   M   V TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 188 DFGLARHTDDE--MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 245
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 246 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLL 305
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV  +P+   FE + L  ++ K + Y E
Sbjct: 306 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE 364
Query: 241 ALALNP 246
            ++  P
Sbjct: 365 VISFVP 370

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  246 bits (629), Expect = 7e-66,   Method: Compositional matrix adjust.
 Identities = 118/244 (48%), Positives = 167/244 (68%), Gaps = 4/244 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++S Q+LS+EH Q+ +YQLLRGLKYIHSA +IHRDLKPSN+ +N + +L+I 
Sbjct: 115 MGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR   E   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  + LFPG
Sbjct: 174 DFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +D++ Q++ ++E++GTP+   L  + +E A+ YI+ LP  P++ L+ +F   +PLAIDL+
Sbjct: 232 SDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLL 291
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
            RML  D  +R++  EALAH Y ++ HD  DEP   EP+    E +    E+ K++ YQE
Sbjct: 292 GRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EPYDESVEAKERTLEEWKELTYQE 350
Query: 241 ALAL 244
            L+ 
Sbjct: 351 VLSF 354

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  244 bits (623), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 117/244 (47%), Positives = 166/244 (68%), Gaps = 4/244 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q+LS+EH Q+ +YQLLRGLKYIHSA +IHRDLKPSN+ +N + +L+I 
Sbjct: 115 MGADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR   E   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  + LFPG
Sbjct: 174 DFGLARQADEE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 231
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +D++ Q++ ++E++GTP+   L  + +E A+ YI+ LP  P++ L+ +F   +PLAIDL+
Sbjct: 232 SDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLL 291
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
            RML  D  +R++  EALAH Y ++ HD  DEP   EP+    E +    E+ K++ YQE
Sbjct: 292 GRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEA-EPYDESVEAKERTLEEWKELTYQE 350
Query: 241 ALAL 244
            L+ 
Sbjct: 351 VLSF 354

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  224 bits (571), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 108/246 (43%), Positives = 153/246 (62%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL +I+      SEE  QY +YQ+L+GLKYIHSA V+HRDLKP NL +N +C+LKI 
Sbjct: 129 MQTDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 186
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR       MT YVVTRWYRAPE++L+   Y   +D+WSVGCI  E++  + LF G
Sbjct: 187 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D++ Q+  ++++ G P    +  + ++ AK YI+ LPQ PR+   Q+FP   P A DL+
Sbjct: 245 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 304
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KR+T  +AL HP+     D  +E    +PF    E + L  ++ K  IY+E
Sbjct: 305 EKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKE 364
Query: 241 ALALNP 246
            +  +P
Sbjct: 365 IVNFSP 370

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  224 bits (570), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 108/246 (43%), Positives = 153/246 (62%), Gaps = 4/246 (1%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL +I+      SEE  QY +YQ+L+GLKYIHSA V+HRDLKP NL +N +C+LKI 
Sbjct: 111 MQTDLQKIM--GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR       MT YVVTRWYRAPE++L+   Y   +D+WSVGCI  E++  + LF G
Sbjct: 169 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D++ Q+  ++++ G P    +  + ++ AK YI+ LPQ PR+   Q+FP   P A DL+
Sbjct: 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 286
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KR+T  +AL HP+     D  +E    +PF    E + L  ++ K  IY+E
Sbjct: 287 EKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKE 346
Query: 241 ALALNP 246
            +  +P
Sbjct: 347 IVNFSP 352

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  221 bits (563), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 107/247 (43%), Positives = 164/247 (66%), Gaps = 6/247 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL ++++ ++ L E+  Q+ +YQ+L+GL+YIH+A +IHRDLKP NL +N +C+LKI 
Sbjct: 112 MGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 170
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR       M   VVTRWYRAPE++LN   YT  +D+WSVGCI  E++  + LF G
Sbjct: 171 DFGLARQADSE--MXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +DH+ Q++ ++++ GTP    +  +++++AK Y++ LP+  ++  A +  +  PLA++L+
Sbjct: 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 288
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEP-VCPEPFSFDFEQQSLGEEQIKDMIYQ 239
           ++ML  D  +R+T  EALAHPY   LHD  DEP V     SFD   ++L E   K + Y+
Sbjct: 289 EKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDE--WKRVTYK 346
Query: 240 EALALNP 246
           E L+  P
Sbjct: 347 EVLSFKP 353

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  195 bits (496), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 107/255 (41%), Positives = 153/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I  +  L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 109 MDANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR  S N  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  EL+    +F G
Sbjct: 167 DFGLARTASTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQG 225
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPL---- 175
            DH+ Q   +IE LGTP+ A+         + Y+   P +P  +  ++FP  + P     
Sbjct: 226 TDHIDQWNKVIEQLGTPS-AEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESER 284
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VDEAL HPY+   +D A+ E   P+ +    E++ 
Sbjct: 285 DKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEERE 344
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 345 HAIEEWKELIYKEVM 359

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  195 bits (495), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 107/255 (41%), Positives = 153/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I  +  L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    N  MT YVVTR+YRAPE++L    Y A +D+WSVGCI  EL+    +F G
Sbjct: 169 DFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPL---- 175
            DH+ Q   +IE LGTP+ A+         + Y+   P++P     ++FP  + P     
Sbjct: 228 TDHIDQWNKVIEQLGTPS-AEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESER 286
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VDEAL HPY+   +D A+ E   P+ +    E++ 
Sbjct: 287 DKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEERE 346
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 347 HAIEEWKELIYKEVM 361

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  195 bits (495), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 115/305 (37%), Positives = 162/305 (53%), Gaps = 60/305 (19%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           D+D  ++ R+   L+E H +  LY LL G+KY+HSA ++HRDLKP+N L+N +C +K+CD
Sbjct: 140 DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD 199
Query: 62  FGLAR--------------------------PTSEN--EFMTEYVVTRWYRAPELLLNSS 93
           FGLAR                          P ++N    +T +VVTRWYRAPEL+L   
Sbjct: 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259
Query: 94  DYTAAIDVWSVGCIFMELMN-----------RRPLFPG-------------ND------- 122
           +YT AIDVWS+GCIF EL+N           R PLFPG             ND       
Sbjct: 260 NYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRG 319
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
           +  Q+ ++  +LGTP++ D+  +  EDAKRYIR  P+     LA+ FP     AI L+ R
Sbjct: 320 NRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKR 379
Query: 183 MLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDF-EQQSLGEEQIKDMIYQEA 241
           ML F+P KRIT++E LAHP+   +     E    E     F +  ++ E Q++    +E 
Sbjct: 380 MLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEI 439
Query: 242 LALNP 246
              +P
Sbjct: 440 QRYHP 444

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  190 bits (483), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 108/297 (36%), Positives = 160/297 (53%), Gaps = 52/297 (17%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           D+DL ++ ++   L+EEH +  LY LL G  +IH + +IHRDLKP+N LLN +C +K+CD
Sbjct: 113 DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD 172
Query: 62  FGLARPTS------------ENEF-----------MTEYVVTRWYRAPELLLNSSDYTAA 98
           FGLAR  +            ENE            +T +VVTRWYRAPEL+L   +YT +
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232
Query: 99  IDVWSVGCIFMELM-----------NRRPLFPGND-----------HVH------QMRLL 130
           ID+WS GCIF EL+           NR PLFPG+             VH      Q+ ++
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNII 292
Query: 131 IELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
             ++GTPT+ DL  +   +  +YI+  P     +L Q +P +    I+L++ ML F+P K
Sbjct: 293 FNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNK 352
Query: 191 RITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQ-QSLGEEQIKDMIYQEALALNP 246
           RIT+D+AL HPYL  +  +  E    +     F+    L E Q++ +  +E  + +P
Sbjct: 353 RITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHP 409

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  187 bits (476), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 93/225 (41%), Positives = 135/225 (60%), Gaps = 3/225 (1%)
Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M TDL Q+I   +  +S +H QYF+Y +L GL  +H A V+HRDL P N+LL  N D+ I
Sbjct: 116 MRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           CDF LAR  + +   T YV  RWYRAPEL++    +T  +D+WS GC+  E+ NR+ LF 
Sbjct: 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR-QLPQHPRQSLAQVFPHVHPLAID 178
           G+   +Q+  ++E++GTP   D+    +  A+ Y+R  L   P ++   V P   P+A+D
Sbjct: 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFD 222
           L+ +ML F+P +RI+ ++AL HPY   L D  D      E F FD
Sbjct: 296 LIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFHFD 340

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  187 bits (476), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 106/260 (40%), Positives = 153/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  187 bits (476), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 93/225 (41%), Positives = 135/225 (60%), Gaps = 3/225 (1%)
Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M TDL Q+I   +  +S +H QYF+Y +L GL  +H A V+HRDL P N+LL  N D+ I
Sbjct: 116 MRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           CDF LAR  + +   T YV  RWYRAPEL++    +T  +D+WS GC+  E+ NR+ LF 
Sbjct: 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR-QLPQHPRQSLAQVFPHVHPLAID 178
           G+   +Q+  ++E++GTP   D+    +  A+ Y+R  L   P ++   V P   P+A+D
Sbjct: 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFD 222
           L+ +ML F+P +RI+ ++AL HPY   L D  D      E F FD
Sbjct: 296 LIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFHFD 340

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  187 bits (474), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 106/260 (40%), Positives = 153/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  186 bits (473), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 99/253 (39%), Positives = 155/253 (61%), Gaps = 39/253 (15%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDL+ +IR+N  L   H QY +YQL++ +KY+HS  ++HRD+KPSN+LLNA C +K+ 
Sbjct: 93  METDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVA 151
Query: 61  DFGLAR------------PTSENE----------FMTEYVVTRWYRAPELLLNSSDYTAA 98
           DFGL+R            P S NE           +T+YV TRWYRAPE+LL S+ YT  
Sbjct: 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG 211
Query: 99  IDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP 158
           ID+WS+GCI  E++  +P+FPG+  ++Q+  +I ++  P++ D+  +++  AK  I  L 
Sbjct: 212 IDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLK 271
Query: 159 QHP--RQS------------LAQVFPHV--HPLAIDLVDRMLTFDPMKRITVDEALAHPY 202
           +    RQS            L ++ P    +  A+DL+D++L F+P KRI+ ++AL HP+
Sbjct: 272 EKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF 331
Query: 203 LARLHDEADEPVC 215
           ++  H+  +EP C
Sbjct: 332 VSIFHNPNEEPNC 344

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 108/294 (36%), Positives = 160/294 (54%), Gaps = 55/294 (18%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           D+DL ++ ++   L+E+H +  LY LL G K+IH + +IHRDLKP+N LLN +C +KICD
Sbjct: 115 DSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICD 174
Query: 62  FGLAR------------------------PTSEN--EFMTEYVVTRWYRAPELLLNSSDY 95
           FGLAR                        P ++N  + +T +VVTRWYRAPEL+L   +Y
Sbjct: 175 FGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 234
Query: 96  TAAIDVWSVGCIFMELM-----------NRRPLFPGN-------DH----VH------QM 127
           T +ID+WS GCIF EL+           NR PLFPG+       DH    VH      Q+
Sbjct: 235 TNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQL 294
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
            ++  ++GTP + DL  +  ++  +YI+  P      L++ +  +    IDL++ ML F+
Sbjct: 295 NIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFN 354
Query: 188 PMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQ-QSLGEEQIKDMIYQE 240
             KRIT+D+AL+HPYL  +  E  E    E     F+    L E Q++ +  +E
Sbjct: 355 AQKRITIDKALSHPYLKDVRKENLENFSTEKIILPFDDWMVLSETQLRYIFLKE 408

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 106/260 (40%), Positives = 152/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 112 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 228
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 229 TDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 287
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 288 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 346
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 347 EHTI--EEWKELIYKEVMDL 364

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  186 bits (471), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 106/260 (40%), Positives = 152/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  185 bits (470), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 154/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 110 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 167
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 168 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 226
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 227 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 285
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 286 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 345
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 346 HTIEEWKELIYKEVM 360

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  185 bits (470), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 154/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 346
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 347 HTIEEWKELIYKEVM 361

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  185 bits (470), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 154/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 346
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 347 HTIEEWKELIYKEVM 361

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  185 bits (470), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 154/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 112 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 228
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 229 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 287
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 288 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 347
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 348 HTIEEWKELIYKEVM 362

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  185 bits (470), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 154/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 112 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 228
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 229 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 287
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 288 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 347
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 348 HTIEEWKELIYKEVM 362

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  185 bits (469), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 105/260 (40%), Positives = 152/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  185 bits (469), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 154/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 149 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 384
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 385 HTIEEWKELIYKEVM 399

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  185 bits (469), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 154/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 149 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 384
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 385 HTIEEWKELIYKEVM 399

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  185 bits (469), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 154/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 104 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 220
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 339
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 340 HTIEEWKELIYKEVM 354

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  185 bits (469), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 154/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 105 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 162
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 163 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 222 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 280
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 281 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 340
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 341 HTIEEWKELIYKEVM 355

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  185 bits (469), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 154/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 105 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 162
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 163 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 222 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 280
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 281 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 340
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 341 HTIEEWKELIYKEVM 355

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  184 bits (468), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 99/226 (43%), Positives = 141/226 (62%), Gaps = 21/226 (9%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKI 59
           M+TDL  ++     L EEH + F+YQLLRGLKYIHSANV+HRDLKP+NL +N  +  LKI
Sbjct: 104 METDLANVLEQG-PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162
Query: 60  CDFGLARPT----SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR      S    ++E +VT+WYR+P LLL+ ++YT AID+W+ GCIF E++  +
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR-------YIRQLPQHPRQSLAQV 168
            LF G   + QM+L++E         +  V  ED +        YIR     P + L Q+
Sbjct: 223 TLFAGAHELEQMQLILE--------SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQL 274
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
            P +   A+D ++++LTF PM R+T +EAL+HPY++      DEP+
Sbjct: 275 LPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  184 bits (468), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 105/260 (40%), Positives = 152/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  184 bits (467), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 105/260 (40%), Positives = 152/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  183 bits (464), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 105/260 (40%), Positives = 153/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 116 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 174 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPG 232
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            D++ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 233 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 291
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 292 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 350
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 351 EHTI--EEWKELIYKEVMDL 368

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 151/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 113 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 170
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  M  +VVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 171 DFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 229
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 230 TDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 288
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 289 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 347
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 348 EHTI--EEWKELIYKEVMDL 365

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 100/255 (39%), Positives = 153/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 346
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 347 HTIEEWKELIYKEVM 361

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  182 bits (463), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 100/255 (39%), Positives = 153/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 346
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 347 HTIEEWKELIYKEVM 361

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  182 bits (463), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 105/260 (40%), Positives = 153/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 105 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 162
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 163 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPG 221
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            D++ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 222 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 280
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 281 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 339
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 340 EHTI--EEWKELIYKEVMDL 357

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  182 bits (462), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 100/255 (39%), Positives = 153/255 (60%), Gaps = 17/255 (6%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 104 MDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKIL 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 220
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+ E   P+ +    +++ 
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 339
Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 340 HTIEEWKELIYKEVM 354

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  182 bits (462), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 105/260 (40%), Positives = 151/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT  VVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NALKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 151/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVG I  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  182 bits (461), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 151/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVG I  E++    LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            DH+ Q   +IE LGTP+   +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 TDHIDQWNKVIEQLGTPSPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  180 bits (456), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 152/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  M   VVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVCHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            D++ Q   +IE LGTP  A +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 RDYIDQWNKVIEQLGTPCPAFMKKLQ-PTVRNYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  177 bits (448), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 151/260 (58%), Gaps = 23/260 (8%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  M   VVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-------- 172
            D++ Q   +IE LGTP    +  ++    + Y+   P++   S  ++FP V        
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 173 ----HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD----EADEPVCPEPFSFDFE 224
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D    EA  P  P+    D  
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK-QLDER 345
Query: 225 QQSLGEEQIKDMIYQEALAL 244
           + ++  E+ K++IY+E + L
Sbjct: 346 EHTI--EEWKELIYKEVMDL 363

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  175 bits (443), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 99/254 (38%), Positives = 149/254 (58%), Gaps = 24/254 (9%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLXQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSL 228
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A      E       + ++
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAXXXXXDE------REHTI 340
Query: 229 GEEQIKDMIYQEAL 242
             E+ K++IY+E +
Sbjct: 341 --EEWKELIYKEVM 352

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  171 bits (432), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 91/215 (42%), Positives = 132/215 (61%), Gaps = 16/215 (7%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++  LKI 
Sbjct: 111 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL---- 175
            D++ Q   +IE LGTP    +  ++    + Y+   P++   +  ++FP  + P     
Sbjct: 228 RDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 176 -------AIDLVDRMLTFDPMKRITVDEALAHPYL 203
                  A DL+ +ML  DP KRI+VD+AL HPY+
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  164 bits (414), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 86/211 (40%), Positives = 125/211 (59%), Gaps = 5/211 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEH-CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL Q +    ++   H  + FL+QLLRGL Y H   V+HRDLKP NLL+N   +LK+
Sbjct: 82  LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKL 141
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  S   +     VVT WYR P++LL S+DY+  ID+W VGCIF E+   RPLF
Sbjct: 142 ADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201
Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+    Q+  +  +LGTPT+    G + NE+ K Y    P++  ++L    P +     
Sbjct: 202 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY--NYPKYRAEALLSHAPRLDSDGA 259
Query: 178 DLVDRMLTFDPMKRITVDEALAHPYLARLHD 208
           DL+ ++L F+   RI+ ++A+ HP+   L +
Sbjct: 260 DLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 93/208 (44%), Positives = 125/208 (60%), Gaps = 9/208 (4%)
Query: 2   DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           D DL +   S N  L  E  + FL+QLL+GL + HS NV+HRDLKP NLL+N N +LK+ 
Sbjct: 84  DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLA 143
Query: 61  DFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLF 118
           DFGLAR         +  VVT WYR P++L  +  Y+ +ID+WS GCIF EL N  RPLF
Sbjct: 144 DFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLF 203
Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHP-RQSLAQVFPHVHPLA 176
           PGND   Q++ +  LLGTPT+       +  D K Y    P +P   SL  V P ++   
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY----PMYPATTSLVNVVPKLNATG 259
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLA 204
            DL+  +L  +P++RI+ +EAL HPY +
Sbjct: 260 RDLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  161 bits (407), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 92/208 (44%), Positives = 125/208 (60%), Gaps = 9/208 (4%)
Query: 2   DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           D DL +   S N  L  E  + FL+QLL+GL + HS NV+HRDLKP NLL+N N +LK+ 
Sbjct: 84  DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLA 143
Query: 61  DFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLF 118
           +FGLAR         +  VVT WYR P++L  +  Y+ +ID+WS GCIF EL N  RPLF
Sbjct: 144 NFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHP-RQSLAQVFPHVHPLA 176
           PGND   Q++ +  LLGTPT+       +  D K Y    P +P   SL  V P ++   
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY----PMYPATTSLVNVVPKLNATG 259
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLA 204
            DL+  +L  +P++RI+ +EAL HPY +
Sbjct: 260 RDLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  159 bits (402), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 82/201 (40%), Positives = 120/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 152 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 328
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 329 PTARLTPLEACAHSFFDELRD 349

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  159 bits (402), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 82/201 (40%), Positives = 120/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 324
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 325 PTARLTPLEACAHSFFDELRD 345

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  159 bits (402), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 82/201 (40%), Positives = 120/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 142 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 318
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 319 PTARLTPLEACAHSFFDELRD 339

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  159 bits (402), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 82/201 (40%), Positives = 120/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 193 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 369
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 370 PTARLTPLEACAHSFFDELRD 390

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  159 bits (402), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 82/201 (40%), Positives = 120/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 119 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 179 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 238
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 239 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 295
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 296 PTARLTPLEACAHSFFDELRD 316

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  159 bits (402), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 82/201 (40%), Positives = 120/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 150 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 326
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 327 PTARLTPLEACAHSFFDELRD 347

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/201 (40%), Positives = 120/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFAFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 291 PTARLTPLEACAHSFFDELRD 311

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/201 (40%), Positives = 120/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 127 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 303
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 304 PTARLTPLEACAHSFFDELRD 324

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/201 (40%), Positives = 120/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 291 PTARLTPLEACAHSFFDELRD 311

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/201 (40%), Positives = 120/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 291 PTARLTPLEACAHSFFDELRD 311

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 81/201 (40%), Positives = 119/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 324
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 325 PTARLTPLEACAHSFFDELRD 345

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  155 bits (393), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 81/201 (40%), Positives = 119/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFAFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 291 PTARLTPLEACAHSFFDELRD 311

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  155 bits (393), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 81/201 (40%), Positives = 119/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 302
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 303 PTARLTPLEACAHSFFDELRD 323

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 80/208 (38%), Positives = 122/208 (58%), Gaps = 3/208 (1%)
Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+ DL +++  N++ L +   + +LYQLLRG+ + H   ++HRDLKP NLL+N++  LK+
Sbjct: 101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR         T  VVT WYRAP++L+ S  Y+ ++D+WS+GCIF E++  +PLF
Sbjct: 161 ADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG     Q+  +  +LGTP   +   V+     +  R      ++  + + P      ID
Sbjct: 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGID 279
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLARL 206
           L+  ML FDP KRI+  +A+ HPY   L
Sbjct: 280 LLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 81/201 (40%), Positives = 119/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 133 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 309
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 310 PTARLTPLEACAHSFFDELRD 330

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 80/208 (38%), Positives = 122/208 (58%), Gaps = 3/208 (1%)
Query: 1   MDTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+ DL +++  N++ L +   + +LYQLLRG+ + H   ++HRDLKP NLL+N++  LK+
Sbjct: 101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR         T  VVT WYRAP++L+ S  Y+ ++D+WS+GCIF E++  +PLF
Sbjct: 161 ADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG     Q+  +  +LGTP   +   V+     +  R      ++  + + P      ID
Sbjct: 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGID 279
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLARL 206
           L+  ML FDP KRI+  +A+ HPY   L
Sbjct: 280 LLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 81/201 (40%), Positives = 119/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 122 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 298
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 299 PTARLTPLEACAHSFFDELRD 319

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 81/201 (40%), Positives = 119/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 302
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 303 PTARLTPLEACAHSFFDELRD 323

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 81/201 (40%), Positives = 119/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 291 PTARLTPLEACAHSFFDELRD 311

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 81/201 (40%), Positives = 119/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 118 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 178 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 237
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 238 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 294
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 295 PTARLTPLEACAHSFFDELRD 315

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 81/201 (40%), Positives = 119/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 291 PTARLTPLEACAHSFFDELRD 311

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 81/201 (40%), Positives = 119/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 290
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 291 PTARLTPLEACAHSFFDELRD 311

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 81/201 (40%), Positives = 119/201 (59%), Gaps = 5/201 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPT 68
           R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 115 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
              E     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG+  V Q+ 
Sbjct: 175 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 234
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFD 187
            +I++LGTPT   +  +     +    Q+  HP     +VF P   P AI L  R+L + 
Sbjct: 235 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP---WTKVFRPRTPPEAIALCSRLLEYT 291
Query: 188 PMKRITVDEALAHPYLARLHD 208
           P  R+T  EA AH +   L D
Sbjct: 292 PTARLTPLEACAHSFFDELRD 312

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 110/186 (59%), Gaps = 5/186 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 112 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 171
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 172 VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 231
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 232 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 288
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 289 LAHPFF 294

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  154 bits (388), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 80/185 (43%), Positives = 110/185 (59%), Gaps = 5/185 (2%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVV 79
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  VV
Sbjct: 106 KSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD 139
           T WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP +
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 140 ADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL 198
               G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   AL
Sbjct: 226 VVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 199 AHPYL 203
           AHP+ 
Sbjct: 283 AHPFF 287

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  154 bits (388), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 110/186 (59%), Gaps = 5/186 (2%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYV 78
            + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  V
Sbjct: 105 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 165 VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 224
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 225 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 282 LAHPFF 287

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  154 bits (388), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 88/229 (38%), Positives = 130/229 (56%), Gaps = 9/229 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPTSENEFMTEYVV 79
           + ++YQLLR L YIHS  + HRD+KP NLLL+     LK+ DFG A+     E     + 
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC 203
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD 139
           +R+YRAPEL+  +++YT  ID+WS GC+  ELM  +PLFPG   + Q+  +I++LGTP+ 
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263
Query: 140 ADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHPLAIDLVDRMLTFDPMKRITVDEAL 198
             +  +     +    Q+  HP    ++VF P   P AIDL+ R+L + P  R+T  EAL
Sbjct: 264 EQIKTMNPNYMEHKFPQIRPHP---FSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320
Query: 199 AHPYLARLH-DEADEP---VCPEPFSFDFEQQSLGEEQIKDMIYQEALA 243
            HP+   L   EA  P     P  F++  E+ S+  + I  ++ Q A A
Sbjct: 321 CHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEA 369

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  154 bits (388), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 80/185 (43%), Positives = 110/185 (59%), Gaps = 5/185 (2%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVV 79
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  VV
Sbjct: 113 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 172
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD 139
           T WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP +
Sbjct: 173 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 232
Query: 140 ADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL 198
               G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   AL
Sbjct: 233 VVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 289
Query: 199 AHPYL 203
           AHP+ 
Sbjct: 290 AHPFF 294

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  154 bits (388), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 80/185 (43%), Positives = 110/185 (59%), Gaps = 5/185 (2%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVV 79
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  VV
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD 139
           T WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP +
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 225
Query: 140 ADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL 198
               G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   AL
Sbjct: 226 VVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 199 AHPYL 203
           AHP+ 
Sbjct: 283 AHPFF 287

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  154 bits (388), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 80/185 (43%), Positives = 110/185 (59%), Gaps = 5/185 (2%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVV 79
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  VV
Sbjct: 107 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 166
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD 139
           T WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP +
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 226
Query: 140 ADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL 198
               G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   AL
Sbjct: 227 VVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 283
Query: 199 AHPYL 203
           AHP+ 
Sbjct: 284 AHPFF 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  154 bits (388), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 80/183 (43%), Positives = 109/183 (59%), Gaps = 5/183 (2%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVTR 81
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  VVT 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 167
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD 141
           WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP +  
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 227
Query: 142 L-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH 200
             G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   ALAH
Sbjct: 228 WPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 201 PYL 203
           P+ 
Sbjct: 285 PFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  154 bits (388), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 80/183 (43%), Positives = 109/183 (59%), Gaps = 5/183 (2%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVTR 81
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  VVT 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 166
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD 141
           WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP +  
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 142 L-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH 200
             G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   ALAH
Sbjct: 227 WPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 201 PYL 203
           P+ 
Sbjct: 284 PFF 286

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  154 bits (388), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 80/183 (43%), Positives = 109/183 (59%), Gaps = 5/183 (2%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVTR 81
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  VVT 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 166
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD 141
           WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP +  
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 142 L-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH 200
             G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   ALAH
Sbjct: 227 WPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 201 PYL 203
           P+ 
Sbjct: 284 PFF 286

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  153 bits (387), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 80/183 (43%), Positives = 109/183 (59%), Gaps = 5/183 (2%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVTR 81
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  VVT 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 167
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD 141
           WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP +  
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 227
Query: 142 L-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH 200
             G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   ALAH
Sbjct: 228 WPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 201 PYL 203
           P+ 
Sbjct: 285 PFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  153 bits (387), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 80/183 (43%), Positives = 109/183 (59%), Gaps = 5/183 (2%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVTR 81
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  VVT 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 166
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD 141
           WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP +  
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 142 L-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH 200
             G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   ALAH
Sbjct: 227 WPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 201 PYL 203
           P+ 
Sbjct: 284 PFF 286

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  153 bits (387), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 80/185 (43%), Positives = 110/185 (59%), Gaps = 5/185 (2%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVV 79
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  VV
Sbjct: 105 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD 139
           T WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP +
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 140 ADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL 198
               G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   AL
Sbjct: 225 VVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
Query: 199 AHPYL 203
           AHP+ 
Sbjct: 282 AHPFF 286

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  153 bits (387), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 80/185 (43%), Positives = 110/185 (59%), Gaps = 5/185 (2%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVV 79
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR         T  VV
Sbjct: 110 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 169
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD 139
           T WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP +
Sbjct: 170 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 229
Query: 140 ADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL 198
               G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   AL
Sbjct: 230 VVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 286
Query: 199 AHPYL 203
           AHP+ 
Sbjct: 287 AHPFF 291

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/184 (43%), Positives = 110/184 (59%), Gaps = 7/184 (3%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYVVT 80
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E VVT
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-VVT 166
Query: 81  RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDA 140
            WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP + 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 141 DL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA 199
              G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   ALA
Sbjct: 227 VWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283
Query: 200 HPYL 203
           HP+ 
Sbjct: 284 HPFF 287

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 107 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 165
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 225
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 226 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 283 LAHPFF 288

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 167
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 227
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 228 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 285 LAHPFF 290

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 79/212 (37%), Positives = 128/212 (60%), Gaps = 5/212 (2%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFG 63
           L   IRS +S+       ++YQL R + +IHS  + HRD+KP NLL+N+  + LK+CDFG
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            A+    +E     + +R+YRAPEL+L +++YT +ID+WS+GC+F EL+  +PLF G   
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP-LAIDLVDR 182
           + Q+  +I+++GTPT   +  +R       +R  P    +   ++ P   P LAIDL+++
Sbjct: 248 IDQLVRIIQIMGTPTKEQM--IRMNPHYTEVR-FPTLKAKDWRKILPEGTPSLAIDLLEQ 304
Query: 183 MLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
           +L ++P  RI   EA+AHP+   L +  +  V
Sbjct: 305 ILRYEPDLRINPYEAMAHPFFDHLRNSYESEV 336

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 108 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 166
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 167 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 226
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 227 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 284 LAHPFF 289

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 108 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 166
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 167 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 226
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 227 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 284 LAHPFF 289

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 167
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 227
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 228 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 285 LAHPFF 290

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 108 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 166
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 167 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 226
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 227 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 284 LAHPFF 289

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 167
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 227
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 228 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 285 LAHPFF 290

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 167
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 227
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 228 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 285 LAHPFF 290

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 107 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 165
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 225
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 226 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 283 LAHPFF 288

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/184 (43%), Positives = 110/184 (59%), Gaps = 7/184 (3%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYVVT 80
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E VVT
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-VVT 166
Query: 81  RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDA 140
            WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP + 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 141 DL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA 199
              G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   ALA
Sbjct: 227 VWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283
Query: 200 HPYL 203
           HP+ 
Sbjct: 284 HPFF 287

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 107 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 165
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 225
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 226 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 283 LAHPFF 288

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 167
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 227
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 228 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 285 LAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 108 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 166
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 167 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 226
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 227 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 284 LAHPFF 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/184 (43%), Positives = 110/184 (59%), Gaps = 7/184 (3%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYVVT 80
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E VVT
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-VVT 165
Query: 81  RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDA 140
            WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP + 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 141 DL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA 199
              G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   ALA
Sbjct: 226 VWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
Query: 200 HPYL 203
           HP+ 
Sbjct: 283 HPFF 286

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 164
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 224
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 225 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 282 LAHPFF 287

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  152 bits (383), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 110 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 168
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 169 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 228
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 229 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 285
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 286 LAHPFF 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 164
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 224
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 225 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 282 LAHPFF 287

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 80/184 (43%), Positives = 110/184 (59%), Gaps = 7/184 (3%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYVVT 80
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E VVT
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-VVT 165
Query: 81  RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDA 140
            WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP + 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 141 DL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA 199
              G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   ALA
Sbjct: 226 VWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
Query: 200 HPYL 203
           HP+ 
Sbjct: 283 HPFF 286

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 167
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 227
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 228 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 285 LAHPFF 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 80/186 (43%), Positives = 111/186 (59%), Gaps = 7/186 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYV 78
           + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E V
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE-V 164
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT 138
           VT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP 
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 224
Query: 139 DADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
           +    G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   A
Sbjct: 225 EVVWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 198 LAHPYL 203
           LAHP+ 
Sbjct: 282 LAHPFF 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 80/184 (43%), Positives = 110/184 (59%), Gaps = 7/184 (3%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP--TSENEFMTEYVVT 80
           +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ DFGLAR        +  E VVT
Sbjct: 109 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE-VVT 167
Query: 81  RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDA 140
            WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFPG+  + Q+  +   LGTP + 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 227
Query: 141 DL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA 199
              G     D   Y    P+  RQ  ++V P +      L+ +ML +DP KRI+   ALA
Sbjct: 228 VWPGVTSMPD---YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 284
Query: 200 HPYL 203
           HP+ 
Sbjct: 285 HPFF 288

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  150 bits (380), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 78/189 (41%), Positives = 113/189 (59%), Gaps = 5/189 (2%)
Query: 18  EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY 77
           E  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL SS Y   +D+WSVGCIF E+  R+PLF G+  V Q+  +++++G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
            + D       D     +       Q + +    +  L  DL+ + LTF+P KRI+   A
Sbjct: 239 GEEDW----PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 198 LAHPYLARL 206
           L+HPY   L
Sbjct: 295 LSHPYFQDL 303

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  150 bits (380), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 77/186 (41%), Positives = 112/186 (60%), Gaps = 5/186 (2%)
Query: 18  EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY 77
           E  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL SS Y   +D+WSVGCIF E+  R+PLF G+  V Q+  +++++G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
            + D       D     +       Q + +    +  L  DL+ + LTF+P KRI+   A
Sbjct: 239 GEEDW----PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 198 LAHPYL 203
           L+HPY 
Sbjct: 295 LSHPYF 300

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  150 bits (380), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 79/189 (41%), Positives = 116/189 (61%), Gaps = 5/189 (2%)
Query: 18  EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY 77
           E  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR  S    +T  
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           VVT WYRAPE+LL SS Y   +D+WSVGCIF E+  R+PLF G+  V Q+  +++++G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 138 TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA 197
            + D  + R+    R  +       Q + +    +  L  DL+ + LTF+P KRI+   A
Sbjct: 239 GEED--WPRDVALPR--QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 198 LAHPYLARL 206
           L+HPY   L
Sbjct: 295 LSHPYFQDL 303

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/224 (38%), Positives = 128/224 (57%), Gaps = 16/224 (7%)
Query: 1   MDTDLYQIIRSN------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           MD DL + + S       + L     +YF +QLL+GL + H   ++HRDLKP NLL+N  
Sbjct: 85  MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR 144
Query: 55  CDLKICDFGLARPTS--ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
             LK+ DFGLAR      N F +E VVT WYRAP++L+ S  Y+ +ID+WS GCI  E++
Sbjct: 145 GQLKLGDFGLARAFGIPVNTFSSE-VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PH 171
             +PLFPG +   Q++L+ +++GTP ++    V      +Y   + Q P + L QV  PH
Sbjct: 204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV--TKLPKYNPNIQQRPPRDLRQVLQPH 261
Query: 172 V-HPLAIDLVD---RMLTFDPMKRITVDEALAHPYLARLHDEAD 211
              PL  +L+D    +L  +P  R++  +AL HP+ A  +  A 
Sbjct: 262 TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS 305

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  147 bits (372), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 86/215 (40%), Positives = 117/215 (54%), Gaps = 24/215 (11%)
Query: 1   MDTDLYQIIR-SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL +++      L     + FL QLL G+ Y H   V+HRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 60  CDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR    P  +    T  VVT WYRAP++L+ S  Y+  ID+WSVGCIF E++N  
Sbjct: 142 ADFGLARAFGIPVRK---YTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH-PRQSLAQVFPHVHP 174
           PLFPG     Q+  +  +LGTP         N      + +LP++ P  ++ +  P    
Sbjct: 199 PLFPGVSEADQLMRIFRILGTP---------NSKNWPNVTELPKYDPNFTVYEPLPWESF 249
Query: 175 L------AIDLVDRMLTFDPMKRITVDEALAHPYL 203
           L       IDL+ +ML  DP +RIT  +AL H Y 
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  147 bits (371), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 86/215 (40%), Positives = 117/215 (54%), Gaps = 24/215 (11%)
Query: 1   MDTDLYQIIR-SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL +++      L     + FL QLL G+ Y H   V+HRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 60  CDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR    P  +    T  VVT WYRAP++L+ S  Y+  ID+WSVGCIF E++N  
Sbjct: 142 ADFGLARAFGIPVRK---YTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGA 198
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH-PRQSLAQVFPHVHP 174
           PLFPG     Q+  +  +LGTP         N      + +LP++ P  ++ +  P    
Sbjct: 199 PLFPGVSEADQLMRIFRILGTP---------NSKNWPNVTELPKYDPNFTVYEPLPWESF 249
Query: 175 L------AIDLVDRMLTFDPMKRITVDEALAHPYL 203
           L       IDL+ +ML  DP +RIT  +AL H Y 
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  147 bits (370), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 85/215 (39%), Positives = 117/215 (54%), Gaps = 24/215 (11%)
Query: 1   MDTDLYQIIR-SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL +++      L     + FL QLL G+ Y H   V+HRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 60  CDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR    P  +    T  +VT WYRAP++L+ S  Y+  ID+WSVGCIF E++N  
Sbjct: 142 ADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH-PRQSLAQVFPHVHP 174
           PLFPG     Q+  +  +LGTP         N      + +LP++ P  ++ +  P    
Sbjct: 199 PLFPGVSEADQLMRIFRILGTP---------NSKNWPNVTELPKYDPNFTVYEPLPWESF 249
Query: 175 L------AIDLVDRMLTFDPMKRITVDEALAHPYL 203
           L       IDL+ +ML  DP +RIT  +AL H Y 
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 83/220 (37%), Positives = 119/220 (54%), Gaps = 7/220 (3%)
Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+TDL  II+ N   L+  H + ++   L+GL+Y+H   ++HRDLKP+NLLL+ N  LK+
Sbjct: 94  METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL 153
Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA+   S N      VVTRWYRAPELL  +  Y   +D+W+VGCI  EL+ R P  
Sbjct: 154 ADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG+  + Q+  + E LGTPT+     + +       +  P  P   L  +F       +D
Sbjct: 214 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP---LHHIFSAAGDDLLD 270
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEP 218
           L+  +  F+P  RIT  +AL   Y +  +     P C  P
Sbjct: 271 LIQGLFLFNPCARITATQALKMKYFS--NRPGPTPGCQLP 308

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 81/198 (40%), Positives = 115/198 (58%), Gaps = 7/198 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
            L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
           +T  VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF GN    Q+  + +L
Sbjct: 176 LTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +G P + D  + R+    R     P+ PR  +  V P +      L+  MLTF+P KRI+
Sbjct: 235 IGLPPEDD--WPRDVSLPRGAFP-PRGPR-PVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 194 VDEALAHPYLARLHDEAD 211
              AL H YL +  DE +
Sbjct: 291 AFRALQHSYLHK--DEGN 306

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  141 bits (355), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 78/190 (41%), Positives = 110/190 (57%), Gaps = 5/190 (2%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
            L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 167
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
           +   VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF GN    Q+  + +L
Sbjct: 168 LAPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +G P + D  + R+    R     P+ PR  +  V P +      L+  MLTF+P KRI+
Sbjct: 227 IGLPPEDD--WPRDVSLPRGAFP-PRGPR-PVQSVVPEMEESGAQLLLEMLTFNPHKRIS 282
Query: 194 VDEALAHPYL 203
              AL H YL
Sbjct: 283 AFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 78/190 (41%), Positives = 110/190 (57%), Gaps = 5/190 (2%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
            L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 167
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
           +   VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF GN    Q+  + +L
Sbjct: 168 LDPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +G P + D  + R+    R     P+ PR  +  V P +      L+  MLTF+P KRI+
Sbjct: 227 IGLPPEDD--WPRDVSLPRGAFP-PRGPR-PVQSVVPEMEESGAQLLLEMLTFNPHKRIS 282
Query: 194 VDEALAHPYL 203
              AL H YL
Sbjct: 283 AFRALQHSYL 292

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  140 bits (353), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 80/198 (40%), Positives = 114/198 (57%), Gaps = 7/198 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
            L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 167
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
           +   VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF GN    Q+  + +L
Sbjct: 168 LFPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 226
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +G P + D  + R+    R     P+ PR  +  V P +      L+  MLTF+P KRI+
Sbjct: 227 IGLPPEDD--WPRDVSLPRGAFP-PRGPR-PVQSVVPEMEESGAQLLLEMLTFNPHKRIS 282
Query: 194 VDEALAHPYLARLHDEAD 211
              AL H YL +  DE +
Sbjct: 283 AFRALQHSYLHK--DEGN 298

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  135 bits (339), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 76/207 (36%), Positives = 113/207 (54%), Gaps = 26/207 (12%)
Query: 21  QYFLYQLLRGLKYIH--SANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTEY 77
           + FL+QL+R +  +H  S NV HRD+KP N+L+N A+  LK+CDFG A+  S +E    Y
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           + +R+YRAPEL+  +  YT A+D+WSVGCIF E+M   P+F G++   Q+  ++ +LG P
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 138 ------------TDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                       TD DL    N     +      H  +   + +        DL+  +L 
Sbjct: 252 SREVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAY--------DLLSALLQ 300
Query: 186 FDPMKRITVDEALAHPYLARLHDEADE 212
           + P +R+   EAL HPY   LHD A +
Sbjct: 301 YLPEERMKPYEALCHPYFDELHDPATK 327

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/221 (37%), Positives = 124/221 (56%), Gaps = 19/221 (8%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD----- 56
           + DL + +  N  +S    + FLYQL+ G+ + HS   +HRDLKP NLLL+ +       
Sbjct: 116 ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175
Query: 57  LKICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LKI DFGLAR    P  +    T  ++T WYR PE+LL S  Y+ ++D+WS+ CI+ E++
Sbjct: 176 LKIGDFGLARAFGIPIRQ---FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVF-P 170
            + PLFPG+  + Q+  + E+LG P D    G     D K   +  P+   ++L +V   
Sbjct: 233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK---QSFPKFRGKTLKRVLGA 289
Query: 171 HVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD 211
            +    +DL+  ML  DP+KRI+   AL HPY +  H++ D
Sbjct: 290 LLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS--HNDFD 328

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  130 bits (328), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 69/187 (36%), Positives = 108/187 (57%), Gaps = 7/187 (3%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVV 79
           Q +L+Q++ G+ + HS N+IHRD+KP N+L++ +  +K+CDFG AR   +  E   + V 
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA 186
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGT--P 137
           TRWYRAPELL+    Y  A+DVW++GC+  E+    PLFPG+  + Q+  ++  LG   P
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246
Query: 138 TDADLGFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDE 196
              +L    N++      +LP+   R+ L + +P +  + IDL  + L  DP KR    E
Sbjct: 247 RHQEL---FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303
Query: 197 ALAHPYL 203
            L H + 
Sbjct: 304 LLHHDFF 310

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  130 bits (328), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 113/210 (53%), Gaps = 1/210 (0%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           T L+++ R  + + E   +   +Q L+ + + H  N IHRD+KP N+L+  +  +K+CDF
Sbjct: 87  TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDF 146
Query: 63  GLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G AR  T  +++  + V TRWYR+PELL+  + Y   +DVW++GC+F EL++  PL+PG 
Sbjct: 147 GFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
             V Q+ L+ + LG                  ++       + L   FP++   A+ L+ 
Sbjct: 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLK 266
Query: 182 RMLTFDPMKRITVDEALAHPYLARLHDEAD 211
             L  DP +R+T ++ L HPY   + +  D
Sbjct: 267 GCLHMDPTERLTCEQLLHHPYFENIREIED 296

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  129 bits (324), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 72/183 (39%), Positives = 102/183 (55%), Gaps = 6/183 (3%)
Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS--ENEFMTEY---VVTR 81
           LL GL YIH   ++HRD+K +N+L+  +  LK+ DFGLAR  S  +N     Y   VVT 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD 141
           WYR PELLL   DY   ID+W  GCI  E+  R P+  GN   HQ+ L+ +L G+ T   
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 253
Query: 142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH-PLAIDLVDRMLTFDPMKRITVDEALAH 200
              V N +    +  +    R+   ++  +V  P A+DL+D++L  DP +RI  D+AL H
Sbjct: 254 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 313
Query: 201 PYL 203
            + 
Sbjct: 314 DFF 316

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  129 bits (323), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 72/183 (39%), Positives = 102/183 (55%), Gaps = 6/183 (3%)
Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS--ENEFMTEY---VVTR 81
           LL GL YIH   ++HRD+K +N+L+  +  LK+ DFGLAR  S  +N     Y   VVT 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD 141
           WYR PELLL   DY   ID+W  GCI  E+  R P+  GN   HQ+ L+ +L G+ T   
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 253
Query: 142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH-PLAIDLVDRMLTFDPMKRITVDEALAH 200
              V N +    +  +    R+   ++  +V  P A+DL+D++L  DP +RI  D+AL H
Sbjct: 254 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 313
Query: 201 PYL 203
            + 
Sbjct: 314 DFF 316

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  129 bits (323), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 72/183 (39%), Positives = 102/183 (55%), Gaps = 6/183 (3%)
Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS--ENEFMTEY---VVTR 81
           LL GL YIH   ++HRD+K +N+L+  +  LK+ DFGLAR  S  +N     Y   VVT 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD 141
           WYR PELLL   DY   ID+W  GCI  E+  R P+  GN   HQ+ L+ +L G+ T   
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 253
Query: 142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH-PLAIDLVDRMLTFDPMKRITVDEALAH 200
              V N +    +  +    R+   ++  +V  P A+DL+D++L  DP +RI  D+AL H
Sbjct: 254 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 313
Query: 201 PYL 203
            + 
Sbjct: 314 DFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  129 bits (323), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 72/183 (39%), Positives = 102/183 (55%), Gaps = 6/183 (3%)
Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS--ENEFMTEY---VVTR 81
           LL GL YIH   ++HRD+K +N+L+  +  LK+ DFGLAR  S  +N     Y   VVT 
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 192
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD 141
           WYR PELLL   DY   ID+W  GCI  E+  R P+  GN   HQ+ L+ +L G+ T   
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252
Query: 142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH-PLAIDLVDRMLTFDPMKRITVDEALAH 200
              V N +    +  +    R+   ++  +V  P A+DL+D++L  DP +RI  D+AL H
Sbjct: 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312
Query: 201 PYL 203
            + 
Sbjct: 313 DFF 315

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 123/244 (50%), Gaps = 55/244 (22%)
Query: 4   DLYQIIRSNQS---------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           DL+ II+ +++         L     +  LYQ+L G+ Y+H+  V+HRDLKP+N+L+   
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 164
Query: 55  C----DLKICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
                 +KI D G AR    P      +   VVT WYRAPELLL +  YT AID+W++GC
Sbjct: 165 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 224
Query: 107 IFMELMNRRPLF--------PGNDHVH-QMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
           IF EL+   P+F          N + H Q+  +  ++G P D D      ED    I+++
Sbjct: 225 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW-----ED----IKKM 275
Query: 158 PQHPRQSLAQVFPH----------------VHP--LAIDLVDRMLTFDPMKRITVDEALA 199
           P+H   +L + F                  V P   A  L+ ++LT DP+KRIT ++A+ 
Sbjct: 276 PEH--STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333
Query: 200 HPYL 203
            PY 
Sbjct: 334 DPYF 337

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 118/201 (58%), Gaps = 8/201 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 142 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 201
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 202 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 261
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +A L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 262 KVLGTDGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 321
Query: 186 FDPMKRITVDEALAHPYLARL 206
           +D  +R+T  EA+ HPY  ++
Sbjct: 322 YDHQERLTALEAMTHPYFQQV 342

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 124/223 (55%), Gaps = 17/223 (7%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q L++   ++++Y+LL+ L Y HS  ++HRD+KP N++++     L++ 
Sbjct: 119 NTDFKQLY---QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLI 175
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ RR P F 
Sbjct: 176 DWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFH 235
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAK---RYIRQLPQHPRQSLAQVFPH----- 171
           G D+  Q+  + ++LG  T+   G+++         +   L QH R+     F H     
Sbjct: 236 GQDNYDQLVRIAKVLG--TEELYGYLKKYHIDLDPHFNDILGQHSRKRWEN-FIHSENRH 292
Query: 172 -VHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP 213
            V P A+DL+D++L +D  +R+T  EA+ HPY   +  E  +P
Sbjct: 293 LVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQP 335

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 125/223 (56%), Gaps = 13/223 (5%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVC 215
            P A+D +D++L +D   R+T  EA+ HPY   +  E  +P  
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTAREAMEHPYFYPVVKEQSQPCA 336

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 117/201 (58%), Gaps = 8/201 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITVDEALAHPYLARL 206
           +D  +R+T  EA+ HPY  ++
Sbjct: 301 YDHQERLTALEAMTHPYFQQV 321

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 117/201 (58%), Gaps = 8/201 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITVDEALAHPYLARL 206
           +D  +R+T  EA+ HPY  ++
Sbjct: 301 YDHQERLTALEAMTHPYFQQV 321

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 117/201 (58%), Gaps = 8/201 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITVDEALAHPYLARL 206
           +D  +R+T  EA+ HPY  ++
Sbjct: 301 YDHQERLTALEAMTHPYFQQV 321

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 117/201 (58%), Gaps = 8/201 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITVDEALAHPYLARL 206
           +D  +R+T  EA+ HPY  ++
Sbjct: 301 YDHQERLTALEAMTHPYFQQV 321

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 117/201 (58%), Gaps = 8/201 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 242 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 301
Query: 186 FDPMKRITVDEALAHPYLARL 206
           +D  +R+T  EA+ HPY  ++
Sbjct: 302 YDHQERLTALEAMTHPYFQQV 322

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 117/201 (58%), Gaps = 8/201 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 123 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 182
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 183 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 242
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 243 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 302
Query: 186 FDPMKRITVDEALAHPYLARL 206
           +D  +R+T  EA+ HPY  ++
Sbjct: 303 YDHQERLTALEAMTHPYFQQV 323

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 117/201 (58%), Gaps = 8/201 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 242 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 301
Query: 186 FDPMKRITVDEALAHPYLARL 206
           +D  +R+T  EA+ HPY  ++
Sbjct: 302 YDHQERLTALEAMTHPYFQQV 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 117/201 (58%), Gaps = 8/201 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITVDEALAHPYLARL 206
           +D  +R+T  EA+ HPY  ++
Sbjct: 301 YDHQERLTALEAMTHPYFQQV 321

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 117/201 (58%), Gaps = 8/201 (3%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE 72
           +L++   +Y++Y+LL+ L Y HS  ++HRD+KP N++++     L++ D+GLA      +
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 73  FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLI 131
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ R+ P F G+D+  Q+  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 132 ELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----VHPLAIDLVDRMLT 185
           ++LGT   +  L   R E   +    + +H R+   +         V P AID +D++L 
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 186 FDPMKRITVDEALAHPYLARL 206
           +D  +R+T  EA+ HPY  ++
Sbjct: 301 YDHQERLTALEAMTHPYFQQV 321

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N+L++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 120/213 (56%), Gaps = 17/213 (7%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q L++   ++++Y+LL+ L Y HS  ++HRD+KP N++++     L++ 
Sbjct: 124 NTDFKQLY---QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLI 180
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ RR P F 
Sbjct: 181 DWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFH 240
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAK---RYIRQLPQHPRQSLAQVFPH----- 171
           G D+  Q+  + ++LG  T+   G+++         +   L QH R+     F H     
Sbjct: 241 GQDNYDQLVRIAKVLG--TEELYGYLKKYHIDLDPHFNDILGQHSRKRWEN-FIHSENRH 297
Query: 172 -VHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            V P A+DL+D++L +D  +R+T  EA+ HPY 
Sbjct: 298 LVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQL---RQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 117 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 174 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 234 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 292
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 293 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 117 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 174 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 234 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 292
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 293 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 118 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 174
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 175 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 235 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 293
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 294 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 123 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 179
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 180 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 239
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 240 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 298
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 299 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 121/211 (57%), Gaps = 13/211 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKIC 60
           +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++ 
Sbjct: 116 NTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 172
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFP 119
           D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F 
Sbjct: 173 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFPH------V 172
           G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   + F H      V
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER-FVHSENQHLV 291
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            P A+D +D++L +D   R+T  EA+ HPY 
Sbjct: 292 SPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 31/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 106 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 165
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 166 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 223
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 224 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 259
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           LV ++L  DP  R T +EAL HP+L
Sbjct: 260 LVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 31/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 99  ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 158
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 159 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 216
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 217 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 252
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           LV ++L  DP  R T +EAL HP+L
Sbjct: 253 LVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 31/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 100 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 218 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 253
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           LV ++L  DP  R T +EAL HP+L
Sbjct: 254 LVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  110 bits (275), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 31/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 100 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 218 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 253
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           LV ++L  DP  R T +EAL HP+L
Sbjct: 254 LVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  110 bits (275), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 31/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 100 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 218 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 253
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           LV ++L  DP  R T +EAL HP+L
Sbjct: 254 LVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 31/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 225 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 342
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 343 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 378
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           LV ++L  DP  R T +EAL HP+L
Sbjct: 379 LVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 31/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 239 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 298
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++  ++ Y  A+D WS+G I    ++  P  
Sbjct: 299 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP-- 356
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           P ++H  Q+ L  ++    T     F+                     +V+  V   A+D
Sbjct: 357 PFSEHRTQVSLKDQI----TSGKYNFI--------------------PEVWAEVSEKALD 392
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           LV ++L  DP  R T +EAL HP+L
Sbjct: 393 LVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 115/237 (48%), Gaps = 35/237 (14%)
Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCD 56
           +  +LY++I+ N  Q  S    + F + +L+ L  +H   +IH DLKP N+LL       
Sbjct: 181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           +K+ DFG +    E++ +   + +R+YRAPE++L +  Y   ID+WS+GCI  EL+   P
Sbjct: 241 IKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYP 297
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADL-------GFVRNEDAKRYIR-------------- 155
           L PG D   Q+  +IELLG P+   L        FV  +   RY                
Sbjct: 298 LLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGG 357
Query: 156 -------QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
                  + P   R+    +     PL +D + + L +DP  R+T  +AL HP+L R
Sbjct: 358 RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  107 bits (268), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 115/237 (48%), Gaps = 35/237 (14%)
Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCD 56
           +  +LY++I+ N  Q  S    + F + +L+ L  +H   +IH DLKP N+LL       
Sbjct: 181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           +K+ DFG +    E++ +   + +R+YRAPE++L +  Y   ID+WS+GCI  EL+   P
Sbjct: 241 IKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYP 297
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADL-------GFVRNEDAKRYIR-------------- 155
           L PG D   Q+  +IELLG P+   L        FV  +   RY                
Sbjct: 298 LLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGG 357
Query: 156 -------QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
                  + P   R+    +     PL +D + + L +DP  R+T  +AL HP+L R
Sbjct: 358 RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  107 bits (266), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 114/237 (48%), Gaps = 35/237 (14%)
Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCD 56
           +  +LY++I+ N  Q  S    + F + +L+ L  +H   +IH DLKP N+LL       
Sbjct: 181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           +K+ DFG +    E++ +   + +R+YRAPE++L +  Y   ID+WS+GCI  EL+   P
Sbjct: 241 IKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYP 297
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADL-------GFVRNEDAKRYIR-------------- 155
           L PG D   Q+  +IELLG P    L        FV  +   RY                
Sbjct: 298 LLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGG 357
Query: 156 -------QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
                  + P   R+    +     PL +D + + L +DP  R+T  +AL HP+L R
Sbjct: 358 RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I   +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL +   +CD+KI 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+    +N  M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +    ++ +                  +  +Y   LPQ         +  +   A DL+
Sbjct: 225 KNEYDILKRV------------------ETGKYAFDLPQ---------WRTISDDAKDLI 257
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEA 210
            +MLTF P  RIT  + L HP++ +   E 
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKYSSET 287

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 32/209 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I   +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL +   +CD+KI 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+    +N  M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y   LPQ         +  +   A DL+
Sbjct: 225 KN------------------EYDILKRVETGKYAFDLPQ---------WRTISDDAKDLI 257
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDE 209
            +MLTF P  RIT  + L HP++ +   E
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKYSSE 286

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 32/209 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I   +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL +   +CD+KI 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+    +N  M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y   LPQ         +  +   A DL+
Sbjct: 225 KN------------------EYDILKRVETGKYAFDLPQ---------WRTISDDAKDLI 257
Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDE 209
            +MLTF P  RIT  + L HP++ +   E
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKYSSE 286

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 37/222 (16%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLL-LNANCDL------------------KICD 61
           ++  +QL + +K++H   + H DLKP N+L +N++ +L                  ++ D
Sbjct: 140 RHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVD 199
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG A  T ++E  +  V TR YRAPE++L    ++   DVWS+GCI  E      LF  +
Sbjct: 200 FGSA--TFDHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTH 256
Query: 122 DHVHQMRLLIELLG-------TPTDADLGFVR-------NEDAKRYIRQLPQHPRQSLAQ 167
           D+   + ++  +LG         T     F R       N  A RY+R+  +  R+ L  
Sbjct: 257 DNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTS 316
Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE 209
                H L  DL++ ML ++P KR+T+ EAL HP+ ARL  E
Sbjct: 317 EAEEHHQL-FDLIESMLEYEPAKRLTLGEALQHPFFARLRAE 357

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 32/206 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I      +E      + Q+L G+ Y+H  N++HRDLKP NLLL +   +  +KI 
Sbjct: 122 ELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV 181
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+      + M E + T +Y APE+L     Y    DVWS+G I   L+   P F G
Sbjct: 182 DFGLSAVFENQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGG 239
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                            TD ++  +R  +  +Y    P+         + +V   A DL+
Sbjct: 240 Q----------------TDQEI--LRKVEKGKYTFDSPE---------WKNVSEGAKDLI 272
Query: 181 DRMLTFDPMKRITVDEALAHPYLARL 206
            +ML FD  +RI+  +AL HP++  +
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKEM 298

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 39/222 (17%)
Query: 19  HCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL-LNA------------------NCDLKI 59
           H ++  YQL   L+++H   + H DLKP N+L +N+                  N  +++
Sbjct: 156 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 215
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG A  T ++E  T  V TR YR PE++L    +    DVWS+GCI  E      LF 
Sbjct: 216 ADFGSA--TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQ 272
Query: 120 GNDHVHQMRLLIELLGTPTDADL-------------GFVRNEDAK--RYIRQLPQHPRQS 164
            +++   + ++ ++LG P  + +             G V +E++   RY+++  + P +S
Sbjct: 273 THENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKS 330
Query: 165 LAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL 206
                   H    DL+ RML FDP +RIT+ EAL HP+ A L
Sbjct: 331 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 372

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 39/222 (17%)
Query: 19  HCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL-LNA------------------NCDLKI 59
           H ++  YQL   L+++H   + H DLKP N+L +N+                  N  +++
Sbjct: 133 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 192
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG A  T ++E  T  V TR YR PE++L    +    DVWS+GCI  E      LF 
Sbjct: 193 ADFGSA--TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQ 249
Query: 120 GNDHVHQMRLLIELLGTPTDADL-------------GFVRNEDAK--RYIRQLPQHPRQS 164
            +++   + ++ ++LG P  + +             G V +E++   RY+++  + P +S
Sbjct: 250 THENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKS 307
Query: 165 LAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL 206
                   H    DL+ RML FDP +RIT+ EAL HP+ A L
Sbjct: 308 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 349

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 107/233 (45%), Gaps = 39/233 (16%)
Query: 6   YQIIRSNQSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---------- 53
           Y  I+ N  L    +H +   YQ+ + + ++HS  + H DLKP N+L             
Sbjct: 104 YDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163
Query: 54  ---------NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 104
                    N D+K+ DFG A  T ++E  +  V TR YRAPE++L +  ++   DVWS+
Sbjct: 164 IKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSI 220
Query: 105 GCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR--------------NEDA 150
           GCI +E      +FP +D    + ++  +LG      +   R              +  A
Sbjct: 221 GCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA 280
Query: 151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            RY+ +  + P +         H    DL+ +ML +DP KRIT+ EAL HP+ 
Sbjct: 281 GRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 39/222 (17%)
Query: 19  HCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-------------------ANCDLKI 59
           H ++  YQL   L+++H   + H DLKP N+L                      N  +++
Sbjct: 124 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG A  T ++E  T  V TR YR PE++L    +    DVWS+GCI  E      LF 
Sbjct: 184 ADFGSA--TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQ 240
Query: 120 GNDHVHQMRLLIELLGTPTDADL-------------GFVRNEDAK--RYIRQLPQHPRQS 164
            +++   + ++ ++LG P  + +             G V +E++   RY+++  + P +S
Sbjct: 241 THENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKS 298
Query: 165 LAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL 206
                   H    DL+ RML FDP +RIT+ EAL HP+ A L
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 32/203 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL +   + +++I 
Sbjct: 136 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 195
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++ M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 196 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNG 253
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y  +LPQ         +  V   A DL+
Sbjct: 254 AN------------------EYDILKKVEKGKYTFELPQ---------WKKVSESAKDLI 286
Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
            +MLT+ P  RI+  +AL H ++
Sbjct: 287 RKMLTYVPSMRISARDALDHEWI 309

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 32/203 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL +   + +++I 
Sbjct: 135 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 194
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++ M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 195 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNG 252
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y  +LPQ         +  V   A DL+
Sbjct: 253 AN------------------EYDILKKVEKGKYTFELPQ---------WKKVSESAKDLI 285
Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
            +MLT+ P  RI+  +AL H ++
Sbjct: 286 RKMLTYVPSMRISARDALDHEWI 308

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 32/203 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL +   + +++I 
Sbjct: 112 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 171
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++ M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 172 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNG 229
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y  +LPQ         +  V   A DL+
Sbjct: 230 AN------------------EYDILKKVEKGKYTFELPQ---------WKKVSESAKDLI 262
Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
            +MLT+ P  RI+  +AL H ++
Sbjct: 263 RKMLTYVPSMRISARDALDHEWI 285

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 32/203 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL +   + +++I 
Sbjct: 118 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 177
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++ M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 178 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNG 235
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y  +LPQ         +  V   A DL+
Sbjct: 236 AN------------------EYDILKKVEKGKYTFELPQ---------WKKVSESAKDLI 268
Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
            +MLT+ P  RI+  +AL H ++
Sbjct: 269 RKMLTYVPSMRISARDALDHEWI 291

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 39/233 (16%)
Query: 6   YQIIRSNQSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---------- 53
           Y  I+ N  L    +H +   YQ+ + + ++HS  + H DLKP N+L             
Sbjct: 104 YDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163
Query: 54  ---------NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 104
                    N D+K+ DFG A  T ++E  +  V  R YRAPE++L +  ++   DVWS+
Sbjct: 164 IKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSI 220
Query: 105 GCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR--------------NEDA 150
           GCI +E      +FP +D    + ++  +LG      +   R              +  A
Sbjct: 221 GCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA 280
Query: 151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
            RY+ +  + P +         H    DL+ +ML +DP KRIT+ EAL HP+ 
Sbjct: 281 GRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 32/207 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  + ++H+ N++HRDLKP N+LL+ N  +++ DFG
Sbjct: 186 ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELMNRRPLF 118
            +      E + E   T  Y APE+L  S D     Y   +D+W+ G I   L+   P F
Sbjct: 246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                +  +R+++E                   +Y    P+   +S             D
Sbjct: 306 WHRRQILMLRMIME------------------GQYQFSSPEWDDRS---------STVKD 338
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLAR 205
           L+ R+L  DP  R+T ++AL HP+  R
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 32/206 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L+  I   Q  SE      + Q+L G  Y+H  N++HRDLKP NLLL +      +KI 
Sbjct: 90  ELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIV 149
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+        M E + T +Y APE+L     Y    DVWS G I   L+   P F G
Sbjct: 150 DFGLSAHFEVGGKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGG 207
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                            TD ++  ++  +  ++    P          +  V   A  LV
Sbjct: 208 Q----------------TDQEI--LKRVEKGKFSFDPPD---------WTQVSDEAKQLV 240
Query: 181 DRMLTFDPMKRITVDEALAHPYLARL 206
             MLT++P KRI+ +EAL HP++ + 
Sbjct: 241 KLMLTYEPSKRISAEEALNHPWIVKF 266

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 32/206 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L+  I   Q  SE      + Q+L G  Y+H  N++HRDLKP NLLL +      +KI 
Sbjct: 107 ELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIV 166
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+        M E + T +Y APE+L     Y    DVWS G I   L+   P F G
Sbjct: 167 DFGLSAHFEVGGKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGG 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                            TD ++  ++  +  ++    P          +  V   A  LV
Sbjct: 225 Q----------------TDQEI--LKRVEKGKFSFDPPD---------WTQVSDEAKQLV 257
Query: 181 DRMLTFDPMKRITVDEALAHPYLARL 206
             MLT++P KRI+ +EAL HP++ + 
Sbjct: 258 KLMLTYEPSKRISAEEALNHPWIVKF 283

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 32/206 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + ++Q+L  + +IH  +++HRDLKP NLLL + C    +K+ 
Sbjct: 116 ELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLA 175
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     E +    +  T  Y +PE +L    Y   +D+W+ G I            
Sbjct: 176 DFGLAIEVQGEQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDIWACGVI------------ 222
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  +  +Q+        +  +  V P A +L
Sbjct: 223 ---------LYILLVGYPPFWD------EDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 267
Query: 180 VDRMLTFDPMKRITVDEALAHPYLAR 205
           +++MLT +P KRIT D+AL HP++ +
Sbjct: 268 INQMLTINPAKRITADQALKHPWVCQ 293

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 107 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 166
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F    
Sbjct: 167 LATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---- 221
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E         L   +NE +      +P+           H++P+A  L+ +
Sbjct: 222 ---ETSCLKETY-------LRIKKNEYS------IPK-----------HINPVAASLIQK 254
Query: 183 MLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
           ML  DP  R T++E L   +    +  A  P+
Sbjct: 255 MLQTDPTARPTINELLNDEFFTSGYIPARLPI 286

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 103 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 162
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F    
Sbjct: 163 LATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---- 217
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E         L   +NE +      +P+           H++P+A  L+ +
Sbjct: 218 ---ETSCLKETY-------LRIKKNEYS------IPK-----------HINPVAASLIQK 250
Query: 183 MLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
           ML  DP  R T++E L   +    +  A  P+
Sbjct: 251 MLQTDPTARPTINELLNDEFFTSGYIPARLPI 282

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 103 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 162
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F    
Sbjct: 163 LATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---- 217
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E         L   +NE +      +P+           H++P+A  L+ +
Sbjct: 218 ---ETSCLKETY-------LRIKKNEYS------IPK-----------HINPVAASLIQK 250
Query: 183 MLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
           ML  DP  R T++E L   +    +  A  P+
Sbjct: 251 MLQTDPTARPTINELLNDEFFTSGYIPARLPI 282

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 127 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 186
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F    
Sbjct: 187 LATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---- 241
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E         L   +NE +      +P+           H++P+A  L+ +
Sbjct: 242 ---ETSCLKETY-------LRIKKNEYS------IPK-----------HINPVAASLIQK 274
Query: 183 MLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
           ML  DP  R T++E L   +    +  A  P+
Sbjct: 275 MLQTDPTARPTINELLNDEFFTSGYIPARLPI 306

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 125 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 184
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F    
Sbjct: 185 LATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---- 239
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E         L   +NE +      +P+           H++P+A  L+ +
Sbjct: 240 ---ETSCLKETY-------LRIKKNEYS------IPK-----------HINPVAASLIQK 272
Query: 183 MLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
           ML  DP  R T++E L   +    +  A  P+
Sbjct: 273 MLQTDPTARPTINELLNDEFFTSGYIPARLPI 304

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFG
Sbjct: 101 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 160
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F  + 
Sbjct: 161 LATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS- 218
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                           +  L   +NE +      +P+           H++P+A  L+ +
Sbjct: 219 -------------CLKETYLRIKKNEYS------IPK-----------HINPVAASLIQK 248
Query: 183 MLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
           ML  DP  R T++E L   +    +  A  P+
Sbjct: 249 MLQTDPTARPTINELLNDEFFTSGYIPARLPI 280

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 33/201 (16%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++ +  ++++E   +YF+ Q ++G++Y+H+  VIHRDLK  NL LN + D+KI DFGL
Sbjct: 129 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 65  ARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A     + E   +   T  Y APE+L     ++  +D+WS+GCI   L+  +P F     
Sbjct: 189 ATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTLLVGKPPF----- 242
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             +   L E                    YIR      +++   V  H++P+A  L+ RM
Sbjct: 243 --ETSCLKET-------------------YIRI-----KKNEYSVPRHINPVASALIRRM 276
Query: 184 LTFDPMKRITVDEALAHPYLA 204
           L  DP  R +V E L   +  
Sbjct: 277 LHADPTLRPSVAELLTDEFFT 297

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 33/201 (16%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++ +  ++++E   +YF+ Q ++G++Y+H+  VIHRDLK  NL LN + D+KI DFGL
Sbjct: 113 LLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGL 172
Query: 65  ARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A     + E   +   T  Y APE+L     ++  +D+WS+GCI   L+  +P F     
Sbjct: 173 ATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTLLVGKPPF----- 226
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             +   L E                    YIR      +++   V  H++P+A  L+ RM
Sbjct: 227 --ETSCLKET-------------------YIRI-----KKNEYSVPRHINPVASALIRRM 260
Query: 184 LTFDPMKRITVDEALAHPYLA 204
           L  DP  R +V E L   +  
Sbjct: 261 LHADPTLRPSVAELLTDEFFT 281

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 31/203 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I             
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVI------------- 219
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   L I L+G P   D      ED  R   Q+        +  +  V P A  L+
Sbjct: 220 --------LYILLVGYPPFWD------EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265
Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
           D MLT +P KRIT D+AL  P++
Sbjct: 266 DSMLTVNPKKRITADQALKVPWI 288

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 31/203 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 91  ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I             
Sbjct: 151 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVI------------- 196
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   L I L+G P   D      ED  R   Q+        +  +  V P A  L+
Sbjct: 197 --------LYILLVGYPPFWD------EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
           D MLT +P KRIT D+AL  P++
Sbjct: 243 DSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 31/203 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 91  ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I             
Sbjct: 151 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVI------------- 196
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   L I L+G P   D      ED  R   Q+        +  +  V P A  L+
Sbjct: 197 --------LYILLVGYPPFWD------EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
           D MLT +P KRIT D+AL  P++
Sbjct: 243 DSMLTVNPKKRITADQALKVPWI 265

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 33/202 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++++E   +YF+ Q ++G++Y+H+  VIHRDLK  NL LN + D+KI DFG
Sbjct: 128 SLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFG 187
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE+L     ++  +D+WS+GCI   L+  +P F    
Sbjct: 188 LATKIEFDGERKKTLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTLLVGKPPF---- 242
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E                    YIR      +++   V  H++P+A  L+ R
Sbjct: 243 ---ETSCLKET-------------------YIRI-----KKNEYSVPRHINPVASALIRR 275
Query: 183 MLTFDPMKRITVDEALAHPYLA 204
           ML  DP  R +V E L   +  
Sbjct: 276 MLHADPTLRPSVAELLTDEFFT 297

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 31/203 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 90  ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 149
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I             
Sbjct: 150 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVI------------- 195
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   L I L+G P   D      ED  R   Q+        +  +  V P A  L+
Sbjct: 196 --------LYILLVGYPPFWD------EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 241
Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
           D MLT +P KRIT D+AL  P++
Sbjct: 242 DSMLTVNPKKRITADQALKVPWI 264

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 33/202 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L ++ +  ++++E   +YF+ Q ++G++Y+H+  VIHRDLK  NL LN + D+KI DFG
Sbjct: 128 SLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFG 187
Query: 64  LARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA     + E       T  Y APE+L     ++  +D+WS+GCI   L+  +P F    
Sbjct: 188 LATKIEFDGERKKXLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTLLVGKPPF---- 242
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              +   L E                    YIR      +++   V  H++P+A  L+ R
Sbjct: 243 ---ETSCLKET-------------------YIRI-----KKNEYSVPRHINPVASALIRR 275
Query: 183 MLTFDPMKRITVDEALAHPYLA 204
           ML  DP  R +V E L   +  
Sbjct: 276 MLHADPTLRPSVAELLTDEFFT 297

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 32/203 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y H   ++HRDLKP NLLL +   + +++I 
Sbjct: 112 ELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRII 171
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++   + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 172 DFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNG 229
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +                  +   ++  +  +Y  +LPQ         +  V   A DL+
Sbjct: 230 AN------------------EYDILKKVEKGKYTFELPQ---------WKKVSESAKDLI 262
Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
            + LT+ P  RI+  +AL H ++
Sbjct: 263 RKXLTYVPSXRISARDALDHEWI 285

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 25/195 (12%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I+  +  SE    Y + +L+  + ++H   V+HRDLKP NLL    N N ++KI 
Sbjct: 92  ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKII 151
Query: 61  DFGLAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFG AR    +N+ +     T  Y APE LLN + Y  + D+WS+G I   +++ +  F 
Sbjct: 152 DFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            +D        +E++      D  F                      + + +V   A DL
Sbjct: 211 SHDRSLTCTSAVEIMKKIKKGDFSFE--------------------GEAWKNVSQEAKDL 250
Query: 180 VDRMLTFDPMKRITV 194
           +  +LT DP KR+ +
Sbjct: 251 IQGLLTVDPNKRLKM 265

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 113/249 (45%), Gaps = 42/249 (16%)
Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLLN--AN 54
           +  +LY ++R+   + +S    + F  Q+   L ++ +   ++IH DLKP N+LL     
Sbjct: 119 LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 178
Query: 55  CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
             +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+GCI +E+   
Sbjct: 179 SAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTG 235
Query: 115 RPLFPGNDHVHQMRLLIELLGTP------------------TDADLGFVRNEDAKRYIRQ 156
            PLF G + V QM  ++E+LG P                   D      + +D KR  + 
Sbjct: 236 EPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKP 295
Query: 157 LPQHPRQSLAQV----------FPHVHPLA-----IDLVDRMLTFDPMKRITVDEALAHP 201
                  ++  V              H +A      DL+ RML +DP  RI    AL H 
Sbjct: 296 PGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHS 355
Query: 202 YLARLHDEA 210
           +  +  DE 
Sbjct: 356 FFKKTADEG 364

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 177 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 235
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 236 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 262
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 263 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 233 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 259
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 113/248 (45%), Gaps = 42/248 (16%)
Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLLN--AN 54
           +  +LY ++R+   + +S    + F  Q+   L ++ +   ++IH DLKP N+LL     
Sbjct: 138 LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 55  CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
             +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+GCI +E+   
Sbjct: 198 SAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTG 254
Query: 115 RPLFPGNDHVHQMRLLIELLGTP------------------TDADLGFVRNEDAKRYIRQ 156
            PLF G + V QM  ++E+LG P                   D      + +D KR  + 
Sbjct: 255 EPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKP 314
Query: 157 LPQHPRQSLAQV----------FPHVHPLA-----IDLVDRMLTFDPMKRITVDEALAHP 201
                  ++  V              H +A      DL+ RML +DP  RI    AL H 
Sbjct: 315 PGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHS 374
Query: 202 YLARLHDE 209
           +  +  DE
Sbjct: 375 FFKKTADE 382

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 235 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 261
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 177 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 235
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 236 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 262
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 263 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 233 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 259
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 233 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 259
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 235 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 261
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 121 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 180
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 181 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 239
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 240 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 266
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 267 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 299

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 235 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 261
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 119 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 178
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 179 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 237
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-HPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 238 RAGNEYLIFQKII---------------------------------KLEYDFPAAFFPKA 264
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 265 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 297

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 233 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 259
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 92  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 151
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 152 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 210
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 211 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 237
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 94  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 153
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 154 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 212
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 213 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 239
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 240 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 272

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSS-DLWALGCIIYQLVAGLPPF 234
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+ +   +++                                  L   FP    P A
Sbjct: 235 RAGNEGLIFAKII---------------------------------KLEYDFPEKFFPKA 261
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 91  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 150
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 151 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 209
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 210 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 236
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 237 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 269

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 115/251 (45%), Gaps = 48/251 (19%)
Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLLNANCD 56
           +  +LY ++R+   + +S    + F  Q+   L ++ +   ++IH DLKP N+LL   C+
Sbjct: 138 LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL---CN 194
Query: 57  -----LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
                +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+GCI +E+
Sbjct: 195 PKRXAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEM 251
Query: 112 MNRRPLFPGNDHVHQMRLLIELLGTP------------------TDADLGFVRNEDAKRY 153
               PLF G + V QM  ++E+LG P                   D      + +D KR 
Sbjct: 252 HTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKRE 311
Query: 154 IRQLPQHPRQSLAQV----------FPHVHPLA-----IDLVDRMLTFDPMKRITVDEAL 198
            +        ++  V              H +A      DL+ RML +DP  RI    AL
Sbjct: 312 YKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYAL 371
Query: 199 AHPYLARLHDE 209
            H +  +  DE
Sbjct: 372 QHSFFKKTADE 382

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 173 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 231
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 232 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 258
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 259 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 93  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 152
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 153 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 211
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 212 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 238
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 239 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 271

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 98  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 157
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 158 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 216
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 217 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 243
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 244 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 276

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 45/210 (21%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I DFG 
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 65  AR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF-PG 120
           A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F  G
Sbjct: 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSS-DLWALGCIIYQLVAGLPPFRAG 237
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLAIDL 179
           N+++   +++                                  L   FP    P A DL
Sbjct: 238 NEYLIFQKII---------------------------------KLEYDFPEKFFPKARDL 264
Query: 180 VDRMLTFDPMKRITVDEA------LAHPYL 203
           V+++L  D  KR+  +E        AHP+ 
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 173 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 231
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+++   +++                                  L   FP    P A
Sbjct: 232 RAGNEYLIFQKII---------------------------------KLEYDFPEKFFPKA 258
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 259 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 45/213 (21%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG A+   P S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 119 -PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-VHPLA 176
             GN+ +   +++                                  L   FP    P A
Sbjct: 235 RAGNEGLIFAKII---------------------------------KLEYDFPEKFFPKA 261
Query: 177 IDLVDRMLTFDPMKRITVDEA------LAHPYL 203
            DLV+++L  D  KR+  +E        AHP+ 
Sbjct: 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 31/202 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  N  L E+  +    Q+L G+ Y H   V+HRDLKP N+LL+A+ + KI DFG
Sbjct: 102 ELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 161
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+   S+ EF+     +  Y APE++         +D+WS G I   L+     F  +DH
Sbjct: 162 LSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF-DDDH 220
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           V  +                F +  D   Y  Q              +++P  I L+  M
Sbjct: 221 VPTL----------------FKKICDGIFYTPQ--------------YLNPSVISLLKHM 250
Query: 184 LTFDPMKRITVDEALAHPYLAR 205
           L  DPMKR T+ +   H +  +
Sbjct: 251 LQVDPMKRATIKDIREHEWFKQ 272

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 33/192 (17%)
Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENE 72
           SE    +++ Q+L  L+Y H  N+IHRD+KP N+LL +   +  +K+ DFG+A    E+ 
Sbjct: 128 SEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG 187
Query: 73  FMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
            +    V T  + APE ++    Y   +DVW  G I   L++                 +
Sbjct: 188 LVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSG---------------CL 231
Query: 132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
              GT      G ++         +   +PRQ     + H+   A DLV RML  DP +R
Sbjct: 232 PFYGTKERLFEGIIKG--------KYKMNPRQ-----WSHISESAKDLVRRMLMLDPAER 278
Query: 192 ITVDEALAHPYL 203
           ITV EAL HP+L
Sbjct: 279 ITVYEALNHPWL 290

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L++ I + +  SE    + + Q+L  + + H   V+HRDLKP NLLL +      +K+ 
Sbjct: 107 ELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLA 166
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     E +    +  T  Y +PE +L    Y   +D+W+ G I            
Sbjct: 167 DFGLAIEVEGEQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDLWACGVI------------ 213
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  R  +Q+        +  +  V P A DL
Sbjct: 214 ---------LYILLVGYPPFWD------EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 258
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           +++MLT +P KRIT  EAL HP+++
Sbjct: 259 INKMLTINPSKRITAAEALKHPWIS 283

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 32/206 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + + H   V+HRDLKP NLLL + C    +K+ 
Sbjct: 89  ELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLA 148
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     + +    +  T  Y +PE+L   + Y   +D+W+ G I            
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA-YGKPVDIWACGVI------------ 195
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  +  +Q+        +  +  V P A +L
Sbjct: 196 ---------LYILLVGYPPFWD------EDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 240
Query: 180 VDRMLTFDPMKRITVDEALAHPYLAR 205
           +++MLT +P KRIT  EAL HP++ +
Sbjct: 241 INQMLTINPAKRITAHEALKHPWVCQ 266

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG
Sbjct: 110 ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            +      E + E   T  Y APE++      N   Y   +D+WS G I   L+   P F
Sbjct: 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                 H+ ++L+  +    +   G    +D    ++                      D
Sbjct: 230 -----WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK----------------------D 262
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           LV R L   P KR T +EALAHP+ 
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG
Sbjct: 97  ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 156
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            +      E + E   T  Y APE++      N   Y   +D+WS G I   L+   P F
Sbjct: 157 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                 H+ ++L+  +    +   G    +D    ++                      D
Sbjct: 217 -----WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK----------------------D 249
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLAR 205
           LV R L   P KR T +EALAHP+  +
Sbjct: 250 LVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I + +  SE    + + Q+L  + + H   ++HRDLKP NLLL   +    +K+ 
Sbjct: 89  ELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLA 148
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     + +    +  T  Y +PE+L     Y   +D+W+ G I            
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDMWACGVI------------ 195
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  R  +Q+        +  +  V P A DL
Sbjct: 196 ---------LYILLVGYPPFWD------EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 180 VDRMLTFDPMKRITVDEALAHPYLAR 205
           +++MLT +P KRIT  EAL HP++ +
Sbjct: 241 INKMLTINPAKRITASEALKHPWICQ 266

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I + +  SE    + + Q+L  + + H   ++HRDLKP NLLL   +    +K+ 
Sbjct: 89  ELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLA 148
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     + +    +  T  Y +PE+L     Y   +D+W+ G I            
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDMWACGVI------------ 195
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  R  +Q+        +  +  V P A DL
Sbjct: 196 ---------LYILLVGYPPFWD------EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 180 VDRMLTFDPMKRITVDEALAHPYLAR 205
           +++MLT +P KRIT  EAL HP++ +
Sbjct: 241 INKMLTINPAKRITASEALKHPWICQ 266

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 35/202 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I   + ++E+  + F  Q++  ++Y H   ++HRDLKP NLLL+ N ++KI DFG
Sbjct: 94  ELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFG 153
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFPGND 122
           L+   ++  F+     +  Y APE++         +DVWS G + ++ L+ R P      
Sbjct: 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF----- 208
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
                             D  F+ N   K            S   V P  + P A  L+ 
Sbjct: 209 ------------------DDEFIPNLFKK----------VNSCVYVMPDFLSPGAQSLIR 240
Query: 182 RMLTFDPMKRITVDEALAHPYL 203
           RM+  DPM+RIT+ E    P+ 
Sbjct: 241 RMIVADPMQRITIQEIRRDPWF 262

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L++ I + +  SE    + + Q+L  + + H   V+HR+LKP NLLL +      +K+ 
Sbjct: 96  ELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLA 155
Query: 61  DFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     E +    +  T  Y +PE+L     Y   +D+W+ G I            
Sbjct: 156 DFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVI------------ 202
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                    L I L+G P   D      ED  R  +Q+        +  +  V P A DL
Sbjct: 203 ---------LYILLVGYPPFWD------EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           +++MLT +P KRIT  EAL HP+++
Sbjct: 248 INKMLTINPSKRITAAEALKHPWIS 272

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 31/196 (15%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            +L+  I     +SE+  + F  Q++  ++Y H   ++HRDLKP NLLL+ + ++KI DF
Sbjct: 92  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADF 151
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           GL+   ++  F+     +  Y APE++         +DVWS G I   ++ RR       
Sbjct: 152 GLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR------- 204
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                         P D +   V  ++    +  LP+            + P A  L+ R
Sbjct: 205 -------------LPFDDESIPVLFKNISNGVYTLPK-----------FLSPGAAGLIKR 240
Query: 183 MLTFDPMKRITVDEAL 198
           ML  +P+ RI++ E +
Sbjct: 241 MLIVNPLNRISIHEIM 256

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 31/196 (15%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            +L+  I     +SE+  + F  Q++  ++Y H   ++HRDLKP NLLL+ + ++KI DF
Sbjct: 88  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADF 147
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           GL+   ++  F+     +  Y APE++         +DVWS G I   ++ RR       
Sbjct: 148 GLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR------- 200
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                         P D +   V  ++    +  LP+            + P A  L+ R
Sbjct: 201 -------------LPFDDESIPVLFKNISNGVYTLPK-----------FLSPGAAGLIKR 236
Query: 183 MLTFDPMKRITVDEAL 198
           ML  +P+ RI++ E +
Sbjct: 237 MLIVNPLNRISIHEIM 252

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG
Sbjct: 110 ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            +      E +     T  Y APE++      N   Y   +D+WS G I   L+   P F
Sbjct: 170 FSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                 H+ ++L+  +    +   G    +D    ++                      D
Sbjct: 230 -----WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK----------------------D 262
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           LV R L   P KR T +EALAHP+ 
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 31/196 (15%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            +L+  I     +SE+  + F  Q++  ++Y H   ++HRDLKP NLLL+ + ++KI DF
Sbjct: 98  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADF 157
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           GL+   ++  F+     +  Y APE++         +DVWS G I   ++ RR       
Sbjct: 158 GLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR------- 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                         P D +   V  ++    +  LP+            + P A  L+ R
Sbjct: 211 -------------LPFDDESIPVLFKNISNGVYTLPK-----------FLSPGAAGLIKR 246
Query: 183 MLTFDPMKRITVDEAL 198
           ML  +P+ RI++ E +
Sbjct: 247 MLIVNPLNRISIHEIM 262

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 99  ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 159 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 216
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 217 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 249
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 250 FIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+                T A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTK------------QETLANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 31/196 (15%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            +L+  I     +SE+  + F  Q++  ++Y H   ++HRDLKP NLLL+ + ++KI DF
Sbjct: 97  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADF 156
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           GL+   ++  F+     +  Y APE++         +DVWS G I   ++ RR       
Sbjct: 157 GLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR------- 209
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                         P D +   V  ++    +  LP+            + P A  L+ R
Sbjct: 210 -------------LPFDDESIPVLFKNISNGVYTLPK-----------FLSPGAAGLIKR 245
Query: 183 MLTFDPMKRITVDEAL 198
           ML  +P+ RI++ E +
Sbjct: 246 MLIVNPLNRISIHEIM 261

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 99  ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 159 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 216
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 217 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 249
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 250 FIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+                T A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTK------------QETLANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+                T A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTK------------QETLANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+     +            A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTKQETL------------ANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPAFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+                T A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTK------------QETLANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+    +   L  +     D D  F                        F H   LA D 
Sbjct: 220 GDT---KQETLANITSVSYDFDEEF------------------------FSHTSELAKDF 252
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           + ++L  +  KR+T+ EAL HP++ 
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 60  CDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA      NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 160 IDFGLAHKIDFGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G+                T A++  V  E    Y               F +   LA D
Sbjct: 218 LGDTK------------QETLANVSAVNYEFEDEY---------------FSNTSALAKD 250
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP KR+T+ ++L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+    +   L  +     D D  F                        F H   LA D 
Sbjct: 220 GDT---KQETLANITSVSYDFDEEF------------------------FSHTSELAKDF 252
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           + ++L  +  KR+T+ EAL HP++ 
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+    +   L  +     D D  F                        F H   LA D 
Sbjct: 220 GDT---KQETLANITSVSYDFDEEF------------------------FSHTSELAKDF 252
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           + ++L  +  KR+T+ EAL HP++ 
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 29/198 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +TE   T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 167 ETTSHNSLTEPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 221
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 222 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 261
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 262 TEPTQRMTITEFMNHPWI 279

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I +     E      + Q+L G+ Y+H  N++HRD+KP N+LL   N+  ++KI 
Sbjct: 132 ELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+   S++  + + + T +Y APE+L     Y    DVWS G I   L+   P F G
Sbjct: 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGG 249
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                             D D+           I+++ +         + ++   A +L+
Sbjct: 250 ----------------QNDQDI-----------IKKVEKGKYYFDFNDWKNISDEAKELI 282
Query: 181 DRMLTFDPMKRITVDEALAHPYLAR 205
             MLT+D  KR T +EAL   ++ +
Sbjct: 283 KLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 37/207 (17%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL---LNANCDLKIC 60
           +L+  I      +E      ++Q+L  +KY+H   ++HRDLKP NLL   L+ +  + I 
Sbjct: 102 ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFP 119
           DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I ++ L    P + 
Sbjct: 162 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 220
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRN--EDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
            ND     +L  ++L    + D  +  +  + AK +IR L +                  
Sbjct: 221 END----AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEK----------------- 259
Query: 178 DLVDRMLTFDPMKRITVDEALAHPYLA 204
                    DP KR T ++AL HP++A
Sbjct: 260 ---------DPEKRFTCEQALQHPWIA 277

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 33/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL---LNANCDLKIC 60
           +L+  I      +E      ++Q+L  +KY+H   ++HRDLKP NLL   L+ +  + I 
Sbjct: 102 ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFP 119
           DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I ++ L    P + 
Sbjct: 162 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 220
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            ND     +L  ++L    + D                        +  +  +   A D 
Sbjct: 221 END----AKLFEQILKAEYEFD------------------------SPYWDDISDSAKDF 252
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           +  ++  DP KR T ++AL HP++A
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 33/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL---LNANCDLKIC 60
           +L+  I      +E      ++Q+L  +KY+H   ++HRDLKP NLL   L+ +  + I 
Sbjct: 102 ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFP 119
           DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I ++ L    P + 
Sbjct: 162 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 220
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            ND     +L  ++L    + D  +                        +  +   A D 
Sbjct: 221 END----AKLFEQILKAEYEFDSPY------------------------WDDISDSAKDF 252
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           +  ++  DP KR T ++AL HP++A
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 75/136 (55%), Gaps = 3/136 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L  GL ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 116 DLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 175
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L++   ++E     +  T  Y APE ++N   ++ + D WS G +  E++     F G D
Sbjct: 176 LSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKD 234
Query: 123 HVHQMRLLIEL-LGTP 137
               M L+++  LG P
Sbjct: 235 RKETMTLILKAKLGMP 250

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 33/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL---LNANCDLKIC 60
           +L+  I      +E      ++Q+L  +KY+H   ++HRDLKP NLL   L+ +  + I 
Sbjct: 102 ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFP 119
           DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I ++ L    P + 
Sbjct: 162 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 220
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            ND     +L  ++L    + D  +                        +  +   A D 
Sbjct: 221 END----AKLFEQILKAEYEFDSPY------------------------WDDISDSAKDF 252
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           +  ++  DP KR T ++AL HP++A
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 31/194 (15%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSEN 71
           +SE      + Q+L G+ Y+H  N++H DLKP N+LL++     D+KI DFG++R     
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
             + E + T  Y APE +LN    T A D+W++G I   L+     F G D         
Sbjct: 188 CELREIMGTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--------- 237
Query: 132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
                          N++    I Q+     +   + F  V  LA D +  +L  +P KR
Sbjct: 238 ---------------NQETYLNISQVNVDYSE---ETFSSVSQLATDFIQSLLVKNPEKR 279
Query: 192 ITVDEALAHPYLAR 205
            T +  L+H +L +
Sbjct: 280 PTAEICLSHSWLQQ 293

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 89/192 (46%), Gaps = 33/192 (17%)
Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENE 72
           SE    +++ Q+L  L+Y H  N+IHRD+KP  +LL +   +  +K+  FG+A    E+ 
Sbjct: 130 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 189
Query: 73  FMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
            +    V T  + APE++     Y   +DVW  G I   L++                 +
Sbjct: 190 LVAGGRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSG---------------CL 233
Query: 132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
              GT      G ++         +   +PRQ     + H+   A DLV RML  DP +R
Sbjct: 234 PFYGTKERLFEGIIKG--------KYKMNPRQ-----WSHISESAKDLVRRMLMLDPAER 280
Query: 192 ITVDEALAHPYL 203
           ITV EAL HP+L
Sbjct: 281 ITVYEALNHPWL 292

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 33/192 (17%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEF 73
            SE   ++F++Q++ G+ Y+HS  ++HRDL  SNLLL  N ++KI DFGLA      +E 
Sbjct: 109 FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
                 T  Y +PE+   S+ +    DVWS+GC+F  L+  RP                 
Sbjct: 169 HYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRP----------------- 210
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
              P D D   V+N   K  +         S+          A DL+ ++L  +P  R++
Sbjct: 211 ---PFDTDT--VKNTLNKVVLADYEMPSFLSIE---------AKDLIHQLLRRNPADRLS 256
Query: 194 VDEALAHPYLAR 205
           +   L HP+++R
Sbjct: 257 LSSVLDHPFMSR 268

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 123 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 182
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 183 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 237
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 238 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 277
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 278 TEPTQRMTITEFMNHPWI 295

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 75/136 (55%), Gaps = 3/136 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L   L ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L++ + ++E     +  T  Y APE ++N   +T + D WS G +  E++     F G D
Sbjct: 172 LSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
Query: 123 HVHQMRLLIEL-LGTP 137
               M ++++  LG P
Sbjct: 231 RKETMTMILKAKLGMP 246

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 89/192 (46%), Gaps = 33/192 (17%)
Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENE 72
           SE    +++ Q+L  L+Y H  N+IHRD+KP  +LL +   +  +K+  FG+A    E+ 
Sbjct: 128 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 73  FMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
            +    V T  + APE++     Y   +DVW  G I   L++                 +
Sbjct: 188 LVAGGRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSG---------------CL 231
Query: 132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
              GT      G ++         +   +PRQ     + H+   A DLV RML  DP +R
Sbjct: 232 PFYGTKERLFEGIIKG--------KYKMNPRQ-----WSHISESAKDLVRRMLMLDPAER 278
Query: 192 ITVDEALAHPYL 203
           ITV EAL HP+L
Sbjct: 279 ITVYEALNHPWL 290

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 30/196 (15%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           I S   L+EE        +L+ L Y+H+  VIHRD+K  ++LL  +  +K+ DFG     
Sbjct: 132 IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191
Query: 69  SENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           S++    + +V T ++ APE +++ S Y   +D+WS+G + +E+++  P +  +  V  M
Sbjct: 192 SKDVPKRKXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
           + L        D+    ++N                        V P+  D ++RML  D
Sbjct: 251 KRL-------RDSPPPKLKNSH---------------------KVSPVLRDFLERMLVRD 282
Query: 188 PMKRITVDEALAHPYL 203
           P +R T  E L HP+L
Sbjct: 283 PQERATAQELLDHPFL 298

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 113 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 172
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 173 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 227
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 228 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 267
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 268 TEPTQRMTITEFMNHPWI 285

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 114 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 173
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 174 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 228
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 229 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 268
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 269 TEPTQRMTITEFMNHPWI 286

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 115 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 174
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 175 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 229
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 230 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 269
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 270 TEPTQRMTITEFMNHPWI 287

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+    +   L  +     D D  F                        F     LA D 
Sbjct: 220 GDT---KQETLANITAVSYDFDEEF------------------------FSQTSELAKDF 252
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           + ++L  +  KR+T+ EAL HP++ 
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 108 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 167
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 168 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 222
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 223 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 262
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 263 TEPTQRMTITEFMNHPWI 280

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+    +   L  +     D D  F                        F     LA D 
Sbjct: 220 GDT---KQETLANITAVSYDFDEEF------------------------FSQTSELAKDF 252
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           + ++L  +  KR+T+ EAL HP++ 
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 75/136 (55%), Gaps = 3/136 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L   L ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 113 DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 172
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L++ + ++E     +  T  Y APE ++N   +T + D WS G +  E++     F G D
Sbjct: 173 LSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 231
Query: 123 HVHQMRLLIEL-LGTP 137
               M ++++  LG P
Sbjct: 232 RKETMTMILKAKLGMP 247

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 267
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 268 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 307
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 308 TEPTQRMTITEFMNHPWI 325

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 223
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 224 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 263
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 264 TEPTQRMTITEFMNHPWI 281

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 159 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 218
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 219 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 273
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 274 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 313
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 314 TEPTQRMTITEFMNHPWI 331

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 75/136 (55%), Gaps = 3/136 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L   L ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L++ + ++E     +  T  Y APE ++N   +T + D WS G +  E++     F G D
Sbjct: 172 LSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
Query: 123 HVHQMRLLIEL-LGTP 137
               M ++++  LG P
Sbjct: 231 RKETMTMILKAKLGMP 246

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 167 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 221
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 222 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 261
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 262 TEPTQRMTITEFMNHPWI 279

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 223
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 224 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 263
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 264 TEPTQRMTITEFMNHPWI 281

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 32/192 (16%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E +    L ++L+GL Y+HS   IHRD+K +N+LL+   D+K+ DFG+A   ++ +  
Sbjct: 113 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 172
Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
              +V T ++ APE++  S+ Y    D+WS+G   +EL    P  P +D +H MR+L   
Sbjct: 173 RNXFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLF-- 226
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
                                  +P++   +L     H  P   + V+  L  DP  R T
Sbjct: 227 ----------------------LIPKNSPPTLEG--QHSKPFK-EFVEACLNKDPRFRPT 261
Query: 194 VDEALAHPYLAR 205
             E L H ++ R
Sbjct: 262 AKELLKHKFITR 273

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+    +   L  +     D D  F                        F     LA D 
Sbjct: 220 GDT---KQETLANITAVSYDFDEEF------------------------FSQTSELAKDF 252
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           + ++L  +  KR+T+ EAL HP++ 
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 96  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 155
Query: 64  LAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 156 LCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 214
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 215 HERLFELIL 223

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 32/197 (16%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-----NANCDLKICDFGLARP-T 68
            SE    + L+ + + ++Y+HS  V+HRDLKPSN+L      N  C L+ICDFG A+   
Sbjct: 118 FSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLR 176
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
           +EN  +     T  + APE +L    Y    D+WS+G +   ++     F          
Sbjct: 177 AENGLLMTPCYTANFVAPE-VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANG------- 228
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
                   P+D     +    + ++               +  V   A DLV +ML  DP
Sbjct: 229 --------PSDTPEEILTRIGSGKFTLS---------GGNWNTVSETAKDLVSKMLHVDP 271
Query: 189 MKRITVDEALAHPYLAR 205
            +R+T  + L HP++ +
Sbjct: 272 HQRLTAKQVLQHPWVTQ 288

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 64  LARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 151 LCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 210 HERLFELIL 218

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 94  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 153
Query: 64  LAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 154 LCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 212
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 213 HERLFELIL 221

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 64  LAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 151 LCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 210 HERLFELIL 218

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 64  LAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 151 LCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 210 HERLFELIL 218

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 64  LAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 151 LCKEGISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 210 HERLFELIL 218

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 32/197 (16%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-----NANCDLKICDFGLARP-T 68
            SE    + L+ + + ++Y+HS  V+HRDLKPSN+L      N  C L+ICDFG A+   
Sbjct: 118 FSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLR 176
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
           +EN  +     T  + APE +L    Y    D+WS+G +   ++     F          
Sbjct: 177 AENGLLMTPCYTANFVAPE-VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANG------- 228
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
                   P+D     +    + ++               +  V   A DLV +ML  DP
Sbjct: 229 --------PSDTPEEILTRIGSGKFTLS---------GGNWNTVSETAKDLVSKMLHVDP 271
Query: 189 MKRITVDEALAHPYLAR 205
            +R+T  + L HP++ +
Sbjct: 272 HQRLTAKQVLQHPWVTQ 288

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 2/129 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 64  LAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           L +   S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   D
Sbjct: 151 LCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 123 HVHQMRLLI 131
           H     L++
Sbjct: 210 HERLFELIL 218

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 68/108 (62%), Gaps = 5/108 (4%)
Query: 24  LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-TEYVVTRW 82
           L ++L+GL Y+HS   IHRD+K +N+LL+   D+K+ DFG+A   ++ +     +V T +
Sbjct: 126 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 185
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
           + APE++  S+ Y +  D+WS+G   +EL    P  P +D +H MR+L
Sbjct: 186 WMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVL 229

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 37/223 (16%)
Query: 1   MDTDL----YQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANC 55
           MDT L     Q+I   Q++ E+        +++ L+++HS  +VIHRD+KPSN+L+NA  
Sbjct: 132 MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG 191
Query: 56  DLKICDFGLARPTSENEFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMELM 112
            +K+CDFG++    ++   T     + Y APE +   LN   Y+   D+WS+G   +EL 
Sbjct: 192 QVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 251
Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV 172
             R  FP +      + L +++  P+                   PQ P    +  F   
Sbjct: 252 ILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPADKFSAEF--- 287
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVC 215
               +D   + L  +  +R T  E + HP+   LH+     V 
Sbjct: 288 ----VDFTSQCLKKNSKERPTYPELMQHPFFT-LHESKGTDVA 325

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN--CDLKICDFGL 64
           +I   +  +SE     ++ Q   GLK++H  +++H D+KP N++        +KI DFGL
Sbjct: 138 RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
           A   + +E +     T  + APE++ +        D+W++G +   L++    F G D  
Sbjct: 198 ATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD- 255
Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
                 +E L      D  F  +EDA                  F  V P A D +  +L
Sbjct: 256 ------LETLQNVKRCDWEF--DEDA------------------FSSVSPEAKDFIKNLL 289
Query: 185 TFDPMKRITVDEALAHPYLARLH 207
             +P KR+TV +AL HP+L   H
Sbjct: 290 QKEPRKRLTVHDALEHPWLKGDH 312

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 31/202 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   +    Q+L  + Y H   V+HRDLKP N+LL+A+ + KI DFG
Sbjct: 97  ELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 156
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+   S+ EF+ +   +  Y APE++         +D+WS G I   L+     F  ++H
Sbjct: 157 LSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DEH 215
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           V  +                F +      YI   P++  +S+A +  H           M
Sbjct: 216 VPTL----------------FKKIRGGVFYI---PEYLNRSVATLLMH-----------M 245
Query: 184 LTFDPMKRITVDEALAHPYLAR 205
           L  DP+KR T+ +   H +  +
Sbjct: 246 LQVDPLKRATIKDIREHEWFKQ 267

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 32/195 (16%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCD-LKICDFGLARP-TS 69
            SE      L+ + + ++Y+H+  V+HRDLKPSN+L    + N + ++ICDFG A+   +
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC-IFMELMNRRPLFPGNDHVHQMR 128
           EN  +     T  + APE +L    Y AA D+WS+G  ++  L    P   G D   +  
Sbjct: 173 ENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE-- 229
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
              E+L     A +G  +   +  Y               +  V   A DLV +ML  DP
Sbjct: 230 ---EIL-----ARIGSGKFSLSGGY---------------WNSVSDTAKDLVSKMLHVDP 266
Query: 189 MKRITVDEALAHPYL 203
            +R+T    L HP++
Sbjct: 267 HQRLTAALVLRHPWI 281

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 34/197 (17%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSEN 71
           + LSE+  +++   L++G++Y+H   +IHRD+KPSNLL+  +  +KI DFG++      +
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTA--AIDVWSVGC-IFMELMNRRPLFPGNDHVHQMR 128
             ++  V T  + APE L  +    +  A+DVW++G  ++  +  + P           +
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
           +  + L  P   D+     ED K                          DL+ RML  +P
Sbjct: 252 IKSQALEFPDQPDIA----EDLK--------------------------DLITRMLDKNP 281
Query: 189 MKRITVDEALAHPYLAR 205
             RI V E   HP++ R
Sbjct: 282 ESRIVVPEIKLHPWVTR 298

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 93/175 (53%), Gaps = 25/175 (14%)
Query: 5   LYQIIRSNQSLSEEHCQYF--LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           LY +I S ++L+++  +Y+    Q+L  L YIHS  +IHRDLKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 63  GLAR----------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
           GLA+                P S +  +T  + T  Y A E+L  +  Y   ID++S+G 
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDN-LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 107 IFMELMNRRPLFPGNDHVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQLPQH 160
           IF E++   P   G + V+ ++ L  + +  P D D   ++ E  K+ IR L  H
Sbjct: 220 IFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE--KKIIRLLIDH 270

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 89  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 148
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 93/175 (53%), Gaps = 25/175 (14%)
Query: 5   LYQIIRSNQSLSEEHCQYF--LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           LY +I S ++L+++  +Y+    Q+L  L YIHS  +IHRDLKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 63  GLAR----------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
           GLA+                P S +  +T  + T  Y A E+L  +  Y   ID++S+G 
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDN-LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 107 IFMELMNRRPLFPGNDHVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQLPQH 160
           IF E++   P   G + V+ ++ L  + +  P D D   ++ E  K+ IR L  H
Sbjct: 220 IFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE--KKIIRLLIDH 270

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 70/117 (59%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++  + + EE        +LRGL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 101 LDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG 160
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y APE  L  + Y+   D+WS+G   +EL + R P+ P
Sbjct: 161 VSGQLIDS-MANSFVGTRSYMAPE-RLQGTHYSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 31/202 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   +    Q+L  + Y H   V+HRDLKP N+LL+A+ + KI DFG
Sbjct: 97  ELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 156
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+   S+ EF+     +  Y APE++         +D+WS G I   L+     F  ++H
Sbjct: 157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DEH 215
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           V  +                F +      YI   P++  +S+A +  H           M
Sbjct: 216 VPTL----------------FKKIRGGVFYI---PEYLNRSVATLLMH-----------M 245
Query: 184 LTFDPMKRITVDEALAHPYLAR 205
           L  DP+KR T+ +   H +  +
Sbjct: 246 LQVDPLKRATIKDIREHEWFKQ 267

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 3/112 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 64  LA---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   R  +    + +   T  Y APELL     +   +DVWS G +   ++
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +LR L Y+H+  VIHRD+K  ++LL ++  +K+ DFG  A+ 
Sbjct: 132 IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 191
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE +++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 192 SKEVPKRKXLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 250
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFD 187
           R + + L  P   DL                 H   S+ + F          +D ML  +
Sbjct: 251 RRIRDSL-PPRVKDL-----------------HKVSSVLRGF----------LDLMLVRE 282
Query: 188 PMKRITVDEALAHPYLARLHDEADEPVCPEPF 219
           P +R T  E L HP+L      A  P C  P 
Sbjct: 283 PSQRATAQELLGHPFLKL----AGPPSCIVPL 310

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 29/200 (14%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E         +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE +L    Y  + D WS+G I   L+   P F  N     
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNH---- 267
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 268 ----------------GLAISPGXKTRIRXGQYEFPNPEWSEVSEEVK----XLIRNLLK 307
Query: 186 FDPMKRITVDEALAHPYLAR 205
            +P +R T+ E   HP++ +
Sbjct: 308 TEPTQRXTITEFXNHPWIXQ 327

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     TE   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRR---TELCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 211 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 238
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 105/226 (46%), Gaps = 36/226 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +E   Q ++ +++  L+++H   +I+RD+K  N+LL++N  + + DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 64  LARP--TSENEFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           L++     E E   ++  T  Y AP+++    S +  A+D WS+G +  EL+     F  
Sbjct: 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +   +                    + E ++R ++  P +P++  A        LA DL+
Sbjct: 265 DGEKNS-------------------QAEISRRILKSEPPYPQEMSA--------LAKDLI 297
Query: 181 DRMLTFDPMKRIT-----VDEALAHPYLARLH-DEADEPVCPEPFS 220
            R+L  DP KR+       DE   H +  +++ D+      P PF 
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFK 343

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 32/199 (16%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 101 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T++N   T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 161 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN----- 213
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH--PRQSLAQVFPHVHPLAIDLVDRML 184
                           G   +   KR IR L Q+  P    ++V       A  L+  +L
Sbjct: 214 ---------------TGQAISPGMKRRIR-LGQYGFPNPEWSEVSED----AKQLIRLLL 253
Query: 185 TFDPMKRITVDEALAHPYL 203
             DP +R+T+ + + HP++
Sbjct: 254 KTDPTERLTITQFMNHPWI 272

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 32/199 (16%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T++N   T    T +Y APE +L    Y  + D+WS+G I   L+   P F  N     
Sbjct: 180 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN----- 232
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH--PRQSLAQVFPHVHPLAIDLVDRML 184
                           G   +   KR IR L Q+  P    ++V       A  L+  +L
Sbjct: 233 ---------------TGQAISPGMKRRIR-LGQYGFPNPEWSEVSED----AKQLIRLLL 272
Query: 185 TFDPMKRITVDEALAHPYL 203
             DP +R+T+ + + HP++
Sbjct: 273 KTDPTERLTITQFMNHPWI 291

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +L++ I +    SE+  ++F  QL+ G+ Y H+  V HRDLK  N LL+ +    LKICD
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 160
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +      V T  Y APE+LL         DVWS G                
Sbjct: 161 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------- 204
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP---HVHPLAID 178
                + L + L+G        F   E+ K + + +  H   ++    P   H+ P    
Sbjct: 205 -----VTLYVMLVGA-----YPFEDPEEPKNFRKTI--HRILNVQYAIPDYVHISPECRH 252
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLAR 205
           L+ R+   DP KRI++ E   H +  +
Sbjct: 253 LISRIFVADPAKRISIPEIRNHEWFLK 279

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +L++ I +    SE+  ++F  QL+ G+ Y H+  V HRDLK  N LL+ +    LKICD
Sbjct: 100 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 159
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +      V T  Y APE+LL         DVWS G                
Sbjct: 160 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------- 203
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP---HVHPLAID 178
                + L + L+G        F   E+ K + + +  H   ++    P   H+ P    
Sbjct: 204 -----VTLYVMLVGA-----YPFEDPEEPKNFRKTI--HRILNVQYAIPDYVHISPECRH 251
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLAR 205
           L+ R+   DP KRI++ E   H +  +
Sbjct: 252 LISRIFVADPAKRISIPEIRNHEWFLK 278

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 3/106 (2%)
Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLA-RPTSENEF 73
           +E+   ++  Q+L GLKY+H   ++HRD+K  N+L+N     LKI DFG + R    N  
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 74  MTEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
              +  T  Y APE++      Y  A D+WS+GC  +E+   +P F
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 32/199 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 238 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 298 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 356
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 357 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 387
Query: 187 DPMKRITVDEALAHPYLAR 205
           DP +R T  E L HP+LA+
Sbjct: 388 DPAQRATAAELLKHPFLAK 406

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      +E+     + Q+L  + Y+H   ++HRDLKP NLL    +    + I 
Sbjct: 106 ELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMIS 165
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFP 119
           DFGL++   + + M+    T  Y APE+L     Y+ A+D WS+G I ++ L    P + 
Sbjct: 166 DFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 224
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            ND     +L  ++L    + D  +                        +  +   A D 
Sbjct: 225 ENDS----KLFEQILKAEYEFDSPY------------------------WDDISDSAKDF 256
Query: 180 VDRMLTFDPMKRITVDEALAHPYLA 204
           +  ++  DP KR T ++A  HP++A
Sbjct: 257 IRNLMEKDPNKRYTCEQAARHPWIA 281

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPT 68
            ++LSE +    + Q++  L Y HS +V+H+DLKP N+L    + +  +KI DFGLA   
Sbjct: 118 GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
             +E  T    T  Y APE+     D T   D+WS G +   L+     F G        
Sbjct: 178 KSDEHSTNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGT------- 228
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
                                +   ++Q   +   + A     + P A+DL+ +MLT DP
Sbjct: 229 ---------------------SLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDP 267
Query: 189 MKRITVDEALAHPYLAR 205
            +R +  + L H +  +
Sbjct: 268 ERRPSAAQVLHHEWFKQ 284

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 69/117 (58%), Gaps = 5/117 (4%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DFG+A   ++ +  
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y +  D+WS+G   +EL       P +  +H M++L
Sbjct: 176 RNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVL 228

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 32/199 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 161 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 221 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 279
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 280 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 310
Query: 187 DPMKRITVDEALAHPYLAR 205
           DP +R T  E L HP+LA+
Sbjct: 311 DPAQRATAAELLKHPFLAK 329

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+E+    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +K+
Sbjct: 94  ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 153
Query: 60  CDFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFG+A +  + NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 154 IDFGIAHKIEAGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 211
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G     +   L  +     D D                         + F +   LA D
Sbjct: 212 LGET---KQETLTNISAVNYDFD------------------------EEYFSNTSELAKD 244
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP +R+T+ ++L H ++
Sbjct: 245 FIRRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 32/199 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 118 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 177
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 178 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 236
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 237 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 267
Query: 187 DPMKRITVDEALAHPYLAR 205
           DP +R T  E L HP+LA+
Sbjct: 268 DPAQRATAAELLKHPFLAK 286

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 32/195 (16%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCD-LKICDFGLARP-TS 69
            SE      L+ + + ++Y+H+  V+HRDLKPSN+L    + N + ++ICDFG A+   +
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC-IFMELMNRRPLFPGNDHVHQMR 128
           EN  +     T  + APE +L    Y AA D+WS+G  ++  L    P   G D   +  
Sbjct: 173 ENGLLXTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPE-- 229
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
              E+L     A +G  +   +  Y               +  V   A DLV + L  DP
Sbjct: 230 ---EIL-----ARIGSGKFSLSGGY---------------WNSVSDTAKDLVSKXLHVDP 266
Query: 189 MKRITVDEALAHPYL 203
            +R+T    L HP++
Sbjct: 267 HQRLTAALVLRHPWI 281

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 60/106 (56%), Gaps = 3/106 (2%)
Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDFGLARPTSENEFM 74
           +E+   ++  Q+L GLKY+H   ++HRD+K  N+L+N     LKI DFG ++  +     
Sbjct: 106 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 165
Query: 75  TE-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           TE +  T  Y APE++      Y  A D+WS+GC  +E+   +P F
Sbjct: 166 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 69/117 (58%), Gaps = 5/117 (4%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DFG+A   ++ +  
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 180
Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y +  D+WS+G   +EL       P +  +H M++L
Sbjct: 181 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVL 233

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 32/199 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 116 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 175
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 176 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 234
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 235 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 265
Query: 187 DPMKRITVDEALAHPYLAR 205
           DP +R T  E L HP+LA+
Sbjct: 266 DPAQRATAAELLKHPFLAK 284

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 96  ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 155
Query: 63  GLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 156 GLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 214
Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 215 DHEKLFELIL 224

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 32/199 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 111 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 170
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 171 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 229
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 230 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 260
Query: 187 DPMKRITVDEALAHPYLAR 205
           DP +R T  E L HP+LA+
Sbjct: 261 DPAQRATAAELLKHPFLAK 279

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 32/203 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      +E+     + Q+L  +KY+H   ++HRDLKP NLL      N  + I 
Sbjct: 92  ELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMIT 151
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL++   +N  M+    T  Y APE+L     Y+ A+D WS+G I   L+   P F  
Sbjct: 152 DFGLSK-MEQNGIMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPF-- 207
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                                      E   +   ++ +   +  +  +  +   A D +
Sbjct: 208 -------------------------YEETESKLFEKIKEGYYEFESPFWDDISESAKDFI 242
Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
             +L  DP +R T ++AL+HP++
Sbjct: 243 CHLLEKDPNERYTCEKALSHPWI 265

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 32/199 (16%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           I ++  ++EE        +L+ L  +H+  VIHRD+K  ++LL  +  +K+ DFG  A+ 
Sbjct: 107 IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166
Query: 68  TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQM 127
           + E       V T ++ APE L++   Y   +D+WS+G + +E+++  P +     +  M
Sbjct: 167 SKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225
Query: 128 RLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPLAIDLVDRMLTF 186
           +++ +                        LP  PR ++L +V P +       +DR+L  
Sbjct: 226 KMIRD-----------------------NLP--PRLKNLHKVSPSLK----GFLDRLLVR 256
Query: 187 DPMKRITVDEALAHPYLAR 205
           DP +R T  E L HP+LA+
Sbjct: 257 DPAQRATAAELLKHPFLAK 275

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 95  ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 154
Query: 63  GLAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 155 GLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 213
Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 214 DHEKLFELIL 223

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 69/117 (58%), Gaps = 5/117 (4%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DFG+A   ++ +  
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y +  D+WS+G   +EL       P +  +H M++L
Sbjct: 161 RNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVL 213

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 69/117 (58%), Gaps = 5/117 (4%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DFG+A   ++ +  
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 75  -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
              +V T ++ APE++  S+ Y +  D+WS+G   +EL       P +  +H M++L
Sbjct: 161 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVL 213

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 94  ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 153
Query: 63  GLAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 154 GLCKEGIKDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 212
Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 213 DHEKLFELIL 222

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 37/223 (16%)
Query: 1   MDTDL----YQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANC 55
           MDT L     Q+I   Q++ E+        +++ L+++HS  +VIHRD+KPSN+L+NA  
Sbjct: 88  MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG 147
Query: 56  DLKICDFGLARPTSENEFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMELM 112
            +K+CDFG++    ++         + Y APE +   LN   Y+   D+WS+G   +EL 
Sbjct: 148 QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 207
Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV 172
             R  FP +      + L +++  P+                   PQ P    +  F   
Sbjct: 208 ILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPADKFSAEF--- 243
Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVC 215
               +D   + L  +  +R T  E + HP+   LH+     V 
Sbjct: 244 ----VDFTSQCLKKNSKERPTYPELMQHPFFT-LHESKGTDVA 281

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +K+ DFG
Sbjct: 127 DMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           D++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +K+ DFG
Sbjct: 127 DMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 96/204 (47%), Gaps = 30/204 (14%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDF 62
            L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K+CDF
Sbjct: 109 SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 168
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFPGN 121
           G++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+  G+
Sbjct: 169 GVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGS 226
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
             +    LL  ++  P                    P+ P    +  F        D V+
Sbjct: 227 GSMAIFELLDYIVNEPP-------------------PKLPSGVFSLEFQ-------DFVN 260
Query: 182 RMLTFDPMKRITVDEALAHPYLAR 205
           + L  +P +R  + + + H ++ R
Sbjct: 261 KCLIKNPAERADLKQLMVHAFIKR 284

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 44/115 (38%), Positives = 63/115 (54%), Gaps = 7/115 (6%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLLNANCDLKICDFGL 64
           +  Q L EE     + QL   LK  H  +     V+HRDLKP+N+ L+   ++K+ DFGL
Sbjct: 103 KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162
Query: 65  ARPTSENE-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           AR  + +E F  E+V T +Y +PE  +N   Y    D+WS+GC+  EL    P F
Sbjct: 163 ARILNHDEDFAKEFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           ++Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG
Sbjct: 99  EVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158
Query: 64  LA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N
Sbjct: 159 WSVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLV 180
            +                        E  KR  R         +   FP  V   A DL+
Sbjct: 215 TY-----------------------QETYKRISR---------VEFTFPDFVTEGARDLI 242
Query: 181 DRMLTFDPMKRITVDEALAHPYLA 204
            R+L  +P +R  + E L HP++ 
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 237 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 296
Query: 63  GLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 297 GLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 355
Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 356 DHEKLFELIL 365

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 3/130 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 234 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293
Query: 63  GLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  R  F   
Sbjct: 294 GLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
Query: 122 DHVHQMRLLI 131
           DH     L++
Sbjct: 353 DHEKLFELIL 362

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T+   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRR---TDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 211 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 238
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 100 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 159
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T+   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 160 SVHAPSSRR---TDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 216 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 243
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWIT 266

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T+   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRR---TDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 211 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 238
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWIT 261

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 67/122 (54%), Gaps = 3/122 (2%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + I S+  LS +    F  Q+L G+K+ H   ++HRD+KP N+L+++N  LKI DFG+
Sbjct: 98  LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI 157
Query: 65  ARPTSENEFM-TEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           A+  SE     T +V+ T  Y +PE     +      D++S+G +  E++   P F G  
Sbjct: 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGET 216
Query: 123 HV 124
            V
Sbjct: 217 AV 218

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 121 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 180
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 181 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 237 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 264
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 265 RLLKHNPSQRPMLREVLEHPWIT 287

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 96  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T+   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 156 SVHAPSSRR---TDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 212 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 239
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWIT 262

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEF 73
           L+E   Q    Q L  L Y+H   +IHRDLK  N+L   + D+K+ DFG+ A+ T   + 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 191
Query: 74  MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL 129
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+     + P +  ++ MR+
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 130 LIEL-------LGTPTDADLGFV--------RNEDAKRYIRQLPQHP 161
           L+++       L  P+     F         +N DA+    QL QHP
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 295

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEF 73
           L+E   Q    Q L  L Y+H   +IHRDLK  N+L   + D+K+ DFG+ A+ T   + 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 74  MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL 129
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+     + P +  ++ MR+
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 130 LIEL-------LGTPTDADLGFV--------RNEDAKRYIRQLPQHP 161
           L+++       L  P+     F         +N DA+    QL QHP
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 295

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 112 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 171
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 172 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 227
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 228 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 255
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 256 RLLKHNPSQRPMLREVLEHPWIT 278

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 158 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 214 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 241
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           ++Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG
Sbjct: 99  EVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158
Query: 64  LA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N
Sbjct: 159 WSVHAPSSRRXXLXG---TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLV 180
            +                        E  KR  R         +   FP  V   A DL+
Sbjct: 215 TY-----------------------QETYKRISR---------VEFTFPDFVTEGARDLI 242
Query: 181 DRMLTFDPMKRITVDEALAHPYLA 204
            R+L  +P +R  + E L HP++ 
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 211 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 238
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 42/206 (20%)
Query: 5   LYQIIRSNQSLS---EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           L  + R  Q LS   E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI D
Sbjct: 97  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 156
Query: 62  FGLA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           FG +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F 
Sbjct: 157 FGWSVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAID 178
            N +                        E  KR  R         +   FP  V   A D
Sbjct: 213 ANTY-----------------------QETYKRISR---------VEFTFPDFVTEGARD 240
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLA 204
           L+ R+L  +P +R  + E L HP++ 
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+E+    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +K+
Sbjct: 101 ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 160
Query: 60  CDFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFG+A +  + NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 161 IDFGIAHKIEAGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G     +   L  +     D D                         + F +   LA D
Sbjct: 219 LGET---KQETLTNISAVNYDFD------------------------EEYFSNTSELAKD 251
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP +R+ + ++L H ++
Sbjct: 252 FIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 90/175 (51%), Gaps = 25/175 (14%)
Query: 5   LYQIIRSNQSLSEEHCQYF--LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           LY +I S ++L+++  +Y+    Q+L  L YIHS  +IHR+LKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDF 160
Query: 63  GLAR----------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 106
           GLA+                P S +  +T  + T  Y A E+L  +  Y   ID +S+G 
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDN-LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGI 219
Query: 107 IFMELMNRRPLFPGNDHVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQLPQH 160
           IF E +   P   G + V+ ++ L  + +  P D D    + E  K+ IR L  H
Sbjct: 220 IFFEXI--YPFSTGXERVNILKKLRSVSIEFPPDFDDNKXKVE--KKIIRLLIDH 270

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 32/204 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  I      SE      + Q+L  + Y+H   ++HRDLKP NLL      +  LKI 
Sbjct: 134 ELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIA 193
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFP 119
           DFGL++       M     T  Y APE+L   + Y   +D+WSVG I ++ L    P + 
Sbjct: 194 DFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYD 252
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                   R ++       + +  F+            P     SL          A DL
Sbjct: 253 ERGDQFMFRRIL-------NCEYYFIS-----------PWWDEVSLN---------AKDL 285
Query: 180 VDRMLTFDPMKRITVDEALAHPYL 203
           V +++  DP KR+T  +AL HP++
Sbjct: 286 VRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEF 73
           L+E   Q    Q L  L Y+H   +IHRDLK  N+L   + D+K+ DFG+ A+ T   + 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 74  MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRL 129
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+     + P +  ++ MR+
Sbjct: 192 RDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 130 LIEL-------LGTPTDADLGFV--------RNEDAKRYIRQLPQHP 161
           L+++       L  P+     F         +N DA+    QL QHP
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 295

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 42/206 (20%)
Query: 5   LYQIIRSNQSLS---EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           L  + R  Q LS   E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI D
Sbjct: 96  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 155
Query: 62  FGLA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           FG +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F 
Sbjct: 156 FGWSVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAID 178
            N +                        E  KR  R         +   FP  V   A D
Sbjct: 212 ANTY-----------------------QETYKRISR---------VEFTFPDFVTEGARD 239
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLA 204
           L+ R+L  +P +R  + E L HP++ 
Sbjct: 240 LISRLLKHNPSQRPMLREVLEHPWIT 265

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 158 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 214 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 241
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRR---TXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 211 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 238
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 65/115 (56%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           LA+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 LAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 94  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 153
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 154 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 209
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 210 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 237
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 238 RLLKHNPSQRPMLREVLEHPWIT 260

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 96  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 156 SCHAPSSRR---TTLSGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 212 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 239
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWIT 262

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +L++ I +    SE+  ++F  QL+ G+ Y H+  V HRDLK  N LL+ +    LKIC 
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICA 160
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +    + V T  Y APE+LL         DVWS G                
Sbjct: 161 FGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------- 204
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP---HVHPLAID 178
                + L + L+G        F   E+ K + + +  H   ++    P   H+ P    
Sbjct: 205 -----VTLYVMLVGA-----YPFEDPEEPKNFRKTI--HRILNVQYAIPDYVHISPECRH 252
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLAR 205
           L+ R+   DP KRI++ E   H +  +
Sbjct: 253 LISRIFVADPAKRISIPEIRNHEWFLK 279

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 92  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 151
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 152 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 207
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 208 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 235
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 236 RLLKHNPSQRPMLREVLEHPWIT 258

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +K+ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSN-LLLNANC---DLKI 59
           +L+  +   +SL+E+    FL Q+L G+ Y+HS  + H DLKP N +LL+ N     +K+
Sbjct: 115 ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 174
Query: 60  CDFGLA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFG+A +  + NEF   +  T  + APE ++N        D+WS+G I   L++    F
Sbjct: 175 IDFGIAHKIEAGNEFKNIF-GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPF 232
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G     +   L  +     D D                         + F +   LA D
Sbjct: 233 LGET---KQETLTNISAVNYDFD------------------------EEYFSNTSELAKD 265
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
            + R+L  DP +R+ + ++L H ++
Sbjct: 266 FIRRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 100 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 159
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE  +    +   +D+WS+G +  E +  +P F  N 
Sbjct: 160 SVHAPSSRR---TTLCGTLDYLPPE-XIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANT 215
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 216 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 243
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 244 RLLKHNPSQRPXLREVLEHPWIT 266

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 42/205 (20%)
Query: 5   LYQIIRSNQSLS---EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           L  + R  Q LS   E+    ++ +L   L Y HS  VIHRD+KP NLLL +N +LKI D
Sbjct: 96  LGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIAD 155
Query: 62  FGLA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           FG +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +   P  P
Sbjct: 156 FGWSVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGMP--P 209
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAID 178
              H +Q                     E  +R  R         +   FP  V   A D
Sbjct: 210 FEAHTYQ---------------------ETYRRISR---------VEFTFPDFVTEGARD 239
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           L+ R+L  +  +R+T+ E L HP++
Sbjct: 240 LISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +K+ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 121 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 180
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S  +   +   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 181 SVHAPSSRRD---DLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 237 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 264
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 265 RLLKHNPSQRPMLREVLEHPWIT 287

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 30/179 (16%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +E V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWM 183
Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF 144
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 184 APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTPE------ 235
Query: 145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                         Q+P + L+ +F        D ++R L  D  KR +  E L H +L
Sbjct: 236 -------------LQNP-EKLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 33/207 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +LY+ I +    SE+  ++F  QLL G+ Y HS  + HRDLK  N LL+ +    LKICD
Sbjct: 102 ELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD 161
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +      V T  Y APE+LL         DVWS G                
Sbjct: 162 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCG---------------- 205
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP---HVHPLAID 178
                + L + L+G        F   E+ + Y + + +    S+    P    + P    
Sbjct: 206 -----VTLYVMLVGA-----YPFEDPEEPRDYRKTIQRI--LSVKYSIPDDIRISPECCH 253
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLAR 205
           L+ R+   DP  RI++ E   H +  +
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWFLK 280

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +L++ I +    SE+  ++F  QL+ G+ Y H+  V HRDLK  N LL+ +    LKIC 
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICA 160
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +      V T  Y APE+LL         DVWS G                
Sbjct: 161 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------- 204
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP---HVHPLAID 178
                + L + L+G        F   E+ K + + +  H   ++    P   H+ P    
Sbjct: 205 -----VTLYVMLVGA-----YPFEDPEEPKNFRKTI--HRILNVQYAIPDYVHISPECRH 252
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLAR 205
           L+ R+   DP KRI++ E   H +  +
Sbjct: 253 LISRIFVADPAKRISIPEIRNHEWFLK 279

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 96  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S  + +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 156 SVHAPSSRRDTL---CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 212 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 239
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWIT 262

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 42/205 (20%)
Query: 5   LYQIIRSNQSLS---EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           L  + R  Q LS   E+    ++ +L   L Y HS  VIHRD+KP NLLL +N +LKI D
Sbjct: 96  LGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIAD 155
Query: 62  FGLA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           FG +   P+S  + +     T  Y  PE ++    +   +D+WS+G +  E +   P  P
Sbjct: 156 FGWSVHAPSSRRDTLCG---TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGMP--P 209
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAID 178
              H +Q                     E  +R  R         +   FP  V   A D
Sbjct: 210 FEAHTYQ---------------------ETYRRISR---------VEFTFPDFVTEGARD 239
Query: 179 LVDRMLTFDPMKRITVDEALAHPYL 203
           L+ R+L  +  +R+T+ E L HP++
Sbjct: 240 LISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 31/198 (15%)
Query: 8   IIR-SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR 66
           IIR  N++L+E+     L   L+GL+Y+H    IHRD+K  N+LLN     K+ DFG+A 
Sbjct: 114 IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG 173
Query: 67  PTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
             ++       V+ T ++ APE ++    Y    D+WS+G   +E+   +P +     +H
Sbjct: 174 QLTDXMAKRNXVIGTPFWMAPE-VIQEIGYNCVADIWSLGITAIEMAEGKPPYA---DIH 229
Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
            MR +  +   PT+    F + E                 +  F        D V + L 
Sbjct: 230 PMRAIFMI---PTNPPPTFRKPE---------------LWSDNF-------TDFVKQCLV 264
Query: 186 FDPMKRITVDEALAHPYL 203
             P +R T  + L HP++
Sbjct: 265 KSPEQRATATQLLQHPFV 282

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRRXXLCG---TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 211 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 238
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 33/199 (16%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
              E    ++  ++  GL+ +H   +++RDLKP N+LL+ +  ++I D GLA    E + 
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
           +   V T  Y APE++ N   YT + D W++GC+  E++       G     Q +  I  
Sbjct: 342 IKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQSPFQQRKKKI-- 392
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI- 192
                       + E+ +R ++++P+   +  +       P A  L  ++L  DP +R+ 
Sbjct: 393 ------------KREEVERLVKEVPEEYSERFS-------PQARSLCSQLLCKDPAERLG 433
Query: 193 ----TVDEALAHPYLARLH 207
               +  E   HP   +L+
Sbjct: 434 CRGGSAREVKEHPLFKKLN 452

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S  +   +   T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 158 SVHAPSSRRD---DLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 214 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 241
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWIT 264

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 34/204 (16%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDF 62
            L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K+CDF
Sbjct: 93  SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 152
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFPGN 121
           G++     +E   E+V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P  P  
Sbjct: 153 GVSGQLI-DEMANEFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPP-- 208
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
                   + EL        L ++ NE         P+ P    +  F        D V+
Sbjct: 209 ------MAIFEL--------LDYIVNEPP-------PKLPSAVFSLEFQ-------DFVN 240
Query: 182 RMLTFDPMKRITVDEALAHPYLAR 205
           + L  +P +R  + + + H ++ R
Sbjct: 241 KCLIKNPAERADLKQLMVHAFIKR 264

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 97  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 156
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 157 SVHAPSSRRXXL---CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 213 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 240
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 241 RLLKHNPSQRPMLREVLEHPWIT 263

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 54/244 (22%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPT---- 68
           SLS +  + ++  L + LK IH   ++HRD+KPSN L N       + DFGLA+ T    
Sbjct: 113 SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172
Query: 69  -------------------------SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 103
                                    S  + +     T  +RAPE+L    + T AID+WS
Sbjct: 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232
Query: 104 VGCIFMELMNRR-PLFPGNDHVHQMRLLIELLGT-------PTDADLGFVRNEDAKRYIR 155
            G IF+ L++ R P +  +D +  +  ++ + G+        T         E   + +R
Sbjct: 233 AGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLR 292
Query: 156 QLPQHPR---QSLAQVFPHVHPLAIDL-------------VDRMLTFDPMKRITVDEALA 199
           +L +  R    S  ++   +   A +L             +D++L  +P  RIT +EAL 
Sbjct: 293 KLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352
Query: 200 HPYL 203
           HP+ 
Sbjct: 353 HPFF 356

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 90/191 (47%), Gaps = 33/191 (17%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           ++  ++  GL+ +H   +++RDLKP N+LL+ +  ++I D GLA    E + +   V T 
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD 141
            Y APE++ N   YT + D W++GC+  E++       G     Q +  I          
Sbjct: 350 GYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQSPFQQRKKKI---------- 392
Query: 142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDE 196
               + E+ +R ++++P+   +  +       P A  L  ++L  DP +R+     +  E
Sbjct: 393 ----KREEVERLVKEVPEEYSERFS-------PQARSLCSQLLCKDPAERLGCRGGSARE 441
Query: 197 ALAHPYLARLH 207
              HP   +L+
Sbjct: 442 VKEHPLFKKLN 452

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 157
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 158 SVHAPSSRRXXLCG---TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 214 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 241
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 42/206 (20%)
Query: 5   LYQIIRSNQSLS---EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           L  + R  Q LS   E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI D
Sbjct: 95  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 154
Query: 62  FGLA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           FG +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F 
Sbjct: 155 FGWSVHAPSSRRAALCG---TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAID 178
            N +                        E  KR  R         +   FP  V   A D
Sbjct: 211 ANTY-----------------------QETYKRISR---------VEFTFPDFVTEGARD 238
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLA 204
           L+ R+L  +P +R  + E L HP++ 
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 65/115 (56%), Gaps = 2/115 (1%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H  N+I+RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           A      +  T+ Y  T  + APELLL   +Y  ++D +++G    E++  R  F
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 65/115 (56%), Gaps = 2/115 (1%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H  N+I+RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           A      +  T+ Y  T  + APELLL   +Y  ++D +++G    E++  R  F
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 65/115 (56%), Gaps = 2/115 (1%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H  N+I+RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           A      +  T+ Y  T  + APELLL   +Y  ++D +++G    E++  R  F
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRRAALCG---TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 211 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 238
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKI 59
           +D    Q+I   Q++ E+        +++ L+++HS  +VIHRD+KPSN+L+NA   +K 
Sbjct: 119 LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKX 178
Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMELMNRRP 116
           CDFG++    ++         + Y APE +   LN   Y+   D+WS+G   +EL   R 
Sbjct: 179 CDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILR- 237
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
            FP +      + L +++  P+                   PQ P    +  F       
Sbjct: 238 -FPYDSWGTPFQQLKQVVEEPS-------------------PQLPADKFSAEF------- 270
Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHD 208
           +D   + L  +  +R T  E   HP+   LH+
Sbjct: 271 VDFTSQCLKKNSKERPTYPELXQHPFFT-LHE 301

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--AGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 65/115 (56%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           LA+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 LAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 65/115 (56%), Gaps = 2/115 (1%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H  N+I+RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           A      +  T+ Y  T  + APELLL   +Y  ++D +++G    E++  R  F
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI +FG 
Sbjct: 97  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW 156
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 157 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 213 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 240
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 241 RLLKHNPSQRPMLREVLEHPWIT 263

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICD 61
           +L++ I +    SE+  ++F  QL+ G+ Y H+  V HRDLK  N LL+ +    LKI D
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIAD 160
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +      V T  Y APE+LL         DVWS G                
Sbjct: 161 FGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCG---------------- 204
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP---HVHPLAID 178
                + L + L+G        F   E+ K + + +  H   ++    P   H+ P    
Sbjct: 205 -----VTLYVMLVGA-----YPFEDPEEPKNFRKTI--HRILNVQYAIPDYVHISPECRH 252
Query: 179 LVDRMLTFDPMKRITVDEALAHPYLAR 205
           L+ R+   DP KRI++ E   H +  +
Sbjct: 253 LISRIFVADPAKRISIPEIRNHEWFLK 279

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 4   DLYQIIRSNQSL---SEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLNANCD- 56
            LY ++   + L   +  H   +  Q  +G+ Y+HS     +IHRDLKP NLLL A    
Sbjct: 86  SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 145
Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           LKICDFG A        MT    +  + APE +   S+Y+   DV+S G I  E++ RR 
Sbjct: 146 LKICDFGTA--CDIQTHMTNNKGSAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRK 202
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
            F             + +G P    +  V N      I+ LP+ P +S            
Sbjct: 203 PF-------------DEIGGPAFRIMWAVHNGTRPPLIKNLPK-PIES------------ 236
Query: 177 IDLVDRMLTFDPMKRITVDEALA-HPYLARLHDEADEPV 214
             L+ R  + DP +R +++E +    +L R    ADEP+
Sbjct: 237 --LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 273

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI +FG 
Sbjct: 98  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW 157
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S     T    T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 158 SVHAPSSRR---TTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        E  KR  R         +   FP  V   A DL+ 
Sbjct: 214 Y-----------------------QETYKRISR---------VEFTFPDFVTEGARDLIS 241
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 148 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 208 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--XGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 28/205 (13%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 150
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+   R   P  D 
Sbjct: 151 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208
Query: 124 VHQMR---LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
               R    + EL        L ++ NE         P+ P    +  F        D V
Sbjct: 209 KEDSRPPMAIFEL--------LDYIVNEPP-------PKLPSGVFSLEFQ-------DFV 246
Query: 181 DRMLTFDPMKRITVDEALAHPYLAR 205
           ++ L  +P +R  + + + H ++ R
Sbjct: 247 NKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 113 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 172
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 173 FAKRVKGRTWTL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 4   DLYQIIRSNQSL---SEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLNANCD- 56
            LY ++   + L   +  H   +  Q  +G+ Y+HS     +IHRDLKP NLLL A    
Sbjct: 85  SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144
Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           LKICDFG A        MT    +  + APE +   S+Y+   DV+S G I  E++ RR 
Sbjct: 145 LKICDFGTA--CDIQTHMTNNKGSAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
            F             + +G P    +  V N      I+ LP+ P +S            
Sbjct: 202 PF-------------DEIGGPAFRIMWAVHNGTRPPLIKNLPK-PIES------------ 235
Query: 177 IDLVDRMLTFDPMKRITVDEALA-HPYLARLHDEADEPV 214
             L+ R  + DP +R +++E +    +L R    ADEP+
Sbjct: 236 --LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 14/157 (8%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+ ++R +Q       +++  ++   L+Y+HS ++I+RDLKP N+LL+ N  +KI DFG
Sbjct: 92  ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 151
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-NRRPLFPGND 122
            A+   +  +      T  Y APE ++++  Y  +ID WS G +  E++    P +  N 
Sbjct: 152 FAKYVPDVTYXL--CGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208
Query: 123 HVHQMRLLIELLGTPTDADLGF--VRNEDAKRYIRQL 157
                ++L        +A+L F    NED K  + +L
Sbjct: 209 MKTYEKIL--------NAELRFPPFFNEDVKDLLSRL 237

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWTL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 61/112 (54%), Gaps = 6/112 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+  G+ +I   N IHRDL+ +N+L++A+   KI DFGLAR   +NE+         
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 81  -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
            +W  APE  +N   +T   DVWS G + ME++   R  +PG  +   +R L
Sbjct: 349 IKW-TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 61/112 (54%), Gaps = 6/112 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+  G+ +I   N IHRDL+ +N+L++A+   KI DFGLAR   +NE+         
Sbjct: 116 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 175
Query: 81  -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
            +W  APE  +N   +T   DVWS G + ME++   R  +PG  +   +R L
Sbjct: 176 IKW-TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 148 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 208 FAKRVKGATWTL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 114 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFG 173
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 174 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 120 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 180 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 68/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 153 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 212
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 213 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 69/130 (53%), Gaps = 5/130 (3%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 105 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 164
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +     +  T E+  T  Y APE+LL    Y  ++D WS G +  E++  +  F G D
Sbjct: 165 MCKENMLGDAKTNEFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQD 223
Query: 123 H---VHQMRL 129
                H +R+
Sbjct: 224 EEELFHSIRM 233

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 88/179 (49%), Gaps = 30/179 (16%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWM 183
Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF 144
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 184 APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTPE------ 235
Query: 145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                         Q+P + L+ +F        D ++R L  D  KR +  E L H +L
Sbjct: 236 -------------LQNP-EKLSAIFR-------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/125 (36%), Positives = 65/125 (52%), Gaps = 11/125 (8%)
Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLLNAN 54
           DL  +I    +  Q L EE     + QL   LK  H  +     V+HRDLKP+N+ L+  
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152
Query: 55  CDLKICDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            ++K+ DFGLAR  + +  F   +V T +Y +PE  +N   Y    D+WS+GC+  EL  
Sbjct: 153 QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCA 211
Query: 114 RRPLF 118
             P F
Sbjct: 212 LMPPF 216

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 68/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 118 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 178 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 39/203 (19%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 95  VYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGW 154
Query: 65  A--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           +   P+S    +     T  Y  PE ++    +   +D+WS+G +  E +  +P F  N 
Sbjct: 155 SVHAPSSRRAALCG---TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVD 181
           +                        +  KR  R         +   FP  V   A DL+ 
Sbjct: 211 Y-----------------------QDTYKRISR---------VEFTFPDFVTEGARDLIS 238
Query: 182 RMLTFDPMKRITVDEALAHPYLA 204
           R+L  +P +R  + E L HP++ 
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 66/117 (56%), Gaps = 3/117 (2%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR 66
           Q+ R    + +  C ++L ++   L ++H   +I+RDLKP N++LN    +K+ DFGL +
Sbjct: 111 QLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 67  PTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +  +  +T  +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F G +
Sbjct: 170 ESIHDGTVTHXFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 66/117 (56%), Gaps = 3/117 (2%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR 66
           Q+ R    + +  C ++L ++   L ++H   +I+RDLKP N++LN    +K+ DFGL +
Sbjct: 111 QLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 67  PTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +  +  +T  +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F G +
Sbjct: 170 ESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/110 (37%), Positives = 54/110 (49%), Gaps = 5/110 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL---KICDFGLARPTSE 70
            L E   +  L  +   L+Y+H   +IHRDLKP N++L         KI D G A+   +
Sbjct: 118 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 177
Query: 71  NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
            E  TE+V T  Y APE LL    YT  +D WS G +  E +   RP  P
Sbjct: 178 GELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/110 (37%), Positives = 54/110 (49%), Gaps = 5/110 (4%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL---KICDFGLARPTSE 70
            L E   +  L  +   L+Y+H   +IHRDLKP N++L         KI D G A+   +
Sbjct: 117 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 71  NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
            E  TE+V T  Y APE LL    YT  +D WS G +  E +   RP  P
Sbjct: 177 GELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/125 (36%), Positives = 65/125 (52%), Gaps = 11/125 (8%)
Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLLNAN 54
           DL  +I    +  Q L EE     + QL   LK  H  +     V+HRDLKP+N+ L+  
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152
Query: 55  CDLKICDFGLARPTS-ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            ++K+ DFGLAR  + +  F   +V T +Y +PE  +N   Y    D+WS+GC+  EL  
Sbjct: 153 QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCA 211
Query: 114 RRPLF 118
             P F
Sbjct: 212 LMPPF 216

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 88/179 (49%), Gaps = 30/179 (16%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF 144
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 184 APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTPE------ 235
Query: 145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                         Q+P + L+ +F        D ++R L  D  KR +  E L H +L
Sbjct: 236 -------------LQNP-EKLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 45/242 (18%)
Query: 4   DLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--------- 52
            LY+II  N       E  + +  ++L+ L Y+   ++ H DLKP N+LL+         
Sbjct: 121 SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180
Query: 53  ----------------ANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYT 96
                            +  +K+ DFG A  T ++++    + TR YRAPE++LN   + 
Sbjct: 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNLG-WD 237
Query: 97  AAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR- 155
            + D+WS GC+  EL     LF  ++H+  + ++  ++       L      +  +Y+  
Sbjct: 238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK 297
Query: 156 ---QLPQHPRQSLAQVFPHV-----------HPLAIDLVDRMLTFDPMKRITVDEALAHP 201
              +L      S      HV           H L  D +  +L  DP  R +  E L H 
Sbjct: 298 DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357
Query: 202 YL 203
           +L
Sbjct: 358 FL 359

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 65/116 (56%), Gaps = 7/116 (6%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +DL ++ +  + L E       +  L+GL Y+HS N+IHRD+K  N+LL+    +K+ DF
Sbjct: 141 SDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 198
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRP 116
           G A   +       +V T ++ APE++L  +   Y   +DVWS+G   +EL  R+P
Sbjct: 199 GSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NL+++    +K+ DFG
Sbjct: 128 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 64/119 (53%), Gaps = 3/119 (2%)
Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +  DL   ++ N    EE  + F+ +L+  L Y+ +  +IHRD+KP N+LL+ +  + I 
Sbjct: 98  LGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHIT 157
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELM-NRRP 116
           DF +A        +T    T+ Y APE+  +   + Y+ A+D WS+G    EL+  RRP
Sbjct: 158 DFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 68/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 150
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 151 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     +E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 68/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 150
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 151 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 64/116 (55%), Gaps = 7/116 (6%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +DL ++    + L E       +  L+GL Y+HS N+IHRD+K  N+LL+    +K+ DF
Sbjct: 102 SDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRP 116
           G A   +       +V T ++ APE++L  +   Y   +DVWS+G   +EL  R+P
Sbjct: 160 GSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 68/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 150
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 151 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 68/117 (58%), Gaps = 4/117 (3%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFG 63
           L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K+CDFG
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 150
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLFP 119
           ++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+ + R P+ P
Sbjct: 151 VSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 88/179 (49%), Gaps = 30/179 (16%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L+++HS  VIHRD+K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 125 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWM 184
Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF 144
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 185 APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTPE------ 236
Query: 145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                         Q+P + L+ +F        D ++R L  D  KR +  E + H +L
Sbjct: 237 -------------LQNP-EKLSAIFR-------DFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  ++    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 64/115 (55%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NL+++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE+++ S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIII-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 148 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 207
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 208 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 128 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 187
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 188 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 122 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 181
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 182 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R      E H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 120 EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 180 FAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 93/188 (49%), Gaps = 28/188 (14%)
Query: 26  QLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV----- 79
            +L    YIH+  N+ HRD+KPSN+L++ N  +K+ DFG      E+E+M +  +     
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG------ESEYMVDKKIKGSRG 212
Query: 80  TRWYRAPELLLNSSDYTAA-IDVWSVG-CIFMELMNRRPLFPGNDHVHQMRL-LIELLGT 136
           T  +  PE   N S Y  A +D+WS+G C+++   N  P          +++ L+EL   
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF--------SLKISLVELFNN 264
Query: 137 PTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDE 196
               ++ +    D   ++  L  + + + +  F  +    ID +   L  +P +RIT ++
Sbjct: 265 IRTKNIEYPL--DRNHFLYPLT-NKKSTCSNNF--LSNEDIDFLKLFLRKNPAERITSED 319
Query: 197 ALAHPYLA 204
           AL H +LA
Sbjct: 320 ALKHEWLA 327

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 63/119 (52%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    + E+  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 70/133 (52%), Gaps = 9/133 (6%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TDL +  + N +L EE   Y   ++LRGL ++H   VIHRD+K  N+LL  N ++K+ DF
Sbjct: 115 TDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173
Query: 63  GLARPTSEN-EFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMNRRPL 117
           G++            ++ T ++ APE++    +    Y    D+WS+G   +E+    P 
Sbjct: 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 232
Query: 118 FPGNDHVHQMRLL 130
            P  D +H MR L
Sbjct: 233 -PLCD-MHPMRAL 243

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/87 (40%), Positives = 51/87 (58%), Gaps = 1/87 (1%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRA 85
           Q+ +G+ YIHS  +IHRDLKPSN+ L     +KI DFGL      +   T    T  Y +
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELM 112
           PE  ++S DY   +D++++G I  EL+
Sbjct: 204 PE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSE 70
           ++ L+E   Q    Q+L  L ++HS  +IHRDLK  N+L+    D+++ DFG+ A+    
Sbjct: 103 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 162
Query: 71  NEFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            +    ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P +  ++ 
Sbjct: 163 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 219
Query: 127 MRLLIEL-------LGTPTDADLGFV--------RNEDAKRYIRQLPQHP 161
           MR+L+++       L TP+   + F         +N + +    QL +HP
Sbjct: 220 MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 269

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSE 70
           ++ L+E   Q    Q+L  L ++HS  +IHRDLK  N+L+    D+++ DFG+ A+    
Sbjct: 111 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170
Query: 71  NEFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            +    ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P +  ++ 
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 227
Query: 127 MRLLIEL-------LGTPTDADLGFV--------RNEDAKRYIRQLPQHP 161
           MR+L+++       L TP+   + F         +N + +    QL +HP
Sbjct: 228 MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T  Y AP ++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEYLAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 5/130 (3%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163
Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +     +  T  +  T  Y APE+LL    Y  ++D WS G +  E++  +  F G D
Sbjct: 164 MCKENMLGDAKTNXFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
Query: 123 H---VHQMRL 129
                H +R+
Sbjct: 223 EEELFHSIRM 232

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 97  EVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG 156
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G + 
Sbjct: 157 FSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN- 215
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                                         +++L +   +   ++  ++     +L+ R 
Sbjct: 216 ------------------------------LKELRERVLRGKYRIPFYMSTDCENLLKRF 245
Query: 184 LTFDPMKRITVDEALAHPYLARLHDEADEPVCPEP 218
           L  +P+KR T+++ +   ++   H+E +     EP
Sbjct: 246 LVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEP 280

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 57/207 (27%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------NCDLKICDFGLARP-- 67
            L Q+  G+ ++HS  +IHRDLKP N+L++              N  + I DFGL +   
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 68  TSENEFMTEY---VVTRWYRAPELLLNSSD------YTAAIDVWSVGCIFMELMNRRPLF 118
           + ++ F T       T  +RAPELL  S++       T +ID++S+GC+F  ++++    
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-H 238
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ----HPRQSLAQVFPHVHP 174
           P  D                     + R  +  R I  L +    H R  +A+       
Sbjct: 239 PFGDK--------------------YSRESNIIRGIFSLDEMKCLHDRSLIAE------- 271
Query: 175 LAIDLVDRMLTFDPMKRITVDEALAHP 201
            A DL+ +M+  DP+KR T  + L HP
Sbjct: 272 -ATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 27/201 (13%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR------PT 68
           L E      L ++L GL+Y+H    IHRD+K  N+LL  +  ++I DFG++         
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
           + N+    +V T  + APE++     Y    D+WS G   +EL       P + +     
Sbjct: 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKV 235
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
           L++ L   P   + G    E  K+Y +   +                   ++   L  DP
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRK-------------------MISLCLQKDP 276
Query: 189 MKRITVDEALAHPYLARLHDE 209
            KR T  E L H +  +  ++
Sbjct: 277 EKRPTAAELLRHKFFQKAKNK 297

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N+L++A   +K+ DFG+
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGI 162
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 163 ARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221
Query: 121 NDHV 124
           +  V
Sbjct: 222 DSPV 225

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 37/202 (18%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +LY+ ++ +    E+    F+ +L   L Y H   VIHRD+KP NLL+    +LKI DFG
Sbjct: 100 ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159
Query: 64  LA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            +   P+     M     T  Y  PE ++    +   +D+W  G +  E +   P F   
Sbjct: 160 WSVHAPSLRRRXMCG---TLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
            H    R ++       + DL F                         P +   + DL+ 
Sbjct: 216 SHTETHRRIV-------NVDLKFP------------------------PFLSDGSKDLIS 244
Query: 182 RMLTFDPMKRITVDEALAHPYL 203
           ++L + P +R+ +   + HP++
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWV 266

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 30/179 (16%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARPTSENEFMTEYVVTRWYR 84
           + L+ L+++HS  VIHR++K  N+LL  +  +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 125 ECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 184
Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF 144
           APE++   + Y   +D+WS+G + +E++   P +  N++  +   LI   GTP       
Sbjct: 185 APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTPE------ 236
Query: 145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                         Q+P + L+ +F        D ++R L  D  KR +  E + H +L
Sbjct: 237 -------------LQNP-EKLSAIFR-------DFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 2/116 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F
Sbjct: 156 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 37/202 (18%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +LY+ ++ +    E+    F+ +L   L Y H   VIHRD+KP NLL+    +LKI DFG
Sbjct: 101 ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 160
Query: 64  LA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            +   P+     M     T  Y  PE ++    +   +D+W  G +  E +   P F   
Sbjct: 161 WSVHAPSLRRRXMCG---TLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 216
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
            H    R ++       + DL F                         P +   + DL+ 
Sbjct: 217 SHTETHRRIV-------NVDLKFP------------------------PFLSDGSKDLIS 245
Query: 182 RMLTFDPMKRITVDEALAHPYL 203
           ++L + P +R+ +   + HP++
Sbjct: 246 KLLRYHPPQRLPLKGVMEHPWV 267

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 2/116 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 92  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 151
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F
Sbjct: 152 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 2/116 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F
Sbjct: 199 MCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 63/115 (54%), Gaps = 3/115 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            A+      +      T    APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 187 FAKRVKGRTWXL--CGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 100 EVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG 159
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            +   +    +  +     Y APEL          +DVWS+G I   L++    F G + 
Sbjct: 160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN- 218
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                                         +++L +   +   ++  ++     +L+ R 
Sbjct: 219 ------------------------------LKELRERVLRGKYRIPFYMSTDCENLLKRF 248
Query: 184 LTFDPMKRITVDEALAHPYLARLHDEADEPVCPEP 218
           L  +P+KR T+++ +   ++   H+E +     EP
Sbjct: 249 LVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEP 283

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 27/197 (13%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR------PT 68
           L E      L ++L GL+Y+H    IHRD+K  N+LL  +  ++I DFG++         
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 172
Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
           + N+    +V T  + APE++     Y    D+WS G   +EL       P + +     
Sbjct: 173 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKV 230
Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
           L++ L   P   + G    E  K+Y +   +                   ++   L  DP
Sbjct: 231 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRK-------------------MISLCLQKDP 271
Query: 189 MKRITVDEALAHPYLAR 205
            KR T  E L H +  +
Sbjct: 272 EKRPTAAELLRHKFFQK 288

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ +   +   E      +  +L  + Y H  NV HRDLKP N L    + +  LK+ 
Sbjct: 109 ELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLI 168
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA      + M   V T +Y +P++L     Y    D WS G +   L+   P F  
Sbjct: 169 DFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPECDEWSAGVMMYVLLCGYPPF-- 224
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                           PTD ++     E    +       P +     + +V P A  L+
Sbjct: 225 --------------SAPTDXEVMLKIREGTFTF-------PEKD----WLNVSPQAESLI 259
Query: 181 DRMLTFDPMKRITVDEALAHPYLAR 205
            R+LT  P +RIT  +AL H +  +
Sbjct: 260 RRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 2/116 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 107 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 166
Query: 64  LARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + +      +  + +  T  Y APE +L   DY  ++D W++G +  E+M  R  F
Sbjct: 167 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 32/205 (15%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ +   +   E      +  +L  + Y H  NV HRDLKP N L    + +  LK+ 
Sbjct: 92  ELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLI 151
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA      + M   V T +Y +P++L     Y    D WS G +   L+   P F  
Sbjct: 152 DFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPECDEWSAGVMMYVLLCGYPPF-- 207
Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                           PTD ++     E    +       P +     + +V P A  L+
Sbjct: 208 --------------SAPTDXEVMLKIREGTFTF-------PEKD----WLNVSPQAESLI 242
Query: 181 DRMLTFDPMKRITVDEALAHPYLAR 205
            R+LT  P +RIT  +AL H +  +
Sbjct: 243 RRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 38/209 (18%)
Query: 20  CQYFLY--QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR---PTSENEFM 74
           CQ   Y  QL+ GL+Y+HS  ++H+D+KP NLLL     LKI   G+A    P + ++  
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 75  TEYVVTRWYRAPELLLNSSDYTA-AIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL 133
                +  ++ PE+      ++   +D+WS G     +      F G D++++   L E 
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYK---LFEN 224
Query: 134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT 193
           +G  + A  G                              P   DL+  ML ++P KR +
Sbjct: 225 IGKGSYAIPG---------------------------DCGPPLSDLLKGMLEYEPAKRFS 257
Query: 194 VDEALAHPYLARLHDEADEPVCPEPFSFD 222
           + +   H +  + H  A+ PV P P S D
Sbjct: 258 IRQIRQHSWFRKKHPPAEAPV-PIPPSPD 285

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 63/116 (54%), Gaps = 2/116 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +   E   +++  ++   L Y+HS N+++RDLKP N+LL++   + + DFG
Sbjct: 125 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184
Query: 64  LARPTSE-NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           L +   E N   + +  T  Y APE +L+   Y   +D W +G +  E++   P F
Sbjct: 185 LCKENIEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 28/181 (15%)
Query: 38  NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD--- 94
            +IHRD+KPSN+LL+ + ++K+CDFG++    ++   T     R Y APE +  S+    
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 95  YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI 154
           Y    DVWS+G    EL   R  +P  + V   +L   + G P       + N + + + 
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFD-QLTQVVKGDPPQ-----LSNSEEREF- 258
Query: 155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
                              P  I+ V+  LT D  KR    E L HP++    + A E  
Sbjct: 259 ------------------SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVA 300
Query: 215 C 215
           C
Sbjct: 301 C 301

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 53/203 (26%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------NCDLKICDFGLARPTS 69
            L Q+  G+ ++HS  +IHRDLKP N+L++              N  + I DFGL +   
Sbjct: 138 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 70  ENEF-----MTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGND 122
             +      +     T  +RAPELL  S+    T +ID++S+GC+F  ++++    P  D
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK-HPFGD 256
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ----HPRQSLAQVFPHVHPLAID 178
                                + R  +  R I  L +    H R  +A+        A D
Sbjct: 257 K--------------------YSRESNIIRGIFSLDEMKCLHDRSLIAE--------ATD 288
Query: 179 LVDRMLTFDPMKRITVDEALAHP 201
           L+ +M+  DP+KR T  + L HP
Sbjct: 289 LISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 53/203 (26%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------NCDLKICDFGLARPTS 69
            L Q+  G+ ++HS  +IHRDLKP N+L++              N  + I DFGL +   
Sbjct: 138 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 70  ENEF-----MTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGND 122
             +      +     T  +RAPELL  S+    T +ID++S+GC+F  ++++    P  D
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK-HPFGD 256
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ----HPRQSLAQVFPHVHPLAID 178
                                + R  +  R I  L +    H R  +A+        A D
Sbjct: 257 K--------------------YSRESNIIRGIFSLDEMKCLHDRSLIAE--------ATD 288
Query: 179 LVDRMLTFDPMKRITVDEALAHP 201
           L+ +M+  DP+KR T  + L HP
Sbjct: 289 LISQMIDHDPLKRPTAMKVLRHP 311

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 67/117 (57%), Gaps = 8/117 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDF 62
            L Q+++    L E+   Y+L Q L GL+Y+HS  ++H D+K  N+LL+++     +CDF
Sbjct: 171 SLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDF 230
Query: 63  GLA---RPT--SENEFMTEYV-VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           G A   +P    ++    +Y+  T  + APE++L  S   A +DVWS  C+ + ++N
Sbjct: 231 GHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSSCCMMLHMLN 286

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 67/117 (57%), Gaps = 8/117 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDF 62
            L Q+++    L E+   Y+L Q L GL+Y+HS  ++H D+K  N+LL+++     +CDF
Sbjct: 152 SLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDF 211
Query: 63  GLA---RPT--SENEFMTEYV-VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           G A   +P    ++    +Y+  T  + APE++L  S   A +DVWS  C+ + ++N
Sbjct: 212 GHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSSCCMMLHMLN 267

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG+
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221
Query: 121 NDHV 124
           +  V
Sbjct: 222 DSPV 225

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 66/109 (60%), Gaps = 1/109 (0%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 39/216 (18%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLA 65
           I   +  +E      +  +   L ++H+  + HRDLKP N+L    N    +KICDFGL 
Sbjct: 102 IHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLG 161
Query: 66  ---------RPTSENEFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELM 112
                     P S  E +T    +  Y APE++      +S Y    D+WS+G I   L+
Sbjct: 162 SGIKLNGDCSPISTPELLTP-CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220
Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-- 170
           +  P F G                   +D G+ R E        L +  ++   + FP  
Sbjct: 221 SGYPPFVGR----------------CGSDCGWDRGEACPACQNMLFESIQEGKYE-FPDK 263
Query: 171 ---HVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
              H+   A DL+ ++L  D  +R++  + L HP++
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 66/109 (60%), Gaps = 1/109 (0%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 277 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 336
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 337 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG+
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221
Query: 121 NDHV 124
           +  V
Sbjct: 222 DSPV 225

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG+
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221
Query: 121 NDHV 124
           +  V
Sbjct: 222 DSPV 225

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 66/109 (60%), Gaps = 1/109 (0%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 66/109 (60%), Gaps = 1/109 (0%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 62/119 (52%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 61/119 (51%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+ + ++KI DFG
Sbjct: 100 EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFG 159
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 160 FSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 62/119 (52%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 39/208 (18%)
Query: 26  QLLRGLKYIHS-ANVIHRDLKPSNLLLNAN------CDLKICDFGLARPTSENEFMTEYV 78
           QLL GL Y+H    +IH D+KP N+L+           +KI D G A     +E  T  +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF---------PGNDHVHQMRL 129
            TR YR+PE+LL +  +    D+WS  C+  EL+    LF           +DH+ Q   
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ--- 252
Query: 130 LIELLGTPTDADLGFVRNE-------DAKRYIRQLPQHPRQSLAQVFPHVHPLA------ 176
           +IELLG         +RN        +++  +R + +     L  V    +  +      
Sbjct: 253 IIELLGELPSY---LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309
Query: 177 -IDLVDRMLTFDPMKRITVDEALAHPYL 203
             D +  ML  DP KR      + HP+L
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 33/205 (16%)
Query: 26  QLLRGLKYIHS-ANVIHRDLKPSNLLLNAN------CDLKICDFGLARPTSENEFMTEYV 78
           QLL GL Y+H    +IH D+KP N+L+           +KI D G A     +E  T  +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF---------PGNDHVHQMRL 129
            TR YR+PE+LL +  +    D+WS  C+  EL+    LF           +DH+ Q   
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ--- 252
Query: 130 LIELLGTPTDADL-------GFVRNEDAKRYIRQLPQHPRQS-LAQVFPHVHPLAIDLVD 181
           +IELLG      L        F  +    R I +L   P +  L + +      A ++ D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312
Query: 182 ---RMLTFDPMKRITVDEALAHPYL 203
               ML  DP KR      + HP+L
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 62/119 (52%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 64/121 (52%), Gaps = 5/121 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG+
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 162
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 221
Query: 121 N 121
           +
Sbjct: 222 D 222

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG+
Sbjct: 120 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 179
Query: 65  ARPTSENE---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  E++   P F G
Sbjct: 180 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTG 238
Query: 121 NDHV 124
           +  V
Sbjct: 239 DSPV 242

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+  G+ YI   N IHRDL+ +N+L++ +   KI DFGLAR   +NE+         
Sbjct: 115 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 174
Query: 81  -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPGNDHVHQMRLL 130
            +W  APE  +N   +T   DVWS G +  E++    + +PG  +   M  L
Sbjct: 175 IKW-TAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTAL 224

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 38/198 (19%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLK--ICDFGLAR--PTSENEFMT 75
            L Q   GL ++HS N++HRDLKP N+L+   NA+  +K  I DFGL +      + F  
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 76  EYVV--TRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLI 131
              V  T  + APE+L      + T  +D++S GC+F  +++      G     Q  +  
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-- 240
Query: 132 ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR 191
            LLG  +   L                 HP +       H   +A +L+++M+  DP KR
Sbjct: 241 -LLGACSLDCL-----------------HPEK-------HEDVIARELIEKMIAMDPQKR 275
Query: 192 ITVDEALAHPYLARLHDE 209
            +    L HP+   L  +
Sbjct: 276 PSAKHVLKHPFFWSLEKQ 293

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 57/207 (27%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------NCDLKICDFGLARPTS 69
            L Q+  G+ ++HS  +IHRDLKP N+L++              N  + I DFGL +   
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 70  ENEF-----MTEYVVTRWYRAPELLLNSSD------YTAAIDVWSVGCIFMELMNRRPLF 118
             +      +     T  +RAPELL  S++       T +ID++S+GC+F  ++++    
Sbjct: 180 SGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-H 238
Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ----HPRQSLAQVFPHVHP 174
           P  D                     + R  +  R I  L +    H R  +A+       
Sbjct: 239 PFGDK--------------------YSRESNIIRGIFSLDEMKCLHDRSLIAE------- 271
Query: 175 LAIDLVDRMLTFDPMKRITVDEALAHP 201
            A DL+ +M+  DP+KR T  + L HP
Sbjct: 272 -ATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 61/119 (51%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +     Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 62/119 (52%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 92  EVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFG 151
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +  +  Y APEL          +DVWS+G I   L++    F G +
Sbjct: 152 FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 60/102 (58%), Gaps = 3/102 (2%)
Query: 21  QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-PTSENEFMTEYVV 79
           +YF+ QL   L+++HS  V+HRD+KP+N+ + A   +K+ D GL R  +S+       V 
Sbjct: 140 KYFV-QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           T +Y +PE  ++ + Y    D+WS+GC+  E+   +  F G+
Sbjct: 199 TPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +   + YVV   
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 222
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + N   YT   DVWS G    EL +
Sbjct: 223 ARLPVKWM-APESIFNCV-YTFESDVWSYGIFLWELFS 258

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +   + YVV   
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 224
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + N   YT   DVWS G    EL +
Sbjct: 225 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 260

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +   + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 229
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + N   YT   DVWS G    EL +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +   + YVV   
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 206
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + N   YT   DVWS G    EL +
Sbjct: 207 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 242

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           + +Q+ RG++++ S   IHRDL   N+LL+ N  +KICDFGLAR   +N        TR 
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 83  ---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
              + APE + +   Y+   DVWS G +  E+ +
Sbjct: 264 PLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFS 296

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 10/109 (9%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F  Q+  G+ +I   N IHRDL+ +N+L++A+   KI DFGLAR  ++          +W
Sbjct: 283 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAK-------FPIKW 335
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
             APE  +N   +T   DVWS G + ME++   R  +PG  +   +R L
Sbjct: 336 -TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 382

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    +   + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKND---SNYVVKGN 229
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE + N   YT   DVWS G    EL +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 431 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 17/167 (10%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  RG+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 116 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT- 138
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  + 
Sbjct: 176 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSL 231
Query: 139 DADLGFVRNEDAKRYIRQLPQ------HPRQSLAQVFPHVHPLAIDL 179
             DL  VR+   KR  R + +        R S  ++   +  LA +L
Sbjct: 232 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 278

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+  G+ YI   N IHRDL+ +N+L++ +   KI DFGLAR   +NE+         
Sbjct: 114 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 81  -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPGNDHVHQMRLL 130
            +W  APE  +N   +T   +VWS G +  E++    + +PG  +   M  L
Sbjct: 174 IKW-TAPE-AINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL 223

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 269
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 270 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 298

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 17/167 (10%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  RG+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT- 138
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  + 
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSL 243
Query: 139 DADLGFVRNEDAKRYIRQLPQ------HPRQSLAQVFPHVHPLAIDL 179
             DL  VR+   KR  R + +        R S  ++   +  LA +L
Sbjct: 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAREL 290

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 178
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 179 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 58/108 (53%), Gaps = 9/108 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+ + N +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM--NRRPLFPGNDH 123
           +  RW  APE  ++   +T+A DVWS G +  E+M    RP +  ++H
Sbjct: 212 IPIRW-TAPE-AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 37/215 (17%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLA 65
           I+  +  +E      +  +   L ++H+  + HRDLKP N+L  +      +KICDF L 
Sbjct: 102 IQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLG 161
Query: 66  RPTSENEFMTEYVV--------TRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMN 113
                N   T            +  Y APE++   +D    Y    D+WS+G +   +++
Sbjct: 162 SGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLS 221
Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP--- 170
             P F G+                  AD G+ R E  +    +L +  ++   + FP   
Sbjct: 222 GYPPFVGH----------------CGADCGWDRGEVCRVCQNKLFESIQEGKYE-FPDKD 264
Query: 171 --HVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
             H+   A DL+ ++L  D  +R++  + L HP++
Sbjct: 265 WAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 60/119 (50%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++    E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 99  EVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFG 158
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
            +   +    +  +     Y APEL          +DVWS+G I   L++    F G +
Sbjct: 159 FSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 156 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 215
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 216 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 244

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 30/200 (15%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGL 64
           ++   +  +SE+    ++ Q+ +GL ++H  N +H DLKP N++     + +LK+ DFGL
Sbjct: 244 KVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
                  + +     T  + APE +          D+WSVG +   L++    F G +  
Sbjct: 304 TAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362
Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
             +R +        D+    + +ED K +IR+L                          L
Sbjct: 363 ETLRNVKSCDWNMDDSAFSGI-SEDGKDFIRKL--------------------------L 395
Query: 185 TFDPMKRITVDEALAHPYLA 204
             DP  R+T+ +AL HP+L 
Sbjct: 396 LADPNTRMTIHQALEHPWLT 415

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 30/200 (15%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGL 64
           ++   +  +SE+    ++ Q+ +GL ++H  N +H DLKP N++     + +LK+ DFGL
Sbjct: 138 KVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 197
Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
                  + +     T  + APE +          D+WSVG +   L++    F G +  
Sbjct: 198 TAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 256
Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
             +R +        D+    + +ED K +IR+L                          L
Sbjct: 257 ETLRNVKSCDWNMDDSAFSGI-SEDGKDFIRKL--------------------------L 289
Query: 185 TFDPMKRITVDEALAHPYLA 204
             DP  R+T+ +AL HP+L 
Sbjct: 290 LADPNTRMTIHQALEHPWLT 309

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 151 YQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 210
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 211 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 239

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 172
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 173 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 209

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 175 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 211

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++  +    R   
Sbjct: 153 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 212
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 213 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 241

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 170
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 171 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 207

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  ++       R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 35/195 (17%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN--CDLKICDFGLARP-----TSENEFMT 75
            + Q+   L Y+H+  + HRD+KP N L + N   ++K+ DFGL++        E   MT
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 76  EYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELL 134
               T ++ APE+L  +++ Y    D WS G +   L+     FPG              
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG-------------- 278
Query: 135 GTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV 194
               DAD   +     K+   + P +   S         PLA DL+  +L  +  +R   
Sbjct: 279 --VNDADT--ISQVLNKKLCFENPNYNVLS---------PLARDLLSNLLNRNVDERFDA 325
Query: 195 DEALAHPYLARLHDE 209
             AL HP++++  D+
Sbjct: 326 MRALQHPWISQFSDK 340

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW 178
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 179 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 7   QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL-LNANCD-LKICDFGL 64
           +II  + +L+E     F+ Q+  G++++H   ++H DLKP N+L +N +   +KI DFGL
Sbjct: 176 RIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFPGNDH 123
           AR     E +     T  + APE ++N    +   D+WSVG I +M L    P    ND 
Sbjct: 236 ARRYKPREKLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND- 293
Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                 L  +L    D        ED                 + F  +   A + + ++
Sbjct: 294 ---AETLNNILACRWDL-------ED-----------------EEFQDISEEAKEFISKL 326
Query: 184 LTFDPMKRITVDEALAHPYLA--RLH 207
           L  +   RI+  EAL HP+L+  +LH
Sbjct: 327 LIKEKSWRISASEALKHPWLSDHKLH 352

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 127 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 187 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 66/130 (50%), Gaps = 2/130 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E    ++  ++  GL ++H   +I+RDLK  N++L++   +KI DFG
Sbjct: 106 DLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFG 165
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +    +   T E+  T  Y APE++     Y  ++D W+ G +  E++  +P F G D
Sbjct: 166 MCKEHMMDGVTTREFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGED 224
Query: 123 HVHQMRLLIE 132
                + ++E
Sbjct: 225 EDELFQSIME 234

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 182
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 112 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 171
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 172 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 208

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 1/87 (1%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRA 85
           Q+ +G+ YIHS  +I+RDLKPSN+ L     +KI DFGL      +        T  Y +
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMS 189
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELM 112
           PE  ++S DY   +D++++G I  EL+
Sbjct: 190 PE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 122 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 182 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 77/141 (54%), Gaps = 11/141 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  RG+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT- 138
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  + 
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSL 243
Query: 139 DADLGFVRNEDAKRYIRQLPQ 159
             DL  VR+   KR  R + +
Sbjct: 244 SPDLSKVRSNCPKRMKRLMAE 264

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  ++I DFGLAR  +  ++  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 182
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 183 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL  +N+L+  N   K+ DFGLAR   +NE+          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 195 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 102/267 (38%), Gaps = 71/267 (26%)
Query: 5   LYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNAN-------- 54
           L  II+SN Q L     +  + Q+L+GL Y+H+   +IH D+KP N+LL+ N        
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 55  -----------------------------------------CDLKICDFGLARPTSENEF 73
                                                      +KI D G A     ++ 
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKH 249
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF---PGNDHVH---QM 127
            TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF    G ++      +
Sbjct: 250 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308
Query: 128 RLLIELLG-TPTDADLG-------FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            L+IELLG  P    +        F +  D K   +  P    + L + +      A   
Sbjct: 309 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGF 368
Query: 180 VD---RMLTFDPMKRITVDEALAHPYL 203
            D    ML   P KR T  E L HP+L
Sbjct: 369 TDFLLPMLELIPEKRATAAECLRHPWL 395

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  +   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 208 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 256

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  +  +   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 4/118 (3%)
Query: 4   DLYQIIRSNQSL--SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DL++ I + + +   E+    +  Q+   LK++H   ++HRD+K  N+ L  +  +++ D
Sbjct: 109 DLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGD 168
Query: 62  FGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           FG+AR   S  E     + T +Y +PE+  N   Y    D+W++GC+  EL   +  F
Sbjct: 169 FGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAF 225

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 158
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 159 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 207

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 39/216 (18%)
Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLA 65
           I   +  +E      +  +   L ++H+  + HRDLKP N+L    N    +KICDF L 
Sbjct: 102 IHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161
Query: 66  ---------RPTSENEFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELM 112
                     P S  E +T    +  Y APE++      +S Y    D+WS+G I   L+
Sbjct: 162 SGIKLNGDCSPISTPELLTP-CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220
Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-- 170
           +  P F G                   +D G+ R E        L +  ++   + FP  
Sbjct: 221 SGYPPFVGR----------------CGSDCGWDRGEACPACQNMLFESIQEGKYE-FPDK 263
Query: 171 ---HVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
              H+   A DL+ ++L  D  +R++  + L HP++
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGL R   +NE+          +W
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW 348
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 349 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           G      +  + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 102/267 (38%), Gaps = 71/267 (26%)
Query: 5   LYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNAN-------- 54
           L  II+SN Q L     +  + Q+L+GL Y+H+   +IH D+KP N+LL+ N        
Sbjct: 116 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 175
Query: 55  -----------------------------------------CDLKICDFGLARPTSENEF 73
                                                      +KI D G A     ++ 
Sbjct: 176 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKH 233
Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF---PGNDHVH---QM 127
            TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF    G ++      +
Sbjct: 234 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 292
Query: 128 RLLIELLG-TPTDADLG-------FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            L+IELLG  P    +        F +  D K   +  P    + L + +      A   
Sbjct: 293 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGF 352
Query: 180 VD---RMLTFDPMKRITVDEALAHPYL 203
            D    ML   P KR T  E L HP+L
Sbjct: 353 TDFLLPMLELIPEKRATAAECLRHPWL 379

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE           +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 181
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 196
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 136 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 195
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE           +W
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  L    +T   DVWS G +  EL  + R  +PG
Sbjct: 172 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 208

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 156 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 215
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 216 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 193 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 135 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 194
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 195 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 157 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 216
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 217 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E+ + +  T  
Sbjct: 130 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 189
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 190 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 125 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 184
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 185 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 221

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 182
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 196 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 196 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 6/102 (5%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ YI   N IHRDL+ +N+L+      KI DFGLAR   +NE           +W
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW 172
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDH 123
             APE  L    +T   DVWS G +  EL+ + R  +PG ++
Sbjct: 173 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNN 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 126 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 185
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 186 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 222

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHR+L+ +N+L++     KI DFGLAR   +NE+          +W
Sbjct: 113 QIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 172
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 173 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 209

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 79/198 (39%), Gaps = 50/198 (25%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+                         Y  + D+WS+G I   L+   P F  N     
Sbjct: 169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 202
Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLP-QHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                           G   +   K  IR    + P    ++V   V      L+  +L 
Sbjct: 203 ----------------GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM----LIRNLLK 242
Query: 186 FDPMKRITVDEALAHPYL 203
            +P +R+T+ E + HP++
Sbjct: 243 TEPTQRMTITEFMNHPWI 260

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 66/130 (50%), Gaps = 2/130 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++ S  +I+RDLK  N++L++   +KI DFG
Sbjct: 107 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166
Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +    +   T+ +  T  Y APE++     Y  ++D W+ G +  E++  +  F G D
Sbjct: 167 MCKENIWDGVTTKXFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGED 225
Query: 123 HVHQMRLLIE 132
                + ++E
Sbjct: 226 EDELFQSIME 235

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 19/127 (14%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE------- 72
           C +   Q+   ++++HS  ++HRDLKPSN+    +  +K+ DFGL     ++E       
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 73  ------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
                   T  V T+ Y +PE +  +S Y+  +D++S+G I  EL     L+P +  + +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMER 233
Query: 127 MRLLIEL 133
           +R L ++
Sbjct: 234 VRTLTDV 240

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 118 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 177
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 178 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 119 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 178
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 179 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 215

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   +NE           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 255 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 295

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 66/117 (56%), Gaps = 8/117 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDF 62
            L Q+I+    L E+   Y+L Q L GL+Y+H+  ++H D+K  N+LL+++     +CDF
Sbjct: 152 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDF 211
Query: 63  GLA---RP--TSENEFMTEYV-VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           G A   +P    ++    +Y+  T  + APE+++      A +D+WS  C+ + ++N
Sbjct: 212 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLN 267

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 257 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 297

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 66/117 (56%), Gaps = 8/117 (6%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKICDF 62
            L Q+I+    L E+   Y+L Q L GL+Y+H+  ++H D+K  N+LL+++     +CDF
Sbjct: 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDF 195
Query: 63  GLA---RP--TSENEFMTEYV-VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           G A   +P    ++    +Y+  T  + APE+++      A +D+WS  C+ + ++N
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLN 251

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDX 204
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 66/119 (55%), Gaps = 8/119 (6%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-LKIC 60
              L Q+I+    L E+   Y+L Q L GL+Y+H+  ++H D+K  N+LL+++     +C
Sbjct: 148 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALC 207
Query: 61  DFGLA---RP--TSENEFMTEYV-VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           DFG A   +P    ++    +Y+  T  + APE+++      A +D+WS  C+ + ++N
Sbjct: 208 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLN 265

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 250 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 290

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 198
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 199 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 248 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 288

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 241
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 242 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 282

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 257 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 136 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 195
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 143 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 202
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 203 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 207 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 247

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 66/130 (50%), Gaps = 2/130 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++ S  +I+RDLK  N++L++   +KI DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
Query: 64  LARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +    +   T+ +  T  Y APE++     Y  ++D W+ G +  E++  +  F G D
Sbjct: 488 MCKENIWDGVTTKXFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGED 546
Query: 123 HVHQMRLLIE 132
                + ++E
Sbjct: 547 EDELFQSIME 556

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 196 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 33/206 (16%)
Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKIC 60
           D+++ I ++   L+E     +++Q+   L+++HS N+ H D++P N++     +  +KI 
Sbjct: 87  DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKII 146
Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC-IFMELMNRRPLFP 119
           +FG AR     +          Y APE+  +    TA  D+WS+G  +++ L    P   
Sbjct: 147 EFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT-DMWSLGTLVYVLLSGINPFLA 205
Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
             +         +++    +A+  F  +E+A                  F  +   A+D 
Sbjct: 206 ETNQ--------QIIENIMNAEYTF--DEEA------------------FKEISIEAMDF 237
Query: 180 VDRMLTFDPMKRITVDEALAHPYLAR 205
           VDR+L  +   R+T  EAL HP+L +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + EF + +  T  
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGA 198
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 199 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 201 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   ++   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 196 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + E  + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGA 196
Query: 81  ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFP 119
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 234

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 237

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 238

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 230

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           SN  + E+  +++  +++  L  IHS  +IHRD+KP N+LL+ +  LK+ DFG      E
Sbjct: 167 SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 226
Query: 71  NEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
              +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 227 TGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 286

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 9/118 (7%)
Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL Q IRS Q + + +    F  Q+ RG++Y+     +HRDL   N +L+ +  +K+ DF
Sbjct: 109 DLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADF 168
Query: 63  GLARPTSENEFMT------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           GLAR   + E+ +        +  +W       L +  +T   DVWS G +  EL+ R
Sbjct: 169 GLARDILDREYYSVQQHRHARLPVKWTALES--LQTYRFTTKSDVWSFGVLLWELLTR 224

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV--- 79
           F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR    +   + YVV   
Sbjct: 177 FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD---SNYVVRGN 233
Query: 80  ----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                +W  APE L     YT   DVWS G +  E+ +
Sbjct: 234 ARLPVKW-MAPESLFEGI-YTIKSDVWSYGILLWEIFS 269

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 57/104 (54%), Gaps = 11/104 (10%)
Query: 24  LYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR----PTSENEFMTEY-- 77
           L  +  G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R     TS+  + +    
Sbjct: 141 LRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 200
Query: 78  -VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
            +  RW  APE  +    +T+A DVWS G +  E+M+   RP +
Sbjct: 201 KIPIRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 242

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 73  FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
              +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 56/111 (50%), Gaps = 13/111 (11%)
Query: 23  FLYQLLRGLKYIHS---ANVIHRDLKPSNLLLN--------ANCDLKICDFGLARPTSEN 71
           +  Q+ RG+ Y+H      +IHRDLK SN+L+         +N  LKI DFGLAR     
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
             M+      W  APE++  +S ++   DVWS G +  EL+     F G D
Sbjct: 170 TKMSAAGAYAWM-APEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGLAR     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 14/106 (13%)
Query: 20  CQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF------ 73
           C +   Q+   ++++HS  ++HRDLKPSN+    +  +K+ DFGL     ++E       
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 74  -MTEY------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            M  Y      V T+ Y +PE  ++ ++Y+  +D++S+G I  EL+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/99 (39%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+HS + IHR+L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                  WY APE L     Y A+ DVWS G    EL+ 
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 13/144 (9%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +    ++        R 
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRD 190
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
               WY APE L+ S  Y A+ DVWS G    EL+        +     M L ++++G P
Sbjct: 191 SPVFWY-APECLMQSKFYIAS-DVWSFGVTLHELLTY-----CDSDSSPMALFLKMIG-P 242
Query: 138 TDADLGFVRNEDAKRYIRQLPQHP 161
           T   +   R  +  +  ++LP  P
Sbjct: 243 THGQMTVTRLVNTLKEGKRLPCPP 266

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 13/144 (9%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +    ++        R 
Sbjct: 119 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRD 178
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
               WY APE L+ S  Y A+ DVWS G    EL+        +     M L ++++G P
Sbjct: 179 SPVFWY-APECLMQSKFYIAS-DVWSFGVTLHELLTY-----CDSDSSPMALFLKMIG-P 230
Query: 138 TDADLGFVRNEDAKRYIRQLPQHP 161
           T   +   R  +  +  ++LP  P
Sbjct: 231 THGQMTVTRLVNTLKEGKRLPCPP 254

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 104/265 (39%), Gaps = 69/265 (26%)
Query: 5   LYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNA--------- 53
           L  II+SN Q L     +  + Q+L+GL Y+HS   +IH D+KP N+L+           
Sbjct: 126 LKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMA 185
Query: 54  -----------------------------------NCD---LKICDFGLARPTSENEFMT 75
                                              N D   +KI D G A     ++  T
Sbjct: 186 AEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNA--CWVHKHFT 243
Query: 76  EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF---PGNDHVH---QMRL 129
           E + TR YR+ E+L+ +  Y+   D+WS  C+  EL     LF    G D+      +  
Sbjct: 244 EDIQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAH 302
Query: 130 LIELLGT-PTDADLG------FVRNEDAKRYIRQL-PQHPRQSLAQVFPHVHPLAIDLVD 181
           +IELLG+ P    L       F       R+I +L P      L + +   H  A    D
Sbjct: 303 IIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTD 362
Query: 182 ---RMLTFDPMKRITVDEALAHPYL 203
               ML   P KR +  E L HP+L
Sbjct: 363 FLIPMLEMVPEKRASAGECLRHPWL 387

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT---RW 82
           Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   + E           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 83  YRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPG 120
             APE  +N   +T   DVWS G +  E++   R  +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+   + +HRDL   N+L+N+N   K+ DFG++R     P +        
Sbjct: 136 MLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 195
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           +  RW  APE +     +T+A DVWS G +  E+M+
Sbjct: 196 IPIRWT-APEAIAYRK-FTSASDVWSYGIVMWEVMS 229

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 150 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 210 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 250

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL R     P +        
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 212 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G++Y+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 150 MLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  APE  +    +T+A DVWS G +  E+M+   RP +
Sbjct: 210 IPVRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 250

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 140 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 200 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 240

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 183 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 223

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL+R     P +        
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  +PE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 183 IPIRW-TSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYW 223

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           + + L E       Y + +G+ Y+H+ N  ++HRDLK  NLL++    +K+CDFGL+R  
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 69  SENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +     ++    T  + APE+L +      + DV+S G I  EL
Sbjct: 190 ASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWEL 232

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 16/107 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE------ 76
           F   +  G+ Y+HS N+IHRDL   N L+  N ++ + DFGLAR   + +   E      
Sbjct: 113 FAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 77  -------YVVTR--WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
                  Y V    ++ APE ++N   Y   +DV+S G +  E++ R
Sbjct: 173 KPDRKKRYTVVGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
            L  +  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R   EN     Y  +  
Sbjct: 121 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 81  -----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                RW  APE +     +T+A D WS G +  E+M+
Sbjct: 181 GKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVMS 216

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+H+ + IHR+L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                  WY APE L     Y A+ DVWS G    EL+ 
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 12/110 (10%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           +N +LS     +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 71  NEFMTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           +   + Y+V        +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 217 D---SNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT---SENEFMTEYVVTRWYRAP 86
           G+ ++H  + IHRD+K +N+LL+     KI DFGLAR +   ++    +  V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           E L    + T   D++S G + +E++   P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 39/203 (19%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +LY+ ++ + +  E+     + +L   L Y H   VIHRD+KP NLLL    +LKI DFG
Sbjct: 109 ELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFG 168
Query: 64  LA--RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            +   P+   + M     T  Y  PE ++    +   +D+W +G +  EL+   P F   
Sbjct: 169 WSVHAPSLRRKTMCG---TLDYLPPE-MIEGRMHNEKVDLWCIGVLCYELLVGNPPFESA 224
Query: 122 DHVHQMRLLIEL-LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            H    R ++++ L  P     G                                A DL+
Sbjct: 225 SHNETYRRIVKVDLKFPASVPTG--------------------------------AQDLI 252
Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
            ++L  +P +R+ + +  AHP++
Sbjct: 253 SKLLRHNPSERLPLAQVSAHPWV 275

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+   + +HRDL   N+L+N+N   K+ DFG++R     P +        
Sbjct: 121 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 180
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  APE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 181 IPIRWT-APEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYW 221

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+H+ + IHRDL   N+LL+ +  +KI DFGLA+   E      Y V   
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EXYRVRED 196
Query: 82  ------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 WY APE L     Y A+ DVWS G    EL+ 
Sbjct: 197 GDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 232

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEY 77
            L  +  G+KY+   + +HRDL   N+L+N+N   K+ DFG++R     P +        
Sbjct: 115 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 78  VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           +  RW  APE +     +T+A DVWS G +  E+M+   RP +
Sbjct: 175 IPIRW-TAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYW 215

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 54/109 (49%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  I  +  L E    Y   QL+  + Y+   ++IHRD+K  N+++  +  +K+ DFG
Sbjct: 116 DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175
Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            A      +    +  T  Y APE+L+ +      +++WS+G     L+
Sbjct: 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 50/99 (50%), Gaps = 13/99 (13%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+H+ + IHR L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 116 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 172
Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                  WY APE L     Y A+ DVWS G    EL+ 
Sbjct: 173 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 50/99 (50%), Gaps = 13/99 (13%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           F  Q+  G+ Y+H+ + IHR L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 117 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 173
Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                  WY APE L     Y A+ DVWS G    EL+ 
Sbjct: 174 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 210

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KI DFGLAR   ++   
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 75  TEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 R    + APE + +   YT   DVWS G +  E+ +
Sbjct: 201 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 58/110 (52%), Gaps = 2/110 (1%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+ ++   E   +++  +++  L ++H   +I+RDLK  N+LL+     K+ DFG
Sbjct: 110 DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 169
Query: 64  LARPTSENEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           + +    N   T  +  T  Y APE +L    Y  A+D W++G +  E++
Sbjct: 170 MCKEGICNGVTTATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEML 218

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           SN  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG     ++
Sbjct: 166 SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 225
Query: 71  NEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
              +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 226 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           SN  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG     ++
Sbjct: 166 SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 225
Query: 71  NEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
              +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 226 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           SN  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG     ++
Sbjct: 161 SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220
Query: 71  NEFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELM 112
              +     V T  Y +PE+L +      Y    D WSVG    E++
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-------EFMT 75
            L  +  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R   EN         + 
Sbjct: 123 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182
Query: 76  EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             +  RW  APE +     +T+A D WS G +  E+M+
Sbjct: 183 GKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVMS 218

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515
Query: 65  ARP--TSENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 516 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 564

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR----PTSENEFMTEY- 77
            L  +  G+KY+   N +HR L   N+L+N+N   K+ DFGL+R     TS+  + +   
Sbjct: 114 MLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173
Query: 78  --VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
             +  RW  APE  +    +T+A DVWS G +  E+M+   RP +
Sbjct: 174 GKIPIRW-TAPE-AIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 216

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 65  ARP--TSENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 565

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT---SENEFMTEYVVTRWYRAP 86
           G+ ++H  + IHRD+K +N+LL+     KI DFGLAR +   ++       V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           E L    + T   D++S G + +E++   P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT---SENEFMTEYVVTRWYRAP 86
           G+ ++H  + IHRD+K +N+LL+     KI DFGLAR +   ++    +  V T  Y AP
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           E L    + T   D++S G + +E++   P
Sbjct: 196 EAL--RGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 16/118 (13%)
Query: 15  LSEEHCQYFLYQLL-------RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR- 66
           L +   Q+ + QL+        G+KY+     +HRDL   N+L+N+N   K+ DFGL+R 
Sbjct: 114 LKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 173
Query: 67  ----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
               P +        +  RW  APE +     +T+A DVWS G +  E+++   RP +
Sbjct: 174 LEDDPEAAYTTRGGKIPIRW-TAPEAIA-FRKFTSASDVWSYGIVMWEVVSYGERPYW 229

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 65  ARP--TSENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 158 SKALRADENXYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 206

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 27  LLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRA 85
           +++ L Y+     VIHRD+KPSN+LL+    +K+CDFG++    +++          Y A
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMA 192
Query: 86  PELL----LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELL 134
           PE +        DY    DVWS+G   +EL   +  FP  +      +L ++L
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FPYKNCKTDFEVLTKVL 243

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT---SENEFMTEYVVTRWYRAP 86
           G+ ++H  + IHRD+K +N+LL+     KI DFGLAR +   ++       V T  Y AP
Sbjct: 139 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           E L    + T   D++S G + +E++   P
Sbjct: 199 EAL--RGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           + + L E       Y + +G+ Y+H+ N  ++HR+LK  NLL++    +K+CDFGL+R  
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 69  SENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
           +     ++    T  + APE+L +      + DV+S G I  EL
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWEL 232

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 65  ARP--TSENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 65  ARP--TSENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 65  ARP--TSENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 172 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 220

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 63/133 (47%), Gaps = 17/133 (12%)
Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKIC 60
            +  + + S   LS +      YQ  R ++++H     +IHRDLK  NLLL+    +K+C
Sbjct: 121 VEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180
Query: 61  DFGLARPTS---------ENEFMTEYVVTR----WYRAPELLLNSSDYTAA--IDVWSVG 105
           DFG A   S         +   + E  +TR     YR PE++   S++      D+W++G
Sbjct: 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240
Query: 106 CIFMELMNRRPLF 118
           CI   L  R+  F
Sbjct: 241 CILYLLCFRQHPF 253

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 7/106 (6%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           +  +LS +   +F   + RG+ Y+     IHRDL   N+L+  N   KI DFGL+R   +
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ 192
Query: 71  NEFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             ++ + +     RW       LN S YT   DVWS G +  E+++
Sbjct: 193 EVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 50/104 (48%), Gaps = 3/104 (2%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           +  +LS +   +F   + RG+ Y+     IHRDL   N+L+  N   KI DFGL+R    
Sbjct: 125 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 184
Query: 71  NEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
               T   +  RW       LN S YT   DVWS G +  E+++
Sbjct: 185 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 42/215 (19%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 95  NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 153
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 154 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 213
Query: 109 MELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
             +   +   P    ++Q+  L  ++              D    I + P  P + L   
Sbjct: 214 YYMTYGKT--PFQQIINQISKLHAII--------------DPNHEI-EFPDIPEKDLQ-- 254
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                    D++   L  DP +RI++ E LAHPY+
Sbjct: 255 ---------DVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 65  ARP--TSENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 212

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 44/216 (20%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 197
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 109 MELM-NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             +   + P     + + ++  +I                 D    I + P  P + L  
Sbjct: 258 YYMTYGKTPFQQIINQISKLHAII-----------------DPNHEI-EFPDIPEKDLQ- 298
Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                     D++   L  DP +RI++ E LAHPY+
Sbjct: 299 ----------DVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 65  ARP--TSENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 158 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 206

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 200 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 42/215 (19%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 197
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 109 MELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
             +   +  F     ++Q+  L  ++              D    I + P  P + L   
Sbjct: 258 YYMTYGKTPF--QQIINQISKLHAII--------------DPNHEI-EFPDIPEKDLQ-- 298
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                    D++   L  DP +RI++ E LAHPY+
Sbjct: 299 ---------DVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 65  ARP--TSENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 202

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 139 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 199 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 231

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 65  ARP--TSENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
           ++     EN +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 152 SKALRADENYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 200

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 12/110 (10%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           +N + S     +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 71  NEFMTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           +   + Y+V        +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 217 D---SNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 200 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 55/93 (59%), Gaps = 5/93 (5%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE---NEFMTEYVVTRW 82
           Q  +G+ Y+H+ N+IHRD+K +N+ L+    +KI DFGLA   S    ++ + +   +  
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 83  YRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           + APE+  + +++ ++   DV+S G +  ELM 
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 42/215 (19%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 91  NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 149
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 150 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 209
Query: 109 MELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
             +   +   P    ++Q+  L  ++              D    I + P  P + L   
Sbjct: 210 YYMTYGKT--PFQQIINQISKLHAII--------------DPNHEI-EFPDIPEKDLQ-- 250
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                    D++   L  DP +RI++ E LAHPY+
Sbjct: 251 ---------DVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 132 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 192 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 224

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 42/215 (19%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 111 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 169
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 109 MELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
             +   +   P    ++Q+  L  ++              D    I + P  P + L   
Sbjct: 230 YYMTYGKT--PFQQIINQISKLHAII--------------DPNHEI-EFPDIPEKDLQ-- 270
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                    D++   L  DP +RI++ E LAHPY+
Sbjct: 271 ---------DVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 177 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 177 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 114 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 174 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 206

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA----RPTSENEFMTEYVVTR 81
           Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFGLA    R +  ++F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 82  WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE+  + + + Y+   DV++ G +  ELM 
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVVTR 81
            L+Q+  G+KY+   N +HRDL   N+LL      KI DFGL++   +++ + T     +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           W   + APE  +N   +++  DVWS G    E ++
Sbjct: 175 WPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 42/215 (19%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 92  NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 150
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210
Query: 109 MELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
             +   +   P    ++Q+  L  ++              D    I + P  P + L   
Sbjct: 211 YYMTYGKT--PFQQIINQISKLHAII--------------DPNHEI-EFPDIPEKDLQ-- 251
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                    D++   L  DP +RI++ E LAHPY+
Sbjct: 252 ---------DVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTEYVVT 80
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +  P  +  F  +    
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 81  R---WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 237 IVFHLIELL 245

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 65/132 (49%), Gaps = 25/132 (18%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHR+L   N+L+     +KI DFGL +   +++   EY   + 
Sbjct: 120 YTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDK---EYYKVKE 176
Query: 82  -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHV 124
                  WY APE  L  S ++ A DVWS G +  EL      ++ P        GND  
Sbjct: 177 PGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 234
Query: 125 HQMRL--LIELL 134
            QM +  LIELL
Sbjct: 235 GQMIVFHLIELL 246

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 80/202 (39%), Gaps = 41/202 (20%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL--LNANCDLKICD 61
           DL+  I     L E   + F  Q++  +++ HS  V+HRD+K  N+L  L   C  K+ D
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC-AKLID 183
Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG +     +E  T++  TR Y  PE +     +     VWS+G +  +++         
Sbjct: 184 FG-SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC-------- 234
Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
                              D+ F R+++        P            HV P    L+ 
Sbjct: 235 ------------------GDIPFERDQEILEAELHFPA-----------HVSPDCCALIR 265
Query: 182 RMLTFDPMKRITVDEALAHPYL 203
           R L   P  R +++E L  P++
Sbjct: 266 RCLAPKPSSRPSLEEILLDPWM 287

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 54/108 (50%), Gaps = 12/108 (11%)
Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS     +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    + 
Sbjct: 161 EQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND- 219
Query: 73  FMTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             + Y+V        +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 220 --SNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 52/117 (44%), Gaps = 2/117 (1%)
Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
             SL E     +L   L  L ++HS  ++H D+KP+N+ L      K+ DFGL       
Sbjct: 151 GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210
Query: 72  EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
                      Y APELL  S  Y  A DV+S+G   +E+     L  G +   Q+R
Sbjct: 211 GAGEVQEGDPRYMAPELLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQLR 265

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 209
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 210 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 268 IVFHLIELL 276

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 13/96 (13%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR---- 81
           Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+    ++   +Y V R    
Sbjct: 122 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQ 178
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
               WY APE  L+ + ++   DVWS G +  EL  
Sbjct: 179 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 126 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 185
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 186 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 243
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 244 IVFHLIELL 252

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 125 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 185 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 242
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 243 IVFHLIELL 251

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 124 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 184 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 241
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 242 IVFHLIELL 250

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 13/96 (13%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR---- 81
           Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+    ++   +Y V R    
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQ 191
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
               WY APE  L+ + ++   DVWS G +  EL  
Sbjct: 192 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 117 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 176
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 177 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 234
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 235 IVFHLIELL 243

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 239
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 240 IVFHLIELL 248

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 13/96 (13%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR---- 81
           Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+    ++   +Y V R    
Sbjct: 123 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQ 179
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
               WY APE  L+ + ++   DVWS G +  EL  
Sbjct: 180 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 239
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 240 IVFHLIELL 248

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---Y 83
           +  G+ Y+  A+VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   +
Sbjct: 112 VCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 170
Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            +PE + + S Y++  DVWS G +  E+ +
Sbjct: 171 ASPE-VFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 3/104 (2%)
Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           +  +LS +   +F   + RG+ Y+     IHR+L   N+L+  N   KI DFGL+R    
Sbjct: 132 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV 191
Query: 71  NEFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
               T   +  RW       LN S YT   DVWS G +  E+++
Sbjct: 192 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 123 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 183 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 240
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 241 IVFHLIELL 249

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 239
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 240 IVFHLIELL 248

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 237 IVFHLIELL 245

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP-TSENEFMTEYVVTR 81
            L+Q+  G+KY+   N +HR+L   N+LL      KI DFGL++   +++ + T     +
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           W   + APE  +N   +++  DVWS G    E ++
Sbjct: 501 WPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 6/95 (6%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YV 78
           F +Q+ +G++Y+   +++HRDL   N+L+     +KI DFGL+R   E +   +     +
Sbjct: 155 FAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI 214
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             +W     L      YT   DVWS G +  E++ 
Sbjct: 215 PVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 237 IVFHLIELL 245

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEYVVTRWYR 84
           G++Y+     +HRDL   N+L+++N   K+ DFGL+R     P +        +  RW  
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT- 221
Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELM--NRRPLF 118
           APE +   + +++A DVWS G +  E++    RP +
Sbjct: 222 APEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYW 256

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 118 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 178 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 235
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 236 IVFHLIELL 244

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 42/215 (19%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 111 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 169
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P          V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 170 FGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 109 MELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
             +   +   P    ++Q+  L  ++              D    I + P  P + L   
Sbjct: 230 YYMTYGKT--PFQQIINQISKLHAII--------------DPNHEI-EFPDIPEKDLQ-- 270
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                    D++   L  DP +RI++ E LAHPY+
Sbjct: 271 ---------DVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 197 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 254
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 255 IVFHLIELL 263

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR- 81
           +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DFGL +   +++   +      
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 82  ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----NRRP-----LFPGNDHVHQM 127
               WY APE  L  S ++ A DVWS G +  EL      ++ P        GND   QM
Sbjct: 197 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 254
Query: 128 RL--LIELL 134
            +  LIELL
Sbjct: 255 IVFHLIELL 263

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YV 78
           F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E +   +     +
Sbjct: 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI 214
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             +W     L      YT   DVWS G +  E++ 
Sbjct: 215 PVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV-- 79
           +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    +   + Y+V  
Sbjct: 164 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND---SNYIVKG 220
Query: 80  -----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 221 NARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 257

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW 82
           F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E +    YV    
Sbjct: 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED---SYVKRSQ 211
Query: 83  YRAPELLLNSSD-----YTAAIDVWSVGCIFMELMN 113
            R P   +         YT   DVWS G +  E++ 
Sbjct: 212 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 79/189 (41%), Gaps = 40/189 (21%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-------ARP 67
           L+E+   + L  + RGL+ IH+    HRDLKP+N+LL       + D G           
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 68  TSENEFMTEYVVTRW---YRAPELLLNSSDYT--AAIDVWSVGCIFMELMNRRPLFPGND 122
           + +   + ++   R    YRAPEL    S        DVWS+GC+   +M     +   D
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY---D 247
Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
            V Q            D+    V+N+ +      +PQ PR S A            L++ 
Sbjct: 248 MVFQ----------KGDSVALAVQNQLS------IPQSPRHSSA---------LWQLLNS 282
Query: 183 MLTFDPMKR 191
           M+T DP +R
Sbjct: 283 MMTVDPHQR 291

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV-- 79
           +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    +   + Y+V  
Sbjct: 162 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND---SNYIVKG 218
Query: 80  -----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 219 NARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 255

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 11/112 (9%)
Query: 9   IRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP 67
           +R N+  L  +    +  Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR 
Sbjct: 109 VRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARL 168
Query: 68  TSENEFMTEY------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
              +E  TEY      V  +W     +L     +T   DVWS G    ELM 
Sbjct: 169 LDIDE--TEYHADGGKVPIKWMALESILRRR--FTHQSDVWSYGVTVWELMT 216

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 42/215 (19%)
Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLID 197
Query: 62  FGLA---RPTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A   +P + +      V    Y  PE + + S            +   DVWS+GCI 
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 109 MELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
             +   +  F     ++Q+  L  ++              D    I + P  P + L   
Sbjct: 258 YYMTYGKTPF--QQIINQISKLHAII--------------DPNHEI-EFPDIPEKDLQ-- 298
Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                    D++   L  DP +RI++ E LAHPY+
Sbjct: 299 ---------DVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV-- 79
           +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    +   + Y+V  
Sbjct: 156 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND---SNYIVKG 212
Query: 80  -----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 +W  APE + +   YT   DVWS G +  E+ +
Sbjct: 213 NARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 249

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR-----PTSENEFMTEYVVTRWYR 84
           G++Y+     +HRDL   N+L+++N   K+ DFGL+R     P +        +  RW  
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT- 221
Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELM--NRRPLF 118
           APE +   + +++A DVWS G +  E++    RP +
Sbjct: 222 APEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYW 256

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 556 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTRWYRA 85
           G++Y+ S   IHRDL   N L+     LKI DFG++R  ++  +        V  +W  A
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW-TA 283
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMN 113
           PE  LN   Y++  DVWS G +  E  +
Sbjct: 284 PE-ALNYGRYSSESDVWSFGILLWETFS 310

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---Y 83
           +  G+ Y+  A VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   +
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 168
Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            +PE + + S Y++  DVWS G +  E+ +
Sbjct: 169 ASPE-VFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 58/112 (51%), Gaps = 7/112 (6%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
            L E+  ++++ +++  +  IH  + +HRD+KP N+LL+ N  +++ DFG     +++  
Sbjct: 171 KLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT 230
Query: 74  MTEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMNRRPLF 118
           +   V   T  Y +PE+L    D    Y    D WS+G C++  L    P +
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---Y 83
           +  G+ Y+  A VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   +
Sbjct: 132 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 190
Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            +PE + + S Y++  DVWS G +  E+ +
Sbjct: 191 ASPE-VFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---Y 83
           +  G+ Y+  A VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   +
Sbjct: 112 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 170
Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            +PE + + S Y++  DVWS G +  E+ +
Sbjct: 171 ASPE-VFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 8/99 (8%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT----EYVVTR 81
           Q+  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R     ++        +  R
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELM--NRRPLF 118
           W   PE ++    +T   DVWS G I  E+    ++P F
Sbjct: 201 WM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 58/111 (52%), Gaps = 7/111 (6%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L E+  ++++ +++  +  IH  + +HRD+KP N+LL+ N  +++ DFG     +++  +
Sbjct: 188 LPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV 247
Query: 75  TEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMNRRPLF 118
              V   T  Y +PE+L    D    Y    D WS+G C++  L    P +
Sbjct: 248 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 298

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---Y 83
           +  G+ Y+  A VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   +
Sbjct: 115 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 173
Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            +PE + + S Y++  DVWS G +  E+ +
Sbjct: 174 ASPE-VFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 27  LLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW---Y 83
           +  G+ Y+  A VIHRDL   N L+  N  +K+ DFG+ R   ++++ T    T++   +
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 171
Query: 84  RAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            +PE + + S Y++  DVWS G +  E+ +
Sbjct: 172 ASPE-VFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 173 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 56/111 (50%), Gaps = 7/111 (6%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L EE  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG      E+  +
Sbjct: 172 LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231
Query: 75  TEYVV--TRWYRAPELLL----NSSDYTAAIDVWSVG-CIFMELMNRRPLF 118
              V   T  Y +PE+L         Y    D WS+G C++  L    P +
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 118 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 177
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 178 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 217

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 178
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 179 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 218

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 144 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 203
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 204 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 243

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 151 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 210
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 211 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 248

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 178 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 215

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       + 
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 181 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVV--TRWYRA 85
           RGL Y+H+  +IHRD+K  N+LL+ N   KI DFG+++  +E ++     VV  T  Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           PE  +     T   DV+S G +  E++  R
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVLCAR 238

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 127 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 186
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 187 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 123 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 182
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 183 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 220

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 221

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 121 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 180
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 181 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 218

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVV--TRWYRA 85
           RGL Y+H+  +IHRD+K  N+LL+ N   KI DFG+++  +E  +     VV  T  Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
           PE  +     T   DV+S G +  E++  R
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVLCAR 238

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L++A   +K+ DFGL+R   ++ +       + 
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 556 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 142 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 201
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 202 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 239

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT-- 80
           F+  +  G++Y+ S N IHRDL   N +L  +  + + DFGL+R     ++  +   +  
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 81  --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
             +W     L  N   YT   DVW+ G    E+M R
Sbjct: 202 PVKWLALESLADNL--YTVHSDVWAFGVTMWEIMTR 235

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 178 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 215

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 25  YQLLRGLKYIHSA---------NVIHRDLKPSNLLLNANCDLKICDFGLA---------R 66
           + + RGL Y+H+           + HRDL   N+L+  +    I DFGL+         R
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 67  PTSENEFMTEYVVTRWYRAPELL---LNSSDYTAA---IDVWSVGCIFMELMNR-RPLFP 119
           P  E+      V T  Y APE+L   +N  D  +A   +D++++G I+ E+  R   LFP
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 120 GND-HVHQMRLLIELLGTPTDADLGFVRNEDAKR 152
           G     +QM    E+   PT  D+  + + + +R
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR 271

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 171 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 208

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 7/93 (7%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTEYVVTR-- 81
           Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+  P  ++  +         
Sbjct: 119 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 82  -WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            WY APE  L+ + ++   DVWS G +  EL  
Sbjct: 179 FWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR---PTSENEFMTEYVV 79
           + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R    ++  +     + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLP 175
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 6/102 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE---YVV 79
           + YQL   L Y+ S   +HRD+   N+L++A   +K+ DFGL+R   ++ +       + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 80  TRWYRAPELLLNSSDYTAAIDVWSVG-CIFMELMNRRPLFPG 120
            +W  APE  +N   +T+A DVW  G C++  LM+    F G
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 44/88 (50%), Gaps = 6/88 (6%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTRWYRA 85
           G++Y+ S   IHRDL   N L+     LKI DFG++R  ++           V  +W  A
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKW-TA 283
Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMN 113
           PE  LN   Y++  DVWS G +  E  +
Sbjct: 284 PE-ALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 3/120 (2%)
Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   +R    L+       + Q+   L   H+A   HRD+KP N+L++A+    + DFG
Sbjct: 120 DLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG 179
Query: 64  LARPTSENEF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           +A  T++ +   +   V T +Y APE   + S  T   D++++ C+  E +   P + G+
Sbjct: 180 IASATTDEKLTQLGNTVGTLYYXAPE-RFSESHATYRADIYALTCVLYECLTGSPPYQGD 238

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+  G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E E+  
Sbjct: 114 QYLLNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 173
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 174 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 211

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 8/104 (7%)
Query: 14  SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF 73
           S +E+ C     Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     ++
Sbjct: 172 SCAEQLC--IARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 74  M----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
                 + +  RW     +  N   YT   DVW+ G +  E+ +
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFS 271

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + F T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF-TAHAGAK 171
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL 223

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW-- 82
           Y +  G+ ++ S   IHRDL   N L++ +  +K+ DFG+ R   ++++++  V T++  
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS-VGTKFPV 169
Query: 83  -YRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            + APE + +   Y++  DVW+ G +  E+ +
Sbjct: 170 KWSAPE-VFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY---VV 79
           +L++ + GLK  H   + HRD+K  N+LL  N    I DFGLA      +   +    V 
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 80  TRWYRAPELLLNSSDYTA----AIDVWSVGCIFMELMNR 114
           TR Y APE+L  + ++       ID++++G +  EL +R
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRAP 86
            ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW  +P
Sbjct: 112 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SP 169
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMEL 111
             +L  S +++  D+W+ G +  E+
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEI 194

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 176
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 121 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 180
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 181 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 218

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRAP 86
            ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW  +P
Sbjct: 116 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SP 173
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMEL 111
             +L  S +++  D+W+ G +  E+
Sbjct: 174 PEVLMYSKFSSKSDIWAFGVLMWEI 198

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRAP 86
            ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW  +P
Sbjct: 117 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SP 174
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMEL 111
             +L  S +++  D+W+ G +  E+
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 183
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 221

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 47/85 (55%), Gaps = 5/85 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRAP 86
            ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW   P
Sbjct: 123 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPP 181
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMEL 111
           E+L+ S  +++  D+W+ G +  E+
Sbjct: 182 EVLMYSK-FSSKSDIWAFGVLMWEI 205

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 21  QYFL---YQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMT 75
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFG A+     E E+  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 76  E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           E   V  +W     +L     YT   DVWS G    ELM 
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 25/84 (29%), Positives = 46/84 (54%), Gaps = 5/84 (5%)
Query: 31  LKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRAPE 87
           ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW  +P 
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SPP 190
Query: 88  LLLNSSDYTAAIDVWSVGCIFMEL 111
            +L  S +++  D+W+ G +  E+
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 134 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTY-TAHAGAK 192
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGND 122
           +   + APE L  ++ ++   DVW+ G +  E+       +PG D
Sbjct: 193 FPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGID 236

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 30  GLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV---TRWYRAP 86
            ++Y+ S   +HRDL   N L+N    +K+ DFGL+R   ++E+ +        RW  +P
Sbjct: 117 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRW--SP 174
Query: 87  ELLLNSSDYTAAIDVWSVGCIFMEL 111
             +L  S +++  D+W+ G +  E+
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 54/110 (49%), Gaps = 8/110 (7%)
Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM 74
           L++    +   Q+  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R     ++ 
Sbjct: 125 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 184
Query: 75  T----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM--NRRPLF 118
                  +  RW   PE ++    +T   DVWS+G +  E+    ++P +
Sbjct: 185 RVGGHTMLPIRWM-PPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWY 232

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 5/95 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 185
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           V   + APE  L +  ++ A D W  G    E+  
Sbjct: 186 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 5/95 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           V   + APE  L +  ++ A D W  G    E+  
Sbjct: 186 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 178
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTR 81
           ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++  +     +  R
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE L +   +T + D+WS G +  E+ +
Sbjct: 197 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 226

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 178
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTR 81
           ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE L +   +T + D+WS G +  E+ +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 5/95 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           V   + APE  L +  ++ A D W  G    E+  
Sbjct: 176 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 5/95 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           V   + APE  L +  ++ A D W  G    E+  
Sbjct: 176 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 175
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 176 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 5/95 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           V   + APE  L +  ++ A D W  G    E+  
Sbjct: 180 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 175
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 176 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 227

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 5/95 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           V   + APE  L +  ++ A D W  G    E+  
Sbjct: 176 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 128 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 186
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L   + ++   DVW+ G +  E+       +PG D      LL
Sbjct: 187 FPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 238

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 177
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 178 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 5/95 (5%)
Query: 23  FLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY-V 78
           +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DFGL R   +N+    M E+  
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 79  VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           V   + APE  L +  ++ A D W  G    E+  
Sbjct: 180 VPFAWCAPE-SLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 178
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 178
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 3/102 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
           R    L  +    F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S
Sbjct: 100 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 159
Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
             +  T  +  +W  APE L  ++ ++   DVWS G +  E+
Sbjct: 160 STQ-DTGKLPVKW-TAPEALREAA-FSTKSDVWSFGILLWEI 198

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE  L  + ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR 81
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + + T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAK 173
Query: 82  W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
           +   + APE  L  + ++   DVW+ G +  E+       +PG D      LL
Sbjct: 174 FPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 57/114 (50%), Gaps = 7/114 (6%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
           R+  SL       +  Q+ + + Y+ S N +HRD+   N+L+ +   +K+ DFGL+R   
Sbjct: 105 RNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164
Query: 70  ENEFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           + ++    V     +W  +PE  +N   +T A DVW       E+++  ++P F
Sbjct: 165 DEDYYKASVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 57/114 (50%), Gaps = 7/114 (6%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
           R+  SL       +  Q+ + + Y+ S N +HRD+   N+L+ +   +K+ DFGL+R   
Sbjct: 117 RNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 176
Query: 70  ENEFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           + ++    V     +W  +PE  +N   +T A DVW       E+++  ++P F
Sbjct: 177 DEDYYKASVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 57/114 (50%), Gaps = 7/114 (6%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
           R+  SL       +  Q+ + + Y+ S N +HRD+   N+L+ +   +K+ DFGL+R   
Sbjct: 101 RNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 160
Query: 70  ENEFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLF 118
           + ++    V     +W  +PE  +N   +T A DVW       E+++  ++P F
Sbjct: 161 DEDYYKASVTRLPIKW-MSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 3/102 (2%)
Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
           R    L  +    F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S
Sbjct: 109 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168
Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
             +  T  +  +W  APE  L    ++   DVWS G +  E+
Sbjct: 169 STQ-DTGKLPVKW-TAPE-ALREKKFSTKSDVWSFGILLWEI 207

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 52/113 (46%), Gaps = 6/113 (5%)
Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
           Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ DFGL+R  + + +        
Sbjct: 116 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF 175
Query: 81  --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
             +W  APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 176 PIKW-TAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 226

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTE----YVVTR 81
           ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E +   +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 82  WYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           W  APE L +   +T + D+WS G +  E+ +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	249
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-165
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-161
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-161
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-158
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-157
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-157
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-154
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-152
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-150
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-145
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-145
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-144
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-138
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-135
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-131
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-131
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-119
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-105
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-91
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-90
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-90
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-90
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-89
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-87
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-87
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-86
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-86
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-85
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-85
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-75
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-55
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-55
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-55
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-54
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-54
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-52
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-48
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-47
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-47
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-46
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-45
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-44
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-44
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-43
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-43
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-43
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-42
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-42
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-41
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-41
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-40
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-40
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-40
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-40
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-40
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-39
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-39
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-39
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-39
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-39
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-39
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-39
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-39
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-39
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-39
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-39
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-39
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-38
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-38
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-38
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-38
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-38
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-38
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-38
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-38
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-37
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-37
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-37
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-37
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-37
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-36
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-36
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-36
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-36
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-35
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-35
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-35
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-35
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-34
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-34
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-32
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-32
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-32
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-32
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-32
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-31
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-31
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-31
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-31
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-31
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-30
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-29
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-29
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-27
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-27
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-25
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-25
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-24
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-24
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-24
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-24
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-24
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-23
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-23
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-22
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-22
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-21
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-21
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-20
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-19
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-18
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-18
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-17
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-17
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-17
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-17
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-17
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-17
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-16
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-16
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-15
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-15
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-15
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-15
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-14
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-14
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-14
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-13
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-13
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-13
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-13
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-12
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-12
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-12
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-12
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-12
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-12
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-11
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-10
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  459 bits (1182), Expect = e-165
 Identities = 131/252 (51%), Positives = 183/252 (72%), Gaps = 5/252 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDLY+++++ Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170

Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 291 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 350

Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 351 IFEETARFQPGY 362

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  450 bits (1160), Expect = e-161
 Identities = 130/259 (50%), Positives = 173/259 (66%), Gaps = 17/259 (6%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL+++I + Q LS++H QYF+YQ LR +K +H +NVIHRDLKPSNLL+N+NCDLK+C
Sbjct: 96  MQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVC 154

Query: 61  DFGLAR-----------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
           DFGLAR           PT +   M E+V TRWYRAPE++L S+ Y+ A+DVWS GCI  
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214

Query: 110 ELMNRRPLFPGNDHVHQMRLLIELLGTPT-DADLGFVRNEDAKRYIRQLPQHPRQSLAQV 168
           EL  RRP+FPG D+ HQ+ L+  ++GTP  D DL  + +  A+ YI+ LP +P   L ++
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274

Query: 169 FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVC----PEPFSFDFE 224
           FP V+P  IDL+ RML FDP KRIT  EAL HPYL   HD  DEP      P  F FD  
Sbjct: 275 FPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHY 334

Query: 225 QQSLGEEQIKDMIYQEALA 243
           +++L  + +K +I+ E  +
Sbjct: 335 KEALTTKDLKKLIWNEIFS 353

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  450 bits (1159), Expect = e-161
 Identities = 93/247 (37%), Positives = 139/247 (56%), Gaps = 3/247 (1%)

Query: 1   MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M TDL Q+I   +  +S +H QYF+Y +L GL  +H A V+HRDL P N+LL  N D+ I
Sbjct: 116 MRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           CDF LAR  + +   T YV  RWYRAPEL++    +T  +D+WS GC+  E+ NR+ LF 
Sbjct: 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ-LPQHPRQSLAQVFPHVHPLAID 178
           G+   +Q+  ++E++GTP   D+    +  A+ Y+R  L   P ++   V P   P+A+D
Sbjct: 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295

Query: 179 LVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIY 238
           L+ +ML F+P +RI+ ++AL HPY   L D  D         F F++       +  +  
Sbjct: 296 LIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL-SERFHFDESVTDVYDMHKIFT 354

Query: 239 QEALALN 245
            E    N
Sbjct: 355 AEVERFN 361

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  441 bits (1136), Expect = e-158
 Identities = 108/246 (43%), Positives = 153/246 (62%), Gaps = 4/246 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL +I+      SEE  QY +YQ+L+GLKYIHSA V+HRDLKP NL +N +C+LKI 
Sbjct: 111 MQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR       MT YVVTRWYRAPE++L+   Y   +D+WSVGCI  E++  + LF G
Sbjct: 169 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D++ Q+  ++++ G P    +  + ++ AK YI+ LPQ PR+   Q+FP   P A DL+
Sbjct: 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 286

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KR+T  +AL HP+     D  +E    +PF    E + L  ++ K  IY+E
Sbjct: 287 EKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKE 346

Query: 241 ALALNP 246
            +  +P
Sbjct: 347 IVNFSP 352

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  440 bits (1133), Expect = e-157
 Identities = 121/246 (49%), Positives = 167/246 (67%), Gaps = 4/246 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DL  I++  Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR T++   MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG
Sbjct: 175 DFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            DH+ Q++L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  KRIT  +ALAH Y A+ HD  DEPV   P+    E + L  ++ K + Y E
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDE 351

Query: 241 ALALNP 246
            ++  P
Sbjct: 352 VISFVP 357

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  439 bits (1131), Expect = e-157
 Identities = 104/246 (42%), Positives = 163/246 (66%), Gaps = 4/246 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL ++++  + L E+  Q+ +YQ+L+GL+YIH+A +IHRDLKP NL +N +C+LKI 
Sbjct: 112 MGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 170

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTRWYRAPE++LN   YT  +D+WSVGCI  E++  + LF G
Sbjct: 171 DFGLAR--QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +DH+ Q++ ++++ GTP    +  +++++AK Y++ LP+  ++  A +  +  PLA++L+
Sbjct: 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 288

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  +R+T  EALAHPY   LHD  DEP     +   F+      ++ K + Y+E
Sbjct: 289 EKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKE 347

Query: 241 ALALNP 246
            L+  P
Sbjct: 348 VLSFKP 353

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  435 bits (1121), Expect = e-154
 Identities = 103/300 (34%), Positives = 157/300 (52%), Gaps = 52/300 (17%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
            D+DL ++ ++   L+EEH +  LY LL G  +IH + +IHRDLKP+N LLN +C +K+C
Sbjct: 112 ADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVC 171

Query: 61  DFGLARPTS-----------------------ENEFMTEYVVTRWYRAPELLLNSSDYTA 97
           DFGLAR  +                         + +T +VVTRWYRAPEL+L   +YT 
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231

Query: 98  AIDVWSVGCIFMELMN-----------RRPLFPGN-----------------DHVHQMRL 129
           +ID+WS GCIF EL+N           R PLFPG+                  +  Q+ +
Sbjct: 232 SIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNI 291

Query: 130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPM 189
           +  ++GTPT+ DL  +   +  +YI+  P     +L Q +P +    I+L++ ML F+P 
Sbjct: 292 IFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPN 351

Query: 190 KRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQ-QSLGEEQIKDMIYQEALALNPGF 248
           KRIT+D+AL HPYL  +  +  E    +     F+    L E Q++ +  +E  + +P  
Sbjct: 352 KRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPEL 411

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  431 bits (1109), Expect = e-152
 Identities = 111/306 (36%), Positives = 157/306 (51%), Gaps = 60/306 (19%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
            D+D  ++ R+   L+E H +  LY LL G+KY+HSA ++HRDLKP+N L+N +C +K+C
Sbjct: 139 ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVC 198

Query: 61  DFGLAR----------------------------PTSENEFMTEYVVTRWYRAPELLLNS 92
           DFGLAR                              +    +T +VVTRWYRAPEL+L  
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258

Query: 93  SDYTAAIDVWSVGCIFMELMN-----------RRPLFPGND------------------- 122
            +YT AIDVWS+GCIF EL+N           R PLFPG+                    
Sbjct: 259 ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTR 318

Query: 123 -HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
            +  Q+ ++  +LGTP++ D+  +  EDAKRYIR  P+     LA+ FP     AI L+ 
Sbjct: 319 GNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLK 378

Query: 182 RMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFE-QQSLGEEQIKDMIYQE 240
           RML F+P KRIT++E LAHP+   +     E    E     F    ++ E Q++    +E
Sbjct: 379 RMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKE 438

Query: 241 ALALNP 246
               +P
Sbjct: 439 IQRYHP 444

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  423 bits (1090), Expect = e-150
 Identities = 91/285 (31%), Positives = 154/285 (54%), Gaps = 40/285 (14%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M+TDL+ +IR+   L   H QY +YQL++ +KY+HS  ++HRD+KPSN+LLNA C +K+ 
Sbjct: 93  METDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVA 151

Query: 61  DFGLAR----------------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAA 98
           DFGL+R                         +   +T+YV TRWYRAPE+LL S+ YT  
Sbjct: 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG 211

Query: 99  IDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP 158
           ID+WS+GCI  E++  +P+FPG+  ++Q+  +I ++  P++ D+  +++  AK  I  L 
Sbjct: 212 IDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLK 271

Query: 159 QHPRQSLAQVF----------------PHVHPLAIDLVDRMLTFDPMKRITVDEALAHPY 202
           +      +                      +  A+DL+D++L F+P KRI+ ++AL HP+
Sbjct: 272 EKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF 331

Query: 203 LARLHDEADEPVCPEPFSFDF-EQQSLGEEQIKDMIYQEALALNP 246
           ++  H+  +EP C    +    +      +  ++++Y E      
Sbjct: 332 VSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKR 376

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  409 bits (1054), Expect = e-145
 Identities = 102/259 (39%), Positives = 148/259 (57%), Gaps = 17/259 (6%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 112 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++    LFPG
Sbjct: 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPG 228

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH------- 173
            DH+ Q   +IE LGTP    +  +     + Y+   P++   S  ++FP V        
Sbjct: 229 TDHIDQWNKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 287

Query: 174 -----PLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPE-PFSFDFEQQS 227
                  A DL+ +ML  D  KRI+VDEAL HPY+   +D ++    P        +++ 
Sbjct: 288 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDERE 347

Query: 228 LGEEQIKDMIYQEALALNP 246
              E+ K++IY+E + L  
Sbjct: 348 HTIEEWKELIYKEVMDLEH 366

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  407 bits (1048), Expect = e-145
 Identities = 97/219 (44%), Positives = 141/219 (64%), Gaps = 7/219 (3%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKI 59
           M+TDL  ++     L EEH + F+YQLLRGLKYIHSANV+HRDLKP+NL +N  +  LKI
Sbjct: 104 METDLANVLEQGP-LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162

Query: 60  CDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            DFGLAR      S    ++E +VT+WYR+P LLL+ ++YT AID+W+ GCIF E++  +
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
            LF G   + QM+L++E +    + D   + +     YIR     P + L Q+ P +   
Sbjct: 223 TLFAGAHELEQMQLILESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISRE 281

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
           A+D ++++LTF PM R+T +EAL+HPY++      DEP+
Sbjct: 282 AVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  410 bits (1055), Expect = e-144
 Identities = 99/259 (38%), Positives = 150/259 (57%), Gaps = 17/259 (6%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+    L  E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 149 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 265

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH------- 173
            D++ Q   +IE LGTP    +  +     + Y+   P++   +  ++FP          
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324

Query: 174 -----PLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE-PVCPEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+     P+ +    +++ 
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 384

Query: 228 LGEEQIKDMIYQEALALNP 246
              E+ K++IY+E +    
Sbjct: 385 HTIEEWKELIYKEVMNSEE 403

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  392 bits (1009), Expect = e-138
 Identities = 79/253 (31%), Positives = 128/253 (50%), Gaps = 13/253 (5%)

Query: 1   MDTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIH--SANVIHRDLKPSNLLLN-A 53
           +   L++  R+      +      + FL+QL+R +  +H  S NV HRD+KP N+L+N A
Sbjct: 108 VPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167

Query: 54  NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           +  LK+CDFG A+  S +E    Y+ +R+YRAPEL+  +  YT A+D+WSVGCIF E+M 
Sbjct: 168 DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP-RQSLAQVFPHV 172
             P+F G++   Q+  ++ +LG P+   L  +        +      P     +      
Sbjct: 228 GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKD 287

Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE-----PVCPEPFSFDFEQQS 227
              A DL+  +L + P +R+   EAL HPY   LHD A +      +  + F F   +  
Sbjct: 288 AKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIE 347

Query: 228 LGEEQIKDMIYQE 240
           +  E  K  + ++
Sbjct: 348 VMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  384 bits (989), Expect = e-135
 Identities = 82/265 (30%), Positives = 145/265 (54%), Gaps = 22/265 (8%)

Query: 1   MDTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD 56
           +   L+++++    S +S+       ++YQL R + +IHS  + HRD+KP NLL+N+  +
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 57  -LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            LK+CDFG A+    +E    Y+ +R+YRAPEL+L +++YT +ID+WS+GC+F EL+  +
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP- 174
           PLF G   + Q+  +I+++GTPT   +  +     +      P    +   ++ P   P 
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR---FPTLKAKDWRKILPEGTPS 296

Query: 175 LAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVC-------------PEPFSF 221
           LAIDL++++L ++P  RI   EA+AHP+   L +  +  V              P+ F+F
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNF 356

Query: 222 DFEQQSLGEEQIKDMIYQEALALNP 246
              + S+    + + I  +  + N 
Sbjct: 357 SPYELSIIPGNVLNRILPKNFSPNY 381

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  377 bits (970), Expect = e-131
 Identities = 87/249 (34%), Positives = 133/249 (53%), Gaps = 12/249 (4%)

Query: 1   MDTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD 56
           +   +Y++ R    + Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +  
Sbjct: 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194

Query: 57  -LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            LK+CDFG A+     E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHP 174
           P+FPG+  V Q+  +I++LGTPT   +  +          + PQ       +VF P   P
Sbjct: 255 PIFPGDSGVDQLVEIIKVLGTPTREQIREMN---PNYTEFKFPQIKAHPWTKVFRPRTPP 311

Query: 175 LAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP--VCPEPFSFDFEQQSLGEEQ 232
            AI L  R+L + P  R+T  EA AH +   L D   +       P  F+F  Q L    
Sbjct: 312 EAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP 371

Query: 233 -IKDMIYQE 240
            +  ++   
Sbjct: 372 PLATILIPP 380

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  375 bits (966), Expect = e-131
 Identities = 87/251 (34%), Positives = 134/251 (53%), Gaps = 13/251 (5%)

Query: 1   MDTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD 56
           +   +Y+  R      Q++     + ++YQLLR L YIHS  + HRD+KP NLLL+    
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG 179

Query: 57  -LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR 115
            LK+ DFG A+     E    Y+ +R+YRAPEL+  +++YT  ID+WS GC+  ELM  +
Sbjct: 180 VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF-PHVHP 174
           PLFPG   + Q+  +I++LGTP+   +  +          + PQ      ++VF P   P
Sbjct: 240 PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN---YMEHKFPQIRPHPFSKVFRPRTPP 296

Query: 175 LAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA----DEPVCPEPFSFDFEQQSLGE 230
            AIDL+ R+L + P  R+T  EAL HP+   L        +    P  F++  E+ S+  
Sbjct: 297 DAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRP 356

Query: 231 EQIKDMIYQEA 241
           + I  ++ Q A
Sbjct: 357 DLISRLVPQHA 367

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  342 bits (879), Expect = e-119
 Identities = 63/217 (29%), Positives = 121/217 (55%), Gaps = 11/217 (5%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKI 59
            +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++
Sbjct: 116 NNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 172

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLF 118
            D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F
Sbjct: 173 IDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232

Query: 119 PGNDHVHQMRLLIELLGTPTDAD-LGFVRNEDAKRYIRQLPQHPRQSLAQVFPH-----V 172
            G+D+  Q+  + ++LGT    D +     E   R+   L +H R+   +         V
Sbjct: 233 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 292

Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE 209
            P A+D +D++L +D   R+T  EA+ HPY   +  +
Sbjct: 293 SPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  306 bits (786), Expect = e-105
 Identities = 68/228 (29%), Positives = 115/228 (50%), Gaps = 3/228 (1%)

Query: 1   MDTDLYQII-RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
            D  +   + R  + + E   +   +Q L+ + + H  N IHRD+KP N+L+  +  +K+
Sbjct: 84  CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKL 143

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           CDFG AR  T  +++  + V TRWYR+PELL+  + Y   +DVW++GC+F EL++  PL+
Sbjct: 144 CDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG   V Q+ L+ + LG                  ++       + L   FP++   A+ 
Sbjct: 204 PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALG 263

Query: 179 LVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPE-PFSFDFEQ 225
           L+   L  DP +R+T ++ L HPY   + +  D     + P    + Q
Sbjct: 264 LLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAENLYFQ 311

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  282 bits (723), Expect = 2e-95
 Identities = 70/206 (33%), Positives = 111/206 (53%), Gaps = 6/206 (2%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D  +   +      L  +  Q +L+Q++ G+ + HS N+IHRD+KP N+L++ +  +K+
Sbjct: 106 VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKL 165

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           CDFG AR   +  E   + V TRWYRAPELL+    Y  A+DVW++GC+  E+    PLF
Sbjct: 166 CDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVHPLA 176
           PG+  + Q+  ++  LG         F +N        +LP+   R+ L + +P +  + 
Sbjct: 226 PGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV--RLPEIKEREPLERRYPKLSEVV 283

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPY 202
           IDL  + L  DP KR    E L H +
Sbjct: 284 IDLAKKCLHIDPDKRPFCAELLHHDF 309

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  268 bits (689), Expect = 6e-91
 Identities = 78/205 (38%), Positives = 105/205 (51%), Gaps = 6/205 (2%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL +++      L     + FL QLL G+ Y H   V+HRDLKP NLL+N   +LKI
Sbjct: 82  LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR         T  +VT WYRAP++L+ S  Y+  ID+WSVGCIF E++N  PLF
Sbjct: 142 ADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG     Q+  +  +LGTP   +                   +           +    I
Sbjct: 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD---PNFTVYEPLPWESFLKGLDESGI 258

Query: 178 DLVDRMLTFDPMKRITVDEALAHPY 202
           DL+ +ML  DP +RIT  +AL H Y
Sbjct: 259 DLLSKMLKLDPNQRITAKQALEHAY 283

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  269 bits (689), Expect = 3e-90
 Identities = 80/205 (39%), Positives = 112/205 (54%), Gaps = 7/205 (3%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+TDL  II+  +  L+  H + ++   L+GL+Y+H   ++HRDLKP+NLLL+ N  LK+
Sbjct: 94  METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL 153

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLA+   S N   T  VVTRWYRAPELL  +  Y   +D+W+VGCI  EL+ R P  
Sbjct: 154 ADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+  + Q+  + E LGTPT+          D           P   L  +F       +
Sbjct: 214 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV----TFKSFPGIPLHHIFSAAGDDLL 269

Query: 178 DLVDRMLTFDPMKRITVDEALAHPY 202
           DL+  +  F+P  RIT  +AL   Y
Sbjct: 270 DLIQGLFLFNPCARITATQALKMKY 294

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  267 bits (686), Expect = 4e-90
 Identities = 77/205 (37%), Positives = 116/205 (56%), Gaps = 5/205 (2%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           M+ DL +++      L +   + +LYQLLRG+ + H   ++HRDLKP NLL+N++  LK+
Sbjct: 101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR         T  VVT WYRAP++L+ S  Y+ ++D+WS+GCIF E++  +PLF
Sbjct: 161 ADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG     Q+  +  +LGTP   +          K+         ++  + + P      I
Sbjct: 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR--TFQVFEKKPWSSIIPGFCQEGI 278

Query: 178 DLVDRMLTFDPMKRITVDEALAHPY 202
           DL+  ML FDP KRI+  +A+ HPY
Sbjct: 279 DLLSNMLCFDPNKRISARDAMNHPY 303

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  266 bits (683), Expect = 1e-89
 Identities = 85/221 (38%), Positives = 126/221 (57%), Gaps = 9/221 (4%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           +D DL Q +      ++  + + FL+QLLRGL Y H   V+HRDLKP NLL+N   +LK+
Sbjct: 82  LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKL 141

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            DFGLAR  +   +     VVT WYR P++LL S+DY+  ID+W VGCIF E+   RPLF
Sbjct: 142 ADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           PG+    Q+  +  +LGTPT+    G + NE+ K Y    P++  ++L    P +     
Sbjct: 202 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY--NYPKYRAEALLSHAPRLDSDGA 259

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEP 218
           DL+ ++L F+   RI+ ++A+ HP+         E +   P
Sbjct: 260 DLLTKLLQFEGRNRISAEDAMKHPFF----LSLGERIHKLP 296

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  260 bits (667), Expect = 2e-87
 Identities = 78/205 (38%), Positives = 110/205 (53%), Gaps = 9/205 (4%)

Query: 1   MDTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           +D DL   +       L  E  +  + Q LRGL ++H+  ++HRDLKP N+L+ +   +K
Sbjct: 101 VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 160

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + DFGLAR  S    +T  VVT WYRAPE+LL S+ Y   +D+WSVGCIF E+  R+PLF
Sbjct: 161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLF 219

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
            GN    Q+  + +L+G P + D    V            P    + +  V P +     
Sbjct: 220 CGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA-----FPPRGPRPVQSVVPEMEESGA 274

Query: 178 DLVDRMLTFDPMKRITVDEALAHPY 202
            L+  MLTF+P KRI+   AL H Y
Sbjct: 275 QLLLEMLTFNPHKRISAFRALQHSY 299

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  261 bits (669), Expect = 2e-87
 Identities = 80/224 (35%), Positives = 119/224 (53%), Gaps = 13/224 (5%)

Query: 1   MDTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK 58
           +D DL   +       +  E  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K
Sbjct: 101 VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + DFGLAR  S    +T  VVT WYRAPE+LL SS Y   +D+WSVGCIF E+  R+PLF
Sbjct: 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLF 219

Query: 119 PGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
            G+  V Q+  +++++G P + D    V                 Q + +    +  L  
Sbjct: 220 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-----FHSKSAQPIEKFVTDIDELGK 274

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSF 221
           DL+ + LTF+P KRI+   AL+HPY      + +          
Sbjct: 275 DLLLKCLTFNPAKRISAYSALSHPYF----QDLERCKENLDSHL 314

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  259 bits (664), Expect = 1e-86
 Identities = 78/210 (37%), Positives = 117/210 (55%), Gaps = 11/210 (5%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---- 56
            + DL + +  N  +S    + FLYQL+ G+ + HS   +HRDLKP NLLL+ +      
Sbjct: 115 AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP 174

Query: 57  -LKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
            LKI DFGLAR         T  ++T WYR PE+LL S  Y+ ++D+WS+ CI+ E++ +
Sbjct: 175 VLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFP-HV 172
            PLFPG+  + Q+  + E+LG P D    G     D   + +  P+   ++L +V    +
Sbjct: 235 TPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD---WKQSFPKFRGKTLKRVLGALL 291

Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPY 202
               +DL+  ML  DP+KRI+   AL HPY
Sbjct: 292 DDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  256 bits (656), Expect = 6e-86
 Identities = 92/207 (44%), Positives = 124/207 (59%), Gaps = 9/207 (4%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
            D DL +   S N  L  E  + FL+QLL+GL + HS NV+HRDLKP NLL+N N +LK+
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPL 117
            +FGLAR         +  VVT WYR P++L  +  Y+ +ID+WS GCIF EL N  RPL
Sbjct: 143 ANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

Query: 118 FPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPR-QSLAQVFPHVHPL 175
           FPGND   Q++ +  LLGTPT+       +  D K Y    P +P   SL  V P ++  
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY----PMYPATTSLVNVVPKLNAT 258

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPY 202
             DL+  +L  +P++RI+ +EAL HPY
Sbjct: 259 GRDLLQNLLKCNPVQRISAEEALQHPY 285

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  257 bits (659), Expect = 1e-85
 Identities = 71/211 (33%), Positives = 108/211 (51%), Gaps = 11/211 (5%)

Query: 1   MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
            + DL  ++ +     +    +  +  LL GL YIH   ++HRD+K +N+L+  +  LK+
Sbjct: 106 CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL 165

Query: 60  CDFGLARP-----TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
            DFGLAR       S+    T  VVT WYR PELLL   DY   ID+W  GCI  E+  R
Sbjct: 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
            P+  GN   HQ+ L+ +L G+ T          E  ++   +L +  ++ +        
Sbjct: 226 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL--ELVKGQKRKVKDRLKAYV 283

Query: 174 --PLAIDLVDRMLTFDPMKRITVDEALAHPY 202
             P A+DL+D++L  DP +RI  D+AL H +
Sbjct: 284 RDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  255 bits (655), Expect = 2e-85
 Identities = 75/232 (32%), Positives = 117/232 (50%), Gaps = 20/232 (8%)

Query: 1   MDTDLYQIIRSN------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN 54
           MD DL + + S       + L     +YF +QLL+GL + H   ++HRDLKP NLL+N  
Sbjct: 85  MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR 144

Query: 55  CDLKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
             LK+ DFGLAR         +  VVT WYRAP++L+ S  Y+ +ID+WS GCI  E++ 
Sbjct: 145 GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADL-GFVRNEDAKRYIRQLPQHPRQSLAQVF--- 169
            +PLFPG +   Q++L+ +++GTP ++      +          + Q P + L QV    
Sbjct: 205 GKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN---PNIQQRPPRDLRQVLQPH 261

Query: 170 --PHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPF 219
               +    +D +  +L  +P  R++  +AL HP+      E          
Sbjct: 262 TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF----AEYYHHASMGGS 309

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  233 bits (595), Expect = 3e-75
 Identities = 73/235 (31%), Positives = 113/235 (48%), Gaps = 33/235 (14%)

Query: 1   MDTDLYQIIRS---------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL 51
            + DL+ II+             L     +  LYQ+L G+ Y+H+  V+HRDLKP+N+L+
Sbjct: 102 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 161

Query: 52  NANCD----LKICDFGLAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 103
                    +KI D G AR    P      +   VVT WYRAPELLL +  YT AID+W+
Sbjct: 162 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 221

Query: 104 VGCIFMELMNRRPLFPGND---------HVHQMRLLIELLGTPTDADL-GFVRNEDAKRY 153
           +GCIF EL+   P+F             H  Q+  +  ++G P D D     +  +    
Sbjct: 222 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTL 281

Query: 154 IRQLPQHP------RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPY 202
           ++   ++        + + +        A  L+ ++LT DP+KRIT ++A+  PY
Sbjct: 282 MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  180 bits (459), Expect = 1e-55
 Identities = 68/237 (28%), Positives = 105/237 (44%), Gaps = 39/237 (16%)

Query: 5   LYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---------- 52
            Y  I+ N       +H +   YQ+ + + ++HS  + H DLKP N+L            
Sbjct: 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162

Query: 53  ---------ANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 103
                     N D+K+ DFG A  T ++E  +  V TR YRAPE++L    ++   DVWS
Sbjct: 163 KIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILALG-WSQPCDVWS 219

Query: 104 VGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP--------------TDADLGFVRNED 149
           +GCI +E      +FP +D    + ++  +LG                    L +  +  
Sbjct: 220 IGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSS 279

Query: 150 AKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL 206
           A RY+ +    P +         H    DL+ +ML +DP KRIT+ EAL HP+   L
Sbjct: 280 AGRYVSR-ACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  180 bits (460), Expect = 1e-55
 Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 39/240 (16%)

Query: 5   LYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---------- 52
            ++ ++ N  Q     H ++  YQL   L+++H   + H DLKP N+L            
Sbjct: 108 TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167

Query: 53  ---------ANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 103
                     N  +++ DFG A  T ++E  T  V TR YR PE++L    +    DVWS
Sbjct: 168 HKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWS 224

Query: 104 VGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP--------------TDADLGFVRNED 149
           +GCI  E      LF  +++   + ++ ++LG                    L +  N  
Sbjct: 225 IGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSS 284

Query: 150 AKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE 209
             RY+++  +  +  + Q     H    DL+ RML FDP +RIT+ EAL HP+ A L  E
Sbjct: 285 DGRYVKENCKPLKSYMLQDSLE-HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  182 bits (463), Expect = 2e-55
 Identities = 72/237 (30%), Positives = 113/237 (47%), Gaps = 35/237 (14%)

Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCD 56
           +  +LY++I+ N  Q  S    + F + +L+ L  +H   +IH DLKP N+LL       
Sbjct: 181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240

Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           +K+ DFG +    E++ +  Y+ +R+YRAPE++L +  Y   ID+WS+GCI  EL+   P
Sbjct: 241 IKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYP 297

Query: 117 LFPGNDHVHQMRLLIELLGTP--------TDADLGFVRNED------------------- 149
           L PG D   Q+  +IELLG P          A                            
Sbjct: 298 LLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGG 357

Query: 150 -AKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
            ++R   + P   R+    +     PL +D + + L +DP  R+T  +AL HP+L R
Sbjct: 358 RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  177 bits (450), Expect = 7e-54
 Identities = 69/248 (27%), Positives = 109/248 (43%), Gaps = 42/248 (16%)

Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLL--NAN 54
           +  +LY ++R+   + +S    + F  Q+   L ++ +   ++IH DLKP N+LL     
Sbjct: 138 LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197

Query: 55  CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
             +KI DFG +      + + +Y+ +R+YR+PE+LL    Y  AID+WS+GCI +E+   
Sbjct: 198 SAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTG 254

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTD--------ADLGFVRNEDA---------------- 150
            PLF G + V QM  ++E+LG P          A   F +  D                 
Sbjct: 255 EPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKP 314

Query: 151 ---------KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHP 201
                           P   R   +      +    DL+ RML +DP  RI    AL H 
Sbjct: 315 PGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHS 374

Query: 202 YLARLHDE 209
           +  +  DE
Sbjct: 375 FFKKTADE 382

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  176 bits (449), Expect = 8e-54
 Identities = 61/246 (24%), Positives = 96/246 (39%), Gaps = 29/246 (11%)

Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCD- 56
           +  +L  +I+    + +   + +    QLL GL Y+H    +IH D+KP N+L+      
Sbjct: 112 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171

Query: 57  -----LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
                +KI D G A     +E  T  + TR YR+PE+LL +  +    D+WS  C+  EL
Sbjct: 172 ENLIQIKIADLGNA--CWYDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFEL 228

Query: 112 MNRRPLFPGND------HVHQMRLLIELLGTPTDADL-------GFVRNEDAKRYIRQLP 158
           +    LF  ++          +  +IELLG      L        F  +    R I +L 
Sbjct: 229 ITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 288

Query: 159 QHPRQ----SLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
             P +       +          D +  ML  DP KR      + HP+L       +  V
Sbjct: 289 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348

Query: 215 CPEPFS 220
                 
Sbjct: 349 PDRELY 354

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  172 bits (437), Expect = 4e-52
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 45/241 (18%)

Query: 5   LYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---------- 52
           LY+II  N       E  + +  ++L+ L Y+   ++ H DLKP N+LL+          
Sbjct: 122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181

Query: 53  ---------------ANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTA 97
                           +  +K+ DFG A  T ++++    + TR YRAPE++LN   +  
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNLG-WDV 238

Query: 98  AIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP--------TDADLGFVRNED 149
           + D+WS GC+  EL     LF  ++H+  + ++  ++           T  +     N+D
Sbjct: 239 SSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKD 298

Query: 150 AKRYIRQLPQHPRQSLAQVFPHV-------HPLAIDLVDRMLTFDPMKRITVDEALAHPY 202
             +           S+  V   +       H L  D +  +L  DP  R +  E L H +
Sbjct: 299 ELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKF 358

Query: 203 L 203
           L
Sbjct: 359 L 359

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  161 bits (409), Expect = 2e-48
 Identities = 48/226 (21%), Positives = 88/226 (38%), Gaps = 44/226 (19%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 111 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 169

Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A    P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229

Query: 109 MELMNRRPLFPG-NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             +   +  F    + + ++  +I+                    +  + P         
Sbjct: 230 YYMTYGKTPFQQIINQISKLHAIID------------------PNHEIEFP--------- 262

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP 213
                     D++   L  DP +RI++ E LAHPY+       ++ 
Sbjct: 263 --DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 306

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  160 bits (407), Expect = 1e-47
 Identities = 35/208 (16%), Positives = 59/208 (28%), Gaps = 25/208 (12%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  +                 QL+R    + S  ++H    P NL +  +  L + D   
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 65  ARPTSENEFMTEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
                         V   Y   E L  +++ +T A++ W +G     +      F     
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             +       L  P    L F                           +      L+ R 
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAF----------------------GSCTPLPDFVKTLIGRF 336

Query: 184 LTFDPMKRITVDEALAHPYLARLHDEAD 211
           L FD  +R+   EA+  P   +L +E  
Sbjct: 337 LNFDRRRRLLPLEAMETPEFLQLQNEIS 364

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  157 bits (399), Expect = 4e-47
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 45/222 (20%)

Query: 4   DLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            LY +I S N +   +       Q+L  L YIHS  +IHRDLKP N+ ++ + ++KI DF
Sbjct: 101 TLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160

Query: 63  GLAR---------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 107
           GLA+                   ++ +T  + T  Y A E+L  +  Y   ID++S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220

Query: 108 FMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
           F E++   P   G + V+ ++ L                       I   P         
Sbjct: 221 FFEMIY--PFSTGMERVNILKKLR-------------------SVSIEFPPDFD------ 253

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE 209
              +   +   ++  ++  DP KR      L   +L   H +
Sbjct: 254 --DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  156 bits (396), Expect = 3e-46
 Identities = 52/257 (20%), Positives = 95/257 (36%), Gaps = 44/257 (17%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 92  NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 150

Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A    P + +      V T  Y  PE + + S            +   DVWS+GCI 
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210

Query: 109 MELMNRRPLFPG-NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             +   +  F    + + ++  +I+                    +  + P         
Sbjct: 211 YYMTYGKTPFQQIINQISKLHAIID------------------PNHEIEFP--------- 243

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQS 227
                     D++   L  DP +RI++ E LAHPY+       ++          +    
Sbjct: 244 --DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQ 301

Query: 228 LGEEQIKDMIYQEALAL 244
           L      + I + A  L
Sbjct: 302 LVGLNSPNSILKAAKTL 318

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  155 bits (394), Expect = 2e-45
 Identities = 51/257 (19%), Positives = 94/257 (36%), Gaps = 44/257 (17%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           + DL   ++  +S+     + +   +L  +  IH   ++H DLKP+N L+  +  LK+ D
Sbjct: 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 197

Query: 62  FGLAR---PTSENEFMTEYVVTRWYRAPELLLNSSD----------YTAAIDVWSVGCIF 108
           FG+A    P + +      V    Y  PE + + S            +   DVWS+GCI 
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

Query: 109 MELMNRRPLFPG-NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             +   +  F    + + ++  +I+                    +  + P         
Sbjct: 258 YYMTYGKTPFQQIINQISKLHAIID------------------PNHEIEFP--------- 290

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQS 227
                     D++   L  DP +RI++ E LAHPY+       ++          +    
Sbjct: 291 --DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQ 348

Query: 228 LGEEQIKDMIYQEALAL 244
           L      + I + A  L
Sbjct: 349 LVGLNSPNSILKAAKTL 365

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  151 bits (383), Expect = 1e-44
 Identities = 43/215 (20%), Positives = 82/215 (38%), Gaps = 22/215 (10%)

Query: 4   DLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---- 56
            LY ++    +   L E      L  ++ G+ ++    ++HR++KP N++     D    
Sbjct: 95  SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154

Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD-------YTAAIDVWSVGCIFM 109
            K+ DFG AR   ++E       T  Y  P++   +         Y A +D+WS+G  F 
Sbjct: 155 YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214

Query: 110 ELMNRRPLFPGNDHVHQMRLLIE--LLGTPTDADLGFVRNEDAK-RYIRQLPQHPRQSLA 166
                   F   +   + + ++   + G P+ A  G  + E+    +   +P     S  
Sbjct: 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-- 272

Query: 167 QVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHP 201
                +  L   ++  +L  D  K    D+  A  
Sbjct: 273 ---RGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  148 bits (376), Expect = 6e-44
 Identities = 47/211 (22%), Positives = 75/211 (35%), Gaps = 38/211 (18%)

Query: 4   DLYQII--RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
            L Q I  R  + L +        Q+ +G+ YIHS  +I+RDLKPSN+ L     +KI D
Sbjct: 106 TLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FGL      +   T    T  Y +PE + +   Y   +D++++G I  EL+         
Sbjct: 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELL--HVCDTA- 221

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
               +       L                 R    +                     L+ 
Sbjct: 222 ---FETSKFFTDL-----------------RDGI-IS-----------DIFDKKEKTLLQ 249

Query: 182 RMLTFDPMKRITVDEALAHPYLARLHDEADE 212
           ++L+  P  R    E L    + +   E +E
Sbjct: 250 KLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  147 bits (372), Expect = 4e-43
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 32/210 (15%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           +    +LSE+  +  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG +   
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

Query: 69  SENEFMTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
              E + E   T  Y APE++  S +     Y   +D+WS G I   L+   P F     
Sbjct: 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK- 233

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             QM +L  ++      +  F   E                    +        DLV R 
Sbjct: 234 --QMLMLRMIM----SGNYQFGSPE--------------------WDDYSDTVKDLVSRF 267

Query: 184 LTFDPMKRITVDEALAHPYLARLHDEADEP 213
           L   P KR T +EALAHP+  +   E    
Sbjct: 268 LVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  147 bits (374), Expect = 4e-43
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 31/206 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 100 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++     Y  A+D WS+G I    ++  P F
Sbjct: 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
             ++H  Q+ L  ++          F+                       +  V   A+D
Sbjct: 220 --SEHRTQVSLKDQITS----GKYNFIPEV--------------------WAEVSEKALD 253

Query: 179 LVDRMLTFDPMKRITVDEALAHPYLA 204
           LV ++L  DP  R T +EAL HP+L 
Sbjct: 254 LVKKLLVVDPKARFTTEEALRHPWLQ 279

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  149 bits (379), Expect = 4e-43
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 31/206 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKIC 60
           +L+  +  N+ L E  C+ + YQ+L  ++Y+H   +IHRDLKP N+LL++   +C +KI 
Sbjct: 225 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLF 118
           DFG ++   E   M     T  Y APE+L++     Y  A+D WS+G I    ++  P F
Sbjct: 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
             +     ++  I      T     F+                       +  V   A+D
Sbjct: 345 SEHRTQVSLKDQI------TSGKYNFIPEV--------------------WAEVSEKALD 378

Query: 179 LVDRMLTFDPMKRITVDEALAHPYLA 204
           LV ++L  DP  R T +EAL HP+L 
Sbjct: 379 LVKKLLVVDPKARFTTEEALRHPWLQ 404

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  146 bits (370), Expect = 1e-42
 Identities = 49/203 (24%), Positives = 69/203 (33%), Gaps = 35/203 (17%)

Query: 4   DLYQII-RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L Q       SL E     +L   L  L ++HS  ++H D+KP+N+ L      K+ DF
Sbjct: 142 SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDF 201

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           GL                  Y APELL     Y  A DV+S+G   +E+     L  G +
Sbjct: 202 GLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGE 259

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
              Q+R                                P          +      ++  
Sbjct: 260 GWQQLRQGY---------------------------LPPE-----FTAGLSSELRSVLVM 287

Query: 183 MLTFDPMKRITVDEALAHPYLAR 205
           ML  DP  R T +  LA P L +
Sbjct: 288 MLEPDPKLRATAEALLALPVLRQ 310

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  148 bits (376), Expect = 1e-42
 Identities = 45/207 (21%), Positives = 77/207 (37%), Gaps = 38/207 (18%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-----NANCDLKICDF 62
           + + + +         L Q   GL ++HS N++HRDLKP N+L+     +      I DF
Sbjct: 108 VEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167

Query: 63  GLAR----PTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRP 116
           GL +            +    T  + APE+L        T  +D++S GC+F  +++   
Sbjct: 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
              G     Q  +L+                                       H   +A
Sbjct: 228 HPFGKSLQRQANILL-------------------GACSLDCLHPE--------KHEDVIA 260

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYL 203
            +L+++M+  DP KR +    L HP+ 
Sbjct: 261 RELIEKMIAMDPQKRPSAKHVLKHPFF 287

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  143 bits (363), Expect = 3e-41
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 32/207 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  + ++H+ N++HRDLKP N+LL+ N  +++ DFG
Sbjct: 186 ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELMNRRPLF 118
            +      E + E   T  Y APE+L  S D     Y   +D+W+ G I   L+   P F
Sbjct: 246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                  Q+ +L  ++         F   E                    +        D
Sbjct: 306 WHRR---QILMLRMIME----GQYQFSSPE--------------------WDDRSSTVKD 338

Query: 179 LVDRMLTFDPMKRITVDEALAHPYLAR 205
           L+ R+L  DP  R+T ++AL HP+  R
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFER 365

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  142 bits (359), Expect = 7e-41
 Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 35/210 (16%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICDFGLAR- 66
             +    E+     + Q+   L Y+H+  + HRD+KP N L   N + ++K+ DFGL++ 
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219

Query: 67  ----PTSENEFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMNRRPLFPGN 121
                  E   MT    T ++ APE+L  +++ Y    D WS G +   L+     FPG 
Sbjct: 220 FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV 279

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
           +         + +    +  L F                        +  + PLA DL+ 
Sbjct: 280 ND-------ADTISQVLNKKLCFENPN--------------------YNVLSPLARDLLS 312

Query: 182 RMLTFDPMKRITVDEALAHPYLARLHDEAD 211
            +L  +  +R     AL HP++++  D+  
Sbjct: 313 NLLNRNVDERFDAMRALQHPWISQFSDKIY 342

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  140 bits (356), Expect = 8e-41
 Identities = 44/227 (19%), Positives = 81/227 (35%), Gaps = 49/227 (21%)

Query: 4   DLYQIIRSNQSLS---EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +L   +    ++       C +   Q+   ++++HS  ++HRDLKPSN+    +  +K+ 
Sbjct: 101 NLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160

Query: 61  DFGLAR-------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 107
           DFGL               P       T  V T+ Y +PE +  +S Y+  +D++S+G I
Sbjct: 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLI 219

Query: 108 FMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             EL+   P     + V  +  +                                     
Sbjct: 220 LFELL--YPFSTQMERVRTLTDVRN------------------------------LKFPP 247

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
           +F   +P    +V  ML+  PM+R      + +     L       +
Sbjct: 248 LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVL 294

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  144 bits (365), Expect = 2e-40
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 32/214 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      +E      + Q+L G+ Y+H  N++HRDLKP NLLL     +  +KI 
Sbjct: 122 ELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV 181

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+      + M E + T +Y APE+L     Y    DVWS+G I   L+   P F G
Sbjct: 182 DFGLSAVFENQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGG 239

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   +L ++          F   E                    + +V   A DL+
Sbjct: 240 Q---TDQEILRKVE----KGKYTFDSPE--------------------WKNVSEGAKDLI 272

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
            +ML FD  +RI+  +AL HP++  +  + +  +
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKEMCSKKESGI 306

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  141 bits (357), Expect = 2e-40
 Identities = 42/205 (20%), Positives = 82/205 (40%), Gaps = 34/205 (16%)

Query: 4   DLYQII--RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DL++ I  +      E+    +  Q+   LK++H   ++HRD+K  N+ L  +  +++ D
Sbjct: 109 DLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGD 168

Query: 62  FGLARPTSENEFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           FG+AR  +    +    + T +Y +PE+  N   Y    D+W++GC+  EL   +  F  
Sbjct: 169 FGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEA 227

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
               + +  +I                         +  H    L             LV
Sbjct: 228 GSMKNLVLKII-------------------SGSFPPVSLHYSYDLR-----------SLV 257

Query: 181 DRMLTFDPMKRITVDEALAHPYLAR 205
            ++   +P  R +V+  L   ++A+
Sbjct: 258 SQLFKRNPRDRPSVNSILEKGFIAK 282

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  142 bits (359), Expect = 2e-40
 Identities = 43/214 (20%), Positives = 81/214 (37%), Gaps = 22/214 (10%)

Query: 4   DLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---- 56
            LY ++    +   L E      L  ++ G+ ++    ++HR++KP N++     D    
Sbjct: 95  SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154

Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD-------YTAAIDVWSVGCIFM 109
            K+ DFG AR   ++E       T  Y  P++   +         Y A +D+WS+G  F 
Sbjct: 155 YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214

Query: 110 ELMNRRPLFPGNDHVHQMRLLIE--LLGTPTDADLGFVRNE-DAKRYIRQLPQHPRQSLA 166
                   F   +   + + ++   + G P+ A  G  + E     +   +P     S  
Sbjct: 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-- 272

Query: 167 QVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH 200
                +  L   ++  +L  D  K    D+  A 
Sbjct: 273 ---RGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  139 bits (352), Expect = 3e-40
 Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 43/202 (21%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG 
Sbjct: 96  VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155

Query: 65  ARPTSENEFMT-----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           +     +         +Y+       PE ++    +   +D+WS+G +  E +  +P F 
Sbjct: 156 SVHAPSSRRTDLCGTLDYL------PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            N +    + +          +  F             P             V   A DL
Sbjct: 209 ANTYQETYKRISR-------VEFTF-------------P-----------DFVTEGARDL 237

Query: 180 VDRMLTFDPMKRITVDEALAHP 201
           + R+L  +P +R  + E L HP
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHP 259

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  143 bits (363), Expect = 3e-40
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 32/216 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL   + + +++I 
Sbjct: 112 ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 171

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+     ++ M + + T +Y APE+L     Y    DVWS G I   L++  P F G
Sbjct: 172 DFGLSTHFEASKKMKDKIGTAYYIAPEVL--HGTYDEKCDVWSTGVILYILLSGCPPFNG 229

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +   +  +L ++          F   +                    +  V   A DL+
Sbjct: 230 AN---EYDILKKVE----KGKYTFELPQ--------------------WKKVSESAKDLI 262

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCP 216
            +MLT+ P  RI+  +AL H ++     E      P
Sbjct: 263 RKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  138 bits (350), Expect = 5e-40
 Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 31/201 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 91  ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I   L+   P F  
Sbjct: 151 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D   Q RL  ++          +   E                    +  V P A  L+
Sbjct: 210 ED---QHRLYAQIKA----GAYDYPSPE--------------------WDTVTPEAKSLI 242

Query: 181 DRMLTFDPMKRITVDEALAHP 201
           D MLT +P KRIT D+AL  P
Sbjct: 243 DSMLTVNPKKRITADQALKVP 263

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  144 bits (363), Expect = 1e-39
 Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 16/218 (7%)

Query: 4   DLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---L 57
           DL + +   ++   L E   +  L  +   L+Y+H   +IHRDLKP N++L         
Sbjct: 104 DLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIH 163

Query: 58  KICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           KI D G A+   + E  TE+V T  Y APELL     YT  +D WS G +  E +     
Sbjct: 164 KIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFR- 221

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ-HPRQSLAQVFPHVHPLA 176
            P   +   ++   ++     +  + +     A ++   LP  +    +           
Sbjct: 222 -PFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG------KL 274

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV 214
              +  ML +   +R T  +         L       +
Sbjct: 275 ERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  142 bits (359), Expect = 1e-39
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 32/213 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I +     E      + Q+L G+ Y+H  N++HRD+KP N+LL   N+  ++KI 
Sbjct: 132 ELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+   S++  + + + T +Y APE+L     Y    DVWS G I   L+   P F G
Sbjct: 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGG 249

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +      ++ ++          F  N+                    + ++   A +L+
Sbjct: 250 QN---DQDIIKKVE----KGKYYFDFND--------------------WKNISDEAKELI 282

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEP 213
             MLT+D  KR T +EAL   ++ +  +  ++ 
Sbjct: 283 KLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  138 bits (349), Expect = 1e-39
 Identities = 44/219 (20%), Positives = 82/219 (37%), Gaps = 49/219 (22%)

Query: 4   DLYQIIRSNQSLS---EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +L   +    SL       C +   Q+   ++++HS  ++HRDLKPSN+    +  +K+ 
Sbjct: 147 NLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 206

Query: 61  DFGLAR-------------PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 107
           DFGL               P       T  V T+ Y +PE  ++ ++Y+  +D++S+G I
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLI 265

Query: 108 FMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             EL+         + V  +  +                            + P      
Sbjct: 266 LFELLY--SFSTQMERVRIITDVRN-------------------------LKFP-----L 293

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL 206
           +F   +P    +V  ML+  P +R    + + +     L
Sbjct: 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  138 bits (349), Expect = 2e-39
 Identities = 67/235 (28%), Positives = 106/235 (45%), Gaps = 35/235 (14%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFGL
Sbjct: 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187

Query: 65  A-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A +   + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F     
Sbjct: 188 ATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SC 245

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           + +  L I              +NE    Y   +P            H++P+A  L+ +M
Sbjct: 246 LKETYLRI-------------KKNE----Y--SIP-----------KHINPVAASLIQKM 275

Query: 184 LTFDPMKRITVDEALAHPYLAR--LHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           L  DP  R T++E L   +     +           P  F     SL     K +
Sbjct: 276 LQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  137 bits (348), Expect = 3e-39
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 33/208 (15%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGL 64
           +    + +SE      + Q+L G+ Y+H  N++H DLKP N+LL       D+KI DFG+
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180

Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFPGNDH 123
           +R       + E + T  Y APE +LN    T A D+W++G I +M L +  P F G D+
Sbjct: 181 SRKIGHACELREIMGTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSP-FVGEDN 238

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                   E     +  ++ +                        F  V  LA D +  +
Sbjct: 239 Q-------ETYLNISQVNVDYSEET--------------------FSSVSQLATDFIQSL 271

Query: 184 LTFDPMKRITVDEALAHPYLARLHDEAD 211
           L  +P KR T +  L+H +L +   E  
Sbjct: 272 LVKNPEKRPTAEICLSHSWLQQWDFENL 299

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  140 bits (356), Expect = 3e-39
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 32/212 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I   +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL     +CD+KI 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+    +N  M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYG 224

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +   +  +L  +          F   +                    +  +   A DL+
Sbjct: 225 KN---EYDILKRVE----TGKYAFDLPQ--------------------WRTISDDAKDLI 257

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADE 212
            +MLTF P  RIT  + L HP++ +   E   
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  136 bits (345), Expect = 3e-39
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 32/214 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKI 59
           +L+  +   +SL+E+    FL Q+L G+ Y+HS  + H DLKP N++L      N  +K+
Sbjct: 94  ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 153

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG+A              T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 154 IDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 212

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G           E L   +  +  F                        F +   LA D 
Sbjct: 213 GETKQ-------ETLTNISAVNYDFDEEY--------------------FSNTSELAKDF 245

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHDEADEP 213
           + R+L  DP +R+T+ ++L H ++  +       
Sbjct: 246 IRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  136 bits (344), Expect = 3e-39
 Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 41/212 (19%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLLNAN 54
           DL  +I    +  Q L EE     + QL   LK  H  +     V+HRDLKP+N+ L+  
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152

Query: 55  CDLKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            ++K+ DFGLAR    +  F   +V T +Y +PE +   S Y    D+WS+GC+  EL  
Sbjct: 153 QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCA 211

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
             P F       ++   I                   +   R++P      L        
Sbjct: 212 LMPPFTAFSQ-KELAGKIR------------------EGKFRRIPYRYSDEL-------- 244

Query: 174 PLAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
               +++ RML      R +V+E L +P +  
Sbjct: 245 ---NEIITRMLNLKDYHRPSVEEILENPLILE 273

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  136 bits (344), Expect = 4e-39
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 32/201 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I   +  SE      + Q+  G+ Y+H  N++HRDLKP N+LL     +CD+KI 
Sbjct: 107 ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+    +N  M + + T +Y APE+L  +  Y    DVWS G I   L++  P F G
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYG 224

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +   +  +L  +          F   +                    +  +   A DL+
Sbjct: 225 KN---EYDILKRVE----TGKYAFDLPQ--------------------WRTISDDAKDLI 257

Query: 181 DRMLTFDPMKRITVDEALAHP 201
            +MLTF P  RIT  + L HP
Sbjct: 258 RKMLTFHPSLRITATQCLEHP 278

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  135 bits (343), Expect = 5e-39
 Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 32/213 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ +   +   E      +  +L  + Y H  NV HRDLKP N L    + +  LK+ 
Sbjct: 92  ELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLI 151

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA      + M   V T +Y +P++L     Y    D WS G +   L+   P F  
Sbjct: 152 DFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSA 209

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                   +++++     +    F   +                    + +V P A  L+
Sbjct: 210 PT---DSEVMLKIR----EGTFTFPEKD--------------------WLNVSPQAESLI 242

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEP 213
            R+LT  P +RIT  +AL H +  +    +   
Sbjct: 243 RRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  137 bits (348), Expect = 6e-39
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 31/213 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKIC 60
           +L++ I + +  SE    + + Q+L  + Y HS  ++HR+LKP NLLL +      +K+ 
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   +++E    +  T  Y +PE +L    Y+  +D+W+ G I   L+   P F  
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D   Q RL  ++          +   E                    +  V P A  L+
Sbjct: 233 ED---QHRLYAQIK----AGAYDYPSPE--------------------WDTVTPEAKSLI 265

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEP 213
           D MLT +P KRIT D+AL  P++      A   
Sbjct: 266 DSMLTVNPKKRITADQALKVPWICNRERVASAI 298

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  137 bits (348), Expect = 8e-39
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 30/209 (14%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICDFGLA 65
           I   +  +SE     ++ Q   GLK++H  +++H D+KP N++        +KI DFGLA
Sbjct: 139 IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198

Query: 66  RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
              + +E +     T  + APE +++        D+W++G +   L++    F G D + 
Sbjct: 199 TKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL- 256

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                 E L      D  F  +                     F  V P A D +  +L 
Sbjct: 257 ------ETLQNVKRCDWEFDEDA--------------------FSSVSPEAKDFIKNLLQ 290

Query: 186 FDPMKRITVDEALAHPYLARLHDEADEPV 214
            +P KR+TV +AL HP+L   H      +
Sbjct: 291 KEPRKRLTVHDALEHPWLKGDHSNLTSRI 319

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  135 bits (342), Expect = 9e-39
 Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 43/218 (19%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           LY+ ++ +    E+    F+ +L   L Y H   VIHRD+KP NLL+    +LKI DFG 
Sbjct: 101 LYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW 160

Query: 65  ARPTSENEFMT-----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           +         T     +Y+       PE ++    +   +D+W  G +  E +   P F 
Sbjct: 161 SVHAPSLRRRTMCGTLDYL------PPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
              H    R ++         DL F             P           P +   + DL
Sbjct: 214 SPSHTETHRRIVN-------VDLKF-------------P-----------PFLSDGSKDL 242

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPE 217
           + ++L + P +R+ +   + HP++         PV   
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQS 280

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  135 bits (343), Expect = 1e-38
 Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 32/210 (15%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGLA 65
           I  S   L+E     +++Q+   L+++HS N+ H D++P N++     +  +KI +FG A
Sbjct: 92  INTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151

Query: 66  RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFPGNDHV 124
           R     +          Y APE +      + A D+WS+G + ++ L    P F    + 
Sbjct: 152 RQLKPGDNFRLLFTAPEYYAPE-VHQHDVVSTATDMWSLGTLVYVLLSGINP-FLAETNQ 209

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
                  +++    +A+  F                        F  +   A+D VDR+L
Sbjct: 210 -------QIIENIMNAEYTFDEEA--------------------FKEISIEAMDFVDRLL 242

Query: 185 TFDPMKRITVDEALAHPYLARLHDEADEPV 214
             +   R+T  EAL HP+L +  +     V
Sbjct: 243 VKERKSRMTASEALQHPWLKQKIERVSTKV 272

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  135 bits (343), Expect = 1e-38
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 32/214 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKI 59
           +L+  +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N++L         +K+
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA    +         T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 219

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+          E L   T     F                        F H   LA D 
Sbjct: 220 GDTKQ-------ETLANITSVSYDFDEEF--------------------FSHTSELAKDF 252

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHDEADEP 213
           + ++L  +  KR+T+ EAL HP++  + ++    
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  136 bits (344), Expect = 2e-38
 Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 24/215 (11%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
                +  +  +  +  +L    YIH+  N+ HRD+KPSN+L++ N  +K+ DFG +   
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202

Query: 69  SENEFMT-----EYVVTRWYRAPELLLNSSDY-TAAIDVWSVGCIFMELMNRRPLFPGND 122
            + +        E++       PE   N S Y  A +D+WS+G     +      F    
Sbjct: 203 VDKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
            + ++   I         ++ +  + +   Y     +    +       +    ID +  
Sbjct: 257 SLVELFNNIR------TKNIEYPLDRNHFLYPLTNKKSTCSN-----NFLSNEDIDFLKL 305

Query: 183 MLTFDPMKRITVDEALAHPYLARLHDEADEPVCPE 217
            L  +P +RIT ++AL H +LA  + E       E
Sbjct: 306 FLRKNPAERITSEDALKHEWLADTNIEDLREFSKE 340

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  134 bits (340), Expect = 2e-38
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 33/198 (16%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L ++ +  ++L+E   +Y+L Q++ G +Y+H   VIHRDLK  NL LN + ++KI DFGL
Sbjct: 102 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161

Query: 65  A-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A +   + E       T  Y APE +L+   ++  +DVWS+GCI   L+  +P F     
Sbjct: 162 ATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SC 219

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           + +  L I                   K+    +P            H++P+A  L+ +M
Sbjct: 220 LKETYLRI-------------------KKNEYSIP-----------KHINPVAASLIQKM 249

Query: 184 LTFDPMKRITVDEALAHP 201
           L  DP  R T++E L   
Sbjct: 250 LQTDPTARPTINELLNDE 267

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  135 bits (342), Expect = 4e-38
 Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 32/209 (15%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGL 64
           +   +SLSEE    F+ Q+L G+ Y+H+  + H DLKP N++L         +K+ DFGL
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165

Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
           A    +         T  + APE ++N        D+WS+G I   L++    F G+   
Sbjct: 166 AHEIEDGVEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
                  E L   T     F                        F     LA D + ++L
Sbjct: 225 -------ETLANITAVSYDFDEEF--------------------FSQTSELAKDFIRKLL 257

Query: 185 TFDPMKRITVDEALAHPYLARLHDEADEP 213
             +  KR+T+ EAL HP++  +  +    
Sbjct: 258 VKETRKRLTIQEALRHPWITPVDTQQAMV 286

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  133 bits (338), Expect = 8e-38
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 25/214 (11%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I+  +  SE    Y + +L+  + ++H   V+HRDLKP NLL    N N ++KI 
Sbjct: 92  ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKII 151

Query: 61  DFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFG AR    +N+ +     T  Y APE LLN + Y  + D+WS+G I   +++ +  F 
Sbjct: 152 DFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            +D        +E++      D  F                        + +V   A DL
Sbjct: 211 SHDRSLTCTSAVEIMKKIKKGDFSFEGEA--------------------WKNVSQEAKDL 250

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHDEADEP 213
           +  +LT DP KR+ +     + +L      +  P
Sbjct: 251 IQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  133 bits (338), Expect = 8e-38
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 32/211 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKI 59
           +L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N++L         +KI
Sbjct: 100 ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFGLA              T  + APE ++N        D+WS+G I   L++    F 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFL 218

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+          E L   +  +  F                        F +   LA D 
Sbjct: 219 GDTKQ-------ETLANVSAVNYEFEDEY--------------------FSNTSALAKDF 251

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHDEA 210
           + R+L  DP KR+T+ ++L HP++     + 
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  134 bits (339), Expect = 9e-38
 Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 30/219 (13%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD----LKI 59
           +L   I   +  SE      L+ + + ++Y+H+  V+HRDLKPSN+L          ++I
Sbjct: 102 ELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRI 161

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           CDFG A+   +EN  +     T  + APE+L     Y AA D+WS+G +   ++     F
Sbjct: 162 CDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPF 220

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                     +L  +                                   +  V   A D
Sbjct: 221 ANGPDDTPEEILARIG----SGKFSLSGGY--------------------WNSVSDTAKD 256

Query: 179 LVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPE 217
           LV +ML  DP +R+T    L HP++          +  +
Sbjct: 257 LVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQ 295

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  131 bits (333), Expect = 1e-37
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 34/199 (17%)

Query: 5   LYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           + + +++     SE   ++F++Q++ G+ Y+HS  ++HRDL  SNLLL  N ++KI DFG
Sbjct: 98  MNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG 157

Query: 64  LA-RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           LA +    +E       T  Y +PE +   S +    DVWS+GC+F  L+  RP F   D
Sbjct: 158 LATQLKMPHEKHYTLCGTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIGRPPFDT-D 215

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
            V      +        AD                P             +   A DL+ +
Sbjct: 216 TVKNTLNKV------VLADYEM-------------P-----------SFLSIEAKDLIHQ 245

Query: 183 MLTFDPMKRITVDEALAHP 201
           +L  +P  R+++   L HP
Sbjct: 246 LLRRNPADRLSLSSVLDHP 264

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  132 bits (335), Expect = 3e-37
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 28/207 (13%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++++HS N+ HRD+KP NLL      +  LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T++N   T    T +Y APE+L     Y  + D+WS+G I   L+   P F  N     
Sbjct: 180 ETTQNALQTP-CYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSN---TG 234

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF 186
             +   +         GF   E                    +  V   A  L+  +L  
Sbjct: 235 QAISPGMKRRIRLGQYGFPNPE--------------------WSEVSEDAKQLIRLLLKT 274

Query: 187 DPMKRITVDEALAHPYLARLHDEADEP 213
           DP +R+T+ + + HP++ +       P
Sbjct: 275 DPTERLTITQFMNHPWINQSMVVPQTP 301

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  132 bits (335), Expect = 3e-37
 Identities = 57/204 (27%), Positives = 86/204 (42%), Gaps = 30/204 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      SE      + Q+L  + Y+H   ++HRDLKP NLL      +  LKI 
Sbjct: 134 ELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIA 193

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL++       M     T  Y APE+L   + Y   +D+WSVG I   L+     F  
Sbjct: 194 DFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPF-- 250

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D      +   +L    + +  F+                       +  V   A DLV
Sbjct: 251 YDERGDQFMFRRIL----NCEYYFISPW--------------------WDEVSLNAKDLV 286

Query: 181 DRMLTFDPMKRITVDEALAHPYLA 204
            +++  DP KR+T  +AL HP++ 
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPWVT 310

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  130 bits (330), Expect = 4e-37
 Identities = 54/195 (27%), Positives = 82/195 (42%), Gaps = 33/195 (16%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLAR 66
              ++LSE +    + Q++  L Y HS +V+H+DLKP N+L    + +  +KI DFGLA 
Sbjct: 116 ARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
               +E  T    T  Y APE+     D T   D+WS G +   L+     F G      
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-- 231

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF 186
                E+    T  +  +                 R         + P A+DL+ +MLT 
Sbjct: 232 -----EVQQKATYKEPNY-------------AVECR--------PLTPQAVDLLKQMLTK 265

Query: 187 DPMKRITVDEALAHP 201
           DP +R +  + L H 
Sbjct: 266 DPERRPSAAQVLHHE 280

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  132 bits (334), Expect = 8e-37
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 30/199 (15%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICDFGLA 65
           II  + +L+E     F+ Q+  G++++H   ++H DLKP N+L        +KI DFGLA
Sbjct: 177 IIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236

Query: 66  RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
           R     E +     T  + APE ++N    +   D+WSVG I   L++    F G++   
Sbjct: 237 RRYKPREKLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA- 294

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                 E L             E                    F  +   A + + ++L 
Sbjct: 295 ------ETLNNILACRWDLEDEE--------------------FQDISEEAKEFISKLLI 328

Query: 186 FDPMKRITVDEALAHPYLA 204
            +   RI+  EAL HP+L+
Sbjct: 329 KEKSWRISASEALKHPWLS 347

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  134 bits (340), Expect = 1e-36
 Identities = 46/205 (22%), Positives = 81/205 (39%), Gaps = 30/205 (14%)

Query: 8   IIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICDFGLA 65
           +   +  +SE+    ++ Q+ +GL ++H  N +H DLKP N++     + +LK+ DFGL 
Sbjct: 245 VADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304

Query: 66  RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
                 + +     T  + APE +          D+WSVG +   L++    F G +   
Sbjct: 305 AHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD- 362

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                 E L      D     +                     F  +     D + ++L 
Sbjct: 363 ------ETLRNVKSCDWNMDDSA--------------------FSGISEDGKDFIRKLLL 396

Query: 186 FDPMKRITVDEALAHPYLARLHDEA 210
            DP  R+T+ +AL HP+L   +   
Sbjct: 397 ADPNTRMTIHQALEHPWLTPGNAPG 421

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  130 bits (329), Expect = 3e-36
 Identities = 57/208 (27%), Positives = 83/208 (39%), Gaps = 33/208 (15%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLAR 66
            +    SE    +++ Q+L  L+Y H  N+IHRD+KP  +LL     +  +K+  FG+A 
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181

Query: 67  PTSEN-EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
              E+       V T  + APE ++    Y   +DVW  G I   L++    F G     
Sbjct: 182 QLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-- 238

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
                  L              +                    + H+   A DLV RML 
Sbjct: 239 ------RLFEGIIKGKYKMNPRQ--------------------WSHISESAKDLVRRMLM 272

Query: 186 FDPMKRITVDEALAHPYLARLHDEADEP 213
            DP +RITV EAL HP+L      A + 
Sbjct: 273 LDPAERITVYEALNHPWLKERDRYAYKI 300

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  128 bits (324), Expect = 7e-36
 Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 35/208 (16%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
           DL ++I    +  + + E     +  QL   L+++HS  V+HRD+KP+N+ + A   +K+
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKL 177

Query: 60  CDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            D GL R  +S+       V T +Y +PE +  +  Y    D+WS+GC+  E+   +  F
Sbjct: 178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPF 236

Query: 119 PGND-HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
            G+  +++ +   IE                  +     LP            H      
Sbjct: 237 YGDKMNLYSLCKKIE------------------QCDYPPLPS----------DHYSEELR 268

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYLAR 205
            LV+  +  DP KR  V           
Sbjct: 269 QLVNMCINPDPEKRPDVTYVYDVAKRMH 296

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  128 bits (323), Expect = 7e-36
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 32/204 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      +E+     + Q+L  +KY+H   ++HRDLKP NLL      N  + I 
Sbjct: 92  ELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMIT 151

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL++   +N  M+    T  Y APE+L     Y+ A+D WS+G I   L+   P F  
Sbjct: 152 DFGLSK-MEQNGIMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYE 209

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                + +L  ++     +    F                        +  +   A D +
Sbjct: 210 ET---ESKLFEKIK----EGYYEFESPF--------------------WDDISESAKDFI 242

Query: 181 DRMLTFDPMKRITVDEALAHPYLA 204
             +L  DP +R T ++AL+HP++ 
Sbjct: 243 CHLLEKDPNERYTCEKALSHPWID 266

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  127 bits (322), Expect = 7e-36
 Identities = 44/225 (19%), Positives = 76/225 (33%), Gaps = 59/225 (26%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN----- 54
            L   I    R      E   +  L Q+ RGL+YIHS +++H D+KPSN+ ++       
Sbjct: 97  SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNA 156

Query: 55  --------------CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAID 100
                            KI D G    T  +    E      + A E+L  +  +    D
Sbjct: 157 ASEEGDEDDWASNKVMFKIGDLGHV--TRISSPQVE-EGDSRFLANEVLQENYTHLPKAD 213

Query: 101 VWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH 160
           ++++    +      PL    D  H++R                      +  + ++PQ 
Sbjct: 214 IFALALTVVCAAGAEPLPRNGDQWHEIR----------------------QGRLPRIPQV 251

Query: 161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
             Q              +L+  M+  DP +R +    + H  L  
Sbjct: 252 LSQEF-----------TELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  129 bits (325), Expect = 1e-35
 Identities = 30/216 (13%), Positives = 65/216 (30%), Gaps = 48/216 (22%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L     +++SL          Q++R L  +H   ++H  L+P +++L+    + +  F 
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 64  LARPTSENEFMTEYVVTRWYRAPELL----------LNSSDYTAAIDVWSVGCIFMELMN 113
                          V+R +  PEL              +  T + D W++G +   +  
Sbjct: 252 HLVRDGA---RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
                  +  +     +                     R  + +P               
Sbjct: 309 ADLPITKDAALGGSEWIF--------------------RSCKNIP--------------- 333

Query: 174 PLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE 209
                L++  L +    R+   +A+  P   +L  E
Sbjct: 334 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  129 bits (325), Expect = 2e-35
 Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 35/211 (16%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL      N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212

Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
            T+ +  +T    T +Y APE+L     Y  + D+WS+G I   L+   P F  N     
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNH---- 267

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQ----LPQHPRQSLAQVFPHVHPLAIDLVDR 182
                   G      +        K  IR      P          +  V      L+  
Sbjct: 268 --------GLAISPGM--------KTRIRMGQYEFPNPE-------WSEVSEEVKMLIRN 304

Query: 183 MLTFDPMKRITVDEALAHPYLARLHDEADEP 213
           +L  +P +R+T+ E + HP++ +       P
Sbjct: 305 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  127 bits (321), Expect = 2e-35
 Identities = 51/214 (23%), Positives = 75/214 (35%), Gaps = 44/214 (20%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI 59
            L+  I         L+E+   + L  + RGL+ IH+    HRDLKP+N+LL       +
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175

Query: 60  CDFGLARPTS----------ENEFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCI 107
            D G                  +       T  YRAPEL    S        DVWS+GC+
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235

Query: 108 FMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
              +M     +           L              V+N+        +PQ PR S   
Sbjct: 236 LYAMMFGEGPYDMVFQKGDSVALA-------------VQNQ------LSIPQSPRHS--- 273

Query: 168 VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHP 201
                      L++ M+T DP +R  +   L+  
Sbjct: 274 ------SALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  129 bits (325), Expect = 3e-35
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 51/218 (23%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-------------NANCDL 57
           + +   E +    L Q+  G+ ++HS  +IHRDLKP N+L+               N  +
Sbjct: 108 NLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167

Query: 58  KICDFGLARPTSENEF-----MTEYVVTRWYRAPELLLNSSD------YTAAIDVWSVGC 106
            I DFGL +     +      +     T  +RAPELL  S++       T +ID++S+GC
Sbjct: 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227

Query: 107 IFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL 165
           +F  ++++ +  F                           R  +  R I  L +      
Sbjct: 228 VFYYILSKGKHPFGDKYS----------------------RESNIIRGIFSLDEMKCLHD 265

Query: 166 AQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
                 +   A DL+ +M+  DP+KR T  + L HP  
Sbjct: 266 ----RSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  128 bits (323), Expect = 9e-35
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 32/214 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L++ I + +  SE    + + Q+L  + + H   V+HR+LKP NLLL        +K+ 
Sbjct: 96  ELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLA 155

Query: 61  DFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLA     E +    +  T  Y +PE+L     Y   +D+W+ G I   L+   P F 
Sbjct: 156 DFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFW 214

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
             D   Q RL  ++          F   E                    +  V P A DL
Sbjct: 215 DED---QHRLYQQIK----AGAYDFPSPE--------------------WDTVTPEAKDL 247

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHDEADEP 213
           +++MLT +P KRIT  EAL HP+++     A   
Sbjct: 248 INKMLTINPSKRITAAEALKHPWISHRSTVASCM 281

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  125 bits (315), Expect = 1e-34
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 32/196 (16%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL-ARP 67
           + + + LSE+  +++   L++G++Y+H   +IHRD+KPSNLL+  +  +KI DFG+    
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 68  TSENEFMTEYVVTRWYRAPELLLNSS-DYT-AAIDVWSVGCIFMELMNRRPLFPGNDHVH 125
              +  ++  V T  + APE L  +   ++  A+DVW++G      +  +  F   + + 
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIM 246

Query: 126 QMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLT 185
            +   I                   K    + P  P  +             DL+ RML 
Sbjct: 247 CLHSKI-------------------KSQALEFPDQPDIA---------EDLKDLITRMLD 278

Query: 186 FDPMKRITVDEALAHP 201
            +P  RI V E   HP
Sbjct: 279 KNPESRIVVPEIKLHP 294

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  125 bits (315), Expect = 2e-34
 Identities = 45/207 (21%), Positives = 83/207 (40%), Gaps = 36/207 (17%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFG 63
           L Q+I+    L E+   Y+L Q L GL+Y+H+  ++H D+K  N+LL+++     +CDFG
Sbjct: 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196

Query: 64  LARPTSENEFMTEYVV------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
            A     +      +       T  + APE+++      A +D+WS  C+ + ++N    
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHP 255

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           +       +  L +++   P                   + + P        P   PL  
Sbjct: 256 WT---QYFRGPLCLKIASEPPP-----------------IREIP--------PSCAPLTA 287

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYLA 204
             +   L  +P+ R +  E       A
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVGKA 314

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  124 bits (313), Expect = 3e-34
 Identities = 50/237 (21%), Positives = 104/237 (43%), Gaps = 33/237 (13%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  + ++  + E+  +    Q++  ++Y H   ++HRDLK  NLLL+A+ ++KI DFG
Sbjct: 100 EVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG 159

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            +   +    +  +     Y APEL          +DVWS+G I   L++    F G  +
Sbjct: 160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QN 218

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           + ++R  +                    R   ++P            ++     +L+ R 
Sbjct: 219 LKELRERV-------------------LRGKYRIP-----------FYMSTDCENLLKRF 248

Query: 184 LTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           L  +P+KR T+++ +   ++   H+E +     EP     +Q+ +  + +  M Y +
Sbjct: 249 LVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRI--DIMVGMGYSQ 303

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  119 bits (301), Expect = 1e-32
 Identities = 46/208 (22%), Positives = 83/208 (39%), Gaps = 35/208 (16%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA---RPTSEN 71
                   +  QL+ GL+Y+HS  ++H+D+KP NLLL     LKI   G+A    P + +
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165

Query: 72  EFMTEYVVTRWYRAPELLLNSSDYT-AAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLL 130
           +       +  ++ PE+      ++   +D+WS G     +      F G D+++++   
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFEN 224

Query: 131 IELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
           I                    +    +P               P   DL+  ML ++P K
Sbjct: 225 I-------------------GKGSYAIP-----------GDCGPPLSDLLKGMLEYEPAK 254

Query: 191 RITVDEALAHPYLARLHDEADEPVCPEP 218
           R ++ +   H +  + H  A+ PV   P
Sbjct: 255 RFSIRQIRQHSWFRKKHPPAEAPVPIPP 282

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  119 bits (300), Expect = 3e-32
 Identities = 50/251 (19%), Positives = 88/251 (35%), Gaps = 44/251 (17%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  I  +  L E    Y   QL+  + Y+   ++IHRD+K  N+++  +  +K+ DFG
Sbjct: 116 DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            A      +    +  T  Y APE+L+ +      +++WS+G     L+     F     
Sbjct: 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF----- 230

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                                    + +  +      P          V    + LV  +
Sbjct: 231 ------------------------CELEETVEAAIHPP--------YLVSKELMSLVSGL 258

Query: 184 LTFDPMKRITVDEALAHP------YLARLHDEADEPVC-PEPFSFDFEQQSLGEEQIKDM 236
           L   P +R T+++ +  P       LA    E    V  PE          +G   + D+
Sbjct: 259 LQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDV 318

Query: 237 IYQEALALNPG 247
              + L    G
Sbjct: 319 AQAQELCGGEG 329

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  118 bits (297), Expect = 3e-32
 Identities = 48/200 (24%), Positives = 81/200 (40%), Gaps = 31/200 (15%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFGL
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 151

Query: 65  A---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           A   R  +    + +   T  Y APELL     +   +DVWS G +   ++      P +
Sbjct: 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 209

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
                 +   +                  ++     P          +  +    + L+ 
Sbjct: 210 QPSDSCQEYSDWK----------------EKKTYLNP----------WKKIDSAPLALLH 243

Query: 182 RMLTFDPMKRITVDEALAHP 201
           ++L  +P  RIT+ +     
Sbjct: 244 KILVENPSARITIPDIKKDR 263

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  118 bits (299), Expect = 3e-32
 Identities = 58/249 (23%), Positives = 94/249 (37%), Gaps = 33/249 (13%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFGL
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 151

Query: 65  A---RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           A   R  +    + +   T  Y APELL     +   +DVWS G +   ++      P +
Sbjct: 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 209

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
                 +   +                  ++     P          +  +    + L+ 
Sbjct: 210 QPSDSCQEYSDWK----------------EKKTYLNP----------WKKIDSAPLALLH 243

Query: 182 RMLTFDPMKRITVDEALAHP-YLARLHDEADEP-VCPEPFSFDFEQQSLGEEQIKDMIYQ 239
           ++L  +P  RIT+ +      Y   L   A  P V     S      S   +   D    
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPV 303

Query: 240 EALALNPGF 248
            + +  PG 
Sbjct: 304 NSASRTPGS 312

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  118 bits (298), Expect = 4e-32
 Identities = 47/219 (21%), Positives = 78/219 (35%), Gaps = 43/219 (19%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLA 65
           I   +  +E      +  +   L ++H+  + HRDLKP N+L    N    +KICDF L 
Sbjct: 102 IHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161

Query: 66  RPTSENEFMTEYVVTRW--------YRAPELLLNSSD----YTAAIDVWSVGCIFMELMN 113
                N   +               Y APE++   S+    Y    D+WS+G I   L++
Sbjct: 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTD--------ADLGFVRNEDAKRYIRQLPQHPRQSL 165
             P F G           E      +            F   +                 
Sbjct: 222 GYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD----------------- 264

Query: 166 AQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA 204
              + H+   A DL+ ++L  D  +R++  + L HP++ 
Sbjct: 265 ---WAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (295), Expect = 8e-32
 Identities = 50/209 (23%), Positives = 82/209 (39%), Gaps = 33/209 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDF 62
            L +        +E+   ++  Q+L GLKY+H   ++HRD+K  N+L+N  +  LKI DF
Sbjct: 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDF 167

Query: 63  GLARPTSENEFMTEYVV-TRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMNRRPLFPG 120
           G ++  +     TE    T  Y APE++      Y  A D+WS+GC  +E+   +P  P 
Sbjct: 168 GTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PF 225

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDL 179
            +       +             F         +     HP        P  +   A   
Sbjct: 226 YELGEPQAAM-------------F--------KVGMFKVHPE------IPESMSAEAKAF 258

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHD 208
           + +    DP KR   ++ L   +L     
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  116 bits (294), Expect = 2e-31
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 39/242 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I   + ++E+  + F  Q++  ++Y H   ++HRDLKP NLLL+ N ++KI DFG
Sbjct: 94  ELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFG 153

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+   ++  F+     +  Y APE++         +DVWS G +   ++  R  F   + 
Sbjct: 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EF 212

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           +  +   +                      +  +P             + P A  L+ RM
Sbjct: 213 IPNLFKKV-------------------NSCVYVMP-----------DFLSPGAQSLIRRM 242

Query: 184 LTFDPMKRITVDEALAHP--------YLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKD 235
           +  DPM+RIT+ E    P        YL  + +           S   E     E+ I +
Sbjct: 243 IVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVE 302

Query: 236 MI 237
            +
Sbjct: 303 AL 304

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  118 bits (297), Expect = 2e-31
 Identities = 27/214 (12%), Positives = 59/214 (27%), Gaps = 47/214 (21%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L     +++SL          Q++R L  +H   ++H  L+P +++L+    + +  F  
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257

Query: 65  ARPTSENEFM--TEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPLF 118
                 +               A  +L     + +  T A D W++G     +       
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL--- 175
             +                                              +F     +   
Sbjct: 318 TDDA--------------------------------------ALGGSEWIFRSCKNIPQP 339

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE 209
              L++  L +    R+   +A+  P   +L  E
Sbjct: 340 VRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  117 bits (294), Expect = 3e-31
 Identities = 60/240 (25%), Positives = 91/240 (37%), Gaps = 28/240 (11%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICD 61
           +LY+ I +    SE+  ++F  QLL G+ Y HS  + HRDLK  N LL  +    LKICD
Sbjct: 102 ELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD 161

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FG ++ +  +      V T  Y APE+LL         DVWS G     ++     F   
Sbjct: 162 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
           +     R  I+ +                      +P             + P    L+ 
Sbjct: 222 EEPRDYRKTIQRI----------------LSVKYSIPDD---------IRISPECCHLIS 256

Query: 182 RMLTFDPMKRITVDEALAHP-YLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           R+   DP  RI++ E   H  +L  L  +            + EQ     + I  +I + 
Sbjct: 257 RIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEA 316

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  115 bits (291), Expect = 5e-31
 Identities = 47/222 (21%), Positives = 81/222 (36%), Gaps = 45/222 (20%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDF 62
           DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           G      +  +   +  TR Y  PE +     +  +  VWS+G +  +++     F    
Sbjct: 195 GSGALLKDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---- 249

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                                    E  +  IR                V      L+  
Sbjct: 250 -------------------------EHDEEIIRGQVFFR--------QRVSSECQHLIRW 276

Query: 183 MLTFDPMKRITVDEALAHPYL------ARLHDEADEPVCPEP 218
            L   P  R T +E   HP++          +     + P P
Sbjct: 277 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGP 318

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  115 bits (290), Expect = 5e-31
 Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 42/223 (18%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDF 62
           DL+  I     L E   + F  Q++  +++ HS  V+HRD+K  N+L++      K+ DF
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           G      +  +   +  TR Y  PE +     +     VWS+G +  +++      P   
Sbjct: 185 GSGALLHDEPYTD-FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD--IP--- 238

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                                F R+++        P            HV P    L+ R
Sbjct: 239 ---------------------FERDQEILEAELHFP-----------AHVSPDCCALIRR 266

Query: 183 MLTFDPMKRITVDEALAHPYLARLHDEADEP---VCPEPFSFD 222
            L   P  R +++E L  P++    ++         P P ++ 
Sbjct: 267 CLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWS 309

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  115 bits (290), Expect = 9e-31
 Identities = 54/240 (22%), Positives = 93/240 (38%), Gaps = 53/240 (22%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICD 61
           +  + + S   LS +      YQ  R ++++H     +IHRDLK  NLLL+    +K+CD
Sbjct: 122 EFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181

Query: 62  FGLARP---------TSENEFMTEYVVTR----WYRAPEL--LLNSSDYTAAIDVWSVGC 106
           FG A           +++   + E  +TR     YR PE+  L ++       D+W++GC
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC 241

Query: 107 IFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA 166
           I   L  R+  F       ++R++                     +Y   +P H  Q   
Sbjct: 242 ILYLLCFRQHPFEDG---AKLRIV-------------------NGKY--SIPPHDTQY-- 275

Query: 167 QVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQ 226
                   +   L+  ML  +P +R+++ E +           A       P +   EQ 
Sbjct: 276 -------TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA---AARNVNPKSPITELLEQN 325

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  113 bits (286), Expect = 1e-30
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 31/198 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   +    Q+L  + Y H   V+HRDLKP N+LL+A+ + KI DFG
Sbjct: 97  ELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 156

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+   S+ EF+     +  Y APE++         +D+WS G I   L+     F   +H
Sbjct: 157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EH 215

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           V  +   I                   +  +  +P            +++     L+  M
Sbjct: 216 VPTLFKKI-------------------RGGVFYIP-----------EYLNRSVATLLMHM 245

Query: 184 LTFDPMKRITVDEALAHP 201
           L  DP+KR T+ +   H 
Sbjct: 246 LQVDPLKRATIKDIREHE 263

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  114 bits (286), Expect = 2e-29
 Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 36/233 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  N  L E+  +    Q+L G+ Y H   V+HRDLKP N+LL+A+ + KI DFG
Sbjct: 102 ELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 161

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           L+   S+ EF+     +  Y APE++         +D+WS G I   L+     F   DH
Sbjct: 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DH 220

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           V  +   I                      I   P            +++P  I L+  M
Sbjct: 221 VPTLFKKI-------------------CDGIFYTP-----------QYLNPSVISLLKHM 250

Query: 184 LTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           L  DPMKR T+ +   H +      + D P    P    +    + +E +K++
Sbjct: 251 LQVDPMKRATIKDIREHEWF-----KQDLPKYLFPEDPSYSSTMIDDEALKEV 298

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  110 bits (278), Expect = 3e-29
 Identities = 45/207 (21%), Positives = 74/207 (35%), Gaps = 48/207 (23%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLAR 66
           R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL      N  LK+ DFG   
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-- 166

Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
                             A E       Y  + D+WS+G I   L+   P F  N  +  
Sbjct: 167 ------------------AKETTGEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF 186
              +   +         F   E                    +  V      L+  +L  
Sbjct: 207 SPGMKTRIRM---GQYEFPNPE--------------------WSEVSEEVKMLIRNLLKT 243

Query: 187 DPMKRITVDEALAHPYLARLHDEADEP 213
           +P +R+T+ E + HP++ +       P
Sbjct: 244 EPTQRMTITEFMNHPWIMQSTKVPQTP 270

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  111 bits (279), Expect = 4e-29
 Identities = 47/220 (21%), Positives = 96/220 (43%), Gaps = 17/220 (7%)

Query: 1   MDTD-LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLK 58
           MD   L Q+++    + E+        +++GL Y+     ++HRD+KPSN+L+N+  ++K
Sbjct: 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK 172

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           +CDFG++    ++   + +V TR Y +PE  L  + Y+   D+WS+G   +E+   R   
Sbjct: 173 LCDFGVSGQLIDSMANS-FVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV------ 172
           P  D      +    +           R          +   P  ++ ++  ++      
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290

Query: 173 -------HPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
                       D V++ L  +P +R  + + + H ++ R
Sbjct: 291 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  111 bits (278), Expect = 1e-28
 Identities = 64/277 (23%), Positives = 101/277 (36%), Gaps = 82/277 (29%)

Query: 1   MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNAN--- 54
           +   L + I  +  Q L     +  + Q+L+GL Y+H+   +IH D+KP N+LL+ N   
Sbjct: 127 LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186

Query: 55  ----------------------------------------------CDLKICDFGLARPT 68
                                                           +KI D G A   
Sbjct: 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV 246

Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN------- 121
            ++   TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF  +       
Sbjct: 247 HKH--FTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR 303

Query: 122 --DHVHQMRLLIELLGTPTDADLGFVRNEDAKRY------IRQLPQHPRQSLAQVFPHVH 173
             DH+  +   IELLG      +     + +K +      ++ + +     L +V    +
Sbjct: 304 DEDHIALI---IELLGKVPRKLIV--AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358

Query: 174 PL-------AIDLVDRMLTFDPMKRITVDEALAHPYL 203
                      D +  ML   P KR T  E L HP+L
Sbjct: 359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  108 bits (273), Expect = 1e-28
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 36/213 (16%)

Query: 1   MDT---DLY-QIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANC 55
           MDT     Y Q+I   Q++ E+        +++ L+++HS  +VIHRD+KPSN+L+NA  
Sbjct: 88  MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG 147

Query: 56  DLKICDFGLARPTSENEFMTEYVVTRWYRAPE---LLLNSSDYTAAIDVWSVGCIFMELM 112
            +K+CDFG++    ++         + Y APE     LN   Y+   D+WS+G   +EL 
Sbjct: 148 QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 207

Query: 113 NRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV 172
             R  FP +      + L +++  P+                   PQ P    +  F   
Sbjct: 208 ILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPADKFSAEF--- 243

Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
               +D   + L  +  +R T  E + HP+   
Sbjct: 244 ----VDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  105 bits (265), Expect = 2e-27
 Identities = 51/211 (24%), Positives = 80/211 (37%), Gaps = 33/211 (15%)

Query: 1   MDTDLYQII-RSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLK 58
           M T   ++  R    + E         +++ L Y+     VIHRD+KPSN+LL+    +K
Sbjct: 106 MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIK 165

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPE----LLLNSSDYTAAIDVWSVGCIFMELMNR 114
           +CDFG++    +++          Y APE          DY    DVWS+G   +EL   
Sbjct: 166 LCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHP 174
           +  +          +L ++L             E+       LP H   S          
Sbjct: 226 QFPYKNCKTD--FEVLTKVL------------QEEPPL----LPGHMGFS---------G 258

Query: 175 LAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
                V   LT D  KR   ++ L H ++ R
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  105 bits (263), Expect = 3e-27
 Identities = 38/204 (18%), Positives = 80/204 (39%), Gaps = 34/204 (16%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNA-NCDLKICD 61
           L   ++  + +  +  + +  Q+L+GL+++H+    +IHRDLK  N+ +      +KI D
Sbjct: 116 LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            GLA     + F    + T  + APE+      Y  ++DV++ G   +E+      +   
Sbjct: 176 LGLATLKRAS-FAKAVIGTPEFMAPEMY--EEKYDESVDVYAFGMCMLEMATSEYPYSEC 232

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
            +  Q+                         Y R        S  +V     P   ++++
Sbjct: 233 QNAAQI-------------------------YRRVTSGVKPASFDKVA---IPEVKEIIE 264

Query: 182 RMLTFDPMKRITVDEALAHPYLAR 205
             +  +  +R ++ + L H +   
Sbjct: 265 GCIRQNKDERYSIKDLLNHAFFQE 288

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (266), Expect = 4e-27
 Identities = 46/228 (20%), Positives = 80/228 (35%), Gaps = 31/228 (13%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            DL         ++E    Y L  +L+ L YIH    +HR +K S++L++ +  + +   
Sbjct: 114 KDLICT-HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172

Query: 63  GLA--------RPTSENEFMTEYVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMN 113
                      R    ++F    V    + +PE+L  N   Y A  D++SVG    EL N
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232

Query: 114 RRPLFPGNDHVHQMRLLIELL--GTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH 171
               F     +   ++L+E L    P   D   +  E+      +   +   S +     
Sbjct: 233 GHVPF---KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTST 289

Query: 172 VHPLAI----------------DLVDRMLTFDPMKRITVDEALAHPYL 203
             P                     V++ L  +P  R +    L H + 
Sbjct: 290 PRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  105 bits (263), Expect = 4e-27
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 36/206 (17%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +D+ ++   N++L+E+     L   L+GL+Y+H    IHRD+K  N+LLN     K+ DF
Sbjct: 112 SDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADF 169

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G+  + T         + T ++ APE++     Y    D+WS+G   +E+   +P  P  
Sbjct: 170 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKP--P-Y 225

Query: 122 DHVHQMR--LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
             +H MR   +I     PT                        +  +  F        D 
Sbjct: 226 ADIHPMRAIFMIPTNPPPTFRK--------------------PELWSDNF-------TDF 258

Query: 180 VDRMLTFDPMKRITVDEALAHPYLAR 205
           V + L   P +R T  + L HP++  
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRS 284

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  105 bits (264), Expect = 9e-27
 Identities = 44/205 (21%), Positives = 80/205 (39%), Gaps = 33/205 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++ N    EE  + F+ +L+  L Y+ +  +IHRD+KP N+LL+ +  + I DF 
Sbjct: 101 DLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFN 160

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           +A        +T    T+ Y APE+  +   + Y+ A+D WS+G    EL+  R  +   
Sbjct: 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLV 180
                  +                                       +P       + L+
Sbjct: 221 SSTSSKEI-----------------------VHTFETTVVT------YPSAWSQEMVSLL 251

Query: 181 DRMLTFDPMKRI-TVDEALAHPYLA 204
            ++L  +P +R   + +    PY+ 
Sbjct: 252 KKLLEPNPDQRFSQLSDVQNFPYMN 276

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  103 bits (259), Expect = 1e-26
 Identities = 34/128 (26%), Positives = 61/128 (47%), Gaps = 6/128 (4%)

Query: 5   LYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           LY  + +       +       Q  RG+ Y+H+ ++IHRDLK +N+ L+ +  +KI DFG
Sbjct: 106 LYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG 165

Query: 64  LAR---PTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLF 118
           LA      S +    +   +  + APE++       Y+   DV++ G +  ELM  +  +
Sbjct: 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

Query: 119 PGNDHVHQ 126
              ++  Q
Sbjct: 226 SNINNRDQ 233

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (259), Expect = 1e-26
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 38/206 (18%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TD+         + E        + L+ L+++HS  VIHRD+K  N+LL  +  +K+ DF
Sbjct: 105 TDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 160

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G  A+ T E    +  V T ++ APE++     Y   +D+WS+G + +E++   P  P  
Sbjct: 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEP--P-Y 216

Query: 122 DHVHQMR--LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            + + +R   LI   GTP                   L    + S          +  D 
Sbjct: 217 LNENPLRALYLIATNGTPE------------------LQNPEKLS---------AIFRDF 249

Query: 180 VDRMLTFDPMKRITVDEALAHPYLAR 205
           ++R L  D  KR +  E L H +L  
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLKI 275

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  103 bits (258), Expect = 2e-26
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 55/215 (25%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I DFG
Sbjct: 116 ELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 175

Query: 64  LAR--PTSENEFMT-------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
            A+       +          +YV      +PELL        + D+W++GCI  +L+  
Sbjct: 176 TAKVLSPESKQARANSFVGTAQYV------SPELLTE-KSACKSSDLWALGCIIYQLVAG 228

Query: 115 RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVH 173
            P F   +      L+ +                     I +L           FP    
Sbjct: 229 LPPFRAGNE----YLIFQK--------------------IIKLEYD--------FPEKFF 256

Query: 174 PLAIDLVDRMLTFDPMKRIT------VDEALAHPY 202
           P A DLV+++L  D  KR+            AHP+
Sbjct: 257 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  103 bits (259), Expect = 3e-26
 Identities = 63/251 (25%), Positives = 101/251 (40%), Gaps = 55/251 (21%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +DL ++    + L E       +  L+GL Y+HS N+IHRD+K  N+LL+    +K+ DF
Sbjct: 141 SDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 198

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFP 119
           G  +     N F    V T ++ APE++L      Y   +DVWS+G   +EL  R+P  P
Sbjct: 199 GSASIMAPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP--P 252

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
              +++ M  L                          + Q+   +L     H      + 
Sbjct: 253 -LFNMNAMSALY------------------------HIAQNESPALQS--GHWSEYFRNF 285

Query: 180 VDRMLTFDPMKRITVDEALAHP---------YLARLHDEADEPVCPEPFSFDFEQQSLGE 230
           VD  L   P  R T +  L H           +  L     + V         E  +L  
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV--------RELDNLQY 337

Query: 231 EQIKDMIYQEA 241
            ++K +++QEA
Sbjct: 338 RKMKKILFQEA 348

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  103 bits (258), Expect = 3e-26
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 38/206 (18%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TD+         L+EE        +L+ L Y+H+  VIHRD+K  ++LL  +  +K+ DF
Sbjct: 130 TDIVS----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDF 185

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G  A+ + +       V T ++ APE++   S Y   +D+WS+G + +E+++  P  P  
Sbjct: 186 GFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEP--P-Y 241

Query: 122 DHVHQMR--LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                ++    +     P                   L    + S         P+  D 
Sbjct: 242 FSDSPVQAMKRLRDSPPPK------------------LKNSHKVS---------PVLRDF 274

Query: 180 VDRMLTFDPMKRITVDEALAHPYLAR 205
           ++RML  DP +R T  E L HP+L +
Sbjct: 275 LERMLVRDPQERATAQELLDHPFLLQ 300

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (255), Expect = 5e-26
 Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 39/210 (18%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
             +   +  ++ L+E   Q    Q+L  L ++HS  +IHRDLK  N+L+    D+++ DF
Sbjct: 104 DAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADF 161

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPL 117
           G+ A+     +    ++ T ++ APE+++      + Y    D+WS+G   +E+    P 
Sbjct: 162 GVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP- 220

Query: 118 FPGNDHVHQMR--LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
            P +  ++ MR  L I     PT                  L    + S           
Sbjct: 221 -P-HHELNPMRVLLKIAKSDPPT------------------LLTPSKWS---------VE 251

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
             D +   L  +P  R +  + L HP+++ 
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSS 281

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  101 bits (253), Expect = 1e-25
 Identities = 48/213 (22%), Positives = 80/213 (37%), Gaps = 31/213 (14%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +   + +    +  L E      L ++L GL+Y+H    IHRD+K  N+LL  +  ++I 
Sbjct: 104 IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA 163

Query: 61  DFGLARPTSENEFMTE------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR 114
           DFG++   +    +T       +V T  + APE++     Y    D+WS G   +EL   
Sbjct: 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

Query: 115 RPLFPGNDHVHQMR--LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV 172
               P       M+  +L      P+       +    K               + F   
Sbjct: 224 AA--P-YHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKK-------------YGKSF--- 264

Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR 205
                 ++   L  DP KR T  E L H +  +
Sbjct: 265 ----RKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  101 bits (254), Expect = 1e-25
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 35/212 (16%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           TDL +  +   +L EE   Y   ++LRGL ++H   VIHRD+K  N+LL  N ++K+ DF
Sbjct: 115 TDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173

Query: 63  GLARP-TSENEFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPL 117
           G++            ++ T ++ APE++       + Y    D+WS+G   +E+    P 
Sbjct: 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 232

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
            P    +H MR L                          +P++P   L            
Sbjct: 233 -P-LCDMHPMRALF------------------------LIPRNPAPRLKS--KKWSKKFQ 264

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYLARLHDE 209
             ++  L  +  +R   ++ + HP++    +E
Sbjct: 265 SFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 99.7 bits (249), Expect = 6e-25
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 34/218 (15%)

Query: 1   MDT---DLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNAN 54
           M T     Y+ + S  +  + EE         ++ L ++     +IHRD+KPSN+LL+ +
Sbjct: 103 MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS 162

Query: 55  CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMEL 111
            ++K+CDFG++    ++   T     R Y APE +    +   Y    DVWS+G    EL
Sbjct: 163 GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

Query: 112 MNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH 171
              R  +P     + +   +             V   D  +    L     +  +  F  
Sbjct: 223 ATGRFPYP---KWNSVFDQLTQ-----------VVKGDPPQ----LSNSEEREFSPSF-- 262

Query: 172 VHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE 209
                I+ V+  LT D  KR    E L HP++    + 
Sbjct: 263 -----INFVNLCLTKDESKRPKYKELLKHPFILMYEER 295

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 98.6 bits (246), Expect = 1e-24
 Identities = 37/133 (27%), Positives = 57/133 (42%), Gaps = 17/133 (12%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L  II+S            F   +  G+ Y+HS N+IHRDL   N L+  N ++ + DF
Sbjct: 93  TLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADF 152

Query: 63  GLARPTSENEF---------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 107
           GLAR   + +                    V   ++ APE++   S Y   +DV+S G +
Sbjct: 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIV 211

Query: 108 FMELMNRRPLFPG 120
             E++ R    P 
Sbjct: 212 LCEIIGRVNADPD 224

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 99.3 bits (247), Expect = 1e-24
 Identities = 22/135 (16%), Positives = 49/135 (36%), Gaps = 17/135 (12%)

Query: 4   DLYQIIR--SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--------- 52
           +   + +    + + +     F  ++L  ++ +H   +IH D+KP N +L          
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215

Query: 53  --ANCDLKICDFGLARPTS---ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 107
              +  L + D G +       +    T    T  ++  E+L N   +   ID + V   
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAAT 274

Query: 108 FMELMNRRPLFPGND 122
              ++    +   N+
Sbjct: 275 VYCMLFGTYMKVKNE 289

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  100 bits (250), Expect = 3e-24
 Identities = 57/247 (23%), Positives = 104/247 (42%), Gaps = 49/247 (19%)

Query: 4   DL-YQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           DL + I    Q+   E    ++  ++  GL+ +H   +++RDLKP N+LL+ +  ++I D
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD 329

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
            GLA    E + +   V T  Y APE++ N   YT + D W++GC+  E++  +  F   
Sbjct: 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLV 180
                                  ++ E+ +R ++++P+         +     P A  L 
Sbjct: 389 KKK--------------------IKREEVERLVKEVPEE--------YSERFSPQARSLC 420

Query: 181 DRMLTFDPMKRI-----TVDEALAHPYLAR------LHDEADEPVCPEPFS------FDF 223
            ++L  DP +R+     +  E   HP   +           + P  P+P +       D 
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDI 480

Query: 224 EQQSLGE 230
           EQ S  +
Sbjct: 481 EQFSTVK 487

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 96.6 bits (241), Expect = 3e-24
 Identities = 40/127 (31%), Positives = 62/127 (48%), Gaps = 14/127 (11%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLN--------A 53
           L +++   + +  +    +  Q+ RG+ Y+H      +IHRDLK SN+L+         +
Sbjct: 93  LNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151

Query: 54  NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
           N  LKI DFGLAR       M+      W  APE ++ +S ++   DVWS G +  EL+ 
Sbjct: 152 NKILKITDFGLAREWHRTTKMSAAGAYAW-MAPE-VIRASMFSKGSDVWSYGVLLWELLT 209

Query: 114 RRPLFPG 120
               F G
Sbjct: 210 GEVPFRG 216

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 97.4 bits (243), Expect = 4e-24
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 7/123 (5%)

Query: 4   DLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLK 58
            LY+++  + +   L E       Y + +G+ Y+H+ N  ++HR+LK  NLL++    +K
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179

Query: 59  ICDFGLARPTSENEF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           +CDFGL+R  +           T  + APE +L         DV+S G I  EL   +  
Sbjct: 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELATLQQP 238

Query: 118 FPG 120
           +  
Sbjct: 239 WGN 241

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 97.4 bits (243), Expect = 4e-24
 Identities = 30/133 (22%), Positives = 57/133 (42%), Gaps = 16/133 (12%)

Query: 5   LYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           LY ++R     L     +    ++++G+ Y+H+  ++H+DLK  N+  + N  + I DFG
Sbjct: 116 LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174

Query: 64  LAR------PTSENEFMTEYVVTRWYRAPELLLNSSD--------YTAAIDVWSVGCIFM 109
           L             + +        + APE++   S         ++   DV+++G I+ 
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234

Query: 110 ELMNRRPLFPGND 122
           EL  R   F    
Sbjct: 235 ELHAREWPFKTQP 247

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 97.0 bits (242), Expect = 4e-24
 Identities = 44/124 (35%), Positives = 61/124 (49%), Gaps = 10/124 (8%)

Query: 4   DLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLNANCD- 56
            LY ++   +     +  H   +  Q  +G+ Y+HS     +IHRDLKP NLLL A    
Sbjct: 85  SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144

Query: 57  LKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           LKICDFG A        MT    +  + APE +   S+Y+   DV+S G I  E++ RR 
Sbjct: 145 LKICDFGTAC--DIQTHMTNNKGSAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRK 201

Query: 117 LFPG 120
            F  
Sbjct: 202 PFDE 205

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 96.2 bits (240), Expect = 8e-24
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 36/204 (17%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            DL +       L E      L ++L+GL Y+HS   IHRD+K +N+LL+ + ++K+ DF
Sbjct: 108 LDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADF 163

Query: 63  GL-ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           G+  + T        +V T ++ APE++   S Y +  D+WS+G   +EL    P  P +
Sbjct: 164 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEP--PHS 220

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
           + +H M++L                          +P++   +L   +        + V+
Sbjct: 221 E-LHPMKVLF------------------------LIPKNNPPTLEGNYS---KPLKEFVE 252

Query: 182 RMLTFDPMKRITVDEALAHPYLAR 205
             L  +P  R T  E L H ++ R
Sbjct: 253 ACLNKEPSFRPTAKELLKHKFILR 276

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 95.5 bits (238), Expect = 1e-23
 Identities = 28/126 (22%), Positives = 54/126 (42%), Gaps = 11/126 (8%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLL-----NANC 55
           DLY  +      +        +  +  G++Y+ + N  ++HRDL+  N+ L     NA  
Sbjct: 107 DLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV 166

Query: 56  DLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMNR 114
             K+ DFGL++ +  +  ++  +    + APE +    + YT   D +S   I   ++  
Sbjct: 167 CAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

Query: 115 RPLFPG 120
              F  
Sbjct: 225 EGPFDE 230

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.0 bits (244), Expect = 2e-23
 Identities = 45/204 (22%), Positives = 87/204 (42%), Gaps = 34/204 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+           
Sbjct: 338 LACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS------- 389

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                        P        ++E  +  +    + P            P    L++ +
Sbjct: 390 -------------PFRQHKTKDKHEIDRMTLTMAVELP--------DSFSPELRSLLEGL 428

Query: 184 LTFDPMKRI-----TVDEALAHPY 202
           L  D  +R+        E    P+
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPF 452

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 95.1 bits (237), Expect = 2e-23
 Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 19/128 (14%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANCD 56
           LY  ++   +L    C   +  +  GL ++H           + HRDLK  N+L+  N  
Sbjct: 93  LYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151

Query: 57  LKICDFGLARPTSENEFMTEYVV-----TRWYRAPELL-----LNSSDYTAAIDVWSVGC 106
             I D GLA   S++    +        T+ Y APE+L     ++  D    +D+W+ G 
Sbjct: 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211

Query: 107 IFMELMNR 114
           +  E+  R
Sbjct: 212 VLWEVARR 219

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 95.4 bits (238), Expect = 3e-23
 Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 50/197 (25%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ DFG
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186

Query: 64  LARPTSENEFMT-------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
            A+     +  T       E +      APE++L+   Y  A+D W++G +  E+    P
Sbjct: 187 FAK---RVKGRTWTLCGTPEAL------APEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPL 175
            F  +  +     ++           G VR                      FP H    
Sbjct: 237 PFFADQPIQIYEKIVS----------GKVR----------------------FPSHFSSD 264

Query: 176 AIDLVDRMLTFDPMKRI 192
             DL+  +L  D  KR 
Sbjct: 265 LKDLLRNLLQVDLTKRF 281

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 95.2 bits (237), Expect = 3e-23
 Identities = 34/128 (26%), Positives = 51/128 (39%), Gaps = 19/128 (14%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--------VIHRDLKPSNLLLNANCD 56
           LY  ++S  +L  +      Y  + GL ++H+          + HRDLK  N+L+  N  
Sbjct: 122 LYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180

Query: 57  LKICDFGLAR-----PTSENEFMTEYVVTRWYRAPELL-----LNSSDYTAAIDVWSVGC 106
             I D GLA          +      V T+ Y  PE+L      N        D++S G 
Sbjct: 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240

Query: 107 IFMELMNR 114
           I  E+  R
Sbjct: 241 ILWEVARR 248

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.4 bits (240), Expect = 4e-23
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 36/205 (17%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           +Y +   N    E    ++  Q++ GL+++H  N+I+RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335

Query: 65  ARPTSENEFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A      +  T+ Y  T  + APELLL   +Y  ++D +++G    E++  R  F     
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLAIDLVDR 182
                                V N++ K+ + +            +P    P + D  + 
Sbjct: 395 K--------------------VENKELKQRVLEQAVT--------YPDKFSPASKDFCEA 426

Query: 183 MLTFDPMKRI-----TVDEALAHPY 202
           +L  DP KR+     + D    HP 
Sbjct: 427 LLQKDPEKRLGFRDGSCDGLRTHPL 451

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 92.6 bits (231), Expect = 2e-22
 Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 53/211 (25%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+ ++R +Q       +++  ++   L+Y+HS ++I+RDLKP N+LL+ N  +KI DFG
Sbjct: 92  ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 151

Query: 64  LARPTSENEFMT-------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
            A+       +T       +Y+      APE++     Y  +ID WS G +  E++    
Sbjct: 152 FAK---YVPDVTYTLCGTPDYI------APEVVST-KPYNKSIDWWSFGILIYEMLAGYT 201

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
            F  ++ +     ++        A+L F             P           P  +   
Sbjct: 202 PFYDSNTMKTYEKILN-------AELRF-------------P-----------PFFNEDV 230

Query: 177 IDLVDRMLTFDPMKRI-----TVDEALAHPY 202
            DL+ R++T D  +R+       ++   HP+
Sbjct: 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 93.0 bits (232), Expect = 2e-22
 Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 44/206 (21%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E M     T        Y APE+LL    Y  ++D WS G +  E++  +  
Sbjct: 164 MCK-----ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP 217

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F G D   ++   I         +  +                PR         +   A 
Sbjct: 218 FHGQDE-EELFHSI------RMDNPFY----------------PR--------WLEKEAK 246

Query: 178 DLVDRMLTFDPMKRITVDEAL-AHPY 202
           DL+ ++   +P KR+ V   +  HP 
Sbjct: 247 DLLVKLFVREPEKRLGVRGDIRQHPL 272

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 90.8 bits (226), Expect = 5e-22
 Identities = 21/122 (17%), Positives = 44/122 (36%), Gaps = 10/122 (8%)

Query: 5   LYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKIC 60
           LY ++    +  + +     F   + RG+ ++H+    +    L   +++++ +   +I 
Sbjct: 96  LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS 155

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLF 118
              +         M       W  APE L          + D+WS   +  EL+ R   F
Sbjct: 156 MADVKFSFQSPGRMYAP---AWV-APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211

Query: 119 PG 120
             
Sbjct: 212 AD 213

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 91.7 bits (228), Expect = 5e-22
 Identities = 49/207 (23%), Positives = 79/207 (38%), Gaps = 28/207 (13%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA----------NVIHRDLKPSNLLLNAN 54
           L   +++N  +S     +    + RGL Y+H             + HRD+K  N+LL  N
Sbjct: 109 LSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167

Query: 55  CDLKICDFGLAR--PTSENEFMTEYVV-TRWYRAPELL----LNSSDYTAAIDVWSVGCI 107
               I DFGLA      ++   T   V TR Y APE+L        D    ID++++G +
Sbjct: 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227

Query: 108 FMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQ 167
             EL +R     G    + +    E+   P+  D+  V     KR     P         
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR-----PVLRD----Y 278

Query: 168 VFPHVHPLAI-DLVDRMLTFDPMKRIT 193
              H     + + ++     D   R++
Sbjct: 279 WQKHAGMAMLCETIEECWDHDAEARLS 305

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 90.7 bits (226), Expect = 1e-21
 Identities = 38/126 (30%), Positives = 71/126 (56%), Gaps = 12/126 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFG
Sbjct: 91  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           L +     E +++    +       Y APE+L + +DY  A+D W +G +  E+M  R  
Sbjct: 151 LCK-----EGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP 204

Query: 118 FPGNDH 123
           F   DH
Sbjct: 205 FYNQDH 210

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 90.2 bits (224), Expect = 2e-21
 Identities = 30/128 (23%), Positives = 51/128 (39%), Gaps = 19/128 (14%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANCD 56
           L+  +    +++ E           GL ++H           + HRDLK  N+L+  N  
Sbjct: 127 LFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185

Query: 57  LKICDFGLARPTSENEFMTEYVV-----TRWYRAPELLLNSS-----DYTAAIDVWSVGC 106
             I D GLA          +        T+ Y APE+L +S      +     D++++G 
Sbjct: 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245

Query: 107 IFMELMNR 114
           +F E+  R
Sbjct: 246 VFWEIARR 253

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.9 bits (226), Expect = 2e-21
 Identities = 36/172 (20%), Positives = 73/172 (42%), Gaps = 14/172 (8%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  + +  + +  E  +++L +++  +  +H    +HRD+KP N+LL+    +++ DFG 
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208

Query: 65  ARPTSENEFMTEYVV--TRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMNRRP 116
                 +  +   V   T  Y +PE+L        +  Y    D W++G    E+   + 
Sbjct: 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

Query: 117 LFPGNDHVHQMRLLI---ELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL 165
            F  +        ++   E L  P   +      E+A+ +I++L   P   L
Sbjct: 269 PFYADSTAETYGKIVHYKEHLSLPLVDE---GVPEEARDFIQRLLCPPETRL 317

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 90.0 bits (224), Expect = 3e-21
 Identities = 46/212 (21%), Positives = 92/212 (43%), Gaps = 45/212 (21%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +   +  +E   Q ++ +++  L+++H   +I+RD+K  N+LL++N  + + DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204

Query: 64  LARPTSENEFMTEYVVTRW-------YRAPELLL-NSSDYTAAIDVWSVGCIFMELMNRR 115
           L++     EF+ +     +       Y AP+++    S +  A+D WS+G +  EL+   
Sbjct: 205 LSK-----EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
             F  +   +    +   +                   ++  P +P          +  L
Sbjct: 260 SPFTVDGEKNSQAEISRRI-------------------LKSEPPYP--------QEMSAL 292

Query: 176 AIDLVDRMLTFDPMKRI-----TVDEALAHPY 202
           A DL+ R+L  DP KR+       DE   H +
Sbjct: 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 89.6 bits (223), Expect = 4e-21
 Identities = 33/126 (26%), Positives = 60/126 (47%), Gaps = 12/126 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+ ++   E   +++  +++  L ++H   +I+RDLK  N+LL+     K+ DFG
Sbjct: 110 DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 169

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E +   V T        Y APE+L     Y  A+D W++G +  E++     
Sbjct: 170 MCK-----EGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAP 223

Query: 118 FPGNDH 123
           F   + 
Sbjct: 224 FEAENE 229

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 88.8 bits (221), Expect = 5e-21
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 48/210 (22%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +      +EE  +++L +L   L ++HS  +I+RDLKP N+LL+    +K+ DFG
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           L++     E +              Y APE++     +T + D WS G +  E++     
Sbjct: 172 LSK-----ESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP 225

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F G D    M ++++       A LG              P             + P A 
Sbjct: 226 FQGKDRKETMTMILK-------AKLGM-------------P-----------QFLSPEAQ 254

Query: 178 DLVDRMLTFDPMKRI-----TVDEALAHPY 202
            L+  +   +P  R+      V+E   H +
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 88.4 bits (220), Expect = 7e-21
 Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 48/210 (22%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +       E+   ++L ++   L ++H   +I+RDLKP N++LN    +K+ DFG
Sbjct: 107 ELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           L +     E + +  VT        Y APE+L+  S +  A+D WS+G +  +++   P 
Sbjct: 167 LCK-----ESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPP 220

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F G +    +  +++         L               P           P++   A 
Sbjct: 221 FTGENRKKTIDKILK-------CKLNL-------------P-----------PYLTQEAR 249

Query: 178 DLVDRMLTFDPMKRI-----TVDEALAHPY 202
           DL+ ++L  +   R+        E  AHP+
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 89.4 bits (222), Expect = 9e-21
 Identities = 42/206 (20%), Positives = 78/206 (37%), Gaps = 36/206 (17%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  + +    L EE  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG 
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221

Query: 65  ARPTSENEFMTEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMNRRPLF 118
                E+  +   V   T  Y +PE+L         Y    D WS+G    E++     F
Sbjct: 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                V                          + Y + +    R         V   A D
Sbjct: 282 YAESLV--------------------------ETYGKIMNHKERFQFPTQVTDVSENAKD 315

Query: 179 LVDRMLTFDPMKRIT---VDEALAHP 201
           L+ R++      R+    +++   HP
Sbjct: 316 LIRRLIC-SREHRLGQNGIEDFKKHP 340

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.1 bits (219), Expect = 2e-20
 Identities = 33/126 (26%), Positives = 61/126 (48%), Gaps = 12/126 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  ++  +   E   +++  ++   L Y+HS N+++RDLKP N+LL++   + + DFG
Sbjct: 125 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           L +     E +     T        Y APE+L     Y   +D W +G +  E++   P 
Sbjct: 185 LCK-----ENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPP 238

Query: 118 FPGNDH 123
           F   + 
Sbjct: 239 FYSRNT 244

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 87.3 bits (217), Expect = 2e-20
 Identities = 35/126 (27%), Positives = 63/126 (50%), Gaps = 12/126 (9%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++ S  +I+RDLK  N++L++   +KI DFG
Sbjct: 107 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E + + V T+       Y APE++     Y  ++D W+ G +  E++  +  
Sbjct: 167 MCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP 220

Query: 118 FPGNDH 123
           F G D 
Sbjct: 221 FEGEDE 226

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 87.3 bits (217), Expect = 3e-20
 Identities = 44/212 (20%), Positives = 82/212 (38%), Gaps = 42/212 (19%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E +     T        Y APE+L    DY  ++D W++G +  E+M  R  
Sbjct: 156 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 209

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLA 176
           F                                    + + +   +      P  +   A
Sbjct: 210 FDIVGSSDNP------------------DQNTEDYLFQVILEKQIR-----IPRSLSVKA 246

Query: 177 IDLVDRMLTFDPMKRI------TVDEALAHPY 202
             ++   L  DP +R+         +   HP+
Sbjct: 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.2 bits (218), Expect = 3e-20
 Identities = 43/210 (20%), Positives = 86/210 (40%), Gaps = 48/210 (22%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+      E H  ++  ++  GL ++ S  +I+RDLK  N++L++   +KI DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E + + V T+       Y APE++     Y  ++D W+ G +  E++  +  
Sbjct: 488 MCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP 541

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F G D     + ++E        ++ +                P+         +   A+
Sbjct: 542 FEGEDEDELFQSIME-------HNVAY----------------PK--------SMSKEAV 570

Query: 178 DLVDRMLTFDPMKRI-----TVDEALAHPY 202
            +   ++T  P KR+        +   H +
Sbjct: 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.4 bits (217), Expect = 3e-20
 Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 23/167 (13%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL  ++  N  + E+  +++  +++  L  IHS   IHRD+KP N+LL+ +  LK+ DFG
Sbjct: 155 DLVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 213

Query: 64  LARPTSENEFMTEYVV--TRWYRAPELLLN---SSDYTAAIDVWSVGCIFMELMNRRPLF 118
                ++   +       T  Y +PE+L +      Y    D WSVG    E++     F
Sbjct: 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

Query: 119 PGNDHV--------HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL 157
             +  V        H+  L       P D D+     ++AK  I   
Sbjct: 274 YADSLVGTYSKIMNHKNSLTF-----PDDNDIS----KEAKNLICAF 311

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 86.7 bits (215), Expect = 8e-20
 Identities = 41/122 (33%), Positives = 69/122 (56%), Gaps = 3/122 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDF 62
           +L+  +   +  SE+  +++  +++  L Y+HS  NV++RDLK  NL+L+ +  +KI DF
Sbjct: 234 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293

Query: 63  GLARPT-SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           GL +    +   M  +  T  Y APE+L + +DY  A+D W +G +  E+M  R  F   
Sbjct: 294 GLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352

Query: 122 DH 123
           DH
Sbjct: 353 DH 354

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 86.2 bits (214), Expect = 9e-20
 Identities = 44/212 (20%), Positives = 81/212 (38%), Gaps = 42/212 (19%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   ++  + L EEH +++  ++   L Y+H   +I+RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198

Query: 64  LARPTSENEFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           + +     E +     T        Y APE+L    DY  ++D W++G +  E+M  R  
Sbjct: 199 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 252

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP-HVHPLA 176
           F                                    + + +          P  +   A
Sbjct: 253 FDIVGSSDNP------------------DQNTEDYLFQVILEKQ-----IRIPRSLSVKA 289

Query: 177 IDLVDRMLTFDPMKRI------TVDEALAHPY 202
             ++   L  DP +R+         +   HP+
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 84.2 bits (209), Expect = 2e-19
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 9/132 (6%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            DL  ++R    L+       + Q+   L   H+A   HRD+KP N+L++A+    + DF
Sbjct: 119 VDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178

Query: 63  GLARPTSENEF-MTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           G+A  T++ +       V T +Y APE     S  T   D++++ C+  E +   P + G
Sbjct: 179 GIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQG 237

Query: 121 ND------HVHQ 126
           +       H++Q
Sbjct: 238 DQLSVMGAHINQ 249

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 83.0 bits (206), Expect = 6e-19
 Identities = 40/120 (33%), Positives = 62/120 (51%), Gaps = 3/120 (2%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
             L + I S+  LS +    F  Q+L G+K+ H   ++HRD+KP N+L+++N  LKI DF
Sbjct: 96  PTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDF 155

Query: 63  GLARPTSENEFMTEYVV--TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           G+A+  SE        V  T  Y +PE            D++S+G +  E++   P F G
Sbjct: 156 GIAKALSETSLTQTNHVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGEPPFNG 214

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 82.3 bits (204), Expect = 1e-18
 Identities = 34/122 (27%), Positives = 62/122 (50%), Gaps = 5/122 (4%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
             L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DF
Sbjct: 101 VTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 160

Query: 63  GLARPTSENEF---MTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           G+AR  +++      T  V+ T  Y +PE         A  DV+S+GC+  E++   P F
Sbjct: 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPF 219

Query: 119 PG 120
            G
Sbjct: 220 TG 221

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 81.4 bits (201), Expect = 3e-18
 Identities = 32/143 (22%), Positives = 56/143 (39%), Gaps = 24/143 (16%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSA---------NVIHRDLKPSNLLLNANCDLKICD 61
           S  +          + + RGL Y+H+           + HRDL   N+L+  +    I D
Sbjct: 104 SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163

Query: 62  FGLAR---------PTSENEFMTEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGC 106
           FGL+          P  E+      V T  Y APE+L  +            +D++++G 
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

Query: 107 IFMELMNRRPLFPGNDHVHQMRL 129
           I+ E+  R       + V + ++
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQM 246

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 81.1 bits (200), Expect = 9e-18
 Identities = 31/113 (27%), Positives = 52/113 (46%), Gaps = 9/113 (7%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV-TRWYR 84
           ++L  L Y+HS  +++ DLKP N++L     LK+ D G     +       Y+  T  ++
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS----FGYLYGTPGFQ 244

Query: 85  APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTP 137
           APE++      T A D+++VG     L    P   G  +V  +     +L T 
Sbjct: 245 APEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVLKTY 294

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 78.9 bits (195), Expect = 2e-17
 Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 12/117 (10%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   ++ ++  +       +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DF
Sbjct: 99  SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GL +   +++    + V         WY APE L  S  ++ A DVWS G +  EL 
Sbjct: 159 GLTKVLPQDK--EFFKVKEPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 211

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 78.4 bits (194), Expect = 3e-17
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 6/93 (6%)

Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTEYVV-TRWYRA 85
            G+ ++H  + IHRD+K +N+LL+     KI DFGLAR         MT  +V T  Y A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA 203

Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELM-NRRPL 117
           PE L    + T   D++S G + +E++     +
Sbjct: 204 PEAL--RGEITPKSDIYSFGVVLLEIITGLPAV 234

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 78.6 bits (194), Expect = 3e-17
 Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 12/117 (10%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   ++ ++  +       +  Q+ +G++Y+ +   IHRDL   N+L+     +KI DF
Sbjct: 130 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GL +   +++    Y V         WY APE L  S  ++ A DVWS G +  EL 
Sbjct: 190 GLTKVLPQDK--EYYKVKEPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 242

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 76.9 bits (190), Expect = 7e-17
 Identities = 36/126 (28%), Positives = 65/126 (51%), Gaps = 14/126 (11%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFG
Sbjct: 103 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 162

Query: 64  LARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--R 114
           L++    +E    Y          +WY APE  +N   +++  DVWS G +  E  +  +
Sbjct: 163 LSKALRADE--NYYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWEAFSYGQ 218

Query: 115 RPLFPG 120
           +P + G
Sbjct: 219 KP-YRG 223

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 77.3 bits (191), Expect = 7e-17
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 14/126 (11%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R ++ ++  ++   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI DF
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--R 114
           GLA+     E   EY         +W  A E  +    YT   DVWS G    ELM    
Sbjct: 162 GLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYGVTVWELMTFGS 217

Query: 115 RPLFPG 120
           +P + G
Sbjct: 218 KP-YDG 222

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 77.0 bits (190), Expect = 9e-17
 Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 12/117 (10%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L + +  N   ++ +    +  Q+ +G+ Y+ S   +HRDL   N+L+ +   +KI DF
Sbjct: 111 SLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 170

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GL +    ++    Y V         WY APE L+ S  +  A DVWS G    EL+
Sbjct: 171 GLTKAIETDK--EYYTVKDDRDSPVFWY-APECLMQSK-FYIASDVWSFGVTLHELL 223

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 76.6 bits (189), Expect = 2e-16
 Identities = 35/117 (29%), Positives = 58/117 (49%), Gaps = 12/117 (10%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   ++ ++  L       +  Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DF
Sbjct: 112 CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GLA+    ++    YVV         WY APE L ++  ++   DVWS G +  EL 
Sbjct: 172 GLAKLLPLDK--DYYVVREPGQSPIFWY-APESLSDNI-FSRQSDVWSFGVVLYELF 224

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 75.4 bits (186), Expect = 3e-16
 Identities = 38/127 (29%), Positives = 54/127 (42%), Gaps = 15/127 (11%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R +Q          +  Q+  G+ Y+ S   IHRDL   NLLL     +KI DF
Sbjct: 106 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 165

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL R   +N+    YV+         W  APE  L +  ++ A D W  G    E+    
Sbjct: 166 GLMRALPQND--DHYVMQEHRKVPFAWC-APE-SLKTRTFSHASDTWMFGVTLWEMFTYG 221

Query: 114 RRPLFPG 120
           + P + G
Sbjct: 222 QEP-WIG 227

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 74.9 bits (185), Expect = 3e-16
 Identities = 32/127 (25%), Positives = 59/127 (46%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +RS+ + L         Y +  G+ ++ S   IHRDL   N L++ +  +K+ DF
Sbjct: 89  CLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDF 148

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           G+ R   ++    +YV +       +W  APE+      Y++  DVW+ G +  E+ +  
Sbjct: 149 GMTRYVLDD----QYVSSVGTKFPVKWS-APEVFHYFK-YSSKSDVWAFGILMWEVFSLG 202

Query: 114 RRPLFPG 120
           + P +  
Sbjct: 203 KMP-YDL 208

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 75.8 bits (187), Expect = 4e-16
 Identities = 35/133 (26%), Positives = 56/133 (42%), Gaps = 12/133 (9%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           D    +R+    L  +     +     G++Y+ S   IHRDL   N L+     LKI DF
Sbjct: 198 DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257

Query: 63  GLARPTSENEFMTEYVVT----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRP 116
           G++R  ++  +     +     +W  APE L     Y++  DVWS G +  E  +    P
Sbjct: 258 GMSREEADGVYAASGGLRQVPVKWT-APEALNYGR-YSSESDVWSFGILLWETFSLGASP 315

Query: 117 LFPG--NDHVHQM 127
            +P   N    + 
Sbjct: 316 -YPNLSNQQTREF 327

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 76.1 bits (187), Expect = 4e-16
 Identities = 37/116 (31%), Positives = 54/116 (46%), Gaps = 8/116 (6%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
            + + L          Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414

Query: 70  ENEFMTEYVVT---RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
           +NE+          +W  APE       +T   DVWS G +  EL    R P +PG
Sbjct: 415 DNEYTARQGAKFPIKWT-APE-AALYGRFTIKSDVWSFGILLTELTTKGRVP-YPG 467

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 76.0 bits (187), Expect = 4e-16
 Identities = 32/116 (27%), Positives = 54/116 (46%), Gaps = 8/116 (6%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
            + Q +S     Y   Q+   ++Y+   N IHR+L   N L+  N  +K+ DFGL+R  +
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369

Query: 70  ENEFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
            + +          +W  APE  L  + ++   DVW+ G +  E+      P +PG
Sbjct: 370 GDTYTAHAGAKFPIKWT-APE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPG 422

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 75.9 bits (187), Expect = 5e-16
 Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 8/104 (7%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
               Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR   +NE+        
Sbjct: 284 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343

Query: 81  --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
             +W  APE       +T   DVWS G +  EL    R P +PG
Sbjct: 344 PIKWT-APE-AALYGRFTIKSDVWSFGILLTELTTKGRVP-YPG 384

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 74.6 bits (184), Expect = 5e-16
 Identities = 34/127 (26%), Positives = 61/127 (48%), Gaps = 15/127 (11%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L++ +   +  +   +    L+Q+  G+KY+   N +HRDL   N+LL      KI DF
Sbjct: 95  PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 154

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL++    ++  + Y          +WY APE  +N   +++  DVWS G    E ++  
Sbjct: 155 GLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGVTMWEALSYG 210

Query: 114 RRPLFPG 120
           ++P +  
Sbjct: 211 QKP-YKK 216

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 73.8 bits (182), Expect = 8e-16
 Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 6/113 (5%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
           R    L  +    F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S
Sbjct: 109 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168

Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
             +   +  V +W  APE L     ++   DVWS G +  E+ +  R P +P 
Sbjct: 169 STQDTGKLPV-KWT-APEALREKK-FSTKSDVWSFGILLWEIYSFGRVP-YPR 217

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 75.1 bits (185), Expect = 9e-16
 Identities = 41/120 (34%), Positives = 58/120 (48%), Gaps = 16/120 (13%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
                        F  Q+  G+ +I   N IHRDL+ +N+L++A+   KI DFGLAR   
Sbjct: 276 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335

Query: 70  ENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
           +N    EY          +W  APE +   S +T   DVWS G + ME++   R P +PG
Sbjct: 336 DN----EYTAREGAKFPIKWT-APEAINFGS-FTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 74.3 bits (183), Expect = 1e-15
 Identities = 38/108 (35%), Positives = 51/108 (47%), Gaps = 11/108 (10%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
             S+       F  Q+  G+ Y+H+ + IHRDL   N+LL+ +  +KI DFGLA+   E 
Sbjct: 128 RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187

Query: 72  EFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                Y V         WY APE L     +  A DVWS G    EL+
Sbjct: 188 H--EYYRVREDGDSPVFWY-APECLKEYK-FYYASDVWSFGVTLYELL 231

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 73.4 bits (181), Expect = 1e-15
 Identities = 33/127 (25%), Positives = 58/127 (45%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R+ +   + E        +  G+ Y+  A VIHRDL   N L+  N  +K+ DF
Sbjct: 89  CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF 148

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           G+ R   ++    +Y  +       +W  +PE+   S  Y++  DVWS G +  E+ +  
Sbjct: 149 GMTRFVLDD----QYTSSTGTKFPVKWA-SPEVFSFSR-YSSKSDVWSFGVLMWEVFSEG 202

Query: 114 RRPLFPG 120
           + P +  
Sbjct: 203 KIP-YEN 208

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 73.4 bits (181), Expect = 1e-15
 Identities = 36/128 (28%), Positives = 57/128 (44%), Gaps = 18/128 (14%)

Query: 4   DLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           +L   +R    Q +S     Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ D
Sbjct: 95  NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD 154

Query: 62  FGLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN- 113
           FGL+R  + +     Y          +W  APE L  +  ++   DVW+ G +  E+   
Sbjct: 155 FGLSRLMTGD----TYTAHAGAKFPIKWT-APESLAYNK-FSIKSDVWAFGVLLWEIATY 208

Query: 114 -RRPLFPG 120
              P +PG
Sbjct: 209 GMSP-YPG 215

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 74.6 bits (183), Expect = 2e-15
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 15/127 (11%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L++ +   +  +   +    L+Q+  G+KY+   N +HR+L   N+LL      KI DF
Sbjct: 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDF 480

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL++    ++  + Y          +WY APE  +N   +++  DVWS G    E ++  
Sbjct: 481 GLSKALGADD--SYYTARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGVTMWEALSYG 536

Query: 114 RRPLFPG 120
           ++P +  
Sbjct: 537 QKP-YKK 542

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 73.5 bits (181), Expect = 2e-15
 Identities = 31/127 (24%), Positives = 58/127 (45%), Gaps = 16/127 (12%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R ++ +L  +    +  Q+ +G+ Y+    ++HR+L   N+LL +   +++ DF
Sbjct: 100 SLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF 159

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           G+A     ++   + ++        +W  A E +     YT   DVWS G    ELM   
Sbjct: 160 GVADLLPPDD---KQLLYSEAKTPIKWM-ALESIHFGK-YTHQSDVWSYGVTVWELMTFG 214

Query: 114 RRPLFPG 120
             P + G
Sbjct: 215 AEP-YAG 220

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 73.5 bits (181), Expect = 2e-15
 Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 11/116 (9%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R ++ ++  ++   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI DF
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           GLA+     E   EY         +W  A E  +    YT   DVWS G    ELM
Sbjct: 162 GLAKLLGAEE--KEYHAEGGKVPIKWM-ALE-SILHRIYTHQSDVWSYGVTVWELM 213

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 72.7 bits (179), Expect = 2e-15
 Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +L   ++  + SL       + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DF
Sbjct: 101 ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL+R   ++     Y          +W  APE  +N   +T+A DVW  G    E++   
Sbjct: 161 GLSRYMEDS----TYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHG 214

Query: 114 RRPLFPG 120
            +P F G
Sbjct: 215 VKP-FQG 220

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.4 bits (180), Expect = 3e-15
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 12/119 (10%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           ++ +          L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235

Query: 61  DFGLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           DFGLAR   ++    +YV         +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 236 DFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIF 289

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 72.6 bits (179), Expect = 3e-15
 Identities = 39/116 (33%), Positives = 57/116 (49%), Gaps = 8/116 (6%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
            S   L+         Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLAR   
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160

Query: 70  ENEFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
           +NE+          +W  APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 161 DNEYTAREGAKFPIKWT-APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 73.5 bits (181), Expect = 3e-15
 Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 6/113 (5%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
           R    L  +    F   +   ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340

Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
             +   +  V +W  APE L     ++   DVWS G +  E+ +  R P +P 
Sbjct: 341 STQDTGKLPV-KWT-APEALREKK-FSTKSDVWSFGILLWEIYSFGRVP-YPR 389

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 72.4 bits (178), Expect = 4e-15
 Identities = 39/126 (30%), Positives = 60/126 (47%), Gaps = 13/126 (10%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L + +R      S       L  +  G+KY+ + N +HRDL   N+L+N+N   K+ DF
Sbjct: 132 ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 191

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--R 114
           GL+R   ++     Y  +      RW  APE +     +T+A DVWS G +  E+M    
Sbjct: 192 GLSRVLEDDP-EATYTTSGGKIPIRWT-APEAISYRK-FTSASDVWSFGIVMWEVMTYGE 248

Query: 115 RPLFPG 120
           RP +  
Sbjct: 249 RP-YWE 253

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 71.9 bits (177), Expect = 5e-15
 Identities = 30/127 (23%), Positives = 57/127 (44%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R  +     +        +   ++Y+ S   +HRDL   N L+N    +K+ DF
Sbjct: 105 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF 164

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL+R   ++    EY  +       RW   PE+L+ S  +++  D+W+ G +  E+ +  
Sbjct: 165 GLSRYVLDD----EYTSSVGSKFPVRWS-PPEVLMYSK-FSSKSDIWAFGVLMWEIYSLG 218

Query: 114 RRPLFPG 120
           + P +  
Sbjct: 219 KMP-YER 224

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 71.6 bits (176), Expect = 7e-15
 Identities = 33/127 (25%), Positives = 58/127 (45%), Gaps = 15/127 (11%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R++    +       L  +  G++Y+     +HRDL   N+L+++N   K+ DF
Sbjct: 136 SLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL+R   ++        T       RW  APE  +    +++A DVWS G +  E++   
Sbjct: 196 GLSRVLEDDPD--AAYTTTGGKIPIRWT-APE-AIAFRTFSSASDVWSFGVVMWEVLAYG 251

Query: 114 RRPLFPG 120
            RP +  
Sbjct: 252 ERP-YWN 257

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 71.1 bits (175), Expect = 9e-15
 Identities = 32/127 (25%), Positives = 59/127 (46%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +L   +  N+ SL       +  Q+ + + Y+ S N +HRD+   N+L+ +   +K+ DF
Sbjct: 98  ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL+R   +     +Y          +W  +PE  +N   +T A DVW       E+++  
Sbjct: 158 GLSRYIEDE----DYYKASVTRLPIKWM-SPE-SINFRRFTTASDVWMFAVCMWEILSFG 211

Query: 114 RRPLFPG 120
           ++P F  
Sbjct: 212 KQP-FFW 217

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 72.2 bits (177), Expect = 1e-14
 Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 17/127 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           +L   ++  + SL       + YQL   L Y+ S   +HRD+   N+L+++N  +K+ DF
Sbjct: 476 ELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 535

Query: 63  GLARPTSENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-- 113
           GL+R   ++     Y          +W  APE  +N   +T+A DVW  G    E++   
Sbjct: 536 GLSRYMEDS----TYYKASKGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHG 589

Query: 114 RRPLFPG 120
            +P F G
Sbjct: 590 VKP-FQG 595

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 71.1 bits (175), Expect = 1e-14
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
           +N + S     +F  Q+ +G+ ++ S N IHRD+   N+LL      KI DFGLAR    
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +     Y+V        +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 217 DS---NYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIF 260

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 71.6 bits (176), Expect = 1e-14
 Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 16/109 (14%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
             L  +  G+KY+     +HRDL   N+L+N+N   K+ DFGL R   ++    E   T 
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP---EAAYTT 207

Query: 81  -------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG 120
                  RW  +PE  +    +T+A DVWS G +  E+M+   RP +  
Sbjct: 208 RGGKIPIRWT-SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERP-YWE 253

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 69.6 bits (171), Expect = 3e-14
 Identities = 24/118 (20%), Positives = 43/118 (36%), Gaps = 16/118 (13%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL--------KICDFGLARPTSENEF 73
               QL   + ++    +IH ++   N+LL    D         K+ D G++      + 
Sbjct: 117 EVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176

Query: 74  MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--RRPLFPG--NDHVHQM 127
           + E +   W   PE + N  +   A D WS G    E+ +   +P      +    Q 
Sbjct: 177 LQERI--PWV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQF 230

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 70.0 bits (172), Expect = 3e-14
 Identities = 42/109 (38%), Positives = 52/109 (47%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
              +L  E    F YQ+ +G+ ++ S N IHRDL   N+LL      KICDFGLAR    
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +     YVV        +W  APE + N   YT   DVWS G    EL 
Sbjct: 198 DS---NYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGIFLWELF 241

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 68.8 bits (169), Expect = 7e-14
 Identities = 31/113 (27%), Positives = 53/113 (46%), Gaps = 13/113 (11%)

Query: 29  RGLKYIH---SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW--- 82
           RGL Y+H      +IHRD+K +N+LL+   +  + DFGLA+     +    +V T     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTAVRGT 198

Query: 83  --YRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIE 132
             + APE L  +   +   DV+  G + +EL+  +R             +L++
Sbjct: 199 IGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 68.8 bits (169), Expect = 7e-14
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 15/98 (15%)

Query: 29  RGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR--PTSENEFMTEYVV-TRWYRA 85
           RGL Y+H+  +IHRD+K  N+LL+ N   KI DFG+++     +   ++  V  T  Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYID 209

Query: 86  PE-----LLLNSSDYTAAIDVWSVGCIFMELM-NRRPL 117
           PE      L   S      DV+S G +  E++  R  +
Sbjct: 210 PEYFIKGRLTEKS------DVYSFGVVLFEVLCARSAI 241

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 68.4 bits (168), Expect = 8e-14
 Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 12/138 (8%)

Query: 4   DLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL Q IRS  ++ + +    F  Q+ RG++Y+     +HRDL   N +L+ +  +K+ DF
Sbjct: 109 DLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADF 168

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN--R 114
           GLAR   + E+ +           +W  A E L     +T   DVWS G +  EL+    
Sbjct: 169 GLARDILDREYYSVQQHRHARLPVKWT-ALESLQTYR-FTTKSDVWSFGVLLWELLTRGA 226

Query: 115 RPLFPGNDHVHQMRLLIE 132
            P +   D       L +
Sbjct: 227 PP-YRHIDPFDLTHFLAQ 243

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 68.5 bits (168), Expect = 1e-13
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
               L+ E    F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR    
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +     YVV        +W  APE L     YT   DVWS G +  E+ 
Sbjct: 225 DS---NYVVRGNARLPVKWM-APESLFEGI-YTIKSDVWSYGILLWEIF 268

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
               L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR   +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +    +YV         +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 201 DP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIF 244

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 67.4 bits (165), Expect = 3e-13
 Identities = 38/109 (34%), Positives = 54/109 (49%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
             + ++ +      YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  + 
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            +    Y  T       +W  APE L +   YT   DVWS G +  E+ 
Sbjct: 256 ID---YYKKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIF 299

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 67.4 bits (165), Expect = 3e-13
 Identities = 38/107 (35%), Positives = 53/107 (49%), Gaps = 12/107 (11%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
           + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI DFGLAR     +
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 73  FMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
               Y  T       +W  APE L +   YT   DVWS G +  E+ 
Sbjct: 246 ---YYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIF 287

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 66.2 bits (162), Expect = 6e-13
 Identities = 38/109 (34%), Positives = 54/109 (49%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
             + ++ +      YQL RG++Y+ S   IHRDL   N+L+  N  +KI DFGLAR  + 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            +    Y  T       +W  APE L +   YT   DVWS G +  E+ 
Sbjct: 210 ID---YYKKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIF 253

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 66.1 bits (162), Expect = 6e-13
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 12/109 (11%)

Query: 11  SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE 70
             ++L+      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 71  NEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
            +    YV         +W  A E L +   YT   DVWS G +  E++
Sbjct: 203 ED---SYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 65.9 bits (161), Expect = 9e-13
 Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 12/138 (8%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL   IR+   + + +    F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DF
Sbjct: 177 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 236

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-- 114
           GLAR   + EF + +  T      +W  A E L     +T   DVWS G +  ELM R  
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWM-ALESLQTQK-FTTKSDVWSFGVLLWELMTRGA 294

Query: 115 RPLFPGNDHVHQMRLLIE 132
            P +P  +       L++
Sbjct: 295 PP-YPDVNTFDITVYLLQ 311

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 65.4 bits (160), Expect = 9e-13
 Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 12/138 (8%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           DL   IR+   + + +    F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DF
Sbjct: 113 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADF 172

Query: 63  GLARPTSENEFMTEYVVT------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-- 114
           GLAR   + E+ + +  T      +W  A E L     +T   DVWS G +  ELM R  
Sbjct: 173 GLARDMYDKEYYSVHNKTGAKLPVKWM-ALESLQTQK-FTTKSDVWSFGVLLWELMTRGA 230

Query: 115 RPLFPGNDHVHQMRLLIE 132
            P +P  +       L++
Sbjct: 231 PP-YPDVNTFDITVYLLQ 247

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 64.8 bits (158), Expect = 2e-12
 Identities = 23/195 (11%), Positives = 41/195 (21%), Gaps = 53/195 (27%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRA 85
            L       H A V      PS + ++ + D+ +                          
Sbjct: 137 SLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------- 179

Query: 86  PELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV 145
                         D+  +G     L+  R   P       +                  
Sbjct: 180 ----------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---------------- 213

Query: 146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR--ITVDEALAHPYL 203
               A+R     P  P      +   +      +  R +  D   R   T+   +     
Sbjct: 214 ----AERDTAGQPIEPA----DIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATA 265

Query: 204 ARLHDEADEPVCPEP 218
                E   P+   P
Sbjct: 266 VADRTEVLGPIDEAP 280

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 64.6 bits (158), Expect = 2e-12
 Identities = 35/98 (35%), Positives = 45/98 (45%), Gaps = 15/98 (15%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
           +F   + RG+ Y+     IHRDL   N+L+  N   KI DFGL+R          YV   
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------VYVKKT 199

Query: 81  ------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                 RW  A E L  S  YT   DVWS G +  E++
Sbjct: 200 MGRLPVRWM-AIESLNYSV-YTTNSDVWSYGVLLWEIV 235

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 64.7 bits (158), Expect = 2e-12
 Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 12/110 (10%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
            +  +L  +    F+  +  G++Y+ S N IHRDL   N +L  +  + + DFGL+R   
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188

Query: 70  ENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
             +    Y          +W  A E L ++  YT   DVW+ G    E+M
Sbjct: 189 SGD---YYRQGCASKLPVKWL-ALESLADNL-YTVHSDVWAFGVTMWEIM 233

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 12/107 (11%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
             L      +   Q+  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R     +
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

Query: 73  FMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
           +   Y V        RW   PE ++    +T   DVWS G I  E+ 
Sbjct: 188 Y---YRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVILWEIF 229

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 63.9 bits (156), Expect = 4e-12
 Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 12/98 (12%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
               ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++   Y    
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGG 198

Query: 81  ------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                 RW  +PE L +   +T   DVWS G +  E+ 
Sbjct: 199 KGLLPVRWM-SPESLKDGV-FTTYSDVWSFGVVLWEIA 234

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 63.8 bits (156), Expect = 4e-12
 Identities = 26/98 (26%), Positives = 45/98 (45%), Gaps = 12/98 (12%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
            F+  +  G++Y+ + N +HRDL   N +L  +  + + DFGL++     +    Y    
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YYRQGR 207

Query: 81  ------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                 +W  A E L +   YT+  DVW+ G    E+ 
Sbjct: 208 IAKMPVKWI-AIESLADRV-YTSKSDVWAFGVTMWEIA 243

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 63.1 bits (154), Expect = 7e-12
 Identities = 30/110 (27%), Positives = 46/110 (41%), Gaps = 12/110 (10%)

Query: 10  RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS 69
            +   L          Q+  G+ Y+   + +HRDL   N L+     +KI DFG++R   
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209

Query: 70  ENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
             ++   Y V        RW   PE +L    +T   DVWS G +  E+ 
Sbjct: 210 STDY---YRVGGRTMLPIRWM-PPESILYRK-FTTESDVWSFGVVLWEIF 254

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 62.6 bits (153), Expect = 9e-12
 Identities = 27/98 (27%), Positives = 49/98 (50%), Gaps = 12/98 (12%)

Query: 22  YFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT- 80
           + + Q+  G++Y+ S +V+H+DL   N+L+    ++KI D GL R     +    Y +  
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKLLG 188

Query: 81  ------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
                 RW  APE ++    ++   D+WS G +  E+ 
Sbjct: 189 NSLLPIRWM-APEAIMYGK-FSIDSDIWSYGVVLWEVF 224

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 30/100 (30%), Positives = 41/100 (41%), Gaps = 12/100 (12%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE 72
             LS         Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     +
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 73  FMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVG 105
               Y          RW   PE +  +  YT   DVW+ G
Sbjct: 229 ---YYKADGNDAIPIRWM-PPESIFYNR-YTTESDVWAYG 263

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 58.5 bits (142), Expect = 3e-10
 Identities = 28/111 (25%), Positives = 43/111 (38%), Gaps = 15/111 (13%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPT 68
             SL+     +    +  G +Y+   + IHRD+   N LL         KI DFG+AR  
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193

Query: 69  SENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
               +   Y          +W   PE  +    +T+  D WS G +  E+ 
Sbjct: 194 YRASY---YRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIF 239

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 58.2 bits (141), Expect = 3e-10
 Identities = 28/111 (25%), Positives = 43/111 (38%), Gaps = 15/111 (13%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPT 68
             SL+     +    +  G +Y+   + IHRD+   N LL         KI DFG+AR  
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234

Query: 69  SENEFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 112
               +   Y          +W   PE  +    +T+  D WS G +  E+ 
Sbjct: 235 YRAGY---YRKGGCAMLPVKWM-PPEAFMEGI-FTSKTDTWSFGVLLWEIF 280

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.4 bits (140), Expect = 4e-10
 Identities = 31/203 (15%), Positives = 56/203 (27%), Gaps = 34/203 (16%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLAR---- 66
            +  S    +  L+QL   L    ++    HRDL   N+LL      K+      +    
Sbjct: 155 TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI 214

Query: 67  PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
           P+   +                     DYT +        +F ++     LF G D  +Q
Sbjct: 215 PSCGLQVSI-----------------IDYTLSRLERDGIVVFCDVSMDEDLFTG-DGDYQ 256

Query: 127 MRL--LIELLGTPTDADLGFVRNEDAKRYIRQL----PQHPRQSLAQVFPHVHPLAIDLV 180
             +  L++        +     N     Y+            +        +     +  
Sbjct: 257 FDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFH 316

Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
             ML F      +  + L    L
Sbjct: 317 RTMLNFS-----SATDLLCQHSL 334

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 21/65 (32%), Positives = 34/65 (52%), Gaps = 2/65 (3%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCD-LKICD 61
           DL +I   N +  +        ++L  L+YIH    +H D+K +NLLL   N D + + D
Sbjct: 137 DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLAD 196

Query: 62  FGLAR 66
           +GL+ 
Sbjct: 197 YGLSY 201

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 18/46 (39%), Positives = 29/46 (63%), Gaps = 5/46 (10%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKIC---DFGLAR 66
           QL+  ++Y+HS N+I+RD+KP N L+    N   ++    DF LA+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 2/43 (4%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLN-ANCD-LKICDFGLAR 66
           ++L  L+YIH    +H D+K SNLLLN  N D + + D+GLA 
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.4 bits (126), Expect = 3e-08
 Identities = 8/43 (18%), Positives = 21/43 (48%), Gaps = 2/43 (4%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKI--CDFGLAR 66
           +LL  L+++H    +H ++   N+ ++     ++    +G A 
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.4 bits (121), Expect = 1e-07
 Identities = 13/46 (28%), Positives = 25/46 (54%), Gaps = 5/46 (10%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK-----ICDFGLAR 66
           Q+L  ++ IH  ++++RD+KP N L+            + DFG+ +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.4 bits (121), Expect = 1e-07
 Identities = 20/45 (44%), Positives = 28/45 (62%), Gaps = 3/45 (6%)

Query: 25  YQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLAR 66
            Q++  ++YIHS N IHRD+KP N L+        + I DFGLA+
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 48.5 bits (115), Expect = 7e-07
 Identities = 16/45 (35%), Positives = 28/45 (62%), Gaps = 3/45 (6%)

Query: 26  QLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARP 67
           Q++  ++++HS + +HRD+KP N L+        + I DFGLA+ 
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 39.8 bits (92), Expect = 6e-04
 Identities = 32/266 (12%), Positives = 62/266 (23%), Gaps = 86/266 (32%)

Query: 31  LKYIHSANVIHRDLKPSNLLLNANCDLKI-CDFGLARPTSENEFMTEYVVTRWYRAPELL 89
           LK  +S   +   L+   LL   + +     D         +                 L
Sbjct: 189 LKNCNSPETVLEMLQ--KLLYQIDPNWTSRSDHSSNIKLRIHS---------IQAELRRL 237

Query: 90  LNSSDYTAAI----DVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV 145
           L S  Y   +    +V +         N              ++L+    T     +   
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAW--NAFN-----------LSCKILL----TTRFKQVTDF 280

Query: 146 RNEDAKRYIR----QLPQHPRQS---LAQVF-------PH----VHPLAIDLV-----DR 182
            +     +I      +   P +    L +         P      +P  + ++     D 
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340

Query: 183 MLTFDPMKRITVD----------EALAHPYLARLHDE--------------------ADE 212
           + T+D  K +  D            L      ++ D                        
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVI 400

Query: 213 PVCPEPFSFDFEQQSLGEEQIKDMIY 238
                       + SL E+Q K+   
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTI 426

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	249
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.98
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.98
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.98
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.98
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.98
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.98
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.98
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.98
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.98
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.98
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.98
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.98
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.98
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.98
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.98
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.98
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.98
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.98
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.98
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.94
3uqc_A	286	Probable conserved transmembrane protein; structur	99.93
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.88
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.66
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.32
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.14
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.66
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.21
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.64
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.6
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.51
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.5
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.64
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	96.53
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	95.85
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.71
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	94.3
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.0
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	93.94
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	93.86
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	93.7
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	93.24
3ats_A	357	Putative uncharacterized protein; hypothetical pro	92.77
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	92.66
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	92.22
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	91.9
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	91.87
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	91.52
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.77
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	90.6
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.97
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	87.6
3mes_A	424	Choline kinase; malaria, structural genomics, stru	85.66
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	80.31
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.16

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-51  Score=347.75  Aligned_cols=246  Identities=54%  Similarity=0.945  Sum_probs=220.1

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-----Cccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-----EFMT   75 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-----~~~~   75 (249)
                      |+|+|.+++.+.+.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.....     ....
T Consensus       141 ~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~  220 (398)
T 4b99_A          141 MESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT  220 (398)
T ss_dssp             CSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCC
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccc
Confidence            57899999999999999999999999999999999999999999999999999999999999999765332     2334


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+...++..|....+.++...+..........+..
T Consensus       221 ~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~  300 (398)
T 4b99_A          221 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQ  300 (398)
T ss_dssp             SSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHH
T ss_pred             cceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhh
Confidence            57899999999999877778999999999999999999999999999999999999999999988877777777777777


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHH
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKD  235 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (249)
                      ..+......+..+.+.+++++.+||.+||.+||.+|||++|+|+||||++..+...++.+..++.+.++....+.+++++
T Consensus       301 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~k~  380 (398)
T 4b99_A          301 SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKE  380 (398)
T ss_dssp             SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSSCCCCHHHHSCCCHHHHHH
T ss_pred             cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCCCCCCccchhhcCHHHHHH
Confidence            77777777788888999999999999999999999999999999999999998888888888999888888899999999


Q ss_pred             HHHHHHHHhCC
Q 025683          236 MIYQEALALNP  246 (249)
Q Consensus       236 ~~~~~~~~~~~  246 (249)
                      .|.+|.+.|++
T Consensus       381 ~i~~ei~~~~~  391 (398)
T 4b99_A          381 AIVAEIEDFHA  391 (398)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-46  Score=302.20  Aligned_cols=174  Identities=28%  Similarity=0.522  Sum_probs=142.6

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      +||+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...........+||
T Consensus        95 ~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT  174 (275)
T 3hyh_A           95 AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS  174 (275)
T ss_dssp             CCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeEC
Confidence            58999999999999999999999999999999999999999999999999999999999999999877666556678999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+.......+....                          
T Consensus       175 ~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--------------------------  228 (275)
T 3hyh_A          175 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--------------------------  228 (275)
T ss_dssp             CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------------------------
T ss_pred             cccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            999999999877666789999999999999999999998877665555554311                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                           ..++..+|+++.+||.+||+.||.+|||++|+++||||+.
T Consensus       229 -----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          229 -----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                 1123357899999999999999999999999999999974

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.1e-45  Score=311.64  Aligned_cols=248  Identities=42%  Similarity=0.809  Sum_probs=212.8

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--------
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--------   72 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--------   72 (249)
                      |+++|.+++.+...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++......        
T Consensus       112 ~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  191 (432)
T 3n9x_A          112 ADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL  191 (432)
T ss_dssp             CSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC------------
T ss_pred             CCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccc
Confidence            578999999998899999999999999999999999999999999999999999999999999997654321        


Q ss_pred             ---------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-----------CCCCCCCCC----
Q 025683           73 ---------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-----------RRPLFPGND----  122 (249)
Q Consensus        73 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-----------g~~p~~~~~----  122 (249)
                                     .....++|+.|+|||++.....++.++|||||||++|+|++           |.++|.+.+    
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~  271 (432)
T 3n9x_A          192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPL  271 (432)
T ss_dssp             -------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC-
T ss_pred             cccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCcccccc
Confidence                           12456789999999997666678999999999999999997           445555543    


Q ss_pred             -------------hHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCC
Q 025683          123 -------------HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPM  189 (249)
Q Consensus       123 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  189 (249)
                                   ...++..+...+|.++..............+....+......+....+.+++++.+||++||++||.
T Consensus       272 ~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  351 (432)
T 3n9x_A          272 SPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPN  351 (432)
T ss_dssp             ---------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTT
T ss_pred             CcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcc
Confidence                         3678889999999999988888888888888888777777778888889999999999999999999


Q ss_pred             CCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhc-cccCHHHHHHHHHHHHHHhCCCC
Q 025683          190 KRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQ-QSLGEEQIKDMIYQEALALNPGF  248 (249)
Q Consensus       190 ~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  248 (249)
                      +|||++++|+||||+++.....++.+..+....+++ ...+.++++..+++|.++|+|..
T Consensus       352 ~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  411 (432)
T 3n9x_A          352 KRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPEL  411 (432)
T ss_dssp             TSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred             cCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHhCccc
Confidence            999999999999999999998888877777777765 67889999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-44  Score=311.96  Aligned_cols=248  Identities=45%  Similarity=0.825  Sum_probs=211.9

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--------
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--------   72 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--------   72 (249)
                      ++++|.+++.+...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......        
T Consensus       139 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  218 (458)
T 3rp9_A          139 ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI  218 (458)
T ss_dssp             CSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-
T ss_pred             cccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcccccccccc
Confidence            578999999998899999999999999999999999999999999999999999999999999997654221        


Q ss_pred             --------------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-----------CCCCCCCC
Q 025683           73 --------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-----------RRPLFPGN  121 (249)
Q Consensus        73 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-----------g~~p~~~~  121 (249)
                                          .....+||+.|+|||++.....++.++|||||||++|+|++           |.++|++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~  298 (458)
T 3rp9_A          219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGS  298 (458)
T ss_dssp             --------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--
T ss_pred             CccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCC
Confidence                                12345779999999987666668999999999999999998           67777665


Q ss_pred             C--------------------hHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHH
Q 025683          122 D--------------------HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD  181 (249)
Q Consensus       122 ~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  181 (249)
                      .                    ...++..+...++.++...+..........+....+......+.+.++..++++.+||+
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~  378 (458)
T 3rp9_A          299 SCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLK  378 (458)
T ss_dssp             ------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHH
T ss_pred             ccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHH
Confidence            4                    36788889999999999888888888888888888877778888888899999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhc-cccCHHHHHHHHHHHHHHhCCCC
Q 025683          182 RMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQ-QSLGEEQIKDMIYQEALALNPGF  248 (249)
Q Consensus       182 ~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  248 (249)
                      +||.+||.+|||++|+|+||||+++.....++.+..+....+++ ...+..+++..+++|.++|+|.+
T Consensus       379 ~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  446 (458)
T 3rp9_A          379 RMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPEI  446 (458)
T ss_dssp             HHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHTTTCTTC
T ss_pred             HHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhCccc
Confidence            99999999999999999999999998887777665555555554 67889999999999999999976

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.5e-46  Score=302.63  Aligned_cols=177  Identities=32%  Similarity=0.569  Sum_probs=153.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC---Ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---~~~~~~~   78 (249)
                      ||||.++|.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....   ......+
T Consensus       116 gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~  195 (311)
T 4aw0_A          116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV  195 (311)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCC
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcc
Confidence            7899999999999999999999999999999999999999999999999999999999999999865432   2345678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+.......+...-                        
T Consensus       196 GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------------------  250 (311)
T 4aw0_A          196 GTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE------------------------  250 (311)
T ss_dssp             SCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------------------
T ss_pred             cCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence            999999999997654 7999999999999999999999999888777776665411                        


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHH------HhcCccccCCcCCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDE------ALAHPYLARLHDEA  210 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~------ll~h~~~~~~~~~~  210 (249)
                             ..++..+++++++||.+||.+||.+|||++|      +++||||+++..+.
T Consensus       251 -------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          251 -------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  301 (311)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             -------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence                   1123357899999999999999999999987      58899999876443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-44  Score=301.56  Aligned_cols=244  Identities=43%  Similarity=0.846  Sum_probs=210.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ||++|.+++.. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||.+......  .....+|
T Consensus       112 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t  188 (367)
T 1cm8_A          112 MGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVT  188 (367)
T ss_dssp             CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSC
T ss_pred             CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc--cCcCcCC
Confidence            57899999987 67999999999999999999999999999999999999999999999999999765432  3356789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+...++.++|+||+||++++|++|..||.+.+...++..+....+.++..............+....+..
T Consensus       189 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~  268 (367)
T 1cm8_A          189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL  268 (367)
T ss_dssp             GGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCC
T ss_pred             CCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCC
Confidence            99999999987566899999999999999999999999999999999999999999998887777777788888888887


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHHH
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE  240 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (249)
                      ....+..+.+..++++.+||.+||..||.+|||++++|+||||+++.....++... ++...+++.....++++..+++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  347 (367)
T 1cm8_A          269 EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKE  347 (367)
T ss_dssp             CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-CCCCC-----CCHHHHHHHHHHH
T ss_pred             CCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC-CCCCChhhhcCCHHHHHHHHHHH
Confidence            78888888889999999999999999999999999999999999998887776654 67777888888999999999999


Q ss_pred             HHHhCCCC
Q 025683          241 ALALNPGF  248 (249)
Q Consensus       241 ~~~~~~~~  248 (249)
                      ..+|+|..
T Consensus       348 ~~~~~~~~  355 (367)
T 1cm8_A          348 VLSFKPPR  355 (367)
T ss_dssp             HHTCCC--
T ss_pred             HHHhcccc
Confidence            99999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-44  Score=303.38  Aligned_cols=244  Identities=50%  Similarity=0.917  Sum_probs=205.9

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      +|++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+......  .....+|
T Consensus       116 ~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t  192 (367)
T 2fst_X          116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVAT  192 (367)
T ss_dssp             CCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------------CC
T ss_pred             cCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcC
Confidence            47889998876 67999999999999999999999999999999999999999999999999998765432  3346789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+...++.++|||||||++++|++|..||.+.+...++..+...++.+...............+.......
T Consensus       193 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~  272 (367)
T 2fst_X          193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM  272 (367)
T ss_dssp             CTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCC
T ss_pred             cCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCC
Confidence            99999999977566899999999999999999999999999999999999999999998888888888888888888777


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHHH
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE  240 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (249)
                      ....+....+..++++.+||.+||+.||.+|||+.++|+||||+.+.....++... ++...++......+++++.+++|
T Consensus       273 ~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~e  351 (367)
T 2fst_X          273 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDE  351 (367)
T ss_dssp             CCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC-CCCGGGSSCCCCHHHHHHHHHHH
T ss_pred             CCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC-CCCcchhhccCCHHHHHHHHHHH
Confidence            77888888889999999999999999999999999999999999998887777655 67777777888999999999999


Q ss_pred             HHHhCCCC
Q 025683          241 ALALNPGF  248 (249)
Q Consensus       241 ~~~~~~~~  248 (249)
                      ...|+|..
T Consensus       352 ~~~~~~~~  359 (367)
T 2fst_X          352 VISFVPPP  359 (367)
T ss_dssp             HHHCCCCC
T ss_pred             HHHhccCc
Confidence            99999863

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.9e-45  Score=300.72  Aligned_cols=176  Identities=28%  Similarity=0.525  Sum_probs=151.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ......+||
T Consensus       155 gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT  233 (346)
T 4fih_A          155 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  233 (346)
T ss_dssp             TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSC
T ss_pred             CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccC
Confidence            7899999987 67999999999999999999999999999999999999999999999999999876543 345567999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+.......                       
T Consensus       234 p~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-----------------------  289 (346)
T 4fih_A          234 PYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-----------------------  289 (346)
T ss_dssp             GGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-----------------------
T ss_pred             cCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------------------
Confidence            999999998654 48999999999999999999999999888777766664321110                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                           ...+..+++++.+||.+||..||.+|||++|+|+||||++..
T Consensus       290 -----~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          290 -----LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             -----CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             -----CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                 011235789999999999999999999999999999999754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.5e-45  Score=297.67  Aligned_cols=174  Identities=26%  Similarity=0.500  Sum_probs=150.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||||.++|.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ......+||
T Consensus       110 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT  189 (304)
T 3ubd_A          110 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT  189 (304)
T ss_dssp             TCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccC
Confidence            7899999999999999999999999999999999999999999999999999999999999999865433 334567899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+....                          
T Consensus       190 ~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------------------------  242 (304)
T 3ubd_A          190 VEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--------------------------  242 (304)
T ss_dssp             GGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------------------
T ss_pred             cccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--------------------------
Confidence            9999999997554 8899999999999999999999999988777776665311                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                           ..++..+|+++.+||.+||+.||.+|||     ++|+++||||+++.
T Consensus       243 -----~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          243 -----LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence                 0123358899999999999999999998     58999999999865

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-44  Score=292.97  Aligned_cols=173  Identities=21%  Similarity=0.381  Sum_probs=144.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeecc-CCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||||.++|.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||++. ++.+||+|||+++.... ......+
T Consensus       113 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~  191 (290)
T 3fpq_A          113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVI  191 (290)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcc
Confidence            7899999999999999999999999999999999998  999999999999975 79999999999975433 3345678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......+.........+                     
T Consensus       192 GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~---------------------  248 (290)
T 3fpq_A          192 GTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------------------  248 (290)
T ss_dssp             SSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------------------
T ss_pred             cCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC---------------------
Confidence            9999999998853  48999999999999999999999998766544433322111000                     


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                             .......++++.+||.+||+.||.+|||++++|+||||++
T Consensus       249 -------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                   1122346788999999999999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.1e-43  Score=297.88  Aligned_cols=247  Identities=53%  Similarity=1.021  Sum_probs=215.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----ccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~   76 (249)
                      ++++|.+++.. +.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+........    ...
T Consensus       112 ~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  190 (364)
T 3qyz_A          112 METDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE  190 (364)
T ss_dssp             CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred             cCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccc
Confidence            46899999987 5799999999999999999999999999999999999999999999999999976543321    234


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+|+.|+|||.+.+...++.++|||||||++|+|++|..||.+.+.......+...++.+...............+...
T Consensus       191 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (364)
T 3qyz_A          191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS  270 (364)
T ss_dssp             CCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred             cccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHh
Confidence            57899999999987666689999999999999999999999999999999999999999998887777666667777777


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHH
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM  236 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (249)
                      .+......+....+.+++++.+||.+||+.||.+|||+.++++||||+++.....++....++.++.+-...+.+++++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (364)
T 3qyz_A          271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL  350 (364)
T ss_dssp             SCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCCCCC-----CCHHHHHHH
T ss_pred             cCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCcCCcccccccCCHHHHHHH
Confidence            77777777888888999999999999999999999999999999999999888888888888998888888999999999


Q ss_pred             HHHHHHHhCCCC
Q 025683          237 IYQEALALNPGF  248 (249)
Q Consensus       237 ~~~~~~~~~~~~  248 (249)
                      +++|.++|+|+.
T Consensus       351 ~~~e~~~~~~~~  362 (364)
T 3qyz_A          351 IFEETARFQPGY  362 (364)
T ss_dssp             HHHHTGGGCC--
T ss_pred             HHHHHHHhhhhc
Confidence            999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.3e-44  Score=301.87  Aligned_cols=176  Identities=28%  Similarity=0.525  Sum_probs=151.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ......+||
T Consensus       232 gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT  310 (423)
T 4fie_A          232 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  310 (423)
T ss_dssp             TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEEC
T ss_pred             CCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccC
Confidence            7899999976 67999999999999999999999999999999999999999999999999999876543 345567999


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+.......                       
T Consensus       311 p~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-----------------------  366 (423)
T 4fie_A          311 PYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-----------------------  366 (423)
T ss_dssp             TTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------------------
T ss_pred             cCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------------------
Confidence            999999998654 48999999999999999999999999888777766664321100                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                           ...+..+++++.+||.+||..||.+|||++|+|+||||++..
T Consensus       367 -----~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          367 -----LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             -----CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             -----CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                 112346889999999999999999999999999999999753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-44  Score=296.50  Aligned_cols=180  Identities=24%  Similarity=0.408  Sum_probs=148.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCCCC------cc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENE------FM   74 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~~------~~   74 (249)
                      ||||.++|.+.+.|++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+++......      ..
T Consensus       134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~  213 (336)
T 4g3f_A          134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG  213 (336)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecC
Confidence            789999999989999999999999999999999999999999999999999988 69999999998654332      12


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ...+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...                     
T Consensus       214 ~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~---------------------  271 (336)
T 4g3f_A          214 DYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE---------------------  271 (336)
T ss_dssp             CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS---------------------
T ss_pred             CccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC---------------------
Confidence            235799999999999765 4899999999999999999999999876644444444320                     


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHH-------------hcCccccCCcCCC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA-------------LAHPYLARLHDEA  210 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~l-------------l~h~~~~~~~~~~  210 (249)
                             .....++++.+++++.+||.+||+.||.+|||+.|+             ++|||++++.++.
T Consensus       272 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          272 -------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             -------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             -------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                   112234566789999999999999999999999997             5799999876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-44  Score=298.96  Aligned_cols=174  Identities=24%  Similarity=0.438  Sum_probs=149.9

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~   78 (249)
                      ||||.++|.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...... .....+
T Consensus       107 gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~  186 (350)
T 4b9d_A          107 GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI  186 (350)
T ss_dssp             TCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHH
T ss_pred             CCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccC
Confidence            78999999764  457999999999999999999999999999999999999999999999999998765432 234568


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+...-  .                     
T Consensus       187 GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~---------------------  242 (350)
T 4b9d_A          187 GTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--F---------------------  242 (350)
T ss_dssp             SCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--C---------------------
T ss_pred             CCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--C---------------------
Confidence            99999999999755 48999999999999999999999999988777776665411  1                     


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                             ...+..+|+++.+||.+||+.||.+|||++|+|+||||++-
T Consensus       243 -------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          243 -------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             -------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence                   11233678999999999999999999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-43  Score=299.57  Aligned_cols=245  Identities=37%  Similarity=0.750  Sum_probs=195.3

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC----------
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE----------   70 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~----------   70 (249)
                      |+++|.+++.. +.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++....          
T Consensus        93 ~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  171 (388)
T 3oz6_A           93 METDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL  171 (388)
T ss_dssp             CSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGG
T ss_pred             cCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccc
Confidence            57899999987 6899999999999999999999999999999999999999999999999999875432          


Q ss_pred             ------------CCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 025683           71 ------------NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT  138 (249)
Q Consensus        71 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  138 (249)
                                  .......++|+.|+|||++.+...++.++|||||||++++|++|..||.+.+...++..+...++.+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~  251 (388)
T 3oz6_A          172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPS  251 (388)
T ss_dssp             CCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence                        11123357899999999997766789999999999999999999999999999999999999999888


Q ss_pred             cccccccchhhHHHHHHhCCCCC---Ccchh-------------hcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 025683          139 DADLGFVRNEDAKRYIRQLPQHP---RQSLA-------------QVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPY  202 (249)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~  202 (249)
                      ..............+........   .....             ......++++.+||.+||++||.+|||++++|+|||
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~  331 (388)
T 3oz6_A          252 NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF  331 (388)
T ss_dssp             HHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTT
T ss_pred             HHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHH
Confidence            76554433333332222111000   00000             012367889999999999999999999999999999


Q ss_pred             ccCCcCCCCCCCCCCCCCCchhc-cccCHHHHHHHHHHHHHHhCC
Q 025683          203 LARLHDEADEPVCPEPFSFDFEQ-QSLGEEQIKDMIYQEALALNP  246 (249)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  246 (249)
                      |+.+.....++.+...+.+.+.+ .....++++..+++|...|.+
T Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (388)
T 3oz6_A          332 VSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKR  376 (388)
T ss_dssp             TTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhhh
Confidence            99999999999888888888875 577889999999999988865

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.4e-42  Score=289.59  Aligned_cols=242  Identities=45%  Similarity=0.843  Sum_probs=213.0

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ++++|.+++..  .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+......  .....+|
T Consensus       129 ~~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t  204 (371)
T 4exu_A          129 MQTDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVT  204 (371)
T ss_dssp             CCEEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----------CTTCC
T ss_pred             ccccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC--cCCcccC
Confidence            46788888754  6999999999999999999999999999999999999999999999999998765432  3345779


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+...++.++|||||||++++|++|..||.+.+.......+....+.++..............+.......
T Consensus       205 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (371)
T 4exu_A          205 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT  284 (371)
T ss_dssp             CTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCC
T ss_pred             ccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCC
Confidence            99999999976566899999999999999999999999999999999999999999988877777777777888888888


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHHH
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE  240 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (249)
                      ....+....+.+++++.+||.+||+.||.+|||+.++++||||+.+.....+.....++....+....+.+++++.|++|
T Consensus       285 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (371)
T 4exu_A          285 PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKE  364 (371)
T ss_dssp             CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTSSCCCCHHHHHHHHHHH
T ss_pred             cchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCcchhhcccchHHHHHHHHHH
Confidence            88888888889999999999999999999999999999999999998877777777777777778888999999999999


Q ss_pred             HHHhCC
Q 025683          241 ALALNP  246 (249)
Q Consensus       241 ~~~~~~  246 (249)
                      ..+|.|
T Consensus       365 ~~~~~~  370 (371)
T 4exu_A          365 IVNFSP  370 (371)
T ss_dssp             HHHCCC
T ss_pred             HHhccc
Confidence            999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.5e-43  Score=292.44  Aligned_cols=203  Identities=31%  Similarity=0.554  Sum_probs=151.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC-CCeEEeecCCccCCCCCC--------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENE--------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~-~~~kL~dfg~~~~~~~~~--------   72 (249)
                      ||+|.+++.   .+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......        
T Consensus       104 g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~  180 (361)
T 4f9c_A          104 HESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQ  180 (361)
T ss_dssp             CCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-
T ss_pred             cccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccc
Confidence            689999994   59999999999999999999999999999999999999877 799999999997543221        


Q ss_pred             ---------------------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHH
Q 025683           73 ---------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP-GNDHVHQMRLL  130 (249)
Q Consensus        73 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~-~~~~~~~~~~~  130 (249)
                                           .....+||+.|+|||++.+...++.++||||+||++|+|++|..||. +.++..++..|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I  260 (361)
T 4f9c_A          181 SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQI  260 (361)
T ss_dssp             -------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence                                 12235799999999999877778999999999999999999999985 55677888888


Q ss_pred             HHHhCCCCccccc-----------ccchhhHHHHHHhC-------CC-----CCCcchhhcCCCCChHHHHHHHHhcCCC
Q 025683          131 IELLGTPTDADLG-----------FVRNEDAKRYIRQL-------PQ-----HPRQSLAQVFPHVHPLAIDLVDRMLTFD  187 (249)
Q Consensus       131 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~-------~~-----~~~~~~~~~~~~~~~~~~~li~~~L~~d  187 (249)
                      ...+|.+......           ..+...........       +.     .......+.+..+++++++||++||.+|
T Consensus       261 ~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~d  340 (361)
T 4f9c_A          261 MTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLN  340 (361)
T ss_dssp             HHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSC
T ss_pred             HHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCC
Confidence            8877653221110           00001111111000       00     0011122345678999999999999999


Q ss_pred             CCCCCCHHHHhcCccccCCc
Q 025683          188 PMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       188 p~~Rpt~~~ll~h~~~~~~~  207 (249)
                      |.+|+|++|+|+||||+++.
T Consensus       341 P~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          341 PASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             TTTSCCHHHHHTSGGGTTC-
T ss_pred             hhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999763

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6e-42  Score=295.67  Aligned_cols=243  Identities=41%  Similarity=0.747  Sum_probs=183.0

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |+++|.+++..  .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.............+|
T Consensus       149 ~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt  226 (464)
T 3ttj_A          149 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT  226 (464)
T ss_dssp             CSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CC
T ss_pred             CCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCccc
Confidence            46778888865  5999999999999999999999999999999999999999999999999999877665555667889


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+...++..+...++.+......... .....+....+..
T Consensus       227 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~-~~~~~~~~~~~~~  304 (464)
T 3ttj_A          227 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKY  304 (464)
T ss_dssp             CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC-HHHHHHHTTSCCC
T ss_pred             ccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc-hhhhhHhhccccc
Confidence            999999999765 48899999999999999999999999999999999999999998877655443 2334444444443


Q ss_pred             CCcchhhcCCCC------------ChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC-CCCCCCCCCchhccc
Q 025683          161 PRQSLAQVFPHV------------HPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE-PVCPEPFSFDFEQQS  227 (249)
Q Consensus       161 ~~~~~~~~~~~~------------~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~-~~~~~~~~~~~~~~~  227 (249)
                      ....+....+..            ++++.+||.+||.+||.+|||++|+|+||||+.+...... .+.+..+...+++..
T Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (464)
T 3ttj_A          305 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE  384 (464)
T ss_dssp             CCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCCC-----------C
T ss_pred             CCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccCCCCccCCcchhhcc
Confidence            333333333221            5678999999999999999999999999999988754433 233445566667778


Q ss_pred             cCHHHHHHHHHHHHHHhCCC
Q 025683          228 LGEEQIKDMIYQEALALNPG  247 (249)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~  247 (249)
                      .+.+++++.+++|.+++++.
T Consensus       385 ~~~~~~~~~~~~e~~~~~~~  404 (464)
T 3ttj_A          385 HTIEEWKELIYKEVMNSEEK  404 (464)
T ss_dssp             CCHHHHHHHHHHHHHC----
T ss_pred             CCHHHHHHHHHHHHHHhhhc
Confidence            88999999999999887653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=283.87  Aligned_cols=242  Identities=45%  Similarity=0.841  Sum_probs=207.3

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ++++|.+++..  .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+......  .....++
T Consensus       111 ~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t  186 (353)
T 3coi_A          111 MQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVT  186 (353)
T ss_dssp             CSEEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----------CCS
T ss_pred             ccCCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--ccccccC
Confidence            35677777654  6999999999999999999999999999999999999999999999999998765432  2345779


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+...++.++|+|||||++++|++|..||.+.+....+..+....+.++..............+....+..
T Consensus       187 ~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (353)
T 3coi_A          187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT  266 (353)
T ss_dssp             BCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBC
T ss_pred             cCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCC
Confidence            99999999876566889999999999999999999999999999999999999998887777666666667777777776


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHHH
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE  240 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (249)
                      ....+....+.+++++.+||.+||+.||.+|||+.++++||||+.+.....+.....++....+....+.++++..|++|
T Consensus       267 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (353)
T 3coi_A          267 PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKE  346 (353)
T ss_dssp             SSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTTTCCCCHHHHHHHHHHH
T ss_pred             CCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCCCccchhhccCCHHHHHHHHHHH
Confidence            67777777888999999999999999999999999999999999998777776666677777777888999999999999


Q ss_pred             HHHhCC
Q 025683          241 ALALNP  246 (249)
Q Consensus       241 ~~~~~~  246 (249)
                      ..+|.|
T Consensus       347 ~~~~~~  352 (353)
T 3coi_A          347 IVNFSP  352 (353)
T ss_dssp             HHTCCC
T ss_pred             HHhhcc
Confidence            999876

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-41  Score=299.69  Aligned_cols=177  Identities=25%  Similarity=0.425  Sum_probs=148.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|+++|.+.+.|++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...... ....+||+
T Consensus       276 GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp  354 (689)
T 3v5w_A          276 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  354 (689)
T ss_dssp             SCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-CCSCCSCG
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-CCCccCCc
Confidence            79999999999999999999999999999999999999999999999999999999999999998665433 45679999


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||++.....++.++|+|||||++|+|++|..||.+.+...............                        
T Consensus       355 ~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~------------------------  410 (689)
T 3v5w_A          355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------------------------  410 (689)
T ss_dssp             GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC------------------------
T ss_pred             CccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC------------------------
Confidence            99999999755568999999999999999999999997543211111111100000                        


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                          ..++..+|+++.+||.+||..||.+|++     ++++++||||+++.
T Consensus       411 ----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          411 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence                1233468899999999999999999998     79999999999876

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=271.99  Aligned_cols=174  Identities=22%  Similarity=0.332  Sum_probs=139.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC---Cccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---~~~~~~   77 (249)
                      ||||.++|... +++++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....   ......
T Consensus       115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~  194 (307)
T 3omv_A          115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP  194 (307)
T ss_dssp             SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------C
T ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeeccc
Confidence            78999999764 67999999999999999999999999999999999999999999999999999765432   223456


Q ss_pred             cccccccCchhccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           78 VVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      .||+.|+|||++...  ..++.++|||||||++|||++|..||.+.+.......+.......+                 
T Consensus       195 ~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p-----------------  257 (307)
T 3omv_A          195 TGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP-----------------  257 (307)
T ss_dssp             CCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC-----------------
T ss_pred             ccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-----------------
Confidence            899999999998642  3588999999999999999999999988776655554443211111                 


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                              ....++..+++++.+|+.+||+.||.+|||+.+++++
T Consensus       258 --------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          258 --------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             --------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             --------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                    1123445688999999999999999999999988653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.7e-39  Score=272.07  Aligned_cols=244  Identities=38%  Similarity=0.741  Sum_probs=192.5

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ++|+|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.............+
T Consensus       116 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  195 (362)
T 3pg1_A          116 MRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT  195 (362)
T ss_dssp             CSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------------
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecc
Confidence            467899999875 4799999999999999999999999999999999999999999999999999976555554555678


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh-CC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ-LP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  158 (249)
                      ++.|+|||.+.+...++.++|||||||++|+|++|..||.+.........+....+.+...............+... ..
T Consensus       196 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (362)
T 3pg1_A          196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLS  275 (362)
T ss_dssp             CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCC
T ss_pred             cceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcc
Confidence            99999999987756689999999999999999999999999999999999999998887665544444444444332 22


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHH
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIY  238 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (249)
                      ..+...+....+..++.+.+||.+||+.||.+|||+.++++||||+++......... ....+.++.......++++.+.
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  354 (362)
T 3pg1_A          276 NVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG-LSERFHFDESVTDVYDMHKIFT  354 (362)
T ss_dssp             CCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT-CCCCCCCCTTCCCHHHHHHHHH
T ss_pred             cCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc-cccccChhhhhhhHHHHHHHHH
Confidence            334455666777889999999999999999999999999999999998755444322 2233455668888899999999


Q ss_pred             HHHHHhC
Q 025683          239 QEALALN  245 (249)
Q Consensus       239 ~~~~~~~  245 (249)
                      .|-.+|+
T Consensus       355 ~e~~~~~  361 (362)
T 3pg1_A          355 AEVERFN  361 (362)
T ss_dssp             HHHHHHC
T ss_pred             HHHHHhc
Confidence            9998886

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.1e-40  Score=276.89  Aligned_cols=242  Identities=42%  Similarity=0.741  Sum_probs=176.9

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ++++|.+++..  .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+.............+|
T Consensus       112 ~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt  189 (371)
T 2xrw_A          112 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT  189 (371)
T ss_dssp             CSEEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------
T ss_pred             CCCCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceec
Confidence            46789999874  6999999999999999999999999999999999999999999999999999876554444556889


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+....+..+...++.+.......... ....+....+..
T Consensus       190 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  267 (371)
T 2xrw_A          190 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKY  267 (371)
T ss_dssp             CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH-HHHHHHHSSCCC
T ss_pred             CCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh-HHHHHHhhCccc
Confidence            999999999754 488999999999999999999999999999888888888777766544433322 222233332222


Q ss_pred             CCcchhhcCCC------------CChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC-CCCCCCCCchhccc
Q 025683          161 PRQSLAQVFPH------------VHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP-VCPEPFSFDFEQQS  227 (249)
Q Consensus       161 ~~~~~~~~~~~------------~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~-~~~~~~~~~~~~~~  227 (249)
                      ....+....+.            .++++.+||.+||..||.+|||++++++||||+.+....... +.+..+....++..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (371)
T 2xrw_A          268 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDERE  347 (371)
T ss_dssp             CCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCCCCCTTTTCCCC
T ss_pred             cccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCCCCCCCChhhcccc
Confidence            22222222111            256789999999999999999999999999999876543222 12223334445667


Q ss_pred             cCHHHHHHHHHHHHHHhCC
Q 025683          228 LGEEQIKDMIYQEALALNP  246 (249)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~  246 (249)
                      ...+++++.++.+.+.|+-
T Consensus       348 ~~~~~~~~~~~~~~~~~~~  366 (371)
T 2xrw_A          348 HTIEEWKELIYKEVMDLEH  366 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHHHHHHhh
Confidence            7889999999999999974

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.4e-39  Score=268.52  Aligned_cols=240  Identities=53%  Similarity=0.970  Sum_probs=193.7

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--------
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--------   72 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--------   72 (249)
                      ++++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+.......        
T Consensus        96 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  174 (353)
T 2b9h_A           96 MQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG  174 (353)
T ss_dssp             CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----------
T ss_pred             cCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccc
Confidence            46789999987 679999999999999999999999999999999999999999999999999987654321        


Q ss_pred             ---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccc-ccccchh
Q 025683           73 ---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDAD-LGFVRNE  148 (249)
Q Consensus        73 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  148 (249)
                         ......|++.|+|||.+.....++.++|+|||||++|+|++|..||.+.+.......+....+.+.... .......
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (353)
T 2b9h_A          175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESP  254 (353)
T ss_dssp             -----CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCH
T ss_pred             cccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccc
Confidence               112346799999999987666689999999999999999999999999998888888888888766433 2333334


Q ss_pred             hHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCC--C--CCCchh
Q 025683          149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPE--P--FSFDFE  224 (249)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~--~--~~~~~~  224 (249)
                      ....+....+...........+.+++++.+||.+||+.||.+|||+.++++||||+.+......+....  +  +..+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (353)
T 2b9h_A          255 RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHY  334 (353)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCCCGGGGGGGCC
T ss_pred             hhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCCCCcceeeecch
Confidence            444555555555666667777889999999999999999999999999999999999886655443221  1  222333


Q ss_pred             ccccCHHHHHHHHHHHH
Q 025683          225 QQSLGEEQIKDMIYQEA  241 (249)
Q Consensus       225 ~~~~~~~~~~~~~~~~~  241 (249)
                      ....+.+++++.+++|.
T Consensus       335 ~~~~~~~~~~~~~~~~~  351 (353)
T 2b9h_A          335 KEALTTKDLKKLIWNEI  351 (353)
T ss_dssp             SSCCCHHHHHHHHHHHH
T ss_pred             hhcCCHHHHHHHHHHHh
Confidence            56788899999999885

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-40  Score=292.79  Aligned_cols=180  Identities=25%  Similarity=0.424  Sum_probs=155.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC--CCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN--CDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~--~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|+++|.+. +.|++..++.+++||+.||+|||++||+||||||+||+++.+  +.+||+|||+++...........+
T Consensus       238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~  317 (573)
T 3uto_A          238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT  317 (573)
T ss_dssp             CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEEC
T ss_pred             CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeE
Confidence            78999999754 689999999999999999999999999999999999999854  899999999999877766666778


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+.......+                    
T Consensus       318 GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------  376 (573)
T 3uto_A          318 GTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD--------------------  376 (573)
T ss_dssp             SSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC--------------------
T ss_pred             ECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC--------------------
Confidence            999999999997654 89999999999999999999999999887777766654221111                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                             ...+..+++++++||++||..||.+|||+.|+|+||||+.....
T Consensus       377 -------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          377 -------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             -------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             -------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence                   12234688999999999999999999999999999999976543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=265.67  Aligned_cols=202  Identities=39%  Similarity=0.690  Sum_probs=168.3

Q ss_pred             CCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccc
Q 025683            1 MDTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ++++|.+++.+...  +++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+.............
T Consensus       101 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  180 (308)
T 3g33_A          101 VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV  180 (308)
T ss_dssp             CCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGG
T ss_pred             hhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCcc
Confidence            47899999998754  9999999999999999999999999999999999999999999999999998766555556678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +|+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.........+....+.++...+........    ....
T Consensus       181 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~  255 (308)
T 3g33_A          181 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR----GAFP  255 (308)
T ss_dssp             CCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCG----GGSC
T ss_pred             ccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccc----cccC
Confidence            899999999987554 88999999999999999999999999999999999999988877665432211110    1122


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      ...........+.+++++.+||.+||+.||.+|||+.++|+||||++-.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          256 PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             CCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             CCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            2333445566778999999999999999999999999999999999743

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.2e-41  Score=272.85  Aligned_cols=173  Identities=25%  Similarity=0.467  Sum_probs=129.1

Q ss_pred             CccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC------
Q 025683            2 DTDLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~---l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~------   72 (249)
                      ||+|.+++.+...   .+...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......      
T Consensus        99 gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~  178 (299)
T 4g31_A           99 KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL  178 (299)
T ss_dssp             SCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-------------
T ss_pred             CCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccc
Confidence            7899999998754   4456789999999999999999999999999999999999999999999997654322      


Q ss_pred             -------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           73 -------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        73 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                             .....+||+.|+|||++.+. .++.++|||||||++|+|++   ||...  ......+........+      
T Consensus       179 ~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~~~~~~p------  246 (299)
T 4g31_A          179 TPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDVRNLKFP------  246 (299)
T ss_dssp             -------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHTTCCC------
T ss_pred             cccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHHhcCCCC------
Confidence                   12235799999999999754 48999999999999999995   66532  2222222222111110      


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                           ..+...++.+.+||.+||+.||.+|||+.++++||||+++.
T Consensus       247 ---------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          247 ---------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             ---------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             ---------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence                                 01112346678999999999999999999999999999763

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.6e-39  Score=266.77  Aligned_cols=179  Identities=23%  Similarity=0.440  Sum_probs=154.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.............||+
T Consensus        98 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~  177 (328)
T 3fe3_A           98 GGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP  177 (328)
T ss_dssp             TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSG
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCc
Confidence            78999999988999999999999999999999999999999999999999999999999999998766555566678999


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+....+.++|||||||++|+|++|..||.+.+.......+....                           
T Consensus       178 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------------------------  230 (328)
T 3fe3_A          178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---------------------------  230 (328)
T ss_dssp             GGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------------------
T ss_pred             ceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------------------
Confidence            99999999877656789999999999999999999999887665555544311                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                          ..++..+++++.+|+++||+.||.+|||++++++||||+....+..
T Consensus       231 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~  276 (328)
T 3fe3_A          231 ----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE  276 (328)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTCC
T ss_pred             ----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcccc
Confidence                0122247889999999999999999999999999999998765443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.9e-39  Score=264.81  Aligned_cols=206  Identities=38%  Similarity=0.746  Sum_probs=169.5

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      ++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||.+...... .......
T Consensus       101 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  180 (311)
T 3niz_A          101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV  180 (311)
T ss_dssp             CSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCC
T ss_pred             CCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCc
Confidence            467899988875 45999999999999999999999999999999999999999999999999999765433 2233457


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH-hC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR-QL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  157 (249)
                      +++.|+|||.+.+...++.++|||||||++|+|++|..||.+.........+...++.+....+.......  .+.. ..
T Consensus       181 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~  258 (311)
T 3niz_A          181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP--LWKQRTF  258 (311)
T ss_dssp             CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH--HHHSCCC
T ss_pred             ccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc--hhhhccc
Confidence            79999999999776668999999999999999999999999998888999999998887766554333221  1111 11


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      .......+..+.+.+++++.+||.+||+.||.+|||++++++||||+++..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            222334556667789999999999999999999999999999999998754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.2e-39  Score=263.97  Aligned_cols=214  Identities=37%  Similarity=0.709  Sum_probs=171.0

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      ++|+|.+++.+. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+...... .......
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  161 (324)
T 3mtl_A           82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV  161 (324)
T ss_dssp             CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----------
T ss_pred             cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccccc
Confidence            467999999875 46999999999999999999999999999999999999999999999999998765433 2233457


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+.......+...++.+....+.......... ....+
T Consensus       162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~  240 (324)
T 3mtl_A          162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK-TYNYP  240 (324)
T ss_dssp             -CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH-HTCCC
T ss_pred             CcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc-ccccc
Confidence            79999999999776668999999999999999999999999999999999999999988776655433222111 11222


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVC  215 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~  215 (249)
                      ...........+.+++++.+||.+||+.||.+|||++++++||||++........+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  297 (324)
T 3mtl_A          241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPD  297 (324)
T ss_dssp             CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCT
T ss_pred             cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCC
Confidence            223334455567889999999999999999999999999999999998876555443

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4e-39  Score=272.93  Aligned_cols=209  Identities=37%  Similarity=0.707  Sum_probs=167.8

Q ss_pred             CccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec-cCCCeEEeecCCccCCCCCCcccc
Q 025683            2 DTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~   76 (249)
                      ++++.+.+.    ....+++..++.++.||+.||+|||++|++||||||+||+++ .++.+||+|||.++..........
T Consensus       121 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~  200 (394)
T 4e7w_A          121 PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS  200 (394)
T ss_dssp             SEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCS
T ss_pred             CccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcc
Confidence            445554443    357899999999999999999999999999999999999999 789999999999987655555556


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+....+..+...++.+..............   ..
T Consensus       201 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~---~~  277 (394)
T 4e7w_A          201 YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME---HK  277 (394)
T ss_dssp             SCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS---SC
T ss_pred             cccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh---hc
Confidence            788999999999977666899999999999999999999999999999999999999988876543322111100   01


Q ss_pred             CCCCCCcchhh-cCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC
Q 025683          157 LPQHPRQSLAQ-VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP  213 (249)
Q Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~  213 (249)
                      .+......+.. ..+.+++++.+||.+||++||.+|||+.++++||||++++......
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~  335 (394)
T 4e7w_A          278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARM  335 (394)
T ss_dssp             CCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCC
T ss_pred             cccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccC
Confidence            11111122222 3445889999999999999999999999999999999988765544

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-39  Score=265.05  Aligned_cols=173  Identities=21%  Similarity=0.348  Sum_probs=143.9

Q ss_pred             CccHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683            2 DTDLYQIIRSN-------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus         2 ~~~L~~~l~~~-------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      ||||.++|.+.             ..|++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus        99 ~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~  178 (299)
T 4asz_A           99 HGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV  178 (299)
T ss_dssp             TCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred             CCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceec
Confidence            78999999864             36999999999999999999999999999999999999999999999999999754


Q ss_pred             CCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 025683           69 SENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (249)
Q Consensus        69 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (249)
                      .....   .....||+.|+|||.+... .++.++|||||||++|||++ |..||.+.+.......+.....         
T Consensus       179 ~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~---------  248 (299)
T 4asz_A          179 YSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV---------  248 (299)
T ss_dssp             TGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC---------
T ss_pred             CCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            43321   2234689999999999755 48999999999999999998 8999998887766665543111         


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                           ...+..+++++.+|+.+||+.||.+|||+.++  ++|++++.
T Consensus       249 ---------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          249 ---------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             ---------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence                                 11233578899999999999999999999999  45776553

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=264.49  Aligned_cols=168  Identities=20%  Similarity=0.332  Sum_probs=134.7

Q ss_pred             CccHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683            2 DTDLYQIIRSN---------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus         2 ~~~L~~~l~~~---------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      ||||.++|.+.               +++++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus       127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~  206 (329)
T 4aoj_A          127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR  206 (329)
T ss_dssp             TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccce
Confidence            68999999764               359999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 025683           67 PTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADL  142 (249)
Q Consensus        67 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  142 (249)
                      ......   ......||+.|+|||.+.+. .++.++|||||||++|||++ |+.||.+.+.......+.....       
T Consensus       207 ~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~-------  278 (329)
T 4aoj_A          207 DIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE-------  278 (329)
T ss_dssp             -------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC-------
T ss_pred             eccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence            654332   22345789999999998654 48999999999999999998 8999998877666655543111       


Q ss_pred             cccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          143 GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                             ...+..+++++.+|+.+||+.||.+|||+.+|+++
T Consensus       279 -----------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          279 -----------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             -----------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                                   01233578899999999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.3e-39  Score=263.16  Aligned_cols=168  Identities=18%  Similarity=0.331  Sum_probs=140.4

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      ||||.++|...                ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus       113 ~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGla  192 (308)
T 4gt4_A          113 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF  192 (308)
T ss_dssp             SCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCB
T ss_pred             CCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccc
Confidence            68999999753                35999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      +......   ......||+.|+|||.+... .++.++|||||||++|||++ |..||.+.+.......+.....      
T Consensus       193 r~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~------  265 (308)
T 4gt4_A          193 REVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV------  265 (308)
T ss_dssp             CGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC------
T ss_pred             eeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            7643322   23346789999999998755 48999999999999999998 8999998877666555432111      


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                              ...+...++++.+|+.+||+.||.+|||+.+|+++
T Consensus       266 ------------------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          266 ------------------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                    11233578889999999999999999999999874

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.7e-39  Score=268.81  Aligned_cols=169  Identities=27%  Similarity=0.406  Sum_probs=139.0

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      ||||.++|.+.                ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus       153 ~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGla  232 (353)
T 4ase_A          153 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA  232 (353)
T ss_dssp             TEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGG
T ss_pred             CCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhh
Confidence            68999999763                34899999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      +......   ......||+.|+|||.+.+. .++.++|||||||++|||++ |..||.+................+    
T Consensus       233 r~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~----  307 (353)
T 4ase_A          233 RDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----  307 (353)
T ss_dssp             SCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----
T ss_pred             hhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCC----
Confidence            8654332   22345789999999999755 48999999999999999998 899998765433333332211111    


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                               ..+...++++.+++.+||+.||.+|||+.+|++|
T Consensus       308 -------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          308 -------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                                     1223577899999999999999999999999987

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-38  Score=258.43  Aligned_cols=204  Identities=39%  Similarity=0.696  Sum_probs=160.6

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      ++++|.+++... +.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+...... .......
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  161 (288)
T 1ob3_A           82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI  161 (288)
T ss_dssp             CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred             cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccccc
Confidence            467899999875 78999999999999999999999999999999999999999999999999998754322 2233457


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.........+...++.+....+......  ..+.....
T Consensus       162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  239 (288)
T 1ob3_A          162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL--PKYDPNFT  239 (288)
T ss_dssp             CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TTCCTTCC
T ss_pred             ccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc--cccccccc
Confidence            7999999999976666899999999999999999999999999988888888888887665443322110  00000111


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                      ......+......+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            111223445566789999999999999999999999999999999863

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.7e-38  Score=261.65  Aligned_cols=212  Identities=35%  Similarity=0.685  Sum_probs=164.1

Q ss_pred             CCccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Cc
Q 025683            1 MDTDLYQIIRSN------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EF   73 (249)
Q Consensus         1 ~~~~L~~~l~~~------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~   73 (249)
                      ++++|.+++...      ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||.+...... ..
T Consensus        85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  164 (317)
T 2pmi_A           85 MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT  164 (317)
T ss_dssp             CCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC
T ss_pred             cCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc
Confidence            467999999764      46999999999999999999999999999999999999999999999999998765433 22


Q ss_pred             cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHH
Q 025683           74 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (249)
                      .....+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+.......+...++.+....+.......  .+
T Consensus       165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~  242 (317)
T 2pmi_A          165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP--KY  242 (317)
T ss_dssp             CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT--TC
T ss_pred             CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh--hc
Confidence            3445789999999999766668999999999999999999999999999999999999888877655443221110  00


Q ss_pred             HHhCCCCCCcc-----hhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCC
Q 025683          154 IRQLPQHPRQS-----LAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPV  214 (249)
Q Consensus       154 ~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~  214 (249)
                      ...........     .......+++++.+||.+||+.||.+|||+.++++||||+++.......+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~  308 (317)
T 2pmi_A          243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGG  308 (317)
T ss_dssp             CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC------
T ss_pred             ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhccc
Confidence            00000000011     11123467889999999999999999999999999999999876655544

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.2e-38  Score=256.96  Aligned_cols=205  Identities=41%  Similarity=0.716  Sum_probs=162.4

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      ++++|.+++.. .+.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+...... .......
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  162 (292)
T 3o0g_A           83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV  162 (292)
T ss_dssp             CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCC
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCc
Confidence            45677777766 578999999999999999999999999999999999999999999999999999765433 2334467


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +|+.|+|||.+.+...++.++|||||||++++|++|..| |.+.+.......+....+.+....+........  +....
T Consensus       163 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~  240 (292)
T 3o0g_A          163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD--YKPYP  240 (292)
T ss_dssp             SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT--CCCCC
T ss_pred             cccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc--ccccc
Confidence            799999999997766689999999999999999987766 667777888888888888877665443222100  00000


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      ............+.+++++.+||++||+.||.+|||++++++||||+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            11112233445567899999999999999999999999999999999764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=260.68  Aligned_cols=210  Identities=31%  Similarity=0.636  Sum_probs=157.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      |++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+...... .......++
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  165 (311)
T 4agu_A           86 HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT  165 (311)
T ss_dssp             EEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------
T ss_pred             CchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCC
Confidence            4678888888889999999999999999999999999999999999999999999999999999765532 223456789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+...++.++|+||||+++|+|++|..||.+.........+....+.........................
T Consensus       166 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 4agu_A          166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPE  245 (311)
T ss_dssp             GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCS
T ss_pred             ccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCcc
Confidence            99999999977666899999999999999999999999999988888888887776554322111110000000000011


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                      .........+.+++++.+||++||+.||.+|||++++++||||++..+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          246 DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence            112233344678999999999999999999999999999999998865443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3e-38  Score=264.38  Aligned_cols=177  Identities=28%  Similarity=0.511  Sum_probs=152.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC----CeEEeecCCccCCCCCCccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSENEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~----~~kL~dfg~~~~~~~~~~~~~~   77 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++    .++|+|||++............
T Consensus        99 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~  178 (361)
T 2yab_A           99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI  178 (361)
T ss_dssp             SCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccC
Confidence            789999999989999999999999999999999999999999999999998877    7999999999877665555667


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .||+.|+|||.+... .++.++|+|||||++|+|++|..||.+.+.......+.......+                   
T Consensus       179 ~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------  238 (361)
T 2yab_A          179 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD-------------------  238 (361)
T ss_dssp             CSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-------------------
T ss_pred             CCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------------------
Confidence            899999999998654 488999999999999999999999998876666655543211111                   


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                              ...+..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus       239 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          239 --------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             --------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             --------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence                    12234678999999999999999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.2e-37  Score=254.50  Aligned_cols=205  Identities=39%  Similarity=0.705  Sum_probs=168.9

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccc
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ++|+|.+++.+.  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.............
T Consensus       101 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  180 (326)
T 1blx_A          101 VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV  180 (326)
T ss_dssp             CSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCC
T ss_pred             CCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccc
Confidence            468999999885  349999999999999999999999999999999999999999999999999998765544445567


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++..|+|||.+.+. .++.++||||||+++|+|++|..||.+.........+...++.+....+........    ....
T Consensus       181 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~  255 (326)
T 1blx_A          181 VTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR----QAFH  255 (326)
T ss_dssp             CCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG----GGSC
T ss_pred             cccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccch----hhhc
Confidence            89999999998654 488999999999999999999999999999999999988888776554432111100    1111


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                      .............+++.+.+||.+||+.||.+|||+.++++||||+......
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          256 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            2223344556678899999999999999999999999999999999876543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-38  Score=262.69  Aligned_cols=178  Identities=28%  Similarity=0.495  Sum_probs=149.6

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ++|+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.............||
T Consensus        91 ~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt  170 (336)
T 3h4j_B           91 AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGS  170 (336)
T ss_dssp             CCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTS
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCC
Confidence            47899999999899999999999999999999999999999999999999999999999999999877666656677899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+....+.++|||||||++|+|++|..||.......                               ....
T Consensus       171 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------------------------------~~~~  219 (336)
T 3h4j_B          171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-------------------------------LFKK  219 (336)
T ss_dssp             TTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-------------------------------CBCC
T ss_pred             cCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-------------------------------HHHH
Confidence            999999999766545789999999999999999999997543110                               0000


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      ........+..+++++.+||++||+.||.+|||++++++||||+.-..+
T Consensus       220 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  268 (336)
T 3h4j_B          220 VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPD  268 (336)
T ss_dssp             CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred             HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence            1111123345688999999999999999999999999999999865433

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.1e-38  Score=267.71  Aligned_cols=208  Identities=38%  Similarity=0.723  Sum_probs=164.2

Q ss_pred             CccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC-CCeEEeecCCccCCCCCCcccc
Q 025683            2 DTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~   76 (249)
                      +++|.+++.    ....+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||+++..........
T Consensus       136 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~  215 (420)
T 1j1b_A          136 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS  215 (420)
T ss_dssp             CEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCS
T ss_pred             cccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCcee
Confidence            456666654    35789999999999999999999999999999999999999965 5689999999987655554556


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+|+.|+|||.+.+...++.++|||||||++|+|++|..||.+.+...++..+...++.+....+.........   ..
T Consensus       216 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~---~~  292 (420)
T 1j1b_A          216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FK  292 (420)
T ss_dssp             CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC---CC
T ss_pred             eeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh---hc
Confidence            788999999999876656899999999999999999999999999999999999998888765433211100000   00


Q ss_pred             CCCCCCcchhh-cCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC
Q 025683          157 LPQHPRQSLAQ-VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE  212 (249)
Q Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~  212 (249)
                      .+......+.. +.+.+++++.+||.+||.+||.+|||+.++++||||+.+......
T Consensus       293 ~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  349 (420)
T 1j1b_A          293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK  349 (420)
T ss_dssp             CCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCC
T ss_pred             cCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccccc
Confidence            01111111222 234678999999999999999999999999999999998766544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.3e-38  Score=265.11  Aligned_cols=205  Identities=36%  Similarity=0.710  Sum_probs=165.0

Q ss_pred             CCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec-cCCCeEEeecCCccCCCCCCccc
Q 025683            1 MDTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMT   75 (249)
Q Consensus         1 ~~~~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~-~~~~~kL~dfg~~~~~~~~~~~~   75 (249)
                      ++++|.+++.    ..+.+++..++.++.||+.||.|||++|++||||||+||+++ .++.+||+|||.+..........
T Consensus       120 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~  199 (383)
T 3eb0_A          120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV  199 (383)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC
T ss_pred             CCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc
Confidence            3566666654    467899999999999999999999999999999999999998 68899999999998766555555


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...+++.|+|||.+.+...++.++||||+||++|+|++|..||.+.+....+..+...++.++.............   .
T Consensus       200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~---~  276 (383)
T 3eb0_A          200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE---V  276 (383)
T ss_dssp             CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----C
T ss_pred             CcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc---c
Confidence            6788999999999877666899999999999999999999999999999999999999988876543221111000   0


Q ss_pred             hCCCCCCcch-hhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          156 QLPQHPRQSL-AQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       156 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      ..+......+ ..+...+++++.+||.+||+.||.+|||+.++++||||+.++.
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          277 RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             cCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence            0111111112 2234568899999999999999999999999999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.7e-37  Score=255.52  Aligned_cols=174  Identities=28%  Similarity=0.534  Sum_probs=149.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC-CCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~-~~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++... ........+||
T Consensus        89 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt  168 (337)
T 1o6l_A           89 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  168 (337)
T ss_dssp             TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEEC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccC
Confidence            68999999998999999999999999999999999999999999999999999999999999997643 23344567899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+....                          
T Consensus       169 ~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------------------------  221 (337)
T 1o6l_A          169 PEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--------------------------  221 (337)
T ss_dssp             GGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------------------
T ss_pred             hhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            999999998654 47899999999999999999999998877655555543210                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                           ..++..+++++.+||.+||+.||.+||     +++++++||||+...
T Consensus       222 -----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence                 012235789999999999999999999     999999999998765

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.2e-38  Score=262.27  Aligned_cols=222  Identities=33%  Similarity=0.571  Sum_probs=170.2

Q ss_pred             CccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCCCCeeecc-CCCeEEeecCCccCCCCCCcc
Q 025683            2 DTDLYQIIR----SNQSLSEEHCQYFLYQLLRGLKYIH--SANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENEFM   74 (249)
Q Consensus         2 ~~~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH--~~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~~~~~~   74 (249)
                      +++|.+.+.    ....+++..+..++.||+.||.|||  ++|++||||||+||+++. ++.+||+|||.+.........
T Consensus       109 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  188 (360)
T 3e3p_A          109 PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN  188 (360)
T ss_dssp             SCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCC
T ss_pred             cccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCc
Confidence            455555443    5678999999999999999999999  999999999999999997 899999999999877666555


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+.......+...++.++................
T Consensus       189 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (360)
T 3e3p_A          189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDL  268 (360)
T ss_dssp             CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGG
T ss_pred             ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccc
Confidence            56778999999999876666899999999999999999999999999999999999988887765433221110000000


Q ss_pred             H-hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCch
Q 025683          155 R-QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDF  223 (249)
Q Consensus       155 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~  223 (249)
                      . .........+.......++++.+||.+||+.||.+|||+.++++||||++........+.....+.++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~  338 (360)
T 3e3p_A          269 YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDL  338 (360)
T ss_dssp             GCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCCGGG
T ss_pred             cccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCCcHH
Confidence            0 00000000111222336788999999999999999999999999999999987776665555555433

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-37  Score=258.47  Aligned_cols=208  Identities=38%  Similarity=0.682  Sum_probs=168.3

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      ++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+...... .......
T Consensus        94 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  173 (346)
T 1ua2_A           94 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  173 (346)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             CCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCccc
Confidence            467899999875 46999999999999999999999999999999999999999999999999999865433 2334567


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +|+.|+|||.+.+...++.++|||||||++|+|++|..||.+......+..+....+.+....+........  + ....
T Consensus       174 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~-~~~~  250 (346)
T 1ua2_A          174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD--Y-VTFK  250 (346)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT--C-CCCC
T ss_pred             ccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc--c-cccc
Confidence            899999999997666688999999999999999999999999999999999998888776654432211100  0 0011


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                      ..+......+...+++++.+||.+||+.||.+|||+.++++||||++......
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~  303 (346)
T 1ua2_A          251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  303 (346)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             ccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence            11223344556678899999999999999999999999999999998654443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.6e-38  Score=263.23  Aligned_cols=174  Identities=22%  Similarity=0.425  Sum_probs=146.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.... .......+||
T Consensus       108 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt  187 (353)
T 3txo_A          108 GGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGT  187 (353)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCC
Confidence            689999999989999999999999999999999999999999999999999999999999999875433 2334456889


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+.......+.....                         
T Consensus       188 ~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------------------------  241 (353)
T 3txo_A          188 PDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-------------------------  241 (353)
T ss_dssp             GGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------------
T ss_pred             cCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence            9999999986543 78999999999999999999999998887776666654111                         


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH------HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV------DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~~ll~h~~~~~~~  207 (249)
                            ..+..+++++.+||++||+.||.+||++      +++++||||+.+.
T Consensus       242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence                  1123477889999999999999999998      8999999999865

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-37  Score=257.17  Aligned_cols=205  Identities=37%  Similarity=0.692  Sum_probs=156.8

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec-----cCCCeEEeecCCccCCCCC-Ccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-----ANCDLKICDFGLARPTSEN-EFM   74 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~-----~~~~~kL~dfg~~~~~~~~-~~~   74 (249)
                      ++|+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++     ..+.+||+|||.+...... ...
T Consensus       115 ~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  194 (329)
T 3gbz_A          115 AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF  194 (329)
T ss_dssp             CSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------
T ss_pred             CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccccc
Confidence            4679999999999999999999999999999999999999999999999995     4455999999998754322 223


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....++..|+|||.+.+...++.++|||||||++|+|++|..||.+.........+....+.+....+.......  .+.
T Consensus       195 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  272 (329)
T 3gbz_A          195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP--DWK  272 (329)
T ss_dssp             -----CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--TCC
T ss_pred             CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh--hhh
Confidence            345779999999999776668999999999999999999999999999999999999888877655443221100  000


Q ss_pred             HhCCCCCCcchh-hcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          155 RQLPQHPRQSLA-QVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       155 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      ...+......+. .+...+++++.+||.+||+.||.+|||++++++||||++..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            001111111111 12223788999999999999999999999999999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-37  Score=261.35  Aligned_cols=182  Identities=29%  Similarity=0.445  Sum_probs=133.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC--eEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ||+|.+++.+.+++++..++.++.||+.||+|||++|++||||||+||+++.++.  +||+|||.+.............|
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g  179 (361)
T 3uc3_A          100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  179 (361)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcC
Confidence            7899999998889999999999999999999999999999999999999987765  99999999875544444456678


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      |+.|+|||.+.+....+.++|||||||++|+|++|..||.+.........+........                   ..
T Consensus       180 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------------~~  240 (361)
T 3uc3_A          180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK-------------------YS  240 (361)
T ss_dssp             -CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC-------------------CC
T ss_pred             CCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC-------------------CC
Confidence            99999999997666445569999999999999999999976543222222221110000                   00


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      .      .....+++++.+||.+||+.||.+|||+.++++||||.+...
T Consensus       241 ~------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          241 I------PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             C------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             C------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence            0      001247889999999999999999999999999999976543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.7e-37  Score=257.85  Aligned_cols=174  Identities=23%  Similarity=0.419  Sum_probs=150.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++..... .......+||
T Consensus       105 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt  184 (353)
T 2i0e_A          105 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT  184 (353)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCC
Confidence            789999999888999999999999999999999999999999999999999999999999999976432 3334567899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+....                          
T Consensus       185 ~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------------------------  237 (353)
T 2i0e_A          185 PDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------------------------  237 (353)
T ss_dssp             GGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------------------
T ss_pred             ccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            999999998654 48999999999999999999999999887766666655311                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                           ...+..+++++.+||.+||+.||.+||     +++++++||||+.+.
T Consensus       238 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          238 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence                 012235789999999999999999999     479999999999765

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=264.28  Aligned_cols=211  Identities=34%  Similarity=0.639  Sum_probs=155.3

Q ss_pred             CCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee----ccCCCeEEeecCCccC
Q 025683            1 MDTDLYQIIRSN---------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGLARP   67 (249)
Q Consensus         1 ~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~----~~~~~~kL~dfg~~~~   67 (249)
                      ++++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+||++    +.++.+||+|||.+..
T Consensus       102 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  181 (405)
T 3rgf_A          102 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  181 (405)
T ss_dssp             CSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred             CCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence            467888888632         259999999999999999999999999999999999999    6778999999999976


Q ss_pred             CCCC----CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 025683           68 TSEN----EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---------VHQMRLLIELL  134 (249)
Q Consensus        68 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~---------~~~~~~~~~~~  134 (249)
                      ....    .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+...         ...+..+...+
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~  261 (405)
T 3rgf_A          182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  261 (405)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHH
T ss_pred             cCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhh
Confidence            5432    2233467899999999997766689999999999999999999999976543         57888899999


Q ss_pred             CCCCcccccccchhhHH-HHHHhCCCCC------CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          135 GTPTDADLGFVRNEDAK-RYIRQLPQHP------RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       135 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      +.+....+......... ..........      ...........++.+.+||.+||+.||.+|||++++|+||||++..
T Consensus       262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~  341 (405)
T 3rgf_A          262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP  341 (405)
T ss_dssp             CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred             CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence            98887665544322111 1111111000      0001112223478899999999999999999999999999999866


Q ss_pred             CCCC
Q 025683          208 DEAD  211 (249)
Q Consensus       208 ~~~~  211 (249)
                      ....
T Consensus       342 ~~~~  345 (405)
T 3rgf_A          342 LPTS  345 (405)
T ss_dssp             CCCS
T ss_pred             CCcc
Confidence            4443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-37  Score=256.03  Aligned_cols=177  Identities=30%  Similarity=0.501  Sum_probs=150.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC----CeEEeecCCccCCCCCCccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSENEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~----~~kL~dfg~~~~~~~~~~~~~~   77 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||||+||+++.++    .++|+|||.+............
T Consensus        98 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  177 (326)
T 2y0a_A           98 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI  177 (326)
T ss_dssp             SCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCC
T ss_pred             CCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccc
Confidence            689999999888999999999999999999999999999999999999999887    8999999999876655555567


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .+|+.|+|||.+... .++.++|+|||||++|+|++|..||.+.........+.......+                   
T Consensus       178 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------  237 (326)
T 2y0a_A          178 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------------------  237 (326)
T ss_dssp             CSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC-------------------
T ss_pred             cCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC-------------------
Confidence            889999999998644 488999999999999999999999988776665555443211111                   


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                              ...+..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       238 --------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          238 --------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             --------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             --------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                    12233578889999999999999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.5e-37  Score=264.60  Aligned_cols=202  Identities=35%  Similarity=0.634  Sum_probs=160.2

Q ss_pred             CCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC--eEEeecCCccCCCCCCcccc
Q 025683            1 MDTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--LKICDFGLARPTSENEFMTE   76 (249)
Q Consensus         1 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~   76 (249)
                      ++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||+++.++.  +||+|||.+......  ...
T Consensus       181 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~--~~~  258 (429)
T 3kvw_A          181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYT  258 (429)
T ss_dssp             CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCS
T ss_pred             cCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc--ccc
Confidence            5789999998864  5999999999999999999999999999999999999999987  999999998654332  335


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+....+..+...++.++.........  ...++..
T Consensus       259 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~--~~~~~~~  335 (429)
T 3kvw_A          259 YIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR--AKNFVSS  335 (429)
T ss_dssp             SCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT--HHHHBCT
T ss_pred             cCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh--hhhccCC
Confidence            67899999999997654 89999999999999999999999999999999999999998887665432221  1111111


Q ss_pred             CCCC------------------------------CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          157 LPQH------------------------------PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       157 ~~~~------------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                      ....                              .......+....++++.+||++||++||.+|||++|+|+||||++.
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          336 KGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR  415 (429)
T ss_dssp             TSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred             CCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence            1000                              0001111233457889999999999999999999999999999975


Q ss_pred             c
Q 025683          207 H  207 (249)
Q Consensus       207 ~  207 (249)
                      .
T Consensus       416 ~  416 (429)
T 3kvw_A          416 L  416 (429)
T ss_dssp             -
T ss_pred             C
Confidence            3

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.6e-37  Score=258.52  Aligned_cols=174  Identities=26%  Similarity=0.463  Sum_probs=150.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.... .......+||
T Consensus       102 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt  181 (345)
T 1xjd_A          102 GGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT  181 (345)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCC
Confidence            789999999988999999999999999999999999999999999999999999999999999876432 2334557889


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+....                          
T Consensus       182 ~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------------------------  234 (345)
T 1xjd_A          182 PDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--------------------------  234 (345)
T ss_dssp             GGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------------------
T ss_pred             cccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            999999998654 48999999999999999999999999887666655554310                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHH-HHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVD-EALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~-~ll~h~~~~~~~  207 (249)
                           ...+..+++++.+||.+||+.||.+||++. ++++||||+.+.
T Consensus       235 -----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          235 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             -----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence                 011235788999999999999999999998 999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.6e-37  Score=248.97  Aligned_cols=175  Identities=25%  Similarity=0.450  Sum_probs=147.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      ||+|.+++.+ ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+....... ......|+
T Consensus       101 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  179 (297)
T 3fxz_A          101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  179 (297)
T ss_dssp             TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSC
T ss_pred             CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCC
Confidence            7899999987 479999999999999999999999999999999999999999999999999987655432 23456789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+........                      
T Consensus       180 ~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------  236 (297)
T 3fxz_A          180 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL----------------------  236 (297)
T ss_dssp             GGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC----------------------
T ss_pred             cCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------------------
Confidence            999999998755 478999999999999999999999988876655555443221111                      


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                            ..+..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       237 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          237 ------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             ------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence                  1122477889999999999999999999999999999965

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-36  Score=257.07  Aligned_cols=183  Identities=23%  Similarity=0.435  Sum_probs=144.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCC-CCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT-SENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~-~~~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.. .........+||
T Consensus       137 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt  216 (396)
T 4dc2_A          137 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  216 (396)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCC
Confidence            6899999999899999999999999999999999999999999999999999999999999999763 333445567899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++.+. .++.++|+|||||++|+|++|..||...........              ..............   
T Consensus       217 ~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~--------------~~~~~~~~~i~~~~---  278 (396)
T 4dc2_A          217 PNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------------NTEDYLFQVILEKQ---  278 (396)
T ss_dssp             GGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------------CCHHHHHHHHHHCC---
T ss_pred             cccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccch--------------hhHHHHHHHHhccc---
Confidence            999999999755 489999999999999999999999964321110000              00000000011111   


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH------HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV------DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~~ll~h~~~~~~~  207 (249)
                           ..++..+++++.+||++||+.||.+||++      +++++||||+.+.
T Consensus       279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence                 12234678999999999999999999984      8999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-37  Score=256.39  Aligned_cols=179  Identities=26%  Similarity=0.442  Sum_probs=151.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc--CCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~--~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.  ++.++|+|||.+.............
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  164 (321)
T 1tki_A           85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF  164 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEE
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccccc
Confidence            67999999876 47999999999999999999999999999999999999987  7899999999998776655555677


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.........+.......+                    
T Consensus       165 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------  223 (321)
T 1tki_A          165 TAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD--------------------  223 (321)
T ss_dssp             SCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--------------------
T ss_pred             CChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC--------------------
Confidence            89999999998654 478999999999999999999999998877666665554221111                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                             ...++.+++++.+||.+||..||.+|||+.++++||||++...
T Consensus       224 -------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          224 -------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             -------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             -------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence                   1223367899999999999999999999999999999997543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.9e-37  Score=257.55  Aligned_cols=208  Identities=34%  Similarity=0.587  Sum_probs=161.0

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-----Ccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-----EFM   74 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-----~~~   74 (249)
                      ++++|.+.+... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+......     ...
T Consensus       106 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  185 (351)
T 3mi9_A          106 CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY  185 (351)
T ss_dssp             CSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCC
T ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccccccccccc
Confidence            467888888775 67999999999999999999999999999999999999999999999999998754421     223


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....+|+.|+|||.+.+...++.++|||||||++|+|++|..||.+.........+....+..+...+............
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  265 (351)
T 3mi9_A          186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL  265 (351)
T ss_dssp             CSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSS
T ss_pred             CCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhccc
Confidence            34577999999999976666899999999999999999999999999999999999998888776554433221110000


Q ss_pred             HhCCCCCCcchhhcC--CCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          155 RQLPQHPRQSLAQVF--PHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      .... ..........  ...++++.+||.+||+.||.+|||++++++||||+.....
T Consensus       266 ~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          266 ELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             CCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             cccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            0000 0000000000  0136779999999999999999999999999999875443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.8e-37  Score=261.52  Aligned_cols=177  Identities=31%  Similarity=0.487  Sum_probs=150.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec---cCCCeEEeecCCccCCCCCC-ccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---ANCDLKICDFGLARPTSENE-FMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~---~~~~~kL~dfg~~~~~~~~~-~~~~~   77 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++....... .....
T Consensus        94 gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  173 (444)
T 3soa_A           94 GGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF  173 (444)
T ss_dssp             CCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCS
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecc
Confidence            689999999999999999999999999999999999999999999999998   45789999999997665432 23456


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+.......+.                  
T Consensus       174 ~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------------------  234 (444)
T 3soa_A          174 AGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS------------------  234 (444)
T ss_dssp             CSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT------------------
T ss_pred             cCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc------------------
Confidence            889999999998654 4889999999999999999999999888776666665542221111                  


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                               ..+..+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       235 ---------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          235 ---------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ---------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ---------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                     1233678999999999999999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-37  Score=252.26  Aligned_cols=172  Identities=26%  Similarity=0.499  Sum_probs=149.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......  .....||+
T Consensus        90 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~  167 (318)
T 1fot_A           90 GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTP  167 (318)
T ss_dssp             SCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCT
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--cccccCCc
Confidence            6899999999999999999999999999999999999999999999999999999999999999765432  33567899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....                           
T Consensus       168 ~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------------------------  219 (318)
T 1fot_A          168 DYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE---------------------------  219 (318)
T ss_dssp             TTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC---------------------------
T ss_pred             cccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------------------
Confidence            99999998654 48899999999999999999999998887666666554311                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                          ...+..+++++.++|.+||..||.+||     +++++++||||+...
T Consensus       220 ----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          220 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             ----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence                012235788999999999999999999     999999999999865

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.1e-37  Score=257.22  Aligned_cols=177  Identities=32%  Similarity=0.515  Sum_probs=149.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC---CeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~---~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++   .+||+|||++.............
T Consensus       112 gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~  191 (362)
T 2bdw_A          112 GGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA  191 (362)
T ss_dssp             SCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSC
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCC
Confidence            689999999988999999999999999999999999999999999999998654   59999999998776555555678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+.......+.                   
T Consensus       192 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------  251 (362)
T 2bdw_A          192 GTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-------------------  251 (362)
T ss_dssp             SCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------------------
T ss_pred             CCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc-------------------
Confidence            89999999998654 4889999999999999999999999888766655555432211111                   


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                              ..+..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       252 --------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          252 --------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             --------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             --------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                    1123578899999999999999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.5e-37  Score=265.44  Aligned_cols=176  Identities=30%  Similarity=0.504  Sum_probs=152.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++............+|++
T Consensus       100 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~  179 (476)
T 2y94_A          100 GGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP  179 (476)
T ss_dssp             SEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCS
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCc
Confidence            78999999998999999999999999999999999999999999999999999999999999998776655556678999


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+....+.++|||||||++|+|++|..||...+.......+....                           
T Consensus       180 ~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------------------  232 (476)
T 2y94_A          180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI---------------------------  232 (476)
T ss_dssp             TTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC---------------------------
T ss_pred             CeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---------------------------
Confidence            99999999766656789999999999999999999998877655555543211                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                          ...+..+++++.+||++||+.||.+|||+.++++||||++...
T Consensus       233 ----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          233 ----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             ----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence                0112247788999999999999999999999999999987543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-37  Score=256.68  Aligned_cols=204  Identities=33%  Similarity=0.628  Sum_probs=156.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      |++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+...... .......++
T Consensus       108 ~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t  187 (331)
T 4aaa_A          108 HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT  187 (331)
T ss_dssp             EEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCC
T ss_pred             cchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCC
Confidence            4567777777788999999999999999999999999999999999999999999999999998765432 223446789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+...++.++|||||||++|+|++|..||.+.........+....+.................-.......
T Consensus       188 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (331)
T 4aaa_A          188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK  267 (331)
T ss_dssp             CTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCS
T ss_pred             ccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCcccc
Confidence            99999999976656899999999999999999999999999988888888887776554322111110000000000011


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                      .........+.+++++.+||.+||+.||.+|||+.++|+||||+.
T Consensus       268 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             ccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            122344455678999999999999999999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.7e-36  Score=259.42  Aligned_cols=174  Identities=30%  Similarity=0.531  Sum_probs=148.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~   79 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+||+++.++.+||+|||++..... ........|
T Consensus       232 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~g  311 (446)
T 4ejn_A          232 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  311 (446)
T ss_dssp             SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSS
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccC
Confidence            67999999998999999999999999999999998 9999999999999999999999999999876433 333455788


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      |+.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+....                         
T Consensus       312 t~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------------------------  365 (446)
T 4ejn_A          312 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------------------  365 (446)
T ss_dssp             CGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------------
T ss_pred             CccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-------------------------
Confidence            9999999998654 48999999999999999999999998887665555554311                         


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                            ..++..+++++.+||.+||+.||.+||     |++++++||||+.+.
T Consensus       366 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          366 ------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             ------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence                  012235788999999999999999999     999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.8e-37  Score=256.84  Aligned_cols=178  Identities=24%  Similarity=0.455  Sum_probs=147.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.............||+
T Consensus        99 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~  178 (384)
T 4fr4_A           99 GGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTK  178 (384)
T ss_dssp             TEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCG
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCc
Confidence            78999999998999999999999999999999999999999999999999999999999999998776666566778999


Q ss_pred             cccCchhccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           82 WYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        82 ~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      .|+|||.+...  ..++.++|+|||||++|+|++|..||...........+....                    ..   
T Consensus       179 ~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--------------------~~---  235 (384)
T 4fr4_A          179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------------TT---  235 (384)
T ss_dssp             GGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH--------------------HC---
T ss_pred             cccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--------------------hc---
Confidence            99999998642  347889999999999999999999997543211111111100                    00   


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-HHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-VDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~~ll~h~~~~~~~  207 (249)
                           ....+..+++++.+||.+||+.||.+||+ ++++++||||+.+.
T Consensus       236 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          236 -----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             -----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence                 01123357889999999999999999998 99999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.1e-36  Score=253.96  Aligned_cols=172  Identities=26%  Similarity=0.466  Sum_probs=149.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++......  .....||+
T Consensus       125 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~  202 (350)
T 1rdq_E          125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTP  202 (350)
T ss_dssp             TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECG
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--cccccCCc
Confidence            7899999999889999999999999999999999999999999999999999999999999999765433  33568899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+....                           
T Consensus       203 ~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------------------------  254 (350)
T 1rdq_E          203 EALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------------------------  254 (350)
T ss_dssp             GGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------------------
T ss_pred             cccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC---------------------------
Confidence            99999998654 48899999999999999999999998887666665554311                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                          ..++..+++++.++|.+||+.||.+||+     ++++++||||+...
T Consensus       255 ----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence                0122357889999999999999999998     99999999999764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-36  Score=253.00  Aligned_cols=183  Identities=23%  Similarity=0.432  Sum_probs=143.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC-CCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~-~~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++... ........+||
T Consensus        94 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt  173 (345)
T 3a8x_A           94 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  173 (345)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCC
Confidence            68999999998899999999999999999999999999999999999999999999999999997633 23344567889


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+|||||++|+|++|..||...........              ..............   
T Consensus       174 ~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------------~~~~~~~~~i~~~~---  235 (345)
T 3a8x_A          174 PNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------------NTEDYLFQVILEKQ---  235 (345)
T ss_dssp             GGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------------CHHHHHHHHHHCC---
T ss_pred             ccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--------------ccHHHHHHHHHcCC---
Confidence            999999998654 478999999999999999999999965321100000              00000000001110   


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH------HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV------DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~~ll~h~~~~~~~  207 (249)
                           ..++..+++++.++|.+||+.||.+||++      +++++||||++..
T Consensus       236 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          236 -----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence                 11234678999999999999999999995      8999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.3e-37  Score=256.74  Aligned_cols=201  Identities=28%  Similarity=0.534  Sum_probs=154.2

Q ss_pred             CCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-------------------------
Q 025683            1 MDTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------------------   53 (249)
Q Consensus         1 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-------------------------   53 (249)
                      +|++|.+++....  .+++..++.++.||+.||+|||++|++||||||+||+++.                         
T Consensus       118 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (360)
T 3llt_A          118 LGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK  197 (360)
T ss_dssp             CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEES
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccC
Confidence            5889999998864  5999999999999999999999999999999999999975                         


Q ss_pred             CCCeEEeecCCccCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 025683           54 NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIEL  133 (249)
Q Consensus        54 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  133 (249)
                      ++.+||+|||.+......  .....+|+.|+|||.+.+. .++.++|||||||++|+|++|..||...........+...
T Consensus       198 ~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  274 (360)
T 3llt_A          198 STGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI  274 (360)
T ss_dssp             CCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHh
Confidence            788999999999764432  2356789999999999755 4899999999999999999999999999988888888888


Q ss_pred             hCCCCcccccccchhhHHHHHHhC------CCCC---------CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHh
Q 025683          134 LGTPTDADLGFVRNEDAKRYIRQL------PQHP---------RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL  198 (249)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll  198 (249)
                      .+..+..............+....      +...         ...........++.+.+||.+||+.||.+|||+.++|
T Consensus       275 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL  354 (360)
T 3llt_A          275 IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL  354 (360)
T ss_dssp             TCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred             cCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHh
Confidence            777665432211111000000000      0000         0000001112347788999999999999999999999


Q ss_pred             cCcccc
Q 025683          199 AHPYLA  204 (249)
Q Consensus       199 ~h~~~~  204 (249)
                      +||||+
T Consensus       355 ~hp~f~  360 (360)
T 3llt_A          355 KHKFLE  360 (360)
T ss_dssp             TSGGGC
T ss_pred             cCcccC
Confidence            999996

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.2e-37  Score=251.48  Aligned_cols=211  Identities=45%  Similarity=0.823  Sum_probs=160.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec-cCCCeEEeecCCccCCCCC----Cccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSEN----EFMT   75 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~-~~~~~kL~dfg~~~~~~~~----~~~~   75 (249)
                      ++|+|.+++.+ +.+++..++.++.||+.||+|||++|++|+||||+||+++ .++.+||+|||.+......    ....
T Consensus       104 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  182 (320)
T 2i6l_A          104 METDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS  182 (320)
T ss_dssp             CSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCC
T ss_pred             cCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccc
Confidence            46799999975 6799999999999999999999999999999999999997 5678999999998765432    2223


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...++..|+|||.+.....++.++|+||||+++|+|++|..||.+.........+.................. ...+..
T Consensus       183 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  261 (320)
T 2i6l_A          183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSV-IPVYIR  261 (320)
T ss_dssp             GGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTT-SCHHHH
T ss_pred             cccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhc-Cccccc
Confidence            4466888999999876566899999999999999999999999999888888777766544433221111000 001111


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP  213 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~  213 (249)
                      ..............+.+++++.+||.+||+.||.+|||+.++++||||+....+..+|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~~  319 (320)
T 2i6l_A          262 NDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEP  319 (320)
T ss_dssp             HHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-----
T ss_pred             ccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCCC
Confidence            2222334445566778999999999999999999999999999999999876555443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-36  Score=256.02  Aligned_cols=203  Identities=33%  Similarity=0.633  Sum_probs=155.8

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCCCCeeec--cCCCeEEeecCCccCCCCCCcc
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIH--SANVIHRDLKPSNLLLN--ANCDLKICDFGLARPTSENEFM   74 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH--~~~i~H~dik~~nil~~--~~~~~kL~dfg~~~~~~~~~~~   74 (249)
                      ++++|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+||+++  .++.+||+|||.+......  .
T Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~  215 (382)
T 2vx3_A          138 LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--I  215 (382)
T ss_dssp             CCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--C
T ss_pred             CCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc--c
Confidence            478999999886  46999999999999999999999  46899999999999995  4778999999999765432  3


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+....+..+....+.++.......+.  ...++
T Consensus       216 ~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~  292 (382)
T 2vx3_A          216 YQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK--ARKFF  292 (382)
T ss_dssp             CSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT--HHHHE
T ss_pred             ccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH--HHHHH
Confidence            3567899999999997654 88999999999999999999999999999999999999888777554432211  11222


Q ss_pred             HhCCCCC-----------------CcchhhcCC-----------C-------CChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          155 RQLPQHP-----------------RQSLAQVFP-----------H-------VHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       155 ~~~~~~~-----------------~~~~~~~~~-----------~-------~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ...+...                 ...+.....           .       .++++.+||.+||++||.+|||+.++|+
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          293 EKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ  372 (382)
T ss_dssp             EECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhc
Confidence            2111100                 000000000           0       0136899999999999999999999999


Q ss_pred             CccccCCcC
Q 025683          200 HPYLARLHD  208 (249)
Q Consensus       200 h~~~~~~~~  208 (249)
                      ||||++..+
T Consensus       373 hp~f~~~~~  381 (382)
T 2vx3_A          373 HSFFKKTAD  381 (382)
T ss_dssp             SGGGCC---
T ss_pred             CcccccCCC
Confidence            999997654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.3e-37  Score=261.25  Aligned_cols=183  Identities=22%  Similarity=0.410  Sum_probs=152.4

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--ccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~   78 (249)
                      ||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........  ....+
T Consensus       158 gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~  237 (437)
T 4aw2_A          158 GGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV  237 (437)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCC
T ss_pred             CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccccccc
Confidence            7899999988 57899999999999999999999999999999999999999999999999999976544332  23367


Q ss_pred             ccccccCchhcc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           79 VTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        79 ~~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ||+.|+|||.+.    +...++.++|+|||||++|+|++|..||.+.+.......+.......                 
T Consensus       238 GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------  300 (437)
T 4aw2_A          238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF-----------------  300 (437)
T ss_dssp             SCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-----------------
T ss_pred             CCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc-----------------
Confidence            899999999986    24457899999999999999999999999988777777765321100                 


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCcCCC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~h~~~~~~~~~~  210 (249)
                               .+......+++++.+||++||..+|.+  |++++++++||||+++..+.
T Consensus       301 ---------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~  349 (437)
T 4aw2_A          301 ---------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN  349 (437)
T ss_dssp             ---------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred             ---------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence                     001112357899999999999998888  99999999999999876443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-36  Score=254.92  Aligned_cols=177  Identities=29%  Similarity=0.573  Sum_probs=149.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.............|++
T Consensus       184 g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~  263 (365)
T 2y7j_A          184 KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP  263 (365)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCG
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCC
Confidence            67999999988899999999999999999999999999999999999999999999999999988766655556678899


Q ss_pred             cccCchhccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           82 WYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        82 ~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .|+|||.+.+     ...++.++|||||||++|+|++|..||...........+........                  
T Consensus       264 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------------------  325 (365)
T 2y7j_A          264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS------------------  325 (365)
T ss_dssp             GGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------------------
T ss_pred             CccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC------------------
Confidence            9999999853     23478899999999999999999999988776555555443111111                  


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                               ...+..+++.+.++|.+||+.||.+|||+.++++||||++
T Consensus       326 ---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          326 ---------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             ---------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ---------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                     1112357788999999999999999999999999999974

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3e-36  Score=244.06  Aligned_cols=183  Identities=31%  Similarity=0.502  Sum_probs=153.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC---eEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~---~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.   ++|+|||.+.............
T Consensus        89 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  168 (284)
T 3kk8_A           89 GGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA  168 (284)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCC
Confidence            6799999998889999999999999999999999999999999999999987655   9999999998776665555678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +++.|+|||.+.+. .++.++|+||||+++++|++|..||...........+.......+.                   
T Consensus       169 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------  228 (284)
T 3kk8_A          169 GTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-------------------  228 (284)
T ss_dssp             SCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------------------
T ss_pred             CCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc-------------------
Confidence            89999999998654 4789999999999999999999999887766655555432221111                   


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE  212 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~  212 (249)
                              ..+..+++++.+||.+||+.||.+|||+.++++||||++.......
T Consensus       229 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  274 (284)
T 3kk8_A          229 --------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA  274 (284)
T ss_dssp             --------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred             --------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence                    1123578899999999999999999999999999999986544443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.5e-36  Score=255.13  Aligned_cols=174  Identities=25%  Similarity=0.486  Sum_probs=149.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC-CCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~-~~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++... ........+||
T Consensus       123 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt  202 (373)
T 2r5t_A          123 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGT  202 (373)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCC
Confidence            68999999998999999999999999999999999999999999999999999999999999987532 23344567899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+....                          
T Consensus       203 ~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------------------------  255 (373)
T 2r5t_A          203 PEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------------------------  255 (373)
T ss_dssp             CCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--------------------------
T ss_pred             ccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------------------
Confidence            999999998654 48899999999999999999999998887666666554310                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH----HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV----DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~~ll~h~~~~~~~  207 (249)
                           ..+.+.+++++.+||.+||+.||.+||++    .++++||||+...
T Consensus       256 -----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          256 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             -----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             -----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence                 01223578899999999999999999986    6999999999865

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.3e-36  Score=258.24  Aligned_cols=178  Identities=25%  Similarity=0.370  Sum_probs=149.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~   79 (249)
                      ||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......  .....+|
T Consensus       153 gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~g  231 (410)
T 3v8s_A          153 GGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG  231 (410)
T ss_dssp             TEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCS
T ss_pred             CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcC
Confidence            7899999987 579999999999999999999999999999999999999999999999999997665443  2335689


Q ss_pred             cccccCchhccCCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           80 TRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~---~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      |+.|+|||++.....   ++.++|+|||||++|+|++|..||.+.+.......+.........                 
T Consensus       232 t~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-----------------  294 (410)
T 3v8s_A          232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF-----------------  294 (410)
T ss_dssp             CGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC-----------------
T ss_pred             CccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC-----------------
Confidence            999999999875432   678999999999999999999999988877777776542110000                 


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCC--CCCHHHHhcCccccCCc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK--RITVDEALAHPYLARLH  207 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~~ll~h~~~~~~~  207 (249)
                                .....+++++.+||++||..+|.+  |++++++++||||++..
T Consensus       295 ----------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          295 ----------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             ----------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             ----------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence                      011257899999999999999988  99999999999999865

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.9e-36  Score=249.65  Aligned_cols=204  Identities=32%  Similarity=0.592  Sum_probs=157.5

Q ss_pred             CCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-------------------CCCeEE
Q 025683            1 MDTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-------------------NCDLKI   59 (249)
Q Consensus         1 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-------------------~~~~kL   59 (249)
                      +|++|.+++...+  .+++..+..++.||+.||+|||++|++||||||+||+++.                   ++.++|
T Consensus        99 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl  178 (339)
T 1z57_A           99 LGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV  178 (339)
T ss_dssp             CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEE
T ss_pred             CCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceE
Confidence            5789999998875  6899999999999999999999999999999999999987                   678999


Q ss_pred             eecCCccCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 025683           60 CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD  139 (249)
Q Consensus        60 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  139 (249)
                      +|||.+......  .....+|+.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+....+..+.
T Consensus       179 ~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~  255 (339)
T 1z57_A          179 VDFGSATYDDEH--HSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPK  255 (339)
T ss_dssp             CCCSSCEETTSC--CCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCH
T ss_pred             eeCcccccCccc--cccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            999998764432  2345789999999998654 4889999999999999999999999999888888888887776654


Q ss_pred             cccccc--------------chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          140 ADLGFV--------------RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       140 ~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                      ......              .......+........ ..........++++.+||.+||+.||.+|||+.++++||||+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          256 HMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPL-KEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             HHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             HHHhhccchhHHhhccccccccccccchhhhcCcch-hhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence            322111              1111111111111100 0011112223567899999999999999999999999999998


Q ss_pred             CcC
Q 025683          206 LHD  208 (249)
Q Consensus       206 ~~~  208 (249)
                      ++.
T Consensus       335 ~~~  337 (339)
T 1z57_A          335 LKK  337 (339)
T ss_dssp             GGC
T ss_pred             Hhc
Confidence            754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.6e-36  Score=250.09  Aligned_cols=178  Identities=29%  Similarity=0.518  Sum_probs=150.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC----CeEEeecCCccCCCCCCccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSENEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~----~~kL~dfg~~~~~~~~~~~~~~   77 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||||+||+++.++    .++|+|||.+............
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (321)
T 2a2a_A           99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI  178 (321)
T ss_dssp             SCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccccccc
Confidence            689999999988999999999999999999999999999999999999999888    7999999999876655555566


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.........+.......+                   
T Consensus       179 ~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-------------------  238 (321)
T 2a2a_A          179 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD-------------------  238 (321)
T ss_dssp             CSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-------------------
T ss_pred             CCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC-------------------
Confidence            789999999998644 478999999999999999999999988776655555432111110                   


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                              ...+..+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus       239 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          239 --------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             --------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             --------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence                    122335788899999999999999999999999999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.4e-37  Score=246.30  Aligned_cols=179  Identities=30%  Similarity=0.465  Sum_probs=151.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee---ccCCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||++   +.++.++|+|||.+.............
T Consensus        90 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  169 (277)
T 3f3z_A           90 GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV  169 (277)
T ss_dssp             SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccC
Confidence            67999999998999999999999999999999999999999999999999   788899999999998766655556678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +++.|+|||.+.+  .++.++|+||||+++++|++|..||...........+.......+.                   
T Consensus       170 ~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------  228 (277)
T 3f3z_A          170 GTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE-------------------  228 (277)
T ss_dssp             SCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH-------------------
T ss_pred             CCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc-------------------
Confidence            8999999999854  3889999999999999999999999888766666555442211111                   


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                              ..+..+++++.++|.+||+.||.+|||+.++++||||++....
T Consensus       229 --------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          229 --------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             --------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             --------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence                    1122578899999999999999999999999999999875443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.6e-37  Score=252.19  Aligned_cols=183  Identities=30%  Similarity=0.476  Sum_probs=147.8

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc---CCCeEEeecCCccCCCCCCcccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~---~~~~kL~dfg~~~~~~~~~~~~~   76 (249)
                      ||+|.+++...  +.+++..+..++.||+.||+|||++|++||||||+||+++.   ++.++|+|||.+...........
T Consensus       113 ~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~  192 (327)
T 3lm5_A          113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE  192 (327)
T ss_dssp             TEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--------
T ss_pred             CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcccccc
Confidence            67899988654  67999999999999999999999999999999999999988   78999999999987665554556


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+++.|+|||.+... .++.++|+||||+++|+|++|..||...........+.......+                  
T Consensus       193 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------------  253 (327)
T 3lm5_A          193 IMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS------------------  253 (327)
T ss_dssp             -CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------------------
T ss_pred             ccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC------------------
Confidence            6789999999998644 488999999999999999999999988876666655544322211                  


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE  212 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~  212 (249)
                               ......+++.+.+||.+||+.||.+|||++++++||||+++..+...
T Consensus       254 ---------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~  300 (327)
T 3lm5_A          254 ---------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF  300 (327)
T ss_dssp             ---------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred             ---------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence                     11233578899999999999999999999999999999988654443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-36  Score=251.01  Aligned_cols=174  Identities=25%  Similarity=0.510  Sum_probs=145.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+...... .......|+
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  184 (327)
T 3a62_A          105 GGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGT  184 (327)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSC
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCC
Confidence            6899999998889999999999999999999999999999999999999999999999999998754332 233456789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+.......+.....                         
T Consensus       185 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------------------------  238 (327)
T 3a62_A          185 IEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-------------------------  238 (327)
T ss_dssp             CTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-------------------------
T ss_pred             cCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-------------------------
Confidence            999999998654 478999999999999999999999988876666555543111                         


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                            .+++.+++++.++|.+||+.||.+||     +++++++||||+...
T Consensus       239 ------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          239 ------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             ------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence                  12235788999999999999999999     899999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=250.38  Aligned_cols=171  Identities=27%  Similarity=0.308  Sum_probs=138.3

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ++++|.+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||.+.............|
T Consensus       139 ~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~g  218 (311)
T 3p1a_A          139 CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEG  218 (311)
T ss_dssp             CCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCC
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCC
Confidence            578999998774 5699999999999999999999999999999999999999999999999999877665555555678


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      |+.|+|||.+.+  .++.++|||||||++|+|++|..++......   ..+..   ..                      
T Consensus       219 t~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~---~~----------------------  268 (311)
T 3p1a_A          219 DPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQ---GY----------------------  268 (311)
T ss_dssp             CGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTT---TC----------------------
T ss_pred             CccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhc---cC----------------------
Confidence            999999998864  4899999999999999999997766543211   11110   00                      


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                          ........+++++.+||.+||+.||.+|||++++++||||++
T Consensus       269 ----~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 ----LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                001223467899999999999999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-36  Score=257.63  Aligned_cols=183  Identities=22%  Similarity=0.376  Sum_probs=150.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--ccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~   78 (249)
                      ||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........  ....+
T Consensus       145 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~  224 (412)
T 2vd5_A          145 GGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV  224 (412)
T ss_dssp             SCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceec
Confidence            78999999875 4899999999999999999999999999999999999999999999999999976654332  23458


Q ss_pred             ccccccCchhccC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           79 VTRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        79 ~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                      ||+.|+|||++..      ...++.++|+|||||++|+|++|..||.+.+.......+........              
T Consensus       225 Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------  290 (412)
T 2vd5_A          225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS--------------  290 (412)
T ss_dssp             SCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------------
T ss_pred             cccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC--------------
Confidence            8999999999863      33478999999999999999999999998887777666653210000              


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCC---CCHHHHhcCccccCCcCCCC
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKR---ITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~~ll~h~~~~~~~~~~~  211 (249)
                                  +......+++++.+||++||. +|.+|   |+++++++||||+.+..+..
T Consensus       291 ------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          291 ------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             ------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             ------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence                        011123578999999999999 99998   59999999999998765444

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=251.84  Aligned_cols=178  Identities=31%  Similarity=0.476  Sum_probs=137.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc---CCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~---~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.   ++.+||+|||.+.............
T Consensus       132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  211 (349)
T 2w4o_A          132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC  211 (349)
T ss_dssp             SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccccc
Confidence            6899999999889999999999999999999999999999999999999975   8899999999988665544445567


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH-QMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      |++.|+|||.+.+. .++.++|||||||++|+|++|..||....... ....+......                     
T Consensus       212 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~---------------------  269 (349)
T 2w4o_A          212 GTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY---------------------  269 (349)
T ss_dssp             -CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC---------------------
T ss_pred             CCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc---------------------
Confidence            89999999998654 48899999999999999999999997665443 22222211000                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                            .....+..++.++.+||++||+.||.+|||+.++++||||+...
T Consensus       270 ------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          270 ------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             ------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             ------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                  01122346788999999999999999999999999999998643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-36  Score=257.54  Aligned_cols=211  Identities=19%  Similarity=0.266  Sum_probs=143.8

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC--------
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN--------   71 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~--------   71 (249)
                      ||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+......        
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~  189 (389)
T 3gni_B          110 YGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH  189 (389)
T ss_dssp             TCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBC
T ss_pred             CCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccc
Confidence            68999999886  78999999999999999999999999999999999999999999999999987543211        


Q ss_pred             CccccccccccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-------ccccc
Q 025683           72 EFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT-------DADLG  143 (249)
Q Consensus        72 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~  143 (249)
                      .......++..|+|||.+.+. ..++.++|||||||++|+|++|..||.+.........+........       .....
T Consensus       190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (389)
T 3gni_B          190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELT  269 (389)
T ss_dssp             CCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------
T ss_pred             cccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccc
Confidence            112234778899999999753 4588999999999999999999999987665444433322110000       00000


Q ss_pred             ccch-----hhHHHH---HHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC
Q 025683          144 FVRN-----EDAKRY---IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE  212 (249)
Q Consensus       144 ~~~~-----~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~  212 (249)
                      ....     ......   ....+.............+++++.+||++||+.||.+|||+.++|+||||+++.....+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~~~~  346 (389)
T 3gni_B          270 MSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE  346 (389)
T ss_dssp             ------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---CCS
T ss_pred             ccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhcchh
Confidence            0000     000000   00000001111222445688999999999999999999999999999999998754433

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.2e-36  Score=261.59  Aligned_cols=178  Identities=33%  Similarity=0.589  Sum_probs=149.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec---cCCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---ANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~---~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.............
T Consensus       105 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  184 (486)
T 3mwu_A          105 GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI  184 (486)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCT
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCc
Confidence            689999999889999999999999999999999999999999999999995   45679999999998766555555678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.........+.........                   
T Consensus       185 gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------  243 (486)
T 3mwu_A          185 GTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-------------------  243 (486)
T ss_dssp             TGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS-------------------
T ss_pred             CCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-------------------
Confidence            9999999999864  3889999999999999999999999988877666665442111111                   


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                              ..+..+++++.+||++||+.||.+|||+.++|+||||++...
T Consensus       244 --------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          244 --------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             --------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             --------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence                    112357889999999999999999999999999999998653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-36  Score=257.68  Aligned_cols=178  Identities=28%  Similarity=0.501  Sum_probs=137.0

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc---CCCeEEeecCCccCCCCCCcccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~---~~~~kL~dfg~~~~~~~~~~~~~   76 (249)
                      ||+|.+++.+.+  .+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||++...........
T Consensus       143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~  222 (400)
T 1nxk_A          143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT  222 (400)
T ss_dssp             SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------
T ss_pred             CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCcccc
Confidence            689999998753  5999999999999999999999999999999999999998   78899999999987655544556


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCcccccccchhhHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH----QMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                      ..+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.......    ....+..                    
T Consensus       223 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~--------------------  281 (400)
T 1nxk_A          223 PCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--------------------  281 (400)
T ss_dssp             ----CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH--------------------
T ss_pred             CCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc--------------------
Confidence            788999999999854 458999999999999999999999997654211    1111110                    


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                         .....+    ...+..+++++.+||++||+.||.+|||+.++++||||.+..
T Consensus       282 ---~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          282 ---GQYEFP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             ---TCCCCC----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             ---CcccCC----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence               000000    112346889999999999999999999999999999998654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-36  Score=250.70  Aligned_cols=181  Identities=27%  Similarity=0.427  Sum_probs=145.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC---Ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---~~~~~~~   78 (249)
                      |++|.+++.+...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+......   .......
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  168 (323)
T 3tki_A           89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC  168 (323)
T ss_dssp             TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCC
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCc
Confidence            6799999998889999999999999999999999999999999999999999999999999998754322   2233567


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      |++.|+|||.+.+....+.++|||||||++|+|++|..||..................                      
T Consensus       169 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------------------  226 (323)
T 3tki_A          169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----------------------  226 (323)
T ss_dssp             SCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT----------------------
T ss_pred             cCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc----------------------
Confidence            8999999999976665578999999999999999999999765532211111110000                      


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                            ....+..+++++.+||.+||+.||.+|||+.++++||||++.....
T Consensus       227 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~  272 (323)
T 3tki_A          227 ------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG  272 (323)
T ss_dssp             ------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCCC
T ss_pred             ------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccccc
Confidence                  0011224778899999999999999999999999999998765433

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.5e-36  Score=244.66  Aligned_cols=182  Identities=30%  Similarity=0.512  Sum_probs=150.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.............++.
T Consensus       108 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  187 (298)
T 1phk_A          108 KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP  187 (298)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCG
T ss_pred             CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCc
Confidence            57999999988899999999999999999999999999999999999999999999999999998766555555667899


Q ss_pred             cccCchhcc-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           82 WYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        82 ~y~aPE~~~-----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .|+|||.+.     ....++.++|+||||+++++|++|..||...........+.......+.                 
T Consensus       188 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------  250 (298)
T 1phk_A          188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS-----------------  250 (298)
T ss_dssp             GGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----------------
T ss_pred             cccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc-----------------
Confidence            999999885     2345788999999999999999999999887765555544432111110                 


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                                ..+..+++.+.++|.+||+.||.+|||+.++++||||++...+.
T Consensus       251 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (298)
T 1phk_A          251 ----------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE  294 (298)
T ss_dssp             ----------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred             ----------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence                      11124678899999999999999999999999999999876543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3e-36  Score=270.53  Aligned_cols=174  Identities=23%  Similarity=0.436  Sum_probs=151.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCC-CCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~-~~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .........||
T Consensus       426 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT  505 (674)
T 3pfq_A          426 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT  505 (674)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCC
Confidence            78999999998999999999999999999999999999999999999999999999999999997533 33344567899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++... .++.++|+|||||++|+|++|..||.+.+.......+....                          
T Consensus       506 ~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------------------------  558 (674)
T 3pfq_A          506 PDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------------------------  558 (674)
T ss_dssp             SSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--------------------------
T ss_pred             CcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            999999998654 48999999999999999999999999888776666664311                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITV-----DEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~~ll~h~~~~~~~  207 (249)
                           ..++..+++++.+||++||+.||.+||++     +++++||||+.+.
T Consensus       559 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          559 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             -----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence                 11233578999999999999999999997     9999999999875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-36  Score=253.99  Aligned_cols=178  Identities=28%  Similarity=0.479  Sum_probs=148.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc--CCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~--~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.  ++.+||+|||.+.............
T Consensus       132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  211 (387)
T 1kob_A          132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT  211 (387)
T ss_dssp             CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEEC
T ss_pred             CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeec
Confidence            68999999875 47999999999999999999999999999999999999974  4779999999998766555455567


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +|+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+........                    
T Consensus       212 gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--------------------  270 (387)
T 1kob_A          212 ATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD--------------------  270 (387)
T ss_dssp             SSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------------------
T ss_pred             cCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------
Confidence            89999999998654 488999999999999999999999998876665555543111100                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                             ...+..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       271 -------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          271 -------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             -------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                   112336789999999999999999999999999999998643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.4e-36  Score=250.84  Aligned_cols=205  Identities=32%  Similarity=0.585  Sum_probs=157.1

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee-------------------ccCCCeEE
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL-------------------NANCDLKI   59 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~-------------------~~~~~~kL   59 (249)
                      ++++|.+++...  ..+++..+..++.||+.||.|||++|++||||||+||++                   +.++.++|
T Consensus       104 ~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl  183 (355)
T 2eu9_A          104 LGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV  183 (355)
T ss_dssp             CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEE
T ss_pred             cCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEE
Confidence            478888888876  379999999999999999999999999999999999999                   66789999


Q ss_pred             eecCCccCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCc
Q 025683           60 CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTD  139 (249)
Q Consensus        60 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  139 (249)
                      +|||.+......  .....+|+.|+|||.+.+. .++.++|||||||++|+|++|..||...........+....+..+.
T Consensus       184 ~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~  260 (355)
T 2eu9_A          184 ADFGSATFDHEH--HTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPS  260 (355)
T ss_dssp             CCCTTCEETTSC--CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eecCcccccccc--ccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcH
Confidence            999998764432  2346789999999999654 4889999999999999999999999999888888888888877665


Q ss_pred             ccccccch--------------hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          140 ADLGFVRN--------------EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       140 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                      ........              .....+........ ..........++++.+||.+||+.||.+|||+.++++||||++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  339 (355)
T 2eu9_A          261 HMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG  339 (355)
T ss_dssp             HHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             HHhhhccchhhhcccccccccccchhccccccCCcc-cccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcC
Confidence            33211110              01111111111000 0000011123457889999999999999999999999999998


Q ss_pred             CcCC
Q 025683          206 LHDE  209 (249)
Q Consensus       206 ~~~~  209 (249)
                      ...+
T Consensus       340 ~~~~  343 (355)
T 2eu9_A          340 LTPE  343 (355)
T ss_dssp             CCHH
T ss_pred             CChh
Confidence            7644

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.3e-36  Score=246.55  Aligned_cols=201  Identities=29%  Similarity=0.600  Sum_probs=150.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |++|.+++.   .+++..+..++.||+.||+|||++|++||||||+||+++.++ .++|+|||.+.............++
T Consensus       117 ~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  193 (330)
T 3nsz_A          117 NTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS  193 (330)
T ss_dssp             CCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSC
T ss_pred             chhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcccccccc
Confidence            578888875   489999999999999999999999999999999999999777 8999999999876655555567889


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCccccc----ccchhhHHHHHH
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP-GNDHVHQMRLLIELLGTPTDADLG----FVRNEDAKRYIR  155 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~  155 (249)
                      ..|+|||.+.+...++.++|||||||++|+|++|..||. +......+..+...++........    ........... 
T Consensus       194 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  272 (330)
T 3nsz_A          194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL-  272 (330)
T ss_dssp             GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHH-
T ss_pred             ccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhh-
Confidence            999999999775668999999999999999999999985 445555666655544421110000    00000000000 


Q ss_pred             hCCCCCCcchhhc-----CCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          156 QLPQHPRQSLAQV-----FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       156 ~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                        .......+...     ...+++++.+||.+||+.||.+|||++++|+||||+....
T Consensus       273 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          273 --GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             --CCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             --hhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence              11111111111     2237899999999999999999999999999999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-36  Score=264.33  Aligned_cols=179  Identities=32%  Similarity=0.550  Sum_probs=152.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee---ccCCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||++   +.++.+||+|||.+.............
T Consensus       110 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  189 (484)
T 3nyv_A          110 GGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI  189 (484)
T ss_dssp             SCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHT
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCC
Confidence            78999999999999999999999999999999999999999999999999   567899999999987665555555678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||.+.+  .++.++|||||||++|+|++|..||.+.+.......+.........                   
T Consensus       190 gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------  248 (484)
T 3nyv_A          190 GTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL-------------------  248 (484)
T ss_dssp             TGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-------------------
T ss_pred             CCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC-------------------
Confidence            8999999999865  4889999999999999999999999988877766666542111111                   


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                              ..+..+++++.+||++||+.||.+|||+.++|+||||+....+
T Consensus       249 --------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          249 --------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE  291 (484)
T ss_dssp             --------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred             --------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence                    1123578899999999999999999999999999999987543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.9e-36  Score=250.28  Aligned_cols=184  Identities=27%  Similarity=0.477  Sum_probs=125.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC---CeEEeecCCccCCCCC-Cccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPTSEN-EFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~---~~kL~dfg~~~~~~~~-~~~~~~   77 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++   .++|+|||.+...... ......
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  169 (325)
T 3kn6_A           90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP  169 (325)
T ss_dssp             SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccccc
Confidence            679999999999999999999999999999999999999999999999998766   7999999999755433 233456


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ---MRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      .+|+.|+|||.+.+. .++.++|||||||++|+|++|..||........   ...+...+..                  
T Consensus       170 ~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~------------------  230 (325)
T 3kn6_A          170 CFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK------------------  230 (325)
T ss_dssp             --------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT------------------
T ss_pred             CCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc------------------
Confidence            779999999998654 488999999999999999999999976542110   0011111000                  


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                           .........+..+++++.+||.+||+.||.+|||+.++++||||++....
T Consensus       231 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          231 -----GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             -----TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred             -----CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence                 00000112223578999999999999999999999999999999975433

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=249.64  Aligned_cols=168  Identities=23%  Similarity=0.424  Sum_probs=144.0

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRW   82 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~   82 (249)
                      .+|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+.............||+.
T Consensus       115 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~  194 (335)
T 3dls_A          115 LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE  194 (335)
T ss_dssp             CBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGG
T ss_pred             ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCcc
Confidence            49999999999999999999999999999999999999999999999999999999999999987766555556778999


Q ss_pred             ccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCC
Q 025683           83 YRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPR  162 (249)
Q Consensus        83 y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (249)
                      |+|||.+.+....+.++|||||||++|+|++|..||......                             .        
T Consensus       195 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------------------~--------  237 (335)
T 3dls_A          195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------------------V--------  237 (335)
T ss_dssp             GCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------------------T--------
T ss_pred             ccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------------------H--------
Confidence            999999976665588999999999999999999999643210                             0        


Q ss_pred             cchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          163 QSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      ......+..+++++.+||.+||+.||.+|||++++++||||++..
T Consensus       238 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          238 EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            000111224788999999999999999999999999999998743

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.6e-36  Score=242.67  Aligned_cols=175  Identities=27%  Similarity=0.439  Sum_probs=139.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.............+++
T Consensus        95 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  174 (276)
T 2h6d_A           95 GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP  174 (276)
T ss_dssp             SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----------
T ss_pred             CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCc
Confidence            67999999988899999999999999999999999999999999999999999999999999998766554445567899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+....+.++|+||||+++++|++|..||...........+....                           
T Consensus       175 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------------  227 (276)
T 2h6d_A          175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV---------------------------  227 (276)
T ss_dssp             --CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------------------
T ss_pred             cccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---------------------------
Confidence            99999998765545789999999999999999999998776554444433210                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                          ......++..+.++|.+||+.||.+|||+.++++||||++..
T Consensus       228 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          228 ----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             ----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence                011224678899999999999999999999999999998643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.3e-36  Score=242.74  Aligned_cols=176  Identities=28%  Similarity=0.464  Sum_probs=145.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+....... .....++.
T Consensus        93 ~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~  171 (279)
T 3fdn_A           93 LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTDLCGTL  171 (279)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---------CCCC
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-ccccCCCC
Confidence            57999999988899999999999999999999999999999999999999999999999999886544332 33457899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.....                          
T Consensus       172 ~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------------  224 (279)
T 3fdn_A          172 DYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--------------------------  224 (279)
T ss_dssp             TTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------------------------
T ss_pred             CccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------------------------
Confidence            99999998654 478899999999999999999999988776555554433111                          


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                           ..+..+++++.+||.+||+.||.+|||+.++++||||+......
T Consensus       225 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~  268 (279)
T 3fdn_A          225 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP  268 (279)
T ss_dssp             -----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred             -----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence                 11234678899999999999999999999999999999865443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-35  Score=240.84  Aligned_cols=174  Identities=32%  Similarity=0.469  Sum_probs=136.9

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee---ccCCCeEEeecCCccCCCCCCcc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEFM   74 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~---~~~~~~kL~dfg~~~~~~~~~~~   74 (249)
                      |++|.+++..    ...+++..+..++.||+.||+|||++|++|+||||+||++   +.++.++|+|||.+.........
T Consensus       104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~  183 (285)
T 3is5_A          104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS  183 (285)
T ss_dssp             CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------
T ss_pred             CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccC
Confidence            5799998854    3789999999999999999999999999999999999999   45678999999999876555545


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....+++.|+|||.+.  ..++.++|+||||+++++|++|..||.+.........+.......                 
T Consensus       184 ~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  244 (285)
T 3is5_A          184 TNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY-----------------  244 (285)
T ss_dssp             ---CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------------
T ss_pred             cCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc-----------------
Confidence            5667899999999884  347899999999999999999999998876554443332211000                 


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                                 ......+++++.+||.+||+.||.+|||+.++++||||++
T Consensus       245 -----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          245 -----------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             -----------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             -----------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                       0011236788999999999999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.1e-35  Score=243.62  Aligned_cols=175  Identities=30%  Similarity=0.531  Sum_probs=145.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      |++|.+++.+ ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+....... ......||
T Consensus       126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  204 (321)
T 2c30_A          126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT  204 (321)
T ss_dssp             SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSC
T ss_pred             CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCC
Confidence            6899999875 679999999999999999999999999999999999999999999999999987654432 23456789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++||||||+++|+|++|..||...........+.......                       
T Consensus       205 ~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------------  260 (321)
T 2c30_A          205 PYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-----------------------  260 (321)
T ss_dssp             GGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-----------------------
T ss_pred             ccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----------------------
Confidence            999999998644 47899999999999999999999998877655554443211000                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                           ......+++.+.++|.+||+.||.+|||+.++++||||.+.
T Consensus       261 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          261 -----LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             -----CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             -----cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence                 00112467889999999999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.3e-36  Score=260.26  Aligned_cols=177  Identities=34%  Similarity=0.571  Sum_probs=151.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC---CCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~---~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|.+++.+...+++..+..++.||+.||.|||++|++||||||+||+++..   +.+||+|||++.............
T Consensus       120 ~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~  199 (494)
T 3lij_A          120 GGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL  199 (494)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccC
Confidence            68999999988999999999999999999999999999999999999999764   459999999998766555556678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||.+.  ..++.++||||+||++|+|++|..||.+.........+.........                   
T Consensus       200 gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------  258 (494)
T 3lij_A          200 GTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS-------------------  258 (494)
T ss_dssp             SCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS-------------------
T ss_pred             CCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-------------------
Confidence            999999999885  34889999999999999999999999988877666665542221111                   


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                              ..+..+++++.+||++||+.||.+|||+.++|+||||++..
T Consensus       259 --------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          259 --------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             --------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             --------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence                    12336789999999999999999999999999999998764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.8e-36  Score=252.84  Aligned_cols=178  Identities=27%  Similarity=0.424  Sum_probs=150.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee--ccCCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL--NANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~--~~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.+++.+. ..+++..+..++.||+.||+|||++|++||||||+||++  +.++.+||+|||++.............
T Consensus       170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  249 (373)
T 2x4f_A          170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF  249 (373)
T ss_dssp             TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence            67999999765 579999999999999999999999999999999999999  566789999999998776655555667


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +|+.|+|||.+.. ..++.++|||||||++|+|++|..||.+.+.......+.......+                    
T Consensus       250 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--------------------  308 (373)
T 2x4f_A          250 GTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE--------------------  308 (373)
T ss_dssp             SSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC--------------------
T ss_pred             CCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--------------------
Confidence            8999999998854 4488999999999999999999999998887776666654221111                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                             ...+..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       309 -------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          309 -------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             -------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             -------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                   112335789999999999999999999999999999999753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.1e-36  Score=248.80  Aligned_cols=181  Identities=28%  Similarity=0.483  Sum_probs=144.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC----CCeEEeecCCccCCCCC-Ccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN----CDLKICDFGLARPTSEN-EFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~----~~~kL~dfg~~~~~~~~-~~~~~   76 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||++..+    +.+||+|||++...... .....
T Consensus       100 gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  179 (342)
T 2qr7_A          100 GGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT  179 (342)
T ss_dssp             SCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceec
Confidence            68999999999999999999999999999999999999999999999998543    35999999999765433 33445


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCcccccccchhhHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND---HVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (249)
                      ..+|+.|+|||.+.+.. ++.++|+|||||++|+|++|..||....   .......+...  ..                
T Consensus       180 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--~~----------------  240 (342)
T 2qr7_A          180 PCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--KF----------------  240 (342)
T ss_dssp             SSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC--CC----------------
T ss_pred             cCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC--Cc----------------
Confidence            67899999999986443 7889999999999999999999997532   22222222210  00                


Q ss_pred             HHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                               ......+..+++++.+||++||+.||.+|||+.++++||||..+..-.
T Consensus       241 ---------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~  288 (342)
T 2qr7_A          241 ---------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP  288 (342)
T ss_dssp             ---------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGSC
T ss_pred             ---------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccccc
Confidence                     000122346889999999999999999999999999999998875443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.1e-36  Score=260.95  Aligned_cols=179  Identities=30%  Similarity=0.498  Sum_probs=153.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC---CeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~---~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++   .+||+|||++.............
T Consensus       130 gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  209 (504)
T 3q5i_A          130 GGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL  209 (504)
T ss_dssp             TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCcccccc
Confidence            689999999989999999999999999999999999999999999999998876   69999999998776655556678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||.+.  ..++.++||||+||++|+|++|..||.+.+.......+.......+                    
T Consensus       210 gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------  267 (504)
T 3q5i_A          210 GTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD--------------------  267 (504)
T ss_dssp             SCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------------
T ss_pred             CCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------------------
Confidence            999999999985  3488999999999999999999999998887766666554211111                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                             ...+..+++++.+||++||+.||.+|||++++|+||||++....
T Consensus       268 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          268 -------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             -------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             -------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence                   11233688999999999999999999999999999999986543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.9e-37  Score=258.69  Aligned_cols=169  Identities=17%  Similarity=0.233  Sum_probs=137.3

Q ss_pred             CCccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc
Q 025683            1 MDTDLYQIIRSNQSLSE-------EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~-------~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~   73 (249)
                      ++|+|.+++.+.+.+++       ..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....  .
T Consensus       182 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~  259 (377)
T 3byv_A          182 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--R  259 (377)
T ss_dssp             CSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--E
T ss_pred             cCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--c
Confidence            47899999998666666       88889999999999999999999999999999999999999999999976433  2


Q ss_pred             cccccccccccCchhccCC----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 025683           74 MTEYVVTRWYRAPELLLNS----------SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (249)
                      .....| +.|+|||.+.+.          ..++.++|||||||++|+|++|..||........                 
T Consensus       260 ~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~-----------------  321 (377)
T 3byv_A          260 VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG-----------------  321 (377)
T ss_dssp             EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC-----------------
T ss_pred             ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc-----------------
Confidence            334566 899999998755          2488999999999999999999999965431110                 


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                        ..........+++++.+||.+||+.||.+|||+.++++||||+++.
T Consensus       322 ------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          322 ------------------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             ------------------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             ------------------hhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence                              0011112246789999999999999999999999999999998754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.2e-36  Score=241.39  Aligned_cols=179  Identities=25%  Similarity=0.485  Sum_probs=149.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....... .....+++
T Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~  176 (284)
T 2vgo_A           98 RGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-RRTMCGTL  176 (284)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-BCCCCSCG
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-cccccCCC
Confidence            57999999988899999999999999999999999999999999999999999999999999886554322 33467899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+. .++.++|+||||+++|+|++|..||...........+....                           
T Consensus       177 ~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------------------------  228 (284)
T 2vgo_A          177 DYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD---------------------------  228 (284)
T ss_dssp             GGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------------------------
T ss_pred             CcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc---------------------------
Confidence            99999998654 47899999999999999999999998876555444433210                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP  213 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~  213 (249)
                          ...+..+++++.++|.+||+.||.+|||++++++||||+........+
T Consensus       229 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~  276 (284)
T 2vgo_A          229 ----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP  276 (284)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred             ----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence                012235788899999999999999999999999999999765444333

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=247.48  Aligned_cols=179  Identities=26%  Similarity=0.390  Sum_probs=138.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~   77 (249)
                      .|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+|||.+........   ....
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~  169 (343)
T 3dbq_A           91 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ  169 (343)
T ss_dssp             CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCC
Confidence            4789999999999999999999999999999999999999999999999997 67899999999976544322   2345


Q ss_pred             cccccccCchhccC----------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           78 VVTRWYRAPELLLN----------SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        78 ~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                      .||+.|+|||.+.+          ...++.++|||||||++|+|++|..||........  .+........         
T Consensus       170 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~---------  238 (343)
T 3dbq_A          170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KLHAIIDPNH---------  238 (343)
T ss_dssp             CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHHHCTTS---------
T ss_pred             cCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH--HHHHHhcCCc---------
Confidence            78999999999853          24578899999999999999999999976533211  1111111100         


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                                       ....+...++++.+||.+||+.||.+|||+.++++||||+....
T Consensus       239 -----------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          239 -----------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             -----------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             -----------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence                             01122345678999999999999999999999999999986543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-36  Score=247.68  Aligned_cols=186  Identities=19%  Similarity=0.240  Sum_probs=126.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhC--------CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~--------~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-   72 (249)
                      ||||.++|.+ .+++++.+.+++.|++.||+|||++        +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        85 ~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  163 (303)
T 3hmm_A           85 HGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD  163 (303)
T ss_dssp             TCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             CCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCC
Confidence            6899999987 5799999999999999999999987        89999999999999999999999999987543322 


Q ss_pred             ----ccccccccccccCchhccCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 025683           73 ----FMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        73 ----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (249)
                          .....+||+.|+|||.+.+..     .++.++|||||||++|||++|..||.......          .+......
T Consensus       164 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~----------~p~~~~~~  233 (303)
T 3hmm_A          164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----------LPYYDLVP  233 (303)
T ss_dssp             EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC----------CTTTTTSC
T ss_pred             ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc----------ccchhccc
Confidence                122457999999999986532     25678999999999999999987764322100          00000000


Q ss_pred             c-cchhhHHHHHHhCCCCCCcchhhc--CCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          144 F-VRNEDAKRYIRQLPQHPRQSLAQV--FPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       144 ~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      . ..............  .+......  ....++.+.+|+.+||+.||.+|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~--~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQK--LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTSC--CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhccc--CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0 00000111110000  01111110  11123467899999999999999999999863

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-36  Score=244.74  Aligned_cols=174  Identities=28%  Similarity=0.478  Sum_probs=139.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      |++|.+++. .+.+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||.+....... ......++
T Consensus       122 ~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  200 (298)
T 2zv2_A          122 QGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGT  200 (298)
T ss_dssp             TCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSC
T ss_pred             CCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCC
Confidence            456666543 3679999999999999999999999999999999999999999999999999987654432 23456789


Q ss_pred             ccccCchhccCCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           81 RWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        81 ~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +.|+|||.+.+...  .+.++|||||||++|+|++|..||...........+.......                     
T Consensus       201 ~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------------  259 (298)
T 2zv2_A          201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF---------------------  259 (298)
T ss_dssp             GGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------------------
T ss_pred             ccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCC---------------------
Confidence            99999999865442  3778999999999999999999998776544433332210000                     


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                              ...+.+++++.+||.+||+.||.+|||+.++++||||++
T Consensus       260 --------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          260 --------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             --------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             --------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence                    012357889999999999999999999999999999974

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.5e-36  Score=263.84  Aligned_cols=175  Identities=28%  Similarity=0.504  Sum_probs=146.3

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ||+|.+++.+.+  .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.............|
T Consensus       268 gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~G  347 (576)
T 2acx_A          268 GGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG  347 (576)
T ss_dssp             SCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCS
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccccccCC
Confidence            789999998764  499999999999999999999999999999999999999999999999999987765555556789


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      |+.|+|||++.+. .++.++|+|||||++|+|++|..||.....   ...+......                       
T Consensus       348 T~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-----------------------  403 (576)
T 2acx_A          348 TVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-----------------------  403 (576)
T ss_dssp             CGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-----------------------
T ss_pred             CccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-----------------------
Confidence            9999999998654 488999999999999999999999976542   1111111110                       


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                      ..       ...+..+++++.+||++||+.||.+||     +++++++||||++..
T Consensus       404 ~~-------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          404 VP-------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             CC-------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             cc-------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence            00       112235789999999999999999999     899999999999865

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4e-36  Score=256.42  Aligned_cols=178  Identities=34%  Similarity=0.617  Sum_probs=136.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC---CeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~---~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++   .+||+|||.+.............
T Consensus       223 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  302 (419)
T 3i6u_A          223 GGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC  302 (419)
T ss_dssp             TCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC---------
T ss_pred             CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccC
Confidence            689999999889999999999999999999999999999999999999997544   59999999998776655555678


Q ss_pred             ccccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           79 VTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        79 ~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ||+.|+|||.+..  ...++.++|+|||||++|+|++|..||.................                     
T Consensus       303 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~---------------------  361 (419)
T 3i6u_A          303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK---------------------  361 (419)
T ss_dssp             --CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC---------------------
T ss_pred             CCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC---------------------
Confidence            8999999999853  34578899999999999999999999976532211111111000                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                           .......+..+++.+.+||.+||+.||.+|||++++++||||+.
T Consensus       362 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          362 -----YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             -----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             -----CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence                 01112234468899999999999999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.8e-36  Score=246.53  Aligned_cols=196  Identities=24%  Similarity=0.369  Sum_probs=135.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC---eEEeecCCccCCCCCC------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENE------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~---~kL~dfg~~~~~~~~~------   72 (249)
                      |++|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++.   +||+|||++.......      
T Consensus        95 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (316)
T 2ac3_A           95 GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS  174 (316)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred             CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence            6899999999889999999999999999999999999999999999999998776   9999999987543211      


Q ss_pred             --ccccccccccccCchhccCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 025683           73 --FMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR  146 (249)
Q Consensus        73 --~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (249)
                        ......+++.|+|||.+...    ..++.++|||||||++|+|++|..||.+........        ..........
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--------~~~~~~~~~~  246 (316)
T 2ac3_A          175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW--------DRGEACPACQ  246 (316)
T ss_dssp             -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------------CCHHHH
T ss_pred             ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc--------cccccchhHH
Confidence              12234589999999998641    236789999999999999999999997654211000        0000000000


Q ss_pred             hhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      ..............+    ...+..+++++.+||.+||+.||.+|||+.++++||||++...+
T Consensus       247 ~~~~~~i~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          247 NMLFESIQEGKYEFP----DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHHHHHCCCCCC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred             HHHHHHHhccCcccC----chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence            000000011100000    11223578899999999999999999999999999999976543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-35  Score=241.44  Aligned_cols=177  Identities=28%  Similarity=0.440  Sum_probs=132.1

Q ss_pred             CCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccc
Q 025683            1 MDTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT   75 (249)
Q Consensus         1 ~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~   75 (249)
                      ++|+|.+++..    ...+++..+..++.||+.||+|||++ |++|+||||+||+++.++.++|+|||.+..........
T Consensus        88 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  167 (290)
T 3fme_A           88 MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD  167 (290)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred             hccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccccc
Confidence            45677777654    57899999999999999999999998 99999999999999999999999999997765554444


Q ss_pred             cccccccccCchhcc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           76 EYVVTRWYRAPELLL---NSSDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      ...+++.|+|||.+.   ....++.++|+||||+++|+|++|..||.... ............. +              
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~--------------  232 (290)
T 3fme_A          168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-P--------------  232 (290)
T ss_dssp             --CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-C--------------
T ss_pred             ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-C--------------
Confidence            567899999999972   34457899999999999999999999997643 3333332222100 0              


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                                    ......+++++.++|.+||+.||.+|||+.++++||||+..
T Consensus       233 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          233 --------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             --------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             --------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                          00112578899999999999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.8e-36  Score=242.28  Aligned_cols=181  Identities=27%  Similarity=0.482  Sum_probs=146.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC----CeEEeecCCccCCCCCCccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSENEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~----~~kL~dfg~~~~~~~~~~~~~~   77 (249)
                      |++|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++    .++|+|||.+............
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~  171 (283)
T 3bhy_A           92 GGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI  171 (283)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCccccc
Confidence            689999999888999999999999999999999999999999999999998877    8999999999876555444556


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .+++.|+|||.+... .++.++|+||||+++++|++|..||...........+.......                    
T Consensus       172 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------  230 (283)
T 3bhy_A          172 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF--------------------  230 (283)
T ss_dssp             CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--------------------
T ss_pred             CCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC--------------------
Confidence            789999999998644 48899999999999999999999998877655544443211100                    


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                             .......+++.+.+++.+||+.||.+|||+.++++||||+..+...
T Consensus       231 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          231 -------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             -------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             -------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence                   0122335788899999999999999999999999999999876443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.5e-35  Score=238.65  Aligned_cols=173  Identities=20%  Similarity=0.342  Sum_probs=141.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeec-cCCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|  ++|+||||+||+++ .++.++|+|||.+....... .....
T Consensus       113 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  191 (290)
T 1t4h_A          113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-AKAVI  191 (290)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-BEESC
T ss_pred             CCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc-ccccc
Confidence            6799999999889999999999999999999999999  99999999999997 78999999999986544332 33457


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +++.|+|||.+.+  .++.++|+||||+++++|++|..||..................                      
T Consensus       192 ~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------------------  247 (290)
T 1t4h_A          192 GTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------------------  247 (290)
T ss_dssp             SSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------------------
T ss_pred             CCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC----------------------
Confidence            8999999998853  4889999999999999999999999876544333322211000                      


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                            ........++++.++|.+||+.||.+|||+.++++||||++
T Consensus       248 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 ------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                  01122246688999999999999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.9e-35  Score=248.88  Aligned_cols=178  Identities=25%  Similarity=0.414  Sum_probs=139.6

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---ccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY   77 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---~~~~~   77 (249)
                      .|++|.+++.+...+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.......   .....
T Consensus       138 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~  216 (390)
T 2zmd_A          138 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ  216 (390)
T ss_dssp             CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCS
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCC
Confidence            3689999999999999999999999999999999999999999999999995 6899999999998654332   12346


Q ss_pred             cccccccCchhccCC----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccc
Q 025683           78 VVTRWYRAPELLLNS----------SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-HQMRLLIELLGTPTDADLGFVR  146 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  146 (249)
                      .||+.|+|||.+...          ..++.++|||||||++|+|++|..||...... .....+.   .....       
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~---~~~~~-------  286 (390)
T 2zmd_A          217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNHE-------  286 (390)
T ss_dssp             CCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH---CTTSC-------
T ss_pred             CcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh---Ccccc-------
Confidence            789999999998641          34788999999999999999999999765432 2222211   11000       


Q ss_pred             hhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                                         ...+...++++.+||.+||+.||.+|||+.++++||||+....
T Consensus       287 -------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          287 -------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             -------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             -------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence                               0112234678999999999999999999999999999986543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.5e-35  Score=245.95  Aligned_cols=177  Identities=33%  Similarity=0.495  Sum_probs=141.8

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC---eEEeecCCccCCCCCCc-
Q 025683            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENEF-   73 (249)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~---~kL~dfg~~~~~~~~~~-   73 (249)
                      |++|.+++.+.    ..+++..+..++.||+.||+|||++|++||||||+||+++.++.   +||+|||.+........ 
T Consensus       110 g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~  189 (351)
T 3c0i_A          110 GADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV  189 (351)
T ss_dssp             SCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred             CCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCee
Confidence            68998888653    35999999999999999999999999999999999999987654   99999999977654432 


Q ss_pred             cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHH
Q 025683           74 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (249)
                      .....||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.. ......+.......                
T Consensus       190 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~----------------  251 (351)
T 3c0i_A          190 AGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM----------------  251 (351)
T ss_dssp             CCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC----------------
T ss_pred             ecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC----------------
Confidence            3456789999999998654 47899999999999999999999997753 22222222210000                


Q ss_pred             HHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                 ....+..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       252 -----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          252 -----------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             -----------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             -----------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence                       0112335789999999999999999999999999999998643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.8e-35  Score=239.72  Aligned_cols=180  Identities=32%  Similarity=0.522  Sum_probs=149.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus        99 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  178 (294)
T 2rku_A           99 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT  178 (294)
T ss_dssp             TCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCC
Confidence            5899999998889999999999999999999999999999999999999999999999999998765432 223345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+||||+++++|++|..||...........+....                          
T Consensus       179 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------------  231 (294)
T 2rku_A          179 PNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------------------------  231 (294)
T ss_dssp             CSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--------------------------
T ss_pred             CCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--------------------------
Confidence            999999998654 47889999999999999999999998776544433332100                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP  213 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~  213 (249)
                           ..+...+++.+.+++.+||+.||.+|||++++++||||++.......+
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~  279 (294)
T 2rku_A          232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP  279 (294)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCC
T ss_pred             -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCC
Confidence                 112235778899999999999999999999999999999876555444

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.7e-35  Score=245.81  Aligned_cols=207  Identities=27%  Similarity=0.421  Sum_probs=152.2

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeecc------CCCeEEeecCCccCCCCC
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNA------NCDLKICDFGLARPTSEN   71 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~------~~~~kL~dfg~~~~~~~~   71 (249)
                      +|++|.+++.+.  ..+++..+..++.||+.||+|||++ |++||||||+||+++.      .+.++|+|||.+......
T Consensus       112 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~  191 (373)
T 1q8y_A          112 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH  191 (373)
T ss_dssp             CCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC
T ss_pred             CCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC
Confidence            478999999874  5699999999999999999999998 9999999999999954      347999999998765432


Q ss_pred             CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCccccccc
Q 025683           72 EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND------HVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        72 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                        .....+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||....      .......+...++..+.......
T Consensus       192 --~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  268 (373)
T 1q8y_A          192 --YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG  268 (373)
T ss_dssp             --CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHC
T ss_pred             --CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhcc
Confidence              33457899999999997654 7899999999999999999999997654      45667777777777665432211


Q ss_pred             chhhHHHHHHhCCCC------CCcc-------hhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC
Q 025683          146 RNEDAKRYIRQLPQH------PRQS-------LAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE  212 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~------~~~~-------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~  212 (249)
                      ..  ...++......      ....       ...+....++++.+||.+||+.||.+|||+.++++||||++.......
T Consensus       269 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  346 (373)
T 1q8y_A          269 KY--TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEI  346 (373)
T ss_dssp             TT--HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTC
T ss_pred             ch--hhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCcccc
Confidence            10  00000000000      0000       001122345778999999999999999999999999999987655443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.5e-35  Score=239.11  Aligned_cols=177  Identities=29%  Similarity=0.494  Sum_probs=147.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee---ccCCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||.+...... ......
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~  168 (304)
T 2jam_A           90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTAC  168 (304)
T ss_dssp             SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHH
T ss_pred             CccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cccccc
Confidence            67999999988899999999999999999999999999999999999999   77889999999998754332 233456


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.......+                    
T Consensus       169 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------  227 (304)
T 2jam_A          169 GTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE--------------------  227 (304)
T ss_dssp             SCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC--------------------
T ss_pred             CCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--------------------
Confidence            89999999998654 488999999999999999999999988776655555443111110                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                             ...+..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       228 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          228 -------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             -------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             -------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                   112346789999999999999999999999999999998643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2e-35  Score=238.20  Aligned_cols=178  Identities=26%  Similarity=0.448  Sum_probs=143.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC---Ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---~~~~~~~   78 (249)
                      |++|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+......   .......
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  168 (276)
T 2yex_A           89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC  168 (276)
T ss_dssp             TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCC
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCc
Confidence            5799999988888999999999999999999999999999999999999999999999999998754322   2233457


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH-QMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+.+....+.++|+||||+++++|++|..||....... ....+..   ..                    
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~--------------------  225 (276)
T 2yex_A          169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---KK--------------------  225 (276)
T ss_dssp             SCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---TC--------------------
T ss_pred             cccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---cc--------------------
Confidence            89999999998765545789999999999999999999997654321 1111110   00                    


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      .      ....+..+++.+.++|.+||+.||.+|||++++++||||++...
T Consensus       226 ~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          226 T------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             T------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             c------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            0      00112247788999999999999999999999999999997643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.8e-35  Score=243.38  Aligned_cols=180  Identities=32%  Similarity=0.522  Sum_probs=149.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      |++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+...... .......++
T Consensus       125 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  204 (335)
T 2owb_A          125 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT  204 (335)
T ss_dssp             TCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSC
T ss_pred             CCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCC
Confidence            5799999998889999999999999999999999999999999999999999999999999998765432 223446789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+.+. .++.++||||||+++|+|++|..||...........+....                          
T Consensus       205 ~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------------------------  257 (335)
T 2owb_A          205 PNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------------------------  257 (335)
T ss_dssp             CSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--------------------------
T ss_pred             ccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--------------------------
Confidence            999999998654 47889999999999999999999998776554443332210                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP  213 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~  213 (249)
                           ..+...+++.+.+||.+||+.||.+|||++++++|+||++.......+
T Consensus       258 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~~  305 (335)
T 2owb_A          258 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP  305 (335)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCC
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccCC
Confidence                 012235778899999999999999999999999999999876544333

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.2e-35  Score=247.87  Aligned_cols=200  Identities=31%  Similarity=0.470  Sum_probs=149.6

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCC----------------------
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANC----------------------   55 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~----------------------   55 (249)
                      ++++|.+++.+.  +.+++..++.++.||+.||+|||++ ||+||||||+||+++.++                      
T Consensus       127 ~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (397)
T 1wak_A          127 LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS  206 (397)
T ss_dssp             CCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-----------
T ss_pred             cCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCC
Confidence            578888888775  5799999999999999999999998 999999999999998775                      


Q ss_pred             ---------------------------CeEEeecCCccCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHH
Q 025683           56 ---------------------------DLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF  108 (249)
Q Consensus        56 ---------------------------~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l  108 (249)
                                                 .++|+|||.+......  .....+|+.|+|||.+.+.. ++.++|||||||++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  283 (397)
T 1wak_A          207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMA  283 (397)
T ss_dssp             ----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-CCTHHHHHHHHHHH
T ss_pred             CCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-CCcHHHHHHHHHHH
Confidence                                       7999999998765433  33457899999999997654 88999999999999


Q ss_pred             HHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC-------CCcc------hhhcC
Q 025683          109 MELMNRRPLFPGND------HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH-------PRQS------LAQVF  169 (249)
Q Consensus       109 ~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~------~~~~~  169 (249)
                      |+|++|..||...+      .......+...++.++..........  ..++......       +...      .....
T Consensus       284 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (397)
T 1wak_A          284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWS  361 (397)
T ss_dssp             HHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCC
T ss_pred             HHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCccccccccccCCcchhHhhhhhcccc
Confidence            99999999997654      45667777777777654322110000  0000000000       0000      00011


Q ss_pred             CCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          170 PHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       170 ~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                      ...++++.+||.+||+.||.+|||+.++|+||||++
T Consensus       362 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          362 QEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            123467889999999999999999999999999974

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.6e-35  Score=239.11  Aligned_cols=179  Identities=34%  Similarity=0.598  Sum_probs=148.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC---CCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN---CDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~---~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.+   +.++|+|||.+.............
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  184 (287)
T 2wei_A          105 GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI  184 (287)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHH
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcccccc
Confidence            68999999888899999999999999999999999999999999999999764   469999999987665554445567


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +++.|+|||.+.+  .++.++|+||||+++++|++|..||.+.........+........                    
T Consensus       185 ~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------  242 (287)
T 2wei_A          185 GTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD--------------------  242 (287)
T ss_dssp             HHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------------
T ss_pred             CcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------------------
Confidence            8999999998854  378999999999999999999999988776655554433111000                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                             ...+..+++++.++|.+||+.||.+|||+.++++||||+++..+
T Consensus       243 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             -------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred             -------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence                   01123578899999999999999999999999999999987543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2e-35  Score=243.66  Aligned_cols=180  Identities=33%  Similarity=0.617  Sum_probs=144.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC---eEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~---~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      |++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.   ++|+|||.+.............
T Consensus        98 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  177 (322)
T 2ycf_A           98 GGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC  177 (322)
T ss_dssp             TEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHH
T ss_pred             CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccccccccccc
Confidence            6799999999899999999999999999999999999999999999999987664   9999999998765544444567


Q ss_pred             ccccccCchhcc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           79 VTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        79 ~~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      +++.|+|||.+.  ....++.++|||||||++|+|++|..||.................                     
T Consensus       178 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------------  236 (322)
T 2ycf_A          178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK---------------------  236 (322)
T ss_dssp             SCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC---------------------
T ss_pred             CCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc---------------------
Confidence            899999999974  344578999999999999999999999976542211111111100                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                           .......+..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       237 -----~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          237 -----YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             -----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             -----cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence                 0011223346789999999999999999999999999999998643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-35  Score=247.52  Aligned_cols=179  Identities=25%  Similarity=0.448  Sum_probs=142.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~   79 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......  ......|
T Consensus       143 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g  222 (355)
T 1vzo_A          143 GGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG  222 (355)
T ss_dssp             SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGS
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCccc
Confidence            67999999988899999999999999999999999999999999999999999999999999987654322  2234578


Q ss_pred             cccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      |+.|+|||.+.+. ..++.++|||||||++|+|++|..||...........+...                   ..... 
T Consensus       223 t~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-------------------~~~~~-  282 (355)
T 1vzo_A          223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-------------------ILKSE-  282 (355)
T ss_dssp             CCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-------------------HHHCC-
T ss_pred             CcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH-------------------HhccC-
Confidence            9999999998753 34688999999999999999999999754321111111110                   00000 


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                             ...+..++..+.+||.+||..||.+||     |++++++||||++..
T Consensus       283 -------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          283 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             -------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence                   112335778899999999999999999     999999999999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.9e-36  Score=252.03  Aligned_cols=183  Identities=18%  Similarity=0.198  Sum_probs=138.5

Q ss_pred             CCccHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHC------QYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~------~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~   73 (249)
                      |+|+|.+++... ..++...+      ..++.||+.||+|||++|++||||||+||+++.++.+||+|||++....... 
T Consensus       170 ~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-  248 (371)
T 3q60_A          170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-  248 (371)
T ss_dssp             CSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-
T ss_pred             CCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-
Confidence            458999999874 34555555      6778999999999999999999999999999999999999999998664322 


Q ss_pred             cccccccccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           74 MTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                       ....+++.|+|||.+.+. ..++.++|||||||++|+|++|..||........        .......           
T Consensus       249 -~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--------~~~~~~~-----------  308 (371)
T 3q60_A          249 -PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK--------GSWKRPS-----------  308 (371)
T ss_dssp             -EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT--------TCCCBCC-----------
T ss_pred             -cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc--------cchhhhh-----------
Confidence             244567999999999641 3578999999999999999999999976631100        0000000           


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                         ................+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus       309 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          309 ---LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             ---TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             ---hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence               0000000111112346889999999999999999999999999999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-35  Score=245.66  Aligned_cols=169  Identities=27%  Similarity=0.486  Sum_probs=134.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC--CeEEeecCCccCCCCC-----CccccccccccccCch
Q 025683           15 LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC--DLKICDFGLARPTSEN-----EFMTEYVVTRWYRAPE   87 (249)
Q Consensus        15 l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~--~~kL~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE   87 (249)
                      +++..+..++.||+.||+|||++|++||||||+||+++.++  .++|+|||.+......     .......+++.|+|||
T Consensus       165 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  244 (345)
T 3hko_A          165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE  244 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence            46888999999999999999999999999999999998776  8999999998753221     1233457899999999


Q ss_pred             hccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchh
Q 025683           88 LLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLA  166 (249)
Q Consensus        88 ~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (249)
                      .+... ..++.++||||||+++|+|++|..||.+.........+.........                           
T Consensus       245 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------  297 (345)
T 3hko_A          245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---------------------------  297 (345)
T ss_dssp             HHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---------------------------
T ss_pred             hhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---------------------------
Confidence            98642 45789999999999999999999999988877666655542211111                           


Q ss_pred             hcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          167 QVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       167 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                      .....+++++.+||.+||+.||.+|||+.++++||||+++.+..
T Consensus       298 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~~  341 (345)
T 3hko_A          298 PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI  341 (345)
T ss_dssp             GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHhh
Confidence            01123678899999999999999999999999999999876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.3e-35  Score=242.52  Aligned_cols=174  Identities=28%  Similarity=0.412  Sum_probs=144.1

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         1 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      +.|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+......   ....+
T Consensus       136 ~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~g  212 (348)
T 1u5q_A          136 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVG  212 (348)
T ss_dssp             CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCS
T ss_pred             CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---CcccC
Confidence            45788888864 578999999999999999999999999999999999999999999999999998765432   34578


Q ss_pred             cccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           80 TRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        80 ~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++.|+|||.+..  ...++.++|||||||++|+|++|..||...+.......+.....  +.                  
T Consensus       213 t~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~--~~------------------  272 (348)
T 1u5q_A          213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PA------------------  272 (348)
T ss_dssp             CGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CC------------------
T ss_pred             CcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CC------------------
Confidence            999999999853  34578899999999999999999999988776555544432110  00                  


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                               .....+++.+.+||.+||+.||.+|||++++++||||.+.
T Consensus       273 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          273 ---------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                     0112467889999999999999999999999999999863

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-34  Score=253.50  Aligned_cols=174  Identities=28%  Similarity=0.473  Sum_probs=144.0

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-ccc
Q 025683            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~   76 (249)
                      ||+|.+++.+.    ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........ ...
T Consensus       269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~  348 (543)
T 3c4z_A          269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG  348 (543)
T ss_dssp             TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCC
T ss_pred             CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCccccc
Confidence            68999999874    4699999999999999999999999999999999999999999999999999987654432 334


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCcccccccchhhHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH----VHQMRLLIELLGTPTDADLGFVRNEDAKR  152 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (249)
                      .+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+...    ......+..                    
T Consensus       349 ~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--------------------  407 (543)
T 3c4z_A          349 YAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--------------------  407 (543)
T ss_dssp             CCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--------------------
T ss_pred             ccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--------------------
Confidence            5899999999999754 489999999999999999999999976532    222222211                    


Q ss_pred             HHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          153 YIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                         ..        ...+..+++++.+||++||+.||.+||+     ++++++||||+.+.
T Consensus       408 ---~~--------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          408 ---QA--------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             ---CC--------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             ---cc--------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence               00        1122367899999999999999999995     58999999999865

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-34  Score=235.17  Aligned_cols=182  Identities=23%  Similarity=0.415  Sum_probs=146.6

Q ss_pred             CCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC---CCccc
Q 025683            1 MDTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE---NEFMT   75 (249)
Q Consensus         1 ~~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~---~~~~~   75 (249)
                      ++++|.+++..  ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.....   .....
T Consensus        90 ~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~  169 (305)
T 2wtk_C           90 CVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR  169 (305)
T ss_dssp             CSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEEC
T ss_pred             ccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccc
Confidence            34568888876  46799999999999999999999999999999999999999999999999999876542   22233


Q ss_pred             cccccccccCchhccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ...++..|+|||.+.+.. ..+.++||||||+++|+|++|..||...........+....                    
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--------------------  229 (305)
T 2wtk_C          170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--------------------  229 (305)
T ss_dssp             CCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--------------------
T ss_pred             cCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--------------------
Confidence            456899999999986432 24679999999999999999999998876554444433210                    


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP  213 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~  213 (249)
                                 ..+...+++.+.++|.+||+.||.+|||+.++++||||++.......+
T Consensus       230 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~  277 (305)
T 2wtk_C          230 -----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAP  277 (305)
T ss_dssp             -----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CCC
T ss_pred             -----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCCC
Confidence                       012235778899999999999999999999999999999876554443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.6e-35  Score=239.69  Aligned_cols=187  Identities=24%  Similarity=0.415  Sum_probs=138.7

Q ss_pred             CccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-
Q 025683            2 DTDLYQIIRS--------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-   72 (249)
Q Consensus         2 ~~~L~~~l~~--------~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-   72 (249)
                      |++|.+++..        .+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  176 (303)
T 2vwi_A           97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD  176 (303)
T ss_dssp             TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC----
T ss_pred             CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCC
Confidence            6899999974        4679999999999999999999999999999999999999999999999999886543221 


Q ss_pred             -----ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           73 -----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        73 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                           ......+++.|+|||.+.....++.++|+||||+++|+|++|..||..............  ...+...      
T Consensus       177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~------  248 (303)
T 2vwi_A          177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDPPSLE------  248 (303)
T ss_dssp             -----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SSCCCTT------
T ss_pred             ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--cCCCccc------
Confidence                 123356789999999986544578999999999999999999999987654433322211  1000000      


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                                   ...........+++++.++|.+||+.||.+|||+.++++||||++....
T Consensus       249 -------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          249 -------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             -------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             -------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence                         0001122344678899999999999999999999999999999986543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.8e-35  Score=240.92  Aligned_cols=182  Identities=21%  Similarity=0.353  Sum_probs=144.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC----ccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~~   77 (249)
                      |++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+.......    .....
T Consensus       100 g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  179 (311)
T 3ork_A          100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV  179 (311)
T ss_dssp             EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccccccccccc
Confidence            68999999988899999999999999999999999999999999999999999999999999987654332    12235


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .|++.|+|||.+.+. .++.++||||||+++|+|++|..||.+................                     
T Consensus       180 ~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------------  237 (311)
T 3ork_A          180 IGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI---------------------  237 (311)
T ss_dssp             --CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC---------------------
T ss_pred             CcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC---------------------
Confidence            689999999998755 4889999999999999999999999887765554444321110                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD  211 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~  211 (249)
                            ........+++++.++|.+||+.||.+||++.+++.|+|++.......
T Consensus       238 ------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~  285 (311)
T 3ork_A          238 ------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP  285 (311)
T ss_dssp             ------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred             ------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence                  111223468899999999999999999999999999999987654433

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.5e-35  Score=235.24  Aligned_cols=174  Identities=30%  Similarity=0.538  Sum_probs=121.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Cccccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~   79 (249)
                      |++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus        95 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  174 (278)
T 3cok_A           95 NGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG  174 (278)
T ss_dssp             TEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------
T ss_pred             CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccC
Confidence            67999999876 67999999999999999999999999999999999999999999999999998765432 22234567


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      ++.|+|||.+.+. .++.++|+||||+++++|++|..||...........+.                            
T Consensus       175 ~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------------------------  225 (278)
T 3cok_A          175 TPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV----------------------------  225 (278)
T ss_dssp             ------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC----------------------------
T ss_pred             CCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh----------------------------
Confidence            8999999988644 47889999999999999999999997654221111100                            


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                         ......+..++.++.++|.+||+.||.+|||++++++||||++..
T Consensus       226 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          226 ---LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             ---SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             ---hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence               000112335788999999999999999999999999999998643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6e-35  Score=236.45  Aligned_cols=169  Identities=23%  Similarity=0.318  Sum_probs=135.4

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC-------------------CCeE
Q 025683            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-------------------CDLK   58 (249)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~-------------------~~~k   58 (249)
                      |++|.+++.+.    +.+++..+..++.||+.||.|||++|++|+||||+||+++.+                   ..++
T Consensus        95 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~k  174 (289)
T 1x8b_A           95 GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK  174 (289)
T ss_dssp             TCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEE
T ss_pred             CCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEE
Confidence            67999999875    679999999999999999999999999999999999999844                   4799


Q ss_pred             EeecCCccCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 025683           59 ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPT  138 (249)
Q Consensus        59 L~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  138 (249)
                      |+|||.+.......   ...++..|+|||.+.+...++.++||||||+++++|++|..++.....   ...+..      
T Consensus       175 l~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~------  242 (289)
T 1x8b_A          175 IGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQ------  242 (289)
T ss_dssp             ECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHT------
T ss_pred             EcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHc------
Confidence            99999987654432   345899999999997665577899999999999999999877654321   111110      


Q ss_pred             cccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                                              .....++..+++++.++|.+||+.||.+|||+.++++||||++.
T Consensus       243 ------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          243 ------------------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             ------------------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             ------------------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence                                    01112334678999999999999999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-34  Score=237.27  Aligned_cols=176  Identities=23%  Similarity=0.423  Sum_probs=137.5

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~   78 (249)
                      |++|.+++...  ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+...... .......
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  190 (326)
T 2x7f_A          111 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI  190 (326)
T ss_dssp             TEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------
T ss_pred             CCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcccccccc
Confidence            56999999875  57999999999999999999999999999999999999999999999999998765432 2233457


Q ss_pred             ccccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           79 VTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        79 ~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      +++.|+|||.+..    ...++.++|||||||++|+|++|..||...........+...  ..+                
T Consensus       191 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----------------  252 (326)
T 2x7f_A          191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--PAP----------------  252 (326)
T ss_dssp             CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCC----------------
T ss_pred             CCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccc----------------
Confidence            8999999999862    334788999999999999999999999877655444333221  000                


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                                 ......+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       253 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          253 -----------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             -----------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             -----------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                       00123567899999999999999999999999999999864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.3e-35  Score=245.23  Aligned_cols=201  Identities=22%  Similarity=0.394  Sum_probs=145.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|||.+...... ......++
T Consensus       115 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt  193 (360)
T 3eqc_A          115 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGT  193 (360)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCC
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCC
Confidence            679999999988999999999999999999999985 9999999999999999999999999988543221 22345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc-----------------
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG-----------------  143 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------  143 (249)
                      +.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+.............                 
T Consensus       194 ~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (360)
T 3eqc_A          194 RSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR  272 (360)
T ss_dssp             CTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------------
T ss_pred             CCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCC
Confidence            999999998654 48899999999999999999999998876544433322111110000000                 


Q ss_pred             -ccchhhH-HHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          144 -FVRNEDA-KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       144 -~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                       ....... .........      ......++.++.+||.+||+.||.+|||++++++||||++...+.
T Consensus       273 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  335 (360)
T 3eqc_A          273 PPMAIFELLDYIVNEPPP------KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  335 (360)
T ss_dssp             -CCCHHHHHHHHHHSCCC------CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             CcccchhhhhHHhccCCC------CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence             0000000 011111000      011224688999999999999999999999999999999865443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.2e-35  Score=241.11  Aligned_cols=167  Identities=26%  Similarity=0.483  Sum_probs=141.2

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec-cCCCeEEeecCCccCCCCCCccccccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ++|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++ .++.+||+|||.+....... .....+++
T Consensus       134 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~  212 (320)
T 3a99_A          134 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTR  212 (320)
T ss_dssp             EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC-BCCCCSCG
T ss_pred             ccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc-ccCCCCCc
Confidence            79999999888999999999999999999999999999999999999999 77899999999987655432 33457899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+......+.++||||||+++|+|++|..||.....      +..  +.                         
T Consensus       213 ~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~-------------------------  259 (320)
T 3a99_A          213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQ-------------------------  259 (320)
T ss_dssp             GGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CC-------------------------
T ss_pred             cCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--cc-------------------------
Confidence            999999987665557899999999999999999999964321      000  00                         


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                          ......+++++.+||.+||+.||.+|||++++++||||++..
T Consensus       260 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          260 ----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             ----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ----ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence                011235788999999999999999999999999999999765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.1e-34  Score=233.38  Aligned_cols=177  Identities=27%  Similarity=0.467  Sum_probs=144.0

Q ss_pred             CccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Cccccccc
Q 025683            2 DTDLYQIIR-SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~-~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~   79 (249)
                      |++|.+++. ....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus       108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  187 (314)
T 3com_A          108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIG  187 (314)
T ss_dssp             TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCS
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCC
Confidence            569999997 4578999999999999999999999999999999999999999999999999998765433 22334578


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+...  ..+.                    
T Consensus       188 ~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~--------------------  244 (314)
T 3com_A          188 TPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN--PPPT--------------------  244 (314)
T ss_dssp             CGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCC--------------------
T ss_pred             CCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CCcc--------------------
Confidence            9999999998654 4789999999999999999999999877654433332211  0000                    


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                            ......+++.+.++|.+||+.||.+|||+.++++||||++..
T Consensus       245 ------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          245 ------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             ------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             ------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                  001123678899999999999999999999999999999754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.6e-35  Score=244.45  Aligned_cols=184  Identities=26%  Similarity=0.434  Sum_probs=122.0

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc---CCCeEEeecCCccCCCCCCcccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~---~~~~kL~dfg~~~~~~~~~~~~~   76 (249)
                      ||+|.+++.+.+  .+++..+..++.||+.||.|||++|++||||||+||+++.   ++.++|+|||.+...... ....
T Consensus       110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~  188 (336)
T 3fhr_A          110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQT  188 (336)
T ss_dssp             TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-cccc
Confidence            679999998864  6999999999999999999999999999999999999986   455999999998765432 2334


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+++.|+|||.+... .++.++||||||+++|+|++|..||..................                   .
T Consensus       189 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------------~  248 (336)
T 3fhr_A          189 PCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-------------------G  248 (336)
T ss_dssp             ---------------C-HHHHHHHHHHHHHHHHHHHHSSCCC--------------------------------------
T ss_pred             CCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-------------------c
Confidence            5779999999988543 4788999999999999999999999765432221111100000                   0


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                      ..    ......+..+++++.+||.+||+.||.+|||+.++++||||++.....
T Consensus       249 ~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  298 (336)
T 3fhr_A          249 QY----GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP  298 (336)
T ss_dssp             ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred             cc----ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence            00    000112235789999999999999999999999999999999765433

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6e-34  Score=233.87  Aligned_cols=177  Identities=26%  Similarity=0.400  Sum_probs=136.4

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~   77 (249)
                      .|++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||||+||+++ ++.++|+|||.+........   ....
T Consensus       110 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~  188 (313)
T 3cek_A          110 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ  188 (313)
T ss_dssp             CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-------------
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCC
Confidence            3689999999999999999999999999999999999999999999999996 58999999999876543321   2345


Q ss_pred             cccccccCchhccCC----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCcccccccc
Q 025683           78 VVTRWYRAPELLLNS----------SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVH-QMRLLIELLGTPTDADLGFVR  146 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  146 (249)
                      .+++.|+|||.+...          ..++.++||||||+++|+|++|..||....... ....+.   ....        
T Consensus       189 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~--------  257 (313)
T 3cek_A          189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNH--------  257 (313)
T ss_dssp             -CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTTS--------
T ss_pred             CCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH---hccc--------
Confidence            689999999998641          347889999999999999999999997654321 111111   1000        


Q ss_pred             hhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                        ........++++.++|.+||+.||.+|||+.++++||||+...
T Consensus       258 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          258 ------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             ------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             ------------------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence                              0112224578899999999999999999999999999998653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.2e-34  Score=234.15  Aligned_cols=178  Identities=22%  Similarity=0.430  Sum_probs=140.8

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Cccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~   79 (249)
                      |++|.+++.+ ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  179 (302)
T 2j7t_A          100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG  179 (302)
T ss_dssp             TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----C
T ss_pred             CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccC
Confidence            6789999876 577999999999999999999999999999999999999999999999999986432111 11233567


Q ss_pred             cccccCchhcc----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           80 TRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        80 ~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      +..|+|||.+.    ....++.++|+||||+++|+|++|..||...+.......+....  .+.                
T Consensus       180 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~----------------  241 (302)
T 2j7t_A          180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPT----------------  241 (302)
T ss_dssp             CGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCC----------------
T ss_pred             ChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--Ccc----------------
Confidence            89999999984    34457899999999999999999999998877655544433211  000                


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                ......++.++.++|.+||+.||.+|||+.++++||||++..
T Consensus       242 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          242 ----------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             ----------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             ----------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence                      001124678899999999999999999999999999999753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.3e-34  Score=236.03  Aligned_cols=172  Identities=24%  Similarity=0.446  Sum_probs=133.4

Q ss_pred             CccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC------
Q 025683            2 DTDLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~---l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~------   72 (249)
                      |++|.+++.+...   .++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||.+.......      
T Consensus       145 ~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~  224 (332)
T 3qd2_B          145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL  224 (332)
T ss_dssp             SSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------
T ss_pred             CCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc
Confidence            6799999998643   5666799999999999999999999999999999999999999999999987655431      


Q ss_pred             -------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           73 -------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        73 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                             ......+|+.|+|||.+.+. .++.++|+|||||++|+|++|..|+.     .....+........       
T Consensus       225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~-------  291 (332)
T 3qd2_B          225 TPMPAYATHTGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKF-------  291 (332)
T ss_dssp             -------CCCSCC-CGGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCC-------
T ss_pred             ccccccccccccCCCcCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCC-------
Confidence                   12335689999999998755 48999999999999999999866531     11111111111100       


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                                          .......++++.+||.+||+.||.+|||+.++++||||+++
T Consensus       292 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          292 --------------------PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             --------------------CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             --------------------CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence                                00111245678899999999999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=238.19  Aligned_cols=174  Identities=25%  Similarity=0.428  Sum_probs=140.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec-cCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++ .++.++|+|||.+....... .....++
T Consensus       123 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~  201 (312)
T 2iwi_A          123 AQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGT  201 (312)
T ss_dssp             EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC-BCCCCSC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc-ccccCCc
Confidence            689999999888999999999999999999999999999999999999999 78999999999987655432 3456789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      ..|+|||.+......+.++|+||||+++|+|++|..||.....      +..                       ..   
T Consensus       202 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~-----------------------~~---  249 (312)
T 2iwi_A          202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE-----------------------AE---  249 (312)
T ss_dssp             TTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-----------------------TC---
T ss_pred             ccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh-----------------------hc---
Confidence            9999999987655456689999999999999999999964311      110                       00   


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP  213 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~  213 (249)
                           ..+...+++++.++|.+||+.||.+|||++++++||||+...+.....
T Consensus       250 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~~~  297 (312)
T 2iwi_A          250 -----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN  297 (312)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--------
T ss_pred             -----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccccc
Confidence                 012235788999999999999999999999999999999876544333

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-35  Score=249.95  Aligned_cols=169  Identities=16%  Similarity=0.230  Sum_probs=137.8

Q ss_pred             CCccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc
Q 025683            1 MDTDLYQIIRS-------NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (249)
Q Consensus         1 ~~~~L~~~l~~-------~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~   73 (249)
                      ++++|.+++..       .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......  
T Consensus       187 ~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--  264 (413)
T 3dzo_A          187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--  264 (413)
T ss_dssp             CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--
T ss_pred             hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--
Confidence            36789988851       245888999999999999999999999999999999999999999999999998765433  


Q ss_pred             cccccccccccCchhcc---------CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 025683           74 MTEYVVTRWYRAPELLL---------NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~---------~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (249)
                      .....| +.|+|||.+.         ....++.++|||||||++|+|++|..||.........                 
T Consensus       265 ~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~-----------------  326 (413)
T 3dzo_A          265 AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS-----------------  326 (413)
T ss_dssp             ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS-----------------
T ss_pred             cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH-----------------
Confidence            344566 8999999983         3334678999999999999999999999765411100                 


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                        .........+++++.+||.+||+.||.+|||+.++++||||+.+.
T Consensus       327 ------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          327 ------------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             ------------------GGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ------------------HHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence                              000111235789999999999999999999999999999998865

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.2e-34  Score=232.31  Aligned_cols=173  Identities=27%  Similarity=0.460  Sum_probs=143.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      |++|.+++.+ +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus       104 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  182 (303)
T 3a7i_A          104 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT  182 (303)
T ss_dssp             TEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSC
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCC
Confidence            5799999976 679999999999999999999999999999999999999999999999999987654432 23345789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+...  .                        
T Consensus       183 ~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~------------------------  235 (303)
T 3a7i_A          183 PFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--N------------------------  235 (303)
T ss_dssp             GGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--C------------------------
T ss_pred             cCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--C------------------------
Confidence            999999998654 4788999999999999999999999877655444333210  0                        


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                          ...+...++..+.++|.+||+.||.+|||+.++++||||.+.
T Consensus       236 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          236 ----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ----CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ----CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                011233578889999999999999999999999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.8e-34  Score=232.77  Aligned_cols=178  Identities=24%  Similarity=0.369  Sum_probs=131.5

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      |+.+..++.. .+.+++..+..++.||+.||.|||++ |++|+||+|+||+++.++.++|+|||.+.............+
T Consensus       107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  186 (318)
T 2dyl_A          107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAG  186 (318)
T ss_dssp             SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCC
Confidence            4555555544 57899999999999999999999995 999999999999999999999999999876655444445678


Q ss_pred             cccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           80 TRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        80 ~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ++.|+|||.+..    ...++.++||||||+++|+|++|..||.... .......+....  .+.               
T Consensus       187 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~---------------  249 (318)
T 2dyl_A          187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PPL---------------  249 (318)
T ss_dssp             CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CCC---------------
T ss_pred             CccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CCC---------------
Confidence            999999999852    3447889999999999999999999997643 333333332210  000               


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                 ......+++++.++|.+||+.||.+|||++++++||||+++.
T Consensus       250 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          250 -----------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             -----------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             -----------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                       001124788999999999999999999999999999999764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-33  Score=229.47  Aligned_cols=179  Identities=26%  Similarity=0.462  Sum_probs=139.5

Q ss_pred             CccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-CCCeEEeecCCccCCCCCC-cccc
Q 025683            2 DTDLYQIIRSN---QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKICDFGLARPTSENE-FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-~~~~kL~dfg~~~~~~~~~-~~~~   76 (249)
                      |++|.+++.+.   ..+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||.+....... ....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  182 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET  182 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence            68999999875   35779999999999999999999999999999999999988 8999999999987654322 2334


Q ss_pred             ccccccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+... ..++.++|+||||+++|+|++|..||..................                   
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------------  243 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-------------------  243 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------------
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------------
Confidence            5789999999998643 23788999999999999999999999754432221111111110                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                               ...++..+++++.++|.+||+.||.+|||++++++||||+....
T Consensus       244 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          244 ---------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             ---------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence                     01223467889999999999999999999999999999996543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-34  Score=239.40  Aligned_cols=192  Identities=22%  Similarity=0.339  Sum_probs=143.9

Q ss_pred             CccHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC
Q 025683            2 DTDLYQI------IRS--NQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (249)
Q Consensus         2 ~~~L~~~------l~~--~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~   72 (249)
                      |++|.++      +.+  ...+++..+..++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus       127 ~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-  205 (348)
T 2pml_X          127 NDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-  205 (348)
T ss_dssp             TCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-
T ss_pred             CCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc-
Confidence            4588887      666  5789999999999999999999999 99999999999999999999999999998765433 


Q ss_pred             ccccccccccccCchhccCCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCcccccccchhhH
Q 025683           73 FMTEYVVTRWYRAPELLLNSSDYTA-AIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDA  150 (249)
Q Consensus        73 ~~~~~~~~~~y~aPE~~~~~~~~~~-~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (249)
                      ......++..|+|||.+.+...++. ++|+||||+++++|++|..||..... ......+.......+.......     
T Consensus       206 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~-----  280 (348)
T 2pml_X          206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFL-----  280 (348)
T ss_dssp             EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSST-----
T ss_pred             cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhh-----
Confidence            3445678999999999976644555 99999999999999999999987765 4443333221111111000000     


Q ss_pred             HHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                             ..............+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       281 -------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          281 -------YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             -------TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             -------ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence                   0000001112234688999999999999999999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.5e-34  Score=231.00  Aligned_cols=174  Identities=28%  Similarity=0.445  Sum_probs=131.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC---------
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---------   71 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---------   71 (249)
                      |++|.+++.+. ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+......         
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  178 (303)
T 1zy4_A           99 NGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ  178 (303)
T ss_dssp             SCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC----------
T ss_pred             CCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccc
Confidence            67999999865 46889999999999999999999999999999999999999999999999998765421         


Q ss_pred             ------CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccc
Q 025683           72 ------EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-HQMRLLIELLGTPTDADLGF  144 (249)
Q Consensus        72 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  144 (249)
                            .......+++.|+|||.+.+...++.++|+||||+++|+|++   ||...... .....+.......       
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~-------  248 (303)
T 1zy4_A          179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEF-------  248 (303)
T ss_dssp             ---------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCC-------
T ss_pred             cccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcccccccc-------
Confidence                  122345678999999999766568999999999999999997   44332211 1111111100000       


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                                          ........++.+.++|++||+.||.+|||+.++++||||+.
T Consensus       249 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          249 --------------------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             --------------------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             --------------------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence                                01123356678999999999999999999999999999985

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-33  Score=231.65  Aligned_cols=174  Identities=24%  Similarity=0.422  Sum_probs=134.5

Q ss_pred             CccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccc
Q 025683            2 DTDLYQIIRSNQS---LSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMT   75 (249)
Q Consensus         2 ~~~L~~~l~~~~~---l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~   75 (249)
                      ||+|.+++.+.+.   +++..+..++.||+.||+|||++|  ++||||||+||+++.++.+||+|||.+....... ...
T Consensus       118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  197 (309)
T 3p86_A          118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK  197 (309)
T ss_dssp             TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred             CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccc
Confidence            6799999998654   999999999999999999999999  9999999999999999999999999987544332 233


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+......                   
T Consensus       198 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------------------  257 (309)
T 3p86_A          198 SAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-------------------  257 (309)
T ss_dssp             ----CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-------------------
T ss_pred             cCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------------
Confidence            467899999999986554 789999999999999999999999887765554444221110                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc--CccccC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA--HPYLAR  205 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~--h~~~~~  205 (249)
                                ..+...+++++.+||.+||+.||.+|||+.++++  .+++++
T Consensus       258 ----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 ----------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                      1223467899999999999999999999999987  456554

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.6e-33  Score=228.26  Aligned_cols=172  Identities=15%  Similarity=0.180  Sum_probs=137.6

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC-----eEEeecCCccCCCCCC--
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-----LKICDFGLARPTSENE--   72 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~-----~kL~dfg~~~~~~~~~--   72 (249)
                      +|++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.     ++|+|||.+.......  
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~  167 (298)
T 1csn_A           88 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  167 (298)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             cCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence            478999999975 46999999999999999999999999999999999999987765     9999999987654332  


Q ss_pred             ------ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCccccc
Q 025683           73 ------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND---HVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        73 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~  143 (249)
                            ......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||....   .......+.....        
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  238 (298)
T 1csn_A          168 QHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--------  238 (298)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH--------
T ss_pred             ccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc--------
Confidence                  12345689999999998654 47999999999999999999999998743   2222222221110        


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                        ..........+++++.+++.+||+.||.+|||++++++
T Consensus       239 ------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          239 ------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             ------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ------------------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence                              01112334468899999999999999999999999976

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6e-34  Score=235.24  Aligned_cols=182  Identities=29%  Similarity=0.433  Sum_probs=123.3

Q ss_pred             CCccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc
Q 025683            1 MDTDLYQIIRS-----NQSLSEEHCQYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM   74 (249)
Q Consensus         1 ~~~~L~~~l~~-----~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~   74 (249)
                      ++++|.+++..     ...+++..+..++.|++.||.|||++ |++|+||||+||+++.++.+||+|||.+.........
T Consensus       103 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  182 (327)
T 3aln_A          103 MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK  182 (327)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred             cCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccccc
Confidence            45678888874     57899999999999999999999999 9999999999999999999999999999776554444


Q ss_pred             ccccccccccCchhcc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           75 TEYVVTRWYRAPELLL---NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      ....+++.|+|||.+.   ....++.++||||||+++|+|++|..||........  .+    .....            
T Consensus       183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~~~~------------  244 (327)
T 3aln_A          183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QL----TQVVK------------  244 (327)
T ss_dssp             -----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCC------------
T ss_pred             ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HH----HHHhc------------
Confidence            4457899999999984   233478999999999999999999999976432100  00    00000            


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                             .............+++++.+||.+||+.||.+|||+.++++||||....
T Consensus       245 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          245 -------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             -------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             -------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                   0000000112235789999999999999999999999999999998654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-33  Score=232.81  Aligned_cols=177  Identities=24%  Similarity=0.379  Sum_probs=130.5

Q ss_pred             CccHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--
Q 025683            2 DTDLYQIIRSNQ------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--   73 (249)
Q Consensus         2 ~~~L~~~l~~~~------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--   73 (249)
                      ||+|.+++....      .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+........  
T Consensus       115 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~  194 (323)
T 3qup_A          115 HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR  194 (323)
T ss_dssp             TCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecccccccccccccc
Confidence            679999997642      699999999999999999999999999999999999999999999999999976544322  


Q ss_pred             -cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           74 -MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        74 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                       .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.........+.....                
T Consensus       195 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----------------  257 (323)
T 3qup_A          195 QGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR----------------  257 (323)
T ss_dssp             ------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------
T ss_pred             ccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC----------------
Confidence             1223457789999998654 48899999999999999999 9999987765544444332110                


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-------HHHHhcCccccCCcCC
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-------VDEALAHPYLARLHDE  209 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-------~~~ll~h~~~~~~~~~  209 (249)
                                    ......+++++.+|+.+||+.||.+|||       ++++++|+|+......
T Consensus       258 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          258 --------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             --------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence                          1122357788999999999999999999       7778889999976443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=232.95  Aligned_cols=195  Identities=20%  Similarity=0.324  Sum_probs=140.2

Q ss_pred             CccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee----ccCCCeEEeecCCccCCCCCCcc
Q 025683            2 DTDLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGLARPTSENEFM   74 (249)
Q Consensus         2 ~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~----~~~~~~kL~dfg~~~~~~~~~~~   74 (249)
                      |++|.+++....   .+++..+..++.||+.||+|||++|++|+||||+||++    +.++.+||+|||.+.........
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~  172 (319)
T 4euu_A           93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF  172 (319)
T ss_dssp             TCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCB
T ss_pred             CCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCce
Confidence            689999998753   39999999999999999999999999999999999999    77778999999999877665555


Q ss_pred             ccccccccccCchhccC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCccccc
Q 025683           75 TEYVVTRWYRAPELLLN-------SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH----VHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~  143 (249)
                      ....+++.|+|||.+..       ...++.++|||||||++|+|++|..||.....    ...+..+..   ..+...+.
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---~~p~~~~~  249 (319)
T 4euu_A          173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT---GKPSGAIS  249 (319)
T ss_dssp             CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH---HCCTTCCE
T ss_pred             eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc---CCCcccch
Confidence            56778999999998852       34578999999999999999999999964332    223333322   12111111


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPY  202 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~  202 (249)
                      ......... .......  .....+...+++.+.++|++||+.||.+|||++|+++||-
T Consensus       250 ~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          250 GVQKAENGP-IDWSGDM--PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             EEECSTTCC-EEEESSC--CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             hhhcccCCc-cccCccC--CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            110000000 0000000  0001112234567889999999999999999999999863

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.2e-33  Score=226.49  Aligned_cols=179  Identities=26%  Similarity=0.390  Sum_probs=138.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~   79 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+.......  ......|
T Consensus        95 g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  174 (294)
T 4eqm_A           95 GPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG  174 (294)
T ss_dssp             SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCcccc
Confidence            67999999998899999999999999999999999999999999999999999999999999997654432  2233568


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      ++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+............  ...                      
T Consensus       175 t~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~--~~~----------------------  229 (294)
T 4eqm_A          175 TVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ--DSV----------------------  229 (294)
T ss_dssp             CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--SCC----------------------
T ss_pred             CccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--ccC----------------------
Confidence            99999999987554 78999999999999999999999988765444333221  000                      


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                        ........+.+++.+.++|.+||+.||.+||+..+.+.+.|.+-..
T Consensus       230 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          230 --PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             --CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             --CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence              1111233456889999999999999999999655555656655443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.8e-33  Score=225.96  Aligned_cols=172  Identities=18%  Similarity=0.197  Sum_probs=136.6

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee---ccCCCeEEeecCCccCCCCCCc---
Q 025683            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEF---   73 (249)
Q Consensus         1 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~---~~~~~~kL~dfg~~~~~~~~~~---   73 (249)
                      +|++|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+||++   +.++.++|+|||.+........   
T Consensus        87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (296)
T 3uzp_A           87 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             cCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence            47899999984 4689999999999999999999999999999999999999   4889999999999876543321   


Q ss_pred             -----cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCccccccc
Q 025683           74 -----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH---VHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        74 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                           .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.....   ......+.....          
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  235 (296)
T 3uzp_A          167 IPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM----------  235 (296)
T ss_dssp             CCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH----------
T ss_pred             cccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc----------
Confidence                 23457899999999986544 88999999999999999999999976431   111222111000          


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                      ..........+++++.+++.+||+.||.+|||+.++++
T Consensus       236 ----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          236 ----------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ----------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ----------------CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                            01112233468899999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.6e-33  Score=227.56  Aligned_cols=175  Identities=30%  Similarity=0.469  Sum_probs=141.8

Q ss_pred             CccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCCCCeeeccCCCeEEeecCCccCCCCCC
Q 025683            2 DTDLYQIIRSN----QSLSEEHCQYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (249)
Q Consensus         2 ~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~-----i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~   72 (249)
                      |++|.+++.+.    ..+++..+..++.||+.||+|||++|     ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~  170 (279)
T 2w5a_A           91 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  170 (279)
T ss_dssp             TEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C
T ss_pred             CCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc
Confidence            57999999764    34999999999999999999999999     9999999999999999999999999987654332


Q ss_pred             c-cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           73 F-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        73 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      . .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.....                
T Consensus       171 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----------------  233 (279)
T 2w5a_A          171 SFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----------------  233 (279)
T ss_dssp             HHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------------
T ss_pred             ccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc----------------
Confidence            1 2235678999999998654 478999999999999999999999988765544444332110                


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                    ..+...+++++.++|.+||+.||.+|||+.++++|+|+..-.
T Consensus       234 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          234 --------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             --------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                          112235788999999999999999999999999999998643

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.1e-33  Score=227.47  Aligned_cols=172  Identities=18%  Similarity=0.197  Sum_probs=136.8

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee---ccCCCeEEeecCCccCCCCCC----
Q 025683            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENE----   72 (249)
Q Consensus         1 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~---~~~~~~kL~dfg~~~~~~~~~----   72 (249)
                      +|++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||++   +.++.+||+|||.+.......    
T Consensus        87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~  166 (296)
T 4hgt_A           87 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             CCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCcc
Confidence            47899999985 4689999999999999999999999999999999999999   788999999999987654332    


Q ss_pred             ----ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCccccccc
Q 025683           73 ----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV---HQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        73 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  145 (249)
                          ......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+....   .....+.....          
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  235 (296)
T 4hgt_A          167 IPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM----------  235 (296)
T ss_dssp             CCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH----------
T ss_pred             CCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc----------
Confidence                123457899999999986554 889999999999999999999999764321   11111111000          


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                      ..........+++++.+++.+||+.||.+|||+.++++
T Consensus       236 ----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          236 ----------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ----------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ----------------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                            01112233467899999999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-33  Score=240.56  Aligned_cols=179  Identities=27%  Similarity=0.428  Sum_probs=131.1

Q ss_pred             CCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-----CCCeEEeecCCccCCCCCC--
Q 025683            1 MDTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-----NCDLKICDFGLARPTSENE--   72 (249)
Q Consensus         1 ~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-----~~~~kL~dfg~~~~~~~~~--   72 (249)
                      |+|+|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+||+++.     ...++|+|||++.......  
T Consensus       100 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~  179 (432)
T 3p23_A          100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS  179 (432)
T ss_dssp             CSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred             CCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence            5789999998763 5666678899999999999999999999999999999953     2357899999997654332  


Q ss_pred             --ccccccccccccCchhccC--CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           73 --FMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        73 --~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                        ......||+.|+|||.+..  ...++.++|||||||++|+|++ |..||......... .+   .+.......     
T Consensus       180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~---~~~~~~~~~-----  250 (432)
T 3p23_A          180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-IL---LGACSLDCL-----  250 (432)
T ss_dssp             ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HH---TTCCCCTTS-----
T ss_pred             eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HH---hccCCcccc-----
Confidence              2334678999999999864  2346779999999999999999 88998654332211 11   111110000     


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                         ......+..+.+||.+||+.||.+|||+.++++||||....
T Consensus       251 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          251 -------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             -------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             -------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence                               00011235578999999999999999999999999998643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.4e-33  Score=231.96  Aligned_cols=168  Identities=27%  Similarity=0.394  Sum_probs=136.1

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      ||+|.+++.+.+                .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus       171 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  250 (370)
T 2psq_A          171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA  250 (370)
T ss_dssp             TCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSC
T ss_pred             CCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCC
Confidence            679999998753                4899999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      .......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.........+....       
T Consensus       251 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------  322 (370)
T 2psq_A          251 RDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-------  322 (370)
T ss_dssp             EETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-------
T ss_pred             cccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-------
Confidence            7554322   12234567889999998654 48999999999999999998 999998765443333222100       


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                             ....+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       323 -----------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          323 -----------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             -----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   011233577899999999999999999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.9e-33  Score=231.97  Aligned_cols=156  Identities=27%  Similarity=0.429  Sum_probs=126.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---ccccccccccccCchhccC
Q 025683           15 LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEYVVTRWYRAPELLLN   91 (249)
Q Consensus        15 l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~   91 (249)
                      +++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+.......   ......+|..|+|||.+.+
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  269 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  269 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC
Confidence            9999999999999999999999999999999999999999999999999997654332   2233567888999999865


Q ss_pred             CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCC
Q 025683           92 SSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFP  170 (249)
Q Consensus        92 ~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (249)
                      . .++.++||||||+++|+|++ |..||.+................                             ...+.
T Consensus       270 ~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~  319 (359)
T 3vhe_A          270 R-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-----------------------------MRAPD  319 (359)
T ss_dssp             C-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-----------------------------CCCCT
T ss_pred             C-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-----------------------------CCCCC
Confidence            4 48899999999999999998 99999876543333333221111                             11123


Q ss_pred             CCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          171 HVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       171 ~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      .+++++.+++.+||+.||.+|||+.++++|
T Consensus       320 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          320 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            577889999999999999999999999876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-32  Score=231.86  Aligned_cols=168  Identities=27%  Similarity=0.392  Sum_probs=138.5

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      ||+|.+++....                .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||.+
T Consensus       159 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a  238 (382)
T 3tt0_A          159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA  238 (382)
T ss_dssp             TCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCC
T ss_pred             CCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcc
Confidence            679999998754                4999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      .......   ......++..|+|||.+.+. .++.++|||||||++++|++ |..||.+.........+.....      
T Consensus       239 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------  311 (382)
T 3tt0_A          239 RDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR------  311 (382)
T ss_dssp             CCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC------
T ss_pred             cccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            7654432   22334567889999998754 48899999999999999999 9999988765544443332110      


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                              ......+++++.+||.+||+.||.+|||+.+++++
T Consensus       312 ------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          312 ------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             ------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    11123578899999999999999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.1e-33  Score=232.04  Aligned_cols=174  Identities=16%  Similarity=0.141  Sum_probs=136.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC--CeEEeecCCccCCCCCC-------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC--DLKICDFGLARPTSENE-------   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~--~~kL~dfg~~~~~~~~~-------   72 (249)
                      |++|.+++.+.+.+++..+..++.||+.||+|||++|++||||||+||+++.++  .++|+|||.+.......       
T Consensus       135 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  214 (345)
T 2v62_A          135 GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE  214 (345)
T ss_dssp             EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCC
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchh
Confidence            789999999888999999999999999999999999999999999999999887  99999999997553221       


Q ss_pred             -ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHH-HHhCCCCcccccccchhh
Q 025683           73 -FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN-DHVHQMRLLI-ELLGTPTDADLGFVRNED  149 (249)
Q Consensus        73 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  149 (249)
                       ......++..|+|||.+.+. .++.++|||||||++|+|++|..||... .......... ......+.          
T Consensus       215 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  283 (345)
T 2v62_A          215 NPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQ----------  283 (345)
T ss_dssp             CGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTH----------
T ss_pred             ccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccH----------
Confidence             12345789999999998755 4899999999999999999999999642 2222222221 11111110          


Q ss_pred             HHHHHHhCCCCCCcchhhcC--CCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          150 AKRYIRQLPQHPRQSLAQVF--PHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                    ......  ..+++++.++|.+||+.||.+|||++++++.
T Consensus       284 --------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          284 --------------SVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             --------------HHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             --------------HHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence                          001111  1578899999999999999999999999873

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.4e-32  Score=223.36  Aligned_cols=173  Identities=24%  Similarity=0.365  Sum_probs=131.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC---Cccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---~~~~~~   77 (249)
                      |++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+......   ......
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  182 (289)
T 3og7_A          103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL  182 (289)
T ss_dssp             EEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------------
T ss_pred             CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccccccc
Confidence            68999999654 67999999999999999999999999999999999999999999999999998754331   223345


Q ss_pred             cccccccCchhccC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           78 VVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        78 ~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      .+++.|+|||.+..  ...++.++||||||+++|+|++|..||...................+                 
T Consensus       183 ~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------  245 (289)
T 3og7_A          183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-----------------  245 (289)
T ss_dssp             -CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-----------------
T ss_pred             CCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-----------------
Confidence            68999999999852  34478899999999999999999999988766555555443222111                 


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                              ........+++++.+||.+||+.||.+|||+.++++
T Consensus       246 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 --------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             --------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                    112233467889999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-33  Score=236.79  Aligned_cols=175  Identities=19%  Similarity=0.255  Sum_probs=140.7

Q ss_pred             CccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC---CeEEeecCCccCCCC-
Q 025683            2 DTDLYQIIRSN-------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC---DLKICDFGLARPTSE-   70 (249)
Q Consensus         2 ~~~L~~~l~~~-------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~---~~kL~dfg~~~~~~~-   70 (249)
                      ||+|.+++...       ..+++..+..++.||+.||+|||++|++||||||+||+++.++   .+||+|||.+..... 
T Consensus       158 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~  237 (367)
T 3l9p_A          158 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA  237 (367)
T ss_dssp             TEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHH
T ss_pred             CCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccc
Confidence            68999999874       3599999999999999999999999999999999999999555   599999999864321 


Q ss_pred             --CCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           71 --NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        71 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                        ........+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||...........+......           
T Consensus       238 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~-----------  305 (367)
T 3l9p_A          238 GYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-----------  305 (367)
T ss_dssp             SSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-----------
T ss_pred             cccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence              1222335668899999998655 48899999999999999998 99999888765555444321110           


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                         .....+++.+.+|+.+||+.||.+|||+.+++++.++-...
T Consensus       306 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          306 -------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence                               11235778899999999999999999999999987766443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.5e-33  Score=233.38  Aligned_cols=177  Identities=16%  Similarity=0.154  Sum_probs=135.9

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec--cCCCeEEeecCCccCCCCCCc----
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCDLKICDFGLARPTSENEF----   73 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~--~~~~~kL~dfg~~~~~~~~~~----   73 (249)
                      +|++|.+++... +.+++..+..++.||+.||+|||++|++||||||+||+++  .++.+||+|||++........    
T Consensus       134 ~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~  213 (364)
T 3op5_A          134 FGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY  213 (364)
T ss_dssp             EEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCS
T ss_pred             CCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCccccc
Confidence            378999999886 6899999999999999999999999999999999999999  889999999999975443211    


Q ss_pred             ----cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCcccccccchh
Q 025683           74 ----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNE  148 (249)
Q Consensus        74 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  148 (249)
                          .....||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+... .............            
T Consensus       214 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~------------  280 (364)
T 3op5_A          214 AADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRE------------  280 (364)
T ss_dssp             SCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHH------------
T ss_pred             ccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhh------------
Confidence                12345899999999986554 89999999999999999999999985332 2222111111100            


Q ss_pred             hHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ......+...         .....++++.+++..||+.||.+||++.++++
T Consensus       281 ~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          281 NIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             CHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            0011111000         01357889999999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3e-32  Score=225.43  Aligned_cols=171  Identities=18%  Similarity=0.255  Sum_probs=134.8

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC-----eEEeecCCccCCCCCCc-
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD-----LKICDFGLARPTSENEF-   73 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~-----~kL~dfg~~~~~~~~~~-   73 (249)
                      +|++|.+++... +.+++..+..++.||+.||+|||++|++||||||+||+++.++.     ++|+|||.+........ 
T Consensus        87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~  166 (330)
T 2izr_A           87 LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK  166 (330)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred             CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence            478999999874 78999999999999999999999999999999999999998876     99999999976433221 


Q ss_pred             -------cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCccccc
Q 025683           74 -------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV---HQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        74 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  143 (249)
                             .....||+.|+|||.+.+. .++.++|+|||||++|+|++|..||.+....   .....+.......+     
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-----  240 (330)
T 2izr_A          167 KHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-----  240 (330)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-----
T ss_pred             ccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-----
Confidence                   2356789999999998754 4789999999999999999999999875422   22222221110000     


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                           ........+ ++.+++..||+.||.+||+++++++
T Consensus       241 ---------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          241 ---------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             ---------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ---------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                                 011122344 8999999999999999999998876

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-32  Score=229.26  Aligned_cols=176  Identities=10%  Similarity=0.133  Sum_probs=137.7

Q ss_pred             CCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC--CeEEeecCCccCCCCCC----
Q 025683            1 MDTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC--DLKICDFGLARPTSENE----   72 (249)
Q Consensus         1 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~--~~kL~dfg~~~~~~~~~----   72 (249)
                      +|++|.+++.+.  ..+++..+..++.||+.||.|||++|++||||||+||+++.++  .++|+|||.+.......    
T Consensus       140 ~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  219 (352)
T 2jii_A          140 LGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA  219 (352)
T ss_dssp             CCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCC
T ss_pred             CCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccc
Confidence            478999999986  7899999999999999999999999999999999999999998  89999999997654321    


Q ss_pred             ----ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHH-HhCCCCcccccccc
Q 025683           73 ----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIE-LLGTPTDADLGFVR  146 (249)
Q Consensus        73 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~  146 (249)
                          ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.... .......... ....+.... .   
T Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~---  294 (352)
T 2jii_A          220 YVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFV-G---  294 (352)
T ss_dssp             CCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEE-C---
T ss_pred             ccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhh-h---
Confidence                12334789999999998654 48899999999999999999999997653 2222222221 111111000 0   


Q ss_pred             hhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                        ....+..+++++.+||.+||+.||.+|||++++++
T Consensus       295 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          295 ------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             ------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ------------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence                              00012246889999999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.3e-33  Score=238.69  Aligned_cols=179  Identities=28%  Similarity=0.435  Sum_probs=128.4

Q ss_pred             CCccHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC-------------CCeEEe
Q 025683            1 MDTDLYQIIRSNQSLS-------EEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-------------CDLKIC   60 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~-------~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~-------------~~~kL~   60 (249)
                      ++|+|.+++.......       +..+..++.||+.||+|||++|++||||||+||+++.+             +.++|+
T Consensus        91 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             CSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             CCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            5789999998864432       33457899999999999999999999999999999754             479999


Q ss_pred             ecCCccCCCCCCc-----cccccccccccCchhccC------CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 025683           61 DFGLARPTSENEF-----MTEYVVTRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMR  128 (249)
Q Consensus        61 dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~  128 (249)
                      |||.+........     .....||+.|+|||.+.+      ...++.++|||||||++|+|++ |..||.......  .
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~  248 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--S  248 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--H
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--H
Confidence            9999986554321     234578999999999865      2457899999999999999998 999997654332  1


Q ss_pred             HHHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                      .+..........  .                      ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       249 ~i~~~~~~~~~~--~----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          249 NIIRGIFSLDEM--K----------------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHTCCCCCCC--T----------------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHhcCCCCcccc--c----------------------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            111111000000  0                      0000124567899999999999999999999999999964

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.2e-33  Score=229.10  Aligned_cols=168  Identities=21%  Similarity=0.261  Sum_probs=135.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---ccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---~~~~~   77 (249)
                      ||+|.+++.+. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+.......   .....
T Consensus        98 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  177 (325)
T 3kex_A           98 LGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA  177 (325)
T ss_dssp             TCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC----
T ss_pred             CCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCC
Confidence            68999999875 689999999999999999999999999999999999999999999999999998654332   12334


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+.... ++.++||||||+++|+|++ |..||.+.........+.....                     
T Consensus       178 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------------  235 (325)
T 3kex_A          178 KTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER---------------------  235 (325)
T ss_dssp             -CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB---------------------
T ss_pred             CCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------------------
Confidence            5677899999986544 8899999999999999999 9999987664444333321100                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                               .......+.++.+++.+||+.||.+|||+.+++++
T Consensus       236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          236 ---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                     01122356778899999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.8e-33  Score=223.58  Aligned_cols=168  Identities=24%  Similarity=0.384  Sum_probs=127.7

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--ccccc
Q 025683            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~   78 (249)
                      |++|.+++...+ .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........  .....
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  178 (281)
T 1mp8_A           99 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK  178 (281)
T ss_dssp             TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCC
Confidence            579999998754 799999999999999999999999999999999999999999999999999876544322  22334


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +++.|+|||.+... .++.++|+||||+++|+|++ |..||.+.........+.....                      
T Consensus       179 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~----------------------  235 (281)
T 1mp8_A          179 LPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----------------------  235 (281)
T ss_dssp             CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------------
T ss_pred             CcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC----------------------
Confidence            57789999998644 47899999999999999996 9999987765544443321100                      


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                              ......+++++.+++.+||+.||.+|||+.+++++
T Consensus       236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          236 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                    11234678999999999999999999999999863

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-32  Score=222.99  Aligned_cols=168  Identities=18%  Similarity=0.278  Sum_probs=138.8

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--cccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~   78 (249)
                      |++|.+++.+ ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.......  ......
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  182 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK  182 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTT
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCc
Confidence            6899999987 4679999999999999999999999999999999999999999999999999987654332  122334


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+.... ++.++|+||||+++|+|++ |..||...........+.......                    
T Consensus       183 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------------  241 (283)
T 3gen_A          183 FPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------------------  241 (283)
T ss_dssp             SCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--------------------
T ss_pred             cCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC--------------------
Confidence            577899999987554 8899999999999999998 999998877665555544321111                    


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                .....++.+.+++.+||+.||.+|||+.++++|
T Consensus       242 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          242 ----------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             ----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                      122457889999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-32  Score=226.94  Aligned_cols=167  Identities=20%  Similarity=0.272  Sum_probs=135.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~   76 (249)
                      |++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+........    ...
T Consensus       134 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  213 (325)
T 3kul_A          134 NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG  213 (325)
T ss_dssp             TCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC-
T ss_pred             CCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccC
Confidence            67999999765 6899999999999999999999999999999999999999999999999999976544321    122


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+... .++.++||||||+++|+|++ |..||...........+......                   
T Consensus       214 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  273 (325)
T 3kul_A          214 GKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-------------------  273 (325)
T ss_dssp             --CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-------------------
T ss_pred             CCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-------------------
Confidence            3446789999998644 47889999999999999998 99999888766655554432111                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                 .....+++++.++|.+||+.||.+|||+.++++
T Consensus       274 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          274 -----------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                       112257788999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-32  Score=220.68  Aligned_cols=168  Identities=20%  Similarity=0.301  Sum_probs=137.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--cccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~   78 (249)
                      |++|.+++.+. +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......  ......
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  168 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  168 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcc
Confidence            67999999764 569999999999999999999999999999999999999999999999999987654332  122345


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+... .++.++|+||||+++++|++ |..||...........+......                     
T Consensus       169 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  226 (269)
T 4hcu_A          169 FPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------------------  226 (269)
T ss_dssp             CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------------
T ss_pred             cccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------------------
Confidence            57789999998654 48899999999999999999 99999887766555544321110                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                               ......++++.+++.+||+.||.+|||+.+++++
T Consensus       227 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          227 ---------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                     1122467889999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.2e-33  Score=229.34  Aligned_cols=168  Identities=23%  Similarity=0.288  Sum_probs=135.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~   77 (249)
                      +|+|.+++.+. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.++.......   ....
T Consensus       100 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  179 (327)
T 3poz_A          100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG  179 (327)
T ss_dssp             TCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCC
Confidence            68999999874 6799999999999999999999999999999999999999999999999999875433322   2233


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.........+.....                     
T Consensus       180 ~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---------------------  237 (327)
T 3poz_A          180 KVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---------------------  237 (327)
T ss_dssp             CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---------------------
T ss_pred             CccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC---------------------
Confidence            457789999998754 48899999999999999999 9999987654433332221100                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                               .......+.++.+++.+||+.||.+|||+.+++++
T Consensus       238 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 ---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ---------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ---------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                     01123467889999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.4e-33  Score=228.42  Aligned_cols=168  Identities=26%  Similarity=0.334  Sum_probs=135.5

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      |++|.+++.+.+                .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~  189 (327)
T 1fvr_A          110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  189 (327)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcC
Confidence            679999998764                7999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 025683           66 RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (249)
Q Consensus        66 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (249)
                      .............++..|+|||.+... .++.++|+||||+++|+|++ |..||.+.........+....          
T Consensus       190 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~----------  258 (327)
T 1fvr_A          190 RGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----------  258 (327)
T ss_dssp             ESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC----------
T ss_pred             ccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC----------
Confidence            754433333344567889999998644 37899999999999999998 999998876544433322100          


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                          .......+++++.++|.+||+.||.+|||+.+++++
T Consensus       259 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          259 --------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             --------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                011123577899999999999999999999999984

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-32  Score=221.57  Aligned_cols=168  Identities=20%  Similarity=0.301  Sum_probs=137.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--ccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~   78 (249)
                      |++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........  .....
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  166 (268)
T 3sxs_A           87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK  166 (268)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCC
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCC
Confidence            68999999875 4599999999999999999999999999999999999999999999999999876544332  22234


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+.+. .++.++|+||||+++++|++ |..||...........+......                     
T Consensus       167 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  224 (268)
T 3sxs_A          167 FPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL---------------------  224 (268)
T ss_dssp             CCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------------------
T ss_pred             cCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------------------
Confidence            56779999998644 37889999999999999998 99999887765554444321110                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                               ..+...++.+.+++.+||+.||.+|||+.+++++
T Consensus       225 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          225 ---------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ---------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                     1122467889999999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-32  Score=221.47  Aligned_cols=167  Identities=23%  Similarity=0.299  Sum_probs=136.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc----ccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~----~~~   77 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.........    ...
T Consensus       101 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  180 (291)
T 1xbb_A          101 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  180 (291)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccC
Confidence            6899999999889999999999999999999999999999999999999999999999999998765443221    123


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+.... ++.++|+||||+++|+|++ |..||...........+....                      
T Consensus       181 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------------  237 (291)
T 1xbb_A          181 KWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----------------------  237 (291)
T ss_dssp             CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------------------
T ss_pred             CCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------------
Confidence            4467899999986443 7889999999999999999 999998876554443332110                      


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                              .......+++++.++|.+||+.||.+|||+.++++
T Consensus       238 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 --------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                    01122357889999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.98  E-value=2.2e-32  Score=226.08  Aligned_cols=167  Identities=23%  Similarity=0.294  Sum_probs=130.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---cccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~   77 (249)
                      +|+|.+++.+. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+........   ....
T Consensus       100 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~  179 (327)
T 3lzb_A          100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG  179 (327)
T ss_dssp             SCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCC
Confidence            68999999874 6799999999999999999999999999999999999999999999999999976543322   2223


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.........+.....                     
T Consensus       180 ~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---------------------  237 (327)
T 3lzb_A          180 KVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---------------------  237 (327)
T ss_dssp             CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---------------------
T ss_pred             CccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            457789999998754 48899999999999999999 9999987664443333321110                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ......++.++.++|.+||+.||.+|||+.++++
T Consensus       238 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          238 ---------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                     1112357788999999999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.98  E-value=4.3e-32  Score=222.51  Aligned_cols=169  Identities=30%  Similarity=0.430  Sum_probs=136.4

Q ss_pred             CccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecC
Q 025683            2 DTDLYQIIRSNQ------------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG   63 (249)
Q Consensus         2 ~~~L~~~l~~~~------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg   63 (249)
                      ||+|.+++.+..                  .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  190 (313)
T 1t46_A          111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG  190 (313)
T ss_dssp             TEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCG
T ss_pred             CCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEcccc
Confidence            679999998754                  49999999999999999999999999999999999999999999999999


Q ss_pred             CccCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 025683           64 LARPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTD  139 (249)
Q Consensus        64 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  139 (249)
                      .+........   .....++..|+|||.+.+. .++.++||||||+++++|++ |..||...................  
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--  267 (313)
T 1t46_A          191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM--  267 (313)
T ss_dssp             GGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC--
T ss_pred             ccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC--
Confidence            9876554322   2234567889999988654 48899999999999999998 999998765433333332211100  


Q ss_pred             ccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          140 ADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                                 .....+++++.++|.+||+.||.+|||+.+++++
T Consensus       268 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          268 ---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence                                       1122577889999999999999999999999874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.98  E-value=2e-32  Score=227.31  Aligned_cols=168  Identities=22%  Similarity=0.296  Sum_probs=136.0

Q ss_pred             CccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCe
Q 025683            2 DTDLYQIIRSN------------------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL   57 (249)
Q Consensus         2 ~~~L~~~l~~~------------------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~   57 (249)
                      ||+|.+++.+.                        ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus       134 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~  213 (343)
T 1luf_A          134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV  213 (343)
T ss_dssp             TCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             CCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeE
Confidence            57999999874                        579999999999999999999999999999999999999999999


Q ss_pred             EEeecCCccCCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 025683           58 KICDFGLARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIEL  133 (249)
Q Consensus        58 kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  133 (249)
                      +|+|||.+.......   ......++..|+|||.+.... ++.++|+||||+++|+|++ |..||.+.........+...
T Consensus       214 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  292 (343)
T 1luf_A          214 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG  292 (343)
T ss_dssp             EECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred             EEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCC
Confidence            999999986543221   122346688899999986544 8899999999999999998 99999877655444433221


Q ss_pred             hCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      .                              .......+++++.++|.+||+.||.+|||+.+++++
T Consensus       293 ~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          293 N------------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             C------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            0                              011223577899999999999999999999999863

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.98  E-value=1.3e-32  Score=223.15  Aligned_cols=164  Identities=17%  Similarity=0.223  Sum_probs=131.3

Q ss_pred             CccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC--------eEEeecCCccCCCCCC
Q 025683            2 DTDLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD--------LKICDFGLARPTSENE   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~-l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~--------~kL~dfg~~~~~~~~~   72 (249)
                      |++|.+++.+.+. +++..+..++.||+.||.|||++|++||||||+||+++.++.        ++|+|||.+...... 
T Consensus        96 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-  174 (289)
T 4fvq_A           96 FGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-  174 (289)
T ss_dssp             TCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc-
Confidence            6899999998754 999999999999999999999999999999999999998887        999999998654332 


Q ss_pred             ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        73 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                        ....++..|+|||.+.+...++.++||||||+++|+|++|. .||....... ........                 
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~-----------------  234 (289)
T 4fvq_A          175 --DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDR-----------------  234 (289)
T ss_dssp             --HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTT-----------------
T ss_pred             --cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhcc-----------------
Confidence              23456888999999976456899999999999999999965 4454443322 22222110                 


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                    ...+...++++.+++.+||+.||.+|||+.+++++
T Consensus       235 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 --------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             --------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                          11122456779999999999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.98  E-value=1.9e-32  Score=224.72  Aligned_cols=168  Identities=24%  Similarity=0.355  Sum_probs=136.2

Q ss_pred             CccHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCe
Q 025683            2 DTDLYQIIRSNQS------------------------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL   57 (249)
Q Consensus         2 ~~~L~~~l~~~~~------------------------l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~   57 (249)
                      |++|.+++.+...                        +++..+..++.||+.||.|||++|++|+||||+||+++.++.+
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~  189 (314)
T 2ivs_A          110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM  189 (314)
T ss_dssp             TCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEE
T ss_pred             CCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCE
Confidence            6899999987543                        8999999999999999999999999999999999999999999


Q ss_pred             EEeecCCccCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 025683           58 KICDFGLARPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIEL  133 (249)
Q Consensus        58 kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  133 (249)
                      +|+|||.+........   .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.+.........+...
T Consensus       190 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  268 (314)
T 2ivs_A          190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG  268 (314)
T ss_dssp             EECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             EEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC
Confidence            9999999876543321   2234557889999998654 47899999999999999999 99999876644333332210


Q ss_pred             hCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      .                              .......+++++.++|.+||+.||.+|||+.+++++
T Consensus       269 ~------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          269 H------------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             C------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C------------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            0                              011223578899999999999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=2.1e-32  Score=227.47  Aligned_cols=169  Identities=27%  Similarity=0.366  Sum_probs=135.3

Q ss_pred             CccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeE
Q 025683            2 DTDLYQIIRSNQ-----------------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK   58 (249)
Q Consensus         2 ~~~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~k   58 (249)
                      ||+|.+++....                       .+++..+..++.||+.||.|||++|++||||||+||+++.++.++
T Consensus       133 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k  212 (344)
T 1rjb_A          133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK  212 (344)
T ss_dssp             TCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEE
T ss_pred             CCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEE
Confidence            679999998753                       389999999999999999999999999999999999999999999


Q ss_pred             EeecCCccCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 025683           59 ICDFGLARPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELL  134 (249)
Q Consensus        59 L~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~  134 (249)
                      |+|||.+........   .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.+.........+....
T Consensus       213 L~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  291 (344)
T 1rjb_A          213 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG  291 (344)
T ss_dssp             ECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT
T ss_pred             eCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcC
Confidence            999999875533221   2234567889999998654 48899999999999999998 999998765433333322211


Q ss_pred             CCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          135 GTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ..                             .......++++.+||.+||+.||.+|||+.+++++
T Consensus       292 ~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          292 FK-----------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             CC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC-----------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            00                             01123467889999999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.98  E-value=2.5e-32  Score=220.86  Aligned_cols=168  Identities=21%  Similarity=0.322  Sum_probs=134.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--ccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~   78 (249)
                      |++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........  .....
T Consensus        96 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  175 (281)
T 3cc6_A           96 YGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR  175 (281)
T ss_dssp             TCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCC
T ss_pred             CCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCC
Confidence            68999999775 5699999999999999999999999999999999999999999999999999876544321  22345


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+... .++.++|+||||+++|+|++ |..||...........+......                     
T Consensus       176 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---------------------  233 (281)
T 3cc6_A          176 LPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---------------------  233 (281)
T ss_dssp             CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---------------------
T ss_pred             CCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---------------------
Confidence            57789999998644 47899999999999999998 99999766544443333221100                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                               .....+++.+.++|.+||+.||.+|||+.+++++
T Consensus       234 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 ---------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                     1122467889999999999999999999999874

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.98  E-value=5.1e-32  Score=221.08  Aligned_cols=194  Identities=24%  Similarity=0.417  Sum_probs=137.3

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc---CCCeEEeecCCccCCCCCCcccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~---~~~~kL~dfg~~~~~~~~~~~~~   76 (249)
                      |++|.+++.+..  .+++..+..++.||+.||+|||++|++|+||||+||+++.   ++.++|+|||.+....       
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-------  171 (299)
T 3m2w_A           99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------  171 (299)
T ss_dssp             SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-------
Confidence            679999998864  6999999999999999999999999999999999999998   7889999999875322       


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                                     ...++.++|+|||||++|+|++|..||...........+..                       .
T Consensus       172 ---------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-----------------------~  213 (299)
T 3m2w_A          172 ---------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-----------------------R  213 (299)
T ss_dssp             ---------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-----------------------S
T ss_pred             ---------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-----------------------H
Confidence                           12367899999999999999999999976542211100000                       0


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHH
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM  236 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (249)
                      ............+..+++++.+||.+||+.||.+|||+.++++||||++.......+.   .......+.....+++.+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  290 (299)
T 3m2w_A          214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL---HTSRVLKEDKERWEDVKEE  290 (299)
T ss_dssp             SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC---SHHHHHHHTGGGHHHHHHH
T ss_pred             HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC---cccccchhhcchHHHHHHH
Confidence            0000000001112467899999999999999999999999999999998654333332   1112223334444556655


Q ss_pred             HHHHHHH
Q 025683          237 IYQEALA  243 (249)
Q Consensus       237 ~~~~~~~  243 (249)
                      +.++...
T Consensus       291 ~~~~l~~  297 (299)
T 3m2w_A          291 MTSALAT  297 (299)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            5555443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.98  E-value=3.4e-32  Score=223.40  Aligned_cols=169  Identities=27%  Similarity=0.415  Sum_probs=136.2

Q ss_pred             CccHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSNQS----------------LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~~~----------------l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      |++|.+++.....                +++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+
T Consensus       116 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  195 (316)
T 2xir_A          116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA  195 (316)
T ss_dssp             TEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGG
T ss_pred             CCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccc
Confidence            5799999988654                899999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      ........   .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.+................     
T Consensus       196 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-----  269 (316)
T 2xir_A          196 RDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-----  269 (316)
T ss_dssp             SCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-----
T ss_pred             cccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc-----
Confidence            76543321   2234568889999998654 47899999999999999998 99999776533322222221110     


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                              ......+++++.+++.+||+.||.+|||+.++++|
T Consensus       270 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          270 ------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    01123467889999999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.98  E-value=1.3e-31  Score=219.66  Aligned_cols=175  Identities=26%  Similarity=0.404  Sum_probs=136.0

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc------
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM------   74 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~------   74 (249)
                      |++|.+++.+ ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.........      
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  170 (310)
T 3s95_A           91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS  170 (310)
T ss_dssp             TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----------
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccc
Confidence            6799999998 578999999999999999999999999999999999999999999999999998765432211      


Q ss_pred             ---------ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           75 ---------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        75 ---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                               ....||+.|+|||.+.+. .++.++||||||+++|+|++|..||.......                .  .
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~----------------~--~  231 (310)
T 3s95_A          171 LKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT----------------M--D  231 (310)
T ss_dssp             ---------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC----------------T--T
T ss_pred             ccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH----------------H--H
Confidence                     145789999999998654 48899999999999999999998886532100                0  0


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      ..........          ....+.+++.+.+++.+||+.||.+|||+.++++  +++.+.
T Consensus       232 ~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          232 FGLNVRGFLD----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             SSBCHHHHHH----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             Hhhhhhcccc----------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence            0000011111          1123467888999999999999999999999987  555543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.98  E-value=4.5e-32  Score=222.62  Aligned_cols=168  Identities=20%  Similarity=0.301  Sum_probs=130.7

Q ss_pred             CccHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--
Q 025683            2 DTDLYQIIR------SNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--   73 (249)
Q Consensus         2 ~~~L~~~l~------~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--   73 (249)
                      |++|.+++.      ....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+........  
T Consensus       125 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  204 (313)
T 3brb_A          125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR  204 (313)
T ss_dssp             TCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------
T ss_pred             CCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccC
Confidence            579999994      336799999999999999999999999999999999999999999999999999876543321  


Q ss_pred             -cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           74 -MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        74 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                       .....+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+.....                
T Consensus       205 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------  267 (313)
T 3brb_A          205 QGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR----------------  267 (313)
T ss_dssp             ------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------
T ss_pred             cccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC----------------
Confidence             1234557789999998654 48899999999999999999 8899987765444433322100                


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                    ......+++++.++|.+||+.||.+|||+.+++++
T Consensus       268 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 --------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             --------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                          11223577889999999999999999999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.98  E-value=4.5e-32  Score=218.08  Aligned_cols=167  Identities=26%  Similarity=0.363  Sum_probs=129.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCCCCeeecc--------CCCeEEeecCCccCCCC
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLLNA--------NCDLKICDFGLARPTSE   70 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~---i~H~dik~~nil~~~--------~~~~kL~dfg~~~~~~~   70 (249)
                      |++|.+++.. +.+++..+..++.||+.||.|||++|   ++||||||+||+++.        ++.++|+|||.+.....
T Consensus        90 ~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  168 (271)
T 3dtc_A           90 GGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR  168 (271)
T ss_dssp             TEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC------
T ss_pred             CCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccc
Confidence            6889998864 68999999999999999999999999   889999999999986        67899999999876544


Q ss_pred             CCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhH
Q 025683           71 NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDA  150 (249)
Q Consensus        71 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (249)
                      .. .....+++.|+|||.+.+. .++.++|+||||+++++|++|..||.+.........+.....               
T Consensus       169 ~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  231 (271)
T 3dtc_A          169 TT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL---------------  231 (271)
T ss_dssp             --------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC---------------
T ss_pred             cc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC---------------
Confidence            33 2345789999999998654 488999999999999999999999988765544433321100               


Q ss_pred             HHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                    .......+++.+.+++.+||+.||.+|||+.+++++
T Consensus       232 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          232 --------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                          011223577889999999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.98  E-value=4.8e-32  Score=223.24  Aligned_cols=168  Identities=22%  Similarity=0.375  Sum_probs=136.5

Q ss_pred             CccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC
Q 025683            2 DTDLYQIIRSN----------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (249)
Q Consensus         2 ~~~L~~~l~~~----------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~   71 (249)
                      ||+|.+++.+.          ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+......
T Consensus       112 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~  191 (322)
T 1p4o_A          112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET  191 (322)
T ss_dssp             TCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred             CCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccc
Confidence            57999999763          46799999999999999999999999999999999999999999999999998754332


Q ss_pred             Cc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           72 EF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        72 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                      ..   .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...........+....             
T Consensus       192 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------------  257 (322)
T 1p4o_A          192 DYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-------------  257 (322)
T ss_dssp             GCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-------------
T ss_pred             cccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-------------
Confidence            21   2234567889999998654 47899999999999999999 899998776554444433210             


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                       .......+++.+.++|.+||+.||.+|||+.+++++
T Consensus       258 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 -----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                             011223578889999999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.98  E-value=4.1e-32  Score=221.41  Aligned_cols=174  Identities=24%  Similarity=0.348  Sum_probs=129.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh--------hCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH--------SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH--------~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~   73 (249)
                      ||+|.+++.+ ..+++..+..++.||+.||+|||        ++|++||||||+||+++.++.+||+|||.+........
T Consensus        90 ~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  168 (301)
T 3q4u_A           90 MGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN  168 (301)
T ss_dssp             TCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             CCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccc
Confidence            6799999965 68999999999999999999999        99999999999999999999999999999865433221


Q ss_pred             -----cccccccccccCchhccCCCC-----CCchhHHHHHHHHHHHHHhC----------CCCCCCCC----hHHHHHH
Q 025683           74 -----MTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELMNR----------RPLFPGND----HVHQMRL  129 (249)
Q Consensus        74 -----~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~~l~~l~~g----------~~p~~~~~----~~~~~~~  129 (249)
                           .....+|+.|+|||.+.+...     ++.++|||||||++|+|++|          ..||....    .......
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~  248 (301)
T 3q4u_A          169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK  248 (301)
T ss_dssp             EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred             cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhH
Confidence                 223478999999999865432     34689999999999999999          77775432    1111211


Q ss_pred             HHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      .......                       .+...........++++.+|+.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          249 VVCVDQQ-----------------------RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HHTTSCC-----------------------CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHhccCC-----------------------CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            1111110                       0011111111224567899999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.98  E-value=2.8e-32  Score=235.90  Aligned_cols=172  Identities=17%  Similarity=0.210  Sum_probs=137.7

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee---ccCCCeEEeecCCccCCCCCCc---
Q 025683            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKICDFGLARPTSENEF---   73 (249)
Q Consensus         1 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~---~~~~~~kL~dfg~~~~~~~~~~---   73 (249)
                      +|++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||++   +.++.+||+|||+++.......   
T Consensus        85 ~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (483)
T 3sv0_A           85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH  164 (483)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence            58999999986 4789999999999999999999999999999999999999   6889999999999976543321   


Q ss_pred             -----cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCccccccc
Q 025683           74 -----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV---HQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        74 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  145 (249)
                           .....|+..|+|||.+.+.. ++.++|||||||++|+|++|..||.+....   ..+..+.....          
T Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----------  233 (483)
T 3sv0_A          165 IPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----------  233 (483)
T ss_dssp             CCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----------
T ss_pred             cccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----------
Confidence                 12467899999999986554 889999999999999999999999875432   22222211100          


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                      ......+...+++++.+||..||+.||.+||++.+|++
T Consensus       234 ----------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          234 ----------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             ----------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ----------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                            01112333467899999999999999999999998875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.98  E-value=4.9e-32  Score=233.40  Aligned_cols=167  Identities=28%  Similarity=0.406  Sum_probs=137.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      ||+|.+++.+.  ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.......  ....
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~  345 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  345 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSS
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCC
Confidence            68999999864  3799999999999999999999999999999999999999999999999999976543221  1223


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++|||||||++|+|++ |..||.+.........+......+                   
T Consensus       346 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------------------  405 (454)
T 1qcf_A          346 KFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-------------------  405 (454)
T ss_dssp             SSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-------------------
T ss_pred             cccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence            456789999998644 48899999999999999999 999999887666655554321111                   


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                 .+..+++++.+||.+||+.||.+|||++++++
T Consensus       406 -----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          406 -----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                       12257788999999999999999999999976

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.98  E-value=1.6e-31  Score=214.62  Aligned_cols=165  Identities=16%  Similarity=0.290  Sum_probs=134.9

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~   77 (249)
                      ||+|.+++.+..  .+++..+..++.||+.||+|||++|  ++|+||||+||+++.++.++++||+++.....    ...
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----~~~  168 (271)
T 3kmu_A           93 YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGR  168 (271)
T ss_dssp             TCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----TTC
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc----cCc
Confidence            579999999865  4999999999999999999999999  99999999999999999999998887654322    235


Q ss_pred             cccccccCchhccCCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           78 VVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      .+|+.|+|||.+.+...  .+.++||||||+++|+|++|..||...........+......                   
T Consensus       169 ~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  229 (271)
T 3kmu_A          169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-------------------  229 (271)
T ss_dssp             BSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-------------------
T ss_pred             cCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-------------------
Confidence            67899999999875432  334899999999999999999999887765554444321100                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ...+..+++++.+++.+||+.||.+|||++++++
T Consensus       230 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          230 ----------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      1123357889999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.98  E-value=2.6e-32  Score=220.73  Aligned_cols=169  Identities=26%  Similarity=0.350  Sum_probs=138.0

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      |++|.+++.+.  ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.............+
T Consensus       104 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  183 (284)
T 2a19_B          104 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG  183 (284)
T ss_dssp             SCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCS
T ss_pred             CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCC
Confidence            56999999764  6799999999999999999999999999999999999999999999999999877655544455678


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      ++.|+|||.+.+. .++.++|+||||+++|+|++|..|+....      .....+                   ..    
T Consensus       184 ~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~------~~~~~~-------------------~~----  233 (284)
T 2a19_B          184 TLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS------KFFTDL-------------------RD----  233 (284)
T ss_dssp             CCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH------HHHHHH-------------------HT----
T ss_pred             cccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH------HHHHHh-------------------hc----
Confidence            9999999998654 47899999999999999999988763211      111000                   00    


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                            ..+...+++.+.++|.+||+.||.+|||+.+++++.+.-.-
T Consensus       234 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          234 ------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             ------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence                  01123477889999999999999999999999999776543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.98  E-value=2.2e-31  Score=215.85  Aligned_cols=167  Identities=20%  Similarity=0.335  Sum_probs=133.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeeccCCC-----eEEeecCCccCCCCCCc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCD-----LKICDFGLARPTSENEF   73 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~~~~~-----~kL~dfg~~~~~~~~~~   73 (249)
                      |++|.+++.+. ..+++..+..++.||+.||+|||++|  ++|+||||+||+++.++.     ++|+|||.+.....  .
T Consensus       105 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~  182 (287)
T 4f0f_A          105 CGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--S  182 (287)
T ss_dssp             TCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--C
T ss_pred             CCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--c
Confidence            58999988765 57999999999999999999999999  999999999999988776     99999999875443  2


Q ss_pred             cccccccccccCchhccC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCcccccccchhhH
Q 025683           74 MTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ--MRLLIELLGTPTDADLGFVRNEDA  150 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  150 (249)
                      .....+++.|+|||.+.. ...++.++|+||||+++|+|++|..||........  ...+.. .+..             
T Consensus       183 ~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~-------------  248 (287)
T 4f0f_A          183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGLR-------------  248 (287)
T ss_dssp             EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SCCC-------------
T ss_pred             ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cCCC-------------
Confidence            335678999999998843 33467899999999999999999999976543222  111111 1100             


Q ss_pred             HHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          151 KRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                     ......+++++.++|.+||+.||.+|||+.++++
T Consensus       249 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          249 ---------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                           1123367889999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=4.4e-32  Score=220.14  Aligned_cols=168  Identities=20%  Similarity=0.277  Sum_probs=137.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~   76 (249)
                      |++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+........    ...
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  172 (287)
T 1u59_A           93 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  172 (287)
T ss_dssp             TEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred             CCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccc
Confidence            57999999764 5699999999999999999999999999999999999999999999999999876543321    122


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+... .++.++|+||||+++|+|++ |..||...........+....                     
T Consensus       173 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~---------------------  230 (287)
T 1u59_A          173 GKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---------------------  230 (287)
T ss_dssp             SCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC---------------------
T ss_pred             ccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC---------------------
Confidence            3457889999998644 47889999999999999998 999998876555444433210                     


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                               ....+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       231 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          231 ---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                     011233678999999999999999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=5.6e-32  Score=232.78  Aligned_cols=165  Identities=22%  Similarity=0.343  Sum_probs=133.6

Q ss_pred             CccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ||+|.+++.+.+.  +++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++......  ....+
T Consensus       271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~  348 (450)
T 1k9a_A          271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKL  348 (450)
T ss_dssp             TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------CC
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--cCCCC
Confidence            6799999987643  8999999999999999999999999999999999999999999999999987543322  22355


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +..|+|||.+... .++.++||||||+++|+|++ |..||...........+.....                       
T Consensus       349 ~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----------------------  404 (450)
T 1k9a_A          349 PVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------------------  404 (450)
T ss_dssp             CTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-----------------------
T ss_pred             CcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence            7889999998654 48999999999999999998 9999987654444433321100                       


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                             ...+..+++++.++|.+||+.||.+|||+.++++
T Consensus       405 -------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          405 -------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                   1123357889999999999999999999999975

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=3.4e-32  Score=229.14  Aligned_cols=167  Identities=22%  Similarity=0.349  Sum_probs=134.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc---ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM---TEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~---~~~   77 (249)
                      ||+|.+++.+. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.........   ...
T Consensus       196 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~  275 (377)
T 3cbl_A          196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLR  275 (377)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCC
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCC
Confidence            68999999875 46999999999999999999999999999999999999999999999999998764433211   112


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++|||||||++|+|++ |..||...........+.....                     
T Consensus       276 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------------  333 (377)
T 3cbl_A          276 QVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---------------------  333 (377)
T ss_dssp             EEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC---------------------
T ss_pred             CCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            346779999998644 47899999999999999998 9999988765544433321100                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ...+...++++.++|.+||+.||.+|||+.++++
T Consensus       334 ---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 ---------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                     0112346788999999999999999999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2e-31  Score=217.11  Aligned_cols=167  Identities=26%  Similarity=0.369  Sum_probs=132.7

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-----ccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-----FMT   75 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-----~~~   75 (249)
                      |++|.+++.+ ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+.......     ...
T Consensus       107 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  186 (298)
T 3pls_A          107 HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR  186 (298)
T ss_dssp             TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSS
T ss_pred             CCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCc
Confidence            7899999987 4679999999999999999999999999999999999999999999999999997554322     122


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++|. +||...+.......+.....                   
T Consensus       187 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-------------------  246 (298)
T 3pls_A          187 HARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-------------------  246 (298)
T ss_dssp             CTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-------------------
T ss_pred             CCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-------------------
Confidence            34568889999998644 4789999999999999999955 55554443333322221100                   


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                 ......+++.+.+++.+||+.||.+|||+.++++
T Consensus       247 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          247 -----------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                       0112356788999999999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=8.7e-32  Score=215.86  Aligned_cols=168  Identities=20%  Similarity=0.301  Sum_probs=136.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--cccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~   78 (249)
                      |++|.+++.+. +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.......  ......
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  166 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  166 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccccccc
Confidence            67999999875 569999999999999999999999999999999999999999999999999987654321  122345


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ++..|+|||.+... .++.++|+||||+++|+|++ |..||...........+.....                      
T Consensus       167 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~----------------------  223 (267)
T 3t9t_A          167 FPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------------------  223 (267)
T ss_dssp             CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------------------
T ss_pred             ccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc----------------------
Confidence            57789999998654 47899999999999999999 8999988765555444432110                      


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                              .......++.+.+++.+||+.||.+|||+.+++++
T Consensus       224 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 --------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                    01122467889999999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=1.1e-31  Score=222.49  Aligned_cols=168  Identities=27%  Similarity=0.413  Sum_probs=137.1

Q ss_pred             CccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSNQ----------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      ||+|.+++....                .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+
T Consensus       125 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  204 (334)
T 2pvf_A          125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA  204 (334)
T ss_dssp             TCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEcccccc
Confidence            679999998754                3899999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      ........   .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+.........+.....      
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------  277 (334)
T 2pvf_A          205 RDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR------  277 (334)
T ss_dssp             EECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC------
T ss_pred             ccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC------
Confidence            76544321   2234557889999998654 37899999999999999999 9999987765544443332110      


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                              ......+++++.++|.+||+.||.+|||+.+++++
T Consensus       278 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          278 ------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                    11223577889999999999999999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=4e-32  Score=224.68  Aligned_cols=168  Identities=26%  Similarity=0.424  Sum_probs=118.1

Q ss_pred             CCccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc-
Q 025683            1 MDTDLYQIIRS---NQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM-   74 (249)
Q Consensus         1 ~~~~L~~~l~~---~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~-   74 (249)
                      ++|+|.+++..   .+.+++..+..++.||+.||.|||++|  ++|+||||+||+++.++.++|+|||.+......... 
T Consensus       116 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  195 (337)
T 3ll6_A          116 CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS  195 (337)
T ss_dssp             CSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC---
T ss_pred             cCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCccc
Confidence            46899999875   467999999999999999999999999  999999999999999999999999999765443211 


Q ss_pred             ------------ccccccccccCchhcc--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcc
Q 025683           75 ------------TEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDA  140 (249)
Q Consensus        75 ------------~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  140 (249)
                                  ....+++.|+|||.+.  ....++.++||||||+++|+|++|..||...........   ...     
T Consensus       196 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~-----  267 (337)
T 3ll6_A          196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG---KYS-----  267 (337)
T ss_dssp             ----------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------CC-----
T ss_pred             ccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC---ccc-----
Confidence                        1345788999999884  234478899999999999999999999965432111100   000     


Q ss_pred             cccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 025683          141 DLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHP  201 (249)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~  201 (249)
                                               .......+..+.+||++||+.||.+|||+.+++++-
T Consensus       268 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          268 -------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             -------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             -------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                                     011224567789999999999999999999999873

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=1.4e-32  Score=226.81  Aligned_cols=187  Identities=24%  Similarity=0.313  Sum_probs=131.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhC----------CcccCCCCCCCeeeccCCCeEEeecCCccCCCCC
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA----------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~----------~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~   71 (249)
                      ||+|.+++.+ ..+++..+..++.||+.||+|||+.          |++||||||+||+++.++.+||+|||.+......
T Consensus       106 ~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~  184 (322)
T 3soc_A          106 KGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG  184 (322)
T ss_dssp             TCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTT
T ss_pred             CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccc
Confidence            6799999987 5699999999999999999999999          9999999999999999999999999999654432


Q ss_pred             C---ccccccccccccCchhccCCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 025683           72 E---FMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (249)
Q Consensus        72 ~---~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (249)
                      .   ......+|+.|+|||.+.+..    .++.++|||||||++|+|++|..||.+................+.      
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~------  258 (322)
T 3soc_A          185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS------  258 (322)
T ss_dssp             SCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC------
T ss_pred             cCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc------
Confidence            2   223357899999999986532    245678999999999999999999976532111000000000000      


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcC--CCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVF--PHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                        ...........  .........+  ...++++.+||.+||+.||.+|||+.++++
T Consensus       259 --~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          259 --LEDMQEVVVHK--KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             --HHHHHHHHTTS--CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --hhhhhhhhhcc--cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence              00011111100  0111111111  112355899999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=1.9e-32  Score=242.94  Aligned_cols=200  Identities=24%  Similarity=0.305  Sum_probs=143.8

Q ss_pred             CccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCC---eEEeecCCccCCCCCCccc
Q 025683            2 DTDLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCD---LKICDFGLARPTSENEFMT   75 (249)
Q Consensus         2 ~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~---~kL~dfg~~~~~~~~~~~~   75 (249)
                      ||+|.+++.+..   .+++..+..++.||+.||+|||++|++||||+|+||+++.++.   ++|+|||.+..........
T Consensus       102 ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~  181 (676)
T 3qa8_A          102 GGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT  181 (676)
T ss_dssp             SCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCC
T ss_pred             CCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccc
Confidence            789999998854   6999999999999999999999999999999999999997765   8999999998776665555


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||...............   ............     ..
T Consensus       182 ~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~---~~~~~~~~~~~l-----~g  252 (676)
T 3qa8_A          182 EFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE---KSNEHIVVYDDL-----TG  252 (676)
T ss_dssp             CCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---------CCSCCCC-----SS
T ss_pred             cccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc---ccchhhhhhhhh-----cc
Confidence            67889999999998644 4889999999999999999999999765433211110000   000000000000     00


Q ss_pred             hCC-CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCC
Q 025683          156 QLP-QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEA  210 (249)
Q Consensus       156 ~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~  210 (249)
                      ... .........+...+++.+.+||.+||.+||.+|||+.++++||||+.+..-.
T Consensus       253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            000 0000011122334678899999999999999999999999999999877433

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.6e-31  Score=220.17  Aligned_cols=168  Identities=22%  Similarity=0.323  Sum_probs=131.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~   76 (249)
                      |++|.+++.+. +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........    ...
T Consensus       130 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  209 (333)
T 1mqb_A          130 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG  209 (333)
T ss_dssp             TEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCC
Confidence            57999999875 6799999999999999999999999999999999999999999999999999876543221    112


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+... .++.++||||||+++|+|++ |..||...........+......                   
T Consensus       210 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-------------------  269 (333)
T 1mqb_A          210 GKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-------------------  269 (333)
T ss_dssp             -CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------------------
T ss_pred             CCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-------------------
Confidence            3446789999998654 48899999999999999998 99999877655544443321100                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                 .....+++.+.+++.+||+.||.+||++.+++++
T Consensus       270 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          270 -----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             -----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                       0122467889999999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=2.2e-31  Score=218.94  Aligned_cols=168  Identities=20%  Similarity=0.288  Sum_probs=131.6

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC------Ccc
Q 025683            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN------EFM   74 (249)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~------~~~   74 (249)
                      |++|.+++.+.+ .+++..+..++.||+.||+|||++|++|+||||+||+++ ++.++|+|||.+......      ...
T Consensus       113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~  191 (319)
T 2y4i_B          113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKL  191 (319)
T ss_dssp             SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccccccc
Confidence            689999998764 799999999999999999999999999999999999998 689999999987654321      222


Q ss_pred             ccccccccccCchhccC--------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccc
Q 025683           75 TEYVVTRWYRAPELLLN--------SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVR  146 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (249)
                      ....++..|+|||.+..        ...++.++||||||+++|+|++|..||...........+.......         
T Consensus       192 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  262 (319)
T 2y4i_B          192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN---------  262 (319)
T ss_dssp             BCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC---------
T ss_pred             ccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC---------
Confidence            33467899999999864        2347889999999999999999999998776554444332211000         


Q ss_pred             hhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          147 NEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                          .....++.++.+++.+||+.||.+|||+.++++
T Consensus       263 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          263 --------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             --------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             --------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                001146788999999999999999999999987

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.97  E-value=7.7e-32  Score=219.46  Aligned_cols=183  Identities=17%  Similarity=0.276  Sum_probs=132.1

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC----cccc
Q 025683            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~   76 (249)
                      |++|.+++.+.+ .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.......    ....
T Consensus        97 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  176 (295)
T 3ugc_A           97 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP  176 (295)
T ss_dssp             TCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------C
T ss_pred             CCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccC
Confidence            689999998864 59999999999999999999999999999999999999999999999999997654332    1223


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|+|||.+.+.. ++.++||||||+++|+|++|..|+......     .....+.......   ...........
T Consensus       177 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~  247 (295)
T 3ugc_A          177 GESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQM---IVFHLIELLKN  247 (295)
T ss_dssp             TTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTHH---HHHHHHHHHHT
T ss_pred             CCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccch---hHHHHHHHHhc
Confidence            44677799999986554 889999999999999999999888543211     1111111111000   00011111111


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ...      ...+..+++++.+++.+||+.||.+|||+.++++
T Consensus       248 ~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          248 NGR------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TCC------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCc------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            111      1123467899999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=3.5e-32  Score=224.70  Aligned_cols=175  Identities=19%  Similarity=0.262  Sum_probs=139.2

Q ss_pred             CccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc---CCCeEEeecCCccCCCCC
Q 025683            2 DTDLYQIIRSNQ-------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSEN   71 (249)
Q Consensus         2 ~~~L~~~l~~~~-------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~---~~~~kL~dfg~~~~~~~~   71 (249)
                      |++|.+++....       .+++..+..++.||+.||.|||++|++||||||+||+++.   +..++|+|||.+......
T Consensus       117 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~  196 (327)
T 2yfx_A          117 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA  196 (327)
T ss_dssp             TEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-
T ss_pred             CCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccc
Confidence            789999998863       4999999999999999999999999999999999999984   446999999988643221


Q ss_pred             ---CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           72 ---EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        72 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                         .......+++.|+|||.+... .++.++||||||+++|+|++ |..||...........+.....            
T Consensus       197 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------------  263 (327)
T 2yfx_A          197 SYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR------------  263 (327)
T ss_dssp             -----CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC------------
T ss_pred             cccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC------------
Confidence               122234668889999998654 47899999999999999998 9999987765544443322110            


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                                        ......+++.+.++|.+||+.||.+|||+.+++++.|+-...
T Consensus       264 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          264 ------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence                              011235778899999999999999999999999998876544

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=1.1e-31  Score=225.73  Aligned_cols=167  Identities=21%  Similarity=0.302  Sum_probs=126.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~   76 (249)
                      ||+|.+++.+. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||.+........    ...
T Consensus       130 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  209 (373)
T 2qol_A          130 NGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG  209 (373)
T ss_dssp             TCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccC
Confidence            68999999876 4799999999999999999999999999999999999999999999999999876543321    112


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+... .++.++||||||+++|+|++ |..||...........+......                   
T Consensus       210 ~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-------------------  269 (373)
T 2qol_A          210 GKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-------------------  269 (373)
T ss_dssp             ----CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-------------------
T ss_pred             CCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence            2346789999998654 48899999999999999997 99999877655544443321110                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                 .....++.++.+++.+||+.||.+||++.++++
T Consensus       270 -----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          270 -----------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             -----------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                       012246788999999999999999999999886

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=7.1e-32  Score=217.89  Aligned_cols=167  Identities=25%  Similarity=0.360  Sum_probs=136.7

Q ss_pred             CccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSNQ--SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      |++|.+++.+..  .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........  ....
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  170 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA  170 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCC
Confidence            689999998643  799999999999999999999999999999999999999999999999999876554322  2234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++|+||||+++++|++ |..||.+.........+.....                     
T Consensus       171 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------------  228 (279)
T 1qpc_A          171 KFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------------------  228 (279)
T ss_dssp             CCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------------------
T ss_pred             CCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---------------------
Confidence            457789999998644 47889999999999999999 9999988776554444332100                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ......+++++.+++.+||+.||.+|||+.++++
T Consensus       229 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 ---------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                     0112357789999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=1.7e-31  Score=217.58  Aligned_cols=167  Identities=25%  Similarity=0.365  Sum_probs=132.9

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-----cc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MT   75 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-----~~   75 (249)
                      ||+|.+++.+. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||.+........     ..
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  190 (298)
T 3f66_A          111 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT  190 (298)
T ss_dssp             TCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC----
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhcccccc
Confidence            57999999874 5699999999999999999999999999999999999999999999999999976543321     22


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ...+++.|+|||.+.+. .++.++|+||||+++++|++ +.+||...........+.....                   
T Consensus       191 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  250 (298)
T 3f66_A          191 GAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------------------  250 (298)
T ss_dssp             -CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-------------------
T ss_pred             CCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-------------------
Confidence            34567789999998654 48899999999999999999 6667766554333333321110                   


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                 ......+++.+.+++.+||+.||.+|||+.++++
T Consensus       251 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 -----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       0112246788999999999999999999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=1.1e-31  Score=217.66  Aligned_cols=167  Identities=24%  Similarity=0.373  Sum_probs=136.3

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      |++|.+++.+.  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........  ....
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  172 (288)
T 3kfa_A           93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  172 (288)
T ss_dssp             TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTE
T ss_pred             CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCC
Confidence            58999999874  4599999999999999999999999999999999999999999999999999876554332  2234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++|+||||+++|+|++ |..||...+.......+.....                     
T Consensus       173 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------------------  230 (288)
T 3kfa_A          173 KFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------------------  230 (288)
T ss_dssp             EECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------------------
T ss_pred             ccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---------------------
Confidence            557789999998654 48899999999999999999 9999987664443333322100                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ...+..+++.+.+++.+||+.||.+|||+.++++
T Consensus       231 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 ---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                     1122357889999999999999999999999976

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2e-31  Score=220.67  Aligned_cols=175  Identities=23%  Similarity=0.302  Sum_probs=127.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhC--------CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF   73 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~--------~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~   73 (249)
                      ||+|.+++.+ ..+++..+..++.|++.||.|||++        |++||||||+||+++.++.+||+|||.+........
T Consensus       119 ~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  197 (337)
T 3mdy_A          119 NGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN  197 (337)
T ss_dssp             TCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccc
Confidence            6799999977 5799999999999999999999999        999999999999999999999999999865543321


Q ss_pred             -----cccccccccccCchhccCCCCCCc-----hhHHHHHHHHHHHHHhC----------CCCCCCCC----hHHHHHH
Q 025683           74 -----MTEYVVTRWYRAPELLLNSSDYTA-----AIDVWSVGCIFMELMNR----------RPLFPGND----HVHQMRL  129 (249)
Q Consensus        74 -----~~~~~~~~~y~aPE~~~~~~~~~~-----~~DiwslG~~l~~l~~g----------~~p~~~~~----~~~~~~~  129 (249)
                           .....||+.|+|||.+.+......     ++|||||||++|+|++|          ..||....    .......
T Consensus       198 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  277 (337)
T 3mdy_A          198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE  277 (337)
T ss_dssp             -----CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred             cccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHH
Confidence                 124578999999999865542222     49999999999999999          55554321    1111111


Q ss_pred             HHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ......                       ..+...........++++.+|+.+||+.||.+|||+.+++++
T Consensus       278 ~~~~~~-----------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          278 IVCIKK-----------------------LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHTTSC-----------------------CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHhhhc-----------------------cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            111000                       000000000111345678999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=1.4e-31  Score=230.32  Aligned_cols=173  Identities=26%  Similarity=0.389  Sum_probs=135.8

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      ||+|.+++.+.  ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++........  ....
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  341 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  341 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCC
Confidence            68999999753  5699999999999999999999999999999999999999999999999999976543321  1223


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++||||||+++|+|++ |..||.+.........+......                    
T Consensus       342 ~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------------------  400 (452)
T 1fmk_A          342 KFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------------  400 (452)
T ss_dssp             -CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------------
T ss_pred             cccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            457789999998654 48899999999999999999 99999887766555444321110                    


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc--CccccC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA--HPYLAR  205 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~--h~~~~~  205 (249)
                                ..+..+++.+.++|.+||+.||.+|||++++++  ..++..
T Consensus       401 ----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          401 ----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                      112357788999999999999999999999987  355544

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=2.5e-31  Score=217.96  Aligned_cols=169  Identities=24%  Similarity=0.365  Sum_probs=128.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~   79 (249)
                      |++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.......  ......+
T Consensus       118 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  197 (309)
T 2h34_A          118 GVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVG  197 (309)
T ss_dssp             CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------C
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCC
Confidence            57999999988899999999999999999999999999999999999999999999999999987654332  2234567


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      +..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+ .  ...                      
T Consensus       198 ~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~--~~~----------------------  251 (309)
T 2h34_A          198 TLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-N--QAI----------------------  251 (309)
T ss_dssp             CGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-H--SCC----------------------
T ss_pred             CcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-c--cCC----------------------
Confidence            8999999988644 4788999999999999999999999876533221111 1  000                      


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-CHHHHhc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-TVDEALA  199 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-t~~~ll~  199 (249)
                         .......+.+++++.++|.+||+.||.+|| |++++++
T Consensus       252 ---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 ---PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ---CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ---CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence               011233456889999999999999999999 8888875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=9.1e-32  Score=226.10  Aligned_cols=168  Identities=25%  Similarity=0.363  Sum_probs=126.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-----cc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MT   75 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-----~~   75 (249)
                      ||+|.+++.+. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........     ..
T Consensus       175 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~  254 (373)
T 3c1x_A          175 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT  254 (373)
T ss_dssp             TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred             CCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccC
Confidence            67999999875 5699999999999999999999999999999999999999999999999999875533221     12


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ...++..|+|||.+... .++.++||||||+++|+|++ |.+||...........+.....                   
T Consensus       255 ~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-------------------  314 (373)
T 3c1x_A          255 GAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------------------  314 (373)
T ss_dssp             ---CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-------------------
T ss_pred             CCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            34557789999998654 48899999999999999999 7788876553333222221000                   


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                 ...+..+++.+.+++.+||+.||.+|||+.+++++
T Consensus       315 -----------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 -----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                       01123577889999999999999999999999873

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=8.7e-31  Score=214.61  Aligned_cols=167  Identities=31%  Similarity=0.462  Sum_probs=126.9

Q ss_pred             CccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCCCCeeeccCCC-eEEeecCCccCCCCCCcc
Q 025683            2 DTDLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLLNANCD-LKICDFGLARPTSENEFM   74 (249)
Q Consensus         2 ~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~---~~i~H~dik~~nil~~~~~~-~kL~dfg~~~~~~~~~~~   74 (249)
                      |++|.+++.+..   .++...+..++.||+.||+|||+   +|++||||||+||+++.++. +||+|||.+......  .
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~  160 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--M  160 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--c
Confidence            689999998764   47899999999999999999999   89999999999999998887 799999998754332  2


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ....+++.|+|||.+.+. .++.++||||||+++|+|++|..||................+.                  
T Consensus       161 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------------  221 (307)
T 2eva_A          161 TNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT------------------  221 (307)
T ss_dssp             ----CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC------------------
T ss_pred             ccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC------------------
Confidence            244689999999998654 4889999999999999999999999754321111000000000                  


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                .......+++.+.+++.+||+.||.+|||++++++
T Consensus       222 ----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          222 ----------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ----------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                      01123357889999999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.97  E-value=1.3e-31  Score=239.08  Aligned_cols=167  Identities=23%  Similarity=0.301  Sum_probs=136.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----cccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~~   77 (249)
                      ||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......    ....
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  532 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  532 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence            689999999989999999999999999999999999999999999999999999999999999876543321    1223


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++|||||||++|+|++ |..||.+.........+.....                     
T Consensus       533 ~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---------------------  590 (635)
T 4fl3_A          533 KWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---------------------  590 (635)
T ss_dssp             --CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------------------
T ss_pred             CCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            457789999999654 48999999999999999998 9999988876655554432111                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ...+..+++++.+||.+||+.||.+|||+.+|++
T Consensus       591 ---------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          591 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                     1122357889999999999999999999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=8.6e-32  Score=217.37  Aligned_cols=165  Identities=21%  Similarity=0.332  Sum_probs=128.4

Q ss_pred             CccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSNQS--LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      |++|.+++.+.+.  +++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......  ....+
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~  176 (278)
T 1byg_A           99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKL  176 (278)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------C
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--cCCCc
Confidence            5699999987543  8999999999999999999999999999999999999999999999999987544322  23456


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +..|+|||.+.+. .++.++|+||||+++++|++ |..||...........+....                        
T Consensus       177 ~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------------------  231 (278)
T 1byg_A          177 PVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------------------  231 (278)
T ss_dssp             CTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC------------------------
T ss_pred             cccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------------------
Confidence            7889999998654 47899999999999999998 999997665433332221100                        


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                            .......+++.+.++|.+||+.||.+|||+.++++
T Consensus       232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 ------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                  01123357889999999999999999999999976

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=8.5e-32  Score=218.53  Aligned_cols=168  Identities=22%  Similarity=0.262  Sum_probs=135.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~   76 (249)
                      |++|.+++.+. +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........    ...
T Consensus       104 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  183 (291)
T 1u46_A          104 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH  183 (291)
T ss_dssp             TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC---
T ss_pred             CCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhcc
Confidence            68999999874 6799999999999999999999999999999999999999999999999999876544321    122


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+... .++.++|+||||+++|+|++ |..||...........+......                   
T Consensus       184 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  243 (291)
T 1u46_A          184 RKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-------------------  243 (291)
T ss_dssp             --CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-------------------
T ss_pred             CCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC-------------------
Confidence            3557789999998654 37889999999999999999 99999887765554444321100                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ......+++++.++|.+||+.||.+|||+.++++
T Consensus       244 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          244 ----------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                      0112357889999999999999999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=1.2e-31  Score=221.80  Aligned_cols=169  Identities=24%  Similarity=0.333  Sum_probs=134.6

Q ss_pred             CccHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683            2 DTDLYQIIRSN--------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus         2 ~~~L~~~l~~~--------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      ||+|.+++.+.              ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+..
T Consensus       134 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  213 (333)
T 2i1m_A          134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD  213 (333)
T ss_dssp             TEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCC
T ss_pred             CCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccc
Confidence            57999999753              4689999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 025683           68 TSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        68 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (249)
                      ......   .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+.........+.......      
T Consensus       214 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------  286 (333)
T 2i1m_A          214 IMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM------  286 (333)
T ss_dssp             GGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC------
T ss_pred             cccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC------
Confidence            433221   2234567789999998654 48899999999999999998 999998765443333333211110      


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                             ..+...++.+.+++.+||+.||.+|||+.+++++
T Consensus       287 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          287 -----------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence                                   0122457889999999999999999999999873

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=2.7e-31  Score=231.03  Aligned_cols=167  Identities=23%  Similarity=0.368  Sum_probs=135.8

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      ||+|.+++.+.  ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++........  ....
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  379 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  379 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTC
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCC
Confidence            68999999874  4699999999999999999999999999999999999999999999999999986543321  1223


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++|||||||++|+|++ |..||.+.+.......+.....                     
T Consensus       380 ~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------------  437 (495)
T 1opk_A          380 KFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------------------  437 (495)
T ss_dssp             CCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------------------
T ss_pred             cCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            446789999998644 47899999999999999998 9999987765444333321100                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       438 ---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          438 ---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                     0123357889999999999999999999999976

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=3.7e-31  Score=215.95  Aligned_cols=182  Identities=20%  Similarity=0.365  Sum_probs=135.1

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC----cccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~   76 (249)
                      |++|.+++.+ ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......    ....
T Consensus       109 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  188 (302)
T 4e5w_A          109 SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD  188 (302)
T ss_dssp             TCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCC
T ss_pred             CCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCC
Confidence            6799999955 4679999999999999999999999999999999999999999999999999987655432    1233


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|+|||.+.+.. ++.++|+||||+++|+|++|..|+....     .......+......    ...........
T Consensus       189 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~~  258 (302)
T 4e5w_A          189 RDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQM----TVTRLVNTLKE  258 (302)
T ss_dssp             TTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGGG----HHHHHHHHHHT
T ss_pred             CCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCccccc----CHHHHHHHHhc
Confidence            46678899999986543 7889999999999999999998864321     11122222111110    01111111111


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ..      ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus       259 ~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          259 GK------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TC------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cC------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            11      11233468899999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=1.2e-31  Score=219.34  Aligned_cols=181  Identities=22%  Similarity=0.324  Sum_probs=133.8

Q ss_pred             CccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---ccc
Q 025683            2 DTDLYQIIRS---NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FMT   75 (249)
Q Consensus         2 ~~~L~~~l~~---~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---~~~   75 (249)
                      |++|.+++..   ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus       114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  193 (307)
T 2nru_A          114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS  193 (307)
T ss_dssp             TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECS
T ss_pred             CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccccc
Confidence            6899999974   3569999999999999999999999999999999999999999999999999987654322   123


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...+++.|+|||.+.+  .++.++|+||||+++|+|++|..||...........+.........         ....+..
T Consensus       194 ~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~  262 (307)
T 2nru_A          194 RIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK---------TIEDYID  262 (307)
T ss_dssp             SCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC---------CHHHHSC
T ss_pred             ccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh---------hhhhhcc
Confidence            3568999999998853  3788999999999999999999999765432222222211111000         0000000


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      .       .........+..+.+++.+||+.||.+|||+.+++++
T Consensus       263 ~-------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          263 K-------KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             S-------SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             c-------cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0       0011111234668899999999999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=2.3e-32  Score=225.19  Aligned_cols=180  Identities=25%  Similarity=0.322  Sum_probs=132.4

Q ss_pred             CccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC---cc
Q 025683            2 DTDLYQIIRSNQ----SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE---FM   74 (249)
Q Consensus         2 ~~~L~~~l~~~~----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~---~~   74 (249)
                      ||+|.+++....    .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+.......   ..
T Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  198 (321)
T 2qkw_B          119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS  198 (321)
T ss_dssp             TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred             CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            578999887643    59999999999999999999999999999999999999999999999999987543221   22


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCCcccccccchhhHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR---LLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                      ....+++.|+|||.+.+. .++.++||||||+++|+|++|..||....+.....   ........               
T Consensus       199 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------  262 (321)
T 2qkw_B          199 TVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN---------------  262 (321)
T ss_dssp             CCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT---------------
T ss_pred             cccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc---------------
Confidence            334679999999998654 48899999999999999999999997543211000   00000000               


Q ss_pred             HHHHhCCCCCCc-chhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          152 RYIRQLPQHPRQ-SLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       152 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                         ......... ....+.+..+..+.+++.+||+.||.+|||+.+++++
T Consensus       263 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          263 ---GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             ---TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               000000000 0011122345678899999999999999999999975

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=1.6e-31  Score=220.80  Aligned_cols=183  Identities=20%  Similarity=0.298  Sum_probs=135.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC----cccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~   76 (249)
                      |++|.+++.+. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+.......    ....
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  189 (327)
T 3lxl_A          110 SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP  189 (327)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSC
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeecc
Confidence            78999999873 569999999999999999999999999999999999999999999999999997654332    1223


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|+|||.+.+. .++.++||||||+++++|++|..||.........     .......    .............
T Consensus       190 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~----~~~~~~~~~~~~~  259 (327)
T 3lxl_A          190 GQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGCERD----VPALSRLLELLEE  259 (327)
T ss_dssp             CCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC--------CCHHHHHHHHHHT
T ss_pred             CCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hcccccc----cccHHHHHHHhhc
Confidence            4567889999998654 3788999999999999999999998654321110     0000000    0000001111111


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ...      ......+++++.+||.+||+.||.+|||+.+++++
T Consensus       260 ~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          260 GQR------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             TCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccC------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            110      11234678999999999999999999999999764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=1.4e-30  Score=213.36  Aligned_cols=183  Identities=27%  Similarity=0.421  Sum_probs=128.2

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccc
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~   76 (249)
                      |++|.+++..    ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus       116 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  195 (310)
T 2wqm_A          116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS  195 (310)
T ss_dssp             SCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------------
T ss_pred             CCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccc
Confidence            5699999875    4679999999999999999999999999999999999999999999999999987654332 2234


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+... .++.++|+||||+++|+|++|..||.+... .............+.                 
T Consensus       196 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------  257 (310)
T 2wqm_A          196 LVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-----------------  257 (310)
T ss_dssp             ---CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC-----------------
T ss_pred             cCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC-----------------
Confidence            5678999999998654 488999999999999999999999975431 111111111000000                 


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVC  215 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~  215 (249)
                                 .....+++++.++|.+||+.||.+|||+.++++  .++++.....++++
T Consensus       258 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~--~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          258 -----------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD--VAKRMHACTASSLE  304 (310)
T ss_dssp             -----------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHHC----
T ss_pred             -----------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHHHHhhhhhhh
Confidence                       011357889999999999999999999999986  45555555555443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.97  E-value=1e-30  Score=232.63  Aligned_cols=167  Identities=20%  Similarity=0.278  Sum_probs=134.3

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc----cc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM----TE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~----~~   76 (249)
                      ||+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++........    ..
T Consensus       419 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          419 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             TCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            68999999765 56999999999999999999999999999999999999999999999999999865433211    12


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+... .++.++|||||||++|+|++ |..||.+.........+.....                    
T Consensus       499 ~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~--------------------  557 (613)
T 2ozo_A          499 GKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------------------  557 (613)
T ss_dssp             ---CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC--------------------
T ss_pred             CCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            2346789999998644 48999999999999999998 9999988776655554432110                    


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       558 ----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          558 ----------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ----------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                      1123357889999999999999999999999854

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=2e-31  Score=219.94  Aligned_cols=186  Identities=23%  Similarity=0.271  Sum_probs=134.3

Q ss_pred             CccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--
Q 025683            2 DTDLYQIIRSNQ----SLSEEHCQYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--   72 (249)
Q Consensus         2 ~~~L~~~l~~~~----~l~~~~~~~i~~qil~~l~~LH~~---~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--   72 (249)
                      ||+|.+++....    .+++..+..++.||+.||+|||++   |++||||||+||+++.++.++|+|||.+.......  
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  190 (326)
T 3uim_A          111 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH  190 (326)
T ss_dssp             TCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC
T ss_pred             CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccccc
Confidence            679999998753    499999999999999999999999   99999999999999999999999999997654332  


Q ss_pred             ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCcccccccch
Q 025683           73 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN-----DHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        73 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                      ......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...     ........+........   ....  
T Consensus       191 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--  264 (326)
T 3uim_A          191 VTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---LEAL--  264 (326)
T ss_dssp             EECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC---STTS--
T ss_pred             ccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh---hhhh--
Confidence            233355899999999986544 789999999999999999999999521     10000000000000000   0000  


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                                ..  ...........++.+.+++.+||+.||.+|||+.++++|-.-..
T Consensus       265 ----------~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          265 ----------VD--VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             ----------SC--TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             ----------cC--hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence                      00  00000111123467899999999999999999999999765433

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=6.1e-31  Score=230.75  Aligned_cols=173  Identities=26%  Similarity=0.388  Sum_probs=139.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      ||+|.++|.+.  ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++........  ....
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  424 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  424 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCST
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCC
Confidence            67999999753  5699999999999999999999999999999999999999999999999999976543221  1223


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .++..|+|||.+... .++.++|||||||++|+|++ |..||.+.........+......                    
T Consensus       425 ~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------------------  483 (535)
T 2h8h_A          425 KFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------------  483 (535)
T ss_dssp             TSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC--------------------
T ss_pred             cCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            456789999998654 48899999999999999999 99999887766555444321110                    


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC--ccccC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH--PYLAR  205 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h--~~~~~  205 (249)
                                .....+++.+.+||.+||+.||.+|||+++|++.  .++..
T Consensus       484 ----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          484 ----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                      1123577889999999999999999999999873  44443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=222.52  Aligned_cols=188  Identities=20%  Similarity=0.281  Sum_probs=128.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhC---------CcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA---------NVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~---------~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~   72 (249)
                      ||+|.+++... .+++..+..++.||+.||.|||++         |++||||||+||+++.++.+||+|||.+.......
T Consensus        96 ~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~  174 (336)
T 3g2f_A           96 NGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR  174 (336)
T ss_dssp             TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSS
T ss_pred             CCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccccc
Confidence            68999999874 459999999999999999999999         99999999999999999999999999997654321


Q ss_pred             ---------ccccccccccccCchhccCC------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCC
Q 025683           73 ---------FMTEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGCIFMELMNRRPLFPGNDH-VHQMRLLIELLGT  136 (249)
Q Consensus        73 ---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~  136 (249)
                               ......||+.|+|||.+.+.      ..++.++|||||||++|+|++|..||..... ......+....+.
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3g2f_A          175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN  254 (336)
T ss_dssp             CC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCS
T ss_pred             ccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCC
Confidence                     12234689999999998653      2245689999999999999999766533221 0000000000110


Q ss_pred             CCcccccccchhhHHHHHHhCCCCCCcchhhcC---CCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          137 PTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF---PHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      .+.       ............  .+..+...+   ...++++.+||.+||+.||.+|||+.++++
T Consensus       255 ~~~-------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          255 HPT-------FEDMQVLVSREK--QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             SCC-------HHHHHHHHTTSC--CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             Cch-------HHHHHhhhcccc--cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            000       000111111111  111111111   113457999999999999999999999966

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.3e-32  Score=231.63  Aligned_cols=192  Identities=20%  Similarity=0.335  Sum_probs=136.3

Q ss_pred             CccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeee----ccCCCeEEeecCCccCCCCCCcc
Q 025683            2 DTDLYQIIRSNQ---SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL----NANCDLKICDFGLARPTSENEFM   74 (249)
Q Consensus         2 ~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~----~~~~~~kL~dfg~~~~~~~~~~~   74 (249)
                      ||+|.+++.+..   .+++..+..++.||+.||+|||++|++||||||+||++    +.++.+||+|||.+.........
T Consensus        93 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~  172 (396)
T 4eut_A           93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF  172 (396)
T ss_dssp             TEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGS
T ss_pred             CCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCcc
Confidence            689999998753   39999999999999999999999999999999999999    67778999999999877665555


Q ss_pred             ccccccccccCchhccCC-------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCCccccc
Q 025683           75 TEYVVTRWYRAPELLLNS-------SDYTAAIDVWSVGCIFMELMNRRPLFPGND----HVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~  143 (249)
                      ....+++.|+|||.+...       ..++.++|||||||++|+|++|..||....    ....+..+.   ...+...+.
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~---~~~p~~~~~  249 (396)
T 4eut_A          173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII---TGKPSGAIS  249 (396)
T ss_dssp             SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH---HSCCTTCCE
T ss_pred             ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh---cCCCcccch
Confidence            567789999999988531       236779999999999999999999996432    223333322   222221111


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ......... ......  ......+...+++.+.+++++||..||.+|||+.++++
T Consensus       250 ~~~~~~~~~-~~~~~~--~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          250 GVQKAENGP-IDWSGD--MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             EEECSTTCC-EEEESS--CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             hheeccCCC-cccCcc--CCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            110000000 000000  00001112234567889999999999999999999865

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=2.3e-30  Score=231.75  Aligned_cols=167  Identities=25%  Similarity=0.377  Sum_probs=136.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc--cccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM--TEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~   78 (249)
                      ||+|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+.........  ....
T Consensus       474 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  553 (656)
T 2j0j_A          474 LGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK  553 (656)
T ss_dssp             TCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCC
Confidence            68999999875 47999999999999999999999999999999999999999999999999999866443221  2234


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +++.|+|||.+... .++.++||||||+++|+|++ |..||.+.........+......                     
T Consensus       554 ~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---------------------  611 (656)
T 2j0j_A          554 LPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---------------------  611 (656)
T ss_dssp             CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---------------------
T ss_pred             CCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---------------------
Confidence            57789999998654 48899999999999999997 99999888766655555431110                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                               ..++.+++.+.++|.+||+.||.+|||+.++++
T Consensus       612 ---------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          612 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                     122357789999999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=3.2e-31  Score=217.85  Aligned_cols=171  Identities=26%  Similarity=0.378  Sum_probs=130.4

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----   73 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----   73 (249)
                      ||+|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........    
T Consensus       114 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~  193 (317)
T 2buj_A          114 RGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ  193 (317)
T ss_dssp             TCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHH
T ss_pred             CCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccc
Confidence            5799999986    47799999999999999999999999999999999999999999999999998765432111    


Q ss_pred             ------cccccccccccCchhccCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 025683           74 ------MTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFV  145 (249)
Q Consensus        74 ------~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (249)
                            .....+++.|+|||.+....  .++.++||||||+++|+|++|..||.......                    
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------------------  253 (317)
T 2buj_A          194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--------------------  253 (317)
T ss_dssp             HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT--------------------
T ss_pred             cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc--------------------
Confidence                  11234588999999886433  25789999999999999999999984211000                    


Q ss_pred             chhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          146 RNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                        ............      ......+++++.++|.+||+.||.+|||+.+++++
T Consensus       254 --~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          254 --DSVALAVQNQLS------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             --SCHHHHHHCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --chhhHHhhccCC------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence              000000000000      01123578899999999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=1.8e-30  Score=215.42  Aligned_cols=175  Identities=21%  Similarity=0.241  Sum_probs=129.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh--------hCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH--------SANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH--------~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-   72 (249)
                      ||+|.+++.+ ..+++..+..++.||+.||.|||        ++|++|+||||+||+++.++.++|+|||.+....... 
T Consensus       124 ~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  202 (342)
T 1b6c_B          124 HGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD  202 (342)
T ss_dssp             TCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             CCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccccc
Confidence            5799999987 57999999999999999999999        8999999999999999999999999999986544332 


Q ss_pred             ----ccccccccccccCchhccCCCCC-----CchhHHHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHH
Q 025683           73 ----FMTEYVVTRWYRAPELLLNSSDY-----TAAIDVWSVGCIFMELMNR----------RPLFPGNDH----VHQMRL  129 (249)
Q Consensus        73 ----~~~~~~~~~~y~aPE~~~~~~~~-----~~~~DiwslG~~l~~l~~g----------~~p~~~~~~----~~~~~~  129 (249)
                          ......+++.|+|||.+.+....     +.++||||||+++|+|++|          ..||.....    ......
T Consensus       203 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  282 (342)
T 1b6c_B          203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK  282 (342)
T ss_dssp             EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred             ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHH
Confidence                12345789999999998654322     2689999999999999999          677754321    111111


Q ss_pred             HHHHhCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ........+                       .....-.....++.+.+++.+||+.||.+|||+.+++++
T Consensus       283 ~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          283 VVCEQKLRP-----------------------NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHTTSCCCC-----------------------CCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCC-----------------------CCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            110000000                       000000011233568899999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=1.3e-30  Score=214.49  Aligned_cols=181  Identities=23%  Similarity=0.305  Sum_probs=133.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----cccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~~   77 (249)
                      |++|.+++.+. .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........    ....
T Consensus       119 ~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  197 (318)
T 3lxp_A          119 LGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG  197 (318)
T ss_dssp             TCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---C
T ss_pred             CCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCC
Confidence            57999999874 599999999999999999999999999999999999999999999999999976654321    2234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|+|||.+.+.. ++.++||||||+++|+|++|..||.......     .........    ..............
T Consensus       198 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          198 DSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQG----QMTVLRLTELLERG  267 (318)
T ss_dssp             CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCH----HHHHHHHHHHHHTT
T ss_pred             CCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhccccc----chhHHHHHHHHhcc
Confidence            5678899999986543 7889999999999999999999986532110     000000000    00000111111111


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ..      ......+++++.+||++||+.||.+|||+.++++
T Consensus       268 ~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          268 ER------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cC------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            11      1123467899999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=9.3e-31  Score=219.36  Aligned_cols=162  Identities=17%  Similarity=0.254  Sum_probs=127.2

Q ss_pred             CccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-----------CCCeEEeecCCc
Q 025683            2 DTDLYQIIRS-----NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-----------NCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~-----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-----------~~~~kL~dfg~~   65 (249)
                      ||+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+||+++.           ++.+||+|||.+
T Consensus       151 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a  230 (365)
T 3e7e_A          151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS  230 (365)
T ss_dssp             SCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTC
T ss_pred             CCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchh
Confidence            6899999984     567999999999999999999999999999999999999998           899999999999


Q ss_pred             cCC---CCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccc
Q 025683           66 RPT---SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADL  142 (249)
Q Consensus        66 ~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  142 (249)
                      ...   ..........||+.|+|||.+.+.. ++.++|||||||++|+|++|..||......              ....
T Consensus       231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~--------------~~~~  295 (365)
T 3e7e_A          231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG--------------ECKP  295 (365)
T ss_dssp             EEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT--------------EEEE
T ss_pred             hhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC--------------ceee
Confidence            543   2233344567899999999997654 899999999999999999999998543210              0000


Q ss_pred             cccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          143 GFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                         ...+...  ..++.+.+++..||+.+|.+|++..+.+.
T Consensus       296 -------------------~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          296 -------------------EGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             -------------------CSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             -------------------chhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence                               0000000  13466889999999999999976444444

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=4e-30  Score=212.31  Aligned_cols=183  Identities=17%  Similarity=0.268  Sum_probs=134.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~   76 (249)
                      |++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........    ...
T Consensus       128 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  207 (326)
T 2w1i_A          128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP  207 (326)
T ss_dssp             TCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSC
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccC
Confidence            67999999886 5699999999999999999999999999999999999999999999999999876544322    122


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..++..|+|||.+.+.. ++.++||||||+++++|++|..||....     .......+.......   ...........
T Consensus       208 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~~~~  278 (326)
T 2w1i_A          208 GESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQM---IVFHLIELLKN  278 (326)
T ss_dssp             CSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTHH---HHHHHHHHHHT
T ss_pred             CCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchhh---hHHHHHHHhhc
Confidence            34577799999986543 7889999999999999999998875431     111111111111000   00011111111


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      ...      ......+++++.++|.+||+.||.+|||+.++++
T Consensus       279 ~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          279 NGR------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TCC------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCC------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            111      1123467899999999999999999999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.96  E-value=1e-29  Score=210.64  Aligned_cols=167  Identities=16%  Similarity=0.159  Sum_probs=123.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCCCCeeeccCC--------------------CeEEe
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH-SANVIHRDLKPSNLLLNANC--------------------DLKIC   60 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH-~~~i~H~dik~~nil~~~~~--------------------~~kL~   60 (249)
                      ||++.+.+.+ +.+++..++.++.||+.||+||| ++||+||||||+||+++.++                    .+||+
T Consensus       146 ~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~  224 (336)
T 2vuw_A          146 GGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII  224 (336)
T ss_dssp             CCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEEC
T ss_pred             CCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEe
Confidence            4555555544 67999999999999999999999 99999999999999999987                    89999


Q ss_pred             ecCCccCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCC
Q 025683           61 DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI-FMELMNRRPLFPGNDH-VHQMRLLIELLGTPT  138 (249)
Q Consensus        61 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~-l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~  138 (249)
                      |||+++.....    ...||+.|+|||++.+..  +.++||||++++ .++++.|..||..... ......+......  
T Consensus       225 DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--  296 (336)
T 2vuw_A          225 DYTLSRLERDG----IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF--  296 (336)
T ss_dssp             CCTTCBEEETT----EEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC--
T ss_pred             eccccEecCCC----cEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc--
Confidence            99999765432    347899999999997543  789999998776 7778889888743210 0111111110000  


Q ss_pred             cccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHh-cCcccc
Q 025683          139 DADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL-AHPYLA  204 (249)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll-~h~~~~  204 (249)
                                            ........++.+++++.+||++||++|     |++++| +||||+
T Consensus       297 ----------------------~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          297 ----------------------KTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             ----------------------SSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             ----------------------CcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence                                  001111122246788999999999977     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.94  E-value=2e-28  Score=220.53  Aligned_cols=160  Identities=24%  Similarity=0.316  Sum_probs=125.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++..  .+++..+..++.||+.||.|||++||+||||||+||+++.+ .+||+|||.+......   ....||+
T Consensus       168 g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~  241 (681)
T 2pzi_A          168 GQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---GYLYGTP  241 (681)
T ss_dssp             CEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---SCCCCCT
T ss_pred             CCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC---CccCCCc
Confidence            6788888765  89999999999999999999999999999999999999875 8999999998765443   3457899


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+.  .+.++|||||||++++|++|..||.+....           ..+        .              
T Consensus       242 ~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~--------~--------------  286 (681)
T 2pzi_A          242 GFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLP--------E--------------  286 (681)
T ss_dssp             TTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCC--------T--------------
T ss_pred             cccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc-----------ccc--------c--------------
Confidence            99999998643  478999999999999999998887542100           000        0              


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                      ...    ....++.+.+||.+||+.||.+||+..+.+.|+|+.-.
T Consensus       287 ~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          287 DDP----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             TCH----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ccc----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            000    00134678899999999999999998888888887643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.93  E-value=9.7e-26  Score=182.86  Aligned_cols=145  Identities=14%  Similarity=0.066  Sum_probs=111.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+++.+  ......+..++.||+.||+|||++|++||||||+||+++.++.++|++++                  
T Consensus       115 g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------------  174 (286)
T 3uqc_A          115 GGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------------  174 (286)
T ss_dssp             EEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------------
T ss_pred             CCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------------
Confidence            6899999965  34667889999999999999999999999999999999999999998443                  


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                       |++        .++.++|||||||++|+|++|..||.+.+......              . .         .......
T Consensus       175 -~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------------~-~---------~~~~~~~  221 (286)
T 3uqc_A          175 -TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------------P-A---------ERDTAGQ  221 (286)
T ss_dssp             -CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------------E-C---------CBCTTSC
T ss_pred             -ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------------H-H---------HHHhccC
Confidence             222        26789999999999999999999998754210000              0 0         0000011


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ..........+++++.++|.+||+.||.+| |+.++++.
T Consensus       222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            112234556789999999999999999999 99999873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.88  E-value=1.5e-24  Score=191.01  Aligned_cols=109  Identities=20%  Similarity=0.242  Sum_probs=79.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      |++|.++|.+.+++++.   .|+.||+.||+|+|++||+||||||+|||++.+|.+||+|||+++..... ......+||
T Consensus       326 G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGT  402 (569)
T 4azs_A          326 GRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQS  402 (569)
T ss_dssp             SEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHH
T ss_pred             CCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceec
Confidence            78999999999999875   47899999999999999999999999999999999999999999866543 334457899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR  115 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~  115 (249)
                      +.|+|||++.+.  ...++|+|++|++.+++.++.
T Consensus       403 p~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          403 FFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHHHHHC-------------------CCCCTTH
T ss_pred             hhhccHHHhCCC--CCCcccccccccchhhhcccc
Confidence            999999998643  567899999999888765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.66  E-value=9e-18  Score=147.12  Aligned_cols=107  Identities=24%  Similarity=0.362  Sum_probs=89.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--------
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--------   73 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--------   73 (249)
                      |++|.+++.+        +..++.||+.||+|||++||+||||||+||+++.  .+||+|||+++.......        
T Consensus       423 ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~  492 (540)
T 3en9_A          423 GKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVF  492 (540)
T ss_dssp             SEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred             CCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhh
Confidence            6899999886        6789999999999999999999999999999998  999999999987755322        


Q ss_pred             cccccccccccCchhccCC-CCCCchhHHHHHHHHHHHHHhCCCCC
Q 025683           74 MTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMNRRPLF  118 (249)
Q Consensus        74 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~  118 (249)
                      .....||+.|+|||.+... ..++..+|+|+..+-..+-+.++.+|
T Consensus       493 ~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          493 KKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             hhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1246789999999999641 23677789999888888877766655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.32  E-value=3.5e-13  Score=108.63  Aligned_cols=68  Identities=24%  Similarity=0.298  Sum_probs=55.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      |++|.+ +.      ......++.||+.||.|||++|++||||||+||+++ ++.++|+|||.+..            +.
T Consensus       184 g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~------------~~  243 (282)
T 1zar_A          184 AKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE------------VG  243 (282)
T ss_dssp             CEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE------------TT
T ss_pred             CCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE------------CC
Confidence            457766 32      234568999999999999999999999999999999 99999999998853            23


Q ss_pred             cccCchhc
Q 025683           82 WYRAPELL   89 (249)
Q Consensus        82 ~y~aPE~~   89 (249)
                      .+.|||.+
T Consensus       244 ~~~a~e~l  251 (282)
T 1zar_A          244 EEGWREIL  251 (282)
T ss_dssp             STTHHHHH
T ss_pred             CCCHHHHH
Confidence            45677766

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.14  E-value=2.6e-11  Score=96.38  Aligned_cols=60  Identities=22%  Similarity=0.327  Sum_probs=51.4

Q ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683            4 DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH-SANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus         4 ~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH-~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      +|.++...   .++..+..++.||+.+|.||| ++|++||||||.||+++.  .++|+|||.+...
T Consensus       159 ~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          159 TLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             BHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             cHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            66666543   345678899999999999999 999999999999999998  9999999998643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.66  E-value=1.9e-08  Score=83.96  Aligned_cols=50  Identities=16%  Similarity=0.169  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC----------CeEEeecCCccC
Q 025683           18 EHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----------DLKICDFGLARP   67 (249)
Q Consensus        18 ~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~----------~~kL~dfg~~~~   67 (249)
                      .....++.||+.+|.+||++|++||||||.|||++.++          .+.++||+-+..
T Consensus       205 ~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          205 PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            45678899999999999999999999999999998876          388999986644

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.21  E-value=5.3e-05  Score=57.61  Aligned_cols=99  Identities=18%  Similarity=0.126  Sum_probs=65.1

Q ss_pred             cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            4 DLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         4 ~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||.++|.. +.+|+++++..++.|.+.+|.-+-. ..-...=+.|..|++..+|.+.+.+-. +.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~~-s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAA-DD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC-------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccccc-cc-----------cccc
Confidence            68888877 4789999999999999999877622 111123345689999999999876411 10           1122


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP  116 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~  116 (249)
                      .+.+||...  ...+.+.-|||||+++|.-+-...
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCC
Confidence            356777652  235678889999999999876443

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.64  E-value=1.4e-05  Score=64.57  Aligned_cols=81  Identities=19%  Similarity=0.200  Sum_probs=47.0

Q ss_pred             CcccCCCCCCCeeecc--CCCeEEeecCCccCCCCCCccccccccccccCchhcc----CCCC---------CCchhHHH
Q 025683           38 NVIHRDLKPSNLLLNA--NCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLL----NSSD---------YTAAIDVW  102 (249)
Q Consensus        38 ~i~H~dik~~nil~~~--~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~---------~~~~~Diw  102 (249)
                      .++|||+++.||+++.  .+.+.++||+.+.................-.+|+...    ..+.         .....+.|
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~  271 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYW  271 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHH
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHH
Confidence            3799999999999998  4557899999875432210000000000001121110    0000         11236889


Q ss_pred             HHHHHHHHHHhCCCCC
Q 025683          103 SVGCIFMELMNRRPLF  118 (249)
Q Consensus       103 slG~~l~~l~~g~~p~  118 (249)
                      +++.+++.+.+|..+|
T Consensus       272 ~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          272 SFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHcCCHHH
Confidence            9999999999998665

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.60  E-value=4e-05  Score=60.33  Aligned_cols=29  Identities=24%  Similarity=0.272  Sum_probs=24.0

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      ..++|||+++.||+++.++.+.|+||+.+
T Consensus       183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             EEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             ceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence            34899999999999987555679999865

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.51  E-value=0.00012  Score=60.44  Aligned_cols=54  Identities=19%  Similarity=0.351  Sum_probs=46.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhh---------------------------------------------------------
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHS---------------------------------------------------------   36 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~---------------------------------------------------------   36 (249)
                      .++......++.+++..|..||+                                                         
T Consensus       135 ~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  214 (359)
T 3dxp_A          135 GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDAD  214 (359)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSS
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCC
Confidence            46788889999999999999997                                                         


Q ss_pred             -CCcccCCCCCCCeeeccCCC--eEEeecCCccC
Q 025683           37 -ANVIHRDLKPSNLLLNANCD--LKICDFGLARP   67 (249)
Q Consensus        37 -~~i~H~dik~~nil~~~~~~--~kL~dfg~~~~   67 (249)
                       ..++|||+++.||+++.++.  +.|+||+.+..
T Consensus       215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence             35899999999999997753  58999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.50  E-value=6.5e-05  Score=58.79  Aligned_cols=27  Identities=22%  Similarity=0.198  Sum_probs=23.8

Q ss_pred             cccCCCCCCCeeeccCCCeEEeecCCc
Q 025683           39 VIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus        39 i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      ++|||++|.||+++.++.+.|+||+.+
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhc
Confidence            999999999999987665679999875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.64  E-value=0.003  Score=51.27  Aligned_cols=30  Identities=27%  Similarity=0.398  Sum_probs=26.9

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .+++|||+++.||+++.++.+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999998653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=95.85  E-value=0.016  Score=46.65  Aligned_cols=30  Identities=43%  Similarity=0.615  Sum_probs=25.1

Q ss_pred             CcccCCCCCCCeeecc---CCCe-EEeecCCccC
Q 025683           38 NVIHRDLKPSNLLLNA---NCDL-KICDFGLARP   67 (249)
Q Consensus        38 ~i~H~dik~~nil~~~---~~~~-kL~dfg~~~~   67 (249)
                      .++|||+++.||+++.   ++.+ .|+||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            5799999999999987   4665 7999997754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.71  E-value=0.0098  Score=50.09  Aligned_cols=33  Identities=15%  Similarity=0.301  Sum_probs=28.4

Q ss_pred             hhCCcccCCCCCCCeeeccCCCeEEeecCCccCC
Q 025683           35 HSANVIHRDLKPSNLLLNANCDLKICDFGLARPT   68 (249)
Q Consensus        35 H~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~   68 (249)
                      +...++|||+++.||+++.++ +.++||+.+...
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            466899999999999998876 999999987643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=94.30  E-value=0.047  Score=44.03  Aligned_cols=28  Identities=25%  Similarity=0.324  Sum_probs=24.4

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      ..++|||+++.||+++ + .+.++||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            4689999999999999 4 89999998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.00  E-value=0.021  Score=45.96  Aligned_cols=30  Identities=33%  Similarity=0.357  Sum_probs=25.4

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .+++|||+++.||+++.++.+.++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            369999999999999887656899998664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=93.94  E-value=0.023  Score=44.45  Aligned_cols=28  Identities=25%  Similarity=0.347  Sum_probs=24.3

Q ss_pred             cccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           39 VIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        39 i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      ++|||+.+.||+++.++.+-|+||+.+.
T Consensus       195 l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence            8999999999999987767799998653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=93.86  E-value=0.05  Score=44.35  Aligned_cols=31  Identities=19%  Similarity=0.284  Sum_probs=27.2

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      ..++|||+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=93.70  E-value=0.033  Score=45.09  Aligned_cols=32  Identities=28%  Similarity=0.428  Sum_probs=27.1

Q ss_pred             hCCcccCCCCCCCeeeccC----CCeEEeecCCccC
Q 025683           36 SANVIHRDLKPSNLLLNAN----CDLKICDFGLARP   67 (249)
Q Consensus        36 ~~~i~H~dik~~nil~~~~----~~~kL~dfg~~~~   67 (249)
                      ...++|||+.+.||+++.+    +.+.++||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3479999999999999874    6789999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=93.24  E-value=0.086  Score=44.94  Aligned_cols=15  Identities=33%  Similarity=0.410  Sum_probs=14.2

Q ss_pred             CcccCCCCCCCeeec
Q 025683           38 NVIHRDLKPSNLLLN   52 (249)
Q Consensus        38 ~i~H~dik~~nil~~   52 (249)
                      .++|+|+.+.||+++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            589999999999998

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=92.77  E-value=0.038  Score=45.17  Aligned_cols=31  Identities=13%  Similarity=0.239  Sum_probs=25.5

Q ss_pred             hCCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           36 SANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        36 ~~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      ...++|||+++.||+++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            3579999999999999964457899998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=92.66  E-value=0.1  Score=42.93  Aligned_cols=28  Identities=29%  Similarity=0.619  Sum_probs=23.7

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .++|+|+.+.||+++.++ +.|+||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            599999999999997654 8999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=91.90  E-value=0.13  Score=40.94  Aligned_cols=29  Identities=21%  Similarity=0.210  Sum_probs=25.0

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      .++|||+.+.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 6677899999987753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=91.87  E-value=0.17  Score=42.00  Aligned_cols=30  Identities=23%  Similarity=0.409  Sum_probs=25.4

Q ss_pred             hCCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           36 SANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        36 ~~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      ...++|||+.+.||+++.+ .++++||..+.
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            4579999999999999875 48999997664

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=91.52  E-value=0.069  Score=45.09  Aligned_cols=29  Identities=34%  Similarity=0.490  Sum_probs=23.5

Q ss_pred             CcccCCCCCCCeeeccC----------------------------CCeEEeecCCcc
Q 025683           38 NVIHRDLKPSNLLLNAN----------------------------CDLKICDFGLAR   66 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~----------------------------~~~kL~dfg~~~   66 (249)
                      .++|+|+.+.||+++.+                            +.+.|+||..+.
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~  306 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS  306 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence            59999999999999875                            678888887764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=90.60  E-value=0.12  Score=42.87  Aligned_cols=29  Identities=28%  Similarity=0.462  Sum_probs=25.9

Q ss_pred             CcccCCCCCCCeeeccC----CCeEEeecCCcc
Q 025683           38 NVIHRDLKPSNLLLNAN----CDLKICDFGLAR   66 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~----~~~kL~dfg~~~   66 (249)
                      .++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            59999999999999876    789999998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.97  E-value=0.14  Score=42.65  Aligned_cols=28  Identities=29%  Similarity=0.482  Sum_probs=24.2

Q ss_pred             cccCCCCCCCeee------ccCCCeEEeecCCcc
Q 025683           39 VIHRDLKPSNLLL------NANCDLKICDFGLAR   66 (249)
Q Consensus        39 i~H~dik~~nil~------~~~~~~kL~dfg~~~   66 (249)
                      ++|+|+.+.||++      +.++.+.++||.++.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            7899999999999      345779999999874

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=85.66  E-value=0.34  Score=40.77  Aligned_cols=28  Identities=25%  Similarity=0.532  Sum_probs=25.2

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .++|+|+.+.||+ +.++.+.++||..+.
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCC
Confidence            5899999999999 778899999998875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=80.31  E-value=2.7  Score=32.91  Aligned_cols=23  Identities=30%  Similarity=0.373  Sum_probs=19.4

Q ss_pred             CcccCCCCCCCeeeccCCCeEEee
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICD   61 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~d   61 (249)
                      .++|||+.+.||+++.++. .+.|
T Consensus       189 ~LvHGDlw~gNvl~~~~g~-~~iD  211 (288)
T 3f7w_A          189 ARIHGDLWNGNVLWQDDGA-VVID  211 (288)
T ss_dssp             EEECSCCSGGGEEEETTEE-EECS
T ss_pred             eeeecCCCCCcEEEcCCCe-EEEe
Confidence            5999999999999998874 4555

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.16  E-value=2.4  Score=32.00  Aligned_cols=81  Identities=14%  Similarity=0.074  Sum_probs=54.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCchhccCCC
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSS   93 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~   93 (249)
                      .++.....+++.+|+....+++  .-+|--++|+|++++.++.+++.-.|....                ++|.      
T Consensus        77 ~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~~p~i~~RGik~~----------------l~P~------  132 (215)
T 4ann_A           77 SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDGLPIAKTRGLQNV----------------VDPL------  132 (215)
T ss_dssp             GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTSCEEESCCEETTT----------------BSCC------
T ss_pred             hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCCCEEEEEccCccC----------------CCCC------
Confidence            4778889999999988764443  346778999999999999999876654211                1221      


Q ss_pred             CCCchhHHHHHHHHHHHHHhCCCCC
Q 025683           94 DYTAAIDVWSVGCIFMELMNRRPLF  118 (249)
Q Consensus        94 ~~~~~~DiwslG~~l~~l~~g~~p~  118 (249)
                      ..+...=+-..=|++..++.+...|
T Consensus       133 ~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          133 PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            1222222334667888888887665

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	249
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-74
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-67
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-67
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-61
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-56
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-55
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-53
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-53
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-52
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-52
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-49
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-49
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-48
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-48
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-47
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-45
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-43
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-40
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-35
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-31
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-31
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-31
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-30
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-30
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-29
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-28
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-28
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-27
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-27
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-27
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-26
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-26
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-26
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-26
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-25
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-25
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-25
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-25
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-24
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-24
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-23
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-23
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-16

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 3e-74
 Identities = 130/252 (51%), Positives = 180/252 (71%), Gaps = 5/252 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M  DLY++++  Q LS +H  YFLYQ+LRGLKYIHSANV+HRDLKPSNLLLN  CDLKIC
Sbjct: 93  MGADLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 151

Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGLAR    +     F+TEYV TRWYRAPE++LNS  YT +ID+WSVGCI  E+++ RP
Sbjct: 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
           +FPG  ++ Q+  ++ +LG+P+  DL  + N  A+ Y+  LP   +    ++FP+    A
Sbjct: 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 271

Query: 177 IDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM 236
           +DL+D+MLTF+P KRI V++ALAHPYL + +D +DEP+   PF FD E   L +E++K++
Sbjct: 272 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 331

Query: 237 IYQEALALNPGF 248
           I++E     PG+
Sbjct: 332 IFEETARFQPGY 343

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 2e-67
 Identities = 104/246 (42%), Positives = 163/246 (66%), Gaps = 4/246 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           M TDL ++++ ++ L E+  Q+ +YQ+L+GL+YIH+A +IHRDLKP NL +N +C+LKI 
Sbjct: 105 MGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 163

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR       MT YVVTRWYRAPE++LN   YT  +D+WSVGCI  E++  + LF G
Sbjct: 164 DFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +DH+ Q++ ++++ GTP    +  +++++AK Y++ LP+  ++  A +  +  PLA++L+
Sbjct: 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
           ++ML  D  +R+T  EALAHPY   LHD  DEP     +   F+      ++ K + Y+E
Sbjct: 282 EKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKE 340

Query: 241 ALALNP 246
            L+  P
Sbjct: 341 VLSFKP 346

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 4e-67
 Identities = 119/238 (50%), Positives = 163/238 (68%), Gaps = 3/238 (1%)

Query: 9   IRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPT 68
           I   Q L+++H Q+ +YQ+LRGLKYIHSA++IHRDLKPSNL +N +C+LKI DFGLAR T
Sbjct: 112 IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171

Query: 69  SENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMR 128
             ++ MT YV TRWYRAPE++LN   Y   +D+WSVGCI  EL+  R LFPG DH+ Q++
Sbjct: 172 --DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229

Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
           L++ L+GTP    L  + +E A+ YI+ L Q P+ + A VF   +PLA+DL+++ML  D 
Sbjct: 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289

Query: 189 MKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQEALALNP 246
            KRIT  +ALAH Y A+ HD  DEPV   P+   FE + L  ++ K + Y E ++  P
Sbjct: 290 DKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 3e-61
 Identities = 85/235 (36%), Positives = 126/235 (53%), Gaps = 5/235 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKI 59
           +        R+ Q+L   + + ++YQL R L YIHS  + HRD+KP NLLL+ +   LK+
Sbjct: 105 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 164

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           CDFG A+     E    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FP
Sbjct: 165 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+  V Q+  +I++LGTPT   +  +     +    Q+  HP   +    P   P AI L
Sbjct: 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV--FRPRTPPEAIAL 282

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHDEADEP--VCPEPFSFDFEQQSLGEEQ 232
             R+L + P  R+T  EA AH +   L D   +       P  F+F  Q L    
Sbjct: 283 CSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP 337

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-56
 Identities = 77/215 (35%), Positives = 112/215 (52%), Gaps = 4/215 (1%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
              I  ++  L+  H + ++   L+GL+Y+H   ++HRDLKP+NLLL+ N  LK+ DFGL
Sbjct: 87  EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 146

Query: 65  ARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           A+   S N   T  VVTRWYRAPELL  +  Y   +D+W+VGCI  EL+ R P  PG+  
Sbjct: 147 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
           + Q+  + E LGTPT+     + +       +  P  P   L  +F       +DL+  +
Sbjct: 207 LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP---LHHIFSAAGDDLLDLIQGL 263

Query: 184 LTFDPMKRITVDEALAHPYLARLHDEADEPVCPEP 218
             F+P  RIT  +AL   Y +           P P
Sbjct: 264 FLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-55
 Identities = 98/255 (38%), Positives = 149/255 (58%), Gaps = 17/255 (6%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           MD +L Q+I+       E   Y LYQ+L G+K++HSA +IHRDLKPSN+++ ++C LKI 
Sbjct: 104 MDANLCQVIQMELD--HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR    +  MT YVVTR+YRAPE++L    Y   +D+WSVGCI  E++  + LFPG
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG 220

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH--------- 171
            D++ Q   +IE LGTP    +  +     + Y+   P++   +  ++FP          
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279

Query: 172 ---VHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVC-PEPFSFDFEQQS 227
                  A DL+ +ML  DP KRI+VD+AL HPY+   +D A+     P+ +    +++ 
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 339

Query: 228 LGEEQIKDMIYQEAL 242
              E+ K++IY+E +
Sbjct: 340 HTIEEWKELIYKEVM 354

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 1e-53
 Identities = 80/206 (38%), Positives = 116/206 (56%), Gaps = 5/206 (2%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
            D   Y        +  E  +  ++QLLRGL ++HS  V+HRDLKP N+L+ ++  +K+ 
Sbjct: 99  QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 158

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLAR  S    +T  VVT WYRAPE+LL SS Y   +D+WSVGCIF E+  R+PLF G
Sbjct: 159 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRG 217

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +  V Q+  +++++G P + D       D     +       Q + +    +  L  DL+
Sbjct: 218 SSDVDQLGKILDVIGLPGEEDW----PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 273

Query: 181 DRMLTFDPMKRITVDEALAHPYLARL 206
            + LTF+P KRI+   AL+HPY   L
Sbjct: 274 LKCLTFNPAKRISAYSALSHPYFQDL 299

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  170 bits (432), Expect = 7e-53
 Identities = 77/204 (37%), Positives = 103/204 (50%), Gaps = 3/204 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
                  +      L     + FL QLL G+ Y H   V+HRDLKP NLL+N   +LKI 
Sbjct: 83  DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142

Query: 61  DFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLAR         T  +VT WYRAP++L+ S  Y+  ID+WSVGCIF E++N  PLFP
Sbjct: 143 DFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G     Q+  +  +LGTP   +   V   +  +Y      +           +    IDL
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNWPNVT--ELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260

Query: 180 VDRMLTFDPMKRITVDEALAHPYL 203
           + +ML  DP +RIT  +AL H Y 
Sbjct: 261 LSKMLKLDPNQRITAKQALEHAYF 284

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 8e-53
 Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 6/214 (2%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
               +       +    +  +  LL GL YIH   ++HRD+K +N+L+  +  LK+ DFG
Sbjct: 103 LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162

Query: 64  LAR-----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           LAR       S+    T  VVT WYR PELLL   DY   ID+W  GCI  E+  R P+ 
Sbjct: 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHV-HPLAI 177
            GN   HQ+ L+ +L G+ T      V N +    +  +    R+   ++  +V  P A+
Sbjct: 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282

Query: 178 DLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD 211
           DL+D++L  DP +RI  D+AL H +       +D
Sbjct: 283 DLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 6e-52
 Identities = 46/220 (20%), Positives = 94/220 (42%), Gaps = 16/220 (7%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLLNANCDLKICDF 62
            L Q+++    + E+        +++GL Y+   + ++HRD+KPSN+L+N+  ++K+CDF
Sbjct: 90  SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 149

Query: 63  GLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           G++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E+   R   P  D
Sbjct: 150 GVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH----------- 171
                 +    +           R          +   P  ++ ++  +           
Sbjct: 208 AKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267

Query: 172 --VHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE 209
                   D V++ L  +P +R  + + + H ++ R   E
Sbjct: 268 GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 9e-52
 Identities = 79/209 (37%), Positives = 114/209 (54%), Gaps = 3/209 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
            D   +    +   +     + +L+QLL+GL + HS  V+HRDLKP NLL+N    +K+ 
Sbjct: 85  QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 144

Query: 61  DFGLAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFGLAR         T  VVT WYRAPE+LL    Y+ A+D+WS+GCIF E++ RR LFP
Sbjct: 145 DFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+  + Q+  +   LGTP +    +        Y    P+  RQ  ++V P +      L
Sbjct: 205 GDSEIDQLFRIFRTLGTPDEVV--WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL 262

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHD 208
           + +ML +DP KRI+   ALAHP+   +  
Sbjct: 263 LSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-50
 Identities = 84/210 (40%), Positives = 115/210 (54%), Gaps = 4/210 (1%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
                      N  L  E  + FL+QLL+GL + HS NV+HRDLKP NLL+N N +LK+ 
Sbjct: 84  DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLA 143

Query: 61  DFGLARPTSE-NEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLF 118
           +FGLAR         +  VVT WYR P++L  +  Y+ +ID+WS GCIF EL N  RPLF
Sbjct: 144 NFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PGND   Q++ +  LLGTPT+     +       Y          SL  V P ++    D
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTK--LPDYKPYPMYPATTSLVNVVPKLNATGRD 261

Query: 179 LVDRMLTFDPMKRITVDEALAHPYLARLHD 208
           L+  +L  +P++RI+ +EAL HPY +    
Sbjct: 262 LLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (407), Expect = 7e-49
 Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 35/241 (14%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
               +    + L E       +  L+GL Y+HS N+IHRD+K  N+LL+    +K+ DFG
Sbjct: 101 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 160

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMNRRPLFPGN 121
            A   +       +V T ++ APE++L   +  Y   +DVWS+G   +EL  R+P     
Sbjct: 161 SASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
           + +  +                         +I Q      QS      H      + VD
Sbjct: 218 NAMSAL------------------------YHIAQNESPALQS-----GHWSEYFRNFVD 248

Query: 182 RMLTFDPMKRITVDEALAHPYLARLHDEAD-EPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
             L   P  R T +  L H ++ R         +         E  +L   ++K +++QE
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 308

Query: 241 A 241
           A
Sbjct: 309 A 309

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  161 bits (408), Expect = 7e-49
 Identities = 64/210 (30%), Positives = 119/210 (56%), Gaps = 11/210 (5%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-NCDLKI 59
            +TD  Q+    Q+L++   ++++Y++L+ L Y HS  ++HRD+KP N++++  +  L++
Sbjct: 115 NNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 171

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLF 118
            D+GLA      +     V +R+++ PELL++   Y  ++D+WS+GC+   ++ R+ P F
Sbjct: 172 IDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRN-EDAKRYIRQLPQHPRQSLAQVFP-----HV 172
            G+D+  Q+  + ++LGT    D     N E   R+   L +H R+   +         V
Sbjct: 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 291

Query: 173 HPLAIDLVDRMLTFDPMKRITVDEALAHPY 202
            P A+D +D++L +D   R+T  EA+ HPY
Sbjct: 292 SPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  158 bits (400), Expect = 4e-48
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 32/207 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  +    +LSE+  +  +  LL  +  +H  N++HRDLKP N+LL+ + ++K+ DFG
Sbjct: 96  ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 155

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNRRPLF 118
            +      E + E   T  Y APE++      N   Y   +D+WS G I   L+   P F
Sbjct: 156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
                +  +R+++                               Q  +  +        D
Sbjct: 216 WHRKQMLMLRMIM---------------------------SGNYQFGSPEWDDYSDTVKD 248

Query: 179 LVDRMLTFDPMKRITVDEALAHPYLAR 205
           LV R L   P KR T +EALAHP+  +
Sbjct: 249 LVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 7e-48
 Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 31/203 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L+  I  +  + E   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 89  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 148

Query: 64  LAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           LA      +    + +   T  Y APELL     +   +DVWS G +   ++     +  
Sbjct: 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                Q     +   T  +                             +  +    + L+
Sbjct: 209 PSDSCQEYSDWKEKKTYLN----------------------------PWKKIDSAPLALL 240

Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
            ++L  +P  RIT+ +     + 
Sbjct: 241 HKILVENPSARITIPDIKKDRWY 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 7e-48
 Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 33/200 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            +Y+ ++      E+    ++ +L   L Y HS  VIHRD+KP NLLL +  +LKI DFG
Sbjct: 92  TVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 151

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            +     +   T    T  Y  PE++     +   +D+WS+G +  E +  +P F  N +
Sbjct: 152 WSVHAPSSRRTT-LCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTY 209

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
               + +  +  T  D                                V   A DL+ R+
Sbjct: 210 QETYKRISRVEFTFPD-------------------------------FVTEGARDLISRL 238

Query: 184 LTFDPMKRITVDEALAHPYL 203
           L  +P +R  + E L HP++
Sbjct: 239 LKHNPSQRPMLREVLEHPWI 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  157 bits (399), Expect = 3e-47
 Identities = 47/226 (20%), Positives = 87/226 (38%), Gaps = 31/226 (13%)

Query: 4   DLYQII-RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKIC 60
           +L++ +   +  +SE+    ++ Q+ +GL ++H  N +H DLKP N++     + +LK+ 
Sbjct: 109 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLI 168

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL       + +     T  + APE+           D+WSVG +   L++    F G
Sbjct: 169 DFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGG 227

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +    +R +        D                             F  +     D +
Sbjct: 228 ENDDETLRNVKSCDWNMDD---------------------------SAFSGISEDGKDFI 260

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQ 226
            ++L  DP  R+T+ +AL HP+L   +    +   P          
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-45
 Identities = 58/243 (23%), Positives = 101/243 (41%), Gaps = 30/243 (12%)

Query: 4   DLYQII--RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLK 58
           +L+  I  R +Q+ +E      +  +   ++Y+HS N+ HRD+KP NLL  +   N  LK
Sbjct: 95  ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 154

Query: 59  ICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF 118
           + DFG A+ T+ +  +T    T +Y APE +L    Y  + D+WS+G I   L+   P F
Sbjct: 155 LTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
             N  +     +                    K  IR             +  V      
Sbjct: 214 YSNHGLAISPGM--------------------KTRIRMGQYEFPN---PEWSEVSEEVKM 250

Query: 179 LVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVC-PEPFSFDFEQQSLGEEQIKDMI 237
           L+  +L  +P +R+T+ E + HP++ +       P+        D E+    +E++   +
Sbjct: 251 LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL 310

Query: 238 YQE 240
              
Sbjct: 311 ATM 313

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 6e-45
 Identities = 46/208 (22%), Positives = 80/208 (38%), Gaps = 33/208 (15%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
                  ++   + L+E   Q    Q L  L Y+H   +IHRDLK  N+L   + D+K+ 
Sbjct: 93  GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLA 152

Query: 61  DFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMNRR 115
           DFG++   T   +    ++ T ++ APE+++  +     Y    DVWS+G   +E+    
Sbjct: 153 DFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212

Query: 116 PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPL 175
           P     + +  +  +                    K     L Q  R S           
Sbjct: 213 PPHHELNPMRVLLKIA-------------------KSEPPTLAQPSRWS---------SN 244

Query: 176 AIDLVDRMLTFDPMKRITVDEALAHPYL 203
             D + + L  +   R T  + L HP++
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 7e-45
 Identities = 47/231 (20%), Positives = 95/231 (41%), Gaps = 31/231 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKIC 60
           D+++ I ++   L+E     +++Q+   L+++HS N+ H D++P N++     +  +KI 
Sbjct: 87  DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKII 146

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           +FG AR     +          Y APE+  +    + A D+WS+G +   L++    F  
Sbjct: 147 EFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLA 205

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
             +   +  ++    T  +                           + F  +   A+D V
Sbjct: 206 ETNQQIIENIMNAEYTFDE---------------------------EAFKEISIEAMDFV 238

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEE 231
           DR+L  +   R+T  EAL HP+L +  +     V        +    + ++
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKD 289

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  151 bits (383), Expect = 8e-45
 Identities = 55/249 (22%), Positives = 102/249 (40%), Gaps = 33/249 (13%)

Query: 4   DLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKIC 60
           +L+  I +    +SE     ++ Q   GLK++H  +++H D+KP N++        +KI 
Sbjct: 112 ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 171

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA   + +E +     T  + APE +++        D+W++G +   L++    F G
Sbjct: 172 DFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            D +  ++ +        +                             F  V P A D +
Sbjct: 231 EDDLETLQNVKRCDWEFDE---------------------------DAFSSVSPEAKDFI 263

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE 240
             +L  +P KR+TV +AL HP+L   H      +      ++  +Q + E+       Q 
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR--YNKIRQKIKEKYADWPAPQP 321

Query: 241 ALALNPGFA 249
           A+     F+
Sbjct: 322 AIGRIANFS 330

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 5e-44
 Identities = 56/210 (26%), Positives = 84/210 (40%), Gaps = 41/210 (19%)

Query: 4   DLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIH-----SANVIHRDLKPSNLLLNAN 54
           DL  +I    +  Q L EE     + QL   LK  H        V+HRDLKP+N+ L+  
Sbjct: 91  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 150

Query: 55  CDLKICDFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
            ++K+ DFGLAR    +  F   +V T +Y +PE +   S Y    D+WS+GC+  EL  
Sbjct: 151 QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCA 209

Query: 114 RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVH 173
             P F           + E                      R++P               
Sbjct: 210 LMPPFTAFSQKELAGKIRE-------------------GKFRRIP-----------YRYS 239

Query: 174 PLAIDLVDRMLTFDPMKRITVDEALAHPYL 203
               +++ RML      R +V+E L +P +
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 4e-43
 Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 30/204 (14%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           +       + +   + E        + L+ L+++HS  VIHRD+K  N+LL  +  +K+ 
Sbjct: 99  LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 158

Query: 61  DFGLARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           DFG     T E    +  V T ++ APE++   + Y   +D+WS+G + +E++   P + 
Sbjct: 159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYL 217

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
             + +  +  LI   GTP                             Q    +  +  D 
Sbjct: 218 NENPLRALY-LIATNGTPE---------------------------LQNPEKLSAIFRDF 249

Query: 180 VDRMLTFDPMKRITVDEALAHPYL 203
           ++R L  D  KR +  E L H +L
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFL 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 7e-42
 Identities = 36/203 (17%), Positives = 77/203 (37%), Gaps = 34/203 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLNA-NCDLKIC 60
            L   ++  + +  +  + +  Q+L+GL+++H+    +IHRDLK  N+ +      +KI 
Sbjct: 98  TLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           D GLA       F    + T  + APE+      Y  ++DV++ G   +E+      +  
Sbjct: 158 DLGLAT-LKRASFAKAVIGTPEFMAPEMY--EEKYDESVDVYAFGMCMLEMATSEYPYSE 214

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
             +  Q+   +     P   D                                P   +++
Sbjct: 215 CQNAAQIYRRVTSGVKPASFD----------------------------KVAIPEVKEII 246

Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
           +  +  +  +R ++ + L H + 
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFF 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (357), Expect = 2e-41
 Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 31/204 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLL---NANCDLKIC 60
           +L+  I      +E      ++Q+L  +KY+H   ++HRDLKP NLL    + +  + I 
Sbjct: 93  ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 152

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL++       ++    T  Y APE+L     Y+ A+D WS+G I   L+   P F  
Sbjct: 153 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYD 211

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +       +++                                    +  +   A D +
Sbjct: 212 ENDAKLFEQILKAEYEFDS---------------------------PYWDDISDSAKDFI 244

Query: 181 DRMLTFDPMKRITVDEALAHPYLA 204
             ++  DP KR T ++AL HP++A
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWIA 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-40
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 41/210 (19%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           +L + IR   S  E   +++  +++  L+Y+H   +IHRDLKP N+LLN +  ++I DFG
Sbjct: 94  ELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 153

Query: 64  LAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
            A+   P S+      +V T  Y +PELL   S    + D+W++GCI  +L+   P F  
Sbjct: 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRA 212

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
            +     +                       + I+     P            P A DLV
Sbjct: 213 GNEYLIFQ-----------------------KIIKLEYDFP--------EKFFPKARDLV 241

Query: 181 DRMLTFDPMKRITVDEA------LAHPYLA 204
           +++L  D  KR+  +E        AHP+  
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 2e-39
 Identities = 40/203 (19%), Positives = 80/203 (39%), Gaps = 31/203 (15%)

Query: 4   DLYQIIRSNQS-LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            LY  +   ++            Q  +G+ Y+H+ ++IHRDLK +N+ L+ +  +KI DF
Sbjct: 89  SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDF 148

Query: 63  GLAR---PTSENEFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMNRRPL 117
           GLA      S +    +   +  + APE++   + + Y+   DV++ G +  ELM  +  
Sbjct: 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           +   ++  Q+  ++                            +    L++V  +      
Sbjct: 209 YSNINNRDQIIFMVGR-------------------------GYLSPDLSKVRSNCPKAMK 243

Query: 178 DLVDRMLTFDPMKRITVDEALAH 200
            L+   L     +R    + LA 
Sbjct: 244 RLMAECLKKKRDERPLFPQILAS 266

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 6e-39
 Identities = 43/214 (20%), Positives = 83/214 (38%), Gaps = 39/214 (18%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKI 59
              DL+  I    +L EE  + F +Q+L  +++ H+  V+HRD+K  N+L++ N  +LK+
Sbjct: 93  PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 152

Query: 60  CDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
            DFG      ++   T++  TR Y  PE +     +  +  VWS+G +  +++     F 
Sbjct: 153 IDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
            ++ + + ++                                          V      L
Sbjct: 212 HDEEIIRGQVFFR-------------------------------------QRVSSECQHL 234

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHDEADEP 213
           +   L   P  R T +E   HP++  +    +  
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA 268

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-37
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 32/203 (15%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN----ANCDLKIC 60
           L+  +   +SL+EE    FL Q+L G+ Y+HS  + H DLKP N++L         +KI 
Sbjct: 100 LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 159

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGLA              T  + APE++ N        D+WS+G I   L++    F G
Sbjct: 160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +     +  +  +     D                           + F +   LA D +
Sbjct: 219 DTKQETLANVSAVNYEFED---------------------------EYFSNTSALAKDFI 251

Query: 181 DRMLTFDPMKRITVDEALAHPYL 203
            R+L  DP KR+T+ ++L HP++
Sbjct: 252 RRLLVKDPKKRMTIQDSLQHPWI 274

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 5e-37
 Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 34/203 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL   I+S          ++  +++ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 89  DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 148

Query: 64  LAR-PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND 122
           + +     +     +  T  Y APE+LL    Y  ++D WS G +  E++  +  F G D
Sbjct: 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQD 207

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
                                              P +PR         +   A DL+ +
Sbjct: 208 EEELFH-----------------------SIRMDNPFYPR--------WLEKEAKDLLVK 236

Query: 183 MLTFDPMKRITV-DEALAHPYLA 204
           +   +P KR+ V  +   HP   
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFR 259

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  128 bits (322), Expect = 1e-35
 Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 34/205 (16%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
           DL+  +  +   SE   +++  +++ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 93  DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 152

Query: 64  LARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
           LA   S+ +     V T  Y APE+L     Y ++ D +S+GC+  +L+     F  +  
Sbjct: 153 LACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
             +  +                     +  +    + P            P    L++ +
Sbjct: 212 KDKHEID--------------------RMTLTMAVELP--------DSFSPELRSLLEGL 243

Query: 184 LTFDPMKRITV-----DEALAHPYL 203
           L  D  +R+        E    P+ 
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFF 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 4e-35
 Identities = 47/228 (20%), Positives = 95/228 (41%), Gaps = 36/228 (15%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
              +L+  +   +  +E   Q ++ +++  L+++H   +I+RD+K  N+LL++N  + + 
Sbjct: 112 NGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 171

Query: 61  DFGLARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL 117
           DFGL++    +E            +     +    S +  A+D WS+G +  EL+     
Sbjct: 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           F  +   +    +                   ++R ++  P +P          +  LA 
Sbjct: 232 FTVDGEKNSQAEI-------------------SRRILKSEPPYP--------QEMSALAK 264

Query: 178 DLVDRMLTFDPMKRI-----TVDEALAHPYLARLH-DEADEPVCPEPF 219
           DL+ R+L  DP KR+       DE   H +  +++ D+      P PF
Sbjct: 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPF 312

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  124 bits (311), Expect = 3e-34
 Identities = 59/258 (22%), Positives = 96/258 (37%), Gaps = 27/258 (10%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIH-SANVIHRDLKPSNLLLNAN----- 54
            +         ++ +   + +    QLL GL Y+H    +IH D+KP N+L+        
Sbjct: 108 ENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167

Query: 55  -CDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN 113
              +KI D G A    E+      + TR YR+PE+LL +  +    D+WS  C+  EL+ 
Sbjct: 168 LIQIKIADLGNACWYDEHYTN--SIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELIT 224

Query: 114 RRPLFPGND------HVHQMRLLIELLGTPTDADL-------GFVRNEDAKRYIRQLPQH 160
              LF  ++          +  +IELLG      L        F  +    R I +L   
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284

Query: 161 PRQSL----AQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCP 216
           P + +     +          D +  ML  DP KR      + HP+L       +  V  
Sbjct: 285 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 344

Query: 217 EPFSFDFEQQSLGEEQIK 234
                         E+++
Sbjct: 345 RELYGSGSDIPGWFEEVR 362

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 3e-34
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 38/206 (18%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L+  +   +  +EE  +++  +++  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL
Sbjct: 92  LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151

Query: 65  ARP-TSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDH 123
            +   S+   M  +  T  Y APE+L + +DY  A+D W +G +  E+M  R  F   DH
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210

Query: 124 VHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRM 183
                                         + +  + P          + P A  L+  +
Sbjct: 211 ERLFE-----------------------LILMEEIRFP--------RTLSPEAKSLLAGL 239

Query: 184 LTFDPMKRI-----TVDEALAHPYLA 204
           L  DP +R+        E + H +  
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  118 bits (297), Expect = 3e-32
 Identities = 53/263 (20%), Positives = 99/263 (37%), Gaps = 51/263 (19%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
              +++  +R     SE H +++  Q++   +Y+HS ++I+RDLKP NLL++    +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFG A+             T    APE++L+   Y  A+D W++G +  E+    P F  
Sbjct: 184 DFGFAKRVKGR--TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFA 240

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           +  +                           + +    + P         H      DL+
Sbjct: 241 DQPIQIYE-----------------------KIVSGKVRFP--------SHFSSDLKDLL 269

Query: 181 DRMLTFDPMKRI-----TVDEALAHPYLAR------LHDEADEPVCPEPFSFD----FEQ 225
             +L  D  KR       V++   H + A          + + P  P+         F+ 
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

Query: 226 QSLGEEQIKDMIYQEALALNPGF 248
               EE+I+  I ++       F
Sbjct: 330 YE--EEEIRVSINEKCGKEFTEF 350

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  115 bits (289), Expect = 1e-31
 Identities = 44/209 (21%), Positives = 82/209 (39%), Gaps = 33/209 (15%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L  I+ +   ++ +     +    + L + H   +IHRD+KP+N++++A   +K+ DFG
Sbjct: 97  TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156

Query: 64  LAR----PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           +AR      +        + T  Y +PE     S   A  DV+S+GC+  E++   P F 
Sbjct: 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFT 215

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
           G+  V                           +++R+ P  P          +      +
Sbjct: 216 GDSPVSVAY-----------------------QHVREDPIPPS----ARHEGLSADLDAV 248

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHD 208
           V + L  +P  R      +    L R+H+
Sbjct: 249 VLKALAKNPENRYQTAAEMRAD-LVRVHN 276

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-31
 Identities = 36/199 (18%), Positives = 65/199 (32%), Gaps = 34/199 (17%)

Query: 4   DLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
            L   +RS     L  +    F   +   ++Y+   N +HRDL   N+L++ +   K+ D
Sbjct: 87  SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 146

Query: 62  FGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           FGL +  S         +   + APE L     ++   DVWS G +  E+ +   +    
Sbjct: 147 FGLTKEASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPR 203

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
             +  +   +E                  K Y    P               P   +++ 
Sbjct: 204 IPLKDVVPRVE------------------KGYKMDAP-----------DGCPPAVYEVMK 234

Query: 182 RMLTFDPMKRITVDEALAH 200
                D   R +  +    
Sbjct: 235 NCWHLDAAMRPSFLQLREQ 253

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (290), Expect = 2e-31
 Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 39/205 (19%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L+ ++R +Q       +++  ++   L+Y+HS ++I+RDLKP N+LL+ N  +KI DFG 
Sbjct: 91  LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 150

Query: 65  ARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV 124
           A+   +         T  Y APE ++++  Y  +ID WS G +  E++     F  ++ +
Sbjct: 151 AKYVPDV--TYTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207

Query: 125 HQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRML 184
                                      + +    + P        P  +    DL+ R++
Sbjct: 208 KTYE-----------------------KILNAELRFP--------PFFNEDVKDLLSRLI 236

Query: 185 TFDPMKRI-----TVDEALAHPYLA 204
           T D  +R+       ++   HP+  
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFK 261

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 2e-31
 Identities = 42/226 (18%), Positives = 77/226 (34%), Gaps = 30/226 (13%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSA--------NVIHRDLKPSNLLLNANC 55
            L+  +    +++ E           GL ++H           + HRDLK  N+L+  N 
Sbjct: 87  SLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145

Query: 56  DLKICDFGLARPTSENE-----FMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVG 105
              I D GLA                 V T+ Y APE+L +S      +     D++++G
Sbjct: 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205

Query: 106 CIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSL 165
            +F E+  R  +  G    +Q+     +   P+  ++  V  E   R        P    
Sbjct: 206 LVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR--------PNIPN 256

Query: 166 AQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEAD 211
                    +   ++      +   R+T         L++L  +  
Sbjct: 257 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQQEG 300

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-30
 Identities = 45/208 (21%), Positives = 71/208 (34%), Gaps = 36/208 (17%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
               +    + + L          Q+  G+ Y+   N +HRDL+ +N+L+  N   K+ D
Sbjct: 97  SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 156

Query: 62  FGLARPTSENEF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL-MNRRPLF 118
           FGLAR   +NE+           + APE  L    +T   DVWS G +  EL    R  +
Sbjct: 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY 215

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG  +   +  +      P                                P       D
Sbjct: 216 PGMVNREVLDQVERGYRMPCP------------------------------PECPESLHD 245

Query: 179 LVDRMLTFDPMKRITVDEALA--HPYLA 204
           L+ +    +P +R T +   A    Y  
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 1e-30
 Identities = 42/190 (22%), Positives = 68/190 (35%), Gaps = 34/190 (17%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-- 72
           L+ E    F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR    +   
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 73  -FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLL 130
                  +   + APE L     YT   DVWS G +  E+ +     +PG         L
Sbjct: 221 VVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279

Query: 131 IELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
           I+                    +    P            +       ++     FD  K
Sbjct: 280 IQ------------------NGFKMDQP-----------FYATEEIYIIMQSCWAFDSRK 310

Query: 191 RITVDEALAH 200
           R +     + 
Sbjct: 311 RPSFPNLTSF 320

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-29
 Identities = 45/200 (22%), Positives = 70/200 (35%), Gaps = 30/200 (15%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
            D        +  +LS +   +F   + RG+ Y+     IHRDL   N+L+  N   KI 
Sbjct: 110 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169

Query: 61  DFGLARPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           DFGL+R        T   +   + A E L N S YT   DVWS G +  E+++       
Sbjct: 170 DFGLSRGQEVYVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
                ++                            +LPQ  R        +      DL+
Sbjct: 229 GMTCAEL--------------------------YEKLPQGYRLEK---PLNCDDEVYDLM 259

Query: 181 DRMLTFDPMKRITVDEALAH 200
            +     P +R +  + L  
Sbjct: 260 RQCWREKPYERPSFAQILVS 279

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 3e-28
 Identities = 43/207 (20%), Positives = 77/207 (37%), Gaps = 39/207 (18%)

Query: 4   DLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG 63
            L + ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFG
Sbjct: 93  PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 152

Query: 64  LARPTSENEF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLF 118
           L++    +E      T       + APE +     +++  DVWS G +  E  +  +  +
Sbjct: 153 LSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY 211

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
            G        +L                    K      P                   D
Sbjct: 212 RGMKGSEVTAMLE-------------------KGERMGCP-----------AGCPREMYD 241

Query: 179 LVDRMLTFDPMKRIT---VDEALAHPY 202
           L++   T+D   R     V+  L + Y
Sbjct: 242 LMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 3e-28
 Identities = 45/243 (18%), Positives = 81/243 (33%), Gaps = 40/243 (16%)

Query: 5   LYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGL 64
           L  +     ++  ++   +  Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGL
Sbjct: 98  LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 157

Query: 65  AR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGN 121
           A+      +        V   + A E +L+   YT   DVWS G    ELM         
Sbjct: 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDG 216

Query: 122 DHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVD 181
               ++  ++E                  K      P           P        ++ 
Sbjct: 217 IPASEISSILE------------------KGERLPQP-----------PICTIDVYMIMV 247

Query: 182 RMLTFDPMKRITVDEALAH-------PYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIK 234
           +    D   R    E +         P    +    +    P P   +F +  + EE + 
Sbjct: 248 KCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMD 307

Query: 235 DMI 237
           D++
Sbjct: 308 DVV 310

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  105 bits (262), Expect = 1e-27
 Identities = 35/201 (17%), Positives = 61/201 (30%), Gaps = 33/201 (16%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           + T           LS         Q+  G+ Y+     +HRDL   N L+  N  +KI 
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182

Query: 61  DFGLAR--PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPL 117
           DFGL+R   +++               P   +  + YT   DVW+ G +  E+ +     
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           + G  H   +  + +                     I   P            +      
Sbjct: 243 YYGMAHEEVIYYVRD-------------------GNILACP-----------ENCPLELY 272

Query: 178 DLVDRMLTFDPMKRITVDEAL 198
           +L+    +  P  R +     
Sbjct: 273 NLMRLCWSKLPADRPSFCSIH 293

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-27
 Identities = 46/197 (23%), Positives = 73/197 (37%), Gaps = 34/197 (17%)

Query: 6   YQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA 65
           +    S   L+         Q+  G+ +I   N IHRDL+ +N+L++     KI DFGLA
Sbjct: 97  FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156

Query: 66  RPTSENEF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-NRRPLFPGND 122
           R   +NE+           + APE  +N   +T   DVWS G +  E++ + R  +PG  
Sbjct: 157 RLIEDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

Query: 123 HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDR 182
           +   ++ L                 E   R +R               +       L+  
Sbjct: 216 NPEVIQNL-----------------ERGYRMVRP-------------DNCPEELYQLMRL 245

Query: 183 MLTFDPMKRITVDEALA 199
                P  R T D   +
Sbjct: 246 CWKERPEDRPTFDYLRS 262

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 4e-27
 Identities = 36/202 (17%), Positives = 66/202 (32%), Gaps = 33/202 (16%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           + + L ++ +            +  Q+  G+ Y+ S   IHRDL   NLLL     +KI 
Sbjct: 94  LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG 153

Query: 61  DFGLARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RP 116
           DFGL R   +N+    M E+    +       L +  ++ A D W  G    E+    + 
Sbjct: 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
            + G +    +                        +  ++  + PR              
Sbjct: 214 PWIGLNGSQIL-----------------------HKIDKEGERLPRP------EDCPQDI 244

Query: 177 IDLVDRMLTFDPMKRITVDEAL 198
            +++ +     P  R T     
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALR 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-26
 Identities = 38/210 (18%), Positives = 73/210 (34%), Gaps = 40/210 (19%)

Query: 4   DLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L++ +    + +   +    L+Q+  G+KY+   N +HRDL   N+LL      KI DF
Sbjct: 94  PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 153

Query: 63  GLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPL 117
           GL++    ++      +       + APE  +N   +++  DVWS G    E ++  +  
Sbjct: 154 GLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALSYGQKP 212

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           +        M  +                    +    + P           P   P   
Sbjct: 213 YKKMKGPEVMAFIE-------------------QGKRMECP-----------PECPPELY 242

Query: 178 DLVDRMLTFDPMKRIT---VDEALAHPYLA 204
            L+     +    R     V++ +   Y +
Sbjct: 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-26
 Identities = 29/203 (14%), Positives = 64/203 (31%), Gaps = 34/203 (16%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
               L  +         +        +   ++Y+ S   +HRDL   N L+N    +K+ 
Sbjct: 83  NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 142

Query: 61  DFGLARPTSENEF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPL 117
           DFGL+R   ++E+           +  PE+L+ S  +++  D+W+ G +  E+ +  +  
Sbjct: 143 DFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMP 201

Query: 118 FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAI 177
           +    +      + + L                                           
Sbjct: 202 YERFTNSETAEHIAQGLRLYRP------------------------------HLASEKVY 231

Query: 178 DLVDRMLTFDPMKRITVDEALAH 200
            ++         +R T    L++
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 2e-26
 Identities = 38/200 (19%), Positives = 67/200 (33%), Gaps = 33/200 (16%)

Query: 4   DLYQIIRSNQSL-SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
            L   +R+ + L + E        +  G+ Y+  A VIHRDL   N L+  N  +K+ DF
Sbjct: 86  CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF 145

Query: 63  GLARPTSENE--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           G+ R   +++    T       + +PE + + S Y++  DVWS G +  E+ +   +   
Sbjct: 146 GMTRFVLDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
           N    ++   I          L                                    ++
Sbjct: 205 NRSNSEVVEDISTGFRLYKPRL-----------------------------ASTHVYQIM 235

Query: 181 DRMLTFDPMKRITVDEALAH 200
           +      P  R      L  
Sbjct: 236 NHCWKERPEDRPAFSRLLRQ 255

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (252), Expect = 4e-26
 Identities = 31/214 (14%), Positives = 64/214 (29%), Gaps = 38/214 (17%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLL---LNANCDLKI 59
           +        ++  S +       Q++  ++YIHS N IHRD+KP N L         + I
Sbjct: 88  SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYI 147

Query: 60  CDFGLARPTSENE--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 111
            DFGLA+   +                 T  Y +    L   + +   D+ S+G + M  
Sbjct: 148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYF 206

Query: 112 MNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPH 171
                 + G     + +                       +Y R   +     +  +   
Sbjct: 207 NLGSLPWQGLKAATKRQ-----------------------KYERISEKKMSTPIEVLCKG 243

Query: 172 VHPLAIDLVDRMLTFDPMKRIT---VDEALAHPY 202
                   ++   +     +     + +   + +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 6e-26
 Identities = 43/192 (22%), Positives = 75/192 (39%), Gaps = 34/192 (17%)

Query: 13  QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLAR---PTS 69
             L+ EH   + +Q+ +G++++ S   IHRDL   N+LL+    +KICDFGLAR      
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

Query: 70  ENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMR 128
           +     +  +   + APE + +   YT   DVWS G +  E+ +     +PG     +  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 129 LLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDP 188
             ++                  +    + P            +  P     +      +P
Sbjct: 248 RRLK------------------EGTRMRAP-----------DYTTPEMYQTMLDCWHGEP 278

Query: 189 MKRITVDEALAH 200
            +R T  E + H
Sbjct: 279 SQRPTFSELVEH 290

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 1e-25
 Identities = 44/210 (20%), Positives = 79/210 (37%), Gaps = 34/210 (16%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
                 +     SL       + YQL   L Y+ S   +HRD+   N+L+++N  +K+ D
Sbjct: 92  GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 151

Query: 62  FGLARPTSENEFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFP 119
           FGL+R   ++ +   ++  +   + APE  +N   +T+A DVW  G    E++       
Sbjct: 152 FGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPF 210

Query: 120 GNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDL 179
                + +   IE                        +P           P+  P    L
Sbjct: 211 QGVKNNDVIGRIE------------------NGERLPMP-----------PNCPPTLYSL 241

Query: 180 VDRMLTFDPMKRITVDEALAHPYLARLHDE 209
           + +   +DP +R    E  A   L+ + +E
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQ--LSTILEE 269

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.4 bits (247), Expect = 2e-25
 Identities = 38/211 (18%), Positives = 69/211 (32%), Gaps = 32/211 (15%)

Query: 2   DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICD 61
           +   Y    + Q +S     Y   Q+   ++Y+   N IHRDL   N L+  N  +K+ D
Sbjct: 99  NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD 158

Query: 62  FGLARPTSENEFMTEY-VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPG 120
           FGL+R  + + +                 L  + ++   DVW+ G +  E+         
Sbjct: 159 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218

Query: 121 NDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLV 180
              + Q+  L+E                  K Y  + P                   +L+
Sbjct: 219 GIDLSQVYELLE------------------KDYRMERP-----------EGCPEKVYELM 249

Query: 181 DRMLTFDPMKRITVDEALAHPYLARLHDEAD 211
                ++P  R +  E         +  E+ 
Sbjct: 250 RACWQWNPSDRPSFAEIHQ--AFETMFQESS 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 99.1 bits (246), Expect = 2e-25
 Identities = 34/237 (14%), Positives = 69/237 (29%), Gaps = 46/237 (19%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-----DL 57
           +    +    +  S +       Q+L  ++ IH  ++++RD+KP N L+          +
Sbjct: 86  SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI 145

Query: 58  KICDFGLARPTSENE--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 109
            + DFG+ +   +                 T  Y +    L   + +   D+ ++G +FM
Sbjct: 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFM 204

Query: 110 ELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVF 169
             +     + G       +                       +Y R   +     L ++ 
Sbjct: 205 YFLRGSLPWQGLKAATNKQ-----------------------KYERIGEKKQSTPLRELC 241

Query: 170 PHVHPLAIDLVDRMLTFDPMKRITVDE--ALAHPYLARLHDEADEPVCPEPFSFDFE 224
                     +              D    L    L RL+   DE        FD+ 
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN-------FDWN 291

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 97.9 bits (243), Expect = 7e-25
 Identities = 35/191 (18%), Positives = 61/191 (31%), Gaps = 36/191 (18%)

Query: 16  SEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMT 75
           +       L  +  G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R   ++    
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185

Query: 76  EYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRL 129
            Y      + P             +T+A DVWS G +  E+M+     +    +   +  
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245

Query: 130 LIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPM 189
           + +    P   D                                     L+      D  
Sbjct: 246 IEQDYRLPPPMD------------------------------CPSALHQLMLDCWQKDRN 275

Query: 190 KRITVDEALAH 200
            R    + +  
Sbjct: 276 HRPKFGQIVNT 286

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 2e-24
 Identities = 36/203 (17%), Positives = 68/203 (33%), Gaps = 34/203 (16%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
                  +   +   S       L  +  G+KY+ + N +HRDL   N+L+N+N   K+ 
Sbjct: 93  NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 152

Query: 61  DFGLARPTSENE----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRP 116
           DFGL+R   ++       +   +   + APE +      +A+ DVWS G +  E+M    
Sbjct: 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGE 211

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
                   H++   I                     +    P                  
Sbjct: 212 RPYWELSNHEVMKAIN------------------DGFRLPTP-----------MDCPSAI 242

Query: 177 IDLVDRMLTFDPMKRITVDEALA 199
             L+ +    +  +R    + ++
Sbjct: 243 YQLMMQCWQQERARRPKFADIVS 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.6 bits (237), Expect = 7e-24
 Identities = 51/200 (25%), Positives = 74/200 (37%), Gaps = 34/200 (17%)

Query: 3   TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDF 62
           T    +     +L  E    F YQ+ +G+ ++ S N IHRDL   N+LL      KICDF
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189

Query: 63  GLAR---PTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLF 118
           GLAR     S         +   + APE + N   YT   DVWS G    EL +     +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPY 248

Query: 119 PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAID 178
           PG     +   +I+                  + +    P            H      D
Sbjct: 249 PGMPVDSKFYKMIK------------------EGFRMLSP-----------EHAPAEMYD 279

Query: 179 LVDRMLTFDPMKRITVDEAL 198
           ++      DP+KR T  + +
Sbjct: 280 IMKTCWDADPLKRPTFKQIV 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 1e-23
 Identities = 44/204 (21%), Positives = 73/204 (35%), Gaps = 35/204 (17%)

Query: 1   MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKIC 60
           ++          + LS +      YQ+ RG++Y+ S   IHRDL   N+L+  +  +KI 
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177

Query: 61  DFGLARPTSENEFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RP 116
           DFGLAR     ++  +     +   + APE L +   YT   DVWS G +  E+      
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGS 236

Query: 117 LFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLA 176
            +PG       +LL E                    +    P            +     
Sbjct: 237 PYPGVPVEELFKLLKE-------------------GHRMDKP-----------SNCTNEL 266

Query: 177 IDLVDRMLTFDPMKRITVDEALAH 200
             ++       P +R T  + +  
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVED 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.5 bits (229), Expect = 8e-23
 Identities = 36/194 (18%), Positives = 68/194 (35%), Gaps = 35/194 (18%)

Query: 12  NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN 71
             + + +    F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + 
Sbjct: 124 THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183

Query: 72  EF-----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ 126
           EF      T   +   + A E L     +T   DVWS G +  ELM R      + +   
Sbjct: 184 EFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242

Query: 127 MRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTF 186
           + + +         +                             +      +++ +    
Sbjct: 243 ITVYLLQGRRLLQPE-----------------------------YCPDPLYEVMLKCWHP 273

Query: 187 DPMKRITVDEALAH 200
               R +  E ++ 
Sbjct: 274 KAEMRPSFSELVSR 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.8 bits (227), Expect = 1e-22
 Identities = 37/214 (17%), Positives = 78/214 (36%), Gaps = 40/214 (18%)

Query: 15  LSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF- 73
            S         ++  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   E ++ 
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189

Query: 74  --MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLL 130
               + ++   + +PE L +   +T   DVWS G +  E+       + G  +   +R +
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248

Query: 131 IELLGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMK 190
           +E                        L   P         +   +  +L+     ++P  
Sbjct: 249 ME----------------------GGLLDKP--------DNCPDMLFELMRMCWQYNPKM 278

Query: 191 RITVDEALAHPYLARLHDEADEPVCPEPFSFDFE 224
           R +  E ++      + +E +       F +  E
Sbjct: 279 RPSFLEIISS-----IKEEMEPGFREVSFYYSEE 307

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.5 bits (177), Expect = 3e-16
 Identities = 15/110 (13%), Positives = 34/110 (30%), Gaps = 14/110 (12%)

Query: 6   YQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA 65
               +    +  E+    L  +L  +   +   ++H DL   N+L++    + I DF  +
Sbjct: 91  LIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 149

Query: 66  RPTSENE-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 110
               E             +  ++           Y    D+ S     ++
Sbjct: 150 VEVGEEGWREILERDVRNIITYFS--------RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	249
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.42
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.89
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.32
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	93.86
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	92.97
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	91.45
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	87.88

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=310.33  Aligned_cols=242  Identities=43%  Similarity=0.862  Sum_probs=205.8

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      +|++|..++.+ +++++..++.++.||+.||+|||++||+||||||+||+++.++.+|++|||.+......  .....+|
T Consensus       105 ~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t  181 (346)
T d1cm8a_         105 MGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVT  181 (346)
T ss_dssp             CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSC
T ss_pred             ccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc--ccccccc
Confidence            46677777765 68999999999999999999999999999999999999999999999999999866443  3456789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+...++.++||||+||++|+|++|..||.+.+....+..+....+.++..............+....+..
T Consensus       182 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (346)
T d1cm8a_         182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL  261 (346)
T ss_dssp             GGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCC
T ss_pred             ccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcc
Confidence            99999999987777899999999999999999999999999999999999999999988777766666666777777777


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHHH
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE  240 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (249)
                      ....+..+....++++.+||.+||..||.+|||+.|+|+||||+...+...++.. ..+...++..+.+.+++++++++|
T Consensus       262 ~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~e~k~~~~~e  340 (346)
T d1cm8a_         262 EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV-QKYDDSFDDVDRTLDEWKRVTYKE  340 (346)
T ss_dssp             CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC-CCCCCC-----CCHHHHHHHHHHH
T ss_pred             cccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccC-CCCCCchhhhhcCHHHHHHHHHHH
Confidence            7778888888999999999999999999999999999999999998877666554 356666777788899999999999


Q ss_pred             HHHhCC
Q 025683          241 ALALNP  246 (249)
Q Consensus       241 ~~~~~~  246 (249)
                      +++|+|
T Consensus       341 ~~~~~~  346 (346)
T d1cm8a_         341 VLSFKP  346 (346)
T ss_dssp             HHTCCC
T ss_pred             hhcCCC
Confidence            999998

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-46  Score=308.18  Aligned_cols=247  Identities=53%  Similarity=1.031  Sum_probs=209.8

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC----cccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTE   76 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~   76 (249)
                      +||||.+++.. +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+.......    ....
T Consensus        93 ~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  171 (345)
T d1pmea_          93 MGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE  171 (345)
T ss_dssp             CCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred             cCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecc
Confidence            48999999987 579999999999999999999999999999999999999999999999999987654332    2344


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..+++.|+|||.+.....++.++||||+||++++|++|..||.+.+..............+...................
T Consensus       172 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (345)
T d1pmea_         172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS  251 (345)
T ss_dssp             CCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred             ccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhccccc
Confidence            67899999999987666689999999999999999999999999998888888888888877766655555555566666


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHH
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDM  236 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (249)
                      .+......+....+.+++++++||.+||+.||.+|||++++|+||||+........+....++..+.+....+.+++++.
T Consensus       252 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  331 (345)
T d1pmea_         252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL  331 (345)
T ss_dssp             SCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC--------CCHHHHHHH
T ss_pred             CCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCccCCChhhhhCCHHHHHHH
Confidence            66666777788888999999999999999999999999999999999999988888887778888777788899999999


Q ss_pred             HHHHHHHhCCCC
Q 025683          237 IYQEALALNPGF  248 (249)
Q Consensus       237 ~~~~~~~~~~~~  248 (249)
                      +++|.+.|.|+.
T Consensus       332 ~~~e~~~~~~~~  343 (345)
T d1pmea_         332 IFEETARFQPGY  343 (345)
T ss_dssp             HHHHSGGGSTTT
T ss_pred             HHHHHHhcCCCC
Confidence            999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=306.11  Aligned_cols=242  Identities=50%  Similarity=0.936  Sum_probs=212.7

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      .||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||.+.....  ......|+
T Consensus       105 ~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--~~~~~~g~  181 (348)
T d2gfsa1         105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVAT  181 (348)
T ss_dssp             CSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--GGSSSCHH
T ss_pred             cCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--cccccccc
Confidence            48999999965 6799999999999999999999999999999999999999999999999999865533  23456789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||...+...++.++|+|||||++|+|++|..||.+.+.......+....+.+.......................
T Consensus       182 ~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (348)
T d2gfsa1         182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM  261 (348)
T ss_dssp             HHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCC
T ss_pred             ccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccC
Confidence            99999999877777889999999999999999999999999999999999999988887777777777777777777777


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCCCCCCCCCCchhccccCHHHHHHHHHHH
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEPVCPEPFSFDFEQQSLGEEQIKDMIYQE  240 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (249)
                      ....+......+++++++||++||..||.+|||+.|+|+||||+++.....++.. .++...+++.....+++++.+++|
T Consensus       262 ~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~k~~~~~e  340 (348)
T d2gfsa1         262 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDE  340 (348)
T ss_dssp             CCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCC-CCCCCGGGGCCCCHHHHHHHHHHH
T ss_pred             CCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCC-CCCCCcccchhcCHHHHHHHHHHH
Confidence            7778888888999999999999999999999999999999999999877776654 477788888999999999999999


Q ss_pred             HHHhCC
Q 025683          241 ALALNP  246 (249)
Q Consensus       241 ~~~~~~  246 (249)
                      ..+|+|
T Consensus       341 ~~~~~p  346 (348)
T d2gfsa1         341 VISFVP  346 (348)
T ss_dssp             HHTCCC
T ss_pred             hhccCC
Confidence            999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=286.76  Aligned_cols=171  Identities=29%  Similarity=0.484  Sum_probs=148.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... .....||+
T Consensus        90 ~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~  168 (263)
T d2j4za1          90 LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTL  168 (263)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-CEETTEEG
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-ccccCCCC
Confidence            68999999998999999999999999999999999999999999999999999999999999997655432 34568999


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...-                           
T Consensus       169 ~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------------------------  220 (263)
T d2j4za1         169 DYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE---------------------------  220 (263)
T ss_dssp             GGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------------------------
T ss_pred             cccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------------------------
Confidence            999999997654 7899999999999999999999998887666555543210                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                          ..++..+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus       221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                1123357899999999999999999999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-44  Score=289.16  Aligned_cols=204  Identities=35%  Similarity=0.623  Sum_probs=166.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      |+++..++..+..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+...... ......++|
T Consensus        84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt  163 (299)
T d1ua2a_          84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT  163 (299)
T ss_dssp             EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCC
T ss_pred             chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceecC
Confidence            3455555555678999999999999999999999999999999999999999999999999999766543 233456789


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.....++.++||||+||++|+|++|..||.+.++.+++..+...++.+....+.........   ......
T Consensus       164 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~  240 (299)
T d1ua2a_         164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY---VTFKSF  240 (299)
T ss_dssp             CTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC---CCCCCC
T ss_pred             hhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh---hhhccC
Confidence            99999999877667899999999999999999999999999999999999999988776554322211100   011122


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      +...+..+.+.+++++++||.+||+.||.+|||++|+|+||||++...
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence            233445566788999999999999999999999999999999986543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=289.15  Aligned_cols=176  Identities=27%  Similarity=0.443  Sum_probs=145.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC---Ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---~~~~~~~   78 (249)
                      ||||.++|.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....   ......+
T Consensus        87 gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~  166 (271)
T d1nvra_          87 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC  166 (271)
T ss_dssp             TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCC
T ss_pred             CCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccccee
Confidence            6899999998899999999999999999999999999999999999999999999999999999865432   2234568


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||++.+...++.++||||+||++|+|++|+.||..................                      
T Consensus       167 GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~----------------------  224 (271)
T d1nvra_         167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----------------------  224 (271)
T ss_dssp             SCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT----------------------
T ss_pred             eCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------------
Confidence            9999999999977665678899999999999999999999765433222221111000                      


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                            ....+..+++++.+||.+||+.||.+|||++|+++||||++
T Consensus       225 ------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         225 ------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             ------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                  01112357889999999999999999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-43  Score=281.40  Aligned_cols=174  Identities=25%  Similarity=0.452  Sum_probs=148.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .......||
T Consensus       101 gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt  179 (293)
T d1yhwa1         101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  179 (293)
T ss_dssp             TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSC
T ss_pred             CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccC
Confidence            7899998876 57999999999999999999999999999999999999999999999999999876543 334556899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+........                      
T Consensus       180 ~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~----------------------  236 (293)
T d1yhwa1         180 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL----------------------  236 (293)
T ss_dssp             GGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC----------------------
T ss_pred             CCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----------------------
Confidence            999999999764 478999999999999999999999998877666655543221110                      


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                            ..++.+++++++||.+||+.||.+|||++|+|+||||+.
T Consensus       237 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         237 ------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             ------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                  112357889999999999999999999999999999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-43  Score=285.33  Aligned_cols=176  Identities=28%  Similarity=0.525  Sum_probs=137.9

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec---cCCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---ANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~---~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||||.++|.+.+.+++..+..++.||+.||+|||++|++||||||+||++.   .++.+||+|||+++...........+
T Consensus        91 gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~  170 (307)
T d1a06a_          91 GGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC  170 (307)
T ss_dssp             SCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------------
T ss_pred             CCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeee
Confidence            689999999999999999999999999999999999999999999999995   47899999999998776665566678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+...-...+                    
T Consensus       171 GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------------------  229 (307)
T d1a06a_         171 GTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD--------------------  229 (307)
T ss_dssp             --CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC--------------------
T ss_pred             eCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC--------------------
Confidence            99999999999655 489999999999999999999999998876666655543111110                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                             ...++.+|+++.+||.+||+.||.+|||++|+++||||++
T Consensus       230 -------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         230 -------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             -------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             -------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                   1233468899999999999999999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-42  Score=279.86  Aligned_cols=201  Identities=39%  Similarity=0.728  Sum_probs=165.9

Q ss_pred             CccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ++++..+...  ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+.............|
T Consensus        98 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~g  177 (305)
T d1blxa_          98 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV  177 (305)
T ss_dssp             SCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCC
T ss_pred             cCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCccc
Confidence            3444443332  36799999999999999999999999999999999999999999999999999987766666667889


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      |+.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+....+..+....+.+....+........    .....
T Consensus       178 T~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~  252 (305)
T d1blxa_         178 TLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR----QAFHS  252 (305)
T ss_dssp             CCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG----GGSCC
T ss_pred             ChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchh----hhhcc
Confidence            9999999998655 489999999999999999999999999999999999999988877655432211111    11122


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                      ............+++.+.+||.+||++||.+|||++|+|+||||+++.
T Consensus       253 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         253 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence            233345556678899999999999999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-43  Score=278.30  Aligned_cols=172  Identities=20%  Similarity=0.374  Sum_probs=143.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCCeeec-cCCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLLN-ANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++...... ......
T Consensus        96 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~  174 (270)
T d1t4ha_          96 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVI  174 (270)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESC
T ss_pred             CCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcc
Confidence            6899999999899999999999999999999999998  99999999999996 4789999999999754333 344578


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||.+.+  .++.++|||||||++|+|++|+.||....+........... ..+                    
T Consensus       175 GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~-~~~--------------------  231 (270)
T d1t4ha_         175 GTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKP--------------------  231 (270)
T ss_dssp             SSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCC--------------------
T ss_pred             cCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC-CCC--------------------
Confidence            9999999998854  48999999999999999999999998765544433322110 000                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLA  204 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~  204 (249)
                             .......++++.+||.+||+.||.+|||++|+|+||||+
T Consensus       232 -------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                   112235778899999999999999999999999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-43  Score=283.41  Aligned_cols=176  Identities=32%  Similarity=0.581  Sum_probs=148.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC---Ccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---~~~~~~~   78 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....   .......
T Consensus        92 gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~  171 (288)
T d1uu3a_          92 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV  171 (288)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CC
T ss_pred             CCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccccccc
Confidence            6899999999999999999999999999999999999999999999999999999999999999865432   2233467


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...-                        
T Consensus       172 GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~------------------------  226 (288)
T d1uu3a_         172 GTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE------------------------  226 (288)
T ss_dssp             CCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC------------------------
T ss_pred             CCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC------------------------
Confidence            999999999997654 7899999999999999999999999887766666554210                        


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHH------HhcCccccCCcCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDE------ALAHPYLARLHDE  209 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~------ll~h~~~~~~~~~  209 (249)
                             ..++..+++++.+||.+||+.||.+|||++|      +++||||+++..+
T Consensus       227 -------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~  276 (288)
T d1uu3a_         227 -------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  276 (288)
T ss_dssp             -------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             -------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence                   0123357899999999999999999999987      5789999987643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-42  Score=278.53  Aligned_cols=178  Identities=30%  Similarity=0.516  Sum_probs=153.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||||.++|..++.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+.............||+
T Consensus        94 ~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~  173 (277)
T d1phka_          94 KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP  173 (277)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCG
T ss_pred             CchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccC
Confidence            68999999998999999999999999999999999999999999999999999999999999998876655556678999


Q ss_pred             cccCchhccC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           82 WYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        82 ~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+.......+...-..++                  
T Consensus       174 ~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------  235 (277)
T d1phka_         174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG------------------  235 (277)
T ss_dssp             GGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------------------
T ss_pred             CCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC------------------
Confidence            9999999852     33468899999999999999999999998887776666654211111                  


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                               .....++|+++++||.+||+.||.+|||++|+++||||+++
T Consensus       236 ---------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         236 ---------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             ---------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ---------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                     11122588999999999999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-42  Score=286.81  Aligned_cols=180  Identities=26%  Similarity=0.434  Sum_probs=153.2

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc--CCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA--NCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~--~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|.+++.+ .+++++..++.++.||+.||+|||++|++||||||+||+++.  ++.+||+|||++.............
T Consensus       107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~  186 (350)
T d1koaa2         107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT  186 (350)
T ss_dssp             SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEEC
T ss_pred             CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceec
Confidence            7899999965 468999999999999999999999999999999999999964  5789999999998776666566678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+.......+.                   
T Consensus       187 gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------  246 (350)
T d1koaa2         187 GTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD-------------------  246 (350)
T ss_dssp             SCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-------------------
T ss_pred             CcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-------------------
Confidence            899999999997654 789999999999999999999999988877777666542221111                   


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                              ..+..+++++.+||.+||+.||.+|||++|+|+||||+.....
T Consensus       247 --------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         247 --------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             --------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             --------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                    1223578899999999999999999999999999999976543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-42  Score=282.28  Aligned_cols=174  Identities=28%  Similarity=0.521  Sum_probs=151.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.++++.++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++.... .......+||
T Consensus        89 gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT  168 (337)
T d1o6la_          89 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  168 (337)
T ss_dssp             TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEEC
T ss_pred             CCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeC
Confidence            789999999999999999999999999999999999999999999999999999999999999986544 3445567899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||++.+.+ ++.++|+|||||++|+|++|..||.+.+.......+...-                          
T Consensus       169 ~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--------------------------  221 (337)
T d1o6la_         169 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--------------------------  221 (337)
T ss_dssp             GGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------------------
T ss_pred             HHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--------------------------
Confidence            9999999987654 7999999999999999999999999887666555544311                          


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                           ..++..+|+++.+||++||++||.+|+     +++++++||||++..
T Consensus       222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence                 112346889999999999999999999     499999999998764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=280.40  Aligned_cols=178  Identities=30%  Similarity=0.499  Sum_probs=151.7

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC----CeEEeecCCccCCCCCCccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC----DLKICDFGLARPTSENEFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~----~~kL~dfg~~~~~~~~~~~~~~   77 (249)
                      ||+|.++|.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++    .+|++|||++............
T Consensus        97 gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~  176 (293)
T d1jksa_          97 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI  176 (293)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCC
T ss_pred             CccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCcccccc
Confidence            689999999989999999999999999999999999999999999999998776    5999999999877666556667


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .+++.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+.......+...-...+                   
T Consensus       177 ~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------  236 (293)
T d1jksa_         177 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------------------  236 (293)
T ss_dssp             CCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC-------------------
T ss_pred             CCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-------------------
Confidence            889999999999654 489999999999999999999999998877666665543111111                   


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                              ...++.+|+++.+||++||+.||.+|||++++++||||+...
T Consensus       237 --------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         237 --------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             --------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             --------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                    123346889999999999999999999999999999998654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=290.15  Aligned_cols=199  Identities=24%  Similarity=0.428  Sum_probs=142.8

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+||+++.++.+||+|||++...... .....+||
T Consensus        88 gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT  166 (322)
T d1s9ja_          88 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGT  166 (322)
T ss_dssp             TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCS
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccccccCC
Confidence            68999999998999999999999999999999997 59999999999999999999999999998754322 23456899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCccccc----------------
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQ-MRLLIELLGTPTDADLG----------------  143 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~----------------  143 (249)
                      +.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.... ........+........                
T Consensus       167 ~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (322)
T d1s9ja_         167 RSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR  245 (322)
T ss_dssp             SCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------
T ss_pred             ccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccc
Confidence            999999999765 489999999999999999999999987653322 22111111111110000                


Q ss_pred             -ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          144 -FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       144 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                       .................   .  .....+|.++.+||.+||..||.+|||++|+|+||||++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~---~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         246 PPMAIFELLDYIVNEPPP---K--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             CCCCHHHHHHHHHTSCCC---C--CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cchhHHHHHhhhhccCCc---c--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence             00000000000000000   0  00123678999999999999999999999999999999743

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=276.55  Aligned_cols=207  Identities=39%  Similarity=0.721  Sum_probs=168.3

Q ss_pred             CCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCC-CCccccc
Q 025683            1 MDTDLYQIIRS--NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSE-NEFMTEY   77 (249)
Q Consensus         1 ~~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~-~~~~~~~   77 (249)
                      +++++.+++..  .+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+..... .......
T Consensus        83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~  162 (298)
T d1gz8a_          83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE  162 (298)
T ss_dssp             CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCC
T ss_pred             cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceee
Confidence            45677777654  36799999999999999999999999999999999999999999999999999976543 3344456


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .||+.|+|||.+......+.++|+||+||++|+|++|..||.+.+....+..+....+.+....+.....  ........
T Consensus       163 ~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~  240 (298)
T d1gz8a_         163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYKPSF  240 (298)
T ss_dssp             BCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG--STTCCTTS
T ss_pred             cccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc--cccccccc
Confidence            8899999999988777778999999999999999999999999998999999888887766544332211  11111222


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDE  209 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~  209 (249)
                      ............+.+++++.+||++||+.||.+|||++|+++||||+++..+
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            2333444556677889999999999999999999999999999999987443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-42  Score=278.58  Aligned_cols=176  Identities=23%  Similarity=0.418  Sum_probs=145.9

Q ss_pred             CccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Cccccccc
Q 025683            2 DTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~   79 (249)
                      ||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......|
T Consensus        93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~G  172 (288)
T d2jfla1          93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG  172 (288)
T ss_dssp             TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCS
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccccccc
Confidence            6899999765 467999999999999999999999999999999999999999999999999998654332 22345688


Q ss_pred             cccccCchhccC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           80 TRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        80 ~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      |+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+....+..+....  ++.                
T Consensus       173 t~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~~----------------  234 (288)
T d2jfla1         173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PPT----------------  234 (288)
T ss_dssp             CCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CCC----------------
T ss_pred             ccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCC----------------
Confidence            999999999852    3347889999999999999999999998877666555554311  000                


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                                ...+..+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus       235 ----------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         235 ----------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ----------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ----------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                      1112357899999999999999999999999999999974

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.4e-42  Score=285.44  Aligned_cols=177  Identities=25%  Similarity=0.423  Sum_probs=148.3

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.++|.+...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++....... .....||+
T Consensus        91 gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-~~~~~GT~  169 (364)
T d1omwa3          91 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  169 (364)
T ss_dssp             SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-CCSCCSCG
T ss_pred             CCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-cccccccc
Confidence            79999999999999999999999999999999999999999999999999999999999999998665433 44568999


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.....++.++|||||||++|+|++|..||.+................                         
T Consensus       170 ~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-------------------------  224 (364)
T d1omwa3         170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------------------------  224 (364)
T ss_dssp             GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-------------------------
T ss_pred             ccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-------------------------
Confidence            9999999976666899999999999999999999999765432222111110000                         


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRIT-----VDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~~ll~h~~~~~~~  207 (249)
                         ....+..+++++.+||.+||+.||.+|||     ++++++||||+++.
T Consensus       225 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         225 ---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             ---CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence               01233468899999999999999999999     79999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.9e-42  Score=283.32  Aligned_cols=177  Identities=28%  Similarity=0.469  Sum_probs=152.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec--cCCCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN--ANCDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~--~~~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|.+++.+. .+|++..++.++.||+.||+|||++||+||||||+|||++  .++.+||+|||++.............
T Consensus       110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~  189 (352)
T d1koba_         110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT  189 (352)
T ss_dssp             CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEEC
T ss_pred             CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeecc
Confidence            68999988765 4799999999999999999999999999999999999998  57899999999998877666666678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+......++                    
T Consensus       190 gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------  248 (352)
T d1koba_         190 ATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD--------------------  248 (352)
T ss_dssp             SSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------------------
T ss_pred             CcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------
Confidence            89999999998654 489999999999999999999999998887777766654221111                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                             ...+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       249 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 -------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             -------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                   12234688999999999999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.5e-42  Score=282.27  Aligned_cols=172  Identities=26%  Similarity=0.460  Sum_probs=150.5

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....  .....||+
T Consensus       125 ~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~  202 (350)
T d1rdqe_         125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTP  202 (350)
T ss_dssp             TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECG
T ss_pred             ccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--cccccCcc
Confidence            7899999999899999999999999999999999999999999999999999999999999999876433  34578999


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.....                          
T Consensus       203 ~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--------------------------  255 (350)
T d1rdqe_         203 EALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--------------------------  255 (350)
T ss_dssp             GGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------------------
T ss_pred             ccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC--------------------------
Confidence            999999997554 78999999999999999999999998877766666543111                          


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                           ..+..+++++.+||++||+.||.+|+     |++++++||||+...
T Consensus       256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence                 12235789999999999999999995     999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.7e-42  Score=278.35  Aligned_cols=172  Identities=28%  Similarity=0.411  Sum_probs=146.1

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....   .....||+
T Consensus        99 ~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~GT~  175 (309)
T d1u5ra_          99 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTP  175 (309)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCCSCG
T ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCccccCc
Confidence            577888888888999999999999999999999999999999999999999999999999999976543   23567999


Q ss_pred             cccCchhccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           82 WYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        82 ~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      .|+|||++.+.  ..++.++|||||||++|+|++|..||.+.+.......+.......                      
T Consensus       176 ~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------  233 (309)
T d1u5ra_         176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA----------------------  233 (309)
T ss_dssp             GGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------------------
T ss_pred             cccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC----------------------
Confidence            99999998642  347889999999999999999999998887666655554311100                      


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                             .....+|+++.+||.+||+.||.+|||++++|+||||.+
T Consensus       234 -------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         234 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             -------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             -------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                   011247889999999999999999999999999999985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1e-41  Score=275.10  Aligned_cols=201  Identities=38%  Similarity=0.658  Sum_probs=161.4

Q ss_pred             ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-ccccccccc
Q 025683            3 TDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVTR   81 (249)
Q Consensus         3 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~   81 (249)
                      +++..+....+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+....... ......+++
T Consensus        85 ~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  164 (286)
T d1ob3a_          85 DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL  164 (286)
T ss_dssp             EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCC
T ss_pred             hhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccc
Confidence            4455555667889999999999999999999999999999999999999999999999999987654332 233456789


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||.+.+...++.++|+|||||++++|++|+.||.+.+...+..++....+.+....+......  ..+........
T Consensus       165 ~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  242 (286)
T d1ob3a_         165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL--PKYDPNFTVYE  242 (286)
T ss_dssp             TTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TTCCTTCCCCC
T ss_pred             hhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh--hhccccccccc
Confidence            9999999987777899999999999999999999999999999999999988888765554322111  11112222233


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                      ........+.+++++.+||++||+.||.+|||++|+++||||++
T Consensus       243 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             CcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            34455667788999999999999999999999999999999984

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-41  Score=280.48  Aligned_cols=239  Identities=41%  Similarity=0.732  Sum_probs=175.5

Q ss_pred             CCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcccccccc
Q 025683            1 MDTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         1 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      |++++.+.+.  ..+++..++.+++||+.||+|||++||+||||||+||+++.++.++++|||.++............+|
T Consensus       104 ~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t  181 (355)
T d2b1pa1         104 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT  181 (355)
T ss_dssp             CSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------C
T ss_pred             cchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccccccccccc
Confidence            4567777775  47999999999999999999999999999999999999999999999999998877766666677889


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+. .++.++||||+||++++|++|..||.+.+.......+....+.+....+...... ...+.......
T Consensus       182 ~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  259 (355)
T d2b1pa1         182 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT-VRNYVENRPKY  259 (355)
T ss_dssp             CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH-HHHHHHTSCCC
T ss_pred             ccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh-HHHHhhcCccc
Confidence            999999999765 5899999999999999999999999999999999999988888766655443332 23333333322


Q ss_pred             CCcchhhc------------CCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCCC-CCCCCCCCchhccc
Q 025683          161 PRQSLAQV------------FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADEP-VCPEPFSFDFEQQS  227 (249)
Q Consensus       161 ~~~~~~~~------------~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~~-~~~~~~~~~~~~~~  227 (249)
                      ........            ....++++++||++||..||.+|||++|||+||||+.+.++.... ..+..+..+.++..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (355)
T d2b1pa1         260 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE  339 (355)
T ss_dssp             CCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC-------CCCC
T ss_pred             cccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCCCCCCCcchhhhh
Confidence            22221111            112467789999999999999999999999999999876433333 33455666677788


Q ss_pred             cCHHHHHHHHHHHHHH
Q 025683          228 LGEEQIKDMIYQEALA  243 (249)
Q Consensus       228 ~~~~~~~~~~~~~~~~  243 (249)
                      .+.++++..|++|.++
T Consensus       340 ~~~~~~~~~~~~~~~~  355 (355)
T d2b1pa1         340 HTIEEWKELIYKEVMN  355 (355)
T ss_dssp             CCHHHHHHHHHHHHHC
T ss_pred             cCHHHHHHHHHHHhcC
Confidence            8899999999999863

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-41  Score=280.06  Aligned_cols=209  Identities=38%  Similarity=0.707  Sum_probs=166.4

Q ss_pred             CCccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCCCCccc
Q 025683            1 MDTDLYQII----RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMT   75 (249)
Q Consensus         1 ~~~~L~~~l----~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~~~~~   75 (249)
                      |++++.+.+    .....+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..........
T Consensus       101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~  180 (350)
T d1q5ka_         101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV  180 (350)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCC
T ss_pred             cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccc
Confidence            345544444    4457899999999999999999999999999999999999999875 89999999998776666666


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ...|+..|+|||.+.+...++.++||||+||++|+|++|..||...+....+..+...++.+....+........   ..
T Consensus       181 ~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~---~~  257 (350)
T d1q5ka_         181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT---EF  257 (350)
T ss_dssp             SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC------CC
T ss_pred             cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh---hc
Confidence            778999999999987776789999999999999999999999999999999999999888876554322111100   00


Q ss_pred             hCCCCCCcc-hhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcCCCCC
Q 025683          156 QLPQHPRQS-LAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHDEADE  212 (249)
Q Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~~~~~  212 (249)
                      ......... .....+..++++.+||.+||.+||.+|||+.|+|+||||+++.+....
T Consensus       258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~  315 (350)
T d1q5ka_         258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK  315 (350)
T ss_dssp             CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCC
T ss_pred             cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCC
Confidence            111111111 122345688999999999999999999999999999999998765543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-42  Score=274.21  Aligned_cols=171  Identities=31%  Similarity=0.507  Sum_probs=135.4

Q ss_pred             CccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCCCCeeeccCCCeEEeecCCccCCCCCC
Q 025683            2 DTDLYQIIRS----NQSLSEEHCQYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLLNANCDLKICDFGLARPTSENE   72 (249)
Q Consensus         2 ~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~-----i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~   72 (249)
                      ||+|.+++.+    .+.+++..++.++.||+.||+|||++|     |+||||||+||+++.++.+||+|||+++......
T Consensus        89 ~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  168 (269)
T d2java1          89 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  168 (269)
T ss_dssp             TEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred             CCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC
Confidence            6899999964    467999999999999999999999876     9999999999999999999999999998765433


Q ss_pred             -ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHH
Q 025683           73 -FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAK  151 (249)
Q Consensus        73 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (249)
                       ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...-                 
T Consensus       169 ~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-----------------  230 (269)
T d2java1         169 SFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-----------------  230 (269)
T ss_dssp             -------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------------
T ss_pred             CccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence             33457889999999998654 48999999999999999999999998877666555543210                 


Q ss_pred             HHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 025683          152 RYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYL  203 (249)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~  203 (249)
                                   ...++..+|+++.+||.+||+.||.+|||++|+++|||+
T Consensus       231 -------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 -------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                         012234678999999999999999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.6e-41  Score=273.78  Aligned_cols=172  Identities=26%  Similarity=0.499  Sum_probs=150.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTR   81 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~   81 (249)
                      ||+|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||.++.....  ....+||+
T Consensus        88 gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~  165 (316)
T d1fota_          88 GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTP  165 (316)
T ss_dssp             SCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCT
T ss_pred             CccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--cccccCcc
Confidence            7899999999999999999999999999999999999999999999999999999999999999876443  33578999


Q ss_pred             cccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCCC
Q 025683           82 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQHP  161 (249)
Q Consensus        82 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (249)
                      .|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...-                           
T Consensus       166 ~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---------------------------  217 (316)
T d1fota_         166 DYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE---------------------------  217 (316)
T ss_dssp             TTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC---------------------------
T ss_pred             cccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC---------------------------
Confidence            99999998654 47899999999999999999999999888776666654311                           


Q ss_pred             CcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          162 RQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                          ..+++.+++++.++|.+||..||.+|+     |++++++||||++..
T Consensus       218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence                112335789999999999999999996     999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-41  Score=274.37  Aligned_cols=174  Identities=26%  Similarity=0.480  Sum_probs=151.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-Ccccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-EFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~   80 (249)
                      ||+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.++..... .......||
T Consensus        87 ~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt  166 (320)
T d1xjda_          87 GGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT  166 (320)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSC
T ss_pred             CCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCC
Confidence            6899999999999999999999999999999999999999999999999999999999999999865543 334456889


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+.......+...  .+                       
T Consensus       167 ~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-----------------------  220 (320)
T d1xjda_         167 PDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-----------------------  220 (320)
T ss_dssp             GGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-----------------------
T ss_pred             CCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-----------------------
Confidence            9999999997654 889999999999999999999999988877666665421  11                       


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHH-HHhcCccccCCc
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVD-EALAHPYLARLH  207 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~-~ll~h~~~~~~~  207 (249)
                            .++..+|+++.+||++||+.||.+|||+. ++++||||+++.
T Consensus       221 ------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         221 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             ------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence                  12235789999999999999999999995 899999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=279.18  Aligned_cols=181  Identities=28%  Similarity=0.498  Sum_probs=143.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc---CCCeEEeecCCccCCCCCCcccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA---NCDLKICDFGLARPTSENEFMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~---~~~~kL~dfg~~~~~~~~~~~~~   76 (249)
                      ||||+++|.+.  ..|++.+++.++.||+.||+|||++||+||||||+||+++.   .+.+||+|||+++..........
T Consensus        93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~  172 (335)
T d2ozaa1          93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT  172 (335)
T ss_dssp             SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCC
T ss_pred             CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCcccc
Confidence            68999999874  47999999999999999999999999999999999999985   46799999999987766666667


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.........                 
T Consensus       173 ~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-----------------  234 (335)
T d2ozaa1         173 PCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-----------------  234 (335)
T ss_dssp             CSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-----------------
T ss_pred             ccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-----------------
Confidence            8899999999988654 4889999999999999999999999766543333322221110000                 


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                        ..+    ...+..+|+++.+||++||+.||.+|||+.++++||||++-
T Consensus       235 --~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         235 --EFP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             --SCC----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             --CCC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence              000    01112478999999999999999999999999999999754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=271.78  Aligned_cols=167  Identities=27%  Similarity=0.481  Sum_probs=141.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC-CCeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN-CDLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      ++++.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.+ +.+||+|||.+...... ......||
T Consensus        94 ~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT  172 (273)
T d1xwsa_          94 VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGT  172 (273)
T ss_dssp             EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSC
T ss_pred             cchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc-cccccccC
Confidence            36889999988999999999999999999999999999999999999999855 78999999999765433 24457899


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQH  160 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (249)
                      +.|+|||.+.+...++.++||||+||++|+|++|..||...+      .+..  +                     .   
T Consensus       173 ~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~--~---------------------~---  220 (273)
T d1xwsa_         173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--G---------------------Q---  220 (273)
T ss_dssp             GGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--C---------------------C---
T ss_pred             CCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh--c---------------------c---
Confidence            999999999766656788999999999999999999996532      1111  0                     0   


Q ss_pred             CCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          161 PRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                           ..+...+|+++.+||++||+.||.+|||++|+++||||++.
T Consensus       221 -----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         221 -----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             -----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             -----cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                 11233688999999999999999999999999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-40  Score=271.30  Aligned_cols=177  Identities=26%  Similarity=0.449  Sum_probs=151.2

Q ss_pred             CccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccC--CCeEEeecCCccCCCCCCcccccc
Q 025683            2 DTDLYQIIRSNQ-SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNAN--CDLKICDFGLARPTSENEFMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~--~~~kL~dfg~~~~~~~~~~~~~~~   78 (249)
                      ||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+||+++.+  ..++|+|||.+.............
T Consensus        85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~  164 (321)
T d1tkia_          85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF  164 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEE
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccc
Confidence            689999998765 79999999999999999999999999999999999999854  489999999998776655556678


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +++.|+|||...+. .++.++|||||||++|+|++|..||.+.+.......+.......+                    
T Consensus       165 ~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------  223 (321)
T d1tkia_         165 TAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD--------------------  223 (321)
T ss_dssp             SCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--------------------
T ss_pred             cccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------
Confidence            89999999988654 478999999999999999999999999887777776654221111                    


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                             ...++.+|+++.+||.+||..||.+|||++|+++||||++-
T Consensus       224 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         224 -------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                   12234678999999999999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-40  Score=262.15  Aligned_cols=174  Identities=23%  Similarity=0.330  Sum_probs=141.0

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC---Cccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN---EFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~---~~~~~~   77 (249)
                      ||+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......   ......
T Consensus        87 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  166 (276)
T d1uwha_          87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL  166 (276)
T ss_dssp             EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------C
T ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccccccc
Confidence            68999999765 67999999999999999999999999999999999999999999999999999765432   223446


Q ss_pred             cccccccCchhccCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           78 VVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      .||+.|+|||++...  ..++.++|||||||++|||++|+.||.+.................+                 
T Consensus       167 ~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p-----------------  229 (276)
T d1uwha_         167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP-----------------  229 (276)
T ss_dssp             CCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC-----------------
T ss_pred             ccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-----------------
Confidence            789999999998643  3478899999999999999999999988776665555544322111                 


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                              ....+...+++++.+||.+||+.||.+|||+.+++++
T Consensus       230 --------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 --------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                    1233445688999999999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=263.19  Aligned_cols=205  Identities=39%  Similarity=0.661  Sum_probs=162.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-FMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~   80 (249)
                      |++|..++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+....... ......++
T Consensus        85 ~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~  164 (292)
T d1unla_          85 QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT  164 (292)
T ss_dssp             EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSC
T ss_pred             ccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccc
Confidence            67888888888999999999999999999999999999999999999999999999999999998765443 23344567


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLF-PGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLPQ  159 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (249)
                      ..|+|||.+.....++.++||||+||++++|++|..|| .+.+.......+....+.+....+.......  ........
T Consensus       165 ~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  242 (292)
T d1unla_         165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP--DYKPYPMY  242 (292)
T ss_dssp             GGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST--TCCCCCCC
T ss_pred             cchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc--cccccccc
Confidence            88999999877766899999999999999999999875 5566677777787777776654433221110  00001111


Q ss_pred             CCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          160 HPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      ............+++++.+||++||+.||.+|||++|+|+||||+++.+
T Consensus       243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence            1223344556678899999999999999999999999999999997643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-40  Score=267.52  Aligned_cols=202  Identities=35%  Similarity=0.608  Sum_probs=156.0

Q ss_pred             ccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC-----Ccccc
Q 025683            3 TDLYQII-RSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN-----EFMTE   76 (249)
Q Consensus         3 ~~L~~~l-~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~-----~~~~~   76 (249)
                      +.+.... .....+++..++.++.||+.||.|||++||+||||||+||+++.++.+|++|||++......     .....
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  180 (318)
T d3blha1         101 HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN  180 (318)
T ss_dssp             EEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCS
T ss_pred             CCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccc
Confidence            3444433 44578999999999999999999999999999999999999999999999999999754432     22234


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      ..||+.|+|||.+.+...++.++||||+||++|+|++|+.||.+.++......+....+.+...................
T Consensus       181 ~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T d3blha1         181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL  260 (318)
T ss_dssp             CCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------C
T ss_pred             eecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcc
Confidence            57899999999998776789999999999999999999999999999999999999988877665544433322222211


Q ss_pred             CCCCCCcchhhc--CCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccC
Q 025683          157 LPQHPRQSLAQV--FPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLAR  205 (249)
Q Consensus       157 ~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~  205 (249)
                      .... .......  ....++++++||.+||+.||.+|||++|+|+||||+.
T Consensus       261 ~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         261 VKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CSSC-CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             cccc-cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            1111 1111110  0123677899999999999999999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-39  Score=267.43  Aligned_cols=204  Identities=29%  Similarity=0.576  Sum_probs=150.6

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCC-CeEEeecCCccCCCCCCcccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANC-DLKICDFGLARPTSENEFMTEYVVT   80 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~   80 (249)
                      +++|.++   .+.+++..++.++.||+.||+|||++||+||||||+||+++.++ .++|+|||.+.............+|
T Consensus       116 ~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t  192 (328)
T d3bqca1         116 NTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS  192 (328)
T ss_dssp             SCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSC
T ss_pred             CCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccC
Confidence            4566554   35799999999999999999999999999999999999999766 5899999999877666666677889


Q ss_pred             ccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccchhh-HHHHHHhCC
Q 025683           81 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND-HVHQMRLLIELLGTPTDADLGFVRNED-AKRYIRQLP  158 (249)
Q Consensus        81 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  158 (249)
                      +.|+|||.+.+...++.++|+||+||++++|++|..||.... .......+...++.+............ ...+.....
T Consensus       193 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  272 (328)
T d3bqca1         193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG  272 (328)
T ss_dssp             GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCC
T ss_pred             ccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcc
Confidence            999999999877778999999999999999999999997654 455566666555432211110000000 000000111


Q ss_pred             CCCCcchhh-----cCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCcC
Q 025683          159 QHPRQSLAQ-----VFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLHD  208 (249)
Q Consensus       159 ~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~~  208 (249)
                      .........     ....+++++++||++||++||.+|||++|+|+||||+.+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            111111111     22347889999999999999999999999999999998653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-39  Score=259.24  Aligned_cols=172  Identities=23%  Similarity=0.309  Sum_probs=141.2

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----cccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~~   77 (249)
                      ||+|.+++.+...+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.......    ....
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            689999999999999999999999999999999999999999999999999999999999999976543321    2234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .||+.|+|||.+... .++.++|||||||++|||++ |..||.+.+.......+...  ..                   
T Consensus       171 ~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~~-------------------  228 (277)
T d1xbba_         171 KWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ER-------------------  228 (277)
T ss_dssp             CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CC-------------------
T ss_pred             CCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--CC-------------------
Confidence            678999999998654 48899999999999999997 89999887765554444321  00                   


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHh---cCcccc
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEAL---AHPYLA  204 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll---~h~~~~  204 (249)
                               ...+..+++++.+||.+||+.||.+|||+++++   +|+|++
T Consensus       229 ---------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         229 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                     112335788999999999999999999999984   566654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-39  Score=261.99  Aligned_cols=169  Identities=27%  Similarity=0.366  Sum_probs=138.4

Q ss_pred             CccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeE
Q 025683            2 DTDLYQIIRSNQ-----------------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLK   58 (249)
Q Consensus         2 ~~~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~k   58 (249)
                      ||+|.++|.+..                       .+++..++.++.||+.||+|||++||+||||||+||+++.++.+|
T Consensus       125 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~K  204 (325)
T d1rjba_         125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK  204 (325)
T ss_dssp             TCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEE
T ss_pred             CCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEE
Confidence            789999997642                       489999999999999999999999999999999999999999999


Q ss_pred             EeecCCccCCCCCCc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 025683           59 ICDFGLARPTSENEF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELL  134 (249)
Q Consensus        59 L~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~  134 (249)
                      |+|||+++.......   .....+|+.|+|||.+.+. .++.++|||||||++|||++ |..||.+......+..+....
T Consensus       205 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~  283 (325)
T d1rjba_         205 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG  283 (325)
T ss_dssp             ECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT
T ss_pred             EeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence            999999976443322   2345679999999998654 48999999999999999997 899998766554444443311


Q ss_pred             CCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          135 GTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      ..                             ...+..+++++.+||.+||+.||.+|||+++|++|
T Consensus       284 ~~-----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         284 FK-----------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC-----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            10                             01233578899999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.8e-38  Score=253.07  Aligned_cols=168  Identities=22%  Similarity=0.286  Sum_probs=130.6

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCcc------
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFM------   74 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~------   74 (249)
                      ||+|.+++... +.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++........      
T Consensus       111 ~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  190 (299)
T d1jpaa_         111 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA  190 (299)
T ss_dssp             TEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred             CCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeec
Confidence            68999999885 57999999999999999999999999999999999999999999999999999865433211      


Q ss_pred             ccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHH
Q 025683           75 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRY  153 (249)
Q Consensus        75 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (249)
                      ....+|+.|+|||.+... .++.++|||||||++|||++ |..||.+.........+......                 
T Consensus       191 ~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-----------------  252 (299)
T d1jpaa_         191 LGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-----------------  252 (299)
T ss_dssp             -----CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----------------
T ss_pred             ccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence            123568899999998654 48899999999999999997 89999888766655554421111                 


Q ss_pred             HHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          154 IRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                   ..+..+++++.+|+.+||+.||.+|||+.+++++
T Consensus       253 -------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         253 -------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                         1123577889999999999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-38  Score=254.60  Aligned_cols=172  Identities=20%  Similarity=0.292  Sum_probs=142.4

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~   76 (249)
                      ||+|.+++.+. +.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.......    ...
T Consensus        92 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  171 (285)
T d1u59a_          92 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  171 (285)
T ss_dssp             TEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccc
Confidence            68999998764 6799999999999999999999999999999999999999999999999999986554322    223


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..+|+.|+|||.+... .++.++|||||||++|||++ |..||.+.........+.....                    
T Consensus       172 ~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~--------------------  230 (285)
T d1u59a_         172 GKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------------------  230 (285)
T ss_dssp             SCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--------------------
T ss_pred             cccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            4678899999998654 48899999999999999997 8999988776655544432110                    


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHH---hcCcccc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEA---LAHPYLA  204 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~l---l~h~~~~  204 (249)
                                ...++.+++++.+||.+||+.||.+|||+.++   |+|+|++
T Consensus       231 ----------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         231 ----------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                      12234678999999999999999999999888   5678775

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-38  Score=258.07  Aligned_cols=179  Identities=24%  Similarity=0.438  Sum_probs=146.0

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC--Cccccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN--EFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~--~~~~~~~~   79 (249)
                      ||+|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||.+......  .......+
T Consensus       113 ~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g  192 (322)
T d1vzoa_         113 GGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG  192 (322)
T ss_dssp             SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGS
T ss_pred             ccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccccccccccccc
Confidence            7899999999999999999999999999999999999999999999999999999999999998765433  22344678


Q ss_pred             cccccCchhccCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      ++.|++||.+.... +++.++|||||||++|+|++|..||.+.........+.....                   ... 
T Consensus       193 ~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~-------------------~~~-  252 (322)
T d1vzoa_         193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-------------------KSE-  252 (322)
T ss_dssp             CCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-------------------HCC-
T ss_pred             ccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-------------------cCC-
Confidence            99999999986543 468899999999999999999999977654333333322110                   000 


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccCCc
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-----TVDEALAHPYLARLH  207 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~~ll~h~~~~~~~  207 (249)
                             ..++..+++++.+||.+||+.||.+||     |++|+++||||+...
T Consensus       253 -------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         253 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             -------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence                   112335789999999999999999999     589999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-38  Score=254.40  Aligned_cols=169  Identities=27%  Similarity=0.407  Sum_probs=131.5

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      ||+|.++|...                ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus       102 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla  181 (299)
T d1ywna1         102 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA  181 (299)
T ss_dssp             TCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC----
T ss_pred             CCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcch
Confidence            68999999764                34899999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      +......   ......||+.|+|||.+.+. .++.++|||||||++|||++| ..||.+................     
T Consensus       182 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~-----  255 (299)
T d1ywna1         182 RDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-----  255 (299)
T ss_dssp             --CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-----
T ss_pred             hhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-----
Confidence            7654332   23345789999999999754 489999999999999999986 5678766544433333321111     


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                              ...+..+++++.++|.+||+.||.+|||++++++|
T Consensus       256 ------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         256 ------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                    11233578899999999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-37  Score=247.39  Aligned_cols=168  Identities=20%  Similarity=0.317  Sum_probs=128.8

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--ccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~   78 (249)
                      +|+|.+++.+. ..++++.+..++.||+.||+|||+++++||||||+||+++.++.+||+|||+++.......  .....
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  163 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  163 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence            68999998775 6789999999999999999999999999999999999999999999999999976544322  22356


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      ||..|+|||.+.+. .++.++|||||||++|||++ |.+||...........+......                     
T Consensus       164 gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---------------------  221 (263)
T d1sm2a_         164 FPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------------------  221 (263)
T ss_dssp             -CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC---------------------
T ss_pred             cCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC---------------------
Confidence            78999999998655 48999999999999999998 56666666655555544331111                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                               ..+...++++.+|+.+||+.||.+|||++++++|
T Consensus       222 ---------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 ---------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                     1122467889999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-38  Score=252.58  Aligned_cols=173  Identities=24%  Similarity=0.335  Sum_probs=139.7

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~   77 (249)
                      +|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~  170 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA  170 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence            68999987654  369999999999999999999999999999999999999999999999999998765433  22345


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .+++.|+|||.+... .++.++|||||||++|||++|. +||...........+.....                     
T Consensus       171 ~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~---------------------  228 (272)
T d1qpca_         171 KFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------------------  228 (272)
T ss_dssp             CCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------------------
T ss_pred             CCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------------------
Confidence            678899999998654 4889999999999999999955 55555554444444332110                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc--CccccC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA--HPYLAR  205 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~--h~~~~~  205 (249)
                               ...+..+++++.+|+.+||+.||.+|||++++++  ++||++
T Consensus       229 ---------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         229 ---------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                     0122357889999999999999999999999998  788864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-37  Score=247.70  Aligned_cols=173  Identities=22%  Similarity=0.297  Sum_probs=137.4

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--cccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~   77 (249)
                      +|+|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  ....
T Consensus        97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~  176 (287)
T d1opja_          97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  176 (287)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTE
T ss_pred             CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccc
Confidence            68999999764  6799999999999999999999999999999999999999999999999999987654322  2234


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .++..|+|||.+.... ++.++|||||||++|+|++|..||....+......+.....                      
T Consensus       177 ~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~----------------------  233 (287)
T d1opja_         177 KFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------------------  233 (287)
T ss_dssp             EECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------------------
T ss_pred             cccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC----------------------
Confidence            5788999999987554 89999999999999999997666554444333333322100                      


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARL  206 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~  206 (249)
                             ....+..+++++.+||.+||+.||.+|||++++++  +|+.+
T Consensus       234 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         234 -------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             -------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                   01223467899999999999999999999999965  44443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-37  Score=250.16  Aligned_cols=174  Identities=22%  Similarity=0.372  Sum_probs=136.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC----Cccccc
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN----EFMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~----~~~~~~   77 (249)
                      |++|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++++|||.+......    ......
T Consensus        95 g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  174 (277)
T d1o6ya_          95 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV  174 (277)
T ss_dssp             EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC------------
T ss_pred             CCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccc
Confidence            6899999999999999999999999999999999999999999999999999999999999987654332    223346


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      .||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+......                     
T Consensus       175 ~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~---------------------  232 (277)
T d1o6ya_         175 IGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI---------------------  232 (277)
T ss_dssp             ----TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC---------------------
T ss_pred             cCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC---------------------
Confidence            789999999998654 4889999999999999999999999988766655554431111                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCC-CHHHHhcCcccc
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRI-TVDEALAHPYLA  204 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-t~~~ll~h~~~~  204 (249)
                            ......+.+|+++.+||.+||+.||.+|| |+++++ |+|.+
T Consensus       233 ------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~r  273 (277)
T d1o6ya_         233 ------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR-ADLVR  273 (277)
T ss_dssp             ------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHHHH
T ss_pred             ------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHHHH
Confidence                  11223446889999999999999999999 566654 56553

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-37  Score=242.25  Aligned_cols=168  Identities=18%  Similarity=0.291  Sum_probs=140.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc--ccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF--MTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~   78 (249)
                      +|+|.+++... ..+++..+.+++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......  .....
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  162 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK  162 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence            57899997664 6799999999999999999999999999999999999999999999999999976544332  22356


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +|..|+|||.+.... ++.++|||||||++|||++ |..||.+.+.......+......                     
T Consensus       163 ~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---------------------  220 (258)
T d1k2pa_         163 FPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---------------------  220 (258)
T ss_dssp             CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---------------------
T ss_pred             CCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---------------------
Confidence            789999999987554 8899999999999999997 89999988876666555432111                     


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                               ..+...++++.+||.+||+.||.+|||++++++|
T Consensus       221 ---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 ---------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                     1122467889999999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-37  Score=245.05  Aligned_cols=174  Identities=25%  Similarity=0.375  Sum_probs=135.5

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--ccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEY   77 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~   77 (249)
                      ||+|..++...  +.+++.++..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++......  .....
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  174 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  174 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence            67888888653  679999999999999999999999999999999999999999999999999997654332  22335


Q ss_pred             cccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHh
Q 025683           78 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQ  156 (249)
Q Consensus        78 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (249)
                      .+|+.|+|||.+... .++.++|||||||++|||++|..| +...........+.....                     
T Consensus       175 ~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---------------------  232 (285)
T d1fmka3         175 KFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---------------------  232 (285)
T ss_dssp             -CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------------------
T ss_pred             cccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------------------
Confidence            678999999999755 488999999999999999996555 455554444444332111                     


Q ss_pred             CCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc--CccccCC
Q 025683          157 LPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA--HPYLARL  206 (249)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~--h~~~~~~  206 (249)
                               ...++.+++++.+||.+||+.||++|||+++|++  ++||++.
T Consensus       233 ---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         233 ---------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ---------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                     1123367889999999999999999999999988  7888764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-37  Score=245.73  Aligned_cols=168  Identities=24%  Similarity=0.361  Sum_probs=129.7

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC--cccccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE--FMTEYV   78 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~   78 (249)
                      ||+|.+++.+. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++......  ......
T Consensus        91 ~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~  170 (273)
T d1mp8a_          91 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK  170 (273)
T ss_dssp             TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------
T ss_pred             CCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceecccee
Confidence            68899987664 679999999999999999999999999999999999999999999999999997654332  223356


Q ss_pred             ccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhC
Q 025683           79 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQL  157 (249)
Q Consensus        79 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (249)
                      +|+.|+|||.+... .++.++|||||||++|||++ |..||...........+.....                      
T Consensus       171 gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~----------------------  227 (273)
T d1mp8a_         171 LPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----------------------  227 (273)
T ss_dssp             CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----------------------
T ss_pred             cCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence            78899999998654 48899999999999999987 8999988776555554432100                      


Q ss_pred             CCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          158 PQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                              ..+++.+++++.+||.+||+.||.+|||+.+|+++
T Consensus       228 --------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         228 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                    12344688999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-37  Score=249.28  Aligned_cols=169  Identities=23%  Similarity=0.282  Sum_probs=136.7

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc---ccc
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF---MTE   76 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~   76 (249)
                      .+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......   ...
T Consensus        93 ~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  172 (317)
T d1xkka_          93 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG  172 (317)
T ss_dssp             TTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC------
T ss_pred             cCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccc
Confidence            368888888775 6899999999999999999999999999999999999999999999999999986544322   223


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..||+.|+|||.+.+. .++.++|||||||++|||++ |..||.+.........+.....                    
T Consensus       173 ~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~--------------------  231 (317)
T d1xkka_         173 GKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--------------------  231 (317)
T ss_dssp             --CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC--------------------
T ss_pred             cccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            4678999999998755 48999999999999999998 7899987665444433332111                    


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                ...++.+++++.+|+.+||+.||.+|||+.++++|
T Consensus       232 ----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         232 ----------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                      01223577889999999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-36  Score=239.63  Aligned_cols=167  Identities=22%  Similarity=0.329  Sum_probs=127.1

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC----cccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE----FMTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~   76 (249)
                      +++|.+++.+. +.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......    ....
T Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  172 (283)
T d1mqba_          93 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG  172 (283)
T ss_dssp             TEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred             cCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEecc
Confidence            57788887765 679999999999999999999999999999999999999999999999999997654322    1223


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPL-FPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..||..|+|||.+... .++.++|||||||++|||+++..| +...........+.....                    
T Consensus       173 ~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--------------------  231 (283)
T d1mqba_         173 GKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR--------------------  231 (283)
T ss_dssp             -CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--------------------
T ss_pred             CCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC--------------------
Confidence            4678899999998654 588999999999999999986555 444444444333322110                    


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ...+...++++.+||.+||+.||.+|||+.++++
T Consensus       232 ----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         232 ----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                      0122346788999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-36  Score=241.34  Aligned_cols=167  Identities=27%  Similarity=0.397  Sum_probs=137.4

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      ||+|.++|...                ..+++.++.+++.||+.||+|||++|++||||||+|||++.++.+||+|||.+
T Consensus       103 ~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~  182 (299)
T d1fgka_         103 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA  182 (299)
T ss_dssp             TCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCC
T ss_pred             CCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhh
Confidence            68999999764                35899999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccc
Q 025683           66 RPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDAD  141 (249)
Q Consensus        66 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  141 (249)
                      .......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.........+...  ..    
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~--~~----  255 (299)
T d1fgka_         183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG--HR----  255 (299)
T ss_dssp             CCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--CC----
T ss_pred             ccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC--CC----
Confidence            7654332   23345778999999998754 48999999999999999997 78888877655444333211  00    


Q ss_pred             ccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          142 LGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                              ...+..+++++.+||.+||+.||.+|||+.+|++
T Consensus       256 ------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         256 ------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             ------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence                                    1123357899999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.1e-36  Score=242.24  Aligned_cols=167  Identities=22%  Similarity=0.303  Sum_probs=135.0

Q ss_pred             CccHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCe
Q 025683            2 DTDLYQIIRSNQ------------------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDL   57 (249)
Q Consensus         2 ~~~L~~~l~~~~------------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~   57 (249)
                      +|+|.++|....                        .+++..+..++.||+.||+|||+++++||||||+||+++.++.+
T Consensus       100 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~  179 (301)
T d1lufa_         100 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV  179 (301)
T ss_dssp             TCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             CCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcE
Confidence            688999997532                        48999999999999999999999999999999999999999999


Q ss_pred             EEeecCCccCCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHH
Q 025683           58 KICDFGLARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLIEL  133 (249)
Q Consensus        58 kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~  133 (249)
                      ||+|||+++......   ......+++.|+|||.+... .++.++|||||||++|||++|. .||.+.+.......+...
T Consensus       180 Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~  258 (301)
T d1lufa_         180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG  258 (301)
T ss_dssp             EECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred             EEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence            999999987543321   22245678899999998754 4889999999999999999985 678777766655554321


Q ss_pred             hCCCCcccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          134 LGTPTDADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                      .                              ...++..+++++.+||.+||+.||.+|||+.+|++
T Consensus       259 ~------------------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         259 N------------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             C------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C------------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            1                              11223467889999999999999999999999964

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-36  Score=239.79  Aligned_cols=168  Identities=22%  Similarity=0.262  Sum_probs=136.5

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc----ccc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF----MTE   76 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~----~~~   76 (249)
                      +|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........    ...
T Consensus        94 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~  173 (273)
T d1u46a_          94 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH  173 (273)
T ss_dssp             TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC---
T ss_pred             CcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCc
Confidence            57888877664 5799999999999999999999999999999999999999999999999999987644322    223


Q ss_pred             ccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHH
Q 025683           77 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIR  155 (249)
Q Consensus        77 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (249)
                      ..++..|+|||.+.+. .++.++|||||||++|||++ |..||.+.+.......+......                   
T Consensus       174 ~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~-------------------  233 (273)
T d1u46a_         174 RKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-------------------  233 (273)
T ss_dssp             --CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-------------------
T ss_pred             cccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC-------------------
Confidence            4567789999999754 48899999999999999997 89999988777666555431100                   


Q ss_pred             hCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          156 QLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                ...+..+++++.+||.+||+.||.+|||+.+|++
T Consensus       234 ----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         234 ----------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                      1123467889999999999999999999999863

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-36  Score=243.81  Aligned_cols=168  Identities=26%  Similarity=0.329  Sum_probs=137.8

Q ss_pred             CccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683            2 DTDLYQIIRSN----------------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus         2 ~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      ||+|.++|.+.                ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a  174 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  174 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccc
Confidence            68999999764                57999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCcccccc
Q 025683           66 RPTSENEFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRR-PLFPGNDHVHQMRLLIELLGTPTDADLGF  144 (249)
Q Consensus        66 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (249)
                      +............+|..|+|||.+... .++.++|||||||++|||++|. +||.+.+.......+....          
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~----------  243 (309)
T d1fvra_         175 RGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----------  243 (309)
T ss_dssp             ESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC----------
T ss_pred             ccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC----------
Confidence            866555444456789999999999755 4889999999999999999965 5677766555444432210          


Q ss_pred             cchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          145 VRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                          ....+..+++++.+||.+||+.||++|||+++++++
T Consensus       244 --------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         244 --------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             --------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                012234678999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-36  Score=236.51  Aligned_cols=166  Identities=20%  Similarity=0.324  Sum_probs=130.5

Q ss_pred             CccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccc
Q 025683            2 DTDLYQIIRSN--QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVV   79 (249)
Q Consensus         2 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~   79 (249)
                      ||+|.++|.+.  ..+++..+++++.||+.||+|||+.+++||||||+||+++.++.+||+|||.++.....  .....+
T Consensus        85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~  162 (262)
T d1byga_          85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKL  162 (262)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------C
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--Cccccc
Confidence            78999999764  35999999999999999999999999999999999999999999999999999765433  234567


Q ss_pred             cccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           80 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        80 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      +..|+|||.+.+. .++.++|||||||++|||++ |.+||...........+...                         
T Consensus       163 ~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-------------------------  216 (262)
T d1byga_         163 PVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-------------------------  216 (262)
T ss_dssp             CTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------------------------
T ss_pred             cccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------------------------
Confidence            8899999998755 48999999999999999998 68888766544443333210                         


Q ss_pred             CCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          159 QHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                           ...+++...++++.+||.+||+.||.+|||+.+++++
T Consensus       217 -----~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         217 -----YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                 0112344678999999999999999999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.6e-35  Score=236.37  Aligned_cols=181  Identities=17%  Similarity=0.194  Sum_probs=137.2

Q ss_pred             CCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeec---cCCCeEEeecCCccCCCCCC----
Q 025683            1 MDTDLYQIIRS-NQSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLN---ANCDLKICDFGLARPTSENE----   72 (249)
Q Consensus         1 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~---~~~~~kL~dfg~~~~~~~~~----   72 (249)
                      +|++|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+||+++   .+..++|+|||.++......    
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence            57888887765 46899999999999999999999999999999999999875   35579999999998654321    


Q ss_pred             ----ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccchh
Q 025683           73 ----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLGFVRNE  148 (249)
Q Consensus        73 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (249)
                          ......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||...........+......            
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~------------  231 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK------------  231 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH------------
T ss_pred             eeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc------------
Confidence                123457899999999987554 899999999999999999999999876544333332211000            


Q ss_pred             hHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHH---HhcCccccC
Q 025683          149 DAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDE---ALAHPYLAR  205 (249)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~---ll~h~~~~~  205 (249)
                                 ...........++|+++.+|+.+||+.||.+||++.+   +|+|+|.+.
T Consensus       232 -----------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         232 -----------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             -----------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             -----------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                       0001123345578899999999999999999999874   467776653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-34  Score=235.10  Aligned_cols=173  Identities=21%  Similarity=0.360  Sum_probs=140.5

Q ss_pred             CccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCC
Q 025683            2 DTDLYQIIRSN----------QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSEN   71 (249)
Q Consensus         2 ~~~L~~~l~~~----------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~   71 (249)
                      +|+|.+++...          ..+++..+.+++.|++.||.|||+++++||||||+|||++.++.+||+|||+++.....
T Consensus       107 ~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~  186 (308)
T d1p4oa_         107 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET  186 (308)
T ss_dssp             TCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred             CCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCC
Confidence            68999998653          34789999999999999999999999999999999999999999999999998765433


Q ss_pred             Cc---cccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCcccccccch
Q 025683           72 EF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNR-RPLFPGNDHVHQMRLLIELLGTPTDADLGFVRN  147 (249)
Q Consensus        72 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (249)
                      ..   .....+++.|+|||.+.+.. ++.++|+||||+++|||++| ..||.+.+.......+.....            
T Consensus       187 ~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~------------  253 (308)
T d1p4oa_         187 DYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL------------  253 (308)
T ss_dssp             GCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC------------
T ss_pred             cceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC------------
Confidence            22   23346789999999987554 78899999999999999997 577877776665555432110            


Q ss_pred             hhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc------CccccC
Q 025683          148 EDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA------HPYLAR  205 (249)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~------h~~~~~  205 (249)
                                        ...+..+++.+.++|.+||+.||.+|||+++|++      +|+|++
T Consensus       254 ------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         254 ------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             ------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence                              1123357789999999999999999999999997      566654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-34  Score=233.56  Aligned_cols=168  Identities=30%  Similarity=0.443  Sum_probs=136.3

Q ss_pred             CccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecC
Q 025683            2 DTDLYQIIRSNQ------------------SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFG   63 (249)
Q Consensus         2 ~~~L~~~l~~~~------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg   63 (249)
                      ||+|.+++.+..                  .+++..+..++.||+.||+|||++|++||||||+||+++.++.++++|||
T Consensus       111 ~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG  190 (311)
T d1t46a_         111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG  190 (311)
T ss_dssp             TEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCG
T ss_pred             CCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccc
Confidence            689999997643                  69999999999999999999999999999999999999999999999999


Q ss_pred             CccCCCCCC---ccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 025683           64 LARPTSENE---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMN-RRPLFPGNDHVHQMRLLIELLGTPTD  139 (249)
Q Consensus        64 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  139 (249)
                      .++......   ......+|+.|+|||.+... .++.++|||||||++|+|++ |.+||...........+...-..+  
T Consensus       191 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~--  267 (311)
T d1t46a_         191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM--  267 (311)
T ss_dssp             GGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC--
T ss_pred             hheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--
Confidence            998765432   22345779999999998654 48999999999999999998 666676665544444443321110  


Q ss_pred             ccccccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          140 ADLGFVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                                 ..+...++.+.+||.+||+.||.+|||++++++
T Consensus       268 ---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         268 ---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             ---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                       112246788999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-34  Score=239.99  Aligned_cols=191  Identities=28%  Similarity=0.434  Sum_probs=139.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCCeeeccCCC------eEEeecCCccCCCCCCcccccccccccc
Q 025683           12 NQSLSEEHCQYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLLNANCD------LKICDFGLARPTSENEFMTEYVVTRWYR   84 (249)
Q Consensus        12 ~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~nil~~~~~~------~kL~dfg~~~~~~~~~~~~~~~~~~~y~   84 (249)
                      ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++.      ++++|||.+.....  ......+|+.|+
T Consensus       119 ~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~  196 (362)
T d1q8ya_         119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYR  196 (362)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGC
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--cccccccccccc
Confidence            4689999999999999999999997 89999999999999987654      89999999875433  234567899999


Q ss_pred             CchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCcccccccchhhHHHHHHhCC
Q 025683           85 APELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGND------HVHQMRLLIELLGTPTDADLGFVRNEDAKRYIRQLP  158 (249)
Q Consensus        85 aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (249)
                      |||.+.... ++.++|+||+||++++|++|..||....      ...........++..+.........  ...+.....
T Consensus       197 aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~--~~~~~~~~~  273 (362)
T d1q8ya_         197 SPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY--TRTFFNSRG  273 (362)
T ss_dssp             CHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTT--HHHHBCC--
T ss_pred             ChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccc--cccccccch
Confidence            999987654 7899999999999999999999996543      3456666677777765443221111  011111000


Q ss_pred             ------CCCCcc-------hhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcCccccCCc
Q 025683          159 ------QHPRQS-------LAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAHPYLARLH  207 (249)
Q Consensus       159 ------~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h~~~~~~~  207 (249)
                            ......       ........++++.+||.+||.+||.+|||++|+|+||||++..
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         274 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             hhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence                  000000       0011223467799999999999999999999999999999664

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-34  Score=232.10  Aligned_cols=168  Identities=25%  Similarity=0.344  Sum_probs=132.2

Q ss_pred             CccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCc-----cc
Q 025683            2 DTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEF-----MT   75 (249)
Q Consensus         2 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~-----~~   75 (249)
                      ||+|.+++... ..+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++.......     ..
T Consensus       113 ~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~  192 (311)
T d1r0pa_         113 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT  192 (311)
T ss_dssp             TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTT
T ss_pred             cCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecc
Confidence            68999999865 5688999999999999999999999999999999999999999999999999986543321     22


Q ss_pred             cccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccchhhHHHHH
Q 025683           76 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV-HQMRLLIELLGTPTDADLGFVRNEDAKRYI  154 (249)
Q Consensus        76 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (249)
                      ...+|..|+|||.+... .++.++||||||+++|||++|..||...... .....+..  +..                 
T Consensus       193 ~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~~-----------------  252 (311)
T d1r0pa_         193 GAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GRR-----------------  252 (311)
T ss_dssp             CSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TCC-----------------
T ss_pred             cccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CCC-----------------
Confidence            34678899999998654 4899999999999999999987776544322 22222111  000                 


Q ss_pred             HhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          155 RQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                                 ...+...++++.+||.+||+.||.+|||+.|++++
T Consensus       253 -----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         253 -----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                       01223567889999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.2e-33  Score=226.59  Aligned_cols=172  Identities=15%  Similarity=0.179  Sum_probs=136.1

Q ss_pred             CCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeecc-----CCCeEEeecCCccCCCCC---
Q 025683            1 MDTDLYQIIRSN-QSLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNA-----NCDLKICDFGLARPTSEN---   71 (249)
Q Consensus         1 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~-----~~~~kL~dfg~~~~~~~~---   71 (249)
                      +|++|.+++... ..++...+..++.|++.||+|||++||+||||||+||+++.     ++.++|+|||+++.....   
T Consensus        83 ~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (293)
T d1csna_          83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  162 (293)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             cCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence            589999999875 57999999999999999999999999999999999999974     578999999999764322   


Q ss_pred             -----CccccccccccccCchhccCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCccccc
Q 025683           72 -----EFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRRPLFPGNDHV---HQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        72 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  143 (249)
                           .......||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+....   .....+.....        
T Consensus       163 ~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~--------  233 (293)
T d1csna_         163 QHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--------  233 (293)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH--------
T ss_pred             cceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC--------
Confidence                 122345789999999999754 4899999999999999999999999765432   22222221100        


Q ss_pred             ccchhhHHHHHHhCCCCCCcchhhcCCCCChHHHHHHHHhcCCCCCCCCCHHHHhc
Q 025683          144 FVRNEDAKRYIRQLPQHPRQSLAQVFPHVHPLAIDLVDRMLTFDPMKRITVDEALA  199 (249)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~  199 (249)
                                        .....++...+|+++.+++..|++.+|.+||+.+.+.+
T Consensus       234 ------------------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         234 ------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             ------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ------------------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                              01123344568899999999999999999999877654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=227.86  Aligned_cols=186  Identities=20%  Similarity=0.250  Sum_probs=127.4

Q ss_pred             CccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh--------CCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCC-
Q 025683            2 DTDLYQIIRSNQSLSEEHCQYFLYQLLRGLKYIHS--------ANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENE-   72 (249)
Q Consensus         2 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~--------~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~-   72 (249)
                      +|+|.++|.+ ..+++..+.+++.|++.||+|||+        +||+||||||+||+++.++.+||+|||++....... 
T Consensus        85 ~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~  163 (303)
T d1vjya_          85 HGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD  163 (303)
T ss_dssp             TCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCc
Confidence            6899999987 469999999999999999999996        599999999999999999999999999987643322 


Q ss_pred             ----ccccccccccccCchhccCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 025683           73 ----FMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMELMNRRPLFPGNDHVHQMRLLIELLGTPTDADLG  143 (249)
Q Consensus        73 ----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (249)
                          ......||+.|+|||.+....     .++.++|||||||++|||++|..||.......          .+......
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~----------~~~~~~~~  233 (303)
T d1vjya_         164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----------LPYYDLVP  233 (303)
T ss_dssp             EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC----------CTTTTTSC
T ss_pred             ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc----------cchhhccc
Confidence                223467899999999986432     14568999999999999999988774322100          00000000


Q ss_pred             c-cchhhHHHHHHhCCCCCCcchhhc--CCCCChHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 025683          144 F-VRNEDAKRYIRQLPQHPRQSLAQV--FPHVHPLAIDLVDRMLTFDPMKRITVDEALAH  200 (249)
Q Consensus       144 ~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~~ll~h  200 (249)
                      . ............  ...+......  .......+.+|+.+||+.||.+|||+.||+++
T Consensus       234 ~~~~~~~~~~~~~~--~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         234 SDPSVEEMRKVVCE--QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTT--SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhc--cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0 000001111110  0111111110  11122458899999999999999999999763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.42  E-value=7.8e-15  Score=109.74  Aligned_cols=90  Identities=18%  Similarity=0.156  Sum_probs=61.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCCeeeccCCCeEEeecCCccCCCCCCccccccccccccCchhccCCC
Q 025683           14 SLSEEHCQYFLYQLLRGLKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPTSENEFMTEYVVTRWYRAPELLLNSS   93 (249)
Q Consensus        14 ~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~   93 (249)
                      .++...+..++.|++.++.|||++|++||||||+||+++.+ .++|+|||.+.....+............ -.+.+  ..
T Consensus        99 ~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~-~~~~f--~r  174 (191)
T d1zara2          99 RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRN-IITYF--SR  174 (191)
T ss_dssp             GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHH-HHHHH--HH
T ss_pred             chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHH-HHHHH--cC
Confidence            35667788999999999999999999999999999999865 4899999988665433211100000000 01112  12


Q ss_pred             CCCchhHHHHHHHH
Q 025683           94 DYTAAIDVWSVGCI  107 (249)
Q Consensus        94 ~~~~~~DiwslG~~  107 (249)
                      .++.++|+||+.--
T Consensus       175 ~y~~~~d~~s~~~~  188 (191)
T d1zara2         175 TYRTEKDINSAIDR  188 (191)
T ss_dssp             HHCCCCCHHHHHHH
T ss_pred             CCCCcccHHHHHHH
Confidence            36778899996543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.89  E-value=0.003  Score=49.01  Aligned_cols=30  Identities=33%  Similarity=0.357  Sum_probs=26.6

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .|++|||+.++||+++.+...-+.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988877899999763

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.32  E-value=0.024  Score=44.03  Aligned_cols=59  Identities=14%  Similarity=0.120  Sum_probs=34.8

Q ss_pred             HHHHHhCCCCCHHH---HHHHHHHHHHHHHHHh----hCCcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683            6 YQIIRSNQSLSEEH---CQYFLYQLLRGLKYIH----SANVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus         6 ~~~l~~~~~l~~~~---~~~i~~qil~~l~~LH----~~~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      ..++.....++.+.   ....+.+++..+.-+-    ..+++|||+.+.||+++. + ..++||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~  219 (325)
T d1zyla1         154 RKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDAR  219 (325)
T ss_dssp             HHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred             HHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence            34444444343332   3334444444443332    136899999999999974 3 4589998765

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=93.86  E-value=0.012  Score=44.05  Aligned_cols=29  Identities=24%  Similarity=0.274  Sum_probs=24.5

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecCCcc
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICDFGLAR   66 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~dfg~~~   66 (249)
                      .++|||+.+.||+++.++.+.|+||+.+.
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhcc
Confidence            38999999999999977666799998653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=92.97  E-value=0.014  Score=43.30  Aligned_cols=28  Identities=21%  Similarity=0.165  Sum_probs=24.4

Q ss_pred             CcccCCCCCCCeeeccCCCeEEeecCCc
Q 025683           38 NVIHRDLKPSNLLLNANCDLKICDFGLA   65 (249)
Q Consensus        38 ~i~H~dik~~nil~~~~~~~kL~dfg~~   65 (249)
                      .++|||+.+.||+++.+..+.|+||+.+
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~  203 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRL  203 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhc
Confidence            3899999999999998766789999865

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=91.45  E-value=0.039  Score=44.00  Aligned_cols=30  Identities=23%  Similarity=0.362  Sum_probs=25.2

Q ss_pred             CCcccCCCCCCCeeeccCCCeEEeecCCccC
Q 025683           37 ANVIHRDLKPSNLLLNANCDLKICDFGLARP   67 (249)
Q Consensus        37 ~~i~H~dik~~nil~~~~~~~kL~dfg~~~~   67 (249)
                      ..++|||+++.||+++.+ .++++||..+..
T Consensus       223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            359999999999999876 489999987643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=87.88  E-value=0.091  Score=41.73  Aligned_cols=15  Identities=40%  Similarity=0.638  Sum_probs=13.5

Q ss_pred             cccCCCCCCCeeecc
Q 025683           39 VIHRDLKPSNLLLNA   53 (249)
Q Consensus        39 i~H~dik~~nil~~~   53 (249)
                      ++|+|+.+.||++..
T Consensus       220 ~CHnDL~~~NiL~~~  234 (395)
T d1nw1a_         220 FCHNDLQEGNILLPK  234 (395)
T ss_dssp             EECSCCCGGGEEEEC
T ss_pred             EEecCCCcccEeecc
Confidence            789999999999854